[
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "Our patient is a 56-year-old male with ESRD secondary to biopsy-proven IgA nephropathy on hemodialysis since late 2016. He has known coronary artery disease with ischemic cardiomyopathy, and he underwent percutaneous coronary intervention to left anterior descending and right coronary arteries shortly after initiation of dialysis. He had an improvement in his cardiac ejection fraction, from 44% in 2016 to 52% on optimal medical therapy. He was initiated on losartan at 25 mg daily when diagnosed with ischemic cardiomyopathy, which was increased to the maximum tolerated dose of 100 mg daily about 12 months prior to this admission. He is a working professional, remains active, and compliant to his prescribed medications and treatments. Up to this point, he has been actively listed for a renal transplant. The patient had recently traveled to South Korea in early January 2020 and had returned to the United States by late January but before the surge of COVID-19 epidemic in Daegu, South Korea, was identified. He remained in good health without any notable symptoms until early March 2020. Five days prior to his admission, he presented to a local urgent care for evaluation of nausea, vomiting, abdominal cramps, and subjective fevers; notably, he had no respiratory complaints. He was diagnosed with viral gastroenteritis, given recommendations for symptom management and discharged home. That same evening, he presented to our emergency department with similar complaints. His laboratory tests, including electrolytes, liver function tests, lactic acid, and blood counts, were unremarkable. His chest X-ray at that time showed no significant focal consolidation, but mild patchy increased interstitial markings at the bilateral lung bases were noted and described as possible atelectasis. His nausea improved while in the emergency department, and his symptoms were again attributed to a viral gastroenteritis from some bad sushi he had reported eating a day prior. Following discharge from the emergency department, he went home and noted that he was feeling better except that he had developed some loose stools. Two days later, he attended his routine outpatient hemodialysis treatment, where he reported feeling better since discharge from the emergency department but continued to have intermittent loose stools approximately 2 times per day. He did not report cough or respiratory symptoms at that time. At the end of dialysis, he was noted to be febrile to 100.4F and blood cultures were sent which showed no bacterial growth. He was seen in Cardiology clinic later that morning after dialysis treatment for an elective appointment, where he was noted to be coughing in the waiting room and given strict precautions, given his intent to travel for essential reasons. The following day the patient traveled by commercial airline from Southern California to Utah where he presented to an emergency department for continued intermittent vomiting and fevers but was now reporting mild congestion and cough. A new chest X-ray at that time in Utah noted mild interstitial prominence and vague infiltrate in the right lung base. His influenza testing was reported negative, and he was prescribed azithromycin given the chest X-ray findings. The next day, he attended his scheduled hemodialysis as a transient visitor in a community dialysis facility in Utah where he reported fever and malaise but was eager to return to California given his acute sickness. He returned to Southern California that evening earlier than planned using commercial airline, because he was feeling quite ill with continued fevers and gastrointestinal symptoms. Furthermore, his respiratory symptoms, which were initially minimal, had progressed rapidly and he was becoming more short-of-breath. Shortly after returning to Southern California, he presented to our emergency department for further reevaluation. In the ED, a repeat chest X-ray demonstrated subtle patchy opacities in both lungs, new from prior X-ray 5 days ago. A CT of the chest revealed multifocal bilateral patchy ground glass opacities predominantly with peripheral distribution concerning for atypical pneumonia and possibly viral infection. COVID-19 testing was performed, the result of which was expected 48 h later, along with standard chemistry and hematology labs, which again revealed no abnormalities with the exception of an elevated procalcitonin level. An evaluation for other causes of atypical pneumonia was simultaneously sent, without additional findings thus far. Imaging demonstrating progression of interstitial pneumonitis due to COVID-19 resulting in ARDS. Chest X-ray sequence with interval increasing patchy opacities in both lungs consistent with evolving infectious process. Chest CT showing new multifocal bilateral patchy groundglass opacities with a predominantly peripheral distribution. There is mild bibasal septal and centrilobular thickening. No evidence of pleural effusion or pneumothorax. There are small biapical subpleural blebs and mild centrilobular pulmonary emphysema in the upper lobes. No evidence of atelectasis. These findings are more consistent with atypical pneumonia which may be secondary to viral infection. Differential considerations include pulmonary edema. He was admitted to the hospital on droplet  eye precautions. Initially, he was noted to have a temperature of 100.6F, but with otherwise normal vital signs. He was initiated on antimicrobial therapy with ceftriaxone and azithromycin. Over the next 24 h, he was febrile to 101F and respiratory status rapidly deteriorated. His repeat chest X-rays demonstrated evolution of the bilateral multifocal opacities consistent with the atypical pneumonia, and there was concern for superimposed pulmonary edema. He underwent dialysis the evening of hospital day 2; he tolerated the treatment poorly, developing new atrial fibrillation with rapid ventricular rate despite only minimal ultrafiltration. His respiratory condition continued to rapidly decline during the night, and he had to be intubated and transferred to the intensive care unit (ICU) for acute hypoxic respiratory failure and shock. His pulmonary condition continued to deteriorate to acute respiratory distress syndrome (ARDS) requiring continued mechanical ventilation with high PEEP >10 cm and FiO2 >60% as well as pressor support. In an effort to maintain close control of his volume status and metabolic parameters, we have initiated him on continuous veno-venous hemodiafiltration. In the setting of ESRD, he has been deemed not a candidate for remdesivir compassionate use trial and was started on hydroxychloroquine and on hospital day 6 he was started on tocilizumab given continued hemodynamic instability with elevated inflammatory markers including interleukin (IL)-6. With the inability to rule out superimposed infection he has also been on broad-spectrum antibiotic coverage with vancomycin and piperacillin-tazobactom since hospital day 6. His clinical course is being followed closely by a multispecialist team, and depending on his trajectory, he may require paralysis as well as more aggressive pulmonary and hemodynamic support with proning and extracorporeal membrane oxygenation. At the current time, his vasopressor requirement remains variable, as does his PaO2/FiO2 ratio, while he remains in critical condition for the past 5 days.",
        "es": "Nuestro paciente es un hombre de 56 a\u00f1os con insuficiencia renal terminal secundaria a nefropat\u00eda por IgA, confirmada mediante biopsia, en hemodi\u00e1lisis desde finales de 2016. Padece arteriopat\u00eda coronaria con cardiomiopat\u00eda isqu\u00e9mica y se someti\u00f3 a una intervenci\u00f3n coronaria percut\u00e1nea en las arterias coronaria derecha e interventricular anterior poco despu\u00e9s del inicio de la di\u00e1lisis. Present\u00f3 una mejora de su fracci\u00f3n de expulsi\u00f3n cardiaca, del 44% en 2016 al 52% bajo terapia m\u00e9dica \u00f3ptima. Inici\u00f3 un tratamiento con losart\u00e1n de 25 mg al d\u00eda cuando se le diagnostic\u00f3 la cardiomiopat\u00eda isqu\u00e9mica, que luego se aument\u00f3 a la dosis m\u00e1xima tolerada de 100 mg al d\u00eda unos 12 meses antes de este ingreso. El paciente es un profesional en activo y cumple con la medicaci\u00f3n y los tratamientos recetados. Hasta este momento, estaba incluido en las listas para trasplante renal. El paciente hab\u00eda viajado recientemente a Corea del Sur a principios de enero de 2020 y hab\u00eda regresado a los Estados Unidos a finales de enero, pero antes de que se identificara el brote de COVID-19 en Daegu (Corea del Sur). Hasta principios de marzo de 2020 se hallaba en buen estado de salud, sin s\u00edntomas relevantes. Cinco d\u00edas antes de su ingreso, acudi\u00f3 a un ambulatorio de urgencias aquejado de n\u00e1useas, v\u00f3mitos, c\u00f3licos intestinales y s\u00edntomas de fiebre; cabe destacar que no report\u00f3 molestias respiratorias. Se le diagnostic\u00f3 gastroenteritis v\u00edrica, se le dieron recomendaciones para la gesti\u00f3n de los s\u00edntomas y fue dado de alta. Esa misma tarde acudi\u00f3 a nuestro servicio de urgencias con los mismos s\u00edntomas. Presentaba febr\u00edcula de 37,8 \u00b0C y sus pruebas anal\u00edticas, incluyendo electr\u00f3litos, pruebas funcionales hep\u00e1ticas, \u00e1cido l\u00e1ctico y hemograma, no dieron resultados a destacar. Su radiograf\u00eda tor\u00e1cica en ese momento no mostr\u00f3 consolidaciones focales significativas, pero se observaron leves tramas intersticiales parcheadas en las bases pulmonares bilaterales, indicativas de posible atelectasia. Sus n\u00e1useas remitieron mientras estaba en urgencias y sus s\u00edntomas se atribuyeron nuevamente a una gastroenteritis v\u00edrica causada por un \"sushi en mal estado\" que hab\u00eda comido el d\u00eda anterior. Tras el alta de urgencias, se dirigi\u00f3 a su casa e indic\u00f3 que se encontraba mejor, excepto por una leve diarrea. Dos d\u00edas despu\u00e9s acudi\u00f3 a su tratamiento ambulatorio habitual de hemodi\u00e1lisis, donde inform\u00f3 encontrarse mejor desde el alta en urgencias, pero segu\u00eda teniendo diarrea intermitente, unas dos veces al d\u00eda. En ese momento no report\u00f3 tos ni s\u00edntomas respiratorios. Al finalizar la di\u00e1lisis, tuvo fiebre de 38 \u00b0C y se hicieron hemocultivos que no mostraron crecimiento bacteriano. Esa misma ma\u00f1ana, tras la di\u00e1lisis, acudi\u00f3 al consultorio de cardiolog\u00eda para una cita programada, en la cual se le observ\u00f3 tos en la sala de espera y se le dieron estrictas recomendaciones de precauci\u00f3n teniendo en cuenta su prop\u00f3sito de viajar por razones esenciales. Al siguiente d\u00eda, el paciente viaj\u00f3 en una aerol\u00ednea comercial. del sur de California a Utah, donde acudi\u00f3 a un servicio de urgencias con v\u00f3mitos intermitentes repetidos y fiebre, pero ahora tambi\u00e9n report\u00f3 congesti\u00f3n leve y tos. Una nueva radiograf\u00eda tor\u00e1cica apreci\u00f3 \"prominencias intersticiales leves e infiltrados vagos en la base del pulm\u00f3n derecho\". Sus pruebas para gripe fueron negativas y se le recet\u00f3 azitromicina, a partir de los resultados radiol\u00f3gicos. Al d\u00eda siguiente asisti\u00f3 a su sesi\u00f3n programada de hemodi\u00e1lisis como visitante pasajero en un centro de di\u00e1lisis local de Utah, donde inform\u00f3 de fiebre y malestar general, pero estaba ansioso por regresar a California debido a su estado. Volvi\u00f3 al sur de California esa misma tarde en una aerol\u00ednea comercial, antes de lo previsto, porque se sent\u00eda bastante enfermo, con fiebre continua y s\u00edntomas gastrointestinales. Adem\u00e1s, sus s\u00edntomas respiratorios, que inicialmente eran m\u00ednimos, hab\u00edan progresado r\u00e1pidamente y su disnea aumentaba. Poco despu\u00e9s del regreso al sur de California, acudi\u00f3 a nuestro servicio de urgencias para una reevaluaci\u00f3n. En urgencias, una nueva radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades parcheadas sutiles en ambos pulmones, de nueva aparici\u00f3n respecto a las im\u00e1genes de 5 d\u00edas antes. Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado parcheadas, multifocales y bilaterales, predominantemente con distribuci\u00f3n perif\u00e9rica, lo que hizo sospechar de neumon\u00eda at\u00edpica y posible infecci\u00f3n v\u00edrica. Se realiz\u00f3 una prueba de COVID-19, cuyo resultado tardar\u00eda 48 horas, junto con las pruebas bioqu\u00edmicas y hematol\u00f3gicas habituales, que no revelaron ninguna anomal\u00eda, a excepci\u00f3n de un alto valor de procalcitonina. Se envi\u00f3 simult\u00e1neamente una evaluaci\u00f3n de otras causas de neumon\u00eda at\u00edpica, sin resultados adicionales hasta la fecha. Las im\u00e1genes mostraron una evoluci\u00f3n de la neumonitis intersticial debido a la COVID-19, con consiguiente SDRA. La secuencia de radiograf\u00edas tor\u00e1cicas con opacidades parcheadas crecientes en ambos pulmones es coherente con la evoluci\u00f3n del proceso infeccioso. Una TAC tor\u00e1cica mostr\u00f3 nuevas opacidades de vidrio esmerilado parcheadas, multifocales y bilaterales con distribuci\u00f3n b\u00e1sicamente perif\u00e9rica. Se apreciaba un engrosamiento centrilobular y septal bibasal. No se apreci\u00f3 derrame pleural ni neumot\u00f3rax. Se observaron peque\u00f1as bullas subpleurales biapicales y enfisema pulmonar leve en los l\u00f3bulos superiores. No hubo evidencia de atelectasia. Estos resultados son m\u00e1s coherentes con neumon\u00eda at\u00edpica, que puede ser secundaria a una sobreinfecci\u00f3n. En el diagn\u00f3stico diferencial se incluye edema pulmonar. El paciente fue ingresado en el hospital teniendo en cuenta precauciones para got\u00edculas y ojos. Inicialmente, se le observ\u00f3 una temperatura de 38,1 \u00b0C, pero, por lo dem\u00e1s, con constantes vitales normales. Se inici\u00f3 una terapia antimicrobiana con ceftriaxona y azitromicina. Durante las siguientes 24 h continu\u00f3 febril, con una temperatura de hasta 38,3 \u00b0C, y un deterioro r\u00e1pido de su estado respiratorio. Radiograf\u00edas tor\u00e1cicas repetidas mostraron evoluci\u00f3n de las opacidades multifocales bilaterales coherentes con neumon\u00eda at\u00edpica y se sospech\u00f3 de un posible edema pulmonar. Se someti\u00f3 a di\u00e1lisis la tarde del segundo d\u00eda de hospitalizaci\u00f3n, pero toler\u00f3 mal el tratamiento, sufriendo fibrilaci\u00f3n auricular con alta frecuencia ventricular, a pesar de m\u00ednima ultrafiltraci\u00f3n. Su cuadro respiratorio empeor\u00f3 r\u00e1pidamente durante la noche y tuvo que ser intubado y trasladado a la unidad de cuidados intensivos (UCI) con insuficiencia respiratoria aguda hip\u00f3xica y choque. Su estado pulmonar sigui\u00f3 empeorando a s\u00edndrome de dificultad respiratoria aguda (SDRA) y el paciente necesit\u00f3 ventilaci\u00f3n mec\u00e1nica con alta presi\u00f3n positiva telespiratoria (PEEP > 10 cm y FiO2 > 60%), as\u00ed como vasopresores. Para mantener un control estrecho de su volemia y los par\u00e1metros metab\u00f3licos, se le aplic\u00f3 hemodiafiltraci\u00f3n venovenosa  continua. Teniendo en cuenta el SDRA, se consider\u00f3 que no era candidato para un ensayo de uso compasivo de remdesivir, de modo que se inici\u00f3 un tratamiento con hidroxicloroquina; el d\u00eda 6 de hospitalizaci\u00f3n se le administr\u00f3 tocilizumab teniendo en cuenta su inestabilidad hemodin\u00e1mica con altos valores de marcadores inflamatorios, incluyendo la interleucina (IL)-6. Con la imposibilidad de descartar una infecci\u00f3n sobrea\u00f1adida, tambi\u00e9n se le administr\u00f3 tratamiento antibi\u00f3tico de amplio espectro con vancomicina y piperacilina-tazobactam desde el d\u00eda 6 de hospitalizaci\u00f3n. Su evoluci\u00f3n est\u00e1 siendo seguida de cerca por un equipo multidisciplinar y, en funci\u00f3n de su desarrollo, puede requerir par\u00e1lisis as\u00ed como asistencia pulmonar y hemodin\u00e1mica m\u00e1s agresiva con oxigenaci\u00f3n por membrana extracorporal y posici\u00f3n en dec\u00fabito prono. En el momento actual, sus requerimientos de vasopresi\u00f3n siguen siendo variables, al igual que la proporci\u00f3n PaO2/FiO2; ha permanecido en estado cr\u00edtico durante los \u00faltimos 5 d\u00edas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A patient in his fifties without any past medical history consulted his general practitioner, in the Marseille area on March 6th, 2020, because of fever, headache and cough evolving since February 29th. He had been sent by his company (company X) to the Central Africa Republic (CAR) from February 13th to February 25th where he gave presentations (training in management) for 6 days, to a public of about 30 resource directors of several CAR ministries. Because of persistence of fever and cough at day 9-post onset, he was referred to the emergency unit of a local hospital on March 9th. On clinical examination he had fever (40C) and dyspnea with oxygen saturation at 91% in ambient air. Pulmonary auscultation revealed bilateral basal crackling sounds. Malaria was ruled-out by blood smear microscopic examination and influenza was ruled-out by PCR on nasal swab fluid. C-reactive protein was at 103 mg/L and white blood cell count was at 8.8 Giga/L. Naso-pharyngeal swab fluid was tested for SARS-CoV-2 by RT-PCR as previously described [1] and resulted positive. The patient was immediately transferred to our center (IHU Mditerrane Infection) for hospitalization in a highly contagious patient section. A Chest CT-scan showed bilateral interstitial pulmonary infiltrates (Figure 1). Progressive aggravation led to his temporary transfer to an intensive care unit for five days, before coming back to our ward where he is still hospitalized at the time of writing.",
        "es": "Un paciente de unos cincuenta a\u00f1os sin antecedentes personales acudi\u00f3 a su m\u00e9dico de cabecera en la zona de Marsella el 6 de marzo de 2020, reportando fiebre, cefalea y tos con una evoluci\u00f3n desde el 29 de febrero. Su empresa (empresa X) lo hab\u00eda destinado a la Rep\u00fablica Centroafricana entre el 13 y el 25 de febrero, donde durante 6 d\u00edas imparti\u00f3 varias conferencias sobre gesti\u00f3n a un p\u00fablico de unos 30 responsables de recursos de varios ministerios de la Rep\u00fablica Centroafricana. A causa de la persistencia de la fiebre y la tos tras 9 d\u00edas de aparici\u00f3n de los s\u00edntomas, se le remiti\u00f3 al servicio de urgencias de un hospital local el 9 de marzo. A la exploraci\u00f3n, present\u00f3 fiebre (40 \u00b0C) y disnea con una saturaci\u00f3n de ox\u00edgeno del 91% en aire ambiental. La auscultaci\u00f3n pulmonar revel\u00f3 crepitantes basales bilaterales. Se descart\u00f3 malaria mediante observaci\u00f3n microsc\u00f3pica de frotis de sangre, as\u00ed como gripe mediante PCR de frotis nasofar\u00edngeo. El valor de prote\u00edna C-reactiva era de 103 mg/L y la cifra de leucocitos de 8,8 Giga/L. Se analiz\u00f3 un frotis far\u00edngeo para SARS-CoV-2 mediante RT-PCR, tal como se ha descrito anteriormente y el resultado fue positivo. Se traslad\u00f3 inmediatamente al paciente a nuestro centro (IHU M\u00e9diterran\u00e9e Infection) para su hospitalizaci\u00f3n en una sala de pacientes altamente contagiosos. Una TAC tor\u00e1cica mostr\u00f3 infiltrados pulmonares intersticiales bilaterales. El empeoramiento progresivo oblig\u00f3 a su traslado temporal a una unidad de cuidados intensivos durante cinco d\u00edas; posteriormente regres\u00f3 a nuestra sala, donde sigue hospitalizado en el momento de la redacci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The inpatient admission of a 59-year-old male was carried out with outpatient-confirmed SARS-CoV-2 infection with positive RT-PCR from a throat swab and relevant clinical symptoms. The patient had previously visited South Tirol. Six days prior to hospital admission, the patient exhibited initial symptoms in the form of chills and fever. He had no pre-existing conditions. At the time of admission there was ahigh fever of 40.0?C and conspicuous tachypnea with a respiratory rate of 28/min with sufficient oxygenation (ambient air saturation 95?%). Clinically, there was also a severe general feeling of malaise with obvious fatigue. ?109/l, lymphopenia with 0.96? ?109/l (25?%), an only slightly increased CRP with 14.7?mg/l and a low procalcitonin of 0.11?ng/ml. D-dimer as risk factor for instability was not increased at 370?g. Interleukin-6 as inflammatory parameter was slightly elevated at 36.4?pg/ml, LDH was 330?U/l and creatinine kinase was 412?U/l. Albumin was initially within the normal range at 4.0?g/dl. The native thin-slice volume CT of the thorax performed on the day of admission showed multifocal, bilateral ground glass opacities, partly with overlapping reticulations appearing as crazy paving. Consolidation was present, but much less pronounced than the ground glass opacities, which were somewhat round and geographically arranged. It was noticeable that they were sometimes sharply delineated from the neighboring healthy lung parenchyma. A positive air bronchogram was evident within the changes. All changes were in the periphery of the lungs, in the craniocaudal plane the base of the lungs, and here the left lower lobe, were most affected. Due to the presence of a risk constellation with clinically significant compromise, high fever, respiratory impairment and CT-morphologically pronounced parenchymal alterations, a decision was quickly made in favor of a therapy including antivirals (Lopinavir-Ritonavir) and a broadly-calculated antibiotic therapy. With persistent fever up to 39.6?C and respiratory deterioration with increasing oxygen demand, a follow-up CT of the thorax was performed on day 6 after admission ([Fig.?2]). The images showed significantly increasing densities, whereby in contrast to the initial CT, consolidations now dominated the image. Still, the periphery and the base of the lungs were most affected. On day 7 a nasal high flow therapy was initiated for severe respiratory insufficiency. By day 16 the patient had improved clinically and was ready for discharge. No more follow-up CT examination was performed.",
        "es": "El ingreso hospitalario de un hombre de 59 a\u00f1os se realiz\u00f3 con infecci\u00f3n de SARS-CoV-2 confirmada ambulatoriamente mediante una RT-PCR positiva a partir de frotis far\u00edngeo y s\u00edntomas cl\u00ednicos relevantes. El paciente hab\u00eda visitado previamente el Tirol del Sur. Seis d\u00edas antes del ingreso hospitalario, el paciente mostr\u00f3 los s\u00edntomas iniciales en forma de escalofr\u00edos y fiebre. No ten\u00eda antecedentes. Al ingreso, presentaba hipertermia de 40,0 \u00b0C y una patente taquipnea con una frecuencia respiratoria de 28 r.p.m con suficiente oxigenaci\u00f3n (saturaci\u00f3n con aire ambiental del 95%). Cl\u00ednicamente, reportaba una fuerte sensaci\u00f3n de malestar general con cansancio manifiesto. Las pruebas anal\u00edticas mostraron leucocitopenia con 3,8 \u00d7 109/l, linfocitopenia con 0,96 \u00d7 109/l (25 %), un ligero aumento de prote\u00edna C-reactiva con 14,7 mg/l y un valor bajo de procalcitonina de 0,11 ng/ml. El d\u00edmero D, como factor de riesgo de inestabilidad, no mostr\u00f3 valores altos, a 370 \u00b5g. La interleucina-6 como par\u00e1metro inflamatorio era algo elevada, con una concentraci\u00f3n de 36,4 pg/ml, la LDH era de 330 U/l y la creatina-cinasa, de 412 U/l. La alb\u00famina estaba inicialmente dentro del intervalo normal, con 4,0 g/dl. La TAC tor\u00e1cica de corte fino realizada el d\u00eda del ingreso mostr\u00f3 opacidades de vidrio esmerilado bilaterales y multifocales, en parte solapadas con reticulaciones en patr\u00f3n de empedrado. Hab\u00eda consolidaci\u00f3n, pero mucho menos destacable que las opacidades de vidrio esmerilado, que eran aproximadamente redondeadas y distribuidas geogr\u00e1ficamente. Es destacable que, en algunos casos, estaban claramente delimitadas del par\u00e9nquima pulmonar sano. En las alteraciones era evidente un broncograma a\u00e9reo positivo. Todas las alteraciones se hallaban en la periferia de los pulmones, en el plano craneocaudal a la base de los pulmones; el l\u00f3bulo inferior izquierdo era el m\u00e1s afectado. A causa del conjunto de riesgos con afectaciones cl\u00ednicamente significativas, fiebre alta, disfunci\u00f3n respiratoria y alteraciones parenquimatosas morfol\u00f3gicamente claras en TAC, se decidi\u00f3 r\u00e1pidamente una terapia con antiv\u00edricos (lopinavir-ritonavir) y antibi\u00f3ticos de amplio espectro. A causa de la fiebre persistente de hasta 39,6 \u00b0C y un empeoramiento de los s\u00edntomas respiratorios, con un aumento de la demanda de ox\u00edgeno, se realiz\u00f3 una TAC tor\u00e1cica de seguimiento el d\u00eda 6 tras el ingreso (fig. 2). Las im\u00e1genes mostraron una clara disminuci\u00f3n de las densidades, pero en contraste con la TAC inicial, las consolidaciones dominaban la imagen. La periferia y la base de los pulmones segu\u00edan siendo las zonas m\u00e1s afectadas. El d\u00eda 7, se inici\u00f3 oxigenoterapia nasal de alto flujo por insuficiencia respiratoria grave. El d\u00eda 16, el paciente hab\u00eda mejorado cl\u00ednicamente y estaba listo para su alta hospitalaria. No se realizaron m\u00e1s TAC de seguimiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 64-year-old woman presented to the emergency department on February 1st, 2020, because of a 7-day fever, with the highest body temperature of 38.7 C, accompanied by cough with a little sputum and muscle soreness, but no chest distress or dyspnea. She just flew back to Hangzhou, China, from Malaysia 7 days ago. Physical examination revealed no dry and moist rales in both lungs with a temperature of 37.3 C, heart rate of 92 beats/min, respiratory rate of 18 times/min, and blood pressure of 113/79 mmHg. Her laboratory tests showed white blood cell count (WBC) was 2.5? ?109 cells/mL with 63.3% neutrophils and 29.2% lymphocytes, and C-reactive protein (CRP) level was 3.62 mg/L. Her sputum test for influenza A?+?B (real-time fluorescent RT-PCR) was negative. The lung CT images of this patient showed multiple ground-glass shadows with unclear edges and uneven densities in the peripheral and posterior lungs, mainly under the pleura. These imagings were in accordance with the early radiographic features of coronavirus disease 2019 (COVID-19). Later, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) RNA was detected in the sputum by real-time fluorescent RT-PCR, and the patient was diagnosed as COVID-19.",
        "es": "El 1 de febrero de 2020 acudi\u00f3 al servicio de urgencias una mujer de 64 a\u00f1os reportando fiebre de 7 d\u00edas de evoluci\u00f3n, con una temperatura m\u00e1xima de 38,7 \u00b0C, que cursaba con tos, poca expectoraci\u00f3n y mialgia, pero sin malestar tor\u00e1cico ni disnea. Hab\u00eda regresado en avi\u00f3n a Hangzhou (China), procedente de Malasia 7 d\u00edas antes. A la exploraci\u00f3n f\u00edsica no se percibieron estertores secos ni h\u00famedos en ambos pulmones y se registr\u00f3 una temperatura de 37,3 \u00b0C, pulso de 92 l.p.m., frecuencia respiratoria de 18 r.p.m. y presi\u00f3n arterial de 113/79 mmHg. Las pruebas anal\u00edticas dieron una f\u00f3rmula leucocitaria de 2,5 x 109 c\u00e9lulas/mL, con un 63,3% de neutr\u00f3filos y un 29,2% de linfocitos; el valor de prote\u00edna C-reactiva era de 3,62 mg/L. Las pruebas de esputo para gripe A+B (mediante RT-PCR en tiempo real) fueron negativas. Las TAC pulmonares de la paciente mostraron varias sombras de vidrio esmerilado con bordes difusos y densidades irregulares en las zonas perif\u00e9ricas y posteriores de los pulmones, b\u00e1sicamente subpleurales. Estas im\u00e1genes concordaban con anteriores manifestaciones radiol\u00f3gicas de la enfermedad por coronavirus 2019 (COVID-19). M\u00e1s adelante, las pruebas mediante RT-PCR de fluorescencia en tiempo real detectaron ARN de SARS-CoV-2 y se diagnostic\u00f3 a la paciente con COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 38-year-old man from Wuhan, the epicenter of the COVID-19 outbreak, presented with binaural hearing loss and tinnitus lasting for two months. He underwent endoscopic tympanometry on January 16; on the second postoperative day, he went outdoors and caught a cold. His body temperature was elevated to 38.1?. Laboratory examination revealed a normal percentage neutrophil count (75.0%, normal range: 40.075.0%) and a decreased percentage lymphocyte count (14.8%, normal range: 20.050.0%). Screening was negative for multiple respiratory pathogens including influenza A, influenza B, respiratory syncytial virus, adenovirus, human parainfluenza virus, mycoplasma pneumoniae, and chlamydia pneumoniae. The patient's sputum tested positive for 2019-nCoV in a real-time polymerase chain reaction assay. On January 26, the patient developed a high fever and cough and was initiated on high-flow nasal cannula (HFNC) oxygen therapy. The fraction of inspired O2 (FiO2) was 80%, while the gas flow-rate was 20 L/min. The patient was continued on HFNC oxygen therapy from January 26 to February 4. On February 1, he suffered from chest tightness and palpitation. The arterial oxygen saturation (SpO2) could reach 90% after oxygen therapy. On February 5, he exhibited aggravated dyspnea and severe hypoxemia (SpO2 < 70%). He received non-invasive mechanical ventilation in the intensive care unit until February 10 with symptomatic relief. The initial FiO2 was 60%, while the gas flow-rate was 50 L/min. The modes used were pressure support ventilation and positive end-expiratory pressure with 1.18 KPa (12 cmH2O) and 0.98 KPa (10 cmH2O), respectively. Thereafter, the patient continued to receive HFNC oxygen therapy until the last follow-up CT scan. The initial chest CT showed ground-glass opacities (GGO) in the left lower lobe. Over the next 10 days, the lesions increased in extent and density and progressed to consolidation. The clinical symptoms deteriorated, and acute respiratory distress syndrome was diagnosed. A follow-up CT scan revealed emphysema. After 15 days of supportive treatment, chest CT showed an improvement in the pulmonary lesions, disappearance of the mediastinal emphysema, and appearance of a giant bulla in the left lung. Eight days later, the final follow-up CT scan revealed a small pneumothorax and pleural effusion in the left thorax",
        "es": "Se present\u00f3 un hombre de 38 a\u00f1os, de Wuhan, epicentro del brote de COVID-19, con ac\u00fafenos e hipoacusia biauricular con una evoluci\u00f3n de dos meses. Se le realiz\u00f3 una timpanometr\u00eda endosc\u00f3pica el d\u00eda 16 de enero; el segundo d\u00eda de posoperatorio sali\u00f3 al exterior y se resfri\u00f3. Su temperatura era de 38,1 \u00baC. Las pruebas anal\u00edticas revelaron un porcentaje de neutr\u00f3filos normal (75,0%; intervalo normal: 40,0-75,0%) y un porcentaje elevado de linfocitos (14,8%; intervalo normal: 20,0-50,0%). Las pruebas de detecci\u00f3n fueron negativas para varios pat\u00f3genos respiratorios, como gripe A, gripe B, virus sincicial respiratorio, adenovirus, virus paragripal, Mycoplasma pneumoniae y Chlamydia pneumoniae. El esputo del paciente dio positivo para 2019-nCoV en el ensayo de PCR en tiempo real. El 26 de enero, el paciente present\u00f3 hipertermia y tos y se inici\u00f3 un tratamiento con oxigenoterapia mediante c\u00e1nula nasal de alto flujo. La fracci\u00f3n inspiratoria de ox\u00edgeno (FIO2) era del 80%, mientras que el caudal de aire era de 20 L/min. El paciente se mantuvo con oxigenoterapia hasta el 4 de febrero. El 1 de febrero report\u00f3 opresi\u00f3n tor\u00e1cica y palpitaciones. La saturaci\u00f3n de ox\u00edgeno arterial (SpO2) lleg\u00f3 al 90% tras la oxigenoterapia. El 5 de febrero, empeor\u00f3 su disnea y present\u00f3 hipoxemia grave (SpO2 < 70%). Se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica no invasiva en la unidad de cuidados intensivos hasta el 10 de febrero, con alivio sintom\u00e1tico. La FIO2 inicial era del 60%, mientras que el caudal de aire era de 50 L/min. Los modos empleados fueron respiraci\u00f3n asistida y alta presi\u00f3n positiva telespiratoria, con 1,18 kPa (12 cmH2O) y 0,98 kPa (10 cmH2O), respectivamente. Posteriormente, el paciente sigui\u00f3 recibiendo oxigenoterapia mediante c\u00e1nula nasal de alto flujo hasta la \u00faltima TAC de seguimiento. La TAC tor\u00e1cica inicial mostr\u00f3 opacidades de vidrio esmerilado en el l\u00f3bulo inferior izquierdo. Durante los 10 d\u00edas siguientes, las lesiones aumentaron en extensi\u00f3n y densidad y pasaron a consolidaciones. Los s\u00edntomas cl\u00ednicos empeoraron y se diagnostic\u00f3 s\u00edndrome de dificultad respiratoria aguda. Una TAC de seguimiento revel\u00f3 enfisema. Tras 15 d\u00edas de tratamiento sintom\u00e1tico, la TAC tor\u00e1cica mostr\u00f3 una mejora de las lesiones pulmonares, desaparici\u00f3n del enfisema mediast\u00ednico y aparici\u00f3n de una gran bulla [MFA1]en el pulm\u00f3n izquierdo. Ocho d\u00edas despu\u00e9s, la TAC final de seguimiento revel\u00f3 un ligero neumot\u00f3rax y derrame pleural en el t\u00f3rax izquierdo. [MFA1]Ok?"
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The patient was a 35-year-old woman without a significant medical history. On January 21, 2020, she travelled to Japan from Wuhan, China. She was healthy until January 30 when she developed fever with mild diarrhoea. On January 31, at the primary care clinic, the rapid influenza antigen test was negative. Chest X-ray revealed signs of pneumonia in the left lower lung and she was transferred to the Japanese Red Cross Narita Hospital. She denied having sore throat, rhinorrhea, chills and cough. She had not visited Huanan market and was not exposed to any wild or dead animals. On admission, her vital signs were as follows: blood pressure 106/66?mmHg, heart rate 93 beats/min, body temperature 37.9?C, respiratory rate 16 breaths/min and oxygen saturation on room air 97%. Her physical examination was unremarkable. Laboratory test results did not reveal leukocytosis, leukocytopenia or elevated liver function enzymes. Computed tomography (CT) scan showed slight ground-glass opacity in the left lower lung lobe. She was admitted to an isolation room with negative pressure. Ceftriaxone and azithromycin were administered after obtaining a throat swab. The PCR test on the throat swab for the novel coronavirus (SARS-CoV-2) was negative. Her fever persisted but she had no respiratory symptoms such as cough. On hospital day 5, induced sputum and a second throat swab were obtained. The PCR test on induced sputum was positive but the throat swab was still negative. Her condition was stable and fever and diarrhoea improved on hospital day 6. She recovered fully and was discharged on hospital day 12 after sputum and throat swab samples tested negative by PCR. During her clinical course, she never had a PCR-positive throat swab. All PCR tests were performed at the reference laboratory by real-time RT-PCR assays following a previously described method.",
        "es": "La paciente era una mujer de 35 a\u00f1os sin antecedentes personales. El d\u00eda 21 de enero de 2020 viaj\u00f3 a Jap\u00f3n desde Wuhan (China). Estaba sana hasta el 30 de enero, cuando present\u00f3 fiebre y diarrea leve. El 31 de enero, en el consultorio de atenci\u00f3n primaria, se le realiz\u00f3 una prueba r\u00e1pida de ant\u00edgenos de la gripe y result\u00f3 negativa. Una TAC tor\u00e1cica revel\u00f3 signos de neumon\u00eda en la zona inferior del pulm\u00f3n izquierdo y fue trasladada al Hospital de la Cruz Roja Japonesa de Narita. Afirm\u00f3 no tener irritaci\u00f3n de garganta, rinorrea, escalofr\u00edos ni tos. No hab\u00eda acudido al mercado de Huanan ni hab\u00eda estado expuesta a animales salvajes o muertos. Al ingreso, sus constantes vitales eran: presi\u00f3n arterial 106/66 mmHG, pulso 93 l.p.m., temperatura 37,9 \u00b0C, frecuencia respiratoria 16 r.p.m. y saturaci\u00f3n de ox\u00edgeno en aire ambiental 97%. La exploraci\u00f3n f\u00edsica fue normal. Las pruebas anal\u00edticas no mostraron leucocitosis, leucocitopenia ni valores altos de enzimas hep\u00e1ticas. Una TAC tor\u00e1cica mostr\u00f3 ligeras opacidades de vidrio esmerilado en el l\u00f3bulo inferior del pulm\u00f3n izquierdo. Se traslad\u00f3 a una sala de aislamiento con presi\u00f3n negativa. Se le administr\u00f3 ceftriaxona y azitromicina tras obtener un frotis far\u00edngeo. La prueba mediante PCR del frotis far\u00edngeo para el nuevo coronavirus (SARS-CoV-2) fue negativa. Continu\u00f3 con fiebre pero no present\u00f3 s\u00edntomas respiratorios, como tos. El d\u00eda 5 de hospitalizaci\u00f3n se obtuvo esputo provocado y un segundo frotis far\u00edngeo. La prueba mediante PCR del esputo fue positiva, pero el frotis far\u00edngeo sigui\u00f3 siendo negativo. Su estado era estable y la fiebre y la diarrea mejoraron el sexto d\u00eda de hospitalizaci\u00f3n. El d\u00eda 12 de hospitalizaci\u00f3n, la paciente ya se hab\u00eda restablecido por completo y las pruebas mediante PCR de esputo y frotis far\u00edngeos resultaron negativas. Durante toda la evoluci\u00f3n cl\u00ednica nunca se obtuvo ninguna prueba positiva de los frotis far\u00edngeos mediante PCR. Todas las pruebas de PCR se realizaron en el laboratorio de referencia mediante ensayos de RT-PCR en tiempo real siguiendo un protocolo ya descrito."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On Jan 23, 2020, a woman aged 61 years presented with acute weakness in both legs and severe fatigue, progressing within 1 day. She returned from Wuhan on Jan 19, but denied fever, cough, chest pain, or diarrhoea. Her body temperature was 365C, oxygen saturation was 99% on room air, and respiratory rate was 16 breaths per min. Lung auscultation showed no abnormalities. Neurological examination disclosed symmetric weakness (Medical Research Council grade 4/5) and areflexia in both legs and feet. 3 days after admission, her symptoms progressed. Muscle strength was grade 4/5 in both arms and hands and 3/5 in both legs and feet. Sensation to light touch and pinprick was decreased distally. Laboratory results on admission were clinically significant for lymphocytopenia (052  109/L, normal: 11-32  109/L) and thrombocytopenia (113  109/L, normal: 125-300  109/L). CSF testing (day 4) showed normal cell counts (5  106/L, normal: 0-8  106/L) and increased protein level (124 mg/dL, normal: 8-43 mg/dL). Nerve conduction studies (day 5) showed delayed distal latencies and absent F waves in early course, supporting demyelinating neuropathy (tables 1, 2). She was diagnosed with Guillain-Barr syn drome and given intravenous immunoglobulin. On day 8 (Jan 30), the patient developed dry cough and a fever of 382C. Chest CT showed ground-glass opacities in both lungs. Oropharyngeal swabs were positive for SARS-CoV-2 on RT-PCR assay. She was immediately transferred to the infection isolation room and received supportive care and antiviral drugs of arbidol, lopinavir, and ritonavir. Her clinical condition improved gradually and her lymphocyte and thrombocyte counts normalised on day 20. At discharge on day 30, she had normal muscle strength in both arms and legs and return of tendon reflexes in both legs and feet. Her respiratory symptoms resolved as well. Oropharyngeal swab tests for SARS-CoV-2 were negative.",
        "es": "El 23 de enero de 2020, se present\u00f3 una mujer de 61 a\u00f1os con astenia aguda en ambas piernas y fatiga intensa, con una evoluci\u00f3n de un d\u00eda. Hab\u00eda regresado de Wuhan el 19 de enero pero no report\u00f3 fiebre, tos, dolor tor\u00e1cico ni diarrea. Su temperatura era de 36,5 \u00b0C, la saturaci\u00f3n de ox\u00edgeno de 99% en aire ambiental y la frecuencia respiratoria de 16 r.p.m. La auscultaci\u00f3n pulmonar no revel\u00f3 ninguna anomal\u00eda. La exploraci\u00f3n neurol\u00f3gica mostr\u00f3 astenia sim\u00e9trica (grado 4/5 del Medical Research Council) y arreflexia en ambas piernas y pies. 3 d\u00edas despu\u00e9s del ingreso, sus s\u00edntomas empeoraron. La fuerza muscular era de grado 4/5 en ambos brazos y manos y de 3/5 en ambas piernas y pies. La sensibilidad al tacto y a los pinchazos disminu\u00eda distalmente. Las pruebas anal\u00edticas al ingreso eran cl\u00ednicamente significativas para linfocitopenia (0,52 x 109/L; intervalo normal: 1,1-3,2 \u00d7 109/L) y trombocitopenia (113 \u00d7 109/L; intervalo normal: 125-300 \u00d7 109/L). Las pruebas de LCR dieron cifras normales de c\u00e9lulas (5 x 106/L; intervalo normal: 0-8 \u00d7 106/L) y valores altos de prote\u00ednas (124 mg/dL; intervalo normal: 8-43 mg/dL). Las pruebas de conducci\u00f3n nerviosa (d\u00eda 5) revelaron latencias distales retardadas y ausencia de ondas F en un estado temprano, manifestaciones coherentes con neuropat\u00eda desmielinizante (tablas 1, 2). Se le diagnostic\u00f3 s\u00edndrome de Guillain-Barr\u00e9 y se le administr\u00f3 inmunoglobulina i.v. El d\u00eda 8 (30 de enero), la paciente present\u00f3 tos seca y fiebre de 38,2 \u00b0C. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado en ambos pulmones. Los frotis orofar\u00edngeos dieron resultado positivo para SARS-CoV-2 mediante prueba de RT-PCR. Inmediatamente, se traslad\u00f3 a la paciente a una planta de enfermedades infecciosas y se le aplic\u00f3 tratamiento sintom\u00e1tico y los f\u00e1rmacos antiv\u00edricos arbidol, lopinavir y ritonavir. Su estado cl\u00ednico mejor\u00f3 gradualmente y sus cifras de linfocitos y trombocitos se normalizaron el d\u00eda 20. Fue dada de alta el d\u00eda 30, con fuerza muscular normal y recuperaci\u00f3n de los reflejos en ambos brazos y piernas. Sus s\u00edntomas respiratorios tambi\u00e9n remitieron. Las pruebas con frotis orofar\u00edngeos para SARS-CoV-2 resultaron negativos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On  January  1,  2020,  a  42-year-old  man  was  admitted to the emergency department of Union Hospital (Tongji Medical  College,  Wuhan,  Hubei  Province)  due  to  a  high-grade  fever (39.6\u00b0C [103.28\u00b0C]), cough, and fatigue for 1 week. Bilat-eral  coarse  breath  sounds  with  wet  rales  distributed  at  the  bases  of  both  lungs  were  heard  on  auscultation. Laboratory  studies  showed  leukopenia  (white  blood  cell  count,  2.88  3  109/L)  and  lymphocytosis (lymphocyte cell count, 0.90 3 109/L). The white blood cell differential count displayed 56.6% neutrophils, 32.1% lymphocytes,  and  10.2%  monocytes. Several  additional  labora-tory  tests  were  abnormal,  including  C-reactive  protein  (158.95  mg/L; normal range, 0\u201310 mg/L), erythrocyte sedimentation rate (38 mm/h; normal range, ,20 mm/h), serum amyloid A protein (607.1 mg/L; normal range, ,10 mg/L), aspartate aminotransfer-ase (53 U/L; normal range, 8\u201340 U/L), and alanine aminotrans-ferase (60 U/L; normal range, 5\u201340 U/L). Real-time fluorescence polymerase chain reaction of the patient\u2019s sputum was positive for the 2019-nCoV nucleic acid. The patient was treated with antiviral drugs (ganciclovir, oseltamivir) and anti-inflammatory drugs (me-ropenem, linezolid), with supportive care from January 1, 2020, until his discharge on January 25, 2020. Serial imaging studies in the Figure illustrate the patient\u2019s improvement after therapy.",
        "es": "El 1 de enero de 2020, ingres\u00f3 en el Union Hospital (facultad de medicina Tongji, Wuhan, provincia de Hubei) un hombre de 42 a\u00f1os con hipertermia (39,6 \u00b0C), tos y que refer\u00eda fatiga de una semana de evoluci\u00f3n. A la auscultaci\u00f3n, se percibieron ruidos respiratorios bilaterales con estertores h\u00famedos en las bases de ambos pulmones. Las pruebas anal\u00edticas mostraron leucocitopenia (cifra de leucocitos: 2,88 3 109/L) y linfocitosis (cifra de linfocitos: 0,90 3 109/L). La f\u00f3rmula leucocitaria mostr\u00f3 un 56,6% de neutr\u00f3filos, un 32,1% de linfocitos y un 10,2% de monocitos. Varias pruebas anal\u00edticas adicionales dieron resultados anormales, como prote\u00edna C-reactiva (158,95 mg/L; intervalo normal: 0-10 mg/L), velocidad de sedimentaci\u00f3n globular (38 mm/h; valor normal: 20 mm/h), prote\u00edna amiloide A s\u00e9rica (607,1 mg/L; valor normal: 10 mg/L), aspartato-aminotransferasa (53 U/L; intervalo normal: 8-40 U/L) y alanina-aminotransferasa (60 U/L; intervalo normal: 5-40 U/L). La PCR de fluorescencia en tiempo real del esputo del paciente result\u00f3 positiva para \u00e1cido nucleico del 2019-nCoV. Se trat\u00f3 al paciente con antivirales (ganciclovir, oseltamivir) y antiinflamatorios (meropenem, linezolid), con tratamiento sintom\u00e1tico, desde el 1 de enero de 2020 hasta su alta el 25 de enero de 2020. Las pruebas consecutivas de diagn\u00f3stico por la imagen que se muestran en la figura ilustran la mejora del paciente tras la terapia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 50-year-old man was admitted to a fever clinic on Jan 21, 2020, with symptoms of fever, chills, cough, fatigue and shortness of breath. He reported a travel history to Wuhan Jan 8\u201312, and that he had initial symptoms of mild chills and dry cough on Jan 14 (day 1 of illness) but did not see a doctor and kept working until Jan 21. Chest x-ray showed multiple patchy shadows in both lungs, and a throat swab sample was taken. On Jan 22 (day 9 of illness), the Beijing Centers for Disease Control (CDC) confirmed by reverse real-time PCR assay that the patient had COVID-19. He was immediately admitted to the isolation ward and received supplemental oxygen through a face mask. He was given interferon alfa-2b (5 million units twice daily, atomisation inhalation) and lopinavir plus ritonavir (500 mg twice daily, orally) as antiviral therapy, and moxifloxacin (0\u00b74 g once daily, intravenously) to prevent secondary infection. Given the serious shortness of breath and hypoxaemia, methylprednisolone (80 mg twice daily, intravenously) was administered to attenuate lung inflammation. After receiving medication, his body temperature reduced from 39\u00b70 to 36\u00b74 \u00b0C. However, his cough, dyspnoea, and fatigue did not improve. On day 12 of illness, after initial presentation, chest x-ray showed progressive infiltrate and diffuse gridding shadow in both lungs. He refused ventilator support in the intensive care unit repeatedly because he suffered from claustrophobia; therefore, he received high-flow nasal cannula (HFNC) oxygen therapy (60% concentration, flow rate 40 L/min). On day 13 of illness, the patient's symptoms had still not improved, but oxygen saturation remained above 95%. In the afternoon of day 14 of illness, his hypoxaemia and shortness of breath worsened. Despite receiving HFNC oxygen therapy (100% concentration, flow rate 40 L/min), oxygen saturation values decreased to 60%, and the patient had sudden cardiac arrest. He was immediately given invasive ventilation, chest compression, and adrenaline injection. Unfortunately, the rescue was not successful, and he died at 18:31 (Beijing time). Biopsy samples were taken from lung, liver, and heart tissue of the patient. Histological examination showed bilateral diffuse alveolar damage with cellular fibromyxoid exudates. The right lung showed evident desquamation of pneumocytes and hyaline membrane formation, indicating acute respiratory distress syndrome (ARDS). The left lung tissue displayed pulmonary oedema with hyaline membrane formation, suggestive of early-phase ARDS. Interstitial mononuclear inflammatory infiltrates, dominated by lymphocytes, were seen in both lungs. Multinucleated syncytial cells with atypical enlarged pneumocytes characterised by large nuclei, amphophilic granular cytoplasm, and prominent nucleoli were identified in the intra-alveolar spaces, showing viral cytopathic-like changes. No obvious intranuclear or intracytoplasmic viral inclusions were identified.",
        "es": "El 21 de enero de 2020, un hombre de 50 a\u00f1os acudi\u00f3 a un consultorio de enfermedades infecciosas con s\u00edntomas de fiebre, escalofr\u00edos, fatiga y disnea. Inform\u00f3 de un viaje a Wuhan los d\u00edas 8-12 de enero y report\u00f3 que ten\u00eda unos s\u00edntomas iniciales de escalofr\u00edos leves y tos seca el d\u00eda 14 de enero (d\u00eda 1 de enfermedad), pero no acudi\u00f3 a la consulta y sigui\u00f3 trabajando hasta el 21 de enero. La TAC tor\u00e1cica mostr\u00f3 m\u00faltiples sombras parcheadas en ambos pulmones y se realiz\u00f3 un frotis far\u00edngeo. EL 22 de enero (d\u00eda 9 de enfermedad), los Centros de Control y Prevenci\u00f3n de Enfermedades de Pek\u00edn (CDC) confirmaron, mediante RT-PCR en tiempo real, que el paciente ten\u00eda COVID-19. Inmediatamente ingres\u00f3 en la planta de enfermedades infecciosas y recibi\u00f3 oxigenoterapia mediante mascarilla. Se le administr\u00f3 interfer\u00f3n alfa-2b (5 millones de unidades dos veces al d\u00eda, atomizado por v\u00eda inhalatoria) y lopinavir y ritonavir (500 mg dos veces al d\u00eda, por v\u00eda oral) como terapia antiv\u00edrica y moxifloxacina (0,4 g una vez al d\u00eda, i.v.) Teniendo en cuenta la disnea grave y la hipoxemia, se le administr\u00f3 metilprednisolona (80 mg dos veces al d\u00eda, i.v.) para atenuar la inflamaci\u00f3n en los pulmones. Tras recibir la medicaci\u00f3n, su temperatura baj\u00f3 de 39,0 \u00b0C a 36,4 \u00b0C; sin embargo, los s\u00edntomas de tos, disnea y fatiga no mejoraron. El d\u00eda 12 de enfermedad, tras la consulta inicial, la TAC tor\u00e1cica mostr\u00f3 infiltrados y sombras difusas en ambos pulmones. El paciente rechaz\u00f3 repetidamente el respirador en la UCI, porque padec\u00eda claustrofobia; en consecuencia, se le aplic\u00f3 oxigenoterapia mediante una c\u00e1nula nasal de alto flujo (concentraci\u00f3n 60%, caudal 40 L/min). El d\u00eda 13 de enfermedad, los s\u00edntomas del paciente segu\u00edan sin mejorar, pero la saturaci\u00f3n de ox\u00edgeno se mantuvo por encima de 95%. En la tarde del d\u00eda 14 de enfermedad, se agrav\u00f3 su hipoxemia y disnea. A pesar de recibir oxigenoterapia (concentraci\u00f3n 100%, caudal 40 L/min), la saturaci\u00f3n de ox\u00edgeno disminuy\u00f3 a 60% y el paciente sufri\u00f3 un paro card\u00edaco s\u00fabito. Inmediatamente se le aplic\u00f3 ventilaci\u00f3n invasiva y masaje card\u00edaco y se le inyect\u00f3 adrenalina. Por desgracia, la reanimaci\u00f3n no dio resultado y el paciente muri\u00f3 a las 18:31 (hora de Pek\u00edn). Se tomaron biopsias de los pulmones, el h\u00edgado y el coraz\u00f3n del paciente. La exploraci\u00f3n histol\u00f3gica mostr\u00f3 da\u00f1os alveolares difusos bilaterales con exudados fibromixoides celulares. El pulm\u00f3n derecho mostr\u00f3 una clara descamaci\u00f3n de neumocitos y formaci\u00f3n de membranas hialinas, lo que indica s\u00edndrome de dificultad respiratoria aguda (SDRA) . El tejido del pulm\u00f3n izquierdo mostr\u00f3 edema pulmonar con formaci\u00f3n de membranas hialinas, indicativo de SDRA inicial. En ambos pulmones se observaron infiltrados inflamatorios mononucleares intersticiales, dominados por linfocitos. Se identificaron c\u00e9lulas sinciciales multinucleadas con neumocitos at\u00edpicos hipertrofiados caracterizados por n\u00facleos grandes, citoplasma granuloso anfof\u00edlico y nucleolos destacados en los espacios intraalveolares, indicativos de cambios v\u00edricos citop\u00e1ticos. No se identificaron inclusiones v\u00edricas evidentes, ni intranucleares ni intracitoplasm\u00e1ticas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On 12 February 2020, days before this outbreak was recognised, an 80-year-old female with a 3-year history of left-sided ulcerative colitis (UC), in maintenance with mesalamine, presented to our clinic with a 7-day history of fever and bloody diarrhoea. On admission, the patient reported four bowel movements per day with blood and fever up to 38.5C. Laboratory tests documented severe anaemia (haemoglobin 7?g/dL) and increased C-reactive protein (CRP) (6?mg/dL). A sigmoidoscopy showed large and deep ulcers in sigmoid colon and rectum (figure 1). Stool cultures were negative, including tests for Clostridium difficile. The patient was therefore diagnosed with a severe UC relapse and intravenous corticosteroid therapy (methylprednisolone 40?mg/day) was started. During the next 3?days, the frequency of bowel movements decreased, fever resolved and CRP returned into normal range. On the fourth day, fever up to 39C developed, followed by dry cough. On the basis of the evolving knowledge regarding SARS-CoV-2 outbreak, including data relative to hospital-acquired infections, a case of COVID-19 was suspected. Chest radiography showed bilateral pneumonia, confirmed by chest CT scan (figure 2). The nasopharyngeal swab sample confirmed the presence of SARS-CoV-2 and a diagnosis of COVID-19 pneumonia was made. The patient was treated with non-invasive ventilation, and a combination of lopinavir/ritonavir and hydroxychloroquine. Intravenous corticosteroid was rapidly switched to oral prednisone, and an accelerated tapering was initiated. Despite an initial improvement, the patient's condition subsequently worsened and the patient died after 14 days of hospitalisation. Prednisone dosage at the time of patient's death was 25?mg daily.",
        "es": "El 12 de febrero de 2020, d\u00edas antes de que se identificara este brote, una mujer de 80 a\u00f1os con antecedentes de tres a\u00f1os de colitis ulcerosa izquierda y tratamiento de mantenimiento con mesalamina acudi\u00f3 a nuestro consultorio con fiebre y diarrea hemorr\u00e1gica de 7 d\u00edas de evoluci\u00f3n. Al ingreso, la paciente report\u00f3 cuatro defecaciones al d\u00eda con sangre y fiebre de hasta 38,5 \u00b0C. Las pruebas anal\u00edticas indicaron anemia grave (hemoglobina 7 g/dL) y valores altos de prote\u00edna C-reactiva (6 mg/dL). Una sigmoidoscopia mostr\u00f3 \u00falceras grandes y profundas en el colon sigmoide y el recto (figura 1). Los cultivos de heces fueron negativos, incluyendo pruebas para Clostridum difficile. A la paciente se le diagnostic\u00f3 recidiva de la colitis ulcerosa y se inici\u00f3 un tratamiento con corticosteroides i.v. (metilprednisolona 40 mg/d\u00eda). Durante los siguientes tres d\u00edas, la frecuencia de las defecaciones disminuy\u00f3, la fiebre remiti\u00f3 y los valores de prote\u00edna C-reactiva volvieron al intervalo normal. El cuarto d\u00eda present\u00f3 fiebre de hasta 39 \u00b0C que curs\u00f3 con tos seca. A partir de los datos en constante evoluci\u00f3n sobre el brote de SARS-CoV-2, incluyendo informaci\u00f3n referente a infecciones nosocomiales, se sospech\u00f3 un caso de COVID-19. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 neumon\u00eda bilateral, confirmada por TAC tor\u00e1cica (figura 2). Los frotis nasofar\u00edngeos confirmaron la presencia de SARS-CoV-2 y se estableci\u00f3 el diagn\u00f3stico de neumon\u00eda por COVID-19. La paciente fue tratada con ventilaci\u00f3n no invasiva y una combinaci\u00f3n de lopinavir/ritonavir e hidroxicloroquina. se sustituyeron r\u00e1pidamente por prednisona por v\u00eda oral y se inici\u00f3 una disminuci\u00f3n progresiva de la dosis. A pesar de una mejora inicial, el estado de la paciente empeor\u00f3 y esta muri\u00f3 tras 14 d\u00edas de hospitalizaci\u00f3n. En el momento de la muerte la dosis de prednisona era de 25 mg al d\u00eda."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On February 2, 2020, a 28-year-old female, who was 30 weeks pregnant, presented to a fever clinic of Suzhou Municipal  Hospital  with  intermittent  fever  for  one  week. She  disclosed  that  she  had  returned  to  Suzhou  on January 24 after traveling to visit family in Wuhan 3 weeks ago. Given the patient\u2019s travel history and fever, two throat  swab  samples  were  collected and tested negative  for SARS-CoV-2  with the  Chinese  Center  for Disease Control and Prevention (CDC) recommended Kit (BioGerm, Shanghai, China), following WHO  guidelines  for quantitative RT-PCR. Chest computed tomography (CT) scan on February 4 demonstrated left-sided subpleural patchy  consolidation  and  right-sided  ground-glass  opacities. Then  she  went  into  isolation  at  that hospital. On  February  6,  the  second  SARS-CoV-2  RT-PCR  results  of  her  sputum  came  back  positive,  so  she was  then  transferred  to  the  intensive  care  unit  (ICU)  in  a  negative  pressure  isolation  room  of  theAffiliated Infectious Hospital of Soochow University, the designated medical center for COVID-19 in Suzhou.On admission, the physical examination revealed a body temperature of 36.2\u00b0C, blood pressure of 95/64 mmHg, pulse  of  92  beats  per  minute,  respiratory  rate  of  22  breaths  per  minute,  and  oxygen  saturation  of  97%  with Venturi mask at 5 liters perminute of oxygen. Lung auscultation revealed little rhonchi over the left lower lung field. Other  laboratory   findings  included  a  leukocyte  count  of  10.60*109/L,  neutrophils  of  9.14*109/L, lymphocytes  of  0.86*109/L,  albumin  of  24.6  g/L,  C-reactive  protein  of  19.6  mg/L,  D-dimer  of  840  ug/L, procalcitonin (PCT) of 0.288 ng/ml, lactate dehydrogenase  (LDH) of 544 U/L, N-terminal  probrain natriuretic peptide  (NT-proBNP)  of  318  pg/ml. Levels  of  creatinine  and  aminotransferase  were  within  normal  limits. A fetal  ultrasound  revealed  a  normally  intrauterine  fetus  with  normal  anatomy  of  approximately  30  weeks  of gestational age. Since SARS-CoV-2 is a newly identified virus, it remains unknown whether the viral shedding during delivery occurs  or  the  vertical  transmission  exists. Several  multidisciplinary  consultations  were  performed,  concluding that given the current situation especially the CT scan and low levels of lymphocytes and albumin, the patient\u2019s condition might be deteriorated at any time, and she was at risk of preterm birth, so emergency scenarios for her were  developed. Treatment  with  Arbidol  (0.2g administered orally  every  8  hours),  Lopinavir  and  Ritonavir Tablets  (400/100mg  administered  orally  every  8  hours),  Cefoperazone  Sodium  and  Sulbactam  Sodium  (3.0gadministered intravenously every 8 hours), and Human Serum Albumin (20g administered intravenously every day)  were  initiated,  dexamethasone and  magnesium  sulphate  as  prophylaxis  for  the  fetus  were  given  and  an emergency  cesarean  section  was  prepared. On  hospital  day  3  morning  (February  8),  a  repeated  chest  CT  scan showed bilateral   multiple   ground-glass   opacities,   a   finding   consistent   with   severe   atypical pneumonia. In the afternoon,  this patient  had disappeared fetal  movement and no  variability of  fetal heart rate monitoring, and no improvement was made on maximal ventilator support for four hours. After  a  multidisciplinary  consultation  was  performed  and  informed  consent  was  obtained,  an  emergency cesarean  section  under  combined  spinal-epidural  anesthesia  was  performed  with  an  estimated  blood  loss  of 200ml  in  a  designated  negative  pressure  isolation  room  and  all  personnel  involved  wore  protective  gear including gown, N 95 mask, eye protection and gloves.A preterm male infant weighing 1.83 kg was delivered uneventfully, with Apgar scores of 9 and 10 at 1 and 5 minutes, respectively. And he  was kept in the isolation ICU of the  neonatal nursery for observation without any contact  with his mother after birth. The  newborn was given  formula  instead  of  breast  milk  ever  since. During  the  delivery,  samples  of  amniotic  fluid,  placenta, umbilical cord blood, gastric juice and throat swabs of the infant were obtained for SARS-CoV-2 RT-PCR tests, and all results were negative. On day 3 after cesarean section (February 11), RT-PCR analyses of the  neonatal throat swab and stool samples were negative. On February 15 and 17, throat swab RT-PCR tests of the mother and  the  infant  were  negative. Three  chest  CT  scans  of  the  mother  on  February  12,  15  and  18,  respectively, demonstrated resolution of infiltrates of both lung fields. All healthcare workers in contact with the  infant during his delivery  and subsequent care  had remained asymptomatic. The  patient and her infant had an uneventful postpartum and neonatal course.",
        "es": "El 2 de febrero de 2020, una mujer de 28 a\u00f1os y 30 semanas de gestaci\u00f3n acudi\u00f3 a un consultorio de enfermedades infecciosas del hospital municipal de Suzh\u00f3u refiriendo fiebre intermitente de una semana de evoluci\u00f3n. Inform\u00f3 de que hab\u00eda llegado a Suzh\u00f3u el 24 de enero tras visitar a su familia en Wuhan tres semanas antes. Teniendo en cuenta los antecedentes del paciente de fiebre y de desplazamiento a Wuhan, se recogieron dos frotis far\u00edngeos, que dieron resultado negativo para el SARS-CoV-2 al ser analizados con el kit recomendado por el Centro de Control de Enfermedades chino (BioGerm, Shangh\u00e1i, China) y de acuerdo con las directrices de la OMS para la RT-PCR cuantitativa. Una TAC tor\u00e1cica el d\u00eda 4 de febrero mostr\u00f3 consolidaciones parcheadas subpleurales en el lado izquierdo y opacidades en vidrio esmerilado en el lado derecho. Se le puso en aislamiento en el mismo hospital. El 6 de febrero, los resultados de la segunda RT-PCR del esputo de la paciente para detectar SARS-CoV-2 fueron positivos, de modo que se transfiri\u00f3 a la unidad de cuidados intensivos (UCI) en una planta de enfermedades infecciosas del Hospital Asociado de Enfermedades Infecciosas de la universidad de Suchow, el centro hospitalario de referencia para la COVID-19 en Suzh\u00f3u. La auscultaci\u00f3n pulmonar revel\u00f3 roncus en el campo pulmonar inferior izquierdo. Otros resultados anal\u00edticos fueron: cifra de leucocitos de 10,60*109/L; cifra de neutr\u00f3filos de 9,14*109/L; cifra de linfocitos de 0,86*109/L; seroalb\u00famina de 24,6 g/L, prote\u00edna C-reactiva de 19,6 mg/L, d\u00edmero D de 840 ug/L, procalcitonina (PCT) de 0,288 ng/ml; lactato-deshidrogenasa (LDH) de 544 U/L; prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral (NT-proBNP) de 318 pg/ml. Las concentraciones de creatinina y aminotransferasa estaban dentro del intervalo normal. Una ecograf\u00eda fetal mostr\u00f3 un feto intrauterino con caracter\u00edsticas anat\u00f3micas normales de unas 30 semanas de gestaci\u00f3n. Como el SARS-CoV-2 es un virus de identificaci\u00f3n reciente, no se sabe si se transmite durante el parto ni si existe transmisi\u00f3n vertical. Se realizaron diversas interconsultas y se lleg\u00f3 a la conclusi\u00f3n de que, teniendo en cuenta la situaci\u00f3n actual (sobre todo la TAC y las bajas concentraciones de linfocitos y seroalb\u00famina), el estado de la paciente pod\u00eda empeorar en cualquier momento y estaba en riesgo de parto prematuro, de modo que se elaboraron supuestos de urgencia para esta eventualidad. Se inici\u00f3 un tratamiento con arbidol (0,2 g por v\u00eda oral cada 8 horas), comprimidos de lopinavir y ritonavir (400/100 mg por v\u00eda oral cada 8 horas), cefoperazona y sulbactam (3,0 g i.v. La ma\u00f1ana del tercer d\u00eda de hospitalizaci\u00f3n (8 de febrero), una TAC tor\u00e1cica mostr\u00f3 m\u00faltiples opacidades bilaterales en vidrio esmerilado, un signo coherente con una neumon\u00eda at\u00edpica grave. Durante la tarde, desapareci\u00f3 el movimiento fetal y no se observ\u00f3 variabilidad de la frecuencia cardiaca fetal; tampoco se observ\u00f3 mejora con respiraci\u00f3n asistida m\u00e1xima durante cuatro horas. Tras diversas interconsultas, se obtuvo el consentimiento informado y se llev\u00f3 a cabo una ces\u00e1rea de urgencia con anestesia epidural, con una hemorragia estimada de 200 ml, en un quir\u00f3fano de aislamiento con presi\u00f3n negativa; todo el personal llevaba equipo de protecci\u00f3n, con bata, mascarilla N 95, protecci\u00f3n ocular y guantes. El ni\u00f1o se mantuvo en observaci\u00f3n en la UCI neonatal sin contacto con su madre tras el parto. Al reci\u00e9n nacido se le dio leche artificial en lugar de leche materna. Durante el parto, se recogieron muestras de l\u00edquido amni\u00f3tico, placenta, sangre del cord\u00f3n umbilical, jugo g\u00e1strico y frotis far\u00edngeos del ni\u00f1o, para efectuar pruebas del SARS-CoV-2 mediante RT-PCR; todos los resultados fueron negativos. El tercer d\u00eda tras la ces\u00e1rea (11 de febrero), los an\u00e1lisis por RT-PCR de los frotis far\u00edngeos y de heces del reci\u00e9n nacido dieron resultado negativo. Los d\u00edas 15 y 17 de febrero, las RT-PCR de los frotis far\u00edngeos de la madre y el ni\u00f1o dieron resultado negativo. Tres TAC tor\u00e1cicas de la madre, los d\u00edas 12, 15 y 18 de febrero, mostraron la eliminaci\u00f3n de los infiltrados en ambos campos pulmonares. Todos los profesionales sanitarios en contacto con el ni\u00f1o durante el parto y la asistencia posterior permanecieron asintom\u00e1ticos. La paciente y su hijo tuvieron una evoluci\u00f3n puerperal y neonatal sin complicaciones."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "In February 2020, a 46-year-old female patient presented with a growing palpable mass on the right parietal region with no any other  symptoms  or  history. She  initially  visited  the  Second Hospital of Luohe City on February 4, 2020, and was examined by  one  physician  who  was  diagnosed  with  COVID-10  onFebruary  5,  2020  (Day  1,  was  in  contact  with  the  infected patient). The diagnosis of lung adenocarcinoma was confirmed by  bronchoscopic  biopsy,  and  the  mass  on  the  right parietal region  was  considered  metastatic. The  patient  was  transferred to  Henan  Chest  Hospital  for  further  treatment  on  February  9, 2020  (Day  5). Henan  Chest  Hospital  was  informed  that  this patient  had  been  in  contact  with  the  diagnosed  infected physician on February 14, 2020, and she immediately had chest CT   and   RT-PCR   tests   for   COVID-19   nucleic   acid   using nasopharyngeal  swabs. Results  of  RT-PCR  testing  for  C  -19 nucleic  acid  were  positive  on  February  14,  2020  (Day  10), however, chest CT did not demonstrate typical reported signs of COVID-19. The  patient  subsequently  developed  intermittent fever to 38\u00b0Celsius on the morning of February 15, 2020, and was  transferred  to  the  Sixth  People  Hospital  of  Zhengzhou, which  is  a  designated  hospital  for  COVID-19. The  patient experienced intermittent chest tightness, nausea and vomiting, and she  received  treatment with traditional Chinese  medicine. Chest  CT  scanning  was  performed  again  on  February  18,  2020 (Day 14), and no typical CT features  for COVID-19 were found. RT-PCR tests for COVID-19 were repeated on February 18 (Day 18)  and  20  (Day  18),  2020,  and  both  were  negative. She  had increased  C-reactive  protein  levels  and  reduced  lymphocyte ratios. Her symptoms started to improve, and she was transferred to a general ward. Chest   CT   images   showed   diffuse   irregular   small   diffuse ground-glass  nodular  opacities  with  partial  consolidation  in bilateral lungs on Day 10, in addition to the mass in  the  left  lung. The  nodules  increased  in  size  and  number  on Day 14. These diffuse irregular small ground-glass opacities with partial consolidation rapidly increased in 4 days in this patient with left lung  cancer,  which  were  consistent  with  inflammation,  rather than  metastasis. Repeat  positive  RT-PCR  tests  for  nucleic  acid confirmed  the  diagnosis  of  COVID-19. White  blood  cell  counts remained   elevated,   even   after   the   patient\u2019s   symptoms improved,  likely  due  to  obstructive  pneumonia  caused  by  the tumor. Chest  CT  images  showed  diffuse  irregular  small  ground-glass opacities with partial consolidation in bilateral lungs on Day 10, in  addition  to  the  mass  in  the  left  lung. The  nodular  opacities increased  in  size  and  number  on  Day  14,  which  was  not  a typically  reported  COVID-19  feature  including  ground  glass opacity  (GGO),  crazy-paving  pattern,  and  consolidation(3,4). The  typical  distribution  of  lung  abnormalities  in  COVID-19  was reported  as  predominantly  subpleural;  however,   this  case showed predominantly diffuse involvement.",
        "es": "En febrero de 2020, una mujer de 46 a\u00f1os apreci\u00f3 un bulto en crecimiento palpable en su regi\u00f3n parietal derecha, sin otros s\u00edntomas ni antecedentes. Acudi\u00f3 al consultorio del Segundo Hospital de Luohe el d\u00eda 4 de febrero de 2020; realiz\u00f3 la exploraci\u00f3n un m\u00e9dico al que luego se  le diagnostic\u00f3 COVID-19 el 5 de febrero de 2020 (d\u00eda 1: en contacto con el paciente infectado). El diagn\u00f3stico de adenocarcinoma pulmonar fue confirmado mediante una biopsia broncosc\u00f3pica y se consider\u00f3 que la masa tumoral de la regi\u00f3n parietal derecha era metast\u00e1sica. El 9 de febrero de 2020 (d\u00eda 5), la paciente fue trasladada al Hospital Neumol\u00f3gico de Henan para su tratamiento. Se inform\u00f3 al Hospital Neumol\u00f3gico de Henan que la paciente hab\u00eda estado en contacto con el m\u00e9dico infectado el 14 de febrero de 2020 e, inmediatamente, se le hizo una TAC tor\u00e1cica y pruebas de RT-PCR para \u00e1cido nucleico de COVID-19 mediante frotis nasofar\u00edngeos. El mismo 14 de febrero (d\u00eda 10), los resultados de las pruebas de RT-PCR para COVID-19 fueron positivos, pero la TAC tor\u00e1cica no mostr\u00f3 los signos habituales de la COVID-19. Posteriormente, la paciente present\u00f3 fiebre intermitente de hasta 38 \u00b0C la ma\u00f1ana del 15 de febrero de 2020 y se traslad\u00f3 al Sexto Hospital Popular de Zhengzhou, uno de los hospitales de referencia para la COVID-19. La paciente present\u00f3 opresi\u00f3n tor\u00e1cica, n\u00e1useas y v\u00f3mitos intermitentes y recibi\u00f3 un tratamiento de medicina tradicional china. El 18 de febrero de 2020 (d\u00eda 14) se le realiz\u00f3 una nueva TAC tor\u00e1cica y no se hallaron manifestaciones t\u00edpicas de la COVID-19. Las pruebas de RT-PCR para COVID-19 se repitieron el 18 de febrero (d\u00eda 14) y el 20 de febrero (d\u00eda 16)y ambas resultaron negativas. Mostr\u00f3 linfocitopenia y valores altos de prote\u00edna C-reactiva. Sus s\u00edntomas empezaron a mejorar y se traslad\u00f3 a la planta de hospitalizaci\u00f3n general. El d\u00eda 10, las TAC tor\u00e1cicas mostraron peque\u00f1as opacidades de vidrio esmerilado, nodulares, irregulares y difusas, con consolidaci\u00f3n parcial en ambos pulmones, adem\u00e1s de la masa tumoral del pulm\u00f3n izquierdo. Los n\u00f3dulos aumentaron en tama\u00f1o y cantidad el d\u00eda 14. Estas peque\u00f1as opacidades de vidrio esmerilado irregulares y difusas con consolidaci\u00f3n parcial aumentaron r\u00e1pidamente en cuatro d\u00edas en esta paciente con adenocarcinoma en el pulm\u00f3n izquierdo, coherentes con el proceso inflamatorio, m\u00e1s que con met\u00e1stasis. Pruebas adicionales de RT-PCR confirmaron el diagn\u00f3stico de COVID-19. La cifra de leucocitos continu\u00f3 siendo alta, incluso despu\u00e9s de la mejora de los s\u00edntomas de la paciente, seguramente a causa de la neumon\u00eda obstructiva provocada por el tumor. El d\u00eda 10, las TAC tor\u00e1cicas mostraron peque\u00f1as opacidades de vidrio esmerilado, irregulares y difusas, con consolidaci\u00f3n parcial en ambos pulmones, adem\u00e1s de la masa tumoral del pulm\u00f3n izquierdo. Las opacidades nodulares aumentaron en tama\u00f1o y cantidad el d\u00eda 14, lo que no es una manifestaci\u00f3n habitual de la COVID-19, con opacidades de vidrio esmerilado, patr\u00f3n en empedrado y consolidaci\u00f3n. Se ha descrito la distribuci\u00f3n habitual de anomal\u00edas pulmonares en la COVID-19 como predominantemente subpleural; sin embargo, este caso mostr\u00f3 una afectaci\u00f3n b\u00e1sicamente difusa."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 23-year-old man with chief complaints of fever and cough for 9 days was admitted to our hospital. His clinical manifestationsdid not improve despite an anti-inflammatory regimen. Physical examination revealed fever with a body temperature of 38.6\u00b0C. Physical examination on admission showed a congested pharynx and mild swelling of the bilateral tonsils. His breath sounds were coarse without rales. Other physical and neurological examinations were unremarkable. In view of the epidemiology, he had been working at a place located a few hundred meters away from the Huanan seafood Market in Wuhan City, China. He went to that market to buy fruits 11 days ago before admission. Laboratory examination on the second day after admission revealed decrease of blood oxygen saturation by 60%, blood gas analysis showed a normal pH of 7.446, normal white blood cell count of 6.66\u00d7109/L, increased percentage of neutrophils of 88.1%, and decreased percentage of lymphocytes of 6.4%. The serum biochemistry showed decreased total protein of 57.6 g/L, decreased albumin of 27.4 g/L, elevated serum glycated hemoglobin of 14.1%, elevated erythrocyte sedimentation rate of 24 mm/h, elevated C-reactive protein of >160.0mg/L, and normal interleukin-6 of 7.48 pg/mL. All routine microbiologic testing including typical respiratoryvirus antibodies were negative. Radiograph and computed tomography (CT) of the chest revealed ground-glass opacities and consolidations in the bilateral lungs. Hence, based on the epidemiologic, clinical manifestations, laboratory data, and radiologic findings, a diagnosis of 2019-nCoV infection was made according to the criteria published by WHO.6 During the hospitalization, in addition to symptomatic treatment, the patient was treated with antibiotics (meropenem, linezolid) and antiviral agents (ganciclovir, oseltamivir). All abnormal laboratory data gradually improved or became unremarkable. He finally recovered and was discharged from the hospital on the 15th day after admission.",
        "es": "Ingres\u00f3 en nuestro hospital un hombre de 23 a\u00f1os cuyos s\u00edntomas principales eran fiebre y tos con una evoluci\u00f3n de 9 d\u00edas. Sus s\u00edntomas cl\u00ednicos no mejoraron a pesar de un tratamiento antiinflamatorio. La exploraci\u00f3n f\u00edsica mostr\u00f3 fiebre con una temperatura de 38,6 \u00b0C y el paciente ten\u00eda antecedentes de hiperglucemia no tratada. Al ingreso, la exploraci\u00f3n f\u00edsica revel\u00f3 congesti\u00f3n far\u00edngea y una ligera inflamaci\u00f3n bilateral de las am\u00edgdalas. Sus ruidos respiratorios eran gruesos sin estertores. Las dem\u00e1s exploraciones f\u00edsicas y neurol\u00f3gicas no dieron datos rese\u00f1ables. Por lo que respecta a la informaci\u00f3n epidemiol\u00f3gica, hab\u00eda estado trabajando en un lugar situado a unos centenares de metros del mercado de marisco de Huanan, en la ciudad de Wuhan (China). Acudi\u00f3 a ese mercado para comprar fruta 11 d\u00edas antes del ingreso. Las pruebas anal\u00edticas en el segundo d\u00eda de ingreso mostraron una baja saturaci\u00f3n de ox\u00edgeno (60%), una gasometr\u00eda con pH normal (7,446), una cifra de leucocitos normal (6,66x109/L), un alto porcentaje de neutr\u00f3filos (88,1%) y un bajo porcentaje de linfocitos (6,4%). El an\u00e1lisis bioqu\u00edmico s\u00e9rico mostr\u00f3 valores bajos de prote\u00edna total (57,6 g/L) y de seroalb\u00famina (27,4 g/L), valores altos de glucohemoglobina (14,1%), de la velocidad de sedimentaci\u00f3n globular (24 mm/h) y de prote\u00edna C-reactiva (> 160,0 mg/L) y valores normales de interleucina 6 (7,48 pg/mL). Todos los an\u00e1lisis microbiol\u00f3gicos habituales, incluidos los de anticuerpos v\u00edricos, fueron negativos. Las radiograf\u00edas y TAC tor\u00e1cicas mostraron opacidades de vidrio esmerilado y consolidaciones bilaterales en los pulmones. En consecuencia, a partir de los datos epidemiol\u00f3gicos, los signos y s\u00edntomas cl\u00ednicos, las pruebas anal\u00edticas y las pruebas radiol\u00f3gicas, se diagnostic\u00f3 infecci\u00f3n por 2019-nCoV, seg\u00fan los criterios publicados por la OMS. Todas las pruebas anal\u00edticas mejoraron gradualmente o se volvieron normales. El paciente se recuper\u00f3 y fue dado de alta el d\u00eda 15 despu\u00e9s del ingreso."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 57-year-old man, without history of respiratory disease, presented to the emergency department with a 3-hour history of hemoptysis in Hunan, China. He denied recent travel to Wuhan City, Hubei Province, or any exposure to 2019-nCoV. No supportive results were found in laboratory tests upon admission. A unenhanced CT scan of the chest showed a localized area of ground-glass opacity (GGO) in the apicoposterior segment of the left upper lobe. Unenhanced chest CT showed area of localized GGO in apicoposterior segment of left upper lobe. Distribution of lesions was mainly located in medial lung. No lesions were observed in other regions of lungs. GGO = ground-glass opacityThis patient was admitted to the hospital with a suspicion of pulmonary infection or tuberculosis. Three days after admission, a small amount of pleural effusion was seen. No affirmative results were found in the drainage of pleural effusion. Hemoptysis was unable to be controlled after symptomatic treatments including hemostasis and anti-infection therapy. Eight days later, a follow-up chest CT scan showed that the GGO in the left upper lobe had evolved into consolidation. CT findings on 8th day after admission. Chest CT showed that GGO in left upper lobe had evolved into consolidation. Newly presented GGO in superior lingual segment of left upper lobe and superior segment of left lower lobe were distributed along subpleural regions. The GGO appeared on the superior segment of the left lower lobe. Bleeding was confirmed in the apicoposterior segment of the left upper lobe by using a fiber bronchoscope on the 10th day after admission. Fever occurred on the 11th day and the patient reached their highest body temperature of 39\u2103. Dyspnea was present on 14th day and gradually increased. On day 18 post admission, the GGOs and consolidation in the medial aspect of the left upper lobe decreased, while diffuse GGO and consolidation increased in the remaining areas of the lungs. The patient showed diffuse haziness in both lungs, batwing appearance, crazy-paving appearance, and the air-bronchogram sign. GGO was also distributed along the peripheral or subpleural regions. CT findings on 18th day after admission. Initial GGOs and consolidation in medial aspect of left upper lobe zone decreased on 18th day, while diffuse GGO and consolidation increased in remaining areas of lungs with appearance of diffuse haziness in both lungs and batwing sign. Crazy-paving and air-bronchogram sign were visible. Some GGO was also distributed along peripheral or subpleural regions. The COVID-19 infection was eventually confirmed by a real time reverse-transcription-polymerase chain-reaction assay. The hemoptysis gradually decreased and the dyspnea was relieved with symptomatic treatment and antiviral therapy according to the Guidelines and Management for COVID-19. A chest CT scan showed that the consolidation in both lungs were obviously absorbed; the GGO region enlarged but the GGO density decreased on day 24. CT findings on 24th day post admission. On day 24, consolidation was clearly absorbed. GGO regions were enlarged but GGO density had decreased. Some GGO was mixed with small patch consolidation. On day 29 post admission, GGO and a small patch of consolidation continued to be absorbed. Initial GGO on the first CT scan and the initial GGO and consolidation on the second CT scan in the apicoposterior segment of the left upper lobe were obviously absorbed. CT findings on 29th day post admission. On day 29, GGO and small patch consolidation continued to absorb. Initial GGO on first CT scan and initial GGO and consolidation on second CT scan in apicoposterior segment of left upper lobe were clearly absorbed. This study was approved by the ethics board of Hunan province Hospital, and the informed consent for present study was waived.",
        "es": "Un hombre de 57 a\u00f1os, sin antecedentes de insuficiencia respiratoria, acudi\u00f3 al servicio de urgencias de Hunan (China) con hemoptisis de 3 horas de evoluci\u00f3n. Neg\u00f3 haber viajado recientemente a Wuhan, en la provincia de Wuhan, o haber tenido ninguna exposici\u00f3n al 2019-nCoV. Las pruebas anal\u00edticas de ingreso no resultaron indicativas. Una TAC tor\u00e1cica simple mostr\u00f3 un \u00e1rea localizada de opacidades de vidrio esmerilado en el segmento apicoposterior del l\u00f3bulo superior izquierdo. Resultados radiol\u00f3gicos al ingresoUna TAC tor\u00e1cica simple mostr\u00f3 un \u00e1rea localizada de opacidades de vidrio esmerilado en el segmento apicoposterior del l\u00f3bulo superior izquierdo. La distribuci\u00f3n de las lesiones era b\u00e1sicamente medial. No se observaron lesiones en otras regiones de los pulmones. El paciente fue ingresado en el hospital con presunta infecci\u00f3n pulmonar o tuberculosis. Tres d\u00edas despu\u00e9s del ingreso, se observ\u00f3 una peque\u00f1a cantidad de derrame pleural. No se hallaron resultados afirmativos en el drenaje del derrame pleural. No se pudo controlar la hemoptisis con tratamiento sintom\u00e1tico, incluida hemostasia y terapia antiinfecciosa. Ocho d\u00edas despu\u00e9s, una TAC tor\u00e1cica de seguimiento mostr\u00f3 que las opacidades de vidrio esmerilado del l\u00f3bulo superior izquierdo hab\u00edan pasado a consolidaciones. Resultados radiol\u00f3gicos el 8.\u00ba d\u00eda despu\u00e9s del ingresoLa TAC tor\u00e1cica mostr\u00f3 que las opacidades de vidrio esmerilado del l\u00f3bulo superior izquierdo hab\u00edan pasado a consolidaciones. Se observaron nuevas opacidades de vidrio esmerilado en el segmento lingual del l\u00f3bulo superior izquierdo y el segmento superior del l\u00f3bulo inferior izquierdo distribuidas en regiones subpleurales. Aparecieron opacidades de vidrio esmerilado en el segmento superior del l\u00f3bulo inferior izquierdo. El d\u00eda 10 tras el ingreso se confirm\u00f3 hemorragia en el segmento apicoposterior del l\u00f3bulo superior izquierdo mediante fibrobroncoscopia. El paciente present\u00f3 fiebre el d\u00eda 11 y alcanz\u00f3 una temperatura m\u00e1xima de 39 \u00baC. El d\u00eda 14 present\u00f3 disnea, que empeor\u00f3 progresivamente. El d\u00eda 18 despu\u00e9s del ingreso, las opacidades de vidrio esmerilado y las consolidaciones en la cara medial del l\u00f3bulo superior izquierdo hab\u00edan disminuido, mientras que las opacidades de vidrio esmerilado difusas y las consolidaciones aumentaron en las restantes \u00e1reas de los pulmones. El paciente mostr\u00f3 infiltraciones difusas en ambos pulmones, con patr\u00f3n en alas de mariposa y patr\u00f3n en empedrado, as\u00ed como broncograma a\u00e9reo. Las opacidades de vidrio esmerilado estaban distribuidas por las regiones perif\u00e9ricas o subpleurales. Resultados radiol\u00f3gicos el 18.\u00ba d\u00eda despu\u00e9s del ingreso En el d\u00eda 18, las opacidades de vidrio esmerilado iniciales y las consolidaciones en la cara medial del l\u00f3bulo superior izquierdo hab\u00edan disminuido, mientras que las opacidades de vidrio esmerilado difusas y las consolidaciones aumentaron en las restantes \u00e1reas de los pulmones, con infiltraciones difusas y patr\u00f3n en alas de mariposa. Algunas opacidades de vidrio esmerilado estaban distribuidas por las regiones perif\u00e9ricas o subpleurales. La infecci\u00f3n por COVID-19 fue confirmada finalmente mediante RT-PCR en tiempo real. La hemoptisis mejor\u00f3 gradualmente y la disnea fue mitigada con tratamiento sintom\u00e1tico y terapia antiv\u00edrica, seg\u00fan las directrices para la COVID-19. Una TAC tor\u00e1cica mostr\u00f3 que las consolidaciones en ambos pulmones se hab\u00edan absorbido; para el d\u00eda 24, el \u00e1rea con opacidades de vidrio esmerilado hab\u00eda aumentado, pero su densidad hab\u00eda disminuido. Resultados radiol\u00f3gicos el 24.\u00ba d\u00eda despu\u00e9s del ingreso El d\u00eda 24 las consolidaciones se hab\u00edan absorbido con claridad. Algunas opacidades de vidrio esmerilado estaban mezcladas con peque\u00f1as consolidaciones parcheadas. El d\u00eda 29 despu\u00e9s del ingreso, las opacidades de vidrio esmerilado y un peque\u00f1o n\u00facleo de consolidaci\u00f3n segu\u00edan absorbi\u00e9ndose. Las opacidades de vidrio esmerilado de la primera TAC y las opacidades de vidrio esmerilado y consolidaciones de la segunda TAC en el segmento apicoposterior del l\u00f3bulo superior izquierdo se hab\u00edan absorbido claramente. Resultados radiol\u00f3gicos el 29.\u00ba d\u00eda despu\u00e9s del ingreso El d\u00eda 29, las opacidades de vidrio esmerilado y un peque\u00f1o n\u00facleo de consolidaci\u00f3n segu\u00edan absorbi\u00e9ndose. Las opacidades de vidrio esmerilado de la primera TAC y las opacidades de vidrio esmerilado y consolidaciones de la segunda TAC en el segmento apicoposterior del l\u00f3bulo superior izquierdo se hab\u00edan absorbido claramente. Este estudio fue autorizado por el comit\u00e9 de \u00e9tica del Hospital Provincial de Hunan y se prescindi\u00f3 del consentimiento informado."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 55-day-old otherwise healthy female infant of mixed feeding became ill with rhinorrhoea and a dry cough on January 28, 2020. She was admitted to our hospital on February 2, 2020. Before the onset of symptoms, she had been taken to Lu\u2019an, Hubei Province by her parents for a family party between January 16 and January 24, 2020. At that party, the infant\u2019s uncle and aunt, Wuhan residents, presented with cough and fever. Then, the child\u2019s parents were diagnosed with coronavirus disease 2019 (COVID-19) on January 31, 2020 based on their symptoms, chest imaging, and viral ribonucleic acid (RNA) in pharyngeal swabs. The nasopharyngeal swab obtained from the infant also tested positive for severe acute respiratory syndrome coronavirus (SARS-CoV-2) on real-time, reverse-transcription polymerase-chain-reaction (RT-PCR) assay. On admission, the physical examination showed that vital signs were within normal ranges except for pharyngeal hyperemia. A chest computed tomographic (CT) scan was reported as showing patchy shadows and ground-glass opacity in the right lung. Laboratory results reflected there were alterations in hepatic function measures and mildly abnormal myocardial zymogram. Lymphocyte count, platelet count, CD8+ T lymphocyte count, and serum immunoglobulin (Ig)M level were all mildly elevated. Other laboratory examinations including hemoglobin, D-dimer, activated partial thromboplastin time, prothrombin time, C-reactive protein, erythrocyte sedimentation rate, and renal function in this patient showed no abnormalities. Both rotavirus in stool and cytomegalovirus deoxyribonucleic acid in blood were negative. Based on the definite contact history and the above test results, the infant was diagnosed as COVID-19 (ordinary type). She was isolated and treated empirically with the inhaled interferon \u03b1-1b (15 \u03bcg, bid), amoxicillin potassium clavulanate (30 mg/kg, q8h, intravenous glucose tolerance test [IVGTT]), reduced glutathione, ursodeoxycholic acid, and traditional Chinese medicine lotus qingwen. On days 2 through 6 of hospitalization (days 7 through 11 of illness), the patient became sicker, presenting as a frequently productive cough accompanied by occasional tachycardia (150\u2013170 beats per minute). Decreased arterial oxygen partial pressures (lowest PaO2, 56 mmHg) with elevated lactic acid while breathing ambient air were found in the morming of hospital day 4. She received sputum suctioning. Meanwhile, oxygen was supplied through a nasal cannula immediately, and ambroxol was administrated to eliminate phlegm. Because there was a trend of aggravation in the disease grade, a second chest CT scan was performed in the evening of hospital day 4 (illness day 9), which showed evidence of progressive pneumonia. These radiographic findings coincided with a progress in respiratory status. Abnormal myocardial zymogram on admission and increased troponin I (0.025 \u03bcg per liter) on hospital day 4 indicated myocardia injury, so intravenous sodium creatine phosphate was added to protect her heart. During this period, the baby still had a good appetite, without diarrhea, oliguria, or shock. On day 11 of the patient\u2019s illness, a stool specimen was collected for the first time to detect the viral RNA, and the PCR result showed positive.",
        "es": "Una ni\u00f1a de 55 d\u00edas, por lo dem\u00e1s sana, con lactancia mixta, se puso enferma con rinorrea y tos seca el 28 de enero de 2020. Ingres\u00f3 en nuestro hospital el 2 de febrero de 2020. Antes del inicio de los s\u00edntomas, entre el 16 y el 24 de enero, sus padres la hab\u00edan llevado a Lu\"an (provincia de Hubei) para una fiesta familiar. En dicha fiesta, el t\u00edo y la t\u00eda de la ni\u00f1a, residentes en Wuhan, presentaron tos y fiebre. Luego, el 31 de enero de 2020, se diagnostic\u00f3 COVID-19 a los padres de la ni\u00f1a, a partir de sus s\u00edntomas, de radiograf\u00edas tor\u00e1cicas y de pruebas de \u00e1cido nucleico de frotis far\u00edngeos. El frotis nasofar\u00edngeo obtenido de la ni\u00f1a tambi\u00e9n result\u00f3 positivo para el s\u00edndrome respiratorio agudo grave de coronavirus (SARS-CoV-2) en una RT-PCR en tiempo real. Al ingreso, la exploraci\u00f3n f\u00edsica mostr\u00f3 que las constantes vitales eran normales excepto por hiperemia far\u00edngea. Una TAC tor\u00e1cica mostr\u00f3 sombras parcheadas y opacidades de vidrio esmerilado en el pulm\u00f3n derecho. Las pruebas anal\u00edticas indicaron alteraciones en los valores de capacidad funcional hep\u00e1tica y un cimograma mioc\u00e1rdico levemente anormal. La cifra de linfocitos, la cifra de trombocitos, la cifra de linfocitos T CD8+ y el valor de la inmunoglobulina (Ig)M s\u00e9rica eran ligeramente altos. Otras pruebas anal\u00edticas de la paciente no mostraron alteraciones, como hemoglobina, d\u00edmero D, tiempo de tromboplastina parcial activado, tiempo de protrombina, prote\u00edna C-reactiva, velocidad de sedimentaci\u00f3n globular y capacidad funcional renal. Las pruebas para rotavirus en heces y para citomegalovirus en sangre fueron negativas. A partir de los claros antecedentes de contacto y los resultados anteriores, se diagnostic\u00f3 a la ni\u00f1a con COVID-19 (tipo normal). Se aisl\u00f3 y se trat\u00f3 emp\u00edricamente con interfer\u00f3n \u03b1-1b (15\u03bcg, dos veces al d\u00eda) por v\u00eda inhalatoria, amoxicilina/clavulanato de potasio (30 mg/kg, cada 8 horas, prueba de tolerancia de glucosa i.v. En los d\u00edas 2 a 6 de hospitalizaci\u00f3n (d\u00edas 7 a 11 de la enfermedad), la paciente empeor\u00f3, presentando tos productiva frecuente y taquicardia ocasional (150-170 l.p.m.). A la ma\u00f1ana del cuarto d\u00eda de hospitalizaci\u00f3n se observ\u00f3 una disminuci\u00f3n de la presi\u00f3n parcial de ox\u00edgeno arterial (PaO2 m\u00e1s baja: 56 mmHg) con altos valores de \u00e1cido l\u00e1ctico al respirar aire ambiental. Se le aplic\u00f3 aspiraci\u00f3n del esputo. Mientras, se le suministr\u00f3 ox\u00edgeno inmediatamente mediante c\u00e1nula nasal y se le administr\u00f3 ambroxol para eliminar la flema. Como se observ\u00f3 una tendencia al empeoramiento, se realiz\u00f3 una segunda TAC tor\u00e1cica la noche del cuarto d\u00eda de hospitalizaci\u00f3n (d\u00eda 9 de enfermedad), que mostr\u00f3 evidencias de progresi\u00f3n de neumon\u00eda. Los resultados radiol\u00f3gicos coincid\u00edan con un empeoramiento del estado respiratorio. El cimograma mioc\u00e1rdico anormal al ingreso y un aumento de la troponina I (0,025 \u03bcg por litro) en el cuarto d\u00eda de hospitalizaci\u00f3n indicaban lesiones mioc\u00e1rdicas, de modo que se le administr\u00f3 fosfocreatina s\u00f3dica i.v. para proteger el coraz\u00f3n. Durante este periodo, la ni\u00f1a segu\u00eda teniendo buen apetito y no present\u00f3 diarrea, oliguria ni choque. El d\u00eda 11 de enfermedad, se recogi\u00f3 una muestra de heces por primera vez para detectar ARN v\u00edrico; el resultado de la PCR fue positivo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 52 years-old-man was evaluated in our Emergency Department (ED) because of fever, cough, asthenia, headache, myalgia and photophobia since one week. He denied any travel during the last months, but reported a history of contact with several Chinese people (none with documented nCoV-19 infection) and Italian people coming from the City of Bergamo (Northern Italy), currently considered a high-risk area for nCoV-19 infection by the Italian Ministry of Health. His on-air oxygen saturation was 90% and low-flow oxygen therapy was started. On clinical examination, the man looked suffering and dyspneic, lung auscultation documented bilateral crackles. The remaining examination was unremarkable. Blood tests showed lymphocytopenia, thrombocytopenia, high LDH and inflammatory markers. Blood cultures were performed, and antibiotic therapy started. Chest X-ray showed a doubtful left peri-hylar hypodiafania. We also performed lung ultrasound. After these procedures, swab for respiratory viruses and nCoV-19 was performed and later resulted positive for nCoV-19. Lung ultrasound was performed with a portable convex probe (3.5 mHz), wireless-connected with a tablet. Such a device, despite providing lower-quality images compared to last generation machines, was chose in order to minimize the risk of contamination of devices and subsequent nosocomial spread. Two operators, one ED physician (operator 1) and one ED nurse (operator 2), entered the isolation room respecting all the preventive measures for respiratory, droplet and contact isolation provided by the World Health Organization for the nCoV-19 outbreak. The ultrasound probe and the tablet were put in two different sterile, plastic probe and tablet covers. Operator 1 performed lung ultrasound using the wireless probe and, therefore, entered in contact with the patient. Operator 2 held the tablet and was responsible to freeze and store images/videos, therefore did not touch neither the patient nor anything else within the room. This procedure was shared and agreed by the two operators before entering the room, in order to minimize contamination risk due to the high-risk setting. At the end of the procedure, the tablet and probe were sterilized in a dedicated area and put into two new sterile plastic bags. The thorax was scanned in the following 12 lung areas at bed-side: anterior superior and inferior, lateral superior and inferior, posterior superior and inferior, bilaterally. Informed consent was obtained. In our Institution, the use of lung ultrasound is routinely included in the management of patients with respiratory conditions and approved by the Ethic Commitee. Lung ultrasound showed, on the anterior and posterior emi-thorax bilaterally, an irregular pleural line with small subpleural consolidations, areas of white lung and thick, confluents and irregular vertical artifacts (B-lines). Spared areas were present bilaterally, mixed with pathological areas.",
        "es": "En nuestro servicio de urgencias se present\u00f3 un hombre de 52 a\u00f1os que report\u00f3 fiebre, tos, astenia, cefalea, mialgia y fotofobia de una semana de evoluci\u00f3n. Afirm\u00f3 no haber viajado durante los \u00faltimos meses, pero inform\u00f3 de contactos con diversas personas chinas (ninguna de ellas con antecedentes de infecci\u00f3n por nCoV-19) e italianas procedentes de la ciudad de B\u00e9rgamo (norte de Italia), actualmente considerada zona de alto riesgo para las infecciones por nCoV-19 por parte del ministerio de salud de Italia. Su saturaci\u00f3n de ox\u00edgeno con aire ambiental era de 90% y se inici\u00f3 oxigenoterapia de bajo flujo. A la exploraci\u00f3n, el paciente ten\u00eda aspecto enfermo y disneico; a la auscultaci\u00f3n se percibieron crepitantes bilaterales. El resto de la exploraci\u00f3n no aport\u00f3 m\u00e1s datos relevantes. Las pruebas anal\u00edticas mostraron linfocitopenia, trombocitopenia, valores altos de LDH y marcadores inflamatorios. Se realizaron hemocultivos y se inici\u00f3 un tratamiento antibi\u00f3tico. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 una posible condensaci\u00f3n perihiliar izquierda. Tambi\u00e9n se realiz\u00f3 una ecograf\u00eda pulmonar. Tras estas intervenciones, se realiz\u00f3 un frotis para pruebas de virus respiratorios y nCoV-19; el resultado fue positivo para nCoV-19. La ecograf\u00eda pulmonar se realiz\u00f3 con un transductor convexo port\u00e1til (3,5 mHz) con conexi\u00f3n inal\u00e1mbrica a una tableta. Se escogi\u00f3 este dispositivo porque, si bien proporciona im\u00e1genes de baja calidad en comparaci\u00f3n con los aparatos de \u00faltima generaci\u00f3n, permit\u00eda minimizar el riesgo de contaminaci\u00f3n de aparatos y la consiguiente propagaci\u00f3n de infecciones nosocomiales. Dos operadores, un m\u00e9dico de urgencias (operador 1) y una enfermera de urgencias (operador 2), entraron en la sala de aislamiento respetando todas las medidas de prevenci\u00f3n para aislamiento respiratorio, de got\u00edculas y de contacto establecidas por la Organizaci\u00f3n Mundial de la Salud para el brote de nCoV-19. El transductor y la tableta se introdujeron en dos fundas de pl\u00e1stico diferentes. El operador 1 realiz\u00f3 la ecograf\u00eda pulmonar mediante el transductor inal\u00e1mbrico y, en consecuencia, entr\u00f3 en contacto con el paciente. El operador 2 sostuvo la tableta y era el responsable de capturar y guardar las im\u00e1genes y v\u00eddeos; en consecuencia no entr\u00f3 en contacto con el paciente ni con ning\u00fan otro objeto de la sala. El protocolo fue compartido y aceptado por los dos operadores antes de entrar en la sala, para minimizar el riesgo de contaminaci\u00f3n en un ambiente de alto riesgo. Al finalizar la intervenci\u00f3n, la tableta y el transductor se esterilizaron en una zona destinada a tal efecto y luego se introdujeron en dos nuevas bolsas de pl\u00e1stico est\u00e9riles. Se explor\u00f3 el t\u00f3rax en las siguientes 12 \u00e1reas: anterior superior e inferior, lateral superior e inferior, posterior superior e inferior, bilateralmente. Se obtuvo el consentimiento informado. En nuestra instituci\u00f3n, el uso de ecograf\u00edas pulmonares se incluye de forma rutinaria en la atenci\u00f3n a pacientes con afecciones respiratorias y est\u00e1 autorizado por el comit\u00e9 de \u00e9tica. La ecograf\u00eda pulmonar mostr\u00f3, en los hemit\u00f3rax anterior y posterior, bilateralmente, una l\u00ednea pleural irregular, con peque\u00f1as consolidaciones subpleurales, zonas de pulm\u00f3n blanco y artefactos verticales irregulares, confluentes y gruesos (l\u00edneas B). Las zonas sanas se presentaban bilateralmente, mezcladas con zonas patol\u00f3gicas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 50-year-old man with end-stage renal disease due to IgA nephropathy, recipient of a 3rd deceased-donor kidney transplant in 2016 with serum creatinine (Cr) of 1.3 mg/dL and estimated glomerular filtration rate (eGFR) of 60 mL/min, was admitted on February 28th to the emergency room (ER) with a 24-hour history of fever (38.2\u00baC/100.8\u00baF) and vomiting. He reported no other symptoms, nor had a history of travels abroad nor exposure to patients infected or suspected of contagious COVID-19. Previous medical history included an elective splenectomy performed in 2003 due to immune thrombocytopenia, and an Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) in 2005, treated with rituximab and withdrawal of immunosuppression, achieving complete response of the PTLD, but leading to rejection and failure of the 2nd kidney graft. Following PTLD remission and a negative EBV viral load, he received a 3rd kidney transplant with induction immunosuppression (IS) with thymoglobulin, tacrolimus, everolimus and steroids, and maintenance IS with tacrolimus, everolimus and prednisone 5 mg QD. He was also under treatment with losartan 50 mg bid due to arterial hypertension. At first evaluation in the ER the patient presented signs of mild dehydration. Physical examination was otherwise unremarkable, including breath sounds on chest auscultation. On blood workup acute phase reactants were normal, such as a C-reactive protein (CRP) of < 0.50 mg/dL (normal range <1.0mg/dL) and white blood cells (WBC) count of 8.58\u00d7 109/L, but a mild kidney function impairment (Cr 1.6 mg/dL, eGFR 50 mL/min). He was discharged with a presumptive diagnosis of non-severe viral gastroenteritis, and oralhydration and on demand acetaminophen were prescribed. Five days later patient returned to the ER with persistent fever, but at this time, with productive cough. He no longer presented gastrointestinal symptoms. Physical examination revealed a body temperature of 37.4\u00b0C, blood pressure of 180/100 mmHg, pulse of 66 beats per minute, respiratory rate of 16 breaths per minute, and blood oxygen saturation of 98% on room air. He presented with signs of mucous dehydration and crackles in the right lower lung, as well as signs of conjunctivitis of his left eye. He presented no murmurs, rubs or gallops on heart exam. His abdomen was soft and nontender, and neurologic examination was unremarkable. WBC count on peripheral blood was 10.15 \u00d7 109/L (total lymphocyte count 1.8\u00d7 109U/L), with a platelet count of 126 \u00d7 109/L, a CRP of 13.2 mg/dL, and a procalcitonin of 0-18ng/mL (normal range <0.50ng/mL). Persistent mild kidney function impairment (Cr 1.6 mg/dL) and hyponatremia of 129 mEq/L were also observed. Liver transaminases and coagulation were within normal reference values. There was a medium lobe consolidation on posteroanterior chest radiograph. Therefore, the diagnosis of community-acquired pneumonia was assumed, and he was empirically started on ceftriaxone 1 g QD and azithromycin 500 mg QD. A nasopharyngeal swab specimen was performed, and a rapid nucleic acidamplification test for influenza A and B and respiratory syncytial virus were reported back as negative. Thereafter, although the patient didn\u2019t have any travel history nor reported known contacts with contagious or infected people, nasopharyngeal and oropharyngeal swab specimens were collected for testing COVID-19, following an update of local authorities\u2019 screening protocol of pneumonia of undetermined aetiology. Both swabs for SARS-CoV-2 by real-time reverse-transcriptase\u2013polymerasechain-reaction (rRT-PCR) assay were reported positive (hereafter assumed as reference day \u2013 D0). Local protocol for COVID-19 was activated, with patient hospitalization under isolation, and treatment with oral Lopinavir/Ritonavir 400/100 BID was initiated at D+1. Due to the interaction of Ritonavir with calcineurin inhibitors, tacrolimus was withdrawn, as was everolimus due to its reported risk for mTOR-inhibitor induced neumonitis. Empirical broad spectrum antibiotic was also initiated (ceftaroline and meropenem) and maintained, despite negative microbiological cultures for viral, bacterial, or fungal infections, including aspergillosis, pneumocystis, and mycobacteria\u2019s. Oral hydroxychloroquine treatment was prescribed (400mg BID for 24h, afterwards 200mg BID; oral). After 10 days since the initial symptoms and 72h after supportive and anti-viral treatment, the patient presented a worsening in respiratory symptoms, with hypoxia in spite of the use of high-flux nasal oxygen delivery, and a progression to diffuse bilateral infiltrates on chest X-ray. Interferon Beta was initiated at this moment. The patient was intubated (D+6), with ventilatory supportive care using high positive end-respiratory pressure (PEEP; 12cmH2O). Serum creatinine increased to 2.1 mg/dL (GFR of 30ml/min), with tacrolimus through level 10 days after suspension remaining at 5.1 ng/mL. As of today (D+12), the patient remains under respiratory supportive therapy in the ICU, hemodynamically stable, under treatment with Lopinavir/Ritonavir 400/100mg BID (oral solution - pending a switch to Remdesivir once it is available at the hospital), Interferon Beta (250mcg every 48h; subcutaneous), and Hydroxychloroquine (200mg BID; oral), with serum creatinine of 3.0mg/dL, Leucocytes 14.5\u00d7 109 U/L, Lymphocytes 0.9\u00d7 109 U/L, Haemoglobin 9.3g/dL, platelet count of 410\u00d7 109 U/L, D-Dimer of 8900ng/mL (normal range <500), and procalcitonin of 0.54ng/mL without further progression of respiratory failure.",
        "es": "El 28 de febrero acudi\u00f3 al servicio de urgencias un hombre de 50 a\u00f1os con nefropat\u00eda por IgA, receptor en 2016 de un tercer ri\u00f1\u00f3n de un donante fallecido, con creatinina s\u00e9rica (Cr) de 1,3 mg/dL y una filtraci\u00f3n glomerular estimada (FGe) de 60 mL/min; report\u00f3 fiebre (38,2 \u00baC) y v\u00f3mitos de 24 horas de evoluci\u00f3n. No report\u00f3 otros s\u00edntomas ni ten\u00eda antecedentes de viajes al extranjero ni de exposici\u00f3n a pacientes infectados o presuntamente infectados de COVID-19. Sus antecedentes m\u00e9dicos indicaban una esplenectom\u00eda programada en 2003, provocada por trombocitopenia, y enfermedad linfoproliferativa postrasplante (ELP) asociada al virus de Epstein-Barr (EBV), tratada con rituximab y retirada de la inmunosupresi\u00f3n, lo que llev\u00f3 a una remisi\u00f3n completa de la ELP, pero provoc\u00f3 rechazo e insuficiencia del segundo injerto renal. Tras la remisi\u00f3n de la ELP y una carga viral negativa de EBV, recibi\u00f3 un tercer trasplante renal con inducci\u00f3n de inmunosupresi\u00f3n (IS) mediante timoglobulina, tracr\u00f3limus, ever\u00f3limus y esteroides, y tratamiento IS de mantenimiento con tacr\u00f3limus, ever\u00f3liumus y prednisona 5 mg al d\u00eda. Tambi\u00e9n estaba en tratamiento de hipertensi\u00f3n arterial con 50 mg de losart\u00e1n dos veces al d\u00eda. En una primera evaluaci\u00f3n en el servicio de urgencias, el paciente mostraba s\u00edntomas de una ligera deshidrataci\u00f3n. La exploraci\u00f3n f\u00edsica fue, por lo dem\u00e1s, irrelevante, incluyendo los ruidos respiratorios a la auscultaci\u00f3n. Los an\u00e1lisis cl\u00ednicos de prote\u00ednas de la fase aguda resultaron normales, como prote\u00edna C-reactiva < 0,50 mg/dL (valor normal < 1,0 mg/dL) y cifra de leucocitos de 8,58 x 109/L, pero una ligera disfunci\u00f3n renal (Cr 1,6 mg/dL, FGe 50 mL/min). Fue dado de alta con un diagn\u00f3stico provisional de gastroenteritis v\u00edrica no grave y se le recet\u00f3hidrataci\u00f3n oral y acetaminof\u00e9n a demanda. Cinco d\u00edas despu\u00e9s, el paciente regres\u00f3 al servicio de urgencias con fiebre persistente pero, esta vez, con tos productiva. Ya no presentaba s\u00edntomas gastrointestinales. La exploraci\u00f3n f\u00edsica mostr\u00f3 una temperatura de 37,4 \u00b0C, presi\u00f3n arterial de 180/100 mmHg, pulso de 66 l.p.m., frecuencia respiratoria de 16 r.p.m. y saturaci\u00f3n de ox\u00edgeno del 98% en aire ambiental. Presentaba signos de deshidrataci\u00f3n mucosa y crepitantes en la parte inferior del pulm\u00f3n derecho, as\u00ed como signos de conjuntivitis en el ojo izquierdo. La exploraci\u00f3n card\u00edaca no mostr\u00f3 soplos, roces ni galopes. El abdomen era blando, indoloro y depresible y la exploraci\u00f3n neurol\u00f3gica fue normal. La cifra de leucocitos en sangre perif\u00e9rica fue de 10,15 x 109/L (cifra de linfocitos total 1,8 x 109 U/L), con una cifra de trombocitos de 126 x 109/L, una prote\u00edna C-reactiva de 13,2 mg/dL y un valor de procalcitonina de 0-18 ng/mL (valor normal < 0,50 ng/mL). Tambi\u00e9n se observ\u00f3 una ligera disfunci\u00f3n renal persistente (Cr 1,6 mg/dL) e hiponatremia (129 mEq/L). Las transaminasas hep\u00e1ticas y la coagulaci\u00f3n estaban dentro de los valores normales de referencia. En la radiograf\u00eda anteroposterior se observ\u00f3 una consolidaci\u00f3n en el l\u00f3bulo medio. En consecuencia, se asumi\u00f3 un diagn\u00f3stico de neumon\u00eda extrahospitalaria y se inici\u00f3 un tratamiento provisional de ceftriaxona (1 g al d\u00eda) y azitromicina (500 mg al d\u00eda). Se realiz\u00f3 un frotis nasofar\u00edngeo y una prueba r\u00e1pida de amplificaci\u00f3n de \u00e1cido nucleico para gripe A y B y virus sincicial respiratorio, que dieron resultado negativo. Posteriormente, aunque el paciente no ten\u00eda antecedentes de viajes ni de contactos conocidos con personas infectadas o contagiosas, se recogieron frotis nasofar\u00edngeos y orofar\u00edngeos para pruebas de COVID-19, tras una actualizaci\u00f3n del protocolo de cribado de las autoridades locales para neumon\u00edas de origen indeterminado. Las pruebas mediante RT-PCR en tiempo real para SARS-CoV-2 de ambos frotis resultaron positivas (a partir de este momento considerado como d\u00eda de referencia: D0). Se activ\u00f3 el protocolo local para la COVID-19, con hospitalizaci\u00f3n del paciente en aislamiento y el d\u00eda D+1 se inici\u00f3 el tratamiento con lopinavir/ritonavir 400/100 dos veces al d\u00eda por v\u00eda oral. A causa de la interacci\u00f3n del ritonavir con los inhibidores de la calcineurina, se retir\u00f3 el tacr\u00f3limus, al igual que el ever\u00f3milus a causa del riesgo se\u00f1alado de neumonitis inducida por inhibidores de la mTOR. Se inici\u00f3 y se mantuvo un tratamiento provisional de antibi\u00f3ticos de amplio espectro (ceftarolina y meronepem), a pesar de los resultados negativos de los cultivos de infecciones v\u00edricas, bacterianas o f\u00fangicas, como aspergilosis, neumocistosis o micobacterias. Se recet\u00f3 hidroxicloroquina por v\u00eda oral (400 mg dos veces al d\u00eda durante 24 horas; despu\u00e9s 200 mg dos veces al d\u00eda). Despu\u00e9s de 10 d\u00edas desde los s\u00edntomas iniciales y 72 h de tratamiento sintom\u00e1tico y antiv\u00edrico, el paciente mostr\u00f3 un empeoramiento de los s\u00edntomas respiratorios, con hipoxia, a pesar del aporte de ox\u00edgeno nasal de alto flujo, y una progresi\u00f3n a infiltrados difusos bilaterales en la TAC tor\u00e1cica. En este momento se le empez\u00f3 a administrar interfer\u00f3n \u00df. El paciente fue intubado (D+6), con respiraci\u00f3n asistida y alta presi\u00f3n positiva telespiratoria (12 cmH2O). Se aument\u00f3 la creatinina s\u00e9rica a 2,1 mg/dL (FGe de 30 ml/min), con tacrolimus, manteni\u00e9ndose 10 d\u00edas despu\u00e9s de la retirada a 5,1 ng/mL. A d\u00eda de hoy (D+12), el paciente sigue con respiraci\u00f3n asistida en la UCI, est\u00e1 hemodin\u00e1micamente estable y sigue con tratamiento de lopinavir/ritonavir 400/100 mg dos veces al d\u00eda (soluci\u00f3n oral, pendiente de cambiar a remdesivir cuando est\u00e9 disponible en el hospital), interfer\u00f3n \u00df (250 mcg cada 48 h, subcut\u00e1neo) e hidroxicloroquina (200 mg dos veces al d\u00eda por v\u00eda oral)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The patient, a 51-year-old male, contacted the Scottish telehealth service for advice on day +1 with a 24-hour history of fever and cough having returned to Scotland from northern Italy on day -2. His symptoms were in keeping with a \u201cpossible\u201d case of COVID-19 according to the national case definition at the time. Community SARS-CoV-2 testing was arranged for day +2. The patient had travelled to Italy on day -9 to watch a rugby match in Rome. He travelled with his partner and two friends in a private rental vehicle through Lombardy, Veneto and Tuscany, staying in private rental accommodation, before flying back to Scotland from Milan on day -2. He was not aware of any contact with cases of COVID-19. On day 0 he developed fever, myalgia, malaise and sinusitis. This progressed to a cough productive of green sputum on day +1. His fever had subsided by day +2. The patient remained in self isolation in the community whilst awaiting the results of SARS-CoV-2 PCR which was performed in the West of Scotland Specialist Virology Centre on a combined nose/throat swab. This sample tested positive for SARS-CoV-2 on day +3 with a threshold cycle (Ct) value of 36. An urgent teleconference was held between virology, public health, Scottish ambulance service and the receiving regional High Consequence Infectious Diseases (HCID) unit. The patient was subsequently transferred by Special Operations Response Team (SORT) ambulance to the HCID unit. The patient was escorted from the ambulance to a laminar flow room (with antechamber) on the first floor of the unit by medical staff in appropriate personal protective equipment (PPE). The patient was wearing a surgical face mask throughout transit. The ambulance staff returned to their base for doffing of PPE. He was a lifelong non-smoker. His medical history consisted only of hypertension. He had no known underlying lung disease. He took an ACE-inhibitor and self-medicated with paracetamol and non-steroidal anti-inflammatory drugs during his illness. On admission, the patient was afebrile with a mild non-productive cough. He had no limitation in exercise tolerance during this acute illness and continued to exercise in his home whilst self-isolating. On assessment, lung fields were clear on auscultation and bilateral scleral injection was noted. Admission vital signs were: heart rate 79 beats per minute, blood pressure 171/105mmHg, respiratory rate 18, pulse oximetry 96% on air and temperature 36.5. By day three of admission the patient had lymphocytopenia, which was found in 80.4% of patients with laboratory-confirmed non-severe COVID-19 in mainland China3. Chest radiography was not clinically indicated. PCR testing for other respiratory viruses, Mycoplasma pneumoniae and Chlamydia pneumoniae on the throat swab was negative. Nose and throat samples for SARS-CoV-2 PCR were obtained daily to monitor viral shedding. SARS-CoV-2 PCR on urine, faeces and EDTA blood was negative. The patient was clinically well throughout the admission; no supportive care was required. He was discharged after 8 days, following two sequential nose and throat swabs negative for SARS-CoV-2 by PCR. The initial viral sample was sequenced by the MRC-University of Glasgow Centre for Virus Research, mapped against the Wuhan-Hu-1 reference genome and aligned with a collection of global SARS-CoV-2 sequences, with the resulting analysis released open access. Phylogenetic analysis demonstrated that Scotland/CVR01/2020 belonged to a clade of isolates all acquired in northern Italy4.",
        "es": "El paciente, un hombre de 51 a\u00f1os, se puso en contacto con el servicio de teleasistencia sanitaria para pedir asesoramiento el d\u00eda +1, con fiebre y tos de un d\u00eda de evoluci\u00f3n; hab\u00eda regresado a Escocia procedente del norte de Italia el d\u00eda -2. Sus s\u00edntomas coincid\u00edan con un posible caso de COVID-19 de acuerdo con la definici\u00f3n nacional de casos en ese momento. Se acord\u00f3 una prueba extrahospitalaria de SARS-CoV-2 para el d\u00eda +2. El paciente hab\u00eda viajado a Italia el d\u00eda -9 para asistir a un partido de rugby en Roma; luego, hab\u00eda viajado con su pareja y dos amigos por la Lombard\u00eda, el V\u00e9neto y la Toscana, desplaz\u00e1ndose en un coche de alquiler y haciendo estancia en casas privadas de alquiler, antes de regresar a Escocia desde Mil\u00e1n el d\u00eda -2. No ten\u00eda constancia de ning\u00fan contacto con casos de COVID-19. El d\u00eda 0 comenz\u00f3 a tener fiebre, mialgia, malestar general y sinusitis. El d\u00eda +1 estos s\u00edntomas evolucionaron a tos productiva con expectoraci\u00f3n verde. La fiebre hab\u00eda desaparecido el d\u00eda +2. El paciente permaneci\u00f3 autoconfinado en su vecindario esperando los resultados de la PCR de SARS-CoV-2, que se realiz\u00f3 en el West of Scotland Specialist Virology Centre a partir de un frotis nasofar\u00edngeo. La muestra dio positivo para SARS-CoV-2 el d\u00eda +3, con ciclo liminar (Ct) de 36. Se celebr\u00f3 una teleconferencia urgente con los servicios de virolog\u00eda, salud p\u00fablica, ambulancias de Escocia y la unidad receptora regional de enfermedades infecciosas de gran relevancia (HCID, High Consequence Infectious Diseases). El paciente fue trasladado a la unidad HCID mediante una ambulancia de operaciones especializadas (SORT, Special Operations Response Team). Se llev\u00f3 al paciente de la ambulancia a una sala de flujo laminar (con antec\u00e1mara) en la primera planta de la unidad, acompa\u00f1ado de personal m\u00e9dico con equipos adecuados de protecci\u00f3n individual (EPI). El paciente llev\u00f3 una mascarilla quir\u00fargica durante todo el traslado. El personal de ambulancia regres\u00f3 a su sede para quitarse los EPI. El paciente gozaba de buena salud y hac\u00eda ejercicio con regularidad. Nunca hab\u00eda sido fumador. Sus antecedentes m\u00e9dicos eran de hipertensi\u00f3n. No ten\u00eda ninguna neumopat\u00eda preexistente. Tomaba un inhibidor de la ECA y se automedic\u00f3 con paracetamol y antinflamatorios no esteroideos durante su afecci\u00f3n. Al ingreso, el paciente estaba afebril, con una tos leve no productiva. No not\u00f3 ning\u00fan l\u00edmite de tolerancia al ejercicio durante su afecci\u00f3n aguda y sigui\u00f3 practicando ejercicio en el hogar durante su autoconfinamiento. Los campos pulmonares eran claros a la auscultaci\u00f3n y se apreci\u00f3 congesti\u00f3n conjuntival. Las constantes vitales al ingreso eran: pulso de 79 l.p.m., presi\u00f3n arterial de 171/105 mmHg, frecuencia respiratoria de 18 r.p.m., pulsioximetr\u00eda de 96% en aire ambiental y temperatura de 36,5 \u00baC. El d\u00eda tres del ingreso el paciente mostr\u00f3 linfocitopenia, manifestaci\u00f3n que se ha hallado en el 80,4% de pacientes con COVID-19 no grave confirmada anal\u00edticamente en China. La radiograf\u00eda tor\u00e1cica no estaba cl\u00ednicamente indicada. Las pruebas mediante PCR de otros virus respiratorios a partir de frotis far\u00edngeos, Mycoplasma pneumoniae y Chlamydia pneumoniae, fueron negativas. Se obten\u00edan diariamente muestras nasofar\u00edngeas para las PCR de SARS-CoV-2, con el objetivo de hacer un seguimiento de la carga v\u00edrica. Los resultados de PCR para SARS-CoV-2 en orina, heces y sangre EDTA fueron negativos. El paciente estuvo cl\u00ednicamente estable durante toda la hospitalizaci\u00f3n y no se necesit\u00f3 tratamiento sintom\u00e1tico. Fue dado de alta despu\u00e9s de 8 d\u00edas, tras dos frotis nasofar\u00edngeos consecutivos negativos para SARS-CoV-2, analizados mediante PCR. La muestra v\u00edrica inicial fue secuenciada por el Centro de Investigaci\u00f3n V\u00edrica de la Universidad de Glasgow-Medical Research Council y se compar\u00f3 con el genoma de referencia Wuhan-Hu-1 y con un conjunto de secuencias globales de SARS-CoV-2; los resultados del an\u00e1lisis est\u00e1n disponibles en acceso libre. Los an\u00e1lisis filogen\u00e9ticos demostraron que Scotland/CVR01/2020 forma parte de un subtipo de cepas aisladas contra\u00eddas todas en el norte de Italia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 38-year-old man from Wuhan, the epicenter of the COVID-19 outbreak, presented with binaural hearing loss and tinnitus lasting for two months. He underwent endoscopic tympanometry on January 16; on the second postoperative day, he went outdoors and caught a cold. His body temperature was elevated to 38.1\u2103. Laboratory examination revealed a normal percentage neutrophil count (75.0%, normal range: 40.0\u201375.0%) and a decreased percentage lymphocyte count (14.8%, normal range: 20.0\u201350.0%). Screening was negative for multiple respiratory pathogens including influenza A, influenza B, respiratory syncytial virus, adenovirus, human parainfluenza virus, mycoplasma pneumoniae, and chlamydia pneumoniae. The patient's sputum tested positive for 2019-nCoV in a real-time polymerase chain reaction assay. On January 26, the patient developed a high fever and cough and was initiated on high-flow nasal cannula (HFNC) oxygen therapy. The fraction of inspired O2 (FiO2) was 80%, while the gas flow-rate was 20 L/min. The patient was continued on HFNC oxygen therapy from January 26 to February 4. On February 1, he suffered from chest tightness and palpitation. The arterial oxygen saturation (SpO2) could reach 90% after oxygen therapy. On February 5, he exhibited aggravated dyspnea and severe hypoxemia (SpO2 < 70%). He received non-invasive mechanical ventilation in the intensive care unit until February 10 with symptomatic relief. The initial FiO2 was 60%, while the gas flow-rate was 50 L/min. The modes used were pressure support ventilation and positive end-expiratory pressure with 1.18 KPa (12 cmH2O) and 0.98 KPa (10 cmH2O), respectively. Thereafter, the patient continued to receive HFNC oxygen therapy until the last follow-up CT scan. The initial chest CT showed ground-glass opacities (GGO) in the left lower lobe. Over the next 10 days, the lesions increased in extent and density and progressed to consolidation. The clinical symptoms deteriorated, and acute respiratory distress syndrome was diagnosed. A follow-up CT scan revealed emphysema. After 15 days of supportive treatment, chest CT showed an improvement in the pulmonary lesions, disappearance of the mediastinal emphysema, and appearance of a giant bulla in the left lung. Eight days later, the final follow-up CT scan revealed a small pneumothorax and pleural effusion in the left thorax.",
        "es": "Se present\u00f3 un hombre de 38 a\u00f1os, de Wuhan, epicentro del brote de COVID-19, con ac\u00fafenos e hipoacusia biauricular con una evoluci\u00f3n de dos meses. Se le realiz\u00f3 una timpanometr\u00eda endosc\u00f3pica el d\u00eda 16 de enero; el segundo d\u00eda de posoperatorio sali\u00f3 al exterior y se resfri\u00f3. Su temperatura era de 38,1 \u00baC. Las pruebas anal\u00edticas revelaron un porcentaje de neutr\u00f3filos normal (75,0%; intervalo normal: 40,0-75,0%) y un porcentaje elevado de linfocitos (14,8%; intervalo normal: 20,0-50,0%). Las pruebas de detecci\u00f3n fueron negativas para varios pat\u00f3genos respiratorios, como gripe A, gripe B, virus sincicial respiratorio, adenovirus, virus paragripal, Mycoplasma pneumoniae y Chlamydia pneumoniae. El esputo del paciente dio positivo para 2019-nCoV en el ensayo de PCR en tiempo real. El 26 de enero, el paciente present\u00f3 hipertermia y tos y se inici\u00f3 un tratamiento con oxigenoterapia mediante c\u00e1nula nasal de alto flujo. La fracci\u00f3n inspiratoria de ox\u00edgeno (FIO2) era del 80%, mientras que el caudal de aire era de 20 L/min. El paciente se mantuvo con oxigenoterapia hasta el 4 de febrero. El 1 de febrero report\u00f3 opresi\u00f3n tor\u00e1cica y palpitaciones. La saturaci\u00f3n de ox\u00edgeno arterial (SpO2) lleg\u00f3 al 90% tras la oxigenoterapia. El 5 de febrero, empeor\u00f3 su disnea y present\u00f3 hipoxemia grave (SpO2 < 70%). Se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica no invasiva en la unidad de cuidados intensivos hasta el 10 de febrero, con alivio sintom\u00e1tico. La FIO2 inicial era del 60%, mientras que el caudal de aire era de 50 L/min. Los modos empleados fueron respiraci\u00f3n asistida y alta presi\u00f3n positiva telespiratoria, con 1,18 kPa (12 cmH2O) y 0,98 kPa (10 cmH2O), respectivamente. Posteriormente, el paciente sigui\u00f3 recibiendo oxigenoterapia mediante c\u00e1nula nasal de alto flujo hasta la \u00faltima TAC de seguimiento. La TAC tor\u00e1cica inicial mostr\u00f3 opacidades de vidrio esmerilado en el l\u00f3bulo inferior izquierdo. Durante los 10 d\u00edas siguientes, las lesiones aumentaron en extensi\u00f3n y densidad y pasaron a consolidaciones. Los s\u00edntomas cl\u00ednicos empeoraron y se diagnostic\u00f3 s\u00edndrome de dificultad respiratoria aguda. Una TAC de seguimiento revel\u00f3 enfisema. Tras 15 d\u00edas de tratamiento sintom\u00e1tico, la TAC tor\u00e1cica mostr\u00f3 una mejora de las lesiones pulmonares, desaparici\u00f3n del enfisema mediast\u00ednico y aparici\u00f3n de una gran bulla en el pulm\u00f3n izquierdo. Ocho d\u00edas despu\u00e9s, la TAC final de seguimiento revel\u00f3 un ligero neumot\u00f3rax y derrame pleural en el t\u00f3rax izquierdo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The inpatient admission of a 59-year-old male was carried out with outpatient-confirmed SARS-CoV-2 infection with positive RT-PCR from a throat swab and relevant clinical symptoms. The patient had previously visited South Tirol. Six days prior to hospital admission, the patient exhibited initial symptoms in the form of chills and fever. He had no pre-existing conditions. At the time of admission there was a high fever of 40.0?\u00b0C and conspicuous tachypnea with a respiratory rate of 28/min with sufficient oxygenation (ambient air saturation 95?%). Clinically, there was also a severe general feeling of malaise with obvious fatigue. Laboratory results showed leukopenia with 3.8?\u00d7?109/l, lymphopenia with 0.96?\u00d7?109/l (25?%), an only slightly increased CRP with 14.7?mg/l and a low procalcitonin of 0.11?ng/ml. D-dimer as risk factor for instability was not increased at 370?\u00b5g. Interleukin-6 as inflammatory parameter was slightly elevated at 36.4?pg/ml, LDH was 330?U/l and creatinine kinase was 412?U/l. Albumin was initially within the normal range at 4.0?g/dl. The native thin-slice volume CT of the thorax performed on the day of admission showed multifocal, bilateral ground glass opacities, partly with overlapping reticulations appearing as crazy paving. Consolidation was present, but much less pronounced than the ground glass opacities, which were somewhat round and geographically arranged. It was noticeable that they were sometimes sharply delineated from the neighboring healthy lung parenchyma. A positive air bronchogram was evident within the changes. All changes were in the periphery of the lungs, in the craniocaudal plane the base of the lungs, and here the left lower lobe, were most affected. Due to the presence of a risk constellation with clinically significant compromise, high fever, respiratory impairment and CT-morphologically pronounced parenchymal alterations, a decision was quickly made in favor of a therapy including antivirals (Lopinavir-Ritonavir) and a broadly-calculated antibiotic therapy. With persistent fever up to 39.6?\u00b0C and respiratory deterioration with increasing oxygen demand, a follow-up CT of the thorax was performed on day 6 after admission ([Fig.?2]). The images showed significantly increasing densities, whereby in contrast to the initial CT, consolidations now dominated the image. Still, the periphery and the base of the lungs were most affected. On day 7 a nasal high flow therapy was initiated for severe respiratory insufficiency. By day 16 the patient had improved clinically and was ready for discharge. No more follow-up CT examination was performed.",
        "es": "El ingreso hospitalario de un hombre de 59 a\u00f1os se realiz\u00f3 con infecci\u00f3n de SARS-CoV-2 confirmada ambulatoriamente mediante una RT-PCR positiva a partir de frotis far\u00edngeo y s\u00edntomas cl\u00ednicos relevantes. El paciente hab\u00eda visitado previamente el Tirol del Sur. Seis d\u00edas antes del ingreso hospitalario, el paciente mostr\u00f3 los s\u00edntomas iniciales en forma de escalofr\u00edos y fiebre. No ten\u00eda antecedentes. Al ingreso, presentaba hipertermia de 40,0 \u00b0C y una patente taquipnea con una frecuencia respiratoria de 28 r.p.m con suficiente oxigenaci\u00f3n (saturaci\u00f3n con aire ambiental del 95%). Cl\u00ednicamente, reportaba una fuerte sensaci\u00f3n de malestar general con cansancio manifiesto. Las pruebas anal\u00edticas mostraron leucocitopenia con 3,8 \u00d7 109/l, linfocitopenia con 0,96 \u00d7 109/l (25 %), un ligero aumento de prote\u00edna C-reactiva con 14,7 mg/l y un valor bajo de procalcitonina de 0,11 ng/ml. El d\u00edmero D, como factor de riesgo de inestabilidad, no mostr\u00f3 valores altos, a 370 \u00b5g. La interleucina-6 como par\u00e1metro inflamatorio era algo elevada, con una concentraci\u00f3n de 36,4 pg/ml, la LDH era de 330 U/l y la creatina-cinasa, de 412 U/l. La alb\u00famina estaba inicialmente dentro del intervalo normal, con 4,0 g/dl. La TAC tor\u00e1cica de corte fino realizada el d\u00eda del ingreso mostr\u00f3 opacidades de vidrio esmerilado bilaterales y multifocales, en parte solapadas con reticulaciones en patr\u00f3n de empedrado. Hab\u00eda consolidaci\u00f3n, pero mucho menos destacable que las opacidades de vidrio esmerilado, que eran aproximadamente redondeadas y distribuidas geogr\u00e1ficamente. Es destacable que, en algunos casos, estaban claramente delimitadas del par\u00e9nquima pulmonar sano. En las alteraciones era evidente un broncograma a\u00e9reo positivo. Todas las alteraciones se hallaban en la periferia de los pulmones, en el plano craneocaudal a la base de los pulmones; el l\u00f3bulo inferior izquierdo era el m\u00e1s afectado. A causa del conjunto de riesgos con afectaciones cl\u00ednicamente significativas, fiebre alta, disfunci\u00f3n respiratoria y alteraciones parenquimatosas morfol\u00f3gicamente claras en TAC, se decidi\u00f3 r\u00e1pidamente una terapia con antiv\u00edricos (lopinavir-ritonavir) y antibi\u00f3ticos de amplio espectro. A causa de la fiebre persistente de hasta 39,6 \u00b0C y un empeoramiento de los s\u00edntomas respiratorios, con un aumento de la demanda de ox\u00edgeno, se realiz\u00f3 una TAC tor\u00e1cica de seguimiento el d\u00eda 6 tras el ingreso (fig. 2). Las im\u00e1genes mostraron una clara disminuci\u00f3n de las densidades, pero en contraste con la TAC inicial, las consolidaciones dominaban la imagen. La periferia y la base de los pulmones segu\u00edan siendo las zonas m\u00e1s afectadas. El d\u00eda 7, se inici\u00f3 oxigenoterapia nasal de alto flujo por insuficiencia respiratoria grave. El d\u00eda 16, el paciente hab\u00eda mejorado cl\u00ednicamente y estaba listo para su alta hospitalaria. No se realizaron m\u00e1s TAC de seguimiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "Our patient is a 56-year-old male with ESRD secondary to biopsy-proven IgA nephropathy on hemodialysis since late 2016. He has known coronary artery disease with ischemic cardiomyopathy, and he underwent percutaneous coronary intervention to left anterior descending and right coronary arteries shortly after initiation of dialysis. He had an improvement in his cardiac ejection fraction, from 44% in 2016 to 52% on optimal medical therapy. He was initiated on losartan at 25 mg daily when diagnosed with ischemic cardiomyopathy, which was increased to the maximum tolerated dose of 100 mg daily about 12 months prior to this admission. He is a working professional, remains active, and compliant to his prescribed medications and treatments. Up to this point, he has been actively listed for a renal transplant. The patient had recently traveled to South Korea in early January 2020 and had returned to the United States by late January but before the surge of COVID-19 epidemic in Daegu, South Korea, was identified. He remained in good health without any notable symptoms until early March 2020. Five days prior to his admission, he presented to a local urgent care for evaluation of nausea, vomiting, abdominal cramps, and subjective fevers; notably, he had no respiratory complaints. He was diagnosed with viral gastroenteritis, given recommendations for symptom management and discharged home. That same evening, he presented to our emergency department with similar complaints. His laboratory tests, including electrolytes, liver function tests, lactic acid, and blood counts, were unremarkable. His chest X-ray at that time showed no significant focal consolidation, but mild patchy increased interstitial markings at the bilateral lung bases were noted and described as possible atelectasis. His nausea improved while in the emergency department, and his symptoms were again attributed to a viral gastroenteritis from some \u201cbad sushi\u201d he had reported eating a day prior. Following discharge from the emergency department, he went home and noted that he was feeling better except that he had developed some loose stools. Two days later, he attended his routine outpatient hemodialysis treatment, where he reported feeling better since discharge from the emergency department but continued to have intermittent loose stools approximately 2 times per day. He did not report cough or respiratory symptoms at that time. At the end of dialysis, he was noted to be febrile to 100.4\u00b0F and blood cultures were sent which showed no bacterial growth. He was seen in Cardiology clinic later that morning after dialysis treatment for an elective appointment, where he was noted to be coughing in the waiting room and given strict precautions, given his intent to travel for essential reasons. The following day the patient traveled by commercial airline from Southern California to Utah where he presented to an emergency department for continued intermittent vomiting and fevers but was now reporting mild congestion and cough. A new chest X-ray at that time in Utah noted \u201cmild interstitial prominence and vague infiltrate in the right lung base.\u201d His influenza testing was reported negative, and he was prescribed azithromycin given the chest X-ray findings. The next day, he attended his scheduled hemodialysis as a transient visitor in a community dialysis facility in Utah where he reported fever and malaise but was eager to return to California given his acute sickness. He returned to Southern California that evening earlier than planned using commercial airline, because he was feeling quite ill with continued fevers and gastrointestinal symptoms. Furthermore, his respiratory symptoms, which were initially minimal, had progressed rapidly and he was becoming more short-of-breath. Shortly after returning to Southern California, he presented to our emergency department for further reevaluation. In the ED, a repeat chest X-ray demonstrated subtle patchy opacities in both lungs, new from prior X-ray 5 days ago. A CT of the chest revealed multifocal bilateral patchy ground glass opacities predominantly with peripheral distribution concerning for atypical pneumonia and possibly viral infection. COVID-19 testing was performed, the result of which was expected 48 h later, along with standard chemistry and hematology labs, which again revealed no abnormalities with the exception of an elevated procalcitonin level. An evaluation for other causes of atypical pneumonia was simultaneously sent, without additional findings thus far. Imaging demonstrating progression of interstitial pneumonitis due to COVID-19 resulting in ARDS. Chest X-ray sequence with interval increasing patchy opacities in both lungs consistent with evolving infectious process. Chest CT showing new multifocal bilateral patchy groundglass opacities with a predominantly peripheral distribution. There is mild bibasal septal and centrilobular thickening. No evidence of pleural effusion or pneumothorax. There are small biapical subpleural blebs and mild centrilobular pulmonary emphysema in the upper lobes. No evidence of atelectasis. These findings are more consistent with atypical pneumonia which may be secondary to viral infection. Differential considerations include pulmonary edema. He was admitted to the hospital on droplet \u2013 eye precautions. Initially, he was noted to have a temperature of 100.6\u00b0F, but with otherwise normal vital signs. He was initiated on antimicrobial therapy with ceftriaxone and azithromycin. Over the next 24 h, he was febrile to 101\u00b0F and respiratory status rapidly deteriorated. His repeat chest X-rays demonstrated evolution of the bilateral multifocal opacities consistent with the atypical pneumonia, and there was concern for superimposed pulmonary edema. He underwent dialysis the evening of hospital day 2; he tolerated the treatment poorly, developing new atrial fibrillation with rapid ventricular rate despite only minimal ultrafiltration. His respiratory condition continued to rapidly decline during the night, and he had to be intubated and transferred to the intensive care unit (ICU) for acute hypoxic respiratory failure and shock. His pulmonary condition continued to deteriorate to acute respiratory distress syndrome (ARDS) requiring continued mechanical ventilation with high PEEP >10 cm and FiO2 >60% as well as pressor support. In an effort to maintain close control of his volume status and metabolic parameters, we have initiated him on continuous veno-venous hemodiafiltration. In the setting of ESRD, he has been deemed not a candidate for remdesivir compassionate use trial and was started on hydroxychloroquine and on hospital day 6 he was started on tocilizumab given continued hemodynamic instability with elevated inflammatory markers including interleukin (IL)-6. With the inability to rule out superimposed infection he has also been on broad-spectrum antibiotic coverage with vancomycin and piperacillin-tazobactom since hospital day 6. His clinical course is being followed closely by a multispecialist team, and depending on his trajectory, he may require paralysis as well as more aggressive pulmonary and hemodynamic support with proning and extracorporeal membrane oxygenation. At the current time, his vasopressor requirement remains variable, as does his PaO2/FiO2 ratio, while he remains in critical condition for the past 5 days.",
        "es": "Nuestro paciente es un hombre de 56 a\u00f1os con insuficiencia renal terminal secundaria a nefropat\u00eda por IgA, confirmada mediante biopsia, en hemodi\u00e1lisis desde finales de 2016. Padece arteriopat\u00eda coronaria con cardiomiopat\u00eda isqu\u00e9mica y se someti\u00f3 a una intervenci\u00f3n coronaria percut\u00e1nea en las arterias coronaria derecha e interventricular anterior poco despu\u00e9s del inicio de la di\u00e1lisis. Present\u00f3 una mejora de su fracci\u00f3n de expulsi\u00f3n cardiaca, del 44% en 2016 al 52% bajo terapia m\u00e9dica \u00f3ptima. Inici\u00f3 un tratamiento con losart\u00e1n de 25 mg al d\u00eda cuando se le diagnostic\u00f3 la cardiomiopat\u00eda isqu\u00e9mica, que luego se aument\u00f3 a la dosis m\u00e1xima tolerada de 100 mg al d\u00eda unos 12 meses antes de este ingreso. El paciente es un profesional en activo y cumple con la medicaci\u00f3n y los tratamientos recetados. Hasta este momento, estaba incluido en las listas para trasplante renal. El paciente hab\u00eda viajado recientemente a Corea del Sur a principios de enero de 2020 y hab\u00eda regresado a los Estados Unidos a finales de enero, pero antes de que se identificara el brote de COVID-19 en Daegu (Corea del Sur). Hasta principios de marzo de 2020 se hallaba en buen estado de salud, sin s\u00edntomas relevantes. Cinco d\u00edas antes de su ingreso, acudi\u00f3 a un ambulatorio de urgencias aquejado de n\u00e1useas, v\u00f3mitos, c\u00f3licos intestinales y s\u00edntomas de fiebre; cabe destacar que no report\u00f3 molestias respiratorias. Se le diagnostic\u00f3 gastroenteritis v\u00edrica, se le dieron recomendaciones para la gesti\u00f3n de los s\u00edntomas y fue dado de alta. Esa misma tarde acudi\u00f3 a nuestro servicio de urgencias con los mismos s\u00edntomas. Presentaba febr\u00edcula de 37,8 \u00b0C y sus pruebas anal\u00edticas, incluyendo electr\u00f3litos, pruebas funcionales hep\u00e1ticas, \u00e1cido l\u00e1ctico y hemograma, no dieron resultados a destacar. Su radiograf\u00eda tor\u00e1cica en ese momento no mostr\u00f3 consolidaciones focales significativas, pero se observaron leves tramas intersticiales parcheadas en las bases pulmonares bilaterales, indicativas de posible atelectasia. Sus n\u00e1useas remitieron mientras estaba en urgencias y sus s\u00edntomas se atribuyeron nuevamente a una gastroenteritis v\u00edrica causada por un \"sushi en mal estado\" que hab\u00eda comido el d\u00eda anterior. Tras el alta de urgencias, se dirigi\u00f3 a su casa e indic\u00f3 que se encontraba mejor, excepto por una leve diarrea. Dos d\u00edas despu\u00e9s acudi\u00f3 a su tratamiento ambulatorio habitual de hemodi\u00e1lisis, donde inform\u00f3 encontrarse mejor desde el alta en urgencias, pero segu\u00eda teniendo diarrea intermitente, unas dos veces al d\u00eda. En ese momento no report\u00f3 tos ni s\u00edntomas respiratorios. Al finalizar la di\u00e1lisis, tuvo fiebre de 38 \u00b0C y se hicieron hemocultivos que no mostraron crecimiento bacteriano. Esa misma ma\u00f1ana, tras la di\u00e1lisis, acudi\u00f3 al consultorio de cardiolog\u00eda para una cita programada, en la cual se le observ\u00f3 tos en la sala de espera y se le dieron estrictas recomendaciones de precauci\u00f3n teniendo en cuenta su prop\u00f3sito de viajar por razones esenciales. Al siguiente d\u00eda, el paciente viaj\u00f3 en una aerol\u00ednea comercial. del sur de California a Utah, donde acudi\u00f3 a un servicio de urgencias con v\u00f3mitos intermitentes repetidos y fiebre, pero ahora tambi\u00e9n report\u00f3 congesti\u00f3n leve y tos. Una nueva radiograf\u00eda tor\u00e1cica apreci\u00f3 \"prominencias intersticiales leves e infiltrados vagos en la base del pulm\u00f3n derecho\". Sus pruebas para gripe fueron negativas y se le recet\u00f3 azitromicina, a partir de los resultados radiol\u00f3gicos. Al d\u00eda siguiente asisti\u00f3 a su sesi\u00f3n programada de hemodi\u00e1lisis como visitante pasajero en un centro de di\u00e1lisis local de Utah, donde inform\u00f3 de fiebre y malestar general, pero estaba ansioso por regresar a California debido a su estado. Volvi\u00f3 al sur de California esa misma tarde en una aerol\u00ednea comercial, antes de lo previsto, porque se sent\u00eda bastante enfermo, con fiebre continua y s\u00edntomas gastrointestinales. Adem\u00e1s, sus s\u00edntomas respiratorios, que inicialmente eran m\u00ednimos, hab\u00edan progresado r\u00e1pidamente y su disnea aumentaba. Poco despu\u00e9s del regreso al sur de California, acudi\u00f3 a nuestro servicio de urgencias para una reevaluaci\u00f3n. En urgencias, una nueva radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades parcheadas sutiles en ambos pulmones, de nueva aparici\u00f3n respecto a las im\u00e1genes de 5 d\u00edas antes. Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado parcheadas, multifocales y bilaterales, predominantemente con distribuci\u00f3n perif\u00e9rica, lo que hizo sospechar de neumon\u00eda at\u00edpica y posible infecci\u00f3n v\u00edrica. Se realiz\u00f3 una prueba de COVID-19, cuyo resultado tardar\u00eda 48 horas, junto con las pruebas bioqu\u00edmicas y hematol\u00f3gicas habituales, que no revelaron ninguna anomal\u00eda, a excepci\u00f3n de un alto valor de procalcitonina. Se envi\u00f3 simult\u00e1neamente una evaluaci\u00f3n de otras causas de neumon\u00eda at\u00edpica, sin resultados adicionales hasta la fecha. Las im\u00e1genes mostraron una evoluci\u00f3n de la neumonitis intersticial debido a la COVID-19, con consiguiente SDRA. La secuencia de radiograf\u00edas tor\u00e1cicas con opacidades parcheadas crecientes en ambos pulmones es coherente con la evoluci\u00f3n del proceso infeccioso. Una TAC tor\u00e1cica mostr\u00f3 nuevas opacidades de vidrio esmerilado parcheadas, multifocales y bilaterales con distribuci\u00f3n b\u00e1sicamente perif\u00e9rica. Se apreciaba un engrosamiento centrilobular y septal bibasal. No se apreci\u00f3 derrame pleural ni neumot\u00f3rax. Se observaron peque\u00f1as bullas subpleurales biapicales y enfisema pulmonar leve en los l\u00f3bulos superiores. No hubo evidencia de atelectasia. Estos resultados son m\u00e1s coherentes con neumon\u00eda at\u00edpica, que puede ser secundaria a una sobreinfecci\u00f3n. En el diagn\u00f3stico diferencial se incluye edema pulmonar. El paciente fue ingresado en el hospital teniendo en cuenta precauciones para got\u00edculas y ojos. Inicialmente, se le observ\u00f3 una temperatura de 38,1 \u00b0C, pero, por lo dem\u00e1s, con constantes vitales normales. Se inici\u00f3 una terapia antimicrobiana con ceftriaxona y azitromicina. Durante las siguientes 24 h continu\u00f3 febril, con una temperatura de hasta 38,3 \u00b0C, y un deterioro r\u00e1pido de su estado respiratorio. Radiograf\u00edas tor\u00e1cicas repetidas mostraron evoluci\u00f3n de las opacidades multifocales bilaterales coherentes con neumon\u00eda at\u00edpica y se sospech\u00f3 de un posible edema pulmonar. Se someti\u00f3 a di\u00e1lisis la tarde del segundo d\u00eda de hospitalizaci\u00f3n, pero toler\u00f3 mal el tratamiento, sufriendo fibrilaci\u00f3n auricular con alta frecuencia ventricular, a pesar de m\u00ednima ultrafiltraci\u00f3n. Su cuadro respiratorio empeor\u00f3 r\u00e1pidamente durante la noche y tuvo que ser intubado y trasladado a la unidad de cuidados intensivos (UCI) con insuficiencia respiratoria aguda hip\u00f3xica y choque. Su estado pulmonar sigui\u00f3 empeorando a s\u00edndrome de dificultad respiratoria aguda (SDRA) y el paciente necesit\u00f3 ventilaci\u00f3n mec\u00e1nica con alta presi\u00f3n positiva telespiratoria (PEEP > 10 cm y FiO2 > 60%), as\u00ed como vasopresores. Para mantener un control estrecho de su volemia y los par\u00e1metros metab\u00f3licos, se le aplic\u00f3 hemodiafiltraci\u00f3n venovenosa continua. Teniendo en cuenta el SDRA, se consider\u00f3 que no era candidato para un ensayo de uso compasivo de remdesivir, de modo que se inici\u00f3 un tratamiento con hidroxicloroquina; el d\u00eda 6 de hospitalizaci\u00f3n se le administr\u00f3 tocilizumab teniendo en cuenta su inestabilidad hemodin\u00e1mica con altos valores de marcadores inflamatorios, incluyendo la interleucina (IL)-6. Con la imposibilidad de descartar una infecci\u00f3n sobrea\u00f1adida, tambi\u00e9n se le administr\u00f3 tratamiento antibi\u00f3tico de amplio espectro con vancomicina y piperacilina-tazobactam desde el d\u00eda 6 de hospitalizaci\u00f3n. Su evoluci\u00f3n est\u00e1 siendo seguida de cerca por un equipo multidisciplinar y, en funci\u00f3n de su desarrollo, puede requerir par\u00e1lisis as\u00ed como asistencia pulmonar y hemodin\u00e1mica m\u00e1s agresiva con oxigenaci\u00f3n por membrana extracorporal y posici\u00f3n en dec\u00fabito prono. En el momento actual, sus requerimientos de vasopresi\u00f3n siguen siendo variables, al igual que la proporci\u00f3n PaO2/FiO2; ha permanecido en estado cr\u00edtico durante los \u00faltimos 5 d\u00edas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 64-year-old woman presented to the emergency department on February 1st, 2020, because of a 7-day fever, with the highest body temperature of 38.7 \u00b0C, accompanied by cough with a little sputum and muscle soreness, but no chest distress or dyspnea. She just flew back to Hangzhou, China, from Malaysia 7 days ago. Physical examination revealed no dry and moist rales in both lungs with a temperature of 37.3 \u00b0C, heart rate of 92 beats/min, respiratory rate of 18 times/min, and blood pressure of 113/79 mmHg. Her laboratory tests showed white blood cell count (WBC) was 2.5?\u00d7?109 cells/mL with 63.3% neutrophils and 29.2% lymphocytes, and C-reactive protein (CRP) level was 3.62 mg/L. Her sputum test for influenza A?+?B (real-time fluorescent RT-PCR) was negative. The lung CT images of this patient showed multiple ground-glass shadows with unclear edges and uneven densities in the peripheral and posterior lungs, mainly under the pleura. These imagings were in accordance with the early radiographic features of coronavirus disease 2019 (COVID-19). Later, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) RNA was detected in the sputum by real-time fluorescent RT-PCR, and the patient was diagnosed as COVID-19.",
        "es": "El 1 de febrero de 2020 acudi\u00f3 al servicio de urgencias una mujer de 64 a\u00f1os reportando fiebre de 7 d\u00edas de evoluci\u00f3n, con una temperatura m\u00e1xima de 38,7 \u00b0C, que cursaba con tos, poca expectoraci\u00f3n y mialgia, pero sin malestar tor\u00e1cico ni disnea. Hab\u00eda regresado en avi\u00f3n a Hangzhou (China), procedente de Malasia 7 d\u00edas antes. A la exploraci\u00f3n f\u00edsica no se percibieron estertores secos ni h\u00famedos en ambos pulmones y se registr\u00f3 una temperatura de 37,3 \u00b0C, pulso de 92 l.p.m., frecuencia respiratoria de 18 r.p.m. y presi\u00f3n arterial de 113/79 mmHg. Las pruebas anal\u00edticas dieron una f\u00f3rmula leucocitaria de 2,5 x 109 c\u00e9lulas/mL, con un 63,3% de neutr\u00f3filos y un 29,2% de linfocitos; el valor de prote\u00edna C-reactiva era de 3,62 mg/L. Las pruebas de esputo para gripe A+B (mediante RT-PCR en tiempo real) fueron negativas. Las TAC pulmonares de la paciente mostraron varias sombras de vidrio esmerilado con bordes difusos y densidades irregulares en las zonas perif\u00e9ricas y posteriores de los pulmones, b\u00e1sicamente subpleurales. Estas im\u00e1genes concordaban con anteriores manifestaciones radiol\u00f3gicas de la enfermedad por coronavirus 2019 (COVID-19). M\u00e1s adelante, las pruebas mediante RT-PCR de fluorescencia en tiempo real detectaron ARN de SARS-CoV-2 y se diagnostic\u00f3 a la paciente con COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The patient was a 35-year-old woman without a significant medical history. On January 21, 2020, she travelled to Japan from Wuhan, China. She was healthy until January 30 when she developed fever with mild diarrhoea. On January 31, at the primary care clinic, the rapid influenza antigen test was negative. Chest X-ray revealed signs of pneumonia in the left lower lung and she was transferred to the Japanese Red Cross Narita Hospital. She denied having sore throat, rhinorrhea, chills and cough. She had not visited Huanan market and was not exposed to any wild or dead animals. On admission, her vital signs were as follows: blood pressure 106/66?mmHg, heart rate 93 beats/min, body temperature 37.9?\u00b0C, respiratory rate 16 breaths/min and oxygen saturation on room air 97%. Her physical examination was unremarkable. Laboratory test results did not reveal leukocytosis, leukocytopenia or elevated liver function enzymes. Computed tomography (CT) scan showed slight ground-glass opacity in the left lower lung lobe. She was admitted to an isolation room with negative pressure. Ceftriaxone and azithromycin were administered after obtaining a throat swab. The PCR test on the throat swab for the novel coronavirus (SARS-CoV-2) was negative. Her fever persisted but she had no respiratory symptoms such as cough. On hospital day 5, induced sputum and a second throat swab were obtained. The PCR test on induced sputum was positive but the throat swab was still negative. Her condition was stable and fever and diarrhoea improved on hospital day 6. She recovered fully and was discharged on hospital day 12 after sputum and throat swab samples tested negative by PCR. During her clinical course, she never had a PCR-positive throat swab. All PCR tests were performed at the reference laboratory by real-time RT-PCR assays following a previously described method.",
        "es": "La paciente era una mujer de 35 a\u00f1os sin antecedentes personales. El d\u00eda 21 de enero de 2020 viaj\u00f3 a Jap\u00f3n desde Wuhan (China). Estaba sana hasta el 30 de enero, cuando present\u00f3 fiebre y diarrea leve. El 31 de enero, en el consultorio de atenci\u00f3n primaria, se le realiz\u00f3 una prueba r\u00e1pida de ant\u00edgenos de la gripe y result\u00f3 negativa. Una TAC tor\u00e1cica revel\u00f3 signos de neumon\u00eda en la zona inferior del pulm\u00f3n izquierdo y fue trasladada al Hospital de la Cruz Roja Japonesa de Narita. Afirm\u00f3 no tener irritaci\u00f3n de garganta, rinorrea, escalofr\u00edos ni tos. No hab\u00eda acudido al mercado de Huanan ni hab\u00eda estado expuesta a animales salvajes o muertos. Al ingreso, sus constantes vitales eran: presi\u00f3n arterial 106/66 mmHG, pulso 93 l.p.m., temperatura 37,9 \u00b0C, frecuencia respiratoria 16 r.p.m. y saturaci\u00f3n de ox\u00edgeno en aire ambiental 97%. La exploraci\u00f3n f\u00edsica fue normal. Las pruebas anal\u00edticas no mostraron leucocitosis, leucocitopenia ni valores altos de enzimas hep\u00e1ticas. Una TAC tor\u00e1cica mostr\u00f3 ligeras opacidades de vidrio esmerilado en el l\u00f3bulo inferior del pulm\u00f3n izquierdo. Se traslad\u00f3 a una sala de aislamiento con presi\u00f3n negativa. Se le administr\u00f3 ceftriaxona y azitromicina tras obtener un frotis far\u00edngeo. La prueba mediante PCR del frotis far\u00edngeo para el nuevo coronavirus (SARS-CoV-2) fue negativa. Continu\u00f3 con fiebre pero no present\u00f3 s\u00edntomas respiratorios, como tos. El d\u00eda 5 de hospitalizaci\u00f3n se obtuvo esputo provocado y un segundo frotis far\u00edngeo. La prueba mediante PCR del esputo fue positiva, pero el frotis far\u00edngeo sigui\u00f3 siendo negativo. Su estado era estable y la fiebre y la diarrea mejoraron el sexto d\u00eda de hospitalizaci\u00f3n. El d\u00eda 12 de hospitalizaci\u00f3n, la paciente ya se hab\u00eda restablecido por completo y las pruebas mediante PCR de esputo y frotis far\u00edngeos resultaron negativas. Durante toda la evoluci\u00f3n cl\u00ednica nunca se obtuvo ninguna prueba positiva de los frotis far\u00edngeos mediante PCR. Todas las pruebas de PCR se realizaron en el laboratorio de referencia mediante ensayos de RT-PCR en tiempo real siguiendo un protocolo ya descrito."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On 12 February 2020, days before this outbreak was recognised, an 80-year-old female with a 3-year history of left-sided ulcerative colitis (UC), inmaintenance with mesalamine, presented to our clinic with a 7-day historyof fever and bloody diarrhoea. On admission, the patient reported fourbowel movements per day with blood and fever up to 38.5\u00b0C. Laboratorytests documented severe anaemia (haemoglobin 7 g/dL) and increasedC-reactive protein (CRP) (6 mg/dL). A sigmoidoscopy showed large anddeep ulcers in sigmoid colon and rectum. Stool cultures were negative,including tests for Clostridium difficile. The patient was thereforediagnosed with a severe UC relapse and intravenous corticosteroidtherapy (methylprednisolone 40 mg/day) was started. During the next3 days, the frequency of bowel movements decreased, fever resolved andCRP returned into normal range. On the fourth day, fever up to 39\u00b0Cdeveloped, followed by dry cough. On the basis of the evolvingknowledge regarding SARS-CoV-2 outbreak, including data relative tohospital-acquired infections, a case of COVID-19 was suspected. Chestradiography showed bilateral pneumonia, confirmed by chest CT scan). The nasopharyngeal swab sample confirmed the presence of SARS-CoV-2 and a diagnosis of COVID-19 pneumonia was made. The patient wastreated with non-invasive ventilation, and a combination oflopinavir/ritonavir and hydroxychloroquine. Intravenous corticosteroid wasrapidly switched to oral prednisone, and an accelerated tapering wasinitiated. Despite an initial improvement, the patient\u2019s conditionsubsequently worsened and the patient died after 14 days ofhospitalisation. Prednisone dosage at the time of patient\u2019s death was25 mg daily.",
        "es": "El 12 de febrero de 2020, d\u00edas antes de que se identificara este brote, una mujer de 80 a\u00f1os con antecedentes de tres a\u00f1os de colitis ulcerosa izquierda y tratamiento de mantenimiento con mesalamina acudi\u00f3 a nuestro consultorio con fiebre y diarrea hemorr\u00e1gica de 7 d\u00edas de evoluci\u00f3n. Al ingreso, la paciente report\u00f3 cuatro defecaciones al d\u00eda con sangre y fiebre de hasta 38,5 \u00b0C. Las pruebas anal\u00edticas indicaron anemia grave (hemoglobina 7 g/dL) y valores altos de prote\u00edna C-reactiva (6 mg/dL). Una sigmoidoscopia mostr\u00f3 \u00falceras grandes y profundas en el colon sigmoide y el recto. Los cultivos de heces fueron negativos, incluyendo pruebas para Clostridum difficile. A la paciente se le diagnostic\u00f3 recidiva de la colitis ulcerosa y se inici\u00f3 un tratamiento con corticosteroides i.v. (metilprednisolona 40 mg/d\u00eda). Durante los siguientes tres d\u00edas, la frecuencia de las defecaciones disminuy\u00f3, la fiebre remiti\u00f3 y los valores de prote\u00edna C-reactiva volvieron al intervalo normal. El cuarto d\u00eda present\u00f3 fiebre de hasta 39 \u00b0C que curs\u00f3 con tos seca. A partir de los datos en constante evoluci\u00f3n sobre el brote de SARS-CoV-2, incluyendo informaci\u00f3n referente a infecciones nosocomiales, se sospech\u00f3 un caso de COVID-19. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 neumon\u00eda bilateral, confirmada por TAC tor\u00e1cica. Los frotis nasofar\u00edngeos confirmaron la presencia de SARS-CoV-2 y se estableci\u00f3 el diagn\u00f3stico de neumon\u00eda por COVID-19. La paciente fue tratada con ventilaci\u00f3n no invasiva y una combinaci\u00f3n de lopinavir/ritonavir e hidroxicloroquina. se sustituyeron r\u00e1pidamente por prednisona por v\u00eda oral y se inici\u00f3 una disminuci\u00f3n progresiva de la dosis. A pesar de una mejora inicial, el estado de la paciente empeor\u00f3 y esta muri\u00f3 tras 14 d\u00edas de hospitalizaci\u00f3n. En el momento de la muerte la dosis de prednisona era de 25 mg al d\u00eda."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On Jan 23, 2020, a woman aged 61 years presented with acute weakness inboth legs and severe fatigue, progressing within 1 day. She returned fromWuhan on Jan 19, but denied fever, cough, chest pain, or diarrhoea. Herbody temperature was 36\u00b75\u00b0C, oxygen saturation was 99% on room air, andrespiratory rate was 16 breaths per min. Lung auscultation showed noabnormalities. Neurological examination disclosed symmetric weakness(Medical Research Council grade 4/5) and areflexia in both legs and feet. 3days after admission, her symptoms progressed. Muscle strength was grade4/5 in both arms and hands and 3/5 in both legs and feet. Sensation to lighttouch and pinprick was decreased distally. Laboratory results on admission were clinically significant forlymphocytopenia (0\u00b752 \u00d7 10 9 /L, normal: 1\u00b71\u20133\u00b72 \u00d7 10 9 /L) andthrombocytopenia (113 \u00d7 10 9 /L, normal: 125\u2013300 \u00d7 10 9 /L). CSF testing (day4) showed normal cell counts (5 \u00d7 10 6 /L, normal: 0\u20138 \u00d7 10 6 /L) and increasedprotein level (124 mg/dL, normal: 8\u201343 mg/dL). Nerve conduction studies(day 5) showed delayed distal latencies and absent F waves in early course,supporting demyelinating neuropathy. She was diagnosed with Guillain-Barr\u00e9 syndrome and given intravenous immunoglobulin. On day 8 (Jan 30),the patient developed dry cough and a fever of 38\u00b72\u00b0C. Chest CT showedground-glass opacities in both lungs. Oropharyngeal swabs were positivefor SARS-CoV-2 on RT-PCR assay. She was immediately transferred to theinfection isolation room and received supportive care and antiviral drugs ofarbidol, lopinavir, and ritonavir. Her clinical condition improved graduallyand her lymphocyte and thrombocyte counts normalised on day 20. Atdischarge on day 30, she had normal muscle strength in both arms and legsand return of tendon reflexes in both legs and feet. Her respiratorysymptoms resolved as well. Oropharyngeal swab tests for SARS-CoV-2 werenegative.",
        "es": "El 23 de enero de 2020, se present\u00f3 una mujer de 61 a\u00f1os con astenia aguda en ambas piernas y fatiga intensa, con una evoluci\u00f3n de un d\u00eda. Hab\u00eda regresado de Wuhan el 19 de enero pero no report\u00f3 fiebre, tos, dolor tor\u00e1cico ni diarrea. Su temperatura era de 36,5 \u00b0C, la saturaci\u00f3n de ox\u00edgeno de 99% en aire ambiental y la frecuencia respiratoria de 16 r.p.m. La auscultaci\u00f3n pulmonar no revel\u00f3 ninguna anomal\u00eda. La exploraci\u00f3n neurol\u00f3gica mostr\u00f3 astenia sim\u00e9trica (grado 4/5 del Medical Research Council) y arreflexia en ambas piernas y pies. 3 d\u00edas despu\u00e9s del ingreso, sus s\u00edntomas empeoraron. La fuerza muscular era de grado 4/5 en ambos brazos y manos y de 3/5 en ambas piernas y pies. La sensibilidad al tacto y a los pinchazos disminu\u00eda distalmente. Las pruebas anal\u00edticas al ingreso eran cl\u00ednicamente significativas para linfocitopenia (0,52 x 109/L; intervalo normal: 1,1-3,2 \u00d7 109/L) y trombocitopenia (113 \u00d7 109/L; intervalo normal: 125-300 \u00d7 109/L). Las pruebas de LCR dieron cifras normales de c\u00e9lulas (5 x 106/L; intervalo normal: 0-8 \u00d7 106/L) y valores altos de prote\u00ednas (124 mg/dL; intervalo normal: 8-43 mg/dL). Las pruebas de conducci\u00f3n nerviosa (d\u00eda 5) revelaron latencias distales retardadas y ausencia de ondas F en un estado temprano, manifestaciones coherentes con neuropat\u00eda desmielinizante. Se le diagnostic\u00f3 s\u00edndrome de Guillain-Barr\u00e9 y se le administr\u00f3 inmunoglobulina i.v. El d\u00eda 8 (30 de enero), la paciente present\u00f3 tos seca y fiebre de 38,2 \u00b0C. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado en ambos pulmones. Los frotis orofar\u00edngeos dieron resultado positivo para SARS-CoV-2 mediante prueba de RT-PCR. Inmediatamente, se traslad\u00f3 a la paciente a una planta de enfermedades infecciosas y se le aplic\u00f3 tratamiento sintom\u00e1tico y los f\u00e1rmacos antiv\u00edricos arbidol, lopinavir y ritonavir. Su estado cl\u00ednico mejor\u00f3 gradualmente y sus cifras de linfocitos y trombocitos se normalizaron el d\u00eda 20. Fue dada de alta el d\u00eda 30, con fuerza muscular normal y recuperaci\u00f3n de los reflejos en ambos brazos y piernas. Sus s\u00edntomas respiratorios tambi\u00e9n remitieron. Las pruebas con frotis orofar\u00edngeos para SARS-CoV-2 resultaron negativos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A patient in his fifties without any past medical history consulted hisgeneral practitioner, in the Marseille area on March 6th, 2020, because offever, headache and cough evolving since February 29th. He had beensent by his company (company X) to the Central Africa Republic (CAR)from February 13th to February 25th where he gave presentations(training in management) for 6 days, to a public of about 30 resourcedirectors of several CAR ministries. Because of persistence of fever andcough at day 9-post onset, he was referred to the emergency unit of alocal hospital on March 9th. On clinical examination he had fever (40 \u00b0C)and dyspnea with oxygen saturation at 91% in ambient air. Pulmonaryauscultation revealed bilateral basal crackling sounds. Malaria was ruled-out by blood smear microscopic examination and influenza was ruled-outby PCR on nasal swab fluid. C-reactive protein was at 103 mg/L and whiteblood cell count was at 8.8 Giga/L. Naso-pharyngeal swab fluid was testedfor SARS-CoV-2 by RT-PCR as previously described and resulted positive. The patient was immediately transferred to our center (IHU M\u00e9diterran\u00e9eInfection) for hospitalization in a highly contagious patient section. AChest CT-scan showed bilateral interstitial pulmonary infiltrates. Progressive aggravation led to his temporary transfer to an intensive careunit for five days, before coming back to our ward where he is stillhospitalized at the time of writing.",
        "es": "Un paciente de unos cincuenta a\u00f1os sin antecedentes personales acudi\u00f3 a su m\u00e9dico de cabecera en la zona de Marsella el 6 de marzo de 2020, reportando fiebre, cefalea y tos con una evoluci\u00f3n desde el 29 de febrero. Su empresa (empresa X) lo hab\u00eda destinado a la Rep\u00fablica Centroafricana entre el 13 y el 25 de febrero, donde durante 6 d\u00edas imparti\u00f3 varias conferencias sobre gesti\u00f3n a un p\u00fablico de unos 30 responsables de recursos de varios ministerios de la Rep\u00fablica Centroafricana. A causa de la persistencia de la fiebre y la tos tras 9 d\u00edas de aparici\u00f3n de los s\u00edntomas, se le remiti\u00f3 al servicio de urgencias de un hospital local el 9 de marzo. A la exploraci\u00f3n, present\u00f3 fiebre (40 \u00b0C) y disnea con una saturaci\u00f3n de ox\u00edgeno del 91% en aire ambiental. La auscultaci\u00f3n pulmonar revel\u00f3 crepitantes basales bilaterales. Se descart\u00f3 malaria mediante observaci\u00f3n microsc\u00f3pica de frotis de sangre, as\u00ed como gripe mediante PCR de frotis nasofar\u00edngeo. El valor de prote\u00edna C-reactiva era de 103 mg/L y la cifra de leucocitos de 8,8 Giga/L. Se analiz\u00f3 un frotis far\u00edngeo para SARS-CoV-2 mediante RT-PCR, tal como se ha descrito anteriormente y el resultado fue positivo. Se traslad\u00f3 inmediatamente al paciente a nuestro centro (IHU M\u00e9diterran\u00e9e Infection) para su hospitalizaci\u00f3n en una sala de pacientes altamente contagiosos. Una TAC tor\u00e1cica mostr\u00f3 infiltrados pulmonares intersticiales bilaterales. El empeoramiento progresivo oblig\u00f3 a su traslado temporal a una unidad de cuidados intensivos durante cinco d\u00edas; posteriormente regres\u00f3 a nuestra sala, donde sigue hospitalizado en el momento de la redacci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 43 years old Caucasian male without  underlying conditions reported himself to the Admission Center of Infectious Diseases Clinic on March 20, 2020 with fever up to 39.5*C,  malaise and non-productive cough that started 6 days before. Patient was in good general condition. On physical examination, apart from throat irritation no abnormalities were discovered. Mild leucopenia (white blood cells (WBC) - 3.57 x 103/L, normal range: 4.0-10.0), thrombocytopenia (platelet count (PLT) - 107 x 103/L, normal range: 150-420) and elevated C-reactive protein (CRP - 113 mg/L, normal range: < 6) were observed in laboratory tests. Influenza quick smear test was negative. A specimen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic test from the nasopharynx was taken. Patient was discharged and advised to self-isolate at home. Next day  laboratory confirmation of COVID-19 was obtained. Two days after  the discharge the patient returned to the hospital due to dyspnea. Laboratory tests revealed further increase of CRP up to 250 mg/L,  normal WBC of 8.26 x 103/L with lymphopenia of 0.7 x 103/L (normal range: 1.0-4.0 x 103/L). The patient had the following vital signs: SpO2 94%, blood pressure (BP) 80/60, body temperature 37.1*C. On chest X-ray bilateral ground-glass opacities in lower lobes and focal consolidation of the left lung were present. The patient was admitted to the Infectious Diseases Ward. Treatment with chloroquine (PO 1.0g per day in two doses), antibiotics (IV ceftriaxone 2.0g per day and PO clarithromycin 1.0g per day in two doses), oxygen (mask) and IV fluids was initiated. On March 23rd  signs of respiratory failure appeared. Patient was transferred to the Intensive Care Unit (ICU) where respiratory mechanical ventilation in bilevel positive airway pressure (BIPAP) mode was introduced as well as norepinephrine iv due to circulatory failure that appeared the next day. Blood, urine and respiratory secretion cultures were negative. Another chest x-ray reveled  progression in ground-glass opacities and focal consolidations, especially in the left lung. In the following days, despite  decrease in inflammatory markers the clinical status remains unchanged. Patient is still hospitalized in the ICU. Bilateral ground-glass opacities and focal consolidations (especially in the periphery and subpleural regions of the lower zones) on chest radiograph observed in this patient are most common radiologic finding in COVID-19. In our patient the clinical worsening was observed  6 days after the symptoms onset, patient was admitted to the hospital after 9 days and transferred to the ICU after 10 days which corresponds to previous findings that the disease progression usually appears in 1-2 weeks after the onset of symptoms.",
        "es": "Un hombre cauc\u00e1sico de 43 a\u00f1os, sin enfermedades previas, acudi\u00f3 al consultorio de enfermedades infecciosas el 20 de marzo de 2020, con fiebre de hasta 39,5 \u00baC, malestar general y tos no productiva de 6 d\u00edas de evoluci\u00f3n. El paciente mostraba un buen estado de salud general. A la exploraci\u00f3n f\u00edsica, excepto irritaci\u00f3n de garganta, no se apreciaron anomal\u00edas. Las pruebas anal\u00edticas dieron los resultados siguientes: leucocitopenia leve (cifra de leucocitos: 3,57 x 103/\u00b5L, intervalo normal: 4,0-10,0), trombocitopenia (cifra de trombocitos: 107 x 103/\u00b5L, intervalo normal: 150-420) prote\u00edna C-reactiva alta (113 mg/L, intervalo normal: < 6). Mediante frotis nasofar\u00edngeo se obtuvo una muestra para la prueba gen\u00e9tica de s\u00edndrome respiratorio agudo grave por coronavirus 2 (SARS-CoV-2). El paciente fue dado de alta y se le aconsej\u00f3 que se autoconfinara en su hogar. Al d\u00eda siguiente, el laboratorio confirm\u00f3 el positivo por COVID-19. Dos d\u00edas despu\u00e9s del alta, el paciente regres\u00f3 al hospital aquejado de disnea. Las pruebas anal\u00edticas mostraron un aumento de la prote\u00edna C-reactiva hasta 250 mg/L, una cifra de leucocitos normal de 8,26 x 103/\u00b5L y linfocitopenia de 0,7 x 103/\u00b5L (intervalo normal: 1,0-4,0 x 103/\u00b5L). El paciente ten\u00eda las siguientes constantes vitales: SpO2 94%, presi\u00f3n arterial 80/60, temperatura 37,1 \u00baC. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales en los l\u00f3bulos inferiores y consolidaci\u00f3n focal en el pulm\u00f3n izquierdo. El paciente ingres\u00f3 en la planta de enfermedades infecciosas. Se inici\u00f3 un tratamiento con cloroquina (1,0 g por d\u00eda en dos dosis, por v\u00eda oral), antibi\u00f3ticos (ceftriaxona 2,0 g por d\u00eda i.v. y claritromicina 1,0 g por d\u00eda en dos dosis, por v\u00eda oral), ox\u00edgeno (mascarilla) y suero i.v. El dia 23 aparecieron signos de insuficiencia respiratoria. Se traslad\u00f3 el paciente a la unidad de cuidados intensivos (UCI) donde se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica de bipresi\u00f3n positiva (BPAP) y se le administr\u00f3 norepinefrina i.v. a causa de la insuficiencia circulatoria que apareci\u00f3 el siguiente d\u00eda. Los hemocultivos y los cultivos de orina y esputo fueron negativos. Otra radiograf\u00eda tor\u00e1cica mostr\u00f3 evoluci\u00f3n en opacidades de vidrio esmerilado y consolidaciones focales, sobre todo en el pulm\u00f3n izquierdo. En los d\u00edas siguientes, a pesar de una disminuci\u00f3n de los marcadores inflamatorios, el estado cl\u00ednico sigui\u00f3 sin cambios. El paciente a\u00fan est\u00e1 hospitalizado en la UCI. Las opacidades de vidrio esmerilado y las consolidaciones focales (sobre todo en las regiones perif\u00e9ricas y subpleurales de las zonas inferiores) en las radiograf\u00edas tor\u00e1cicas observadas en este paciente son los resultados radiol\u00f3gicos m\u00e1s habituales en pacientes con COVID-19. En nuestro paciente, el empeoramiento cl\u00ednico se observ\u00f3 6 d\u00edas despu\u00e9s del inicio de los s\u00edntomas, fue ingresado despu\u00e9s de 9 d\u00edas y fue trasladado a la UCI despu\u00e9s de 10 d\u00edas, lo que se corresponde con los resultados previos de que la progresi\u00f3n de la enfermedad suele aparecer entre 1 y 2 semanas despu\u00e9s de la aparici\u00f3n de los s\u00edntomas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The patient is a 6-month-old, full term, previously healthy and fully immunized female who initially presented to pediatric urgent care with one day of fever, fussiness, and refusal to eat. She did not exhibit cough, congestion or rhinorrhea. Examination showed a fussy infant with a temperature of 38.8\u00b0C, with no focal signs of infection. Laboratory evaluation included a rapid influenza swab and a catheterized urinalysis with urine culture, all of which were negative. She was diagnosed with a viral infection. On day 2 of fever, she developed an erythematous, seemingly non-pruritic, blotchy rash. She re-presented to urgent care on day 4 of fever with persistent rash. Although she remained free of cough, there was possible mild congestion. Vital signs showed temperature of 38.3\u00b0C, sinus tachycardia (200 beats/minute), and tachypnea with an oxygen saturation of 100%. Examination was notable for irritability, limbic-sparing conjunctivitis, and dry cracked lips. There was no appreciable lymphadenopathy and at the time she had normal extremities. She had mild subcostal retractions, though normal breath sounds. Laboratory testing showed a left-shifted white blood cell count with bandemia, normocytic anemia, normal platelets, markedly elevated c-reactive protein 13.3 mg/dL, and erythrocyte sedimentation rate 118 mm/hr. She had hyponatremia (sodium 133 mEq/L) and hypoalbuminemia (albumin 2.8 g/dL), with otherwise normal chemistries including liver function tests. Respiratory pathogen testing by reverse transcription polymerase chain reaction test (RT-PCR) and blood culture were negative. A chest x-ray showed a faint opacity in the left midlung zone. Throughout this period of illness, she had no sick contacts. Her 9-year-old sibling had upper respiratory symptoms 3 weeks prior. The family had self-isolated due to the COVID-19 pandemic for the week prior, without leaving home for school or work. There was no history of recent travel. The patient was referred for admission for KD evaluation. Given her fever, possible mild congestion, and chest x-ray findings, she was sent to the emergency department for COVID-19 testing prior to admission to the pediatric floor. Upon arrival, the patient was on day 5 of fever, had limbic sparing conjunctivitis, prominent tongue papilla, a blanching, polymorphous, maculopapular rash, and swelling of the hands and lower extremities\u2014thus meeting classic criteria for KD. She was treated with a single dose of 2g/kg intravenous immunoglobulin (IVIG) and high dose acetylsalicylic acid (ASA 20mg/kg four times daily) according to treatment guidelines.3 Her last elevated temperature was 38.3\u00b0C just after completing IVIG. An echocardiogram was normal without any evidence of coronary dilation or aneurysm, no pericardial effusion, and with normal valvar and ventricular function. The evening prior to discharge, RT-PCR testing for COVID-19 resulted positive from the Stanford Clinical Virology Laboratory. The Public Health Department was notified, and the family was instructed to quarantine at home for 14 days from positive test date. She was discharged on low dose ASA (3mg/kg daily) with plans to follow-up with pediatric cardiology for repeat echocardiographic evaluation two weeks after discharge, timed to occur after the mandated 14-day quarantine.",
        "es": "La paciente es una ni\u00f1a de 6 meses, nacida a t\u00e9rmino, previamente sana y con el calendario de vacunaci\u00f3n completo, que fue llevada a urgencias pedi\u00e1tricas con fiebre, mareo y rechazo de la lactancia de un d\u00eda de evoluci\u00f3n. No mostraba tos, congesti\u00f3n ni rinorrea. La exploraci\u00f3n mostr\u00f3 una ni\u00f1a con mareo, temperatura de 38,8 \u00b0C y sin signos focales de infecci\u00f3n. Las pruebas anal\u00edticas incluyeron un frotis r\u00e1pido para gripe y un an\u00e1lisis de orina mediante cat\u00e9ter; todos los resultados fueron negativos. Se le diagnostic\u00f3 una infecci\u00f3n v\u00edrica. El d\u00eda 2 de fiebre, present\u00f3 un exantema con manchas eritematosas, aparentemente no prur\u00edticas. Volvi\u00f3 a urgencias el d\u00eda 4 de fiebre con exantema persistente. Aunque segu\u00eda sin tos, parec\u00eda tener una leve congesti\u00f3n. Las constantes vitales eran: temperatura de 38,3 \u00b0C, taquicardia sinusal (200 l.p.m.) y taquipnea con una saturaci\u00f3n de ox\u00edgeno de 100%. A la exploraci\u00f3n se apreci\u00f3 irritabilidad, conjuntivitis sin afectaci\u00f3n limbal y labios secos y agrietados. No se apreci\u00f3 linfoadenopat\u00eda y las extremidades eran normales. Presentaba una leve retracci\u00f3n subcostal, pero los ruidos respiratorios eran normales. Las pruebas anal\u00edticas revelaron leucocitosis con desviaci\u00f3n a la izquierda, anemia normoc\u00edtica, trombocitos normales, prote\u00edna C-reactiva claramente elevada (13,3 mg/dL) y velocidad de sedimentaci\u00f3n globular de 118 mm/h. Presentaba hiponatremia (sodio 133 mEq/L) e hipoalbuminemia (alb\u00famina 2,8 g/dL), con el resto de los valores normales, incluyendo las pruebas funcionales hep\u00e1ticas. Las pruebas de pat\u00f3genos respiratorios mediante RT-PCR y hemocultivos fueron negativas. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 una leve opacidad en la zona medial izquierda. Durante este periodo de enfermedad no tuvo contacto con otros enfermos. Su hermano de 9 a\u00f1os hab\u00eda tenido s\u00edntomas respiratorios de v\u00edas respiratorias altas 3 semanas antes. La familia se hab\u00eda autoconfinado a causa de la pandemia de COVID-19 durante la semana anterior, sin salir para ir a la escuela ni al trabajo. No hab\u00eda antecedentes de viajes recientes. Se remiti\u00f3 a la paciente para su ingreso y evaluaci\u00f3n de posible Kawasaki. Teniendo en cuenta su fiebre, posible congesti\u00f3n leve y los resultados radiol\u00f3gicos, se traslad\u00f3 al servicio de urgencias para pruebas de COVID-19 antes del ingreso en la planta de pediatr\u00eda. Al ingreso, la paciente ten\u00eda fiebre de 5 d\u00edas, conjuntivitis sin afectaci\u00f3n limbal, papilas gustativas prominentes, exantema maculopapuloso p\u00e1lido polim\u00f3rfico e hinchaz\u00f3n de las manos y las extremidades inferiores, manifestaciones coherentes con los criterios cl\u00e1sicos de la enfermedad de Kawasaki. Se trat\u00f3 con una dosis \u00fanica de 2 g/kg de inmunoglobulina i.v. y una dosis alta de \u00e1cido acetilsalic\u00edlico (AAS 20 mg/kg cuatro veces al d\u00eda) seg\u00fan el protocolo de tratamiento. era de 38,3 \u00b0C Una ecocardiograf\u00eda dio resultados normales, sin evidencias de dilataci\u00f3n coronaria o aneurisma ni de derrame peric\u00e1rdico, y con actividad valvular y ventricular normal. La noche anterior al alta, la prueba RT-PCR para COVID-19 dio resultado positivo, realizada en el Stanford Clinical Virology Laboratory. Se notific\u00f3 el caso al departamento de salud p\u00fablica y se indic\u00f3 a la familia que guardara cuarentena durante 14 d\u00edas a partir de la fecha del positivo. La paciente fue dada de alta con una dosis baja de AAS (3 mg/kg por d\u00eda) y con seguimiento por parte del servicio de cardiolog\u00eda pedi\u00e1trica para realizar una evaluaci\u00f3n ecocardiogr\u00e1fica dos semanas tras el alta, programada despu\u00e9s de la cuarentena obligatoria de 14 d\u00edas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 34-year-old man presented to the community hospital with 1-day history of chill and fever (38.7\u00a0\u2103) of unknown cause. Five days ago, he just passed Wuhan high-speed rail station in China on train. Coarse breath sounds of both lungs were heard at auscultation. Laboratory studies showed white blood cell count 5,660,000/mL, lymphocyte cell count 1,150,000/mL, the white blood cell differential count showed 70.6% neutrophils (normal range 40\u201375%), 0.0% eosinophils (normal range 0.4\u20138%), and 8.5% monocytes (normal range 3\u201310%). There were elevated blood levels for C-reactive protein (23.6\u00a0mg/L; normal range 0\u20135\u00a0mg/L), Prothrombin time (13.5\u00a0s; normal range 9.0\u201316.0\u00a0s), Activated partial thromboplastin time (40.3\u00a0s; normal range 27.0\u201345.0\u00a0s). But real-time fluorescence polymerase chain reaction (RT-PCR) of the patient\u2019s pharyngeal swab for severe acute respiratory syndrome-Corona virus-2 (SARS-CoV-2) nucleic acid was always negative for four times at disease onset. The clinical doctor could not diagnose as COVID-19 for the negative RT-PCR testing in its early stage. CXR at disease onset showed patchy opacities in the left middle lung field. Thereafter, he was transferred immediately to the superior hospital, and chest CT showed patchy ground-glass opacity in the upper lobe of the left lung on admission and it rapidly progressed to segmental mixed consolidation and ground glass opacification with air-bronchogram 3\u00a0days after admission and it resolved in left upper lobe and also showed multifocal ground-glass opacities 7\u00a0days after admission and they resolved within 2\u00a0weeks. Fortunately, this patient was diagnosed as \"presumed cases\" based on early CT findings, the patient was immediately isolated for clinical monitoring so as not to cause regional spread. The fifth RT-PCR test was positive on the fifth day after admission; this patient was finally confirmed as COVID-19.",
        "es": "Un hombre de 34 a\u00f1os acudi\u00f3 al hospital local con escalofr\u00edos y fiebre (38,7 \u00b0C) de origen desconocido de un d\u00eda de evoluci\u00f3n. Cinco d\u00edas antes hab\u00eda pasado por la estaci\u00f3n de ferrocarril de alta velocidad de Wuhan (China). A la auscultaci\u00f3n se apreciaron estertores gruesos en ambos pulmones. Las pruebas anal\u00edticas mostraron los valores siguientes: cifra de leucocitos 5.660.000/mL, cifra de linfocitos 1.150.000/mL y f\u00f3rmula leucocitaria con 70,6% de neutr\u00f3filos (intervalo normal: 40-75%), 0,0% de eosin\u00f3filos (intervalo normal: 0,4-8%) y 8,5% de monocitos (intervalo normal: 3-10%). Ten\u00eda valores elevados de prote\u00edna C-reactiva (23,6mg/L, intervalo normal: 0-5mg/L), tiempo de protrombina (13,5 s, intervalo normal 9,0-16,0 s) y tiempo de tromboplastina parcial activado (40,3 s, intervalo normal 27,0-45,0 s). Sin embargo, las RT-PCR de fluorescencia en tiempo real de frotis far\u00edngeos del paciente para detectar el coronavirus del s\u00edndrome respiratorio agudo grave (SARS-CoV-2) dieron cuatro resultados negativos al comienzo de los s\u00edntomas. El doctor no pudo diagnosticar COVID-19 a causa de las pruebas negativas mediante RT-PCR en este estado temprano. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades parcheadas en el campo pulmonar izquierdo medio. Al ingreso, la radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado parcheadas en el l\u00f3bulo superior del pulm\u00f3n izquierdo, que progresaron r\u00e1pidamente a una consolidaci\u00f3n mixta segmentaria y a una opacificaci\u00f3n de vidrio esmerilado con broncograma a\u00e9reo a los tres d\u00edas de ingreso, que se resolvi\u00f3 en el l\u00f3bulo superior izquierdo; tambi\u00e9n mostr\u00f3 opacidades de vidrio esmerilado 7 d\u00edas despu\u00e9s del ingreso, que se resolvieron en dos semanas. Por suerte, este paciente se diagnostic\u00f3 como \u00abposible caso\u00bb a partir de los resultados radiol\u00f3gicos iniciales y fue aislado inmediatamente para su monitorizaci\u00f3n cl\u00ednica, para no provocar transmisi\u00f3n local. La quinta RT-PCR fue positiva, en el quinto d\u00eda de hospitalizaci\u00f3n, de modo que el paciente qued\u00f3 confirmado finalmente con un diagn\u00f3stico de COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 37-year-old obese many with body mass index (BMI) 36.8 kg/m2(18.5-25), smoking status negative, with a 6-days history of fever up to 38.5\u00baC, cough, rhinitis, exertional dyspnea and fatigue. He reported close contact with SARS-CoV-2 infected person 10 days before. At admission to hospital on March 15, 2020 patient was in good general condition, heart rate (HR) was 80/min, oxygen saturation (SO2) 97%(96-99), body temperature 36.7\u00baC, no dyspnea signs. His lungs were clear to auscultation. Chest radiograph was normal. Laboratory investigations revealed a white blood cell count (WBC) of 8.0x103(4-10), C-reactive protein (CRP) 44 mg/l(0.06.0) and procalcitonin 0.062 ng/ml 0.00-0.06). Influenza has been excluded. RT-PCR test performed on the nasopharyngeal swab confirmed severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) infection. On day-2 of hospitalization patient's dyspnea worsened, HR was 102/min, SO294%. The oxygen treatment was implemented, but the patient still reported dyspnea. Laboratory findings showed CRP elevation up to 66 mg/l, PO2  58 mmHg(65-100) in arterial blood gas test, WBC 7.04 x103, lactate dehydrogenase 360 U/l(120-246). A repeated chest radiograph indicated bilateral consolidations in lower parts of lungs, recognized as pneumonia. The lopinavir/ritonavir treatment (400/100mg daily), ribavirin (1200mg daily) and ceftriaxone (2000mg daily) was introduced. From day-5 to day-7, diarrhea (6 loose stools/day) appeared. On day-6, despite the treatment dyspnea was still present. CRP was 133 mg/l, WBC 11.5 x103 and PO2 58 mmHg. Blood culture was negative. Next chest radiograph showed progression of abnormalities. There were consolidations in central part of right lung and bilateral consolidations in lower parts of lungs. Due to SO2 89% oxygen therapy was intensified. Azithromycin (500mg daily) was added. After next two days fever, cough and dyspnea resolved and oxygen therapy was finished on day-10 of hospitalization. CRP decreased at 27 mg/l and PO2 improved to 64 mmHg. On 31 MAR the nasopharyngeal swab for SARS-CoV-2 infection was done with negative result and patient was discharged from hospital.",
        "es": "Hombre de 37 a\u00f1os con obesidad (IMC de 36,8 kg/m2; valor normal: 18,5-25), no fumador, con fiebre de hasta 38,5 \u00b0C, tos, rinitis, disnea de esfuerzo y fatiga. Report\u00f3 contacto cercano con una persona infectada de SARS-CoV-2 10 d\u00edas antes. Al ingreso en el hospital, el d\u00eda 15 de marzo de 2020, el paciente mostraba un buen estado de salud general; el pulso era de 80 l.p.m., la saturaci\u00f3n de ox\u00edgeno (SO2) era de 97% (96-99) y la temperatura, de 36,7 \u00b0C y no mostraba signos de disnea. A la auscultaci\u00f3n, los pulmones se apreciaban normales. La radiograf\u00eda tor\u00e1cica era normal. Las pruebas anal\u00edticas mostraron una cifra de leucocitos de 8,0 x 103(4-10), prote\u00edna C-reactiva de 44 mg/l (0,0-6,0) y procalcitonina de 0,062 ng/ml (0,00-0,06). Se excluy\u00f3 la posibilidad de gripe. Las pruebas mediante RT-PCR a partir de frotis nasofar\u00edngeos confirmaron infecci\u00f3n por el virus del s\u00edndrome respiratorio agudo grave 2 (SARS-CoV-2). El d\u00eda 2 de hospitalizaci\u00f3n empeor\u00f3 la disnea del paciente, el pulso era de 102 l.p.m. Se aplic\u00f3 oxigenoterapia, pero el paciente continuaba mostrando signos de disnea. Las pruebas anal\u00edticas mostraron un aumento de la prote\u00edna C-reactiva hasta 66 mg/l, PO2 de 58 mmHg (65-100) en gasometr\u00eda arterial, linfocitos de 7,04 x 103, lactato-deshidrogenasa de 360 U/l (120-246). Una nueva radiograf\u00eda tor\u00e1cica mostr\u00f3 consolidaciones bilaterales en las partes inferiores de los pulmones, que se identificaron como neumon\u00eda. Se le administr\u00f3 lopinavir/ritonavir (400/100 mg por d\u00eda), ribavirina (1200 mg por d\u00eda) y ceftriaxona (2000 mg por d\u00eda). Entre los d\u00edas 5 y 7 apareci\u00f3 diarrea (6 heces semil\u00edquidas al d\u00eda). El d\u00eda 6, a pesar del tratamiento, el paciente segu\u00eda presentando disnea. La prote\u00edna C-reactiva era de 133 mg/l, linfocitos de 11,5 x 103 y PO2 de 58 mmHg. Los hemocultivos resultaron negativos. La siguiente radiograf\u00eda tor\u00e1cica mostr\u00f3 un empeoramiento de las alteraciones. Se observaron consolidaciones en la parte central del pulm\u00f3n derecho y consolidaciones bilaterales en las partes inferiores de los pulmones. Como la saturaci\u00f3n de ox\u00edgeno era del 89%, se aument\u00f3 la oxigenoterapia. Se a\u00f1adi\u00f3 azitromicina (500 mg por d\u00eda) al tratamiento. Despu\u00e9s de dos d\u00edas, desapareci\u00f3 la fiebre, la tos y la disnea y se retir\u00f3 la oxigenoterapia en el d\u00eda 10 de hospitalizaci\u00f3n. La prote\u00edna C-reactiva baj\u00f3 a 27 mg/l y la PO2 mejor\u00f3 a 64 mmHg. El 31 de marzo, se realiz\u00f3 un frotis nasofar\u00edngeo para detecci\u00f3n de SARS-CoV-2, con resultado negativo, y el paciente fue dado de alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 73-year-old man was admitted to the emergency department with a 4-day history of fever, chills, dry cough, and fatigue. He had arrived in S\u00e3o Paulo, Brazil, on the preceding day. His symptoms had begun when he was traveling in northern Italy with 12 friends, three of whom had been diagnosed with COVID-19. He reported having systemic arterial hypertension and type 2 diabetes mellitus. On examination, he had a temperature of 37.7\u00b0C, heart rate of 85 beats/min, respiratory rate of 15 breaths/min, blood pressure of 112/70 mmHg, and 94% oxygen saturation. His lungs were clear to auscultation. A leukogram was normal, and the patient\u2019s C-reactive protein level was 4.78 mg/dL (normal levels below 1.0 mg/dL). Chest radiography showed ill-defined lung opacities, notably in the periphery of the left lung. Chest computed tomography (CT) revealed predominantly peripheral ground glass-opacities involving all pulmonary lobes, which were more exuberant in the left lung, where small foci of consolidation were also seen. Real-time reverse-transcription polymerase chain reaction testing of a nasopharyngeal swab confirmed COVID-19 infection.",
        "es": "Un hombre de 73 a\u00f1os ingres\u00f3 en el servicio de urgencias con fiebre, escalofr\u00edos, tos seca y fatiga de 4 d\u00edas de evoluci\u00f3n. Hab\u00eda llegado a S\u00e3o Paulo (Brasil) el d\u00eda anterior. Sus s\u00edntomas se hab\u00edan iniciado mientras estaba de viaje en el norte de Italia, junto con 12 amigos, a tres de los cuales ya se les hab\u00eda diagnosticado COVID-19. Report\u00f3 unos antecedentes de hipertensi\u00f3n arterial sist\u00e9mica y diabetes tipo 2. A la exploraci\u00f3n, su temperatura era de 37,7 \u00b0C, su pulso era de 85 l.p.m., su frecuencia respiratoria de 15 r.p.m., su presi\u00f3n arterial de 112/70 mmHg y su saturaci\u00f3n de ox\u00edgeno de 94%. A la auscultaci\u00f3n, los pulmones se apreciaban normales. Su leucograma era normal y el valor de prote\u00edna C-reactiva era de 4,78 mg/dL (valor normal por debajo de 1,0 mg/dL). Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades pulmonares poco definidas, sobre todo en la periferia del pulm\u00f3n izquierdo. Una TAC tor\u00e1cica mostr\u00f3, de forma predominante, opacidades de vidrio esmerilado en todos los l\u00f3bulos pulmonares, m\u00e1s abundantes en el pulm\u00f3n izquierdo, donde tambi\u00e9n se apreciaron peque\u00f1os centros de consolidaci\u00f3n. Las pruebas mediante RT-PCR en tiempo real de un frotis nasofar\u00edngeo confirmaron la infecci\u00f3n por COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A woman in her 40s presented with an acute loss of the olfactory function without nasal obstruction. There was no dysgeusia because the patient reported no changes in salty, sweet, sour, and bitter. A few days before presentation, she also experienced a dry cough associated with cephalalgia and myalgia. She had no fever or rhinorrhea. The otoscopic and anterior rhinoscopic examination results (without endoscopic examination) were normal. The ability to detect and identify odorants was estimated using 5 odorants commonly used to test human olfaction: phenyl-ethyl-alcohol (flower rose), cyclotene (caramel), isovaleric acid (goat cheese), undecalactone (fruits), and skatole (manure). The task was to detect and try to identify each odorant. None of these odorants were identified or detected by the patient. The patient underwent a computed tomographic scan of the nasal cavity that showed bilateral inflammatory obstruction of the olfactory clefts that was confirmed on magnetic resonance imaging (MRI) of the nasal cavity. There were no anomalies of the olfactory bulbs and tracts. Because her husband was also suspected to be infected by SARS-CoV-2, the patient underwent real-time polymerase chain reaction (RT-PCR) for SARS-CoV-2, which yielded positive results.",
        "es": "Se present\u00f3 una mujer de unos cuarenta a\u00f1os con anosmia aguda, sin obstrucci\u00f3n nasal. No se observ\u00f3 disgeusia, porque la paciente no report\u00f3 cambios en la percepci\u00f3n de los gustos salados, dulces, \u00e1cidos y amargos. Pocos d\u00edas antes de la primera consulta, tambi\u00e9n experiment\u00f3 tos seca que curs\u00f3 con cefalea y mialgia. No presentaba fiebre ni rinorrea. Los resultados de la exploraci\u00f3n otosc\u00f3pica y rinosc\u00f3pica anterior (sin exploraci\u00f3n endosc\u00f3pica) fueron normales. La capacidad de detectar e identificar olores se estim\u00f3 mediante 5 compuestos usados habitualmente para pruebas olfativas: alcohol fenet\u00edlico (rosa), cicloteno (caramelo), \u00e1cido isoval\u00e9rico (queso de cabra), undecalactona (fruta) y escatol (esti\u00e9rcol). El objetivo era detectar e intentar identificar cada fragancia. La paciente no pudo identificar ni detectar ninguno de estos olores. La paciente se someti\u00f3 a una TAC de las fosas nasales, que mostr\u00f3 una obstrucci\u00f3n inflamatoria bilateral de las fosas, confirmada mediante RMI. No se observaron anomal\u00edas de los bulbos olfativos ni de los ped\u00fanculos olfativos. Como su esposo era un posible caso de infecci\u00f3n por SARS-CoV-2, se realiz\u00f3 una prueba mediante RT-PCR para SARS-CoV-2 de la paciente, que dio resultado positivo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 43-year-old woman presented to the emergency room for a 3-day history of oppressive chest pain and dyspnoea. On admission, she had a temperature of 37.7\u00b0C, blood pressure 120/80 mmHg, and heart rate 79 b.p.m. Physical exam revealed decreased breath sounds at lung bases with ronchi. Because of oxygen desaturation (SpO2 89%), continuous positive airway pressure (CPAP) was positioned. Chest X-ray documented subtle bilateral opacities suggesting interstitial inflammatory lung disease. In consideration of the local coronavirus epidemic outbreak, nasopharyngeal and oropharyngeal swabs were immediately obtained, confirming SARS-CoV-2 positivity. ECG showed low atrial ectopic rhythm, mild ST-segment elevation in leads V1\u2013V2 and aVR, reciprocal ST depression in V4\u2013V6, and QTc 452 ms with diffuse U-waves. The high-sensitivity troponin T curve was 135\u2013107\u2013106 ng/L (normal value <14), NT-proBNP 512 pg/mL (normal value <153), and C-reactive protein 18 mg/L (normal value <6). Transthoracic echocardiogram showed mild left ventricular systolic dysfunction (LVEF 43%) with inferolateral wall hypokynesis; neither ventricle was dilated and there was no pericardial effusion. Although the first clinical suspicion was myocarditis, coronary computed tomography angiography (CTA) was acquired to rule out coronary artery disease (CAD). Baseline chest scan confirmed bilateral patchy ground-glass opacities; CTA showed no aortic dissection, pulmonary embolism, or epicardial CAD. Dynamic 3D volume-rendering reconstruction demonstrated a clear hypokinesia of the left ventricle mid and basal segments, with normal apical contraction, suggesting a reverse Tako-Tsubo syndrome (TTS) pattern. The patient was admitted to a specialized COVID-19 Unit at our Institution, on droplet precautions. Following multidisciplinary evaluation, both cardiac magnetic resonance (CMR) and endomyocardial biopsy (EMB) were planned to clarify diagnosis. CMR (day 7) showed a recovery of systolic function (from 52% by CTA to 64% by CMR), although with persistence of a mild hypokinesia at basal and mid left ventricular segments; at the same sites, diffuse myocardial oedema, determining wall pseudo-hypertrophy, was observed on short T1 inversion recovery (STIR) sequences and confirmed by T1 and T2 mapping (average native T1 = 1188 ms, normal value <1045; average T2 = 61 ms, normal value <50). Late gadolinium enhancement sequences demonstrated absence of detectable myocardial scar/necrotic foci. EMB documented diffuse T-lymphocytic inflammatory infiltrates (CD3+ >7/mm2) with huge interstitial oedema and limited foci of necrosis. No replacement fibrosis was detected, suggesting an acute inflammatory process. Molecular analysis showed absence of the SARS-CoV-2 genome within the myocardium. No contraction band necrosis or TTS-associated microvascular abnormalities were observed. The final diagnosis was acute virus-negative lymphocytic myocarditis associated with SARS-CoV-2 respiratory infection. The patient started empirical treatment with lopinavir/ritonavir 500 mg b.i.d. and hydroxycholoroquine 200 mg b.i.d. Preserved systolic function (LVEF 65%) was maintained, ECG normalized, and both troponin T and C-reactive protein showed progressive improvement. The patient was discharged with no symptoms (day 13).",
        "es": "Una mujer de 43 a\u00f1os acudi\u00f3 al servicio de urgencias con dolor tor\u00e1cico opresivo y disnea de 3 d\u00edas de evoluci\u00f3n. Sus antecedentes m\u00e9dicos eran anodinos. Al ingreso, ten\u00eda una temperatura de 37,7 \u00b0C, una presi\u00f3n arterial de 120/80 mmHg y un pulso de 79 l.p.m. A la exploraci\u00f3n f\u00edsica se observ\u00f3 una disminuci\u00f3n de los ruidos respiratorios con roncus en la base de los pulmones. A causa de la desaturaci\u00f3n de ox\u00edgeno (SpO2 89%), se aplic\u00f3 ventilaci\u00f3n mec\u00e1nica positiva continua (PPC). Una radiograf\u00eda tor\u00e1cica revel\u00f3 ligeras opacidades bilaterales que apuntaban a una neumopat\u00eda inflamatoria intersticial. Teniendo en cuenta el brote epid\u00e9mico local de coronavirus, se obtuvieron de inmediato frotis nasofar\u00edngeos y orofar\u00edngeos, que confirmaron la infecci\u00f3n por SARS-CoV-2. Un ECG mostr\u00f3 una ligera extras\u00edstole auricular, ligero aumento del segmento ST en las derivaciones V1-V2 y aVR, descenso rec\u00edproco del segmento ST en V4-V6 y QTc de 452 ms con ondas U difusas. La curva de troponina T ultrasensible era de 135-107-106 ng/L (valor normal < 14), NT-proBNP de 512 pg/mL (valor normal < 153) y prote\u00edna C-reactiva de 18 mg/L (valor normal < 6). Un ecocardiograma transtor\u00e1cico mostr\u00f3 una leve disfunci\u00f3n sist\u00f3lica ventricular (LEV 43%) con hipocinesia parietal inferolateral; ninguno de los ventr\u00edculos estaba dilatado y no se observ\u00f3 derrame peric\u00e1rdico. Aunque la primera sospecha cl\u00ednica fue miocarditis, se obtuvo una angiotomograf\u00eda computarizada coronaria (ATC) para descartar arteriopat\u00eda coronaria (AC). La TAC tor\u00e1cica inicial confirm\u00f3 opacidades de vidrio esmerilado parcheadas bilaterales; la ATC no mostr\u00f3 disecci\u00f3n a\u00f3rtica, embolia pulmonar ni AC epic\u00e1rdica. Una reconstrucci\u00f3n en 3D din\u00e1mica mostr\u00f3 una clara hipocinesia de los segmentos medio y basal del ventr\u00edculo izquierdo, con contracci\u00f3n apical normal, lo que suger\u00eda miocardiopat\u00eda de Takotsubo. La paciente fue ingresada en la unidad especializada en COVID-19 de nuestra instituci\u00f3n, con precauciones para got\u00edculas. Tras una evaluaci\u00f3n multidisciplinaria, se program\u00f3 una resonancia magn\u00e9tica card\u00edaca (RMC) y una biopsia endomioc\u00e1rdica (BEM) para aclarar el diagn\u00f3stico. Una RMC (d\u00eda 7) mostr\u00f3 una mejora de la actividad sist\u00f3lica (del 52% en ATC al 64% en RMC), aunque continuaba una leve hipocinesia en los segmentos basal y ventricular medio izquierdo; en los mismos puntos se observ\u00f3 edema mioc\u00e1rdico difuso, que determinaba pseudohipertrofia parietal, en secuencias STIR, y se confirm\u00f3 mediante cartograf\u00eda en T1 y T2 (T1 medio original = 1188 ms, valor normal < 1045; T2 medio = 61 ms, valor normal < 50). Las secuencias de contraste con gadolinio mostraron ausencia de centros necr\u00f3ticos/cicatrices mioc\u00e1rdicos detectables. Una BEM detect\u00f3 infiltrados inflamatorios T-linfoc\u00edticos difusos (CD3+ > 7/mm2) con gran edema intersticial y centros limitados de necrosis. No se detect\u00f3 fibrosis de reemplazo, lo que suger\u00eda un proceso inflamatorio agudo. Los an\u00e1lisis moleculares mostraron ausencia de genoma de SARS-CoV-2 en el miocardio. No se observ\u00f3 necrosis de la banda de contracci\u00f3n ni anomal\u00edas microvasculares asociadas a miocardiopat\u00eda de Takotsubo. El diagn\u00f3stico final fue miocarditis linfoc\u00edtica aguda no v\u00edrica asociada a una infecci\u00f3n respiratoria por SARS-CoV-2. Se inici\u00f3 un tratamiento provisional con lopinavir/ritonavir, 500 mg dos veces al d\u00eda, e hidroxicloroquina, 200 mg dos veces al d\u00eda. Se mantuvo la actividad sist\u00f3lica (LEV 65%), el ECG se normaliz\u00f3 y los valores de troponina T y de prote\u00edna C-reactiva mostraron una mejora progresiva. La paciente fue dada de alta sin s\u00edntomas (d\u00eda 13)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 69\u2010year\u2010old patient presented to the emergency department of the main hospital of a \u2018red zone\u2019 town in Lombardy, Italy. He had been complaining of worsening dyspnoea, persistent cough, and weakness since 4\u2009days. A lung computed tomography scan showed diffuse bilateral interstitial inflammation with sub\u2010pleural consolidations. The nasopharyngeal swab tested positive for COVID\u201019 on real\u2010time reverse transcriptase\u2010polymerase chain reaction assay. Blood analysis demonstrated high inflammatory markers and lymphopenia (white blood cell count 23080/mm3, neutrophils 91.4%, lymphocytes 1.4%, C\u2010reactive protein 52.7 mg/L) and increased hs\u2010TnI (4332 ng/L). Arterial blood gas analysis showed severe metabolic acidosis with hyperlactacidaemia (pH 7.2, excess basis \u20136 mEq/L, lactates 9\u2009mmol/dL) and hypoxaemia. Non\u2010invasive ventilation was initiated. The first echocardiography showed a dilated left ventricle [left ventricular (LV) end\u2010diastolic diameter 56\u2009mm], severe and diffuse LV hypokinesia (LV ejection fraction 34%). Three hours later, LV ejection fraction dropped to 25% and estimated cardiac index was 1.4 L/min/m2. Coronary angiography findings were unremarkable. An intra\u2010aortic balloon pump (IABP) was placed on top of adrenaline (0.07\u2009\u03bcg/kg/min), and noradrenaline (0.1\u2009\u03bcg/kg/min) was added for worsening hypotension (systolic blood pressure: 80/67/60\u2009mmHg). The mobile team from our third level ECMO center was activated for on\u2010site implantation of VA\u2010ECMO and patient retrieval to our hospital. After ECMO institution, the patient developed sudden and marked desaturation requiring orotracheal intubation. On admission to our ICU, due to maintenance of minimal ventricular ejection and aortic valve opening, the inotropic support was gradually decreased and eventually stopped to prevent adrenergic stimulation to the myocardium. EMB was performed and a venous cannula was added at the right jugular vein site for persistent severe hypoxaemia, thus upgrading the VA\u2010ECMO to venous\u2010arterial\u2010venous ECMO. LV function progressively recovered up to normal levels on day 5, when both ECMO and IABP were discontinued. Twelve days after weaning from ECMO, the patient suddenly developed Gram\u2010negative pneumonia (Pseudomonas aeruginosa and Klebsiella pneumoniae) and died of septic shock within a few hours, without any further LV function impairment.",
        "es": "Un paciente de 69 a\u00f1os acudi\u00f3 al servicio de urgencias del hospital principal de una ciudad de la \u00abzona roja\u00bb en la Lombard\u00eda (Italia). Report\u00f3 disnea que empeoraba, tos persistente y debilidad, de cuatro d\u00edas de evoluci\u00f3n. Una TAC tor\u00e1cica mostr\u00f3 inflamaci\u00f3n intersticial bilateral difusa con consolidaciones subpleurales. El frotis nasofar\u00edngeo result\u00f3 positivo para COVID-19 mediante el ensayo de RT-PCR en tiempo real. Las pruebas anal\u00edticas mostraron altos valores de marcadores inflamatorios y linfocitopenia (cifra de leucocitos 23080/mm3, neutr\u00f3filos 91,4%, linfocitos 1,4%, prote\u00edna C-reactiva 52,7 mg/L) y un aumento de hs-TnI (4332 ng/L). La gasometr\u00eda arterial evidenci\u00f3 una acidosis metab\u00f3lica grave, con hiperlactoacidemia (pH 7,2; exceso de base \u20136 mEq/L, lactatos 9 mmol/dL) e hipoxemia. Se inici\u00f3 respiraci\u00f3n asistida no invasiva. La primera ecocardiograf\u00eda mostr\u00f3 dilataci\u00f3n del ventr\u00edculo izquierdo (di\u00e1metro telediast\u00f3lico VI 56 mm), hipocinesia del VI grave y difusa (fracci\u00f3n de expulsi\u00f3n VI 34%). Tres horas despu\u00e9s, la fracci\u00f3n de expulsi\u00f3n del VI cay\u00f3 a un 25% y el \u00edndice card\u00edaco era de 1,4 L/min/m2. Los resultados de una angiograf\u00eda coronaria no aportaron nada destacable. Se coloc\u00f3 un globo de contrapulsaci\u00f3n a\u00f3rtica, adem\u00e1s de adrenalina (0,07 microgramo/kg/min), y se a\u00f1adi\u00f3 noradrenalina (0,1 microgramo/kg/min) a causa de un empeoramiento de la hipotensi\u00f3n (presi\u00f3n arterial sist\u00f3lica: 80/67/60 mmHg). Se activ\u00f3 el equipo m\u00f3vil de nuestro centro de tercer nivel con oxigenaci\u00f3n por membrana extracorporal (OMEC) para aplicaci\u00f3n de OMEC-VA y traslado del paciente a nuestro hospital. Tras aplicaci\u00f3n de la OMEC, el paciente present\u00f3 una clara y s\u00fabita desaturaci\u00f3n que requiri\u00f3 intubaci\u00f3n orotraqueal. Al ingreso en nuestra UCI, a causa del mantenimiento de una m\u00ednima expulsi\u00f3n ventricular y del orificio a\u00f3rtico, se disminuy\u00f3 gradualmente el apoyo inotr\u00f3pico y, finalmente, se retir\u00f3 para evitar una estimulaci\u00f3n adren\u00e9rgica del miocardio. Se realiz\u00f3 una BEM y se coloc\u00f3 un cat\u00e9ter venoso en la vena yugular derecha a causa de la hipoxemia grave persistente, con lo que se pas\u00f3 de OMEC-VA a OMEC-VAV. La actividad del VI volvi\u00f3 progresivamente a los valores normales en el d\u00eda 5, cuando se retir\u00f3 la OMEC y el globo de contrapulsaci\u00f3n a\u00f3rtica. Doce d\u00edas despu\u00e9s de la retirada de la IMEC, el paciente present\u00f3 s\u00fabitamente una neumon\u00eda gramnegativa (Pseudomonas aeruginosa y Klebsiella pneumoniae) y muri\u00f3 de choque s\u00e9ptico en pocas horas, sin ninguna alteraci\u00f3n de la actividad del VI."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A Wuhan-settled 47-year-old female. She has a more than 16-year history of systemic lupus erythematosus (SLE) and has been taking oral prednisone (7.5\u00a0mg/d) since her diagnosis. She had not taken hydroxychloroquine or other immunosuppressive drugs. On January 10th, 2020, she spent 1\u00a0h dancing and singing in a room and one of her partners was later diagnosed with COVID-19. In the following 10\u00a0days, she had no contact with any confirmed or suspected patients. She returned to her parents' home in Yiyang on January 20th and after that never went out. Because of the severity of COVID-19, Hunan province carried out a \u2018level one response to major public health emergencies\u2019 on January 23. Therefore, Case 1 was placed under home quarantine and observation for 14\u00a0days. During the isolation period, she felt good and had no fever, cough or shortness of breath. Therefore, she was released from quarantine on February 6th. Just a day later, however, Case 1 began to have a mild cough, nasal congestion, and runny nose, but no fever. She paid little attention to her symptoms and did not seek further medical help. These symptoms improved 7\u00a0days later. On February 28th, she was admitted to hospital for screening because of her father's diagnosis of COVID-19. Her routine blood examination was abnormal, with a white blood cell (WBC) count of 2.98\u00a0\u2217\u00a010^9/L, hemoglobin concentration of 106\u00a0g/L, and platelet count of 73\u00a0\u2217\u00a010^9/L. Her erythrocyte sedimentation rate (ESR) was 33\u00a0mm/h, which was above normal. IL-6 was normal. The SARS-CoV2 nuclei acid test from nasopharyngeal swabs was negative, but her IgM and IgG antibodies were positive. Mycoplasma pneumoniae and Chlamydia pneumoniae antibodies were negative. Lung CT showed multiple lesions in both lungs. These results supported the diagnosis of COVID-19. Hence, she was given antiviral treatment, including 0.2\u00a0g BID of Abidol orally and 5 million IU of interferon nebulization. Nasopharyngeal swab virus nucleic acid tests were performed again on February 29th and March 3rd, both of which were negative. On March 5th, her lung CT worsened, and ground-glass opacity changes were found in the right upper lung. She was given extra piperacillin sodium tazobactam sodium (4.5 TID), and then glycyrrhizin (150\u00a0mg QD). Her CT showed improvements and she was discharged on March 9th.",
        "es": "Mujer de 47 a\u00f1os residente en Wuhan. Tiene unos antecedentes de m\u00e1s de 16 a\u00f1os de lupus eritematoso diseminado y toma prednisona (7,5 mg/d\u00eda por v\u00eda oral) desde su diagn\u00f3stico. No hab\u00eda tomado hidroxicloroquina ni otros f\u00e1rmacos inmunosupresores. El 10 de enero de 2020, estuvo en una sala bailando y cantando y uno de sus compa\u00f1eros fue diagnosticado posteriormente de COVID-19. En los siguientes 10 d\u00edas, no tuvo ning\u00fan contacto con pacientes confirmados o presuntos. Regres\u00f3 al hogar de sus padres en Yiyang el 20 de enero y, desde entonces, no volvi\u00f3 a salir. A causa de la gravedad de la COVID-19, la provincia de Hunan aplic\u00f3 una respuesta de nivel uno para urgencias de salud p\u00fablica el 23 de enero. En consecuencia, el caso 1 fue puesto bajo cuarentena domiciliaria y en observaci\u00f3n durante 14 d\u00edas. Durante el periodo de aislamiento se sinti\u00f3 bien de salud, sin fiebre, tos ni disnea. As\u00ed, el 6 de febrero se levant\u00f3 su cuarentena. Sin embargo, solo un d\u00eda despu\u00e9s, el caso 1 empez\u00f3 a presentar tos leve, congesti\u00f3n nasal y rinorrea, pero sin fiebre. No prest\u00f3 mucha atenci\u00f3n a sus s\u00edntomas y no pidi\u00f3 asistencia sanitaria. Sus s\u00edntomas mejoraron 7 d\u00edas despu\u00e9s. El 28 de febrero acudi\u00f3 al hospital para someterse a unas pruebas, a causa del diagn\u00f3stico de COVID-19 de su padre. Sus an\u00e1lisis de sangre resultaron anormales, con una cifra de leucocitos de 2,98 * 10^9/L, concentraci\u00f3n de hemoglobina de 106 g/L y cifra de trombocitos de 73 * 10^9/L. Su velocidad de sedimentaci\u00f3n globular (VSG) era de 33 mm/h, por encima del valor normal. La IL-6 era normal. La prueba de \u00e1cido nucleico de SARS-CoV-2 a partir de frotis nasofar\u00edngeos result\u00f3 negativa, pero sus anticuerpos IgM e IgG fueron positivos. Los anticuerpos para Mycoplasma pneumoniae y Chlamydia pneumoniae resultaron negativos. Una TAC pulmonar mostr\u00f3 varias lesiones en ambos pulmones. Estos resultados respaldaban el diagn\u00f3stico de COVID-19. En consecuencia, a la paciente se le administr\u00f3 un tratamiento antiv\u00edrico, con 0,2 g de abidol dos veces al d\u00eda por v\u00eda oral y 5 millones de UI de interfer\u00f3n por nebulizaci\u00f3n. El 29 de febrero y el 3 de marzo se repitieron las pruebas de \u00e1cido nucleico del virus a partir de frotis nasofar\u00edngeos, ambas con resultado negativo. El 5 de marzo, la TAC pulmonar mostr\u00f3 un empeoramiento y se hallaron opacidades de vidrio esmerilado en la parte superior del pulm\u00f3n derecho. Se le dio piperacilina y tazobactam (4,5 tres veces al d\u00eda) y luego glicirrizina (150 mg al d\u00eda). La TAC mostr\u00f3 mejoras y fue dada de alta el 9 de marzo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "Case 2 is an 81-year-old male who has been living in Yiyang for many years. He has a history of prostate cancer and coronary heart disease. He had been living with his eldest daughter since she returned from Wuhan and had not gone out since then. He developed a paroxysmal dry cough and anorexia on February 21st. In the beginning, he did not get treatment. On February 25th, the symptoms aggravated with a fever (38.0\u00a0\u00b0C) and shortness of breath. Influenza A and B viruses were negative. His chest CT was abnormal with bilateral ground-glass opacities. His symptoms did not improve even after treatment with piperacillin-tazobactam (4.5\u00a0g Q48h), ambroxol, ribavirin (500\u00a0mg Q12h), and oseltamivir (75\u00a0mg BID). The SARS-CoV2 nucleic acid test was positive by both nasopharyngeal swabs and sputum on February 27th. His hemoglobin (83\u00a0g/L) and lymphocytes (0.65\u00a0\u2217\u00a010^9/L) were below normal, and his D-dimer (5.46\u00a0mg/mL), C-reactive protein (134\u00a0mg/L), ESR (126\u00a0mm/h), IL-6 (7.6\u00a0pg/mL) were above normal. His arterial blood gas showed a PO2 of 67\u00a0mmHg and a FiO2 of 33%. Therefore, he was diagnosed with severe COVID-19 and admitted to the intensive care unit with support treatments including high fluids, oxygen, interferon, lopinavir-ritonavir and ribavirin for anti-viral therapy, linezolid, meropenem and fluconazole for anti-inflammation, and albumin, gamma globulin, steroids (80\u00a0mg/d) and recovery plasma (200\u00a0mL\u2217\u00a02) to improve his immune system. His virus nucleic acid tests were retested on March 2nd and March 4th, with both showing negative. On March 3rd, his IgM and IgG specific antibodies were positive. Repeat blood gas on March 5th showed a PO2 of 114\u00a0mmHg and a FiO2 of 33%. His lung CT showed that his inflammation lesions were absorbed and ground-glass opacities were improved.",
        "es": "Hombre de 81 a\u00f1os, residente en Yiyang desde hace muchos a\u00f1os. Tiene antecedentes de c\u00e1ncer de pr\u00f3stata y cardiopat\u00eda coronaria. Ha estado viviendo con su hija mayor desde que volvi\u00f3 de Wuhan y no ha salido desde entonces. El 21 de febrero sufri\u00f3 tos seca convulsiva y anorexia. Al principio, no se le dio ning\u00fan tratamiento. El 25 de febrero, los s\u00edntomas empeoraron con fiebre (38,0\u00b0C) y disnea. Las pruebas para gripe A y B fueron negativas. Una TAC tor\u00e1cica mostr\u00f3 anomal\u00edas, con opacidades de vidrio esmerilado. Sus s\u00edntomas no mejoraron incluso despu\u00e9s de tratamiento con piperacilina/tazobactam (4,5 g cada 48 h), ambroxol, ribavirina (500 mg cada 12 h) y oseltamivir (75 mg dos veces al d\u00eda). El 27 de febrero, la prueba de \u00e1cido nucleico de SARS-CoV-2 fue positiva, tanto a partir de frotis nasofar\u00edngeos como de esputo. Su hemoglobina (83 g/L) y linfocitos (0,65 * 10^9/L) estaban por debajo de los valores normales, mientras que el d\u00edmero D (5,46 mg/mL), la prote\u00edna C-reactiva (134mg/L), la VSG (126 mm/h) y la IL-6 (7,6 pg/mL) mostraban valores por encima de los normales. Su gasometr\u00eda arterial mostr\u00f3 una PO2 de 67 mmHg y una FiO2 de 33%. En consecuencia, se le diagnostic\u00f3 COVID-19 grave y fue ingresado en la unidad de cuidados intensivos con ox\u00edgeno, interfer\u00f3n, lopinavir/ritonavir y ribavirina como tratamiento antiv\u00edrico, linezolid, meropenem y fluconazol como antibi\u00f3ticos, y alb\u00famina, gammaglobulina, esteroides (80 mg/d\u00eda) y plasma sustitutivo (200 mL*2) para mejorar su sistema inmunitario. El 2 y el 4 de marzo se repitieron las pruebas de \u00e1cido nucleico y ambas dieron resultado negativo. El 3 de marzo, las pruebas para anticuerpos IgM e IgG fueron positivas. Una repetici\u00f3n de la gasometr\u00eda arterial el d\u00eda 5 de marzo mostr\u00f3 una PO2 de 114 mmHg y una FiO2 de 33%. La TAC pulmonar mostr\u00f3 que las lesiones inflamatorias se hab\u00edan absorbido y que las opacidades de vidrio esmerilado hab\u00edan mejorado."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "Case 3 is a 44-year-old female from Yiyang. She had close contact with her elder sister. She developed a fever (37.8\u00a0\u00b0C) and inappetence on February 13th. Three days later, she was taken to a hospital. Laboratory examination showed a WBC of 2.88\u00a0\u2217\u00a010^9/L, C-reactive protein of 17.06\u00a0mg/L, and fibrinogen of 4.27\u00a0g/L. Influenza A and B were negative. Lung CT showed multiple patchy high-density shadows on both lungs. On February 17th and February 20th, the nasopharyngeal swab was negative for SARS-CoV2. After treatment, the symptoms disappeared. Hence, she was discharged on February 21st and placed under home quarantine. Since her father was diagnosed with COVID-19 on February 28th, she was admitted to the hospital again for further screening. This time, her SARS-CoV2 nucleic acids and specific IgG and IgM antibodies were positive. The ESR was 55.6\u00a0mm/h. Antiviral therapy was given with interferon and lopinavir-ritonavir. On March 2nd, her repeat viral nucleic acid test was still positive. The nasopharyngeal swab was negative twice, respectively on March 4th and March 6th, with simultaneously improved lung CT.",
        "es": "Mujer de 44 a\u00f1os de Yiyang. Hab\u00eda tenido contacto cercano con su hermana mayor. El d\u00eda 13 de febrero present\u00f3 fiebre (37,8\u00b0C) e inapetencia. Tres d\u00edas despu\u00e9s fue llevada al hospital. Las pruebas anal\u00edticas mostraron una cifra de leucocitos de 2,88 x 10^9/L, prote\u00edna C-reactiva de 17,06 mg/L y fibrin\u00f3geno de 4,27 g/L. Las pruebas para gripe A y B fueron negativas. Una TAC tor\u00e1cica mostr\u00f3 varias sombras parcheadas de alta densidad en ambos pulmones. Los d\u00edas 17 y 20 de febrero, los frotis nasofar\u00edngeos resultaron negativos para SARS-CoV-2. Tras el tratamiento, los s\u00edntomas desaparecieron. En consecuencia, fue dada de alta en 21 de febrero y se mantuvo en cuarentena domiciliaria. Como a su padre se le hab\u00eda diagnosticado COVID-19 el 28 de febrero, fue ingresada de nuevo en el hospital para realizar pruebas adicionales. Esta vez, las pruebas para \u00e1cido nucleico de SARS-CoV-2 y anticuerpos espec\u00edficos IgG e IgM dieron resultado positivo. La VSG era de 55,6 mm/h. Se le administr\u00f3 una terapia antiv\u00edrica con interfer\u00f3n y lopinavir/ritonavir. El 2 de marzo, una nueva prueba de \u00e1cido nucleico v\u00edrico tambi\u00e9n fue positiva. El frotis nasofar\u00edngeo fue negativo dos veces, los d\u00edas 4 y 6 de marzo, con una mejora simult\u00e1nea de la TAC pulmonar."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 63-year-old male was admitted to the hospital due to the expectoration of white sticky sputum, a fever of 39.3\u00a0\u2103, and shortness of breath and chest tightness after activity. He had no history of heart disease or hypertension. He had allergic cough for 5\u00a0years and a previous smoking history. He had a recent history of travel to Hubei Province, China. Blood gas analysis after admission showed a pH of 7.049, PCO2 of 76.4\u00a0mmHg, PO2 of 66.2\u00a0mmHg, and SaO2 at 91.8%. Nasal and pharyngeal swabs, bronchoalveolar lavage fluid (BALF), and sputum were tested for common respiratory viruses, and the results were all negative. In addition, blood samples showed increased alanine aminotransferase (ALT) (97\u00a0U/L) and creatinine (157\u00a0\u03bcmol/L) combined with hematuria, indicating deranged liver and renal function. Bedside chest radiographs showed typical ground-glass changes indicative of viral pneumonia. On the first day of admission, he was genetically confirmed to have COVID-19 according to sputum testing, Markers of myocardial injury included elevated troponin I (Trop I) (11.37\u00a0g/L), myoglobin (Myo) (390.97\u00a0ng/mL), and n-terminal brain natriuretic peptide (NTBNP) (22,600\u00a0pg/mL). An electrocardiogram showed sinus tachycardia and no ST-segment elevation. Bedside echocardiography showed an enlarged left ventricle (61\u00a0mm), diffuse myocardial dyskinesia along with a low left ventricular ejection fraction (LVEF) (32%), pulmonary hypertension (44\u00a0mmHg), and no decrease in right cardiac function. No pericardial effusion was observed. The diagnosis was considered severe pneumonia, ARDS, fulminant myocarditis, and multiple organ dysfunction syndrome (MODS). The treatment regimen was ventilatory support, high-flow oxygen, lopinavir\u2013ritonavir antiviral therapy, interferon \u03b1-1b, methylprednisolone, immunoglobulin, piperacillin\u2013tazobactam, and continuous renal replacement therapy (CRRT). Notably, 11\u00a0days after admission, the patient\u2019s lung lesions continued to progress, and the ventilator was unable to maintain oxygen saturation. The ventricular septum thickened to 14\u00a0mm, and interleukin-6 (IL-6) increased to 272.40\u00a0pg/mL. Therefore, extracorporeal membrane oxygenation (ECMO) was used to reduce the cardiopulmonary burden. The rotating speed of ECMO was 3500\u00a0rpm, the blood flow rate was 4.30\u00a0L/min, the air-flow rate was 4.00\u00a0L/min, and FiO2 was 100%. At one time, the patient's condition improved. A blood test 3 days later revealed that Trop I was reduced to 0.10\u00a0g/L, NTBNP was 750\u00a0pg/mL, and IL-6 was 7.63\u00a0pg/mL. After treatment, the LVEF of the patient gradually recovered to 68%, the left ventricle and wall thickness returned to within their normal ranges, and the bedside chest film suggested that the lesion had decreased. However, infection-related markers increased gradually from the 26th day, and vasoactive drugs were needed to maintain blood pressure. Candida, human \u03b1-herpesvirus, and \u03b2-herpesvirus were detected in BALF on the 29th day, and blood culture was positive for Bacteroides ovalus, indicating the aggravation of secondary infection. Pulmonary artery systolic pressure (PASP) and tricuspid annular plane systolic excursion (TAPSE) showed sudden declines on the 26th and 29th days, suggesting impaired right cardiac function. After consultation with the expert group, anti-infection treatment was strengthened, but the effect was not good. Septic shock and disseminated intravascular coagulation (DIC) gradually developed, and ecchymosis was widely observed in the skin. The patient died on the 33rd day of hospitalization.",
        "es": "Un hombre de 63 a\u00f1os ingres\u00f3 en el hospital a causa de expectoraci\u00f3n con esputo blanco pegajoso, fiebre de 39,3 \u00b0C, disnea de esfuerzo y opresi\u00f3n tor\u00e1cica. No ten\u00eda antecedentes de cardiopat\u00edas ni de hipertensi\u00f3n. Hab\u00eda tenido tos al\u00e9rgica durante 5 a\u00f1os y antecedentes de tabaquismo. Recientemente hab\u00eda viajado a la provincia de Hubei (China). La gasometr\u00eda arterial al ingreso mostr\u00f3 un pH de 7,049, PCO2 de 76,4 mmHG, PO2 de 66,2 mmHg y saturaci\u00f3n de ox\u00edgeno de 91,8%. Se hicieron pruebas de frotis nasofar\u00edngeos, de lavado broncoalveolar y de esputo para los virus respiratorios habituales, con resultado negativo en todas ellas. Adem\u00e1s, las muestras de sangre mostraron un aumento de la alanina-aminotransferasa (97 U/L) y de la creatinina (157 \u03bcmol/L), junto con hematuria, lo que indicaba una alteraci\u00f3n de la capacidad hep\u00e1tica y renal. Unas radiograf\u00edas a pie de cama mostraron las t\u00edpicas alteraciones de vidrio esmerilado indicadoras de neumon\u00eda v\u00edrica. El primer d\u00eda de ingreso se confirm\u00f3 gen\u00e9ticamente la COVID-19 a partir de pruebas de esputo. Los marcadores de lesiones mioc\u00e1rdicas eran valores altos de troponina I (11,35 g/L), mioglobina (390,97ng/mL) y p\u00e9ptido natriur\u00e9tico cerebral n-terminal (PNCNT 22.600 pg/mL). Un electrocardiograma revel\u00f3 taquicardia sinusal sin elevaci\u00f3n del segmento ST. Una ecocardiograf\u00eda a pie de cama mostr\u00f3 una dilataci\u00f3n del ventr\u00edculo izquierdo (61 mm), discinesia mioc\u00e1rdica difusa con una baja fracci\u00f3n de expulsi\u00f3n del VI (32%) e hipertensi\u00f3n pulmonar (44 mmHg), sin disminuci\u00f3n de la actividad card\u00edaca derecha. No se observ\u00f3 derrame peric\u00e1rdico. El diagn\u00f3stico se estableci\u00f3 en neumon\u00eda grave, SDRA, miocarditis fulminante e insuficiencia multiorg\u00e1nica. El tratamiento aplicado fue respiraci\u00f3n asistida, oxigenoterapia de alto flujo, terapia antiv\u00edrica lopinavir/ritonavir, interfer\u00f3n \u03b1-1b, metilprednisolona, inmunoglobulina, piperacilina/tazobactam y tratamiento renal sustitutivo. 11 d\u00edas despu\u00e9s del ingreso, las lesiones pulmonares continuaban progresando y el respirador era incapaz de mantener la saturaci\u00f3n de ox\u00edgeno. El tabique interventricular se engros\u00f3 hasta 14 mm y la interleucina 6 (IL-6) aument\u00f3 a 272,40pg/mL. En consecuencia, se aplic\u00f3 oxigenaci\u00f3n por membrana extracorp\u00f3rea (OMEC) para reducir la carga pulmonar. La velocidad de rotaci\u00f3n de la OMEC era de 3.500 rpm, el caudal de sangre de 4,30 L/min, el caudal de aire de 4,00 L/min y la FiO2 de 100%. El estado del paciente mejor\u00f3. Los an\u00e1lisis tres d\u00edas despu\u00e9s mostraron que la troponina I se hab\u00eda reducido a 0,10g/L, el PNCNT era de 750pg/mL y la interleucina 6 era de 7,63pg/mL. Tras el tratamiento, la fracci\u00f3n de expulsi\u00f3n del VI se recuper\u00f3 gradualmente al 68%, el VI y el grosor del tabique regresaron a sus valores normales y la radiograf\u00eda a pie de cama indic\u00f3 que las lesiones hab\u00edan disminuido. Sin embargo, los marcadores de infecci\u00f3n aumentaron gradualmente a partir del d\u00eda 26 y se necesitaron vasoactivos para mantener la tensi\u00f3n arterial. El d\u00eda 29, se detect\u00f3 Candida, \u03b1-herpesvirus humano y \u03b2-herpesvirus en el lavado broncoalveolar; los hemocultivos fueron positivos para Bacteroides ovalus, lo que indicaba un agravamiento de la sobreinfecci\u00f3n. La presi\u00f3n sist\u00f3lica de la arteria pulmonar y el desplazamiento sist\u00f3lico del plano del anillo tricusp\u00eddeo mostraron disminuciones s\u00fabitas los d\u00edas 26 y 29, lo que suger\u00eda un deterioro de la actividad card\u00edaca derecha. Tras una ronda de consultas con el grupo de expertos, se reforz\u00f3 el tratamiento antiinfeccioso, pero el efecto no fue positivo. Gradualmente, se present\u00f3 choque s\u00e9ptico y coagulaci\u00f3n intravascular generalizada, adem\u00e1s de equimosis cut\u00e1nea. El paciente muri\u00f3 el d\u00eda 33 de hospitalizaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 20-year-old previously healthy male originally presented to an urgent care center with a chief complaint of fever and rash. He was diagnosed with a viral upper respiratory infection and sent home with supportive care. Six days later, the patient presented to the emergency department (ED) with continued fever and rash. Vital signs included a temperature of 103.0 \u030a Fahrenheit, heart rate 115 beats per minute, blood pressure 93/54 millimeters of mercury, respiratory rate 24 breaths per minute, and an oxygen saturation of 91%. Physical examination revealed a diffuse, morbilliform rash across the trunk and extremities, sparing the face. There was no mucosal or ocular involvement. Chest radiograph revealed bilateral infiltrates consistent with multifocal pneumonia. Labs included a normal leukocyte count (8300 units per liter [uL], reference range 4200-9100/uL) with an absolute lymphocyte count of 800/uL (reference range 1300-3600/uL). A C-reactive protein was elevated at 118.5 milligrams per liter (mg/L) (reference range 0-5 mg/L). A rapid strep test and an human immunodeficiency virus test were both negative, as was a respiratory viral panel. The patient required escalating amounts of supplemental oxygen during his ED course and was admitted to the intensive care unit (ICU). A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction test resulted positive on hospital day two. The patient remains hospitalized in the ICU on hospital day six.",
        "es": "Un hombre de 20 a\u00f1os, por lo dem\u00e1s sano, acudi\u00f3 a un ambulatorio de urgencias aquejado de fiebre y exantema. Se le diagnostic\u00f3 una infecci\u00f3n v\u00edrica de las v\u00edas respiratorias altas y se le envi\u00f3 a casa con tratamiento sintom\u00e1tico. Seis d\u00edas despu\u00e9s, el paciente acudi\u00f3 al servicio de urgencias con fiebre y exantema persistentes. Las constantes vitales eran: temperatura 39,4 \u00b0C, pulso 115 l.p.m., presi\u00f3n arterial 93/54 mmHg, frecuencia respiratoria 24 r.p.m. y saturaci\u00f3n de ox\u00edgeno 91%. La exploraci\u00f3n f\u00edsica revel\u00f3 un exantema generalizado morbiliforme en el tronco y las extremidades, sin afectaci\u00f3n facial. No hab\u00eda afectaci\u00f3n mucosa ni ocular. La radiograf\u00eda tor\u00e1cica mostr\u00f3 infiltrados bilaterales coherentes con neumon\u00eda multifocal. Las pruebas anal\u00edticas dieron una cifra de leucocitos normal (8300 unidades por litro [uL], intervalo de referencia 4200-9100/uL) con una cifra absoluta de linfocitos de 800/uL (intervalo de referencia 1300-3600/uL). El valor de prote\u00edna C-reactiva era alto, con 118,5 mg/L (intervalo de referencia 0-5 mg/L). Una prueba r\u00e1pida de estreptococos y del virus de la inmunodeficiencia humana fueron ambas negativas, igual que un perfil v\u00edrico respiratorio. El paciente necesit\u00f3 oxigenoterapia cada vez m\u00e1s alta durante su evoluci\u00f3n en urgencias e ingres\u00f3 en la unidad de cuidados intensivos (UCI). Una prueba por PCR del s\u00edndrome respiratorio agudo grave de coronavirus 2 (SARS-CoV-2) result\u00f3 positiva el d\u00eda 2 de hospitalizaci\u00f3n. El paciente permanece en la UCI a d\u00eda 6 de hospitalizaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A Wuhan male had fever, shortness of breath, and myalgia since Jan 28. On Feb 10, his disease deteriorated and his consciousness suddenly progressed to confusion. Laboratory test indicated low WBC count (3.3\u00a0\u00d7\u00a0109/L) and lymphopenia (0.8\u00a0\u00d7\u00a0109/L). Skull computer tomography (CT) was normal while chest CT showed multiple subpleural ground glass opacities (GGOs). The patient was positive for SARS-CoV-2 and sent to our institution. On physical examination, vital signs were stable without altered consciousness. Meningeal irritation signs (including nuchal rigidity, Kernig sign and Brudzinski sign) and extensor plantar response were present. Arterial blood gas analysis indicted PO2/FiO2 ratio of 240\u00a0mmHg. This COVID-19 patient was treated with arbidol and oxygen therapy, whereas his consciousness was not improved. Lumbar puncture was performed on Feb 16, and the cerebrospinal fluid (CSF) pressure was 220\u00a0mmHg. Laboratory tests with CSF showed WBC (0.001\u00a0\u00d7\u00a0109/L), protein (0.27\u00a0g/L), ADA (0.17\u00a0U/L) and sugar (3.14\u00a0mmol/L) contents within normal limits. The CSF specimen was further tested for SARS-CoV-2 but the result was negative. This patient did not have evidence of bacterial or tuberculous infection of the CNS. After careful evaluation by neurologic experts, encephalitis associated with SARS-CoV-2 infection was concluded. Treatment at this moment was largely supportive, including mannitol infusion. Intriguingly, the patient\u2019s consciousness generally ameliorated since Feb 20, and chest CT suggested a resolution of GGOs. His consciousness was completely clear on Feb 24. Two consecutive throat swab tests were negative for SARS-CoV-2. The patient was discharged from hospital on Feb 27.",
        "es": "Un hombre de Wuhan report\u00f3 fiebre, disnea y mialgia desde el 28 de enero. El 10 de febrero su estado empeor\u00f3 y experiment\u00f3 confusi\u00f3n y desorientaci\u00f3n. Las pruebas anal\u00edticas mostraron una baja cifra de leucocitos (3,3\u00d7109/L) y linfocitopenia (0,8\u00d7109/L). La TAC craneal era normal, mientras que la TAC tor\u00e1cica mostr\u00f3 varias opacidades de vidrio esmerilado subpleurales. El paciente result\u00f3 positivo para SARS-CoV-2 y fue trasladado a nuestra instituci\u00f3n. A la exploraci\u00f3n f\u00edsica, las constantes vitales eran estables sin alteraci\u00f3n de la conciencia. Se observaron signos de s\u00edndrome men\u00edngeo (rigidez de la nuca, signo de Kernig y signo de Brudzinski) y signo de Babinski. La gasometr\u00eda arterial mostr\u00f3 una proporci\u00f3n PO2/FiO2 de 240 mmHg. Este paciente de COVID-19 fue tratado con arbidol y oxigenoterapia, pero su desorientaci\u00f3n no mejor\u00f3. El 16 de febrero se le practic\u00f3 una punci\u00f3n lumbar; la presi\u00f3n del l\u00edquido cefalorraqu\u00eddeo (LCR) era de 220 mmHg. Las pruebas anal\u00edticas del LCR dieron unos valores de leucocitos (0,001 \u00d7109/L), de prote\u00edna (0,27 g/L), de ADA (0,17 U/L) y de glucosa (3,14 mmol/L) dentro de los l\u00edmites normales. Con la muestra de LCR se hizo tambi\u00e9n una prueba de SARS-CoV-2, que result\u00f3 negativa. El paciente no mostraba signos de infecci\u00f3n bacteriana ni tuberculosa del SNC. Tras una evaluaci\u00f3n neurol\u00f3gica cuidadosa, se determin\u00f3 encefalitis asociada a infecci\u00f3n por SARS-CoV-2. En esos momentos el tratamiento era b\u00e1sicamente sintom\u00e1tico, que inclu\u00eda administraci\u00f3n de manitol. Curiosamente, la conciencia del paciente mejor\u00f3 a partir del 20 de febrero y la TAC tor\u00e1cica indic\u00f3 una mejora de las opacidades de vidrio esmerilado. Su conciencia estaba totalmente despejada el 24 de febrero. Dos pruebas consecutivas de frotis far\u00edngeos resultaron negativas para SARS-CoV-2. El paciente fue dado de alta el 27 de febrero."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A man in his 50s receiving maintenance hemodialysis presented to the emergency department with a 7-day history of a nonproductive cough. His medical history included kidney failure due to diabetes maintained on thrice-weekly in-center hemodialysis, hypertension, and chronic hepatitis B virus infection. Epidemiologic survey showed that he drove to Wuhan in mid-January 2020, visited his relatives, and drove back to Zhongshan City of Guangdong province in China 1 week later. The patient was admitted to the hospital 2 weeks later with hypoxemia (blood oxygen saturation of 90% while breathing room air) without fever or myalgia. Physical examination results showed temperature of 36.9C, blood pressure of 184/107 mm Hg, heart rate of 74 beats/min, and bilateral normal lung respiratory sounds. Laboratory tests showed white blood cell count of 3.38 \u00d7109/L with 77.5% neutrophils, 15.7% lymphocytes, and 0% eosinophils. C-Reactive protein and procalcitonin levels were 40.1 mg/L and 0.73 ng/mL, respectively. Liver function and cardiac enzyme levels were within the normal range. Computed tomography of the chest showed bilateral multiple ground-glass opacities. The Chinese Guangdong Center for Disease Prevention and Control reported that SARS-CoV-2 nucleic acid tests were positive in throat swab samples 2 times. Based on epidemiologic characteristics and these findings, we diagnosed COVID-19 pneumonia. As soon as COVID-19 pneumonia was diagnosed, the patient was transferred to a specialty hospital and received hemodialysis in a room with isolation facilities designated for patients with COVID-19 infection. Although all hemodialysis patients wear a face mask during dialysis, the other 42 patients who had a potential exposure to patients with atypical symptom COVID-19 infection. Although the patient did not have many of the typical symptoms, including fever, sore throat, nasal congestion, malaise, headache, or myalgia, he had cough, dyspnea, and patients were tested for SARS-CoV-2 nucleic acid at admission and at 14 days, remaining negative. Because of universal precautions taken by the medical staff, the staff tested for SARS-CoV-2 nucleic acid had negative results and were not isolated. The patient was treated with oxygen support by nasal cannula, regular hemodialysis, antihypertensive medications, moxifloxacin (400 mg daily), and lopinavir/ritonavir (2 tablets twice daily) antiviral therapy. The potential side effects of lopinavir/ritonavir, such as nausea, diarrhea, and occasional dizziness, were not observed during treatment. After 8 days of treatment, the SARS-CoV-2 nucleic acid test results were negative in throat swab samples twice, cough had improved, and laboratory tests results and computed tomographic chest images had improved. The patient was discharged from the hospital.",
        "es": "Un hombre de unos 50 a\u00f1os, sometido a hemodi\u00e1lisis de mantenimiento, acudi\u00f3 al servicio de urgencias con tos no productiva de 7 d\u00edas de evoluci\u00f3n. Sus antecedentes inclu\u00edan insuficiencia renal debida a la diabetes, que se trataba con hemodi\u00e1lisis ambulatoria tres veces por semana, hipertensi\u00f3n e infecci\u00f3n cr\u00f3nica con virus de la hepatitis B. Una evaluaci\u00f3n epidemiol\u00f3gica revel\u00f3 que hab\u00eda viajado a Wuhan a mediados de enero de 2020, visit\u00f3 a sus parientes y volvi\u00f3 a la ciudad de Zhongshan, en la provincia de Guangdong (China), una semana m\u00e1s tarde. El paciente ingres\u00f3 en el hospital dos semanas despu\u00e9s con hipoxemia (saturaci\u00f3n de ox\u00edgeno de 90% en aire ambiental) sin fiebre ni mialgia. A la exploraci\u00f3n f\u00edsica mostr\u00f3 temperatura de 36,9 \u00b0C, presi\u00f3n arterial de 184/107 mmHg, pulso de 74 l.p.m. y ruidos respiratorios bilaterales normales. Las pruebas anal\u00edticas mostraron una cifra de leucocitos de 3,38 \u00d7 109/L con 77,5% de neutr\u00f3filos, 15,7% de linfocitos y 0% de eosin\u00f3filos. Los valores de prote\u00edna C-reactiva y de procalcitonina eran 40,1 mg/L y 0,73 ng/mL, respectivamente. La capacidad hep\u00e1tica y los valores de enzimas card\u00edacas estaban dentro de los intervalos normales. Una TAC tor\u00e1cica revel\u00f3 m\u00faltiples opacidades de vidrio esmerilado bilaterales. El Centro de Control y Prevenci\u00f3n de Enfermedades de Guangdong inform\u00f3 que las pruebas de \u00e1cido nucleico de SARS-CoV-2 resultaron positivas dos veces en muestras de frotis far\u00edngeos. A partir de las caracter\u00edsticas epidemiol\u00f3gicas y estos resultados, el diagn\u00f3stico fue neumon\u00eda por COVID-19. En cuanto se diagnostic\u00f3 neumon\u00eda por COVID-19, el paciente se traslad\u00f3 a un hospital especializado y recibi\u00f3 hemodi\u00e1lisis en una sala con equipos de aislamiento dise\u00f1ada para pacientes con COVID-19, donde todos los pacientes de hemodi\u00e1lisis llevan una mascarilla durante la di\u00e1lisis, incluidos los otros 42 pacientes que tuvieron una posible exposici\u00f3n a pacientes con s\u00edntomas at\u00edpicos de infecci\u00f3n por COVID-19. Aunque el paciente no ten\u00eda los s\u00edntomas habituales, como fiebre, dolor de garganta, congesti\u00f3n nasal, malestar, cefalea o mialgia, s\u00ed presentaba tos y disnea; en consecuencia, se hizo una prueba de \u00e1cido nucleico de SARS-CoV-2 a los pacientes, al ingreso y a los 14 d\u00edas, con resultado negativo en ambos casos. A causa de las precauciones tomadas por el equipo m\u00e9dico, se hicieron pruebas de SARS-CoV-2 al personal, que resultaron negativas, y no se aislaron. El paciente fue tratado con oxigenoterapia mediante c\u00e1nula nasal, hemodi\u00e1lisis regular, antihipertensivos, moxifloxacina (400 mg al d\u00eda) y terapia antiv\u00edrica con lopinavir/ritonavir (2 comprimidos dos veces al d\u00eda). No se observ\u00f3 ninguno de los posibles efectos secundarios del lopinavir/ritonavir durante el tratamiento, como n\u00e1useas, diarrea y mareos ocasionales. Tras 8 d\u00edas de tratamiento, las pruebas de \u00e1cido nucleico de SARS-CoV-2 resultaron negativas dos veces en frotis far\u00edngeos, la tos hab\u00eda remitido y las pruebas anal\u00edticas y las im\u00e1genes de TAC tor\u00e1cicas mostraron mejor\u00eda. El paciente fue dado de alta del hospital."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "70-year-old male with a left ventricular assist device (LVAD) implanted in 2016 who developed fever, flank pain and hematuria three days after attending a party. He was evaluated for nephrolithiasis at a local emergency department (ED) with CT abdomen and pelvis which incidentally found possible atypical or viral pneumonia. He was tested for coronavirus disease 2019 (COVID-19), but he left against medical advice. In the ensuing days, he continued to have fevers, new onset myalgias, diarrhea, and dyspnea. He returned to our ED and was in acute hypoxic respiratory failure, requiring supplemental oxygen to maintain peripheral oxygen saturation ?94%. His medical history includes ischemic cardiomyopathy, stage 3 chronic kidney disease, and obesity. His post-LVAD complications include gastrointestinal bleeding, ventricular tachycardia, and right ventricular (RV) dysfunction, but no infectious complications. He does not have diabetes or tobacco use. His blood group is A positive. Pretest probability for COVID-19 was moderate to high due to fever, dyspnea, and hypoxia as well as prior imaging showing peripheral ground-glass opacities. Reverse transcription polymerase chain reaction (RT-PCR) for severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) was positive at the initial ED visit and at our institution. Several markers of disease severity were abnormal including absolute lymphocyte count, C-reactive protein and cardiac enzymes. Chest X-ray showed bilateral infiltrates concerning for atypical pneumonia. The patient was quarantined in a negative-pressure intensive care room. The patient was initiated on hydroxychloroquine for COVID-19 pneumonia while monitoring the QTc. He experienced severe acute respiratory distress syndrome (ARDS) necessitating endotracheal intubation and ventilator support with low tidal volume ARDSNet protocol. Despite aggressive supportive care, cytokine storm ensued with MODS as evidenced by 1) elevated inflammatory markers; 2) severe ARDS; 3) myocardial injury; and 4) vasodilatory shock requiring vasopressors. Two successive doses of intravenous tocilizumab (interleukin-6 [IL-6] receptor antagonist) at 8 mg/kg (max dose of 800mg) were administered. Though clinical improvement was observed after initial tocilizumab therapy, he developed worsening shock, refractory hypoxemia, and suffered pulseless electrical activity (PEA) arrest with successful return of spontaneous circulation.",
        "es": "Hombre de 70 a\u00f1os con dispositivo de asistencia ventricular izquierda (DAVI), implantado en 2016, report\u00f3 fiebre, dolor en fosa lumbar y hematuria tres d\u00edas despu\u00e9s de asistir a una fiesta. Se le evalu\u00f3 para nefrolitiasis en un servicio de urgencias local, con TAC abdominal y p\u00e9lvica que, casualmente, descubri\u00f3 una posible neumon\u00eda at\u00edpica o v\u00edrica. Se le hizo una prueba de la enfermedad por coronavirus 2019 (COVID-19), pero solicit\u00f3 el alta voluntaria. En los d\u00edas siguientes, continu\u00f3 experimentando fiebre, mialgias, diarrea y disnea. Regres\u00f3 a nuestro servicio de urgencias con insuficiencia respiratoria hip\u00f3xica aguda, que oblig\u00f3 a oxigenoterapia para mantener la saturaci\u00f3n de ox\u00edgeno en sangre perif\u00e9rica sobre el 94%. Sus antecedentes mostraban cardiomiopat\u00eda isqu\u00e9mica, nefropat\u00eda cr\u00f3nica en estadio 3 y obesidad. Sus complicaciones post-DAVI fueron hemorragia gastrointestinal, taquicardia ventricular y disfunci\u00f3n del ventr\u00edculo derecho, pero sin infecciones. No tiene diabetes ni es fumador. Su grupo sangu\u00edneo es A positivo. La probabilidad de una prueba preliminar para COVID-19 era entre moderada y alta a causa de la fiebre, disnea e hipoxia, as\u00ed como las radiograf\u00edas previas que mostraban opacidades de vidrio esmerilado perif\u00e9ricas. Una prueba de RT-PCR para el coronavirus del s\u00edndrome respiratorio agudo grave 2 (SARS-CoV-2) fue positiva en la visita inicial a urgencias y en nuestra instituci\u00f3n. Varios marcadores de enfermedad presentaban valores an\u00f3malos, como la cifra de leucocitos, la prote\u00edna C-reactiva y las enzimas card\u00edacas. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 infiltrados bilaterales asociados a neumon\u00eda at\u00edpica. El paciente fue puesto en cuarentena en una sala de cuidados intensivos con presi\u00f3n negativa. Se inici\u00f3 tratamiento con hidroxicloroquina para la neumon\u00eda por COVID-19 mientras se monitorizaba su QTc. Sufri\u00f3 s\u00edndrome de dificultad respiratoria aguda (SDRA) grave que necesit\u00f3 intubaci\u00f3n endotraqueal y respiraci\u00f3n asistida con el protocolo de bajo volumen corriente ARDSNet. A pesar de un tratamiento intensivo, se produjo una tormenta de citocinas con SDMO, evidenciada por: 1) altos valores de marcadores de inflamaci\u00f3n; 2) SDRA grave; 3) lesi\u00f3n mioc\u00e1rdica; 4) choque vasodilatador que requiri\u00f3 vasopresores. Se administraron dos dosis sucesivas de tocilizumab i.v. (antagonista del receptor de la interleucina 6 [IL-6]) a 8 mg/kg (dosis m\u00e1xima de 800 mg). Aunque se observ\u00f3 una mejora cl\u00ednica tras la administraci\u00f3n inicial de tocilizumab, sufri\u00f3 un empeoramiento del choque, hipoxemia resistente y sufri\u00f3 un paro por actividad el\u00e9ctrica sin pulso (AESP), con retorno espont\u00e1neo de la circulaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "This is a case of a 64-year-old male patient of Han Chinese ethnicity and who lived in Wuhan City. He did not have a history of hypertension, diabetes, or cerebrovascular and cardiovascular diseases. The patient developed fever on 28 January 2020, with a maximum body temperature of 38.5?, accompanied by mild cough. Symptomatic treatment alleviated the cough, while his body temperature fluctuated between 37.5? On 30 January, he experienced insomnia and muscle soreness of the whole body without significant tenderness. He was quarantined after a medical consultation on 9 February, during which his consciousness was clear, and he was able to answer questions correctly. On 10 February, the patient was found to be lethargic and unresponsive. Emergency blood tests revealed the following: white blood cell count, 3.3 x 10 9/L, lymphocyte percentage, 24.4%; neutrophil percentage, 62.8%; and C-reactive protein (CRP) level, 10.74 mg/L. Head computed tomography (CT) did not reveal significant abnormalities, whereas chest CT revealed multiple ground-glass opacities with multiple fibrous cord-like shadows in both lungs. Additionally, a throat swab test performed on 11 February indicated that the patient was positive for 2019-nCoV and was later admitted to a hospital. Upon admission, the patient's vital signs were stable, with finger pulse oximetry without oxygenation, and finger pulse oximetry with oxygenation through the nasal cannula (5 L/min) of 88% and 98%, respectively. Neurological examination indicated that the patient was in a poor mental state, with his consciousness alternating between lethargy and irritability. His responses to questions were incorrect, with some indications of contextually dissociated speech. Both lower limbs showed positive ankle clonus, which was more pronounced on the left limb. The lower left limb was positive for the Babinski sign and Chaddock sign; the lower right limb was suspected positive for the Chaddock sign. The patient's neck showed slight stiffness at three fingers below the jaw and was positive for the Brudzinski sign and the straight leg raise test. After admission, the patient receivedoxygen inhalation, arbidol, ribavirin antiviral therapy, traditional Chinese medicine, and symptomatic and supportive care. On 16 February, he underwent lumbar puncture: intracranial pressure, 200 cmH2O (colourless and clear cerebrospinal fluid); cell count, 1 x 10 6/L; cerebrospinal protein level, 275.5 mg/L, glucose (Glu) level, 3.14 mmol/L; chloride level, 123 mmol/L; and instant blood Glu level, 5.1 mmol/L. Moreover, the cerebrospinal fluid tested negative for the 2019-nCoV nucleic acid test. His 2019-nCoV nucleic acid test (throat swab) results were negative on 18 February and positive on 21 February. On 25 February, chest CT revealed significant improvement in pulmonary infection. Based on his neurological examination that same day, he had a clear consciousness, provided correct responses to questions, and showed an essentially normal intelligence. Limb reflexes were relatively active, ankle clonus was already not observed in both lower limbs, his left lower limb was positive for pathological signs, and pathological signs could not be elicited in the right lower limb. The neck was soft and unresisting. The patient tested negative in two consecutive 2019-nCoV nucleic acid tests (throat swab) on 25 and 27 February, and his finger pulse oximetry without oxygenation was 99%. The patient was discharged to a quarantine facility and quarantined for a further 14 days.",
        "es": "Hombre de 64 a\u00f1os de etnia han y residente en la ciudad de Wuhan. No ten\u00eda antecedentes de hipertensi\u00f3n, diabetes ni enfermedad cerebrovascular o cardiovascular. El paciente present\u00f3 fiebre el 28 de enero de 2020, con una temperatura m\u00e1xima de 38,5 \u00b0C y tos leve. El tratamiento sintom\u00e1tico alivi\u00f3 la tos, mientras su temperatura variaba entre 37,5 y 38 \u00b0C y regres\u00f3 a un valor normal el 30 de enero. El 20 de enero padeci\u00f3 insomnio y mialgias en todo el cuerpo, sin dolor significativo a la palpaci\u00f3n. Tras una consulta m\u00e9dica el 9 de febrero, se le puso en cuarentena; durante la consulta estaba consciente y orientado y pudo responder correctamente todas las preguntas. El 10 de febrero, el paciente estaba let\u00e1rgico e hiporreactivo. Los an\u00e1lisis de sangre de urgencias dieron los resultados siguientes: cifra de leucocitos 3,3 x 10 9/L, con 24,4% de linfocitos, 62,8% de neutr\u00f3filos y un valor de prote\u00edna C-reactiva de 10,74 mg/L. La TAC craneal no mostr\u00f3 anomal\u00edas de relevancia, mientras que la TAC tor\u00e1cica revel\u00f3 varias opacidades de vidrio esmerilado con sombras fibrosas en cord\u00f3n en ambos pulmones. Adem\u00e1s, los frotis far\u00edngeos realizados el 11 de febrero indicaron que el paciente era positivo para 2019-nCoV y luego fue ingresado en un hospital. Al ingreso, las constantes vitales del paciente eran estables, con una pulsioximetr\u00eda sin oxigenaci\u00f3n y pulsioximetr\u00eda con oxigenaci\u00f3n mediante c\u00e1nula nasal (5 L/min) de 88% y 98%, respectivamente. La exploraci\u00f3n neurol\u00f3gica indic\u00f3 que el paciente mostraba deterioro del estado mental, alternando entre letargia e irritabilidad. Sus respuestas a preguntas eran incorrectas, con indicios de disociaci\u00f3n contextual del lenguaje. Las dos extremidades inferiores mostraron clono del pie positivo, m\u00e1s pronunciado en el miembro izquierdo. El miembro inferior izquierdo mostr\u00f3 signo de Babinski y signo de Chaddock; el derecho, sospecha de signo de Chaddock. El paciente mostraba una ligera rigidez nucal tres dedos por debajo de la mand\u00edbula y era positivo para signo de Brudzinski y signo de Las\u00e8gue. Al ingreso, el paciente recibi\u00f3 oxigenoterapia, arbidol y terapia antiv\u00edrica con ribavirina, medicina tradicional china y tratamiento sintom\u00e1tico. El 16 de febrero, se le practic\u00f3 una punci\u00f3n lumbar: presi\u00f3n endocraneal 200 cmH2O (l\u00edquido cefalorraqu\u00eddeo incoloro y normal); recuento celular 1 x 10 6/L; proteinorraquia 275,5 mg/L, glucorraquia 3,14 mmol/L; cloruro 123 mmol/L; glucemia instant\u00e1nea 5,1 mmol/L. Adem\u00e1s, el l\u00edquido cefalorraqu\u00eddeo dio negativo para pruebas de \u00e1cido nucleico de 2019-nCoV. Las pruebas de \u00e1cido nucleico de 2019-nCoV (de frotis far\u00edngeos) resultaron negativas el 18 de febrero y positivas el 21 de febrero. El 25 de febrero, una TAC tor\u00e1cica mostr\u00f3 una mejora significativa de la infecci\u00f3n pulmonar. En la exploraci\u00f3n neurol\u00f3gica el mismo d\u00eda, el paciente estaba consciente y orientado, ofreci\u00f3 respuestas correctas a las preguntas y mostr\u00f3 una inteligencia normal. Los reflejos de las extremidades eran relativamente activos, ya no se observ\u00f3 clono del pie en ninguno de los dos miembros y presentaba signos patol\u00f3gicos positivos en miembro inferior izquierdo, mientras que no se pudieron determinar en el miembro inferior derecho. La nuca era blanda y depresible. El paciente dio negativo en dos pruebas consecutivas de \u00e1cido nucleico de 2019-nCoV (de frotis far\u00edngeos), los d\u00edas 25 y 27 de febrero y su pulsioximetr\u00eda sin oxigenaci\u00f3n era del 99%. El paciente fue dado de alta y se traslad\u00f3 a una instalaci\u00f3n de cuarentena, donde estuvo durante 14 d\u00edas m\u00e1s."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "32-year-old woman, affected by psoriasis and psoriatic arthritis since 18 years, previously treated with several conventional and biologic drugs, including cyclosporine, methotrexate, infliximab, etanercept, adalimumab, secukinumab and ixekizumab. She had no other medical conditions. In April 2019 she developed severe Crohn's disease while taking ixekizumab. Therefore, she switched to ustekinumab, with improvement of Crohn's disease but a worsening of both psoriasis and psoriatic arthritis. On 6th November, we added methotrexate 10 mg/week, which was further increased to 25 mg/week after 4 weeks because of an unsatisfactory response. On 23rd December, since psoriasis was still worsening, we switched ustekinumab to guselkumab, while maintaining methotrexate at 25 mg/week. On February 26th , after two injections of guselkumab the patient showed a marked improvement of psoriasis and arthritis. On February 29th, she went out for dinner with some friends and, 2 days later, one of them was discovered to be affected by COVID-19. On March 4 th  she had mild rhinorrhea and fever (37.4 C) and the next day she was tested positive for SARS-CoV-2. The day after the body temperature lowered to 36.3 C and the rhinorrhea was still mild. We advised her to interrupt methotrexate and to postpone the next guselkumab injection, which was originally scheduled for March 16th. In the following days, the body temperature never rose above 36,5 C and she never developed sore throat, cough, shortness of breath or other symptoms of the infection. Her blood tests revealed increased erythrosedimentation rate (120 mm/h), C-reactive protein (4,76 mg/dL), D-dimer (381 ug/L) and fibrinogen (701 mg/dL). All the other parameters were normal. On March 13th  the rhinorrhea subsided. On March 20th RT-PCR was still positive for SARS-CoV-2. On March 28th  and March 30th  the tests resulted negative, meeting the criteria to be considered successfully healed.",
        "es": "Mujer de 32 a\u00f1os, con psoriasis y artritis psori\u00e1sica desde los 18 a\u00f1os, tratada previamente con varios f\u00e1rmacos convencionales y biol\u00f3gicos, como ciclosporina, metotrexato, infliximab, etanercept, adalimumab, secukinumab e ixekizumab. No ten\u00eda ninguna otra dolencia. En abril de 2019 contrajo enfermedad de Crohn grave mientras se trataba con ixekizumab. En consecuencia, se cambi\u00f3 el tratamiento a ustekinumab, con una mejora de la enfermedad de Crohn pero un empeoramiento de la psoriasis y la artritis psori\u00e1sica. El 6 de noviembre, se a\u00f1adi\u00f3 metrotexato 10 mg/semana, que se aument\u00f3 a 25 mg/semana despu\u00e9s de 4 semanas a causa de una respuesta poco satisfactoria. El 23 de diciembre, con un empeoramiento de la psoriasis, se cambi\u00f3 la medicaci\u00f3n a guselkumab, a la vez que se manten\u00eda metotrexato a 25 mg/semana. El 26 de febrero, tras dos inyecciones de guselkumab, la paciente mostr\u00f3 una clara mejora de la psoriasis y la artritis. El 29 de febrero sali\u00f3 a cenar con unos amigos y, dos d\u00edas despu\u00e9s, se hall\u00f3 que uno de ellos estaba contagiado de COVID-19. El 4 de marzo present\u00f3 rinorrea leve y febr\u00edcula (37,4 \u00b0C); el d\u00eda siguiente sus pruebas para SARS-CoV-2 resultaron positivas. El d\u00eda siguiente, la temperatura baj\u00f3 a 36,3 \u00b0C y segu\u00eda teniendo rinorrea leve. Aconsejamos que suspendiera el metrotexato y que pospusiera la siguiente administraci\u00f3n de guselkumab, originalmente programada para el 16 de marzo. En los d\u00edas siguientes, la temperatura nunca super\u00f3 los 36,5 \u00b0C y no present\u00f3 irritaci\u00f3n de garganta, tos, disnea ni otros s\u00edntomas de la infecci\u00f3n. Los an\u00e1lisis de sangre mostraron valores altos de la velocidad de sedimentaci\u00f3n globular (120 mm/h), prote\u00edna C-reactiva (4,76 mg/dL), d\u00edmero D (381 ug/L) y fibrin\u00f3geno (701 mg/dL). Todos los dem\u00e1s par\u00e1metros eran normales. El 13 de marzo la rinorrea remiti\u00f3. El 20 de marzo, las pruebas mediante RT-PCR a\u00fan eran positivas para SARS-CoV-2. Los d\u00edas 28 y 30 de marzo, las pruebas fueron negativas, con lo que se cumplieron los criterios para considerar que la paciente estaba curada."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 28-year-old woman with no previous medical history, initially presented with dry cough, nasal congestion, fatigue, myalgias and arthralgias without fever. She tested positive for coronavirus. As she was feeling well, self-isolation at home was recommended. Four days later she presented with diarrhea, ageusia and anosmia. During the following days she started feeling better but with persistent dry cough, ageusia and anosmia. She only took paracetamol the first 4 days and did not take any other drugs. Thirteen days after being tested (10 days after last dose of paracetamol), the patient started noticing pruritic lesions on both heels. Confluent erythematous-yellowish papules were observed in both heels, without any lesions on the rest of the skin. She denied wearing tight socks, shoes or any local pressure that could explain the distribution of the lesions. A treatment with local corticosteroids was advised. Despite this treatment, three days later, the lesions persisted and became erythematous plaques that were both hardened and pruritic. At this point, urticaria, urticarial vasculitis, idiopathic plantar hidradenitis and neutrophilic dermatosis were considered within the differential diagnosis. However, a biopsy was not performed.",
        "es": "Una mujer de 28 a\u00f1os, sin antecedentes m\u00e9dicos, report\u00f3 tos seca, congesti\u00f3n nasal, fatiga, mialgias y artralgias, sin fiebre. Las pruebas de coronavirus resultaron positivas. Como se sent\u00eda en buen estado, se le recomend\u00f3 confinamiento domiciliario. Cuatro d\u00edas despu\u00e9s report\u00f3 diarrea, ageusia y anosmia. Durante los d\u00edas siguientes empez\u00f3 a sentirse mejor, pero con tos seca persistente, ageusia y anosmia. Los primeros cuatro d\u00edas solo tom\u00f3 paracetamol, sin otros f\u00e1rmacos. Trece d\u00edas despu\u00e9s de las pruebas (10 d\u00edas despu\u00e9s de la \u00faltima dosis de paracetamol), la paciente empez\u00f3 a notar lesiones pruriginosas en ambos talones; al mismo tiempo, observ\u00f3 p\u00e1pulas eritematosas amarillentas en ambos talones, sin otras lesiones cut\u00e1neas. Afirm\u00f3 no llevar medias o zapatos apretados ni ning\u00fan otro tipo de presi\u00f3n local que pudiera explicar la distribuci\u00f3n de las lesiones. Se le recomend\u00f3 un tratamiento local con corticosteroides. A pesar del tratamiento, tres d\u00edas despu\u00e9s, las lesiones persist\u00edan y pasaron a placas eritematosas endurecidas y pruriginosas. En ese momento, en el diagn\u00f3stico diferencial se consider\u00f3 urticaria, vasculitis urticarial, hidrosadenitis plantar idiop\u00e1tica y dermatosis neutrof\u00edlica. Sin embargo, no se practic\u00f3 ninguna biopsia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 27 year-old  woman  with  no  history,  medical  resident  at  the  hospital,  presented  an  odynophagia followed by  diffuse arthralgia and pruritic disseminated erythematous plaques eruption with particular face and acral involvement without cough or fever. The diagnosis of urticaria was confirmed by a dermatologist. No triggers except for the viral context were found and common viral serology was negative. An antihistaminic treatment was established.48  hours  later,  she  reported  chills,  chest  pain  and  fever  up  to  39,2C. She  had  a  moderate lymphopenia,  hepatic  workup  was  normal  and  CRP  level  was  49  mg/l. She  was  tested  positive  for COVID-19 (PCR SARS-CoV-2). She was treated with paracetamol and antihistamines were kept with slow improvement of the symptoms.",
        "es": "Una mujer de 27 a\u00f1os sin antecedentes, residente del hospital, present\u00f3 odinofagia seguida de artralgia difusa y una erupci\u00f3n de placas eritematosas pruriginosas extendidas, con una afectaci\u00f3n b\u00e1sicamente facial y acra. El diagn\u00f3stico de urticaria fue confirmado por un dermat\u00f3logo. No se hallaron desencadenantes excepto por las circunstancias v\u00edricas; las pruebas s\u00e9ricas v\u00edricas habituales resultaron negativas. 48 horas despu\u00e9s, inform\u00f3 de escalofr\u00edos, dolor tor\u00e1cico y fiebre de hasta 39,2 \u00b0C. Ten\u00eda linfocitopenia moderada, los an\u00e1lisis hep\u00e1ticos eran normales y el valor de prote\u00edna C-reactiva era de 49 mg/l. La prueba de COVID-19 (PCR de SARS-CoV-2) dio resultado positivo. Fue tratada con paracetamol y se le mantuvieron los antihistam\u00ednicos, con una lenta mejora de los s\u00edntomas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 65-year-old woman with hypertension, autoimmune hypothyroidism, and known Covid-19 exposure presented to the emergency department with a 4-day history of fatigue, fever, dry cough, and abdominal discomfort. She was afebrile and had a respiratory rate of 28 breaths per minute and an oxygen saturation of 89% while she was breathing ambient air; breath sounds were diminished bilaterally with bibasilar rales. The abdominal examination was normal. Laboratory tests showed a normal white-cell count, hemoglobin level (14.2 g per deciliter), and platelet count (183,000 per cubic millimeter). The C-reactive protein level was elevated at 55 mg per liter, and liver-function tests showed cholestasis. An oropharyngeal swab for Covid-19 testing was positive. Chest computed tomography (CT) showed ground-glass opacities in the lower zones. The patient was admitted and began to receive treatment with intravenous amoxicillin\u2013clavulanic acid, low-molecular-weight heparin, and oxygen. On day 4, lower-extremity purpura appeared and epistaxis occurred. Isolated thrombocytopenia (platelet count, 66,000 per cubic millimeter) was noted; these findings prompted discontinuation of heparin and antibiotics. On day 5, the platelet count was 16,000 per cubic millimeter, and on day 7, it was 8000 per cubic millimeter. The prothrombin and activated partial thromboplastin times were normal; the fibrinogen level was 5 g per liter (normal range, 2 to 4). A peripheral-blood smear showed less than 1% schistocytes. The level of thyroid peroxidase antibodies was 245 U per milliliter (normal value, <35); antiplatelet factor 4, antiplatelet antibodies, and antinuclear antibodies were not detected. Intravenous immune globulin was administered at a rate of 1 g per kilogram of body weight. After 48 hours, the platelet count decreased to 1000 per cubic millimeter and the purpuric lesions progressed; this prompted a second infusion of immune globulin at a dose of 1 g per kilogram. Bone marrow aspiration showed normal cellularity with an increase in pleomorphic megakaryocytes. Erythroblast and granulocyte cell lines were normal, without evidence of hemophagocytosis. On day 9, a right frontal headache developed in the patient, without fever, vomiting, or focal neurologic deficit. CT of the head showed a subarachnoid microhemorrhage in the right frontal lobe. The platelet count was 2000 per cubic millimeter, and a platelet transfusion was administered with 100 mg of prednisolone; eltrombopag (75 mg per day) was initiated. On day 10, the headache had resolved, there were no new neurologic findings, and the platelet count had increased to 10,000 per cubic millimeter. All the other laboratory tests had normalized except for the fibrinogen level, which remained elevated (3.5 g per liter). On day 13, the platelet count was 139,000 per cubic millimeter, and the purpura had disappeared.",
        "es": "Una mujer de 65 a\u00f1os con hipertensi\u00f3n, hipotiroidismo autoinmunitario y exposici\u00f3n conocida a COVID-19 acudi\u00f3 al servicio de urgencias con fatiga, fiebre, tos seca y malestar abdominal, con una evoluci\u00f3n de 4 d\u00edas. Al ingreso estaba afebril, con una frecuencia respiratoria de 28 r.p.m. y una saturaci\u00f3n de ox\u00edgeno de 89% en aire ambiental; se apreci\u00f3 disminuci\u00f3n bilateral de los ruidos respiratorios y estertores bibasales. La exploraci\u00f3n abdominal fue normal. Las pruebas anal\u00edticas mostraron una cifra normal de leucocitos, de hemoglobina (14,2 g/dl) y de trombocitos (183.000 por mm c\u00fabico). El valor de prote\u00edna C-reactiva era alto, con 55 mg/l, y las pruebas funcionales hep\u00e1ticas revelaron colestasis. Una prueba de frotis orofar\u00edngeo para COVID-19 result\u00f3 positiva. Una TAC tor\u00e1cica revel\u00f3 opacidades de vidrio esmerilado en las zonas inferiores. Se ingres\u00f3 a la paciente y empez\u00f3 a recibir un tratamiento con amoxicilina/\u00e1cido clavul\u00e1nico i.v., heparina de bajo peso molecular y ox\u00edgeno. El d\u00eda 4, apareci\u00f3 p\u00farpura y epistaxis en las extremidades inferiores. Se apreci\u00f3 trombocitopenia aislada (trombocitos: 66.000 por mm c\u00fabico); este resultado llev\u00f3 a la retirada de la heparina y los antibi\u00f3ticos. El d\u00eda 5, la cifra de trombocitos era de 16.000 por mm c\u00fabico y el d\u00eda 7, de 8.000 por mm c\u00fabico. Los tiempos de protrombina y de tromboplastina parcial activado eran normales; la concentraci\u00f3n de fibrin\u00f3geno era de 5 g por litro (intervalo normal: 2 a 4). Un frotis de sangre perif\u00e9rica mostr\u00f3 menos de un 1% de esquistocitos. El valor de anticuerpos de peroxidasa tiroidea era de 245 U por mililitro (valor normal < 35); no se detectaron anticuerpos antinucleares, anticuerpos antitromboc\u00edticos ni factor 4 antitromboc\u00edtico. Se administr\u00f3 inmunoglobulina i.v. a una dosis de 1 g por kg de peso. Tras 48 horas, la cifra de trombocitos disminuy\u00f3 a 1.000 por mm c\u00fabico y las lesiones purp\u00fareas progresaron; esto llev\u00f3 a una segunda administraci\u00f3n de inmunoglobulina a una dosis de 1g por kg. Un aspirado medular mostr\u00f3 celularidad normal con un aumento de megacariocitos polimorfos. Las l\u00edneas celulares eritrobl\u00e1sticas y granuloc\u00edticas eran normales, sin pruebas de hemofagocitosis. El d\u00eda 9, la paciente report\u00f3 cefalea frontal derecha, sin fiebre, v\u00f3mitos ni focalidad neurol\u00f3gica. Una TAC craneal mostr\u00f3 una microhemorragia subaracnoidea en el l\u00f3bulo frontal derecho. La cifra de trombocitos era de 2.000 por mm c\u00fabico y se realiz\u00f3 una transfusi\u00f3n de trombocitos con 100 mg de prednisolona; se inici\u00f3 la administraci\u00f3n de eltrombopag (75 mg por d\u00eda). El d\u00eda 10, la cefalea hab\u00eda desaparecido, no hab\u00eda nuevas manifestaciones neurol\u00f3gicas y la cifra de trombocitos hab\u00eda aumentado a 10.000 por mm c\u00fabico. Todas las dem\u00e1s pruebas anal\u00edticas se hab\u00edan normalizado excepto el fibrin\u00f3geno, que continuaba alto (3,5 g por litro). El d\u00eda 13, la cifra de trombocitos era de 139.000 por mm c\u00fabico y la p\u00farpura hab\u00eda desaparecido."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "26-year-old man presented to the emergency department with a3-day history of sudden-onset right-sided pleuritic chest pain andprogressive shortness of breath. The patient had not travelled inthe preceding 2 weeks, had no history of chest trauma, and had no historyof fever, cough or other systemic symptoms. He was previously healthy andwas not taking any medications. His cohabitant had a nonproductive coughfor 1 week. The patient preferred not to disclose any further details. On examination, our patient\u2019s vital signs included a normal temperatureand blood pressure (118/80 mm Hg) and heart rate of 122 beats/min. Hehad mild respiratory distress with normal oxygen saturation on ambient air. His body mass index was 17.6 kg/m2. Results from blood work includedlymphopenia (0.69 [normal 1.0\u20133.2] \u00d7 109/L). Chest radiography showed alarge right pneumothorax with complete collapse of the right lung withoutmediastinal shift. Because of the patient\u2019s respiratory symptoms, we did a nasopharyngealswab for real-time reverse transcription polymerase chain reactiontesting, which showed infection with severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2). We placed a small catheter chest drain, whichwas later removed, with the clinician using full personal protective equipmentprecautions, including an N95 respirator. After 48 hours, our patient\u2019spneumothorax and symptoms resolved. He was dischargedfrom hospital in stable condition, and he reported complete resolution ofsymptoms over video teleconferencing on postdischarge day 1.",
        "es": "Un hombre de 26 a\u00f1os acudi\u00f3 al servicio de urgencias con dolor tor\u00e1cico pleural derecho repentino ydisnea progresiva de 3 d\u00edas de evoluci\u00f3n. El paciente no hab\u00eda viajado en las dos semanas anteriores y no ten\u00eda antecedentes de traumatismo tor\u00e1cico ni de fiebre, tos u otros s\u00edntomas sist\u00e9micos. Por lo dem\u00e1s estaba sano y no tomaba ninguna medicaci\u00f3n. Su pareja presentaba tos no productiva desdehac\u00eda una semana. El paciente prefiri\u00f3 no revelar m\u00e1s detalles. A la exploraci\u00f3n, las constantes vitales mostraron una temperatura, una presi\u00f3n arterial y un pulso normales (118/80 y 122 l.p.m.). Presentaba dificultad respiratoria leve con una saturaci\u00f3n de ox\u00edgeno normal en aire ambiental. Su \u00edndice de masa corporal era de 17,6 kg/m2. Su an\u00e1lisis de sangre revel\u00f3 linfocitopenia (0,69 [normal 1,0\u20133,2] \u00d7 109/L). La radiograf\u00eda tor\u00e1cica mostr\u00f3un gran neumot\u00f3rax derecho con colapso completo del pulm\u00f3n derecho, sin desplazamiento mediast\u00ednico. A causa de los s\u00edntomas respiratorios del paciente, se realiz\u00f3 un frotis nasofar\u00edngeo para una prueba de RT-PCR, que demostr\u00f3 que hab\u00eda infecci\u00f3n por s\u00edndrome respiratorio agudo grave de coronavirus 2 (SARS-CoV-2). Se coloc\u00f3 un tubo de drenaje tor\u00e1cico, que posteriormente se retir\u00f3; para la intervenci\u00f3n el m\u00e9dico us\u00f3 equipo de protecci\u00f3n individual completo, incluida una mascarilla N95. Tras 48 horas, los s\u00edntomas y el neumot\u00f3rax del paciente remitieron. Fue dado de alta del hospital estando estable y luego inform\u00f3 de una desaparici\u00f3n completa de los s\u00edntomas, mediante videollamada, el d\u00eda 1 posterior al alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An ex-full term 5-week-old female with a history of hydronephrosis and duplex kidney, but otherwise developing well infant presented to the Kaiser Permanente Northern California (KPNC) San Francisco Emergency Department (ED) in March 2020 with symptoms of fever to 100.4\u00b0F and somnolence without respiratory distress. She had been breastfeeding well, voiding normally, and otherwise acting well. The patient had known sick contacts, including her father, who co-presented to the ED for five days of fever, myalgias, mild cough, coryza, and pharyngitis without shortness of breath. He reported inability to taste and smell. He had previously presented to urgent care four days prior with these symptoms and had been treated empirically with oseltamivir. The father did not have known sick contacts but works in a client-facing capacity in the restaurant industry. Due to the hospitalization of the patient, her father was tested for SARS-CoV-2. The patient\u2019s mother reported that she had subsequently developed very similar symptoms including fever, myalgia, upper respiratory symptoms, anosmia, and ageusia. On initial physical examination, the infant was febrile with a temperature of 38\u00b0C and tachycardic with a pulse of 179. The patient was otherwise well appearing and no focal signs of infection were observed. Notably, she had a normal respiratory rate and effort with clear lungs. A complete blood count revealed leukopenia (3,000 cells/\u03bcL), lymphopenia (1,050 cells/\u03bcL), neutropenia (1,000 cells/\u03bcL), normocytic anemia (hemoglobin 10.6 g/dL, hematocrit 31.4%, mean corpuscular volume 94 fL), and normal platelets (204 x 103 cells/\u03bcL). Due to the infant\u2019s age and presentation of fever without a source in the setting of leukopenia, a full infant sepsis evaluation was initiated. A urinalysis demonstrated trace hemoglobin and protein but was otherwise normal. The C-reactive protein was not elevated. A lumbar puncture was performed with cerebrospinal fluid (CSF) studies that were unremarkable. Urine, blood, and CSF cultures ultimately demonstrated no growth for bacterial organisms. Out of concern for the parents\u2019 respiratory symptoms, influenza and respiratory syncytial virus RT-PCR were sent and resulted negative. Due to a lack of respiratory symptoms, the patient was not initially tested for SARS-CoV-2. At presentation, the infant received a 20ml/kg normal saline bolus and supportive care. Within hours of hospitalization, her father\u2019s test results returned positive for SARS-CoV-2; subsequently a combination oropharyngeal and bilateral nasopharyngeal swab (three sites to increase sensitivity) from the patient were sent for qualitative nucleic amplification for SARS-CoV-2 (Roche cobas 6800/8800) and resulted positive the same day. At the time SARS-CoV-2 testing was sent, the patient was placed on contact and droplet precautions with eye protection. She was treated empirically with intravenous ceftriaxone given her leukopenia and elevated risk for urinary tract infection, but this was stopped after the urine and blood cultures, which were obtained prior to antibiotics, showed no growth at 24 hours. Acetaminophen was administered as an antipyretic and for discomfort as needed. The baby continued to breastfeed while the mother wore a mask. The infant had a very mild clinical course with resolution of fever within about 30 hours of hospitalization. The infant was observed to have an intermittent dry cough while crying, but otherwise had no increased work of breathing or respiratory distress and did not require supplemental oxygen. She was discharged on hospital day three with a plan for the family to isolate until seven days from onset of symptoms or symptom-free for three days, whichever was longer. The parents were instructed to remain the sole caregivers of the baby given reports of prolonged viral shedding in the stool of infants.",
        "es": "Una ni\u00f1a de 5 semanas, nacida a t\u00e9rmino, con antecedentes de hidronefrosis y duplicidad renal, pero por lo dem\u00e1s en buen estado de salud, fue llevada al servicio de urgencias del Kaiser Permanente del norte de California en San Francisco, en marzo de 2020, con s\u00edntomas de fiebre de 38 \u00b0C y somnolencia, sin disnea. La paciente hab\u00eda tenido contacto con individuos enfermos, incluido su padre, que tambi\u00e9n acudi\u00f3 a urgencias con fiebre, mialgia, tos leve, rinitis y faringitis de cinco d\u00edas de evoluci\u00f3n, sin disnea. El padre refiri\u00f3 anosmia y ageusia. Hab\u00eda acudido previamente a urgencias, cuatro d\u00edas antes, con los mismos s\u00edntomas y se le hab\u00eda administrado un tratamiento sintom\u00e1tico con oseltamivir. El padre no hab\u00eda tenido contactos conocidos con individuos enfermos, pero trabaja en una instalaci\u00f3n de atenci\u00f3n a clientes en hosteler\u00eda. A causa de la hospitalizaci\u00f3n de la paciente, se realiz\u00f3 una prueba de SARS-CoV-2 al padre. La madre inform\u00f3 que, posteriormente, ella tambi\u00e9n hab\u00eda presentado s\u00edntomas muy similares, con fiebre, mialgia, s\u00edntomas en las v\u00edas respiratorias altas, anosmia y ageusia. A la exploraci\u00f3n f\u00edsica inicial, la ni\u00f1a ten\u00eda fiebre con una temperatura de 38 \u00b0C y taquicardia con un pulso de 179 l.p.m. Por lo dem\u00e1s, la paciente presentaba buen aspecto y no se observaron signos focales de infecci\u00f3n. En concreto, su frecuencia respiratoria era normal y los pulmones parec\u00edan normales. Un hemograma completo mostr\u00f3 leucopenia (3.000 c\u00e9lulas/\u03bcL), linfopenia (1.050 c\u00e9lulas/\u03bcL), neutropenia (1.000 c\u00e9lulas/\u03bcL), anemia normoc\u00edtica (hemoglobina 10,6 g/dL, hematocrito 31,4%, volumen globular medio 94 fL) y recuento de trombocitos normal (204 x 103 c\u00e9lulas/\u03bcL). A causa de la edad de la ni\u00f1a y del cuadro de fiebre sin foco en una situaci\u00f3n de leucocitopenia, se procedi\u00f3 a una evaluaci\u00f3n completa de infecciones. Un an\u00e1lisis de orina mostr\u00f3 peque\u00f1as cantidades de hemoglobina y prote\u00edna, pero por lo dem\u00e1s los resultados fueron normales. El valor de prote\u00edna C-reactiva no era elevado. Se realiz\u00f3 una punci\u00f3n lumbar, pero los resultados de los estudios del l\u00edquido cefalorraqu\u00eddeo (LCR) fueron irrelevantes. Los hemocultivos, urocultivos y LCR no mostraron crecimiento de organismos bacterianos. Teniendo en cuenta los s\u00edntomas respiratorios de los padres, se hicieron pruebas de RT-PCR para gripe y virus sincitial respiratorio, con resultado negativo. Como la paciente no presentaba s\u00edntomas respiratorios, no se le hizo ninguna prueba inicial de SARS-CoV-2. En la consulta inicial, la ni\u00f1a recibi\u00f3 20 ml/kg de bolo salino normal y tratamiento sintom\u00e1tico. A las pocas horas de hospitalizaci\u00f3n, los resultados de la prueba de su padre dieron positivo para SARS-CoV-2; luego, se envi\u00f3 una combinaci\u00f3n de frotis orofar\u00edngeo y nasofar\u00edngeo bilateral (en tres sitios para aumentar la sensibilidad) de la paciente para una prueba de amplificaci\u00f3n cualitativa de \u00e1cido nucleico de SARS-CoV-2 (Roche cobas 6800/8800), que dio resultado positivo ese mismo d\u00eda. Al mismo tiempo que se enviaba la muestra para la prueba de SARS-CoV-2, se puso a la paciente bajo protecci\u00f3n de contacto y de got\u00edculas, con protecci\u00f3n ocular. Se le aplic\u00f3 un tratamiento sintom\u00e1tico con ceftriaxona i.v., teniendo en cuenta su leucocitopenia y el alto riesgo de infecci\u00f3n urinaria, pero se retir\u00f3 despu\u00e9s de que los hemocultivos y los urocultivos, obtenidos antes de la administraci\u00f3n del antibi\u00f3tico, no mostraran crecimiento a las 24 horas. Se le administr\u00f3 acetaminof\u00e9n como antipir\u00e9tico y para alivio del malestar. La ni\u00f1a continu\u00f3 lactando, con la madre protegida por una mascarilla. La ni\u00f1a present\u00f3 una evoluci\u00f3n cl\u00ednica muy leve, con remisi\u00f3n de la fiebre a las 30 horas de hospitalizaci\u00f3n. Se observ\u00f3 tos seca intermitente al llorar, pero por lo dem\u00e1s no present\u00f3 aumento del esfuerzo respiratorio ni dificultad respiratoria y no necesit\u00f3 oxigenoterapia. Se le dio de alta del hospital al tercer d\u00eda, con instrucciones para la familia de aislarla hasta pasados siete d\u00edas del inicio de los s\u00edntomas o cuando no presentara ning\u00fan s\u00edntoma durante tres d\u00edas. Se indic\u00f3 a los padres que fueran los \u00fanicos cuidadores de la ni\u00f1a, a causa de la informaci\u00f3n disponible acerca del mantenimiento prolongado de la carga v\u00edrica en las heces de los ni\u00f1os."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 3-week-old boy presented with a 2-day history of nasal congestion, tachypnea, and reduced feeding. He was born at 36 weeks of gestation to a 21-year-old woman (gravida 3, para 1) who had received antenatal treatment for carriage of group B streptococci. He had previously received a 48-hour course of antibiotics for suspected neonatal sepsis because of a fever (temperature, 38.5\u00b0C), but the workup for sepsis was negative, and he was discharged home. On admission of the patient to the emergency department, the temperature was 36.1\u00b0C, the pulse 166 beats per minute, the blood pressure 89/63 mm Hg, the respiratory rate 40 breaths per minute, and the oxygen saturation 87% while the patient was breathing ambient air. Chest radiography showed bilateral linear opacities and consolidation in the right upper lobe. Oxygen and empirical antibiotics (ampicillin and gentamicin) were administered, and the patient was transferred to a pediatric hospital. On transfer, the patient had hypotension, tachycardia, hypothermia, and tachypnea. Droplet and contact precautions were initiated, and he was transferred to a negative-pressure room in the pediatric intensive care unit (PICU), where he was intubated and received crystalloid solution at a dose of 60 ml per kilogram of body weight, followed by vasopressors. Nasal swabs were obtained for severe acute respiratory syndrome coronavi-rus 2 (SARS-CoV-2) testing and a respiratory viral panel. Chest radiography performed after intubation showed bilateral infiltrates and partial collapse of the right upper lobe. Transthoracic echocardiography showed normal cardiac anatomy and function. The white-cell countwas 4000 per cubic millimeter with 55% lymphocytes; levels of inflammatory markers were elevated. Mechanical ventilation was initiated with a positive end-expiratory pressure of 7 cm of water, a fraction of inspired oxygen of 0.6, and a mean airway pressure of 22 cm of water, resulting in a partial pressure of arterial oxygen of 49 mm Hg and a partial pressure of arterial carbon dioxide of 80 mm Hg. Treatment was switched to vancomycin, cefepime, and ampicillin and was discontinued after 48 hours when the cultures were negative. Hydroxychloroquine and azithromycin were initiated for presumed Covid-19. On day 2 after admission, the hypotension resolved. A pneumothorax that developed on the right side was successfully treated by tube thoracostomy. The patient was extubated on day 5 and was transferred out of the PICU. The results of reverse-transcriptase\u2013polymerase-chain-reaction testing to detect SARS-CoV-2 on admission were positive on day 7; he completed the 5-day course of hydroxychloroquine and azithromycin. The patient was discharged on day 9 without supplemental oxygen. One of eight household contacts of the patient, a 49-year-old woman, was symptomatic; however, none of the contacts were tested for SARS-CoV-2.",
        "es": "Un ni\u00f1o de 3 semanas lleg\u00f3 con congesti\u00f3n nasal, taquipnea y reducci\u00f3n de la lactancia de 2 d\u00edas de evoluci\u00f3n. Hab\u00eda nacido a las 36 semanas, de una mujer de 21 a\u00f1os tercigesta prim\u00edpara, que hab\u00eda recibido tratamiento prenatal por ser portadora de estreptococo B. Previamente hab\u00eda recibido un tratamiento de 48 horas con antibi\u00f3ticos por sospecha de sepsis neonatal a causa de fiebre (temperatura 38,5 \u00b0C), pero los an\u00e1lisis de sangre fueron negativos y fue dado de alta. Al ingreso en urgencias, el paciente ten\u00eda una temperatura de 36,1 \u00b0C, pulso de 166 l.p.m., presi\u00f3n arterial de 89/63 mm Hg, frecuencia respiratoria de 40 r.p.m. y saturaci\u00f3n de ox\u00edgeno de 87% en aire ambiental. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades lineales bilaterales y consolidaci\u00f3n en el l\u00f3bulo superior derecho. Se le administr\u00f3 ox\u00edgeno y antibi\u00f3ticos (ampicilina y gentamicina) y se traslad\u00f3 a un hospital pedi\u00e1trico. En el traslado, el paciente present\u00f3 hipotensi\u00f3n, taquicardia, hipotermia y taquipnea. Se aplicaron precauciones contra got\u00edculas y contacto, y se traslad\u00f3 al paciente a una sala con presi\u00f3n negativa en la unidad de cuidados intensivos pedi\u00e1tricos, donde se intub\u00f3 y recibi\u00f3 una soluci\u00f3n de cristaloides a una dosis de 60 ml por kilo de peso corporal, seguida de vasopresores. Se obtuvieron frotis nasales para pruebas del s\u00edndrome respiratorio agudo grave por coronavirus 2 (SARS-CoV-2) y un panel v\u00edrico respiratorio. La radiograf\u00eda tor\u00e1cica realizada tras la intubaci\u00f3n mostr\u00f3 infiltrados bilaterales y colapso parcial del l\u00f3bulo superior derecho. Un ecocardiograma transtor\u00e1cico mostr\u00f3 caracter\u00edsticas card\u00edacas anat\u00f3micas y funcionales normales. El recuento de leucocitos era de 4000 por mm c\u00fabico, con 55% de linfocitos; los valores de marcadores de inflamaci\u00f3n eran altos. Se inici\u00f3 ventilaci\u00f3n mec\u00e1nica con presi\u00f3n positiva telespiratoria de 7 cm de agua, fracci\u00f3n de ox\u00edgeno inspirado de 0,6 y presi\u00f3n media de las v\u00edas respiratorias de 22 cm de agua, para una presi\u00f3n parcial de ox\u00edgeno arterial de 49 mm Hg y una presi\u00f3n parcial de di\u00f3xido de carbono arterial de 80 mm Hg. El tratamiento se cambi\u00f3 a vancomicina, cefepima y amplicilina y se retir\u00f3 48 horas despu\u00e9s, cuando los cultivos dieron resultado negativo. Se inici\u00f3 un tratamiento con hidroxicloroquina y azitromicina por sospecha de COVID-19. La hipotensi\u00f3n desapareci\u00f3 al d\u00eda 2 tras el ingreso. Un neumot\u00f3rax que se present\u00f3 en el lado derecho fue tratado con \u00e9xito mediante drenaje tor\u00e1cico. El paciente fue extubado el d\u00eda 5 y sali\u00f3 de la UCI pedi\u00e1trica. Los resultados de las pruebas de RT-PCR para detectar SARS-CoV-2 al ingreso fueron positivos el d\u00eda 7; el paciente complet\u00f3 el tratamiento de 5 d\u00edas de hidroxicloroquina y azitromicina. El d\u00eda 9, el paciente fue dado de alta sin oxigenoterapia. De los ocho contactos dom\u00e9sticos del paciente, uno (una mujer de 49 a\u00f1os) era sintom\u00e1tico; sin embargo, no se hizo la prueba de SARS-CoV-2 a ninguno de los contactos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 74-year-old male with a recent history of normal left ventricular ejection fraction (LVEF) of 55% was admitted to hospital due to hemodynamically unstable new-onset ventricular tachycardia (VT) of 12 hours duration. After unsuccessful self-administration of metoprolol 200 mg orally, arrhythmia had been electrically cardioverted with subsequent symptomatic bradycardia and hypotension. The patient did not present with a fever or respiratory infection symptoms. The patient had a history of atrial fibrillation, three-time catheter ablation, arterial hypertension, type 2 diabetes, hypothyroidism. As a medical professional, the patient might have been exposed to SARS-CoV-2. Due to the indicative clinical picture of severely reduced LVEF 25% suggestive of myocardial injury as well as recurrent VT, the patient underwent coronary angiography, which revealed no obstructive coronary artery disease. Due to the third-degree atrioventricular block, a temporary transvenous pacemaker had been inserted. The following day next episodes of VT occurred. Serum electrolytes and thyroid hormone levels were within normal limits. Overdrive pacing with a rate of 95/min., magnesium substitution, and intravenous amiodarone stabilized the rhythm. On the 3rd day of hospitalization, the temporary pacemaker was removed, and observation did not reveal any VT recurrence. Laboratory findings were as follows: higher than three neutrophil-lymphocyte-ratio (NLR) (normal range 1-3), elevated high-sensitivity cardiac troponin T \u2013 72\u2192102 ng/l (normal range: <14 ng/l), dynamically evolving C-reactive protein \u2013 1.2\u21921.8\u219294 mg/l (normal range: < 6 mg/l), as well as elevated N-terminal prohormone for brain natriuretic peptide \u2013 2451 ng/l (normal range: <125 ng/l), lactic acid dehydrogenase \u2013 369 U/l (normal range: 80-240 U/l), D-dimers \u2013 1.39 mg/l (normal range: <0.5 mg/l), aspartate aminotransferase \u2013 159 U/l (normal range: <45 U/l) and alanine aminotransferase \u2013 163 U/l (normal range: <35 U/l) while the procalcitonin (normal range: <0.05 ng/ml) was negative. Due to suggestive, especially during the outbreak of COVID-19, laboratory results [2,4] reverse transcription-polymerase chain reaction for SARS-CoV-2 was performed on the 6th day of hospitalization and occurred positive. Consequently, the patient received a single 500 mg dose of azithromycin and a single 75 mg dose of oseltamivir. On the 7th day, he was transferred in good general condition to a hospital for infectious diseases for further treatment. On the 17th day, the patient was still tested positive in a throat swab specimen by RT-PCR and presented no respiratory symptoms. Cardiac magnetic resonance performed on a 1.5 Tesla magnetic resonance scanner revealed left atrium enlargement and global LV hypokinesia with ejection fraction as much as 20%. The T2-weight sequence did not show myocardial edema. In contrast, late gadolinium enhancement (LGE) showed a large patchy and linear non-ischemic pattern of fibrosis localized subepicardially and intramurally in basal and mid-cavity segments of the inferior and inferolateral wall and apical segments of the inferior wall.",
        "es": "Hombre de 74 a\u00f1os con antecedentes recientes de fracci\u00f3n de expulsi\u00f3n del VI (FEVI) de 55%, ingres\u00f3 en el hospital a causa de taquicardia ventricular (TV) de primera aparici\u00f3n, hemodin\u00e1micamente inestable y de 12 horas de duraci\u00f3n. Tras una autoadministraci\u00f3n sin \u00e9xito de 20 mg de metoprolol por v\u00eda oral, se elimin\u00f3 la arritmia mediante cardioversi\u00f3n, con ulterior bradicardia e hipotensi\u00f3n sintom\u00e1tica. El paciente no present\u00f3 fiebre ni s\u00edntomas de infecci\u00f3n respiratoria. El paciente ten\u00eda antecedentes de fibrilaci\u00f3n auricular, ablaci\u00f3n cardiaca triple, hipertensi\u00f3n arterial, diabetes de tipo 2 e hipotiroidismo. En tanto que profesional m\u00e9dico, el paciente pod\u00eda haber estado expuesto al SARS-CoV-2. A causa del cuadro cl\u00ednico con una FEVI gravemente reducida de 25%, indicativa de posibles lesiones mioc\u00e1rdicas, as\u00ed como TV recurrente, el paciente se someti\u00f3 a una angiograf\u00eda coronaria, que no revel\u00f3 ninguna arteriopat\u00eda coronaria obstructiva. Debido al bloqueo auriculoventricular de tercer grado, se le hab\u00eda insertado un marcapasos transvenoso temporal. El d\u00eda siguiente se produjeron m\u00e1s episodios de TV. Los electr\u00f3litos s\u00e9ricos y los valores de hormonas tiroideas se hallaban dentro de los l\u00edmites normales. La electroestimulaci\u00f3n a un ritmo de 95/min, la reposici\u00f3n de magnesio y la administraci\u00f3n de amiodarona i.v. El tercer d\u00eda de hospitalizaci\u00f3n se retir\u00f3 el marcapasos temporal y no se observ\u00f3 recurrencia de la TV. Las pruebas anal\u00edticas dieron los resultados siguientes: proporci\u00f3n entre neutr\u00f3filos y linfocitos superior a 3 (intervalo normal: 1-3), troponina cardiaca ultrasensible elevada T \u2013 72\u2192102 ng/l (intervalo normal: < 14 ng/l), prote\u00edna C-reactiva de evoluci\u00f3n din\u00e1mica \u2013 1,2\u21921,8\u219294 mg/l (intervalo normal: < 6 mg/l), as\u00ed como prohormona N-terminal elevada para el p\u00e9ptido natriur\u00e9tico cerebral \u2013 2451 ng/l (intervalo normal: < 125 ng/l), lactato-deshidrogenasa \u2013 369 U/l (intervalo normal: 80-240 U/l), d\u00edmero D \u2013 1,39 mg/l (intervalo normal: < 0,5 mg/l), aspartato-aminotransferasa\u2013 159 U/l (intervalo normal: < 45 U/l) y alanina-aminotransferasa \u2013 163 U/l (intervalo normal: < 35 U/l); la procalcitonina (intervalo normal: < 0,05 ng/ml) fue negativa. Debido a resultados anal\u00edticos indicativos, sobre todo durante el brote de COVID-19, el d\u00eda 6 de hospitalizaci\u00f3n se realiz\u00f3 una prueba de RT-PCR para el SARS-CoV-2, con resultado positivo. En consecuencia, el paciente recibi\u00f3 una dosis \u00fanica de 500 mg de azitromicina y una dosis \u00fanica de 75 mg de oseltamivir. El d\u00eda 7, en buen estado general, se le traslad\u00f3 a un hospital de enfermedades infecciosas para proseguir el tratamiento. El d\u00eda 17, el paciente volvi\u00f3 a dar positivo en pruebas de RT-PCR de frotis far\u00edngeos, pero no presentaba s\u00edntomas respiratorios. Una resonancia magn\u00e9tica cardiaca realizada con un aparato de 1,5 T revel\u00f3 una hipertrofia auricular izquierda e hipocinesia global del VI con una fracci\u00f3n de expulsi\u00f3n de un m\u00e1ximo de 20%. La secuencia T2 ponderada no mostr\u00f3 edema mioc\u00e1rdico. En cambio, las secuencias de contraste con gadolinio mostraron un gran patr\u00f3n no isqu\u00e9mico de fibrosis, lineal y parcheado, en posici\u00f3n subepic\u00e1rdica e intraparietal en los segmentos basal y mediast\u00ednico medio del tabique inferior e inferolateral y en los segmentos apicales del tabique inferior."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 79-year-old woman, without known medical history, was suffering from fever, deterioration of her general condition and abdominal pain located in the epigastric area associated with diarrhea over the previous 8 days. As acute dyspnea added to its symptoms, she went to the emergency room. Initially the patient was hemodynamically stable (Blood pressure: 168/89mmHg), showed symptoms of acute respiratory insufficiency with polypnea (22 cycles per minutes with 86% of blood oxygen saturation in ambient air) and tachycardia (100bpm). Blood tests revealed C-reactive protein (125mg/L) increase and a hyperleukocytosis (12 600/mm3) with lymphopenia. Blood gas analysis showed compensated lactic acidosis (pH 7,43 with hyperlactatemia : 5,36 mmol/L). Nasopharynx PCR was negative for SARS-CoV-2. Two hours after admission, an unenhanced chest CT-scan displayed typical signs of COVID-19 pneumonia (mostly ground glass opacity without CT-backed evidence of another infection) with critical extent (> 75% of pulmonary parenchyma). The upper abdominal slices showed a spontaneous hyperdensity (71 Hounsfied units (HU) vs 38 HU in the portal vein) in the right portal vein. Further examination with enhanced CT-Scan of the chest, abdomen and pelvis at the arterial and portal phases, performed at the same time, confirmed a right-portal vein thrombosis originating from thrombosis of the distal part of the upper mesenteric vein extended to the spleno-mesaraic trunk. A proximal thrombosis of the upper mesenteric artery and jejunal artery were also observed with subsequent features of bowel ischemia of the caecum and small intestine with small amount of liquid in the peritoneal cavity. No pulmonary embolism was revealed. Laparotomy was undertaken few hours later and confirmed ischemia, where a meter of necrotic ileum and right colon were removed. Thrombolysis and thrombectomy of the upper mesenteric artery were also performed during the same procedure. Despite timely treatment, his medical condition stayed precarious because of extended bowel ischemia in addition to severe lung damage caused by COVID-19. Palliative care was implemented and the patient passed away 4 days later.",
        "es": "Mujer de 78 a\u00f1os, sin antecedentes m\u00e9dicos conocidos, present\u00f3 fiebre, empeoramiento del estado general, dolor abdominal en el \u00e1rea epig\u00e1strica y diarrea, de 8 d\u00edas de evoluci\u00f3n. Acudi\u00f3 al servicio de urgencias cuando a sus s\u00edntomas se a\u00f1adi\u00f3 disnea. Inicialmente, la paciente estaba hemodin\u00e1micamente estable (presi\u00f3n arterial: 168/89 mmHg), mostraba s\u00edntomas de insuficiencia respiratoria aguda con polipnea (22 ciclos por minuto con saturaci\u00f3n de ox\u00edgeno de 86% en aire ambiental) y taquicardia (100 l.p.m.). El an\u00e1lisis de sangre revel\u00f3 un aumento de la prote\u00edna C-reactiva (125 mg/L), hiperleucocitosis (12.600/mm3) y linfocitopenia. La gasometr\u00eda mostr\u00f3 acidosis l\u00e1ctica compensada (pH 7,43 con hiperlactacidemia: 5,36 mmol/L). La PCR de frotis nasofar\u00edngeo fue negativa para SARS-CoV-2. Dos horas despu\u00e9s del ingreso, una TAC tor\u00e1cica sin contraste mostr\u00f3 signos t\u00edpicos de neumon\u00eda por COVID-19 (b\u00e1sicamente opacidades de vidrio esmerilado sin evidencias radiol\u00f3gicas de otra infecci\u00f3n) con afectaci\u00f3n importante (> 75% del par\u00e9nquima pulmonar). Los cortes de la parte superior del abdomen mostraron hiperdensidad espont\u00e1nea (71 unidades Hounsfield (HU) vs. 38 HU en la vena porta) en la vena porta derecha. Una exploraci\u00f3n complementaria con TAC tor\u00e1cicas, abdominal y p\u00e9lvica con contraste en las fases arterial y portal, realizadas al mismo tiempo, confirmaron una trombosis de la vena porta derecha causada por una trombosis de la parte distal de la vena mesent\u00e9rica superior extendida al tronco esplenomesent\u00e9rico. Tambi\u00e9n se observ\u00f3 trombosis proximal de la arteria mesent\u00e9rica superior y de la arteria yeyunal, con caracter\u00edsticas subsiguientes de isquemia del intestino ciego e intestino delgado con una peque\u00f1a cantidad de l\u00edquido en la cavidad peritoneal. No se observ\u00f3 embolia pulmonar. Se practic\u00f3 una laparotom\u00eda pocas horas despu\u00e9s, que confirm\u00f3 la isquemia y elimin\u00f3 un metro de \u00edleon y de colon derecho necr\u00f3ticos. En la misma intervenci\u00f3n tambi\u00e9n se realiz\u00f3 una tromb\u00f3lisis y una tromboectom\u00eda de la arteria mesent\u00e9rica superior. A pesar de tratarse a tiempo, el estado de la paciente sigui\u00f3 siendo precario a causa de la isquemia intestinal generalizada, adem\u00e1s de las graves lesiones pulmonares causadas por la COVID-19. Se iniciaron cuidados paliativos y la paciente falleci\u00f3 4 d\u00edas despu\u00e9s."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An elderly patient with type 2 diabetes, hypertension, peripheral artery disease, and chronic renal failure was admitted to the intensive care unit in the spring of 2020 for acute respiratory distress. One week earlier, the patient had felt some fatigue with fever and dyspnea, which did not improve after treatment with cefpodoxime at a dose of 200 mg twice a day for 5 days. Computed tomography of the chest showed bilateral peripheral ground-glass opacities with subpleural condensation. A nasopharyngeal SARS-CoV-2 reverse transcriptase\u2013polymerase chain reaction (RT-PCR) confirmed the diagnosis of COVID-19. One day after hospital admission, the patient developed a squamous and erythematous periumbilical patch with rapid progression of other similar digitate scaly thin plaques on the lateral side of the trunk and thighs. Some lesions on the upper arms, shoulders, and back were papular. This digitate papulosquamous eruption was clinically reminiscent of pityriasis rosea. A skin biopsy of the left shoulder revealed foci of spongiosis with focal parakeratosis in the epidermis and a few rounded spongiotic vesicles containing aggregates of lymphocytes and Langerhans cells. A moderate lymphohistiocytic infiltrate was present in the superficial dermis and was associated with papillary dermal edema. We performed RT-PCR on a fresh skin biopsy specimen, and the results were negative for SARS-CoV-2. Results of blood tests, including HIV serologic tests, treponemal and nontreponemal antigen tests for syphilis, tests for cytomegalovirus infection, and Mycoplasma pneumoniae PCR, were negative, whereas Epstein-Barr virus (EBV) PCR results were positive, with a viral load of 4.6 log10 copies/mL reflecting EBV replication. Serologic markers indicated reactivation and ruled out acute mononucleosis. The cutaneous rash resolved spontaneously within a week. The patient died of COVID-19\u2013related illness.",
        "es": "Un paciente anciano con diabetes tipo 2, hipertensi\u00f3n, arteriopat\u00eda perif\u00e9rica e insuficiencia renal cr\u00f3nica fue ingresado en la unidad de cuidados intensivos en la primavera de 2020 con disnea aguda. Una semana antes, el paciente hab\u00eda notado cierto cansancio, con fiebre y disnea, que no mejor\u00f3 tras un tratamiento con cefpodoxima a una dosis de 200 mg dos veces al d\u00eda durante 5 d\u00edas. Una TAC tor\u00e1cica revel\u00f3 m\u00faltiples opacidades de vidrio esmerilado bilaterales con condensaci\u00f3n subpleural. Una RT-PCR para detecci\u00f3n de SARS-CoV-2 a partir de un frotis nasofar\u00edngeo confirm\u00f3 el diagn\u00f3stico de COVID-19. Un d\u00eda despu\u00e9s del ingreso hospitalario, el paciente present\u00f3 una mancha periumbilical eritematosa y escamosa con r\u00e1pida progresi\u00f3n de otras placas descamativas digitadas a los lados del tronco y los muslos. Algunas lesiones de los brazos, los hombros y la espalda eran papulosas. La erupci\u00f3n papuloescamosa digitada era cl\u00ednicamente parecida a la pitiriasis rosada. Una biopsia de piel del hombro izquierdo revel\u00f3 focos de espongiosis con paraqueratosis focal epid\u00e9rmica y unas pocas ves\u00edculas espongi\u00f3ticas con conjuntos de linfocitos y c\u00e9lulas de Langerhans. Se observ\u00f3 un infiltrado linfohistioc\u00edtico moderado en la dermis superficial, asociado a un edema papilar d\u00e9rmico. Realizamos una prueba de RT-PCR en una muestra de biopsia en fresco de piel y el resultado fue negativo para SARS-CoV-2. Los resultados de los an\u00e1lisis de sangre, que inclu\u00edan pruebas serol\u00f3gicas para VIH, pruebas de ant\u00edgenos trepon\u00e9micos y no trepon\u00e9micos y PCR para Mycoplasma pneumoniae, fueron negativos, mientras que los resultados de la PCR para el virus de Epstein-Barr (VEB) fueron positivos, con una carga v\u00edrica de 4,6 log10 copias/mL, indicativa de replicaci\u00f3n del VEB. Los marcadores s\u00e9ricos indicaron reactivaci\u00f3n y descartaron mononucleosis aguda. El exantema cut\u00e1neo remiti\u00f3 espont\u00e1neamente en una semana. El paciente muri\u00f3 de enfermedad asociada a COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The second patient, a 75 year-old male with no comorbidities, attended the emergencydepartment with abdominal pain and vomiting for two days, along with worsening of the cough and dyspnoea which he had experienced for the preceding two weeks. On arrival his oxygen saturations were 88% on room air but the remainder of his observations were within normal limits. Electrocardiogram showed sinus rhythm with no ischemic changes. Laboratory studies demonstrated leukocytosis (18.1 x 109/L), lymphopenia (0.9 x 109/L) and a mild thrombocytosis (497 x 109/L). D-dimer levels were elevated (3.2mg/L) but troponin T, renal function and liver function were normal. Chest imaging was indicative of SARS-CoV-2 infection. On CT angiography, intraluminal thrombus was present in the descending thoracic aorta with embolic occlusion of the superior mesenteric artery but no evidence of atherosclerosis. Catheter-directed thrombolysis was commenced but the patient developed worseningabdominal symptoms and underwent laparotomy, requiring resection of 150cm of ischemic small bowel.",
        "es": "Hombre de 75 a\u00f1os sin enfermedades concomitantes, acudi\u00f3 al servicio de urgencias con dolor abdominal y v\u00f3mitos de dos d\u00edas de evoluci\u00f3n, junto con un empeoramiento de la tos y la disnea que sufr\u00eda desde dos semanas antes. Al ingreso, su saturaci\u00f3n de ox\u00edgeno era del 88% en aire ambiental, pero el resto de sus manifestaciones estaban dentro de los l\u00edmites normales. El electrocardiograma mostr\u00f3 ritmo sinusal sin alteraciones isqu\u00e9micas. Las pruebas anal\u00edticas mostraron leucocitosis (18,1 x 109/L), linfocitopenia (0,9 x 109/L) y una leve trombocitosis (497 x 109/L). El valor del d\u00edmero D era alto (3,2 mg/L), pero la troponina T y los indicadores funcionales renales y hep\u00e1ticos eran normales. La radiograf\u00eda tor\u00e1cica se\u00f1alaba la posibilidad de infecci\u00f3n por SARS-CoV-2. En una angiograf\u00eda por TAC se observ\u00f3 un trombo intravascular en la aorta descendiente con oclusi\u00f3n emb\u00f3lica de la arteria mesent\u00e9rica superior, pero sin se\u00f1ales de ateroesclerosis. Se inici\u00f3 una tromb\u00f3lisis mediante cat\u00e9ter, pero el paciente mostr\u00f3 un empeoramientode los s\u00edntomas abdominales y se le practic\u00f3 una laparotom\u00eda, con resecci\u00f3n de 150 cm de intestino delgado isqu\u00e9mico."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The first, a sixty-year old male, presented to hospital with sudden loss of sensation and power in both legs. Prior to this he reported a dry cough, fever and general malaise for two weeks prior to hospital presentation, but no pre-existing symptoms of peripheral vascular disease. Examination revealed signs of bilateral acute lower limb ischemia with tachypnoea and tachycardia. Electrocardiogram was normal. Initial laboratory studies revealed a mild leukocytosis (white cell count 13.1 x 109/L) with a mild lymphopenia (1.1 x 109/L) and hyperfibinogenemia (5.5g/L). D-dimers were markedly elevated (23.6mg/L , reference range 0-0.5mg/L) but prothrombin time, activated partial thromboplastin time and platelet count were within normal limits. Chest radiology demonstrated diffuse bilateral consolidation and peripheral ground-glass opacification consistent with SARS-CoV-2 infection. CT angiography revealed an acute thrombotic occlusion of the infra-renal aorta extending into the common iliac arteries. Intraluminal calcific burden in the aortoiliac segments was minimal with no stenotic disease. The patient underwent thromboembolectomy with retrieval of a large burden of acute thrombus, resulting in significant clinical and radiological improvement",
        "es": "Un hombre de 60 a\u00f1os acudi\u00f3 al hospital con una p\u00e9rdida repentina de sensibilidad y debilidad en ambas piernas. Antes de estos s\u00edntomas, refiri\u00f3 tos seca, fiebre y malestar general de dos semanas de evoluci\u00f3n, antes de la primera consulta, pero sin s\u00edntomas previos de vasculopat\u00eda perif\u00e9rica. A la exploraci\u00f3n se observaron signos de isquemia aguda bilateral de las extremidades inferiores, con taquipnea y taquicardia. El electrocardiograma era normal. Las pruebas anal\u00edticas iniciales revelaron una leve leucocitosis (cifra de leucocitos 13,1 x 109/L) y linfocitopenia (1,1 x 109/L), as\u00ed como hiperfibrinogenemia (5,5 g/L). El d\u00edmero D era claramente elevado (23,6 mg/L; intervalo de referencia 0-0,5 mg/L) pero el tiempo de protrombina, el tiempo de tromboplastina parcial activado y la cifra de trombocitos eran normales. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 consolidaci\u00f3n bilateral difusa y opacidades de vidrio esmerilado perif\u00e9ricas, coherentes con una infecci\u00f3n por SARS-CoV-2. Una angiograf\u00eda por TAC revel\u00f3 una oclusi\u00f3n tromb\u00f3tica aguda en la aorta infrarrenal, que se extend\u00eda hacia las arterias il\u00edacas primitivas. La masa c\u00e1lcica intravascular en los segmentos aortoil\u00edacos era m\u00ednima, sin estenosis. El paciente se someti\u00f3 a una tromboemboloectom\u00eda con extracci\u00f3n de una gran masa de trombo agudo, que llev\u00f3 a una significativa mejora cl\u00ednica y radiol\u00f3gica."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 53-year-old man from Wenzhou, Zhejiang, China was admitted to the First Affiliated Hospital of Wenzhou Medical University on February 1, 2020, with a 9-day history of fever with dizziness, cough, and sputum. On presentation, his temperature was 38.6\u00b0C. Laboratory tests showed a C-reactive protein concentration of 70.5 mg/L (normal range, 0.00-10.00 mg/L). Complete blood count showed elevated white blood cell count (14.9  109/L [normal range, 3.5-9.5  109/L]), neutrophils (14.2  109/L [1.8-6.3  109/L]), and monocytes (0.42  109/L [0.1-0.6  109/L]). D-dimer was 0.68 mg/L (0.00-0.5 mg/L) and platelet count was 163  109/L, whereas the lymphocyte count (0.25) decreased (normal range, 1.0-3.2  109/L). The computed tomography scan presented multiple ground-glass opacities with consolidation and bilateral lung involvement. The patient was diagnosed with coronavirus disease 2019 (COVID-19) on the basis of reverse transcription-polymerase chain reaction (RT-PCR) analysis of sputum samples. The patient developed complications including septic shock, multiple organ dysfunction syndrome, acute respiratory distress syndrome, thrombocytopenia, acute kidney injury, and catheter-related infections. The patient was treated with antibacterial, antiviral, and corticosteroid treatments, mechanical  ventilation, and extracorporeal membrane oxygenation. During hospitalization, peripheral ischemia appeared on the right fingers and toes and gradually resulted in gangrene. Beginning on February 29th, the patient\u2019s right fingertip began to show a slight cyanosis, and on March 7th, the patient\u2019s right fingertip cyanosis continued to progress and the boundaries were clear. After March 10th, the patient started to develop black gangrene-like manifestations on his fingertips.",
        "es": "Un hombre de 53 a\u00f1os de Wenzhou (Zhejiang, China) ingres\u00f3 en el Primer Hospital Asociado de la facultad de medicina de Wenzhou el 1 de febrero de 2020, con fiebre, mareo, tos y expectoraci\u00f3n de 9 d\u00edas de evoluci\u00f3n. En la consulta inicial su temperatura era de 38,6 \u00b0C. Las pruebas anal\u00edticas mostraron una concentraci\u00f3n de prote\u00edna C-reactiva de 70,5 mg/L (intervalo normal: 0,00 - 10,00 mg/L). El hemograma completo mostr\u00f3 una cifra elevada de leucocitos (14,9 x 109/L [intervalo normal, 3,5-9,5 x 109/L]), neutr\u00f3filos (14,2 x 109/L [1,8-6,3 x 109/L]) y monocitos (0,42 x 109/L [0,1-0,6 x 109/L]). El valor de d\u00edmero D era de 0,68 mg/L (0,00-0,5 mg/L) y la cifra de trombocitos era 163 x 109/L, mientras que la cifra de linfocitos era baja (0,25; intervalo normal: 1,0-3,2 x 109/L). Una TAC tor\u00e1cica mostr\u00f3 m\u00faltiples opacidades de vidrio esmerilado con consolidaci\u00f3n y afectaci\u00f3n pulmonar bilateral. Se diagnostic\u00f3 al paciente de enfermedad por coronavirus 2019 (COVID-19) a partir del an\u00e1lisis mediante RT-PCR de muestras de esputo. El paciente present\u00f3 complicaciones, como choque s\u00e9ptico, insuficiencia multiorg\u00e1nica, s\u00edndrome de dificultad respiratoria aguda, trombocitopenia, lesi\u00f3n renal aguda e infecciones asociadas a la sonda. El paciente se trat\u00f3 con antibacterianos, antiv\u00edricos y corticosteroides, ventilaci\u00f3n mec\u00e1nica y oxigenaci\u00f3n por membrana extracorporal. Durante la hospitalizaci\u00f3n, se present\u00f3 isquemia perif\u00e9rica en los dedos de la mano y del pie derechos, que evolucion\u00f3 a gangrena. A partir del 29 de febrero, las yemas de los dedos de la mano derecha empezaron a mostrar una ligera cianosis; el 7 de marzo, la cianosis segu\u00eda progresando, con una delimitaci\u00f3n clara. A partir del 10 de marzo, el paciente empez\u00f3 a presentar manifestaciones gangrenosas negras en las yemas de los dedos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 70-year-old woman, receiving 7.5 mg prednisone as maintenance therapy for rheumatoid arthritis (RA), presented with a rapidly, bilateral weakness and tingling sensation in all four extremities resulting in a total functional disability within 48 hours. The patient denied any sphincter disturbances, dyspnea or swallowing difficulties. She first received a diagnosis of RA exacerbation but no improvement was seen after corticosteroids increase. At admission to our Neurology department, at the tenth day of symptom\u2019s onset (April 13), neurological examination showed quadriplegia, hypotonia, areflexia and bilateral positive Lasegue sign. Cranial nerves were intact. Temperature, lung and cardiac auscultation were also normal. On April 1st, three days prior to the ongoing symptom\u2019s onset, the patient presented an episode of dry cough without dyspnea or fever, spontaneously resolving  within 48 hours. Initial blood tests showed no abnormality, except for a lymphocytopenia (520/ml, normal: 1500\u20135000). A nerve conduction study (NCS), on day 10, revealed a marked reduction or absence of electrical potentials in both motor and sensory nerves in all four limbs, with little or no abnormalities in conduction velocities and latencies. The needle electro-myography (EMG) found diffuse and abundant fibrillation potentials at rest. These findings were consistent with an Acute Motor and Sensory Axonal Neuropathy (AMSAN) subtype of Guillain-Barre \u0301syndrome (GBS). CSF analysis showed increased protein level at 1 g per liter (normal range: 0,2\u20130,4) with normal white blood cell count. Chest CT (day 10) revealed ground-glass opacities in the left lung (Fig. SARS-CoV-2 on RT-PCR assay was positive at oropharyngeal swab (day 10),negative in CSF. The patient was treated with intravenous immunoglobulin (2 g/kg for 5 days) and a combination of Hydroxychloroquine (600 mg per day) and Azithromycine(500 mg at the first day, then 250 mg per day). No significant neurological improvement is seen after one week of treatment",
        "es": "Una mujer de 70 a\u00f1os, tratada con 7,5 mg de prednisona como terapia de mantenimiento para artritis reumatoide present\u00f3 una s\u00fabita debilidad bilateral y sensaci\u00f3n de hormigueo en las cuatro extremidades, que llev\u00f3 a una incapacidad funcional total en 48 horas. La paciente afirm\u00f3 no tener problemas de esf\u00ednteres, disnea ni disfagia. El primer diagn\u00f3stico fue de agravamiento de la artritis reumatoide, pero no se apreci\u00f3 ninguna mejora tras un aumento en la dosis de corticosteroides. Al ingreso en el departamento de neurolog\u00eda, el d\u00eda 10 desde la aparici\u00f3n de los s\u00edntomas (13 de abril), la exploraci\u00f3n neurol\u00f3gica mostr\u00f3 tetraplejia, hipoton\u00eda, arreflexia y signo de Las\u00e8gue bilateral positivo. Los pares craneales eran normales. La temperatura y la auscultaci\u00f3n pulmonar y card\u00edaca tambi\u00e9n eran normales. El 1 de abril, tres d\u00edas antes de la aparici\u00f3n de los s\u00edntomas en curso, la paciente tuvo un episodio de tos seca sin disnea ni fiebre, que remiti\u00f3 espont\u00e1neamente en 48 horas. Los an\u00e1lisis de sangre iniciales no revelaron ninguna alteraci\u00f3n, excepto por linfocitopenia (520/ml; valor normal: 1500\u20135000). Un estudio de conducci\u00f3n nerviosa el d\u00eda 10 revel\u00f3 una clara reducci\u00f3n o ausencia de potenciales el\u00e9ctricos en los nervios sensitivos y motores en las cuatro extremidades, sin anomal\u00edas, o muy leves, en las velocidades de conducci\u00f3n y en las latencias. Un electromiograma hall\u00f3 potenciales de fibrilaci\u00f3n en reposo difusos y abundantes. Estos resultados eran coherentes con una neuropat\u00eda aguda sensitivomotora ax\u00f3nica (NASMA) del s\u00edndrome de Guillain-Barr\u00e9 (SGB). El an\u00e1lisis del LCR mostr\u00f3 un aumento de prote\u00edna a 1 g por litro (valor normal: 0,2\u20130,4) con una cifra de leucocitos normal. Una TAC tor\u00e1cica (d\u00eda 10) mostr\u00f3 opacidades de vidrio esmerilado en el pulm\u00f3n izquierdo. La prueba de RT-PCR para SARS-CoV-2 a partir de un frotis orofar\u00edngeo (d\u00eda 10) fue positiva, pero negativa en LCR. (2 g/kg durante 5 d\u00edas) y una combinaci\u00f3n de hidroxicloroquina (600 mg por d\u00eda) y azitromicina (500 mg el primer d\u00eda, luego 250 mg por d\u00eda). No se observ\u00f3 ninguna mejora neurol\u00f3gica significativa tras una semana de tratamiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "83-year-old female with a past medical history of frequent urinary tract infections, hypertension, hyperlipidemia, diabetes mellitus type 2 and neuropathy presented to the ED with fever, facial droop, slurred speech, and reduced oral intake. Initial vital signs were significant for temperature of 38.6\u00b0 C, HR of 94, blood pressure (BP) of 172/64, saturating 94% on room air. The examination was significant for left facial droop and slurred speech with no other significant neurological deficits. National Institute of Health Stroke Scale (NIHSS) was calculated to be 2. Blood work was significant for leucopenia with lymphopenia. Urine analysis was within normal limits, chest X-Ray showed bilateral peripheral opacities. CT head was negative for any acute changes. CTA of head and neck demonstrated no large vessel occlusion, with focal moderate stenosis of right MCA, and incidental pulmonary ground-glass opacities in bilateral apices. COVID-19 was suspected given the fevers and CT findings. COVID-19 PCR detected the virus. D-Dimer and other inflammatory markers were not checked. CXR progressively worsened with bilateral infiltrates. Urine and blood cultures did not yield any growth. No arrhythmias were noted during the hospitalization. On day 3 of hospitalization, the patient developed left-sided hemineglect, worsening left-sided facial droop with left hemiparesis. The speech was normal. NIHSS was calculated to be 16. Repeat CT of the head demonstrated a new moderate hypodensity in the right frontal lobe representing acute infarct. The patient was deemed too high risk for thrombolysis or neuro-intervention. A CT angiogram was planned prior to starting Integrellin, however her respiratory status worsened, requiring intubation and mechanical ventilation. Soon after, the family decided to withdraw care.",
        "es": "Mujer de 83 a\u00f1os con antecedentes de infecciones urinarias frecuentes, hipertensi\u00f3n, hiperlipidemia, diabetes mellitus de tipo 2 y neuropat\u00eda acudi\u00f3 al servicio de urgencias con fiebre, par\u00e1lisis facial, balbuceo y reducci\u00f3n de la ingesta oral. Las constantes vitales iniciales fueron significativas por lo que respecta a temperatura (38,6 \u00b0C), pulso (94 l.p.m. ), presi\u00f3n arterial (172/64 mmHg) y saturaci\u00f3n en aire ambiental (94%). La exploraci\u00f3n f\u00edsica revel\u00f3 par\u00e1lisis facial izquierda y balbuceo, sin otras carencias neurol\u00f3gicas. Se calcul\u00f3 un valor de 2 en la escala NIHSS. El an\u00e1lisis de sangre mostr\u00f3 leucocitopenia y linfocitopenia. El an\u00e1lisis de orina dio resultados dentro de los l\u00edmites normales; la radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades perif\u00e9ricas bilaterales. La TAC craneal no revel\u00f3 ninguna alteraci\u00f3n aguda. Una angiotomograf\u00eda craneomaxilofacial no apreci\u00f3 grandes oclusiones vasculares, con estenosis focal moderada de la ACM, as\u00ed como opacidades de vidrio esmerilado pulmonares bilaterales en los v\u00e9rtices pulmonares. Teniendo en cuenta la fiebre y los resultados radiol\u00f3gicos, se sospech\u00f3 COVID-19. Una prueba mediante PCR detect\u00f3 la presencia del virus. No se comprob\u00f3 el d\u00edmero D ni otros marcadores de inflamaci\u00f3n. La radiograf\u00eda tor\u00e1cica empeor\u00f3 progresivamente con infiltrados bilaterales. Los hemocultivos y urocultivos no mostraron ning\u00fan crecimiento. Durante la hospitalizaci\u00f3n no se apreciaron arritmias. El d\u00eda 3 de hospitalizaci\u00f3n, la paciente present\u00f3 heminegligencia izquierda y un empeoramiento de la par\u00e1lisis facial izquierda con hemiparesia izquierda. El habla era normal. Se calcul\u00f3 un valor de 16 en la escala NIHSS. Una nueva TAC craneal mostr\u00f3 una nueva hipodensidad moderada en el l\u00f3bulo frontal derecho, indicativa de infarto agudo. Se consider\u00f3 que la paciente presentaba demasiado riesgo para una tromb\u00f3lisis o intervenci\u00f3n neuroquir\u00fargica. Se planific\u00f3 una angiograf\u00eda por TAC antes de iniciar un tratamiento con Integrilin; sin embargo, su estado respiratorio empeor\u00f3 y requiri\u00f3 intubaci\u00f3n y ventilaci\u00f3n mec\u00e1nica. Poco despu\u00e9s, la familia decidi\u00f3 finalizar el tratamiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "80 year-old-female with a history of hypertension was brought to the ED for a chief complaint of altered mental status and left-sided weakness. The family denied history of fever or cough, but reported that the patient has been falling frequently in the past week. The patient was intubated for airway protection and a code stroke was activated. Vital signs in the ED were significant for Temp of 37.9\u00b0 C, HR 101, BP 130/77, Examination was significant for left hemiplegia and aphasia. NIHSS was calculated to be 36. CT head revealed an acute right MCA stroke. CTA of the head and neck demonstrated occlusion of the right internal carotid artery at origin and incidental bilateral patchy apical lung opacities. CT perfusion demonstrated a 305 cc core infarct in the right MCA distribution and a surrounding 109 cc ischemic penumbra. The patient was deemed not a suitable candidate for any acute neuro-intervention due to the large core infarct. Considering these characteristic CT findings, the patient was tested for COVID-19 infection with PCR and was positive. Laboratory data on admission demonstrated leukocytosis with lymphopenia, elevated d-dimer (13966 ng/ml DDU), along with elevated lactate dehydrogenase (712 U/L) and elevated C\u2013reactive protein(16.24 mg/dl). The patient\u2019s hospital course was complicated by acute kidney injury and progressively increasing oxygen requirements. On the third day of admission, her family chose for terminal extubation with control measures.",
        "es": "Mujer de 80 a\u00f1os con antecedentes de hipertensi\u00f3n fue llevada al servicio de urgencias aquejada de alteraci\u00f3n del estado mental y hemiparesia izquierda. La familia afirm\u00f3 que no hab\u00eda antecedentes de tos ni fiebre, pero inform\u00f3 de que la paciente hab\u00eda sufrido frecuentes ca\u00eddas durante la \u00faltima semana. Se intub\u00f3 a la paciente para protecci\u00f3n de las v\u00edas respiratorias y se activ\u00f3 el protocolo para ictus. y presi\u00f3n arterial (130/77 mmHg). La exploraci\u00f3n f\u00edsica mostr\u00f3 hemiplejia izquierda y afasia. Se calcul\u00f3 un valor de 36 en la escala NIHSS. Una TAC craneal revel\u00f3 un ictus agudo de la ACM derecha. Una angiotomograf\u00eda craneomaxilofacial mostr\u00f3 oclusi\u00f3n de la arteria car\u00f3tida interna derecha en origen y opacidades pulmonares apicales parcheadas bilaterales. Una gammagraf\u00eda de perfusi\u00f3n revel\u00f3 un n\u00facleo de infarto de 305 cc en la ACM derecha y una penumbra isqu\u00e9mica circundante de 109 cc. Se consider\u00f3 que la paciente no era candidata a intervenci\u00f3n neuroquir\u00fargica a causa de las grandes dimensiones del n\u00facleo de infarto. Teniendo en cuenta los resultados radiol\u00f3gicos, se le hizo una prueba de infecci\u00f3n para COVID-19 mediante PCR, que result\u00f3 positiva. Las pruebas anal\u00edticas al ingreso mostraron leucocitosis con linfocitopenia, d\u00edmero D elevado (13966 ng/ml DDU), lactato-deshidrogenasa elevada (712 U/L) y prote\u00edna C-reactiva elevada (16,24 mg/dl). El cuadro cl\u00ednico de la paciente se complic\u00f3 a causa de lesiones renales agudas y requerimientos de ox\u00edgeno cada vez m\u00e1s elevados. Al tercer d\u00eda de ingreso, su familia decidi\u00f3 una extubaci\u00f3n paliativa con medidas de control."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "88-year-old female with a past medical history of hypertension, chronic kidney disease, and hyperlipidemia presented to the ED with a transient 15-minute episode of right arm weakness and numbness along with word-finding difficulty. Vital signs on presentation were within normal limits. The initial neurological examination was normal. Code stroke was activated. CT head did not show any acute findings. EKG showed normal sinus rhythm. Thrombolysis was deferred, and she was admitted with a diagnosis of transient ischemic attack. As the patient complained of mild shortness of breath with dry cough, Covid-19 PCR was sent, which detected the virus. D-Dimer (< 880 ng/ml) was elevated to 3,442 ng/ml, and other inflammatory markers were elevated as well. Magnetic Resonance Imaging (MRI) showed an acute infarct in the left medial temporal lobe. Magnetic resonance angiogram (MRA) of the head and neck revealed mild stenosis of the right M1 segment. No arrhythmias were noted on telemetry. Patient was treated with aspirin, statins, and was discharged to a rehab facility with an event monitor.",
        "es": "Una mujer de 88 a\u00f1os con antecedentes de hipertensi\u00f3n, nefropat\u00eda cr\u00f3nica e hiperlipidemia acudi\u00f3 al servicio de urgencias con un episodio de entumecimiento y debilidad transitoria de 15 minutos en el brazo derecho, adem\u00e1s de afasia an\u00f3mica. Las constantes vitales en la primera consulta se hallaban dentro de los valores normales. La exploraci\u00f3n neurol\u00f3gica inicial fue normal. Se activ\u00f3 el protocolo para ictus. La TAC craneal no hall\u00f3 manifestaciones agudas. El ECG mostr\u00f3 un ritmo sinusal normal. Se pospuso una tromb\u00f3lisis y se ingres\u00f3 a la paciente con un diagn\u00f3stico de ictus isqu\u00e9mico transitorio. Como la paciente refiri\u00f3 una leve disnea con tos seca, se realiz\u00f3 una PCR para COVID-19, que dio resultado positivo. El d\u00edmero D ten\u00eda valor elevado, de 3.442 ng/ml (normal < 880 ng/ml); otros marcadores inflamatorios tambi\u00e9n eran elevados. Una RMN mostr\u00f3 un infarto agudo en el l\u00f3bulo temporal medial izquierdo. Una angiograf\u00eda por resonancia magn\u00e9tica (ARM) craneomaxilofacial mostr\u00f3 una leve estenosis del segmento M1 derecho. En la telemetr\u00eda no se detectaron arritmias. La paciente se trat\u00f3 con aspirina, estatinas y fue dada de alta para ser trasladada a un centro de rehabilitaci\u00f3n con monitorizaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 26-year-old, gravida 3, para 1, Latin American woman at 33 weeks and 6 days of gestation presented with shortness of breath, dyspnea, and decreased fetal movement on March 27, 2020. The patient has a history of 1 full-term vaginal delivery, and the patient\u2019s husband was diagnosed as having COVID-19 infection. Her BMI was 37 kg/m2. Her medical history was significant also for polycystic ovary syndrome, and her only medication was a daily prenatal vitamin. The patient\u2019s initial vital signs were HR of 130s beats/min, BP of 110s/70s mm Hg, RR in the mid-20 breaths/min, SpO2 of 95%, and initial temperature of 99.3\u00b0F. SpO2 improved to 97% on 2-L nasal cannula. About 8 hours after presentation, her RR increased to 40 breaths/min, with HR of 130 breaths/min, and SpO2 of 95%. An ABG showed a pH of 7.32, pCO2 of 18 mm Hg, pO2 of 107 mm Hg, HCO3 of 14 mEq/L, and BE of\u00a0\u221214 mmol/L. Chest radiograph demonstrated bilateral infiltrates. Workup for metabolic acidosis with respiratory alkalosis was significant for an anion gap of 19, which when investigated only found an elevated beta-hydroxybutyrate of 3.61 mmol/L (normal 0.02\u20130.27 mmol/L). Lactic acid was 0.6 mmol/L (normal 0.4\u20132.0 mmol/L), and the other differential diagnoses for anion gap acidosis were ruled out. Because there was suspicion for COVID-19 infection, a general respiratory panel was sent and was negative, C-reactive protein (noncardiac) was 7.68 mg/dL (normal <3.0 mg/L), ferritin was 86 ng/mL, BNP was <10 pg/mL, procalcitonin of was 0.17 ng/mL, troponin-I was <0.015, AST was 47 IU/L, and ALT was 52 IU/L. Becton Dickinson COVID-19 testing, which was sent on March 28, 2020, returned positive. The patient was managed with fluid restriction, supplemental oxygen via nasal cannula, ceftriaxone IV, and azithromycin IV. Given our contemporary experience with the patient presented in case 1, out of precaution an echocardiogram was performed that found a moderately reduced LVEF of 40%\u201345% with global hypokinesis. Her SpO2 was 96% on room air. Despite her reduced EF, cardiology did not feel she was clinically in acute heart failure; 12.5-mg metoprolol twice daily was initiated, and the patient was placed on a telemetry monitoring. HR was in the 100s beats/min, BP of 110s/70s mm Hg, and RR of 20s breaths/min, with ABG showing a pH of 7.42, pCO2 of 28.7 mm Hg, pO2 of 101 mm Hg, HCO3 of 18.8 mEq/L, and BE of\u00a0\u22126 mmol/L. Given the unknown course of COVID-19 in pregnancy, as a precaution, and in an effort to deliver the patient before she became critically ill, the patient underwent a primary cesarean delivery on April 1, 2020, and recovered with continuous telemetry monitoring. The patient is currently stable on day 7 of hospital admission and POD 1 from cesarean delivery. She is meeting her POD 1 surgical goals, with an improved respiratory status and SpO2 of 96% on room air. However, the patient developed supraventricular tachycardia (SVT) overnight; therefore, cardiology increased her metoprolol from 12.5 mg orally every 12 hours to 25 mg every 12 hours. Of note, during her entire hospitalization, fever >100.4\u00b0F never developed in the patient. As per the Centers for Disease Control and Prevention, both the mother and neonate are being isolated from the general postpartum population in negative pressure rooms with droplet isolation.",
        "es": "Una mujer latinoamericana de 26 a\u00f1os, tercigesta prim\u00edpara, de 33 semanas y 6 d\u00edas de gestaci\u00f3n acudi\u00f3 al servicio el 27 de marzo de 2020 con disnea y disminuci\u00f3n de los movimientos fetales. La paciente ten\u00eda antecedentes de un parto vaginal a t\u00e9rmino; el marido de la paciente se hab\u00eda diagnosticado con COVID-19. Su IMC era de 37 kg/m2. Sus antecedentes m\u00e9dicos solo eran relevantes por una poliquistosis ov\u00e1rica y su \u00fanica medicaci\u00f3n eran vitaminas prenatales diarias. Las constantes vitales de la paciente eran: pulso de 130 l.p.m., presi\u00f3n arterial de 110/70 mm Hg, frecuencia respiratoria de unas 20 r.p.m., SpO2 de 95% y temperatura inicial de 37,4 \u00b0C. La SpO2 mejor\u00f3 a 97% con c\u00e1nula nasal de 2 L. Unas 8 horas despu\u00e9s de la primera consulta, su frecuencia respiratoria aument\u00f3 a 40 r.p.m., con un pulso de 130 l.p.m. y una SpO2 de 95%. La gasometr\u00eda arterial mostr\u00f3 un pH de 7,32, pCO2 de 18 mm Hg, pO2 de 107 mm Hg, HCO3 de 14 mEq/L y un exceso de base de-14 mmol/L. La radiograf\u00eda tor\u00e1cica revel\u00f3 infiltrados bilaterales. Los an\u00e1lisis de acidosis metab\u00f3lica con alcalosis respiratoria resultaron significativos por un desequilibrio ani\u00f3nico de 19, que cuando se investig\u00f3 solo indic\u00f3 un valor elevado de beta-hidroxibutirato de 3,61 mmol/L (valor normal: 0,02 - 0,27 mmol/L). El \u00e1cido l\u00e1ctico era de 0,6 mmol/L (valor normal: 0,4 - 2,0 mmol/L); los dem\u00e1s diagn\u00f3sticos diferenciales para el desequilibrio ani\u00f3nico se descartaron. Como se sospechaba una infecci\u00f3n por COVID-19, se realiz\u00f3 un perfil respiratorio general, que result\u00f3 negativo; la prote\u00edna C-reactiva (no card\u00edaca) era de 7,68 mg/dL (normal < 3,0 mg/L), la ferritina era de 86 ng/mL, el p\u00e9ptido natriur\u00e9tico cerebral era < 10 pg/mL, la procalcitonina era de 0,17 ng/mL, la troponina-I era < 0,015, la AST era de 47 IU/L y la ALT era de 52 IU/L. La prueba para COVID-19 de Becton Dickinson, que se envi\u00f3 el 28 de marzo de 2020, dio resultado positivo. La paciente se trat\u00f3 con restricci\u00f3n h\u00eddrica, oxigenoterapia mediante c\u00e1nula nasal, ceftriaxona i.v. y azitromicina i.v. Teniendo en cuenta nuestra experiencia previa con la paciente del caso 1, como medida de precauci\u00f3n se realiz\u00f3 un ecocardiograma, que hall\u00f3 una FEVI reducida, del 40%-45%, con hipocinesia global. La SpO2 era de 96% en aire ambiental. A pesar de su baja FE, cardiolog\u00eda no consider\u00f3 que se hallara en insuficiencia card\u00edaca aguda; se inici\u00f3 tratamiento con 12,5 mg de metoprolol por d\u00eda y se aplic\u00f3 monitorizaci\u00f3n de telemetr\u00eda. El pulso estaba alrededor de 100 l.p.m., la presi\u00f3n arterial era de 110/70 mm Hg y la frecuencia respiratoria de unas 20 r.p.m. ; la gasometr\u00eda arterial indic\u00f3 un pH of 7,42, pCO2 de 28,7 mm Hg, pO2 de 101 mm Hg, HCO3 de 18,8 mEq/L y exceso de base de\u22126 mmol/L. Dada la evoluci\u00f3n desconocida de la COVID-19 en el embarazo, como precauci\u00f3n, y para forzar el nacimiento antes de que la madre pasara a un estado cr\u00edtico, se practic\u00f3 una ces\u00e1rea primaria el 1 de abril de 2020. Durante la recuperaci\u00f3n se monitoriz\u00f3 con telemetr\u00eda de manera continua. Actualmente la paciente se halla estable en el d\u00eda 7 del ingreso hospitalario y el d\u00eda 1 tras la intervenci\u00f3n por la ces\u00e1rea. Cumple los objetivos del d\u00eda 1 de posoperatorio, con un mejor estado respiratorio y una SpO2 de 96% en aire ambiental. Sin embargo, la paciente present\u00f3 inesperadamente taquicardia supraventricular (TSV); en consecuencia, cardiolog\u00eda aument\u00f3 la dosis de metoprolol de 12,5 mg por v\u00eda oral cada 12 horas a 25 mg cada 12 horas. Cabe se\u00f1alar que durante toda la hospitalizaci\u00f3n, la paciente nunca present\u00f3 fiebre por encima de 38 \u00baC. De acuerdo con los Centros de Control y Prevenci\u00f3n de Enfermedades, tanto la madre como el reci\u00e9n nacido se hallan en aislamiento respecto a la poblaci\u00f3n general puerperal, en salas de presi\u00f3n negativa con aislamiento de got\u00edculas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 58 year old woman presented with productive cough, fatigue, fever and diarrhea for five days. Physical examination was notable for diffuse rhonchi. Initial vital signs were blood pressure 156/95 mmHg, heart rate 130 beats/min, oxygen saturation 82% on 5L nasal cannula, respiratory rate 24/min, and temperature 38.7\u00b0C. Chest x-ray showed lower lobe predominant bilateral infiltrates. Shortly thereafter she was intubated for hypoxic respiratory failure and likely acute respiratory distress syndrome (ARDS). Electrocardiogram (ECG) showed sinus tachycardia and 1 mm upsloping ST elevations in I and aVL, mild diffuse PR depressions and diffuse ST-T changes. Initial troponin I was negative but eventually peaked at 11.02 ng/mL. Notably there was leukopenia (absolute lymphocyte count of 1.04 K/cu mm). SARS-CoV-2, or Coronavirus Disease 2019 (COVID-19), RNA detected by PCR returned positive. The patient had a medical history of diabetes mellitus type 2, hypertension and dyslipidemia. She denied travel but noted her father was ill with similar symptoms. Given the initial presentation, ECG findings, and troponin elevation, differential diagnosis included ST-elevation myocardial infarction (STEMI), stress cardiomyopathy, and myopericarditis. Transthoracic echocardiogram demonstrated akinetic mid to distal anterior, anteroseptal, anterolateral and apical segments, moderately hypokinetic mid and distal inferolateral segments, and hyperdynamic basal segments. Apical ballooning was also noted. Left ventricular ejection fraction (EF) was 20%. Distal third/apical right ventricular (RV) free wall was akinetic with hyperdynamic RV basal wall motion. RV function was mildly reduced. The patient was admitted to the intensive care unit. Her echocardiogram findings were classic for Takotsubo syndrome, or stress cardiomyopathy, and the distribution of wall motion abnormalities being out of proportion to ECG findings or troponin elevation made STEMI unlikely. Given active COVID-19 infection, the decision was again made to defer coronary angiography for the time. However, she was started conservatively on medical therapy for acute coronary syndrome with dual antiplatelet therapy and anticoagulation with continuous intravenous heparin. For COVID-19, hydroxychloroquine therapy was initially started but subsequently discontinued after echocardiogram given possible risk of worsening cardiomyopathy and further prolonging QT; azithromycin course was completed. Clinically the patient also developed shock, likely cardiogenic/septic with central venous oxygen saturation of 42%, and required dobutamine. Over the following days, cardiogenic shock improved with central venous saturation of 65% and deescalating need for dobutamine. Echocardiogram was repeated six days later with improvement noted in overall wall motion and a left ventricular EF of 55%. Given the rapid improvement in function on repeat echocardiogram, her cardiac presentation was felt to be most consistent with stress cardiomyopathy in the setting of COVID-19 infection. This was further supported by her ECG which demonstrated no evidence of Q-wave myocardial infarction.",
        "es": "Mujer de 58 a\u00f1os que refiri\u00f3 tos productiva, fatiga, fiebre y diarrea de cinco d\u00edas de evoluci\u00f3n. A la exploraci\u00f3n f\u00edsica se apreciaron roncus difusos. Las constantes vitales iniciales eran: presi\u00f3n arterial 156/95 mmHg, pulso 130 l.p.m., saturaci\u00f3n de ox\u00edgeno 82% con c\u00e1nula nasal de 5L, frecuencia respiratoria 24 r.p.m., temperatura 38,7 \u00b0C. La radiograf\u00eda tor\u00e1cica revel\u00f3 infiltrados bilaterales predominantemente en el l\u00f3bulo inferior. Poco despu\u00e9s fue intubada a causa de insuficiencia respiratoria hip\u00f3xica y posible s\u00edndrome de dificultad respiratoria aguda (SDRA). El electrocardiograma (ECG) mostr\u00f3 taquicardia sinusal y elevaci\u00f3n del segmento ST ascendente en I y aVL, descenso leve difuso del segmento PR y cambios difusos del segmento ST y la onda T. La troponina I inicial era negativa pero lleg\u00f3 a un m\u00e1ximo de 11,02 ng/mL. Cabe destacar la presencia de leucocitopenia (cifra absoluta de linfocitos de 1,04 K/cu mm). Las pruebas de ARN mediante PCR de SARS-CoV-2 (COVID-19) fueron positivas. La paciente ten\u00eda antecedentes de diabetes mellitus de tipo 2, hipertensi\u00f3n y dislipidemia. Afirm\u00f3 no haber viajado, pero se\u00f1alo que su padre estaba enfermo con s\u00edntomas similares. Teniendo en cuenta el cuadro cl\u00ednico inicial, los resultados electrocardiogr\u00e1ficos y el aumento de troponina, el diagn\u00f3stico diferencial consisti\u00f3 en infarto de miocardio con elevaci\u00f3n del segmento ST (IMEST), cardiomiopat\u00eda de esfuerzo y miopericarditis. Un ecocardiograma transtor\u00e1cico revel\u00f3 segmentos acin\u00e9ticos apicales, anterolaterales, anteroseptales y anteriores medios a distales, segmentos inferolaterales medios y distales moderadamente hipocin\u00e9ticos y segmentos basales hiperdin\u00e1micos. Tambi\u00e9n se apreci\u00f3 abombamiento apical. La fracci\u00f3n de expulsi\u00f3n del VI era de 20%. El tabique libre tercero distal/apical del ventr\u00edculo derecho (VD) era acin\u00e9tico, con movimiento basal del tabique del VD hiperdin\u00e1mico. La actividad del VD estaba levemente reducida. La paciente fue ingresada en la unidad de cuidados intensivos. Los resultados del ecocardiograma fueron los cl\u00e1sicos del s\u00edndrome de Takotsubo o cardiomiopat\u00eda de esfuerzo, y como la distribuci\u00f3n de anomal\u00edas del movimiento del tabique no correspond\u00edan con los resultados del ECG ni con el aumento de troponina, el IMEST parec\u00eda poco probable. Teniendo en cuenta la infecci\u00f3n por COVID-19, se decidi\u00f3 nuevamente posponer la angiograf\u00eda coronaria. Sin embargo, se inici\u00f3 un tratamiento farmacol\u00f3gico para s\u00edndrome coronario agudo con una terapia de antiagregantes plaquetarios doble y anticoagulante con heparina i.v. continua. Para la COVID-19, se inici\u00f3 un tratamiento con hidroxicloroquina pero se retir\u00f3 posteriormente despu\u00e9s del ecocardiograma a causa del riesgo posible de empeoramiento de la cardiomiopat\u00eda y alargamiento del QT; se complet\u00f3 el tratamiento con azitromicina. Cl\u00ednicamente, la paciente present\u00f3 un choque, seguramente cardi\u00f3genico/s\u00e9ptico con una saturaci\u00f3n de ox\u00edgeno venosa central de 42%, y requiri\u00f3 dobutamina. Durante los d\u00edas siguientes, el choque cardiog\u00e9nico mejor\u00f3, con una saturaci\u00f3n venosa central de 65% y disminuci\u00f3n de requerimientos de dobutamina. Seis d\u00edas despu\u00e9s se repiti\u00f3 el ecocardiograma, que mostr\u00f3 una mejora en el movimiento global del tabique y una FE del VI de 55%. A partir de la r\u00e1pida mejora apreciada en el ecocardiograma de seguimiento, su cuadro card\u00edaco pareci\u00f3 m\u00e1s consistente con cardiomiopat\u00eda de esfuerzo en el contexto de una infecci\u00f3n por COVID-19. Este diagn\u00f3stico qued\u00f3 respaldado por el ECG, que no revel\u00f3 pruebas de infarto de miocardio de onda Q."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 34-year-old man with a medical history of diabetes mellitus and smoking, presented to the emergency room with a 4-day history of weakness, fever and cough. On admission, his temperature was 37.5\u00b0C, pulse was 102 bpm, blood pressure was 133/85 mmHg, and oxygen saturation was 96% while breathing ambient air. Breath sounds were diminished with crackles over the left lower lung field. Chest radiographs showed interstitial opacities in the left lower lobe. Laboratory tests were unremarkable except for mild lymphopenia and thrombocytopenia. Nasopharyngeal and oropharyngeal swabs for COVID-19 were obtained due to a history of exposure to COVID-19 patients. After a positive result was reported, the patient was admitted to an isolation ward. Treatment with antibiotics and hydroxychloroquine was initiated. Direct contact between the staff and the patient was purposely minimal; interaction was primarily via an electronic audio-video link. Visitors were prohibited. During his hospitalization, the patient had no fever or respiratory distress. However, he developed symptoms consistent with anxiety and insomnia. A supportive intervention was initiated by a team of social workers and treatment with brotizolam was commenced. On hospital day 7, the patient attempted suicide by jumping from the third-floor ward. Droplet and contact precautions were initiated, and he was transferred to the trauma bay. All staff caring for the patient wore personal protective equipment. The patient was intubated and transferred under strict infection control measures for computed tomography which revealed subdural and subarachnoid haemorrhages, bladder laceration and pelvic fracture with active bleeding.",
        "es": "Un hombre de 34 a\u00f1os con antecedentes de diabetes mellitus y tabaquismo acudi\u00f3 al servicio de urgencias con debilidad, fiebre y tos de 4 d\u00edas de evoluci\u00f3n. Al ingreso, su temperatura era de 37,5 \u00b0C, el pulso era de 102 l.p.m., la presi\u00f3n arterial era de 133/85 mmHg y la saturaci\u00f3n de ox\u00edgeno era de 96% en aire ambiental. Se apreci\u00f3 disminuci\u00f3n de los ruidos respiratorios con crepitantes en el campo pulmonar izquierdo inferior. Las radiograf\u00edas tor\u00e1cicas mostraron opacidades intersticiales en el l\u00f3bulo inferior izquierdo. Las pruebas anal\u00edticas fueron irrelevantes, excepto por una leve linfocitopenia y trombocitopenia. Se obtuvieron frotis nasofar\u00edngeos y orofar\u00edngeos a causa de antecedentes de exposici\u00f3n a pacientes de COVID-19. Tras obtener un resultado positivo, el paciente ingres\u00f3 en una planta de enfermedades infecciosas. Se inici\u00f3 un tratamiento con antibi\u00f3ticos e hidroxicloroquina. Se minimiz\u00f3 el contacto directo entre el personal y el paciente; la interacci\u00f3n se realiz\u00f3 principalmente mediante una conexi\u00f3n electr\u00f3nica de audio y v\u00eddeo. Se prohibieron las visitas. Durante la hospitalizaci\u00f3n, el paciente no present\u00f3 fiebre ni dificultad respiratoria. Sin embargo, desarroll\u00f3 s\u00edntomas coherentes con ansiedad e insomnio. Se inici\u00f3 una intervenci\u00f3n sintom\u00e1tica con un equipo de asistentes sociales, as\u00ed como un tratamiento con brotizolam. El d\u00eda 7 de hospitalizaci\u00f3n, el paciente intent\u00f3 suicidarse saltando del tercer piso. Se aplicaron precauciones contra contacto y got\u00edculas y se le traslad\u00f3 al servicio de traumatolog\u00eda. Todo el personal que atendi\u00f3 al paciente llevaba equipos de protecci\u00f3n individual. Se intub\u00f3 al paciente y se le traslad\u00f3 con estrictas medidas de control antiinfecciosas para realizarle una TAC, que revel\u00f3 hemorragias subdurales y subaracnoideas, desgarro vesical y fractura p\u00e9lvica."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "92-year-old woman who was admitted with a 4-day history of fever and chills. She had a history of diabetes mellitus and arterial hypertension. Her family confirmed previous contact with patients positive for SARS-CoV-2. Clinical examination in our Internal Medicine department revealed the patient had bilateral crackles in both lungs. She was stable haemodynamically. Arterial blood gas (ABG) analysis, blood tests and a chest x-ray were carried out. The ABG results showed mild hypoxemic hypocapnic respiratory failure, the chest x-ray showed bilateral signs of interstitial pneumonia and the blood tests showed lymphocytopenia, and an elevated erythrocyte sedimentation rate (42 mm), C-reactive protein (138 mg/l) and lactate dehydrogenase (471 U/l). Platelets were low (54 000/mm3) as was procalcitonin. The patient was tested for SARS-CoV-2 with a positive result. Tests for influenza A and B, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila, Herpes simplex virus and Epstein-Barr virus were all negative for recent active infection. In light of the bilateral pneumonia and lymphocytopenia, the patient was also investigated for antibodies against cytomegalovirus (CMV): results showed high IgG (>180 U/ml) and IgM (38.7 U/ml) levels, indicating recent and likely active infection. An infectious disease specialist was consulted and prescribed empirical therapy with lopinavir/ritonavir 200 mg twice a day plus hydroxychloroquine 200 mg twice a day. Bronchoscopy to obtain bronchoalveolar lavage for molecular diagnosis was not possible because of the patient\u2019s unstable condition. Unfortunately, she died 6 days after admission due to severe respiratory failure in the clinical context of acute respiratory distress syndrome (ARDS).",
        "es": "Mujer de 92 a\u00f1os que ingres\u00f3 con fiebre y escalofr\u00edos de 4 d\u00edas de evoluci\u00f3n. Ten\u00eda antecedentes de diabetes mellitus e hipertensi\u00f3n arterial. Su familia confirm\u00f3 contacto previo con pacientes positivos para SARS-CoV-2. La exploraci\u00f3n cl\u00ednica en nuestro departamento de medicina interna revel\u00f3 que la paciente presentaba crepitantes bilaterales en ambos pulmones. Se hallaba hemodin\u00e1micamente estable. Se realiz\u00f3 gasometr\u00eda arterial, an\u00e1lisis de sangre y radiograf\u00eda tor\u00e1cica. La gasometr\u00eda revel\u00f3 insuficiencia respiratoria hipoc\u00e1pnica hipox\u00e9mica, la radiograf\u00eda tor\u00e1cica mostr\u00f3 signos bilaterales de neumon\u00eda intersticial y los an\u00e1lisis de sangre revelaron linfocitopenia y valores altos de la velocidad de sedimentaci\u00f3n globular (42 mm), de prote\u00edna C-reactiva (138 mg/l) y de lactato-deshidrogenasa (471 U/l). Los trombocitos (54.000/mm3) y la procalcitonina ten\u00edan valores bajos. Se efectu\u00f3 una prueba para SARS-CoV-2, que result\u00f3 positiva. Las pruebas de gripe A y B, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila, virus del herpes simple y virus de Epstein-Barr fueron todas negativas para infecciones recientes. Considerando la neumon\u00eda bilateral y la linfocitopenia, se hicieron pruebas para anticuerpos contra citomegalovirus (CMV); los resultados indicaron valores altos de IgG (> 180 U/ml) e IgM (38,7 U/ml), lo que indicaba una infecci\u00f3n reciente y, posiblemente, activa. Se consult\u00f3 con un especialista en enfermedades infecciosas y recet\u00f3 un tratamiento provisional con lopinavir/ritonavir 200 mg dos veces al d\u00eda m\u00e1s hidroxicloroquina 200 mg dos veces al d\u00eda. No fue posible realizar una broncoscopia y obtener un lavado broncoalveolar para un diagn\u00f3stico molecular a causa del estado inestable de la paciente. Por desgracia, falleci\u00f3 6 d\u00edas despu\u00e9s del ingreso a causa de insuficiencia respiratoria grave en el contexto de s\u00edndrome de dificultad respiratoria aguda (SDRA)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 51-year-old male patient was referred to our hospital on April 2nd, 2020 with a 2\u00a0day history of progressive upper and lower limb weakness and acral paresthesias. He also reported fluctuating fever and flu-like symptoms with marked fatigue and dry cough over the last 2\u00a0weeks. On clinical examination, substantial tetraparesis with limb muscle strength ranging from 2/5 to 4/5 (MRC grading scale) as well as generalized areflexia were documented. Vital signs were stable at that point. A low dose chest CT scan upon admission revealed typical bilateral interstitial infiltrates in keeping with Covid-19 pneumonia. Covid-19 infection was then confirmed by a SARS-CoV-2 positive PCR testing result from a pharyngeal swab. Cerebrospinal fluid (CSF) on admission revealed mild pleocytosis (9 cells/\u03bcl), normal protein content and negative PCR testing for SARS-CoV-2. Serum anti-ganglioside antibodies were negative. Electroneurography on the day after admission demonstrated prolonged distal motor latencies (left median nerve 8.4\u00a0ms; left tibial nerve 11.6\u00a0ms) and loss of F waves suggesting peripheral demyelination. Due to a rapidly deteriorating pulmonary gas exchange the patient needed endotracheal intubation on day two after admission. After pulmonary stabilization tracheostomy was performed on day seven after admission and weaning from the ventilator attempted. Despite treatment with intravenous immunoglobulins (IVIG, 30\u00a0g daily for 5\u00a0days starting upon admission) the neurological status deteriorated to an almost complete peripheral locked-in syndrome with tetraplegia, complete sensory loss in all extremities, bilateral facial and hypoglossal paresis as well as ongoing respiratory failure due to muscular weakness. In light of the fulminant neurological course plasma exchange therapy (PE) was begun on day 13 after admission (total of 14 treatments). Just prior to initiation of PE a second CSF sample was taken which now demonstrated marked protein elevation (10.231\u00a0mg/l; normal range up to 450\u00a0mg/l) in the absence of pleocytosis. An MRI of the spine was performed on day 14 after admission and demonstrated massive symmetrical contrast enhancement of the spinal nerve roots at all levels of the spine including the cauda equina. Interestingly anterior and posterior nerve roots were equally affected. MRI (T1 weighted sequences after application of gadolinium) showed symmetrical enhancement of the anterior and posterior roots in the cervical spine and the cauda equina. Thirty-one days after admission the patient was referred to a specialized rehabilitation clinic. At that time, he showed signs of motor improvement with regressive facial and hypoglossal paresis but still needed mechanical ventilation.",
        "es": "Un hombre de 51 a\u00f1os fue derivado a nuestro hospital el 2 de abril de 2020 con debilidad progresiva en las extremidades inferiores y superiores y parestesia acra de dos d\u00edas de evoluci\u00f3n. Tambi\u00e9n refiri\u00f3 fiebre intermitente y s\u00edntomas seudogripales con una clara fatiga y tos seca durante las \u00faltimas dos semanas. A la exploraci\u00f3n cl\u00ednica, se observ\u00f3 tetraparesia considerable, con una fuerza muscular en las extremidades entre 2/5 y 4/5 (en la escala del Medical Research Council), as\u00ed como arreflexia generalizada. Al ingreso, una TAC tor\u00e1cica de baja dosis revel\u00f3 infiltrados intersticiales bilaterales t\u00edpicos de la neumon\u00eda por COVID-19. La infecci\u00f3n por COVID-19 fue confirmada m\u00e1s tarde mediante una prueba PCR positiva para SARS-CoV-2 a partir de un frotis far\u00edngeo. Al ingreso, el l\u00edquido cefalorraqu\u00eddeo (LCR) revel\u00f3 una leve pleocitosis (9 c\u00e9lulas/\u03bcl), valor normal de prote\u00ednas y PCR negativa para SARS-CoV-2. Los anticuerpos antigangli\u00f3sidos s\u00e9ricos fueron negativos. Un electroneurograma el d\u00eda posterior al ingreso mostr\u00f3 latencias motoras distales prolongadas (nervio mediano izquierdo 8,4 ms; nervio tibial izquierdo 11,6 ms) y p\u00e9rdida de ondas F, que suger\u00edan desmielinizaci\u00f3n perif\u00e9rica. A causa de un r\u00e1pido empeoramiento del intercambio pulmonar de gases, el paciente necesit\u00f3 intubaci\u00f3n endotraqueal el segundo d\u00eda de ingreso. Tras estabilizaci\u00f3n pulmonar, se practic\u00f3 una traqueostom\u00eda el d\u00eda 7 de ingreso y se intent\u00f3 retirar la respiraci\u00f3n asistida. A pesar del tratamiento con inmunoglobulinas i.v. (30 g al d\u00eda durante 5 d\u00edas, iniciado al ingreso), el estado neurol\u00f3gico empeor\u00f3 hasta un s\u00edndrome de enclaustramiento perif\u00e9rico casi total, con tetraplejia, hipoestesia completa en todas las extremidades, paresia sublingual y facial bilateral e insuficiencia respiratoria a causa de la debilidad muscular. Teniendo en cuenta la evoluci\u00f3n neurol\u00f3gica fulminante, se inici\u00f3 terapia por plasmaf\u00e9resis el d\u00eda 13 del ingreso (total 14 tratamientos). Justo antes del inicio de la plasmaf\u00e9resis, se obtuvo una segunda muestra de LCR, que mostr\u00f3 un claro aumento de prote\u00ednas (10,231 mg/l; intervalo normal hasta 450 mg/l) sin pleocitosis. El d\u00eda 14 tras el ingreso se realiz\u00f3 una RMN vertebral que mostr\u00f3 un gran realce sim\u00e9trico de contraste en las ra\u00edces de los nervios raqu\u00eddeos en todos los segmentos de la columna, incluyendo la cola de caballo. Cabe se\u00f1alar que las ra\u00edces anteriores y posteriores de los nervios mostraban la misma afectaci\u00f3n. La RMN (secuencias ponderadas en T1 tras aplicaci\u00f3n de gadolinio) mostraron un realce sim\u00e9trico de las ra\u00edces anteriores y posteriores en la columna cervical y en la cola de caballo. 31 d\u00edas despu\u00e9s del ingreso, el paciente fue derivado a una cl\u00ednica especializada de rehabilitaci\u00f3n. En ese momento mostraba signos de mejora motora con paresia sublingual y facial regresiva, pero a\u00fan necesitaba ventilaci\u00f3n mec\u00e1nica."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "66-year-old woman who presented with a 72-h history of increasing difficulty walking and acute fatigue; she had mild fever and cough 10\u00a0days earlier, with spontaneous resolution of fever after a few days. She also manifested a transient pruriginous dorsal rash but had no gastrointestinal symptoms nor relevant medical history, besides mild hypertension treated with beta-blockers. Lung CT scan showed bilateral ground-glass opacities, but the first rhinopharyngeal swab for SARS-CoV-2 was negative; initial routine and gas analyses on blood were unremarkable. On evaluation, she was paraparetic with a rapidly progressive symmetric weakness in the lower limbs, leading to falls and paraplegia. She also had initial distal weakness in the upper limbs (MRC 4/5) and diffuse areflexia, but no clear sensory deficits. She underwent lumbar puncture with demonstration of a typical albumin-cytological dissociation (0 cells/uL, 108\u00a0mg/dL proteins), prompting initiation of intravenous immunoglobulin (IVIg, 0,4\u00a0g/kg for 5\u00a0days) on the presumptive diagnosis of GBS. Ten days after onset, a nerve conduction study disclosed absence of F-waves with diffuse prolonged distal motor latencies and reduced distal compound muscle action potential amplitudes with a slight reduction of conduction velocities, thus suggesting a mixed pattern of demyelination and axonal damage; no sensory nerve action potential was registered. SARS-CoV-2 was not detected on cerebrospinal fluid (CSF), while serology was not available at that time; anti-glycolipid antibodies were also absent. In the meanwhile, the patient had been admitted to a subintensive care unit as her second swab resulted positive for SARS-CoV-2 and thus started combined treatment of antiretroviral drugs (lopinavir and ritonavir) and hydroxychloroquine, maintaining reasonable respiratory function with supplemental oxygen. However, the woman did not benefit from early treatment with IVIg and progressively developed proximal weakness in all limbs, dysesthesia, and unilateral facial palsy. She also needed treatment for transient episodes of confusion with psychomotor agitation. Moreover, gas exchanges worsened with a sudden desaturation, requiring intubation and intensive care unit admission, where she was treated for multi-organ failure along with a leg deep vein thrombosis and a superimposed bacterial infection (ab ingestis pneumonia).",
        "es": "Mujer de 66 a\u00f1os que acudi\u00f3 refiriendo dificultad para andar y fatiga aguda de 72 horas de evoluci\u00f3n; hab\u00eda tenido febr\u00edcula y tos diez d\u00edas antes, con resoluci\u00f3n espont\u00e1nea de la fiebre despu\u00e9s de unos pocos d\u00edas. Tambi\u00e9n refiri\u00f3 un exantema dorsal pruriginoso pasajero, pero no ten\u00eda s\u00edntomas gastrointestinales ni antecedentes m\u00e9dicos relevantes, excepto por hipertensi\u00f3n leve tratada con betabloqueantes. Una TAC pulmonar mostr\u00f3 opacidades de vidrio esmerilado bilaterales, pero el primer frotis rinofar\u00edngeo para SARS-CoV-2 fue negativo; los an\u00e1lisis de sangre y la gasometr\u00eda iniciales fueron anodinos. A la exploraci\u00f3n, la paciente se mostraba parapar\u00e9sica, con una debilidad sim\u00e9trica de r\u00e1pida progresi\u00f3n en las extremidades inferiores, que provocaba ca\u00eddas y paraplejia. Tambi\u00e9n presentaba debilidad distal en las extremidades superiores (puntuaci\u00f3n 4/5 en la escala del Medical Research Council) y arreflexia difusa, pero sin carencias sensoriales claras. Se le practic\u00f3 una punci\u00f3n lumbar que mostr\u00f3 desequilibrio t\u00edpico albumino-citol\u00f3gico (0 c\u00e9lulas/uL, 108 mg/dL prote\u00ednas), lo que llev\u00f3 a iniciar inmediatamente un tratamiento con inmunoglobulina i.v. (0,4 g/kg durante 5 d\u00edas) con presunto diagn\u00f3stico de SGB. Diez d\u00edas despu\u00e9s del inicio de los s\u00edntomas, un estudio de conducci\u00f3n nerviosa revel\u00f3 ausencia de ondas F con latencias motoras distales prolongadas difusas y una reducci\u00f3n de las amplitudes del potencial de acci\u00f3n muscular compuesto distal, con una ligera reducci\u00f3n de las velocidades de conducci\u00f3n, lo que suger\u00eda un patr\u00f3n mixto de desmielinizaci\u00f3n y da\u00f1o ax\u00f3nico; no se observ\u00f3 potencial de acci\u00f3n de los nervios sensitivos. No se detect\u00f3 SARS-CoV-2 en el l\u00edquido cefalorraqu\u00eddeo (LCR), mientras que las pruebas serol\u00f3gicas no estaban disponibles en ese momento; tampoco se detectaron anticuerpos antiglucolip\u00eddicos. Mientras tanto, la paciente hab\u00eda ingresado en una unidad de cuidados subintensivos dado que su segundo frotis hab\u00eda dado positivo para SARS-CoV-2, de modo que se inici\u00f3 un tratamiento combinado de antirretrovirales (lopinavir y ritonavir) e hidroxicloroquina, manteniendo una funci\u00f3n respiratoria razonable con oxigenoterapia. Sin embargo, la mujer no present\u00f3 ninguna mejora por el tratamiento previo con inmunoglobulinas i.v. y present\u00f3 una debilidad progresiva en todas las extremidades, disestesia y par\u00e1lisis facial unilateral. Tambi\u00e9n necesit\u00f3 tratamiento para episodios transitorios de desorientaci\u00f3n con excitaci\u00f3n psicomotora. Adem\u00e1s, el intercambio de gases empeor\u00f3, con una desaturaci\u00f3n s\u00fabita que exigi\u00f3 intubaci\u00f3n e ingreso en la unidad de cuidados intensivos, donde se la trat\u00f3 por insuficiencia multiorg\u00e1nica, trombosis venosa profunda e infecci\u00f3n bacteriana superpuesta (neumon\u00eda por aspiraci\u00f3n)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "66-year-old man who in November 2011 presented to the emergency room of the Mantua city hospital with spontaneous severe cutaneous and muscle bleeding. He had no history of bleeding. Blood tests revealed normocytic anemia (hemoglobin 9 g/dL) with normal white cell and platelet count and a prolonged activated partial-thromboplastin time (aPTT) (ratio 2.97, normal  range 0.82-1.18) with normal prothrombin time. A mixing study resulted in failure of aPTT  correction, suggesting the presence of an inhibitor that was successively identified as directed against FVIII (FVIII <1%, inhibitor titer 25 Bethesda units [BU]). The diagnosis of idiopathic acquired haemophilia A (AHA)  was made. The patient was successfully treated with intravenous recombinant activated factor VII  (90 \u00b5g/Kg every 3 hours until bleeding stopped) and oral prednisone and cyclophosphamide (1 mg/Kg/day for 4 weeks, then gradually tapered) with a complete remission (CR) achieved on day +21. Following a 9-year period of well-being with normal coagulation checks performed every 6 months, the patient was re-admitted to the Mantua city Hospital on March 2020 because of fever (38.7 \u00b0C), cough, asthenia and difficulty breathing for 3 days. The diagnosis of Coronavirus Disease 2019 (COVID-19) was confirmed by RT-PCR in nasal swab. A chest CT scan showed a bilateral interstitial pneumonia. Due to the concomitant presence of an extensive hematoma in the trunk, an aPTT was performed, resulting prolonged (ratio 2.87). The diagnosis of AHA was again formulated (FVIII <1%,  inhibitor titer 19 BU) and the patient  was treated with the same anti-hemorrhagic and immunosuppressive treatment, reaching CR on day +20. In addition, the patient received anti-viral drugs (lopinavir-ritonavir 400 mg/twice daily) and non-invasive mechanical ventilation with oxygen as treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, leading to the resolution of the disease on day +14.",
        "es": "Hombre de 66 a\u00f1os que, en noviembre de 2011, acudi\u00f3 al servicio de urgencias del hospital municipal de Mantua con hemorragia cut\u00e1nea y muscular espont\u00e1nea grave. No ten\u00eda antecedentes de hemorragias. Los an\u00e1lisis de sangre revelaron anemia normoc\u00edtica (hemoglobina 9 g/dL) con cifras normales de leucocitos y trombocitos y un tiempo de tromboplastina parcial activado prolongado (cociente 2,97; intervalo normal 0,82-1,18), con tiempo de protrombina normal. Un estudio de mezclas no logr\u00f3 una correcci\u00f3n del tiempo de tromboplastina parcial activado, lo que suger\u00eda presencia de un inhibidor que se identific\u00f3 correctamente como dirigido al factor VIII (FVIII < 1%, valor de inhibidor 25 unidades de Bethesda [UB]). Se estableci\u00f3 un diagn\u00f3stico de hemofilia A adquirida (HAA) idiop\u00e1tica. (90 \u00b5g/kg cada 3 horas hasta detenci\u00f3n de la hemorragia) y prednisona y ciclofosfamida por v\u00eda oral (1 mg/kg por d\u00eda durante 4 semanas, luego disminuci\u00f3n progresiva), con una remisi\u00f3n completa en el d\u00eda +21. Tras un per\u00edodo de 9 a\u00f1os en buen estado de salud, con pruebas de coagulaci\u00f3n normales efectuadas cada 6 meses, el paciente ingres\u00f3 nuevamente en el hospital municipal de Mantua en marzo de 2020 a causa de fiebre (38,7 \u00b0C), tos, astenia y dificultad respiratoria de 3 d\u00edas de evoluci\u00f3n. El diagn\u00f3stico de enfermedad del coronavirus 2019 (COVID-19) qued\u00f3 confirmado mediante RT-PCR de frotis nasal. Una TAC tor\u00e1cica mostr\u00f3 neumon\u00eda intersticial bilateral. A causa de la presencia concomitante de un extenso hematoma en el tronco, se realiz\u00f3 un an\u00e1lisis de TTPa, que revel\u00f3 un tiempo prolongado (cociente 2,87). Nuevamente, se estableci\u00f3 un diagn\u00f3stico de HAA (FVIII < 1%, valor de inhibidor 19 UB) y el paciente fue tratado con la misma pauta antihemorr\u00e1gica e inmunosupresora, con remisi\u00f3n completa el d\u00eda +20. Adem\u00e1s, el paciente recibi\u00f3 antiv\u00edricos (lopinavir/ritonavir 400 mg dos veces al d\u00eda) y ventilaci\u00f3n mec\u00e1nica no invasiva con oxigenoterapia, a causa de la infecci\u00f3n de s\u00edndrome respiratorio agudo grave de coronavirus 2 (SARS-CoV-2), con resoluci\u00f3n de la enfermedad en el d\u00eda +14."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "32-year-old man, with no comorbidities or risk factors, admitted to our emergency department on day 14 after symptom onset with dry cough, asthenia, arthromyalgia, fever, and right pleuritic pain. A baseline electrocardiogram showed sinus rhythm, 97 bpm, normal PR interval (120\u00a0ms) and normal QRS complex (80\u00a0ms), aQRS 0\u00b0. QTc (Friderica) 415 mseg. Echocardiography was not performed but initial physical examination showed systemic blood pressure values of 136/79\u00a0mmHg, regular rhythm with no murmurs, present and symmetrical distal pulses, and no signs of deep vein thrombosis. Laboratory data showed elevated ferritin levels (615 ng/mL), C-reactive protein (CRP)\u00a0=\u00a03.6\u00a0mg/dL, and increased interleukin-6 (IL-6) (144.7 pg/mL). Coagulation studies: prothrombin time (PT) 12\u00a0seconds, international normalized ratio 1.1, partial thromboplastin time (aPTT) 28.2\u00a0seconds. Lupus anticoagulant testing was positive. Immunoglobulin G and immunoglobulin M anticardiolipin antibodies were also tested with a negative result. D-dimer levels were elevated up to 2460 ug/L and due to high suspicion of pulmonary thromboembolism, dual-energy pulmonary computed tomography (CT) angiography (CTPA) was performed. CTPA confirmed bilateral thromboembolism associated with multiple opacities compatible with viral pneumonia. Iodine map images showed a triangular peripheral pulmonary infarction The patient received therapy with hydroxychloroquine at a loading dose of 400\u00a0mg on the first day followed by a maintenance dose of 200\u00a0mg/d for the next 4 days. Azithromycin 500\u00a0mg/d for 3 days and enoxaparin 80\u00a0mg/12\u00a0h for 10 days were also prescribed. Throughout the admission, the patient showed clinical improvement with no respiratory support requirements, maintaining oxygen saturation levels around 97% to 99% on room air. On the 10th day after admission, 24 days after symptom onset, the patient was discharged with good health status and was asymptomatic. Given the positivity to lupus anticoagulant autoantibodies, thrombophilia testing will be performed in 3 months. A full-dose anticoagulation regimen (80\u00a0mg/12\u00a0h) was prescribed for 6 months.",
        "es": "Hombre de 32 a\u00f1os, sin enfermedades concomitantes ni factores de riesgo, ingresado en nuestro servicio de urgencias el d\u00eda 14 desde el inicio de los s\u00edntomas, con tos seca, astenia, artromialgia, fiebre y dolor pleural derecho. Un electrocardiograma basal mostr\u00f3 ritmo sinusal, 97 l.p.m., intervalo PR normal (120ms) y complejo QRS normal (80ms), aQRS 0\u00b0. QTc (Friderica) 415 ms. No se realiz\u00f3 ecocardiograma, pero la exploraci\u00f3n f\u00edsica inicial revel\u00f3 valor de presi\u00f3n arterial 136/79 mmHg, ritmo regular sin soplos, pulso distal presente y sim\u00e9trico y ausencia de signos de trombosis venosa profunda. Las pruebas anal\u00edticas mostraron valores elevados de ferritina (615 ng/mL), prote\u00edna C-reactiva (PCR) = 3,6 mg/dL y aumento de interleucina 6 (IL-6) (144,7 pg/mL). Estudios de coagulaci\u00f3n: tiempo de protrombina (PT) 12segundos, cociente internacional normalizado 1,1, tiempo de tromboplastina parcial (aPTT) 28,2segundos. La prueba para anticoagulante l\u00fapico fue positiva. Tambi\u00e9n se hicieron pruebas para anticuerpos anticardiolip\u00ednicos, inmunoglobulina G e inmunoglobulina M, con resultado negativo. Los valores de d\u00edmero D eran elevados, con 2460 ug/L y, a causa de la sospecha de tromboembolia pulmonar, se realiz\u00f3 una angiograf\u00eda pulmonar por TAC (APTC) de doble energ\u00eda. La APTC confirm\u00f3 la tromboembolia bilateral asociada a m\u00faltiples opacidades, compatible con neumon\u00eda v\u00edrica. El paciente recibi\u00f3 un tratamiento con hidroxicloroquina a una dosis inicial de 400 mg el primer d\u00eda, seguida de una dosis de mantenimiento de 200 mg/d\u00eda durante los siguientes cuatro d\u00edas. Tambi\u00e9n se le administr\u00f3 azitromicina a 500 mg/d\u00eda durante 3 d\u00edas y enoxaparina a 80 mg/12 h durante 10 d\u00edas. Durante el ingreso, el paciente mostr\u00f3 una mejora cl\u00ednica sin respiraci\u00f3n asistida y mantuvo una saturaci\u00f3n de ox\u00edgeno alrededor del 97% a 99% en aire ambiental. El d\u00eda 10 del ingreso, 24 d\u00edas despu\u00e9s del inicio de los s\u00edntomas, el paciente fue dado de alta en buen estado de salud y asintom\u00e1tico. Dada la positividad para autoanticuerpos de anticoagulante l\u00fapico, se realizar\u00e1 una prueba de trombofilia en 3 meses. Se le recet\u00f3 una pauta anticoagulante completa (80 mg/12 h) durante 6 meses."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "59-year-old woman, with a history of idiopathic hypertension (treated with ramipril 5\u00a0mg/d) and hypothyroidism (treated with levothyroxine 112\u00a0\u03bcg/d), without other risk factors or comorbidities, admitted to our hospital for 10 days with dry cough, myalgia, and fever. The baseline electrocardiogram showed sinus rhythm, 86 bpm, normal PR interval (131\u00a0ms) and normal QRS complex (93\u00a0ms), aQRS 0\u00b0. QTc (Friderica) 412\u00a0ms. Ecocardiography was not performed, but initial physical examination showed systemic blood pressure of 116/78\u00a0mmHg, regular rhythm, and present and symmetrical distal pulses, without signs of deep vein thrombosis. Laboratory data showed elevated ferritin levels (1127 ng/mL), CRP\u00a0=\u00a09.5\u00a0mg/dL, and increased serum IL-6 (75,60 pg/mL). Coagulation studies: prothrombin time (PT) 10.7\u00a0seconds, international normalized ratio 1.09, partial thromboplastin time (aPTT) 33.6\u00a0seconds. D-dimer at admission was 1320 ug/L. The patient received initial treatment with hydroxychloroquine at a loading dose of 400\u00a0mg/12\u00a0h on day 1 followed by a maintenance dose of 200\u00a0mg/12\u00a0h for 4 days. She was also prescribed azithromycin 500\u00a0mg/d for 5 days, anticoagulant prophylaxis with enoxaparin (40\u00a0mg/d), methylprednisolone 70\u00a0mg/d for 5 days, and a single intravenous dose of tocilizumab (400\u00a0mg). On day 9 after admission, the patient showed oxygen desaturation and reported chest pain. D-dimer elevation up to 6120 ug/L was observed (previous 1870 ug/L) and therefore, due to high suspicion of pulmonary thromboembolism, CTPA with dual-energy mode was obtained and confirmed a bilateral acute pulmonary thromboembolism associated with bilateral pulmonary opacities compatible with viral pneumonia. Iodine map images depicted a peripheral pulmonary infarction. A full anticoagulant regimen with enoxaparin 60\u00a0mg/12\u00a0h was added to the treatment from that day until discharge.",
        "es": "Mujer de 59 a\u00f1os con antecedentes de hipertensi\u00f3n idiop\u00e1tica (tratada con ramipril 5mg/d) e hipotiroidismo (tratado con levotiroxina 112 \u03bcg/d), sin otros factores de riesgo ni enfermedades concomitantes, fue ingresada en nuestro hospital con tos seca, mialgia y fiebre de 10 d\u00edas de evoluci\u00f3n. Un electrocardiograma basal mostr\u00f3 ritmo sinusal, 86 l.p.m., intervalo PR normal (131ms) y complejo QRS normal (93ms), aQRS 0\u00b0. QTc (Friderica) 412 ms. No se realiz\u00f3 ecocardiograma, pero la exploraci\u00f3n f\u00edsica inicial revel\u00f3 valor de presi\u00f3n arterial 116/78 mmHg, ritmo regular sin soplos, pulso distal presente y sim\u00e9trico y ausencia de signos de trombosis venosa profunda. Las pruebas anal\u00edticas mostraron valores elevados de ferritina (1127 ng/mL), prote\u00edna C-reactiva (PCR) = 9,5mg/dL y aumento de interleucina 6 (IL-6) (75,60 pg/mL). Estudios de coagulaci\u00f3n: Tiempo de protrombina (TP) 10,7segundos, cociente internacional normalizado 1,09, tiempo de tromboplastina parcial (TTPa) 33,6segundos. El d\u00edmero D al ingreso era de 1320 ug/L. La paciente recibi\u00f3 un tratamiento con hidroxicloroquina a una dosis inicial de 400 mg/12 h el primer d\u00eda, seguida de una dosis de mantenimiento de 200 mg/12 h durante los siguientes cuatro d\u00edas. Tambi\u00e9n se le recet\u00f3 azitromicina a 500 mg/d durante 5 d\u00edas, tratamiento preventivo anticoagulante con enoxaparina (40 mg/d), metilprednisolona a 70 mg/d durante 5 d\u00edas y una dosis \u00fanica i.v. El d\u00eda 9 de ingreso, la paciente present\u00f3 desaturaci\u00f3n de ox\u00edgeno y refiri\u00f3 dolor tor\u00e1cico. Se observ\u00f3 un aumento del d\u00edmero D a 6120 ug/L (antes 1870 ug/L) y, a causa de la sospecha de tromboembolia pulmonar, se realiz\u00f3 una APTC de doble energ\u00eda, que confirm\u00f3 una tromboembolia pulmonar bilateral aguda asociada a opacidades pulmonares bilaterales y compatible con neumon\u00eda v\u00edrica. Las im\u00e1genes de mapas de yodo mostraron un infarto pulmonar perif\u00e9rico. Se a\u00f1adi\u00f3 al tratamiento una pauta anticoagulante completa con enoxaparina a 60 mg/12 h desde ese d\u00eda hasta el alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An 83-year-old female nonsmoker presented to our hospital on March 12, 2020 with fevers, malaise, headache, dry cough, and dyspnea. She had a history of mild intermittent asthma, managed with an albuterol inhaler as needed, mitral valve prolapse with moderate to severe mitral regurgitation, and mild-moderate ulcerative colitis, which was well-controlled on oral budesonide (3 mg daily and being tapered), as well as maintenance-dose sulfasalazine (1500 mg twice daily). Her symptoms had started approximately two weeks prior to presentation, shortly after travel from Florida to Massachusetts, and had failed to improve with courses of azithromycin and amoxicillin-clavulanate. In the emergency department, she had a fever of 39.3\u00b0C and oxygen saturation of 86% on room air, which improved to 95% on 5 liters per minute (L/min) of supplemental oxygen by nasal cannula. Initial laboratory evaluation revealed leukocytosis and relative lymphocytopenia (absolute lymphocyte count 1090 cells/microL). Chest computed tomography (CT) was notable for diffuse bilateral ground glass opacities with patchy bands of atelectasis and small nodular foci of consolidation with a distribution suggestive of a viral pneumonia. Subtle cystic changes were also seen in the affected regions. She was admitted to the medical intensive care unit (ICU) and placed on strict isolation precautions given concern for community acquired SARS-CoV-2. She developed worsening tachypnea with a respiratory rate of 40 breaths per minute, and hypoxia with an oxygen saturation of 80% requiring supplemental oxygen through a non-rebreather mask at a rate of 15 L/min. An arterial blood gas showed a partial pressure of arterial oxygen (PaO2) of 63 mm Hg on 15 L/min of supplemental oxygen. She was intubated for hypoxemic respiratory failure and supported on low tidal volume ventilation according to the Acute Respiratory Distress Syndrome (ARDS) Network lower tidal volume protocol. Her PaO2/FiO2 (ratio of the PaO2 to the fraction of inspired oxygen [FiO2]) was consistent with moderate ARDS.A broad infectious work-up for viral, bacterial, and fungal organisms confirmed the diagnosis of SARS-CoV-2 infection, based on positive detection for the presence of SARS-CoV-2 RNA from a nasopharyngeal swab. In addition, a serum (1,3)-\u03b2-D-glucan level was markedly elevated at 305 pg/mL (reference value <80 pg/mL), prompting additional testing for P.jirovecii with a qualitative real-time PCR assay from a tracheal aspirate, which was positive (fluorescent value 0.160 at melting temperature [Tm] 62.4\u00b0C; minimum fluorescent signal intensity for positive test \u22650.020). Notably, she had no apparent clinical characteristics associated with false positive (1,3)-\u03b2-D-glucan measurements, such as exposure to hemodialysis membranes, intravenous immunoglobulin, albumin,gauze packing, or intravenous \u03b2-lactam antibiotics. Human immunodeficiency virus (HIV)-1/2 antibody/antigen testing was non-reactive. However, a CD4+ T lymphocyte count was low at 291 cells/microL (reference value 441-2156 cells/microL) as was the CD4+/CD8+ ratio (1.18; reference value 1.20-5.30). She was treated with trimethoprim sulfamethoxazole (TMP-SMX) and successfully extubated on hospital day 7. A follow up serum (1,3)-\u03b2-D-glucan level obtained one week after initiating treatment was significantly reduced (90 pg/mL). Moreover, a follow-up CD4+ T lymphocyte count obtained ten days after initial presentation demonstrated improvement (730 cells/microL).",
        "es": "Una mujer de 83 a\u00f1os, no fumadora, acudi\u00f3 a nuestro hospital el 12 de marzo de 2020 con fiebre, malestar general, cefalea, tos seca y disnea. Ten\u00eda antecedentes de asma leve intermitente, tratada con inhalador de albuterol a demanda, prolapso de la v\u00e1lvula mitral con insuficiencia mitral entre moderada y grave y colitis ulcerosa, adecuadamente controlada con budesonida por v\u00eda oral (3 mg/d\u00eda con disminuci\u00f3n progresiva) y sulfasalazina de mantenimiento (1500 mg dos veces al d\u00eda). Sus s\u00edntomas se hab\u00edan iniciado unas dos semanas antes de la primera consulta, poco despu\u00e9s de un viaje de Florida a Massachusetts, y no hab\u00edan mejorado con azitromicina y amoxicilina/clavulanato. En urgencias, ten\u00eda fiebre de 39,3 \u00b0C y saturaci\u00f3n de 86% en aire ambiental, que mejor\u00f3 a 95% con oxigenoterapia mediante c\u00e1nula nasal a 5 litros por minuto. Las pruebas anal\u00edticas iniciales mostraron leucocitosis y linfocitopenia relativa (cifra absoluta de linfocitos 1090 c\u00e9lulas/microlitro). Una TAC tor\u00e1cica fue destacable por opacidades de vidrio esmerilado bilaterales difusas, con bandas parcheadas de atelectasia y peque\u00f1os n\u00facleos nodulares de consolidaci\u00f3n, con una distribuci\u00f3n que suger\u00eda neumon\u00eda v\u00edrica. Tambi\u00e9n se apreciaron ligeras alteraciones qu\u00edsticas en las regiones afectadas. Fue ingresada en la unidad de cuidados intensivos (UCI) y se la puso bajo aislamiento estricto, teniendo en cuenta una posible infecci\u00f3n extrahospitalaria por SARS-CoV-2. Present\u00f3 un empeoramiento de la taquipnea con frecuencia respiratoria de 40 r.p.m. e hipoxia con una saturaci\u00f3n de ox\u00edgeno de 80%, que requiri\u00f3 oxigenoterapia por medio de una mascarilla con reservorio a un ritmo de 15 L/min. La gasometr\u00eda arterial dio una presi\u00f3n parcial de ox\u00edgeno arterial (PaO2) de 63 mm Hg con oxigenoterapia a 15 L/min. Se intub\u00f3 a la paciente a causa de insuficiencia respiratoria hipox\u00e9mica y se mantuvo en respiraci\u00f3n asistida con el protocolo de bajo volumen corriente ARDSNet. Su PaO2/FiO2 (cociente entre PaO2 y la fracci\u00f3n de ox\u00edgeno inspirado [FiO2]) era coherente con una SDRA moderada. Adem\u00e1s, el valor de (1,3)-\u03b2-D-glucano s\u00e9rico era claramente alto, con 305 pg/mL (valor de referencia < 80 pg/mL), lo que implic\u00f3 pruebas adicionales para P. jirovecii mediante PCR cualitativa en tiempo real a partir de un aspirado traqueal, que result\u00f3 positivo (valor de fluorescencia 0,160 a la temperatura de fusi\u00f3n [Tm] 62,4 \u00b0C; intensidad m\u00ednima de la se\u00f1al de fluorescencia para resultado positivo \u2265 0,020). Adem\u00e1s, no mostraba rasgos cl\u00ednicos aparentes asociados con un falso positivo en la determinaci\u00f3n del (1,3)-\u03b2-D-glucano, como exposici\u00f3n a membranas de hemodi\u00e1lisis, inmunoglobulina intravenosa, ap\u00f3sitos de alb\u00famina o antibi\u00f3ticos betalact\u00e1micos intravenosos. La prueba de anticuerpos/ant\u00edgenos del virus de la inmunodeficiencia humana (VIH)-1/2 fue negativa. Sin embargo, el recuento de linfocitos T CD4+ era bajo, con 291 c\u00e9lulas/microlitro (valor de referencia 441-2156 c\u00e9lulas/microlitro), as\u00ed como la proporci\u00f3n CD4+/CD8+ (1,18; valor de referencia 1,20-5,30). Se trat\u00f3 a la paciente con trimetoprima/sulfametoxazol (TMP/SMX) y se extub\u00f3 el d\u00eda 7 de hospitalizaci\u00f3n. El valor de (1,3)-\u03b2-D-glucano s\u00e9rico obtenido una semana despu\u00e9s de iniciar el tratamiento se hab\u00eda reducido significativamente (90 pg/mL). Adem\u00e1s, el recuento de linfocitos T CD4+ diez d\u00edas despu\u00e9s de la consulta inicial mostr\u00f3 una mejora (730 c\u00e9lulas/microlitro)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "On March 17, a 48-year-old man visited the Emergency Department, Policlinico Hospital of Bari, Puglia region (Italy), with fever, cough and shortness of breath, hyporexia for 6\u00a0days. Physical examination revealed normal vital signs but because of 90% oxygen saturation on ambient air, the patient was promptly treated with O2 6\u00a0lt/min (Venturi Mask 31%). The patient did not report any underlying medical condition such as diabetes, hypertension, or cardiovascular disease. For the suspicion of COVID-19, he was immediately admitted to the \u201cgrey zone\u201d of internal medicine, at the \u201cAsclepios\u201d COVID-Hospital, Policlinico. The chest X-ray showed a pneumonia (bilateral multiple thickenings with badly defined margins with consolidation aspects more evident on the right side). The real-time PCR on the nasopharyngeal swab collected on March 18 revealed the presence of SARS-CoV-2. The virus was detected by a real-time PCR assay targeting E-gene, RdRP-gene and N-gene. The patient had a severe form of the disease due to the presence of fever, respiratory symptoms, radiological signs of pneumonia and PaO2/FiO2\u2009<\u2009300\u00a0mmHg. He was treated with O2 at different volumes (up to 60% FiO2 VM), lopinavir/ritonavir (200/50\u00a0mg, 2 tablets\u00a0\u00d7\u00a02/day), hydroxychloroquine (400\u00a0mg b.i.d on the first day, and 200\u00a0mg b.i.d afterwards), enoxaparin 6000\u00a0IU b.i.d., methylprednisolone (starting dose 40\u00a0mg b.i.d, lately tapered). At the checkup after 6\u00a0days, the chest X-ray showed a slight improvement involvement. After 14\u00a0days the patients became afebrile and his respiratory symptoms disappeared. The chest X-ray showed only blurred areas of parenchymal thickening. Our hospital required two consecutive negative SARS-CoV-2 molecular tests, plus normal body temperature, resolution of respiratory symptoms, with the improvement of lung imaging. The two nasopharyngeal swabs collected on March 30 and 31 were both negative for SARS-CoV-2 infection. The patient was therefore discharged and encouraged to maintain home quarantine for at least 14\u00a0days. The molecular test was also negative at his follow-up visit on April 15, suggesting that the patient was cured from COVID-19. In addition, two serological assays (VivaDiag\u2122, VivaChek Laboratories, INC, USA and Anti SARS-CoV-2 ELISA IgG Test, Euroimmun, Lubeck, Germany) revealed the presence of IgM and IgG anti-SARS-CoV-2. However, on April 30, he developed new symptoms, dyspnea and chest pain. He visited again the Emergency Department where he was re-admitted to the same ward with a suspicion of a pulmonary embolism that was confirmed by CT scan. The imaging showed the presence of segmental and sub-segmental signs of arterial microembolism with some parcel area of ground glass. Because of his recent clinical history, a SARS-CoV-2 molecular test was performed and proved to be positive. Moreover, serological assay revealed the presence of only IgG anti-SARS-CoV-2. To date, the patient is well, on anticoagulant therapy and does not require O2 supplementation.",
        "es": "El 17 de marzo, un hombre de 48 a\u00f1os acudi\u00f3 al servicio de urgencias del Hospital Policl\u00ednico de Bari (Pulla, Italia), con fiebre, tos, disnea e hiporexia de 6 d\u00edas de evoluci\u00f3n. A la exploraci\u00f3n f\u00edsica mostr\u00f3 constantes vitales normales, pero a causa de una saturaci\u00f3n del 90% en aire ambiental, se le aplic\u00f3 oxigenoterapia a 6 litros por minuto (mascarilla de Venturi 31%). El paciente no refiri\u00f3 ninguna enfermedad preexistente, como diabetes, hipertensi\u00f3n o enfermedades cardiovasculares. A causa de la sospecha de COVID-19, fue ingresado inmediatamente en la \u00abzona gris\u00bb de medicina interna en el Hospital Policl\u00ednico para COVID \u00abAsclepios\u00bb. La radiograf\u00eda tor\u00e1cica mostr\u00f3 neumon\u00eda (m\u00faltiples engrosamientos bilaterales con bordes mal definidos y consolidaci\u00f3n m\u00e1s evidente en el lado derecho). La PCR en tiempo real de frotis nasofar\u00edngeo recogido el 18 de marzo revel\u00f3 la presencia de SARS-CoV-2. El virus se detect\u00f3 mediante una prueba de PCR en tiempo real dirigida a los genes E, RdRP y N. El paciente presentaba una forma grave de la enfermedad debido a la presencia de fiebre, s\u00edntomas respiratorios, signos radiol\u00f3gicos de neumon\u00eda y PaO2/FiO2\u2009<\u2009300mmHg. Se trat\u00f3 con ox\u00edgeno a varios vol\u00famenes (hasta 60% FiO2 VM), lopinavir/ritonavir (200/50 mg, 2 comprimidos \u00d72/d\u00eda), hidroxicloroquina (400 mg dos veces al d\u00eda en primer d\u00eda y 200 mg dos veces al d\u00eda en los siguientes), enoxaparina (600 UI dos veces al d\u00eda) y metilprednisolona (dosis inicial 40 mg dos veces al d\u00eda, luego disminuci\u00f3n progresiva). En la revisi\u00f3n tras 6 d\u00edas, la radiograf\u00eda tor\u00e1cica evidenci\u00f3 una ligera mejora de las afectaciones. Tras 14 d\u00edas, el paciente se mostr\u00f3 afebril y sus s\u00edntomas respiratorios desaparecieron. La radiograf\u00eda tor\u00e1cica solo revel\u00f3 \u00e1reas difusas de engrosamiento parenquimatoso. Nuestro hospital exig\u00eda dos pruebas moleculares negativas consecutivas de SARS-CoV-2, m\u00e1s temperatura normal, resoluci\u00f3n de los s\u00edntomas respiratorios y mejora de las im\u00e1genes pulmonares. Los dos frotis nasofar\u00edngeos recogidos los d\u00edas 30 y 31 de marzo fueron ambos negativos para la infecci\u00f3n por SARS-CoV-2. En consecuencia, el paciente fue dado de alta y se le recomend\u00f3 mantener cuarentena domiciliaria durante un m\u00ednimo de 14 d\u00edas. Las pruebas moleculares tambi\u00e9n fueron negativas en su visita de seguimiento el 15 de abril, lo que suger\u00eda que el paciente se hab\u00eda curado de la COVID-19. Adem\u00e1s, dos pruebas serol\u00f3gicas (VivaDiag\u2122, VivaChek Laboratories, INC, EE. UU., y Anti SARS-CoV-2 ELISA IgG Test, Euroimmun, L\u00fcbeck, Alemania) revelaron presencia de IgM e IgG anti-SARS-CoV-2. Sin embargo, el 30 de abril present\u00f3 nuevos s\u00edntomas, con disnea y dolor tor\u00e1cico. Acudi\u00f3 nuevamente al servicio de urgencias, donde se le ingres\u00f3 en la misma sala, con sospecha de embolia pulmonar, confirmada mediante TAC. La imagen mostraba la presencia de signos segmentarios y subsegmentarios de microembolia arterial, con algunas zonas de opacidades en vidrio esmerilado. A causa de sus antecedentes cl\u00ednicos recientes, se realiz\u00f3 una prueba molecular de SARS-CoV-2, con resultado positivo. Adem\u00e1s, las pruebas serol\u00f3gicas revelaron la presencia solamente de IgG anti-SARS-CoV-2. Hasta la fecha, el paciente se halla en buen estado de salud, con anticoagulantes y sin necesidad de oxigenoterapia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An otherwise healthy 60-year-old man presented to the Emergency Department for a severealteration of consciousness. According to the relatives, the symptoms started five days earlier with the development of progressive irritability, confusion and asthenia followed two days later by fever, cough and cognitive fluctuations. At admission, his vital parameters were within the normal ranges and his body temperature was 36.8 \u00b0C. Oxygen saturation was within normal limits with a slight reduction of the arterial partial pressure of oxygen (Sp02 73 mmHg). The patient showed a severe akinetic syndrome associated to mutism; he was uncooperative and unable to carry out even simple orders if not stimulated. A positive palmomental and glabella reflexes with moderate nuchal rigidity was detected with no focal signs at the neurological examination. Blood analyses revealed normal blood cell counts, increased D-dimer (968 ng/mL) but normal levels of CRP, fibrinogen and ferritin. Chest x-ray showed moderate bilateral interstitial pneumonia. Based on the history, the radiological findings and the Covid-19 outbreak in the region, a real-time reverse transcriptase-polymerase chain reaction assays (RT-PCR) on nasopharyngeal swab was performed and confirmed a SARS-CoV-2 infection. Antiviral therapy with Lopinavir/Ritonavir 400/100 mg BID and hydroxychloroquine 200 mg BID was started. A brain CT scan was unremarkable, and the patient was hospitalized. At admission, a lumbarpuncture was performed, and CSF showed inflammatory findings with mild lymphocyticpleocytosis (18/uL) and moderate increase of CSF protein (69.6 mg/dL). The analysis ofneurotropic viruses (HSV-1, HSV-2, HSV-6, HSV-8, EBV, VZV, Adenovirus and Enterovirus) was negative. CSF RT-PCR for SARS-CoV-2 was also negative. An electroencephalography (EEG) exhibited generalized slowing with decreased reactivity to acoustic stimuli. The same day an empirical treatment of ampicillin and acyclovir was introduced. The day after, the magnetic resonance imaging (MRI) with gadolinium contrast did not reveal any significant alterations or contrast-enhanced areas within the brain and/or meninges. Three days after admission, given the persistence of clinical symptoms, high-dose intravenous steroid treatment was started (methylprednisolone 1 g/day for five days). CSF analyses, carried out one day after steroid administration, showed lymphocytic pleocytosis (18/uL), hyperproteinorrachia (127.2 mg/dL) and normal Link index without oligoclonal bands. CSF RT-PCR for SARS-CoV-2 was still negative. At this time, CSF analyses revealed relatively slightly increased levels of interleukin 6 (IL-6) of 2.36 pg/mL, strongly increased levels of interleukin 8 (IL-8, higher than 1100 pg/mL) and increased levels of tumor necrosis factor alpha (TNF-\u03b1, 1.31 pg/mL) and \u03b22-microglobulin (\u03b22M, 3.06 mg/L). Biomarkers for neuronal injury (tau and neurofilament light [NfL]) were normal. After the first infusion, the patient improved- He became alert and able toexecute simple tasks on command and to repeat single words. The following days, the patient was able to talk and to answer simple questions. Once the five days-high dose steroid therapy ended, he displayed only mild disinhibition and somewhat fluctuating alertness. A follow-up MRI (9 days post-admission) was normal while serial EEG revealed improvement and normalization of reactivity and slowing. A wide immunological screening of immunemediated encephalitis (antibodies against NMDAR, LGI1, CASPR2, GABAAR, GABABR and AMPAR, Ri, Yo, Ma2, Hu and amphiphysin) was negative, as well as anti-thyroglobulin, antithyroid peroxidase and anti-MOG antibodies. Ten days after the admission, CSF protein concentrations decreased (91.4 mg/dL), but lymphocytic pleocytosis (38 cells/uL) increased. CSF IL-8 and TNF-\u03b1 decreased to 97 pg/mL and 0.28 pg/mL, respectively, whereas IL-6 and \u03b22-microglobulin values were stable. CSF tau and NfL concentrations remained normal. Given the remaining neuroinflammatory changes, oral prednisone was started with progressive tapering. At discharge, eleven days after admission, the patient presented normal neurological examination.",
        "es": "Un hombre de 60 a\u00f1os, por lo dem\u00e1s sano, acudi\u00f3 al servicio de urgencias con una grave alteraci\u00f3n de la conciencia. Seg\u00fan sus familiares, los s\u00edntomas empezaron cinco d\u00edas antes, con irritabilidad progresiva, desorientaci\u00f3n y astenia, seguidos, dos d\u00edas despu\u00e9s, de fiebre, tos y altibajos cognitivos. Al ingreso, sus constantes vitales se hallaban dentro de los valores normales y su temperatura era de 36,8 \u00b0C. La saturaci\u00f3n de ox\u00edgeno estaba dentro de los l\u00edmites normales, con una ligera reducci\u00f3n de la presi\u00f3n parcial de ox\u00edgeno arterial (SpO2 73 mmHg). El paciente mostr\u00f3 un grave s\u00edndrome de mutismo acin\u00e9tico; no se mostr\u00f3 colaborador y era incapaz de llevar a cabo \u00f3rdenes simples si no se le estimulaba. A la exploraci\u00f3n neurol\u00f3gica, se detectaron reflejos positivos palmomentoniano y glabelar con rigidez de nuca moderada, sin signos focales. Los an\u00e1lisis de sangre revelaron cifras normales de gl\u00f3bulos sangu\u00edneos, un aumento del d\u00edmero D (968 ng/mL) y valores normales de prote\u00edna C-reactiva, fibrin\u00f3geno y ferritina. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 neumon\u00eda intersticial bilateral moderada. A partir de los antecedentes, los resultados radiol\u00f3gicos y el brote de COVID-19 en la regi\u00f3n, se realiz\u00f3 una prueba mediante RT-PCR en tiempo real a partir de un frotis nasofar\u00edngeo, que confirm\u00f3 la infecci\u00f3n por SARS-CoV-2. Se inici\u00f3 una terapia antiv\u00edrica con lopinavir/ritonavir 400/100 mg dos veces al d\u00eda e hidroxicloroquina 200 mg dos veces al d\u00eda. Una TAC craneal no dio resultados relevantes y se hospitaliz\u00f3 al paciente. Al ingreso, se realiz\u00f3 una punci\u00f3n lumbar; el LCR mostr\u00f3 evidencias de inflamaci\u00f3n con pleocitosislinfoc\u00edtica leve (18/uL) y una proteinorraquia moderada (69,6 mg/dL). El an\u00e1lisis devirus neurotr\u00f3picos (VHS-1, VHS-2, VHS-6, VHS-8, VEB, VVZ, adenovirus y enterovirus) result\u00f3 negativo. La RT-PCR del LCR para detecci\u00f3n de SARS-CoV-2 tambi\u00e9n fue negativa. Un electroencefalograma (EEG) revel\u00f3 un enlentecimiento generalizado con disminuci\u00f3n de la reactividad a est\u00edmulos ac\u00fasticos. El mismo d\u00eda se inici\u00f3 un tratamiento sintom\u00e1tico de ampicilina y aciclovir. El d\u00eda siguiente, la RMN con contraste de gadolinio no mostr\u00f3 alteraciones significativas ni \u00e1reas con realce de contraste en el cerebro o las meninges. Tres d\u00edas despu\u00e9s del ingreso, dada la persistencia de los s\u00edntomas cl\u00ednicos, se inici\u00f3 un tratamiento de alta dosis de esteroides i.v. (metilprednisolona 1 g/d\u00eda durante 5 d\u00edas). Los an\u00e1lisis de LCR, realizados un d\u00eda despu\u00e9s de la administraci\u00f3n de esteroides, mostraron pleocitosis linfoc\u00edtica (18/uL), hiperproteinorraquia (127,2 mg/dL) e \u00edndice de Link normal sin bandas oligocl\u00f3nicas. La RT-PCR del LCR para detecci\u00f3n de SARS-CoV-2 segu\u00eda siendo negativa. En este momento, los an\u00e1lisis de LCR revelaron valores ligeramente elevados de interleucina 6 (IL-6), con 2,36 pg/mL, fuerte aumento de interleucina 8 (IL-8, superior a 1100 pg/mL) y valores elevados de factor de necrosis tumoral alfa (TNF-\u03b1, 1,31 pg/mL) y microglobulina \u03b22 (\u03b22M, 3,06 mg/L). Los biomarcadores de lesiones neuronales (tau y neurofilamento ligero) eran normales. Tras la primera infusi\u00f3n, el paciente mejor\u00f3. Se mostr\u00f3 alerta y capaz de ejecutar tareas simples siguiendo \u00f3rdenes y repetir palabras individuales. Los d\u00edas siguientes, el paciente pudo hablar y responder a preguntas sencillas. Al finalizar los cinco d\u00edas de alta dosis de esteroides, solo mostr\u00f3 una ligera desinhibici\u00f3n y un estado de alerta fluctuante. Una RMN de seguimiento (9 d\u00edas despu\u00e9s del ingreso) result\u00f3 normal, mientras que el EEG seriado revel\u00f3 mejora y normalizaci\u00f3n de la reactividad y el enlentecimiento. Una prueba inmunol\u00f3gica extensiva de encefalitis inmunitaria (anticuerpos frente a NMDAR, LGI1, CASPR2, GABAAR, GABABR y AMPAR, Ri, Yo, Ma2, Hu y anfifisina) result\u00f3 negativa, as\u00ed como anticuerpos antitiroglobul\u00ednicos, antiperoxidasa tiroidea y anti-GMO. Diez d\u00edas despu\u00e9s del ingreso, la proteinorraquia disminuy\u00f3 (91 mg/dL), pero la pleocitosis linfoc\u00edtica aument\u00f3 (38 c\u00e9lulas/uL). IL-8 y TNF-\u03b1 en LCR disminuyeron a 97 pg/mL y 0,28 pg/mL, respectivamente, mientras que los valores de IL-6 y microglobulina \u03b22 permanecieron estables. Las concentraciones raqu\u00eddeas de tau y neurofilamentos ligeros permanecieron normales. Teniendo en cuenta los cambios neuroinflamatorios restantes, se inici\u00f3 tratamiento con prednisona por v\u00eda oral, con disminuci\u00f3n progresiva. Al alta, once d\u00edas despu\u00e9s del ingreso, la exploraci\u00f3n neurol\u00f3gica fue normal."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 5-month-old boy had been diagnosed with heart failure and mucopolysaccharidosis type I-Hurler syndrome at age 1\u00a0month. When the patient was 5 months old, he was hospitalized after a 24-hour course of irritability, low-grade fever (below 38\u00a0C), cough, runny nose, and vomiting. He showed pallor, slight respiratory distress, and bibasal pulmonary subcrackles. Chest X-ray showed cardiomegaly without consolidations. An electrocardiogram showed sinus rhythm at 160\u00a0bpm and biventricular hypertrophy. The last echocardiogram performed 2 weeks before admission showed left ventricular dilation with left ventricular end diastolic diameter 39\u00a0mm Z\u00a0+\u00a07.3 EF\u00a030%, and longitudinal global strain \u2212\u00a010%. Leukocyte count was 21 400/mm3 with 12\u00a0890/mm3 neutrophils, and C-reactive protein 36\u00a0mg/L. Treatment was started with fluid restriction and conventional oxygen therapy (1-2 LPM). COVID-19 disease was suspected and SARS-CoV-2 polymerase chain reaction was positive. Captopril was withdrawn in the emergency room prior to confirmation of the diagnosis. At 24\u00a0hours after admission, the patient was stable without oxygen therapy. After 48\u00a0hours, there was an increase in bilateral pulmonary crackles and palpebral edema. He had low-grade fever without analytical impairment, so it was interpreted as worsening heart failure with good response to diuretic treatment. However, 72\u00a0hours after admission, he had high fever (39.6\u00a0C) and respiratory distress, and chest X-ray revealed extensive symmetric parahilar consolidations that extended to the paracardiac region and pulmonary base on the left side. Blood testing showed no lymphopenia (2540/\u03bcL), C-reactive protein 244\u00a0mg/L, and D-dimer 973\u00a0ng/mL. Blood culture was negative. Hydroxychloroquine and ceftriaxone were prescribed, and remdesivir requested, but 2\u00a0hours later the patient had a cardiac arrest, requiring intubation. After admission to the pediatric intensive care unit, he had a second cardiac arrest, which proved fatal.",
        "es": "Ni\u00f1o de 5 meses hab\u00eda sido diagnosticado de insuficiencia card\u00edaca y mucopolisacaridosis de tipo I H (s\u00edndrome de Hurler) cuando ten\u00eda 1 mes. A los 5 meses de edad, el paciente fue hospitalizado tras un cuadro de 24 horas de irritabilidad, febr\u00edcula (por debajo de 38 C), tos, rinorrea y v\u00f3mitos. Mostr\u00f3 palidez, una ligera dificultad respiratoria y subcrepitantes pulmonares bibasales. La radiograf\u00eda tor\u00e1cica mostr\u00f3 cardiomegalia sin consolidaciones. Un electrocardiograma revel\u00f3 ritmo sinusal a 160l.p.m. e hipertrofia biventricular. El \u00faltimo ecocardiograma realizado 2 semanas antes del ingreso mostr\u00f3 dilataci\u00f3n ventricular izquierda con un di\u00e1metro telediast\u00f3lico del ventr\u00edculo izquierdo de 39mm Z+7,3 FE30% y deformaci\u00f3n global longitudinal \u221210%. La cifra de leucocitos era de 21.400/mm3 con 12.890/mm3 neutr\u00f3filos y prote\u00edna C-reactiva 36mg/L. Se inici\u00f3 tratamiento con restricci\u00f3n h\u00eddrica y oxigenoterapia convencional (1-2 LPM). Se sospechaba infecci\u00f3n por COVID-19 y una prueba de PCR para SARS-CoV-2 dio resultado positivo. En urgencias se retir\u00f3 el captopril antes de la confirmaci\u00f3n del diagn\u00f3stico. A las 24 horas del ingreso, el paciente se encontraba estable sin oxigenoterapia. Tras 48 horas, se apreci\u00f3 un aumento de los crepitantes pulmonares bilaterales y edema palpebral. Ten\u00eda febr\u00edcula sin afectaci\u00f3n anal\u00edtica, que se interpret\u00f3 como un empeoramiento de insuficiencia cardiaca con buena respuesta al tratamiento diur\u00e9tico. Sin embargo, a las 72 horas del ingreso, present\u00f3 fiebre alta (39,6 C) y dificultad respiratoria; la radiograf\u00eda tor\u00e1cica mostr\u00f3 extensas consolidaciones parahiliares sim\u00e9tricas que llegaban a la regi\u00f3n paracard\u00edaca y a la base pulmonar izquierda. Los an\u00e1lisis de sangre no mostraron linfocitopenia (2540/\u03bcL), el valor de prote\u00edna C-reactiva era de 244mg/L y el de d\u00edmero D, 973ng/mL. Se recet\u00f3 hidroxicloroquina y ceftriaxona, y se solicit\u00f3 remdesivir, pero 2 horas despu\u00e9s el paciente sufri\u00f3 un paro card\u00edaco que requiri\u00f3 intubaci\u00f3n. Tras ingreso en la unidad de cuidados intensivos pedi\u00e1trica, sufri\u00f3 un segundo paro card\u00edaco que result\u00f3 mortal."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 36-year-old man was brought to the emergency department with suspected SARS-CoV2 infection, presenting with a 3-week history of a dry cough, fevers and shortness of breath. He reported significantly worsening breathlessness in the previous 4\u2009hours with associated left-sided pleuritic chest pain. His medical history was significant only for childhood asthma, and a 10 pack-year history of smoking. He had no history of recent trauma or previous pneumothoraces. The patient worked as a courier and had previously held roles in domestic cleaning. The patient was seen in a resuscitation cubicle with attending staff in full personal protective equipment. On presentation, the patient was significantly hypoxaemic, with an SpO2 of 88%\u201390% on 15\u2009L/min of oxygen via non-rebreathe mask, a respiratory rate of 50 breaths per minute, using accessory muscles of respiration and tachycardic with a regular heart rate of 150 beats/min. His trachea remained central, with a jugular venous pressure 3\u2009cm above the sternal angle and a blood pressure of 110/65\u2009mm Hg. On auscultation, breath sounds were absent throughout the left hemithorax with associated reduced vocal fremitus and asymmetrical chest expansion.A portable anteroposterior chest radiograph was performed demonstrating a large left-sided pneumothorax with mediastinal shift and radiological signs of tension. The right lung while compressed displayed signs of severe COVID-19, that is, widespread patchy consolidative changes.The patient\u2019s full blood count demonstrated a raised white cell count (13.64\u00d7109/L) with a neutrophilia (8.91\u00d7109/L), lymphocyte count (3.81\u00d7109/L), haemoglobin (146\u2009g/L), and platelets (1051\u00d7109/L); biochemical markers demonstrated a raised C-reactive protein (28.7\u2009mg/L) and alanine aminotransferase (107\u2009IU/L). These findings supported the possibility of superimposed bacterial infection on a background of COVID-19. A 12-lead ECG showed a sinus tachycardia at 155 beats/min. Lung ultrasound following definitive treatment demonstrated multiple confluence B-lines with pleural thickening bilaterally, in keeping with a diagnosis of COVID-19. A repeat chest radiograph was also performed, confirming lung re-expansion with extensive bilateral consolidation.The patient underwent thoracic CT the following day which demonstrated widespread areas of patchy consolidation, findings consistent with severe COVID-19 infection, with associated bullae. On review of the chest X-ray, the patient was treated with immediate emergency needle decompression of his pneumothorax with a 14-gauge cannula inserted in the second rib space and mid-clavicular line.Following initial decompression, a 12-French Seldinger chest drain was inserted into the patients left axilla.The treatment resulted in immediate improvement in respiratory and cardiovascular physiology with clinical and radiological evidence of lung re-expansion. Within an hour the patient\u2019s oxygen requirement reduced from 15\u2009L/min via a non-rebreathe mask, to 4\u2009L/min via nasal cannula, with normalisation of respiratory and heart rate.The patient was admitted to a COVID-19 ward, with full lung re-expansion and successful chest drain removal performed 2\u2009days later. His initial COVID-19 swab returned negative, however after review of the history and imaging by the infectious diseases team it was felt he very likely had COVID-19, and it was the delay in his presentation that resulted in a negative swab result. He was discharged 2\u2009days after this, and awaits outpatient follow-up with the respiratory team.",
        "es": "Un hombre de 36 a\u00f1os lleg\u00f3 al servicio de urgencias con presunta infecci\u00f3n por SARS-CoV-2 y antecedentes de tos seca, fiebre y disnea de tres semanas de evoluci\u00f3n. Refiri\u00f3 empeoramiento significativo de la disnea en las 4 horas previas, con dolor tor\u00e1cico pleural izquierdo. Sus antecedentes m\u00e9dicos solo eran relevantes por asma infantil y por ser fumador de 10 cajetillas-a\u00f1o. No ten\u00eda antecedentes de traumatismos recientes ni de neumot\u00f3rax previos. El paciente trabajaba como mensajero y hab\u00eda antes hab\u00eda realizado tareas de limpieza dom\u00e9stica. El paciente fue atendido en una sala de reanimaci\u00f3n y el personal llevaba equipo de protecci\u00f3n individual completo. Al ingreso, el paciente estaba claramente hipox\u00e9mico, con una SpO2 de 88%-90% en mascarilla con reservorio a 15 L/min, frecuencia respiratoria de 50 r.p.m., usando m\u00fasculos secundarios de la respiraci\u00f3n, y taquic\u00e1rdico con un pulso regular de 150 l.p.m. Su tr\u00e1quea permanec\u00eda central, con presi\u00f3n venosa yugular 3 cm por encima del \u00e1ngulo costal y presi\u00f3n arterial de 110/65 mmHg. A la auscultaci\u00f3n, no se apreciaron ruidos respiratorios en todo el hemit\u00f3rax izquierdo, con vibraciones vocales reducidas y expansi\u00f3n tor\u00e1cica asim\u00e9trica. Se realiz\u00f3 una radiograf\u00eda port\u00e1til tor\u00e1cica anteroposterior, que revel\u00f3 un gran neumot\u00f3rax izquierdo con desplazamiento mediast\u00ednico y signos radiol\u00f3gicos de tensi\u00f3n. El pulm\u00f3n derecho, comprimido, mostraba signos de COVID-19 grave; es decir, alteraciones consolidativas generalizadas parcheadas. El hemograma completo revel\u00f3 un aumento de leucocitos (13,64\u00d7109/L) con neutrofilia (8,91\u00d7109/L), cifra de linfocitos (3,81\u00d7109/L), hemoglobina (146\u2009g/L) y trombocitos (1051\u00d7109/L); los marcadores bioqu\u00edmicos mostraron un aumento de la prote\u00edna C-reactiva (28,7\u2009mg/L) y alanina-aminotransferasa (107\u2009IU/L). Estos resultados respaldaban la posibilidad de infecci\u00f3n bacteriana superpuesta a COVID-19. Un ECG de 12 derivaciones revel\u00f3 taquicardia sinusal a 155 l.p.m. Una ecograf\u00eda pulmonar tras el tratamiento definitivo mostr\u00f3 m\u00faltiples l\u00edneas B confluentes con engrosamiento pleural bilateral, coherentes con el diagn\u00f3stico de COVID-19. Una nueva radiograf\u00eda tor\u00e1cica confirm\u00f3 la reexpansi\u00f3n pulmonar con consolidaci\u00f3n bilateral extensa. El paciente se someti\u00f3 a una TAC tor\u00e1cica al d\u00eda siguiente, que mostr\u00f3 extensas \u00e1reas de consolidaci\u00f3n parcheada, resultado consistente con infecci\u00f3n grave por COVID-19, con bullas asociadas. Tras analizar los resultados radiol\u00f3gicos, el paciente se someti\u00f3 a una descompresi\u00f3n urgente de su neumot\u00f3rax con una c\u00e1nula del 14 insertada en el segundo espacio intercostal y la l\u00ednea medioclavicular. El tratamiento llev\u00f3 a una mejora inmediata de la actividad respiratoria y cardiovascular, con evidencia cl\u00ednica y radiol\u00f3gica de reexpansi\u00f3n pulmonar. Una hora despu\u00e9s, el requerimiento de ox\u00edgeno del paciente se redujo de 15 L/min con mascarilla con reservorio a 4 L/min mediante c\u00e1nula nasal, con normalizaci\u00f3n del pulso y la frecuencia respiratoria. Su frotis inicial de COVID-19 dio resultado negativo; sin embargo, tras revisar la evoluci\u00f3n y los resultados de diagn\u00f3stico por imagen, el equipo de enfermedades infecciosas consider\u00f3 muy probable la infecci\u00f3n por COVID-19, y que la demora del cuadro cl\u00ednico inicial dio como resultado una prueba negativa. Se le dio de alta dos d\u00edas despu\u00e9s y est\u00e1 a la espera de seguimiento ambulatorio con el equipo de neumolog\u00eda."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 56-year-old patient was admitted in our institution for an acute ischemic stroke due to the occlusion of the right middle cerebral artery. Angio-CT scan performed upon admission showed lesions suggestive of COVID-19, which was confirmed by specific SARS-CoV-2 PCR. The next day, the patient developed abdominal pain and vomiting. CT scan demonstrated a free-floating thrombus of the aortic arch associated with an occlusion of the superior mesenteric artery. There was no sign of aortic atherosclerosis. Absence of enhancement of part of the small bowel wall was also noted. The patient underwent endovascular thrombectomy and a laparotomy with the resection of two meters of the small bowel.",
        "es": "Paciente de 56 a\u00f1os ingresado en nuestra instituci\u00f3n a causa de un ictus isqu\u00e9mico provocado por oclusi\u00f3n de la arteria cerebral media derecha. Una angiotomograf\u00eda realizada al ingreso mostr\u00f3 lesiones indicativas de COVID-19; esta fue confirmada mediante PCR espec\u00edfica para SARS-CoV-2. Al d\u00eda siguiente, el paciente present\u00f3 dolor abdominal y v\u00f3mitos. Una TAC mostr\u00f3 un trombo libre en el cayado a\u00f3rtico, asociado a oclusi\u00f3n de la arteria mesent\u00e9rica superior. No hab\u00eda signos de ateroesclerosis a\u00f3rtica. Tambi\u00e9n se apreci\u00f3 falta de realce de parte del intestino delgado. El paciente se someti\u00f3 a tromboectom\u00eda endovascular y a laparotom\u00eda con resecci\u00f3n de dos metros del intestino delgado."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 52-year-old woman visited our dermatology clinic with itchy erythematous lesions onher limbs and erosions on her lips and buccal mucosa. She had no flu symptoms orfever. She had been treated at a dental clinic 3 days prior (Day -3) and given antibiotics(cefcapene pivoxil hydrochloride hydrate) and the NSAID loxoprofen sodium hydrate. Erythematous lesions and erosions on the lipsappeared 2 days later (Day -1). The skin lesions wereclinically diagnosed as a drug eruption (Day 0). Pathologic analysis of a skin biopsysample obtained from an indurated erythematous lesion on her leg revealedslight liquefaction with perivascular and periadnexal mixed cell infiltrations from thepapillary dermis to the deep subcutaneous tissue. Deep lymphocyticinfiltrations are not typical for drug eruptions. Lymphocyte stimulation tests wereperformed for cefcapene pivoxil hydrochloride hydrate (stimulation index [SI]: 151%)and loxoprofen sodium hydrate (SI: 300%). Oral prednisolone (20 mg/day) was startedimmediately to treat oral lesion worsening. On Day 2, well-demarcated infiltratederythema was observed on her trunk. The erosions of her lower lips and buccal mucosagradually improved. The prednisolone was reduced to 10 mg/day. Five days after decreasing the prednisolone (Day 7), she returned to our clinic with highfever, cough, chills, fatigue, and shortness of breath. She reported no travel history, butworked at a healthcare facility for elderly people. Computed tomography (CT) revealedslight ground glass opacity in the lower lung lobes. She was diagnosed with pneumonia and admitted to an isolation ward withsuspicion of COVID-19. Lymphocytopenia is a COVID-19 severity factor. Onadmission (Day 7), her erythematous lesions worsened precipitously. Serious infectionled us to discontinue the oral prednisolone, and ampicillin/sulbactam and clarithromycinwere administered. On Day 8, new macular papules and erythematous lesions appearedon her face and trunk with some petechiae. The biopsy specimen was taken froman indurated erythematous lesion on her abdominal skin. Pathologic analysis revealedinterface changes with liquefaction and perivascular mixed cell infiltrations includinghistiocytes and neutrophils in the papillary dermis. The ampicillin/sulbactamwas changed to levofloxacin. On Day 10, the erythematous lesions peaked andgradually pigmented. Polymerase chain reaction (PCR) analysis for COVID-19 on Day1 of admission was negative, but CT showed progression of the ground glass opacity. Repeat PCR for COVID-19 was positive on Day 3 of admission and the patient was\tdiagnosed with COVID-19 and transferred to an intensive care unit at another hospital.",
        "es": "Una mujer de 52 a\u00f1os acudi\u00f3 a nuestra cl\u00ednica dermatol\u00f3gica con lesiones prur\u00edticas eritematosas en las extremidades y abrasiones en los labios y mucosa bucal. No ten\u00eda s\u00edntomas gripales ni fiebre. Hab\u00eda sido tratada en una cl\u00ednica dental 3 d\u00edas antes (d\u00eda -3) y se le recetaron antibi\u00f3ticos (cefcapeno) y el AINE loxoprofeno. Las lesiones eritematosas y las abrasiones de los labios aparecieron dos d\u00edas despu\u00e9s (d\u00eda -1). Las lesiones cut\u00e1neas se diagnosticaron como erupci\u00f3n farmacol\u00f3gica (d\u00eda 0). El an\u00e1lisis anatomopatol\u00f3gico de una biopsia de piel obtenida de una lesi\u00f3n eritematosa endurecida de la pierna revel\u00f3 una ligera licuefacci\u00f3n con infiltraciones celulares mixtas perivasculares y perianexiales desde la dermis papilar hasta la hipodermis profunda. Las infiltraciones linfocitarias profundas no son habituales en erupciones farmacol\u00f3gicas. Se realizaron pruebas de estimulaci\u00f3n linfocitaria para cefcapeno (\u00edndice de estimulaci\u00f3n: 151%) y loxoprofeno (\u00edndice de estimulaci\u00f3n: 300%). Se inici\u00f3 inmediatamente una pauta de prednisolona por v\u00eda oral (20 mg/d\u00eda) para tratar el empeoramiento de las lesiones bucales. El d\u00eda 2 se observ\u00f3 un eritema infiltrado bien delimitado en el tronco. Las abrasiones de los labios inferiores y la mucosa bucal mejoraron gradualmente. Se redujo la prednisolona a 10 mg/d\u00eda. Cinco d\u00edas despu\u00e9s de disminuir la prednisolona (d\u00eda 7), la paciente regres\u00f3 a nuestra cl\u00ednica con fiebre alta, tos, escalofr\u00edos, cansancio y disnea. No refiri\u00f3 haber viajado, pero trabajaba en un centro sanitario para ancianos. Una TAC mostr\u00f3 leves opacidades de vidrio esmerilado en los l\u00f3bulos pulmonares inferiores. Se le diagnostic\u00f3 neumon\u00eda y fue ingresada en una planta de enfermedades infecciosas con sospecha de COVID-19. La linfocitopenia es un factor de agravamiento de COVID-19. Al ingreso (d\u00eda 7), sus lesiones eritematosas empeoraron r\u00e1pidamente. La infecci\u00f3n grave nos llev\u00f3 a retirar la prednisolona por v\u00eda oral e iniciar una pauta con ampicilina/sulbactam y claritromicina. El d\u00eda 8, aparecieron nuevas p\u00e1pulas maculares y lesiones eritematosas en el rostro y el tronco, con petequias. Se obtuvo una biopsia de una lesi\u00f3n eritematosa endurecida de la piel abdominal. El an\u00e1lisis anatomopatol\u00f3gico revel\u00f3 cambios interfaciales con licuefacci\u00f3n e infiltraciones celulares mixtas perivasculares, con histiocitos y neutr\u00f3filos en la dermis papilar. Se cambi\u00f3 la ampicilina/sulbactam a levofloxacina. El d\u00eda 10, las lesiones eritematosas alcanzaron su m\u00e1ximo y se pigmentaron gradualmente. Los an\u00e1lisis mediante reacci\u00f3n en cadena de la polimerasa (PCR) para COVID-19 del d\u00eda 1 de ingreso fueron negativos, pero una TAC mostr\u00f3 progresi\u00f3n de las opacidades de vidrio esmerilado. Una segunda PCR para COVID-19 dio positiva el d\u00eda 3 de ingreso y la paciente fue diagnosticada con COVID-19 y trasladada a una unidad de cuidados intensivos de otro hospital."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "14-year-old previously healthy individual who presented to our institution with a 3-dayhistory of pyrexia, abdominal pain, nausea, and vomiting, but without respiratory symptoms. The patient\u2019s mother reported mild respiratory symptoms 3 weeks previously but the patient had not been tested for SARS-CoV-2. On admission (day \u20132), the patient was febrile (38\u30fb1\u00b0C)and cardiovascularly stable, and showed no signs of respiratory distress. The abdomen was tense, with guarding in the right upper and lower quadrants. Initial investigations showed lymphopenia (0\u30fb14 \u00d7 109 cells per L [normal range 1\u30fb5\u20137\u30fb6]), a significant increase in C-reactive protein (242 mg/L [normal range 0\u20138]), and sterile pyuria (30 cells). The patient was started on empiric piperacillin\u2013tazobactam for suspected acute appendicitis, and nasopharyngeal swabs were sent for SARS-CoV-2 PCR testing. Chest radiography and abdominal ultrasound were normal. Within 24 h of admission, the patient developed increasing dyspnoea, cough,and oxygen requirement (8 L/min), finally escalating to continuous positive airway pressure ventilation support. The patient seemed visually more unwell and interacted less, developed a widespread maculopapular blanching rash and received fluid boluses for persistent tachycardia. Chest CT showed typical findings of SARS-CoV-2 pneumonia. A diagnosis of presumptive COVID-19 was made. Secondary multisystem inflammatory disease or cytokine storm syndrome was diagnosed based on clinical symptoms, lymphopenia, anaemia, thrombocytopenia, increased acute phase proteins (C-reactive protein and ferritin), raised serum interleukin (IL)-6 (1098 g/mL [normal range <7]), coagulopathy (D-dimer >4810 ng/mL [normal range <500], prothrombintime 16\u30fb2 s [normal range 9\u30fb8\u201311\u30fb4], and activated partial thromboplastin time 43\u30fb4 s [normal range 24\u30fb2\u201330\u30fb2]), increased liver enzymes (aspartate aminotransferase 166 IU/L [normal range <37] and alanine aminotransferase 156 IU/L [normal range <40]), and hypertriglyceridaemia (2\u30fb3 mmol/L [normal range 0\u30fb4\u20131\u30fb4]). Antinuclear antibodies testednegative. Antiphospholipid antibodies (anticardiolipin IgG 25\u30fb5 U/mL [normal range <20] and anti\u03b22-glycoprotein IgG 28\u30fb8 U/mL [normal range <20]) were positive, and serum complement levels were pathologically low (C3 0\u30fb09 g/L [normal range 0\u30fb90\u20131\u30fb88], C4 0\u30fb12 g/L[normal range 0\u30fb18\u20130\u30fb42]). Furthermore, the patient developed mild polyarticular arthritis of the small joints of the hands. No substantial cervical lymphadenopathy, conjunctivitis, or mucous membrane changes were seen to suggest classic or complete Kawasaki disease. The patient was not eligible for remdesivir compassionate use because SARS-CoV-2 PCR was negative. Because the patient showed clinical features suggestive of COVID-19-associated cytokine storm yndrome, Anti-inflammatory treatment with recombinant IL-1 receptor antagonist (anakinra) was initiated after multidisciplinary discussions. Anakinra was started at 4 mg/kg per day (100 mg twice a day) subcutaneously and increased to 8 mg/kg per day (200 mg twice a day) after 36 h, becausethe patient required inotropic support for hypotension and rising lactate (6 mmol/L). Borderline left-ventricular systolic dysfunction, enzyme leak (troponin-T 45 ng/L), aortic regurgitation, and progressive left coronary dilatation were noted and aspirin was started (2 mg/kg) for its antithrombotic effects. In temporal relation with anakinra treatment, the patient\u2019s respiratory status stabilised and clinical and laboratory variables returned to normal, with the exception of coronary dilation that persisted at the time of discharge. Anakinra was tapered and discontinued after 6 days. Subsequently, serum tested positive for SARS-CoV-2 IgG (borderline day 6, positive day 11). SARSCoV-2 PCR on three nasopharyngeal samples (days 3, 5,and 7) and stool (day 11) were negative.",
        "es": "Ni\u00f1o de 14 a\u00f1os, por lo dem\u00e1s sano, que acudi\u00f3 a nuestra instituci\u00f3n con fiebre,dolor abdominal, n\u00e1useas y v\u00f3mitos de 3 d\u00edas de evoluci\u00f3n, pero sin s\u00edntomas respiratorios. La madre del paciente refiri\u00f3 s\u00edntomas respiratorios leves 3 semanas antes, pero el paciente no se hab\u00eda sometido a ninguna prueba de SARS-CoV-2. Al ingreso (d\u00eda -2), el paciente ten\u00eda fiebre (38,1 \u00b0C) y estaba estable cardiovascularmente; no mostraba signos de dificultad respiratoria. El abdomen estaba tenso, con defensa en los cuadrantes superior e inferior derechos. Los an\u00e1lisis iniciales revelaron linfocitopenia (0,14 x 109 c\u00e9lulas por L [intervalo normal: 1,5-7,6]), aumento significativo de prote\u00edna C-reactiva (242 mg/L [intervalo normal 0-8]) y piuria est\u00e9ril (30 c\u00e9lulas). Se inici\u00f3 un tratamiento sintom\u00e1tico con piperacilina\u2013tazobactam por presunta apendicitis aguda, y se enviaron frotis nasofar\u00edngeos para pruebas de SARS-CoV-2 mediante PCR. La radiograf\u00eda tor\u00e1cica y la ecograf\u00eda abdominal fueron normales. A las 24 horas del ingreso, el paciente present\u00f3 disnea, tos y necesidad de ox\u00edgeno (8 L/min) creciente, hasta necesitar ventilaci\u00f3n mec\u00e1nica positiva continua. El paciente presentaba un aspecto m\u00e1s enfermizo e interactuaba menos, present\u00f3 un exantema p\u00e1lido maculopapular y se administraron bolos a causa de taquicardia persistente. La TAC tor\u00e1cica mostr\u00f3 los resultados t\u00edpicos de neumon\u00eda por SARS-CoV-2. Se determin\u00f3 un diagn\u00f3stico de posible COVID-19. Se diagnostic\u00f3 tambi\u00e9n inflamaci\u00f3n multiorg\u00e1nica secundaria o crisis de citocinas, en base a los s\u00edntomas cl\u00ednicos, linfocitopenia, anemia, trombocitopenia, aumento de prote\u00ednas de la fase aguda (prote\u00edna C-reactiva y ferritina), aumento de interleucina 6 s\u00e9rica (1098 g/mL [valor normal < 7]), coagulopat\u00eda (d\u00edmero D > 4810 ng/mL [valor normal < 500], tiempo de protrombina 16,2 s [intervalo normal 9,8-11,4] y tiempo de tromboplastina parcial activado 43,4 s [intervalo normal 24,2-30,2]), aumento de enzimas hep\u00e1ticas (aspartato-aminotransferasa 166 UI/L [valor normal < 37] y alanina-aminotransferasa 156 UI/L [valor normal < 40]) e hipertrigliceridemia (2,3 mmol/L [intervalo normal 0,4-1,4]). Los anticuerpos antifosfolip\u00eddicos (anticardiolipina IgG 25,5U/mL [intervalo normal < 20] y anti-\u03b22-glucoprote\u00edna IgG 28,8 U/mL [intervalo normal < 20]) resultaron positivos, y los valores de complemento s\u00e9rico eran patol\u00f3gicamente bajos (C3 0,09 g/L [intervalo normal 0,90\u20131,88], C4 0,12 g/L[Intervalo normal 0,18\u20130,42]). Adem\u00e1s, el paciente desarroll\u00f3 leve artritis poliarticular de las articulaciones peque\u00f1as de las manos. No se observ\u00f3 linfoadenopat\u00eda cervical, conjuntivitis ni alteraciones de la mucosa que sugirieran enfermedad de Kawasaki cl\u00e1sica o completa. El paciente no era elegible para uso compasivo de remdesivir, porque la PCR de SARS-CoV-2 fue negativa. Como el paciente mostr\u00f3 caracter\u00edsticas cl\u00ednicas que indicaban una crisis de citocinas asociada a COVID-19, se inici\u00f3 un tratamiento antiinflamatorio con antagonista del receptor de IL-1 recombinante (anakinra) despu\u00e9s de un an\u00e1lisis multidisciplinar. La anakinra se inici\u00f3 a 4 mg/kg por d\u00eda (100 mg dos veces al d\u00eda) por v\u00eda subcut\u00e1nea y se aument\u00f3 a 8 mg/kg por d\u00eda (200 mg dos veces al d\u00eda) despu\u00e9s de 36 h, porque el paciente requiri\u00f3 soporte inotr\u00f3pico a causa de la hipotensi\u00f3n y un aumento de lactato (6 mmol/L). Se observ\u00f3 insuficiencia sist\u00f3lica fronteriza del VI, fuga de enzimas (troponina T 45 ng/L), regurgitaci\u00f3n a\u00f3rtica y dilataci\u00f3n coronaria izquierda progresiva; se inici\u00f3 aspirina (2 mg/kg) por sus efectos antitromb\u00f3ticos. En relaci\u00f3n temporal con el tratamiento con anakinra, el estado respiratorio del paciente se estabiliz\u00f3 y los valores cl\u00ednicos y anal\u00edticos regresaron a la normalidad, con la excepci\u00f3n de la dilataci\u00f3n coronaria, que persist\u00eda en el momento del alta. Se estableci\u00f3 una pauta de disminuci\u00f3n progresiva de anakinra y se retir\u00f3 al cabo de 6 d\u00edas. Posteriormente, las pruebas serol\u00f3gicas dieron positivo para IgG de SARS-CoV-2 (l\u00edmite en d\u00eda 6, positiva en d\u00eda 11). Las PCR para SARS-CoV-2 de tres muestras nasofar\u00edngeas (d\u00edas 3, 5, y 7) y heces (d\u00eda 11) fueron negativas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A previously healthy 8-year-old boy of African origin (height 130 cm and weight 29 kg) presented to our hospital with a 4-day history of fever, coughing, weight loss and severe fatigue. On physical examination, he was febrile (39.6\u00b0C) and presented a warm, painful and swollen erythema with adenopathy on the right side of the neck. He was diagnosed with cellulitis, which was confirmed by echography, and initially hospitalized for intravenousantibiotics. Within a few hours of admission, he developed tachycardia (138 bpm), low blood pressure (94/40 mm Hg) resilient to fluid bolus and associated with the appearance of hepatomegaly and oliguria. The blood test showed an increased C-reactive protein (CRP, 73 mg/L), leukopenia (4260/mm3) with lymphopenia (400/mm3), thrombocytopenia (118,000/mm3), renal function impairment (urea: 37 mg/dL, serum creatinine: 0.62 mg/dL), hepatic cytolysis (glutamic oxaloacetic transaminase: 88 UI/L, glutamic pyruvic ransaminase: 50 UI/L), myocardial necrosis (high-sensitivity troponin T levels: 0.044 ng/mL, N-terminal pro-brain natriuretic peptide: 5112 pg/mL) as well as elevated D dimers (>4.40 \u03bcg/mL) and interleukin-6 (IL-6, 377.8 pg/mL).Two-dimensional echocardiography revealed normal cardiac anatomy with impaired left ventricular function (fractional shortening:21%) and trace mitral insufficiency as well as a small pericardial effusion with neither evidence of left ventricular dilatation nor myocardial hypertrophy or significant pulmonary hypertension. The electrocardiogram was significant for discrete ST elevation inV3 consistent with pericarditis. The patient was admitted to the intensive care unit, anticoagulated with Enoxaparin and treated with Dobutamine which quickly normalized his blood pressure and restored diuresis. He also received oxygen to support heart function. Follow-up blood tests showed a rapid increase of the inflammatory markers (CRP max: 151 mg/L, interleukin-6 max: 1023 pg/mL, ferritin max: 2869 ng/mL), progression of hepatic cytolysis (GOT max: 100 U/L, GPT max: 70 U/L) and kidney failure (creatinine max: 0.75 mg/dL). Cardiac magnetic resonance imaging (CMR) performed at day 3 confirmed biventricular systolic dysfunction (left ventricular ejection fraction: 41%, right ventricular ejection fraction: 46%) with small pericardial effusion, mild subepicardial Gadoliniumenhancement of the lateral wall and signs of diffuse edema. His pulmonary chest scan on day 3 showed bilateral pneumopathies of the inferior lobes with bilateral pleural effusionswithout glass-ground opacities. A nasopharyngeal swab realized on admission came back positive for SARS-CoV2 on real-time reverse transcriptase PCR. Furthermore, a PCR on the stools, which was collected at day 6, was also positive (N1 gene at 39 CT and RdPR gene at 39 CT). The child had high titers of both Ig A and Ig G on the serum sample at day6 (Ig A: 8.39; Ig G: 10.90, using enzyme-linked immunosorbent assay Kit). Screening for other infectious cardiotropic pathogens yielded negative results (nasopharyngeal PCR for adenovirus, coronaviruses NL63, 229E, OC43 and HKU1, enterovirus, parainfluenza,influenza and mycoplasma pneumoniae; throat culture; parvovirus B19 serologies; blood cultures). He received IV immunoglobulins (2 g/kg given in 2 days). Dobutamine (max: 8.5 \u03bcg/kg/min) was stopped at day 2 and followed by Milrinone (max: 0.6 \u03bcg/kg/min) until day 3.As COVID-19 was rapidly confirmed, and as he was developing a life-threatening condition possibly related to a massive inflammatory storm given the inappropriate IL-6 level, Tocilizumab (2 doses of 8 mg/kg2) was administered accordingly to our national COVID-19 guidelines. Surprisingly, the cervical cellulitis-like presentation disappeared after the first dose of Tocilizumab which was well tolerated and without any adverse effect until discharge.The cellulitis like was most likely a dermatologic feature of COVID-19. Follow-up CMR performed a week later displayed normal systolic function and regression of myocardial edema. The child was discharged on day 10 with a normal cardiac function andnormalization of the blood impairments.",
        "es": "Ni\u00f1o de 8 a\u00f1os, por lo dem\u00e1s sano, de origen africano (altura 130 cm, peso 29 kg) acudi\u00f3 a nuestro hospital con fiebre, tos, adelgazamiento y cansancio extremo de 4 d\u00edas de evoluci\u00f3n. A la exploraci\u00f3n f\u00edsica, ten\u00eda fiebre (39,6 \u00b0C) y presentaba un eritema cal\u00f3rico, hinchado y doloroso, con adenopat\u00eda en el lado derecho del cuello. Se diagnostic\u00f3 celulitis, que qued\u00f3 confirmada por ecograf\u00eda; se le hospitaliz\u00f3 para administraci\u00f3n de antibi\u00f3ticosi.v. A las pocas horas del ingreso present\u00f3 taquicardia (138 l.p.m. ), hipotensi\u00f3n (94/40 mmHg) resistente a inyecci\u00f3n i.v. de l\u00edquidos y asociada a una presentaci\u00f3n de hepatomegalia y oliguria. Los an\u00e1lisis de sangre mostraron un aumento de prote\u00edna C-reactiva (73 mg/L), leucocitopenia (4260/mm3) con linfocitopenia (400/mm3), trombocitopenia (118.000/mm3), deficiencia de la actividad renal (urea: 37 mg/dL, creatinina s\u00e9rica: 0,62 mg/dL), cit\u00f3lisis hep\u00e1tica (transaminasa oxaloac\u00e9tica glut\u00e1mica: 88 UI/L, transaminasa pir\u00favica glut\u00e1mica: 50 UI/L), necrosis mioc\u00e1rdica (valores de troponina T de alta sensibilidad: 0,044 ng/mL, prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral: 5112 pg/mL) as\u00ed como valores altos de d\u00edmero D (> 4,40 \u03bcg/mL) e interleucina 6 (IL-6, 377,8 pg/mL). El electrocardiograma fue relevante por una leve elevaci\u00f3n de ST en V3, coherente con pericarditis. El paciente fue ingresado en la unidad de cuidados intensivos, se le administraron anticoagulantes, con enoxaparina, y se trat\u00f3 con dobutamina, que normaliz\u00f3 r\u00e1pidamente su presi\u00f3n arterial y restaur\u00f3 la diuresis. Tambi\u00e9n recibi\u00f3 ox\u00edgeno para ayudar a la actividad card\u00edaca. Los an\u00e1lisis de seguimiento mostraron un r\u00e1pido aumento de marcadores inflamatorios (PCR m\u00e1x: 151 mg/L, interleucina 6 m\u00e1x: 1023 pg/mL, ferritina m\u00e1x: 2869 ng/mL), progreso de cit\u00f3lisis hep\u00e1tica (TOG m\u00e1x: 100 U/L, TPG m\u00e1x: 70 U/L) e insuficiencia renal (creatinina m\u00e1x: 0,75 mg/dL). Una RMN card\u00edaca realizada el d\u00eda 3 confirm\u00f3 disfunci\u00f3n sist\u00f3lica biventricular (fracci\u00f3n de expulsi\u00f3n del VI: 41%, fracci\u00f3n de expulsi\u00f3n del VD: 46%) con leve derrame peric\u00e1rdico, leve realce de gadolinio subepic\u00e1rdico del tabique lateral y signos de edema difuso. Su radiograf\u00eda tor\u00e1cica del d\u00eda 3 mostr\u00f3 neumopat\u00eda bilateral en los l\u00f3bulos inferiores, con derrame pleural bilateral, sin opacidades de vidrio esmerilado. Un frotis nasofar\u00edngeo obtenido al ingreso result\u00f3 positivo para SARS-CoV-2 mediante RT-PCR en tiempo real. Adem\u00e1s, una PCR de las heces, recogidas el d\u00eda 6, tambi\u00e9n dio resultado positivo (gen N1 a 39 CT y gen RdPR a 39 CT). El paciente ten\u00eda valores altos de Ig A e Ig G en muestras s\u00e9ricas del d\u00eda 6 (Ig A: 8,39; Ig G: 10,90, mediante un kit de ensayo de inmunoadsorci\u00f3n enzim\u00e1tica). Las pruebas de otros pat\u00f3genos cardiotr\u00f3picos dieron resultado negativo (PCR de frotis nasofar\u00edngeo para adenovirus, coronavirus NL63, 229E, OC43 y HKU1, enterovirus, virus paragripal, virus de la gripe y Mycoplasma pneumoniae; exudado far\u00edngeo; pruebas serol\u00f3gicas de parvovirus B19; hemocultivos). (2 g/kg en dos d\u00edas). La dobutamina (m\u00e1x: 8,5 \u03bcg/kg/min) se retir\u00f3 al d\u00eda dos, sustituida por milrinona (m\u00e1x: 0,6 \u03bcg/kg/min) hasta el d\u00eda 3. Sorprendentemente, el cuadro celul\u00edtico cervical desapareci\u00f3 tras la primera dosis de tocilizumab, que fue bien tolerado sin efectos adversos hasta el alta. Podr\u00eda ser que el cuadro celul\u00edtico fuera una caracter\u00edstica dermatol\u00f3gica de la COVID-19. Una RMN card\u00edaca de seguimiento realizada una semana despu\u00e9s mostr\u00f3 actividad sist\u00f3lica normal y regresi\u00f3n del edema mioc\u00e1rdico. El paciente fue dado de alta el d\u00eda 10, con actividad card\u00edaca normal y normalizaci\u00f3n de las anomal\u00edas hem\u00e1ticas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 55-year-old female with a PMH of asthma, hypertension, hyperlipidemia, and type IIdiabetes mellitus presented with worsening fever, cough, dyspnea, and weakness forapproximately 2.5 weeks. She was previously treated with azithromycin, amoxicillin clavulanate and levofloxacin from her PCP and presented to our emergency center from home. Her vitals on admission were T 39.4\u2103, HR 111 bpm, BP 115/73mmHg, RR 27, with a SpO2 of 92% and PaO2 of 51mmHg on room air. A chest x-ray showed bilateral patchy infiltratesthroughout both lungs. She was placed on supplemental oxygen by a nasal cannula and admitted to the floor for observation. On hospital day 4, she became tachypneic and her dyspnea worsened. She was subsequently placed on a NRB 100% with minimal improvement; her PaO2 was 67mmHg. She was transferred to ICU with concern for impending intubation. COVID-19 testing returned positive. On hospital day 5, she had an elevated D-dimer of 8.34ug/mL and fibrinogen of 899mg/dL. The following day her PaO2 had decreased to 59mmHg despite being on the NRB and the decision was made to initiate tPA therapy. On post-treatment day 1, her PaO2 improved to 72mmHg, her D-dimer increased to >20ug/mL, and her fibrinogen decreased to 535mg/dL. She remained on NRB 100%. On post-treatment day 2, she completed the hydroxychloroquine regimen and was started on 80mg methylprednisolone every 24 hours. She began further tolerating movement and was interacting with the staff, and her PaO2 further increased to 77mmHg. Her D-dimer stayed above 20ug/mL. On post-treatment day 3, she was transitioned from NRBM to 6L nasal cannula. Her D-dimer decreased to 4.56ug/mL. Post-treatment day 6, she was transferred from the ICU to the floor, and the heparin drip was discontinued, D-dimer at this point was 1.91ug/mL. She felt well with no new complaints and was able to be weaned to room air. By post-treatment day 8, the patient no longer had dyspnea and was discharged home on a steroid taper.",
        "es": "sUna mujer de 55 a\u00f1os con antecedentes de asma, hipertensi\u00f3n, hiperlipidemia y diabetes mellitus de tipo II se present\u00f3 en urgencias con fiebre, tos, disnea y debilidad de unas2,5 semanas de evoluci\u00f3n. Su m\u00e9dico de atenci\u00f3n primaria le hab\u00eda recetado azitromicina, amoxicilina/clavulanato y levofloxacina, y acudi\u00f3 a nuestro servicio de urgencias desde su domicilio. Sus constantes vitales al ingreso eran T 39,4 \u2103, pulso 111 l.p.m., presi\u00f3n arterial 115/73 mmHg, frecuencia respiratoria 27, con SpO2 de 92% y PaO2 de 51 mmHg en aire ambiental. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 infiltrados parcheados bilaterales en ambos pulmones. Se le suministr\u00f3 oxigenoterapia mediante c\u00e1nula nasal y se la llev\u00f3 a planta para observaci\u00f3n. El d\u00eda 4 de hospitalizaci\u00f3n present\u00f3 taquipnea y su disnea empeor\u00f3. Se le puso una mascarilla con reservorio 100%, con una mejora m\u00ednima; su PaO2 era de 67 mmHg. Se la traslad\u00f3 a la UCI por posible intubaci\u00f3n inminente. La prueba de COVID-19 result\u00f3 positiva. El d\u00eda 5 de hospitalizaci\u00f3n, ten\u00eda un valor alto de d\u00edmero D (8,34 ug/mL) y de fibrin\u00f3geno (899 mg/dL). El d\u00eda siguiente su PaO2 hab\u00eda disminuido a 59 mmHg, a pesar de estar con la mascarilla; se decidi\u00f3 iniciar tratamiento con APt. El d\u00eda 1 tras tratamiento, su PaO2 mejor\u00f3 a 72 mmHg, su d\u00edmero D aument\u00f3 a > 20 ug/mL y su fibrin\u00f3geno disminuy\u00f3 a 535 mg/dL. Permaneci\u00f3 en mascarilla con reservorio 100%. El d\u00eda 2 tras tratamiento, complet\u00f3 la pauta de hidroxicloroquina y se inici\u00f3 una pauta con metilprednisolona 80 mg cada 24 horas. Empez\u00f3 a tolerar mejor el movimiento y a interactuar con el personal; su PaO2 aument\u00f3 a 77 mmHg. El d\u00edmero D permaneci\u00f3 por encima de 20 ug/mL. El d\u00eda 3 tras tratamiento, se cambi\u00f3 la mascarilla con reservorio por una c\u00e1nula nasal de 6L. El d\u00edmero D disminuy\u00f3 a 4,56 ug/mL. El d\u00eda 6 despu\u00e9s del tratamiento se la traslad\u00f3 a planta y se retir\u00f3 la heparina i.v. ; en este momento el d\u00edmero D era de 1,91 ug/mL. La paciente se sent\u00eda bien sin nuevos s\u00edntomas, y pudo respirar en aire ambiental. El d\u00eda 8 tras tratamiento, la paciente ya no sufr\u00eda disnea y se la dio de alta con una pauta decreciente de esteroides."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 65-year old subfebrile (98.6 F) Wuhan woman had dry cough, fatigue, and diarrhea (4 times a day). A CT scan showed bilateral ground-glass changes, which is the primary tool for Covid-19 diagnosis in the epidemic area. Swabs did not detect SARS Cov-2. One day after admission, we observed multiple, disseminated, variable size, erythematous patches throughout the body, which faded  on  pressure. Few  patches  were  confluent. We  considered  the  symptoms  as unspecific viral rash due to COVID-19, and included as differential diagnosis a drug eruption due to the anti-neoplastic drug ruxolitinib.",
        "es": "Una mujer de Wuhan con febr\u00edcula (37 C) presentaba tos seca, cansancio y diarrea (4 veces al d\u00eda). Una TAC mostr\u00f3 alteraciones en vidrio esmerilado bilaterales, m\u00e9todo principal de diagn\u00f3stico de COVID-19 en la zona epid\u00e9mica. Los frotis no detectaron SARS-CoV-2. Un d\u00eda despu\u00e9s del ingreso, observamos m\u00faltiples manchas eritematosas diseminadas, de tama\u00f1o variable, por todo el cuerpo, que desaparec\u00edan a la presi\u00f3n. Pocas manchas eran confluyentes. Consideramos estos s\u00edntomas como un exantema v\u00edrico inespec\u00edfico asociado a COVID-19, e incluimos en el diagn\u00f3stico diferencial una erupci\u00f3n farmacol\u00f3gica a causa del f\u00e1rmaco antineopl\u00e1sico ruxolitinib."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 74-year-old Wuhan man presented with fever (100.4 F), dry cough and fatigue. A CT scan of the lung showed ground-glass changes. The throat swab was positive for COVID-19 nucleic acid. Treatment  included  hydroxychloroquine,  lopinavir/ritonavir,  thymosin  and  methylprednisolone. The  rash  appeared  on  the  12th  day  after  admission. In  physical  examination,  the  patient  had diffuse, irregular shaped, partially confluent wheals throughout the body. The patient was diagnosed with COVID-19 pneumonia, and secondary urticaria of undetermined aetiology.",
        "es": "Hombre de 74 a\u00f1os de Wuhan acudi\u00f3 con fiebre (38 C), tos seca y cansancio. Una TAC pulmonar mostr\u00f3 alteraciones en vidrio esmerilado. El frotis far\u00edngeo fue positivo para \u00e1cido nucleico de COVID-19. El tratamiento consisti\u00f3 en hidroxicloroquina, lopinavir/ritonavir, timosina y metilprednisolona. El d\u00eda 12 tras el ingreso apareci\u00f3 un exantema. A la exploraci\u00f3n f\u00edsica, el paciente mostr\u00f3 ronchas difusas, irregulares y parcialmente confluyentes por todo el cuerpo. El paciente fue diagnosticado con neumon\u00eda por COVID-19 y urticaria secundaria de origen indeterminado."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The other case is a 62-year-old male with severe eosinophilic asthma on treatment with benralizumab since July 2018. Previously, he had received treatment with omalizumab and mepolizumab both discontinued because of poor response. As comorbidities, he had moderate obstructive sleep apnoea, chronic rhinosinusitis with nasal polyps, bronchiectasis and obesity (body mass index 33 kg/m2). He did not fulfil criteria of ACOS. On March 25th the patient had cough, fever and darker and thicker than his usual expectoration so he self-medicated with levofloxacin 500 mg for 3 days. Due to lack of improvement of symptoms, he was evaluated at primary care where a chest x-ray was done that showed peripheral and bilateral opacities, more evident in mid / lower lung areas, compatible with COVID-19 pneumonia and was referred to the emergency room. One relative, who lived with him, had the same symptoms. Complementary tests showed lymphopenia with increased levels of LDH, CRP, D dimers, fibrinogen and a baseline pO2 59 mmHg. The diagnosis of SARS CoV2 pneumonia was assumed considering the epidemic context, symptoms, radiologic and laboratory findings and following the Spanish authorities recommendations at that moment. He was placed at home isolation and was monitored by his primary care physician. The patient was treated with azithromycin 500 mg (3 days), hydroxychloroquine 200 mg twice a day (5 days) and amoxicillin-clavulanic 875/125 mg (7 days). One week later, he had no symptoms and he completed 14 days more of isolation.",
        "es": "Hombre de 62 a\u00f1os con asma eosinof\u00edlica grave, en tratamiento con benralizumab desde julio de 2018. Anteriormente, hab\u00eda recibido tratamiento con omalizumab y mepolizumab, interrumpido a causa de una escasa respuesta. Por lo que respecta a la comorbilidad, ten\u00eda apnea del sue\u00f1o, rinosinusitis cr\u00f3nica con p\u00f3lipos nasales, bronquiectasia y obesidad (\u00edndice de masa corporal 33 kg/m2). No cumpl\u00eda criterios para s\u00edndrome mixto de asma y EPOC. El 25 de marzo el paciente present\u00f3 tos, fiebre y esputo m\u00e1s oscuro y denso de lo habitual, de modo que se automedic\u00f3 con levofloxacina (500 mg durante 3 d\u00edas). A causa de la falta de mejora de los s\u00edntomas, fue atendido en un centro de atenci\u00f3n primaria, donde se le realiz\u00f3 una radiograf\u00eda tor\u00e1cica que mostr\u00f3 opacidades perif\u00e9ricas y bilaterales, m\u00e1s evidentes en las \u00e1reas pulmonares media e inferior, compatibles con neumon\u00eda por COVID-19; se le remiti\u00f3 al servicio de urgencias. Un familiar, que viv\u00eda con \u00e9l, ten\u00eda los mismos s\u00edntomas. Las pruebas adicionales revelaron linfocitopenia con un aumento de los valores de LDH, prote\u00edna C-reactiva, d\u00edmero D y fibrin\u00f3geno y una pO2 basal de 59 mmHg. Se presupuso un diagn\u00f3stico de neumon\u00eda por SARS-CoV-2, teniendo en cuenta el contexto epid\u00e9mico, los s\u00edntomas, los resultados anal\u00edticos y radiol\u00f3gicos y de acuerdo con las recomendaciones de las autoridades espa\u00f1olas en ese momento. Se le coloc\u00f3 en aislamiento dom\u00e9stico, con supervisi\u00f3n de su m\u00e9dico de cabecera. El paciente fue tratado con azitromicina (500 mg durante 3 d\u00edas), hidroxicloroquina (200 mg dos veces al d\u00eda durante 5 d\u00edas) y amoxicilina/\u00e1cido clavul\u00e1nico (875/125 mg durante 7 d\u00edas). Una semana despu\u00e9s, no presentaba s\u00edntomas y complet\u00f3 14 d\u00edas m\u00e1s de aislamiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 56-year-old woman who has been followed at our severe asthma unit for late-onset, severe, eosinophilic asthma with bronchiectasis without criteria for Asthma-COPD overlap syndrome (ACOS). Her asthma was controlled with high dose inhaled corticosteroids, long-acting beta2-agonist, montelukast, ipratropium and benralizumab. On March 8th, she went to the emergency room due to a 24-hour episode of fever, arthralgia, myalgia, dyspnea and brownish expectoration. On physical examination, there was no wheeze. Complementary tests showed a unilobar opacity in the right lung, a slightly increased C reactive Protein (CRP) and lactate dehydrogenase, and a positive polymerase chain reaction (PCR) for SARS-CoV2. Levofloxacin 500 mg during 14 days and systemic corticosteroids (1mg/kg) were administered due to brownish expectoration and history of bronchiectasis (lopinovir/ritonavir and hydroxychloroquine were not started according to hospital\u00b4s protocol, at that moment, as the patient did not have hypoxemia). The patient was discharged on the 4th day of admission due to clinical stability, which was maintained without 26 oral corticosteroids. One week later, the patient was asymptomatic. Four relatives also had COVID-19.",
        "es": "Mujer de 56 a\u00f1os, en seguimiento en nuestra unidad de asma grave a causa de asma eosinof\u00edlica grave de aparici\u00f3n tard\u00eda con bronquiectasia y que no cumpl\u00eda los criterios para s\u00edndrome mixto de asma y EPOC. Su asma se controlaba mediante dosis altas de corticosteroides por v\u00eda inhalatoria, agonistas beta2 de acci\u00f3n prolongada, montelukast, ipratropio y benralizumab. El 8 de marzo acudi\u00f3 al servicio de urgencias por un episodio de 24 horas de fiebre, artralgia, mialgia, disnea y esputo parduzco. A la exploraci\u00f3n f\u00edsica no se apreciaron sibilancias. Las pruebas adicionales revelaron una opacidad unilobular en el pulm\u00f3n derecho, un valor ligeramente elevado de prote\u00edna C-reactiva y de lactato-deshidrogenasa y un resultado positivo de la PCR para SARS-CoV-2. Se le administr\u00f3 500 mg de levofloxacina durante 14 d\u00edas as\u00ed como corticoesteroides sist\u00e9micos (1 mg/kg) a causa del esputo parduzco y de los antecedentes de bronquiectasia (seg\u00fan los protocolos del hospital, no se inici\u00f3 ninguna pauta con lopinavir/ritonavir e hidroxicloroquina, pues, en ese momento, la paciente no presentaba hipoxemia). La paciente fue dada de alta al cuarto d\u00eda de ingreso, teniendo en cuenta su situaci\u00f3n cl\u00ednicamente estable, que se mantuvo sin necesidad de corticoesteroides por v\u00eda oral. Una semana despu\u00e9s, la paciente estaba asintom\u00e1tica. Cuatro familiares tambi\u00e9n tuvieron COVID-19."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 65-year-old man presented to the emergency department with a 5-day history of fatigue, fever, and cough. Initial blood work showed an inflammatory syndrome with an elevated C-reactive protein (60\u2009mg/L), bicytopenia (normocytic anemia and thrombocytopenia), and lymphopenia. The patient was admitted to the medical ward for further evaluation. Noncontrast chest CT showed ground-glass opacities characteristic of COVID-19 infection. The diagnosis was confirmed by reverse transcription polymerase chain reaction detection of SARS-CoV-2 from a nasopharyngeal swab. The following day, the patient had a high fever and chills. A lower extremity skin rash was noted. Severe hypoxemia (56\u2009mm Hg) and low oxygen saturation (90.6%) prompted oxygen therapy with a high-concentration mask (15L/min) and antibiotic therapy (spiramycin, amoxicillin, and clavulanic acid). Because oxygen saturation continued to drop to 88%, with worsening of skin rash and tachypnea, the patient was admitted to the pulmonary intensive care unit. Rapid stabilization of pulmonary function was obtained with oxygen and care in the intensive care unit; however, the patient remained drowsy and unarousable despite discontinuation of sedation. CT and MR imaging of the brain were performed to look for possible neurologic complications such as hypoxic-ischemic injuries or encephalitis. CT showed multiple white matter, basal ganglia, and cerebellar hypodensities and bilateral globus pallidus hyperdensities, suggestive of hemorrhage confirmed on T2*-weighted MR imaging. Brain MR imaging showed extensive ischemic lesions with restricted diffusion, involving the centrum semiovale, corpus callosum, basal ganglia, and cerebellum, with patchy/punctuate enhancement. Coronal 3D reconstruction MRA of supra-aortic arteries showed no detectable abnormality of large intra- or extracranial vessels.",
        "es": "Un hombre de 65 a\u00f1os acudi\u00f3 al servicio de urgencias con fiebre, fatiga y tos de 5 d\u00edas de evoluci\u00f3n. El an\u00e1lisis de sangre inicial mostr\u00f3 s\u00edndrome inflamatorio con valores altos de prote\u00edna C-reactiva (60 mg/L), bicitopenia (anemia normoc\u00edtica y trombocitopenia) y linfocitopenia. El paciente fue ingresado en la planta de medicina interna para su evaluaci\u00f3n. Una TAC tor\u00e1cica sin contraste mostr\u00f3 opacidades de vidrio esmerilado, caracter\u00edsticas de infecci\u00f3n por COVID-19. El diagn\u00f3stico qued\u00f3 confirmado con la detecci\u00f3n de SARS-CoV-2 mediante PCR a partir de un frotis nasofar\u00edngeo. El d\u00eda siguiente, el paciente present\u00f3 fiebre alta y escalofr\u00edos. Tambi\u00e9n se apreci\u00f3 un exantema en las extremidades inferiores. Una hipoxemia grave (56 mm Hg) y una baja saturaci\u00f3n de ox\u00edgeno (90,6%) motivaron oxigenoterapia con mascarilla de alta concentraci\u00f3n (15 L/min) y terapia antibi\u00f3tica (espiramicina, amoxicilina y \u00e1cido clavul\u00e1nico). Como la saturaci\u00f3n de ox\u00edgeno sigui\u00f3 disminuyendo hasta el 88%, con un empeoramiento del exantema y taquipnea, se ingres\u00f3 al paciente en la unidad de cuidados intensivos de neumolog\u00eda. Se logr\u00f3 una r\u00e1pida estabilizaci\u00f3n pulmonar con ox\u00edgeno en la unidad de cuidados intensivos; sin embargo, el paciente continu\u00f3 somnoliento a pesar de interrumpir la sedaci\u00f3n. Se realizaron TAC y RMN cerebrales para buscar posibles complicaciones neurol\u00f3gicas, como lesiones isqu\u00e9micas hip\u00f3xicas o encefalitis. La TAC mostr\u00f3 m\u00faltiples hipodensidades cerebelosas, de la sustancia blanca y de los ganglios basales, as\u00ed como hiperdensidades bilaterales del globo p\u00e1lido, todo ello indicativo de hemorragia, confirmada en la secuencia T2* ponderada de la RMN. La RMN cerebral mostr\u00f3 lesiones isqu\u00e9micas amplias, con difusi\u00f3n limitada, que afectaban al centro semioval, al cuerpo calloso, a los ganglios basales y al cerebelo, con realce parcheado/puntuado. Una reconstrucci\u00f3n 3D frontal mediante ARM de las arterias supraa\u00f3rticas no mostr\u00f3 anomal\u00edas detectables de los vasos intra o extracraneales."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 36-year-old man was admitted to our hospital for a severe recurrence of ulcerative colitis. At admission, he had been taking mesalazine in both oral and topical formulations and he reported up to 12 bowel movements with blood. Laboratory tests showed mild normocytic anaemia (haemoglobin, 123 g/L), neutrophilic leucocytosis (neutrophils, 9420/\u03bcL), increased C reactive protein (CRP) (17.1\u2009mg/dL; normal values <0.5\u2009mg/dL) and hypoalbuminaemia (3.2\u2009g/dL). Colonoscopy showed widely ulcerated mucosa, and a histological examination confirmed severely active ulcerative colitis. Chest and abdominal radiographs were normal. Intravenous methylprednisolone (60\u2009mg/day), fluid replacement and antithrombotic prophylaxis with low-molecular-weight heparin were started. Stool culture, Clostridium difficile toxin assay and one nasopharyngeal swab test for SARS-CoV-2 were negative. Screening for infections, as recommended prior to prescribing biological therapies, was negative. After 5 days of intravenous methylprednisolone, the patient\u2019s general well-being and clinical conditions had slightly improved and CRP levels had dropped to 0.95\u2009mg/dL. A proctosigmoidoscopy excluded cytomegalovirus infection. At this point, rescue therapy would have been appropriate, but the patient developed fever, dyspnoea and cough. Laboratory tests showed the return of high CRP levels (3.98\u2009mg/dL). High-resolution CT showed bilateral patchy ground-glass opacities, indicative of severe interstitial pneumonia. A repeat nasopharyngeal swab tested positive for SARS-CoV-2, and steroid therapy was tapered and moved to oral administration. We assessed interleukin 6 (IL-6) serum levels, which was abnormally high (37.4\u2009pg/mL; normal values, 0\u20137\u2009pg/mL). For the ulcerative colitis, we considered medical or surgical option. Surgery seemed contraindicated in a patient with COVID-19, which could complicate the postoperative course and be potentially fatal. So, we opted for infliximab at the dose of 5\u2009mg/kg, also because our recent study found no association between the use of biological therapies and poor outcomes of IBD patients and COVID-19. After 7 days on infliximab, the patient\u2019s intestinal symptoms and general well-being had markedly improved. High-resolution CT showed a clear improvement with reduced extent and density of the ground-glass opacities. Laboratory tests indicated a normalisation of CRP (0.12\u2009mg/dL) and a drop of IL-6 levels to 15.9\u2009pg/mL; two consecutive nasopharyngeal swab tests for SARS-CoV-2 were negative. The patient was discharged in good clinical condition, with two bowel movements without blood in the stools.",
        "es": "Un hombre de 36 a\u00f1os ingres\u00f3 en nuestro hospital por una recidiva grave de colitis ulcerosa. Al ingreso, estaba tomando mesalazina en formulaci\u00f3n oral y t\u00f3pica, y refiri\u00f3 hasta 12 deposiciones con sangre. Las pruebas anal\u00edticas mostraron anemia normoc\u00edtica leve (hemoglobina 123 g/L), leucocitosis neutrof\u00edlica (neutr\u00f3filos 9420/\u03bcL), aumento de prote\u00edna C-reactiva (17,1 mg/dL; valor normal < 0,5 mg/dL) e hipoalbuminemia (3,2 g/dL). Una colonoscopia revel\u00f3 mucosa muy ulcerada y una exploraci\u00f3n histol\u00f3gica confirm\u00f3 la colitis ulcerosa grave y activa. Las radiograf\u00edas tor\u00e1cicas y abdominales eran normales. Se inici\u00f3 tratamiento con metilprednisolona i.v. (60 mg/d\u00eda), rehidrataci\u00f3n y profilaxis antitromb\u00f3tica con heparina de bajo peso molecular. El cultivo de heces, la prueba para la toxina de Clostridium difficile y para SARS-CoV-2 de frotis nasofar\u00edngeo fueron todas negativas. La detecci\u00f3n de infecciones, recomendada antes de iniciar terapias biol\u00f3gicas, fue negativa. Tras 5 d\u00edas de metilprednisolona i.v., el estado general del paciente y su situaci\u00f3n cl\u00ednica mejoraron ligeramente; los valores de prote\u00edna C-reactiva hab\u00edan bajado a 0,95 mg/dL. Una proctosigmoidoscop\u00eda excluy\u00f3 infecci\u00f3n por citomegalovirus. En este momento, hubiera sido adecuado un tratamiento de rescate, pero el paciente present\u00f3 fiebre, disnea y tos. Las pruebas anal\u00edticas mostraron un nuevo aumento de la prote\u00edna C-reactiva (3,98 mg/dL). Una TAC de alta resoluci\u00f3n mostr\u00f3 opacidades de vidrio esmerilado parcheadas bilaterales, indicativas de neumon\u00eda intersticial grave. Un nuevo frotis nasofar\u00edngeo dio positivo para SARS-CoV-2; se disminuy\u00f3 progresivamente el tratamiento con esteroides y se pas\u00f3 a administraci\u00f3n oral. Evaluamos la concentraci\u00f3n s\u00e9rica de interleucina 6, que era alta (37,4 pg/mL; valores normales 0-7 pg/mL). Para la colitis ulcerosa, se consideraron opciones m\u00e9dicas y quir\u00fargicas. La cirug\u00eda se consider\u00f3 contraindicada en un paciente con COVID-19, que podr\u00eda complicar la evoluci\u00f3n posoperatoria y resultar potencialmente mortal. En consecuencia, se opt\u00f3 por infliximab a dosis de 5 mg/kg. Tras 7 d\u00edas con infliximab, los s\u00edntomas intestinales del paciente y su estado general mejoraron considerablemente. Una TAC de alta resoluci\u00f3n mostr\u00f3 una clara mejora, con reducci\u00f3n de la extensi\u00f3n y densidad de las opacidades de vidrio esmerilado. Las pruebas anal\u00edticas reflejaron normalizaci\u00f3n de la prote\u00edna C-reactiva (0,12 mg/dL) y disminuci\u00f3n de la concentraci\u00f3n de IL-6 hasta 15,9 pg/mL; dos pruebas consecutivas para SARS-CoV-2 a partir frotis nasofar\u00edngeos resultaron negativas. El paciente fue dado de alta con buen estado cl\u00ednico, con dos defecaciones sin sangre."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The patient is a twin born at 32+6 weeks for maternal pre-eclampsia with a small atrial septal defect (<4mm) and cleft palate. He was intubated at birth before weaning off respiratory support within a week. At 37+3 weeks corrected gestational age he developed respiratory distress at home and presented to hospital. Of note, he had been in recent contact with both family members and asymptomatic healthcare workers, who subsequently developed symptoms and were confirmed to have SARS-CoV-2 infection. In the emergency department progressive hypoxia led to several failed attempts at intubation. Nasopharyngeal aspirate SARS-CoV-2 RNA PCR was positive (CT 20). Oxygenation and ventilation were maintained via laryngeal mask during transfer to a quaternary center forotolaryngologic input. He was successfully intubated in theatre via microlaryngobronchoscopy, using appropriate personal protective equipment for all personnel. Significant glottic swelling and copious airway secretions were noted. Initial moderate ventilatory pressures and FiO2 of 0.6 were weaned over 3 days. Initial chest xray demonstrated mild bilateral ground glass opacities. CRP was 42 mg/L and he waslymphopenic (1.45x10*9/L) with an otherwise normal blood picture. Serial trachealaspirates, urine and stool cultures excluded bacterial or fungal co-infection. A line-associatedfemoral arterial thrombus was treated with therapeutic anticoagulation. After several days of laryngeal rest ventilation parameters had improved and he was suitable for trial of extubation. The multi-disciplinary team decided to use usual prophylactic steroids to optimize laryngeal conditions for extubation, particularly considering the difficult intubation. Two prophylactic dexamethasone doses were given. Prior to extubation the patient deteriorated, developing fulminant ARDS with correspondingworsening of chest x-ray findings. He could no-longer be managed with conventionalventilation and required high-frequency oscillatory ventilation, nitric oxide, prone ventilation and inotropic support to maintain oxygenation and ventilation. ECMO was considered but notrequired. Possible secondary bacterial infection was treated with broad spectrum antibiotics and excluded by bronchoalveolar lavage, using strict personal protective equipment precautions. Given the life-threatening deterioration, an urgent multidisciplinary meeting was held, followed by an innovative therapy review with the bioethics team and parents via video-link. As there was limited evidence for hyperinflammation (IL6 <50pg/ml, Ferritin 411ug/L), antiviral therapy was preferred to immunomodulation. A compassionate access application for remdesivir was agreed upon and was granted. An intravenous loading dose of 5mg/kg remdesivir was given, followed by 1.25mg/kgmaintenance dose for 10 days. IL10 was raised (110pg/ml) but normalized by day 5 of treatment. CRP peaked at 63mg/L on day 6, Ferritin 789ug/L on day 9, and D-dimer 1143ug/L day 10. Daily SARS-CoV-2 RNA PCR tracheal aspirates became negative after 5 days of remdesivir,excluding an isolated positive on Day 10 of remdesivir. No drug toxicity was observed. The highest troponin was 138ng/L. There were no clinical or echocardiographic signs ofmyocarditis. Echocardiogram on day 7 of illness showed only a small patent foramen ovale with left to right shunt, mild dilation left side structures, and mild mitral regurgitation. Ventilatory and inotropic support were weaned, and extubation was successful on day 18 ofillness. He has been discharged home.",
        "es": "El paciente es un gemelo nacido a las 32+6 semanas a causa de preeclampsia, con una ligera anomal\u00eda en el tabique auricular (< 4 mm) y fisura palatina. Al nacimiento fue intubado antes de retirar progresivamente la respiraci\u00f3n asistida en una semana. A las 37+3 semanas de edad gestacional corregida, present\u00f3 disnea en su hogar y fue llevado al hospital. Cabe se\u00f1alar que hab\u00eda tenido contacto reciente con familiares y con profesionales sanitarios asintom\u00e1ticos, que posteriormente presentaron s\u00edntomas y se les confirm\u00f3 infecci\u00f3n por SARS-CoV-2. En el servicio de urgencias, una hipoxia progresiva llev\u00f3 a varios intentos fallidos de intubaci\u00f3n. Los aspirados nasofar\u00edngeos dieron resultado positivo para SARS-CoV-2 mediante PCR. La oxigenaci\u00f3n y la ventilaci\u00f3n se mantuvieron mediante mascarilla lar\u00edngea durante el traslado a un centro de atenci\u00f3n especializada para intervenci\u00f3n otorrinolaringol\u00f3gica. Fue intubado con \u00e9xito en quir\u00f3fano mediante microlaringobroncoscopia; todo el personal llevaba equipos de protecci\u00f3n individual adecuados. Se apreci\u00f3 inflamaci\u00f3n gl\u00f3tica significativa y abundante secreci\u00f3n de las v\u00edas respiratorias. Las moderadas presiones de respiraci\u00f3n iniciales y FiO2 de 0,6 se redujeron progresivamente durante 3 d\u00edas. La radiograf\u00eda tor\u00e1cica inicial mostr\u00f3 leves opacidades de vidrio esmerilado bilaterales. La prote\u00edna C-reactiva era de 42 mg/L y se detect\u00f3 linfocitopenia (1,45 x 10*9/L), con el resto de los valores normales. Una serie de aspirados traqueales y cultivos de orina y heces excluyeron coinfecciones bacterianas o f\u00fangicas. Un trombo en la arteria femoral asociado a la v\u00eda fue tratado con anticoagulantes. Tras varios d\u00edas de respiraci\u00f3n asistida lar\u00edngea, los par\u00e1metros mejoraron y se pudo intentar la extubaci\u00f3n. El equipo multidisciplinar decidi\u00f3 emplear esteroides preventivos habituales para optimizar las condiciones lar\u00edngeas en la extubaci\u00f3n, especialmente teniendo en cuenta las dificultades previas de intubaci\u00f3n. Se administraron dos dosis preventivas de dexametasona. Antes de la extubaci\u00f3n, el paciente empeor\u00f3, con SDRA fulminante y un empeoramiento asociado en la radiograf\u00eda tor\u00e1cica. No se pudo tratar con respiraci\u00f3nasistida convencional y necesit\u00f3 ventilaci\u00f3n oscilante de alta frecuencia, \u00f3xido n\u00edtrico, ventilaci\u00f3n en dec\u00fabito prono y apoyo in\u00f3tropo para mantener la oxigenaci\u00f3n y la ventilaci\u00f3n. Se consider\u00f3 OMEC pero no fue necesario. Una posible sobreinfecci\u00f3n bacteriana se trat\u00f3 con antibi\u00f3ticos de amplio espectro y qued\u00f3 descartada a partir de un lavado broncoalveolar, realizado con estrictas medidas de seguridad con equipos de protecci\u00f3n individual. Teniendo en cuenta el empeoramiento potencialmente mortal, se reuni\u00f3 un equipo multidisciplinar con car\u00e1cter urgente, que, mediante videoconferencia, realiz\u00f3 una revisi\u00f3n de terapias innovadoras junto con el equipo de bio\u00e9tica y los padres del paciente. Como hab\u00eda pocas pruebas de hiperinflamaci\u00f3n (IL6 < 50pg/ml, ferritina 411 ug/L), se prefiri\u00f3 una terapia antiv\u00edrica a inmunomodulaci\u00f3n. Se acord\u00f3 solicitar uso compasivo de remdesivir. Se administr\u00f3 una dosis inicial de 5 mg/kg seguida de una dosis de mantenimiento de 1,25 mg/kg durante 10 d\u00edas. La IL10 mostr\u00f3 un aumento (110 pg/ml) pero se normaliz\u00f3 al d\u00eda 5 de tratamiento. La prote\u00edna C-reactiva lleg\u00f3 a un m\u00e1ximo de 63 mg/L el d\u00eda 6, la ferritina a 789 el d\u00eda 9 y el d\u00edmero D a 1143 ug/L el d\u00eda 10. Aspirados traqueales diarios para PCR de SARS-CoV-2 resultaron negativos 5 d\u00edas despu\u00e9s de la administraci\u00f3n de remdesivir, excluyendo un positivo aislado al d\u00eda 10. No se observaron reacciones adversas. El valor m\u00e1ximo de troponina fue 138 ng/L. No hab\u00eda signos ecocardiogr\u00e1ficos ni cl\u00ednicosde miocarditis. El ecocardiograma el d\u00eda 7 de enfermedad solo mostr\u00f3 un peque\u00f1o agujero oval con comunicaci\u00f3n entre izquierda y derecha, leve dilataci\u00f3n de las estructuras del lado izquierdo y leve insuficiencia mitral. El apoyo respiratorio e in\u00f3tropo se redujeron progresivamente y se logr\u00f3 extubar al paciente con \u00e9xito el d\u00eda 18 de enfermedad. Fue dado de alta para su traslado al domicilio."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 51-year-old man presented with fever, arthromyalgia, dyspnoea, and atypical chest pain, but no coughing or anosmia/ageusia. Troponin I was 2900 ng/mL, N-terminal pro-brain natriuretic peptide (NT-proBNP) was 900 pg/mL, C-reactive protein was 270 mg/L, and fibrinogen was >10 g/L. ECG showed non-specific T wave changes. Acute myocarditis was suspected. Two COVID-19 PCR tests on nasopharyngeal swabs were performed within 48 h, along with a chest CT, all being negative for the diagnosis of COVID-19. Serological tests showed past parvovirus B19 and Epstein\u2013Barr virus (EBV) infection. Other tests were negative (HBV, HCV, HIV, CMV, Coxsackie, HSV1, HSV2, VZV, VRS, and influenza virus). CMR was performed 8 days after the onset of symptoms, showing subepicardial oedema on the lateral/inferior left ventricular (LV) wall, with late gadolinium enhancement, consistent with acute myocarditis. Cine imaging showed preserved LVEF and volumes, no wall motion abnormalities, but a 5 mm thrombus was present at the LV apex. The unusual finding of a clot despite preserved LVEF and the profound biological signs of inflammation were interpreted as uncommon, and a COVID-19 serological test was thus performed. Results were positive for SARS-COV-2 on IgG and IgM. The patient was treated with tocilizumab.",
        "es": "Hombre de 51 a\u00f1os que refiri\u00f3 fiebre, artromialgia, disnea y dolor tor\u00e1cico at\u00edpico, pero sin tos ni anosmia/ageusia. Los valores de troponina I eran 200 ng/mL, de prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral 900 pg/mL, de prote\u00edna C-reactiva 270 mg/L y de fibrin\u00f3geno > 10 g/L. El ECG mostr\u00f3 cambios inespec\u00edficos en la onda T. El ecocardiograma no dio resultados relevantes. Se sospech\u00f3 miocarditis aguda. Se realizaron dos pruebas PCR para COVID-19 a partir de frotis nasofar\u00edngeos, en un intervalo de 48 horas, junto con una TAC tor\u00e1cica, y en ambos casos el resultado fue negativo para diagn\u00f3stico de COVID-19. Las pruebas serol\u00f3gicas mostraron infecciones previas por parvovirus B19 y virus de Epstein-Barr. Otras pruebas dieron resultado negativo (VHB, VHC, VIH, CMV, Coxsackie, VHS1, VHS2, VVZ, VSR y virus de la gripe). 8 d\u00edas despu\u00e9s del inicio de los s\u00edntomas se realiz\u00f3 una RMN card\u00edaca que mostr\u00f3 edema subepic\u00e1rdico en la pared del ventr\u00edculo izquierdo (VI) lateral/inferior, con realce tard\u00edo con gadolinio, coherentes con miocarditis aguda. Una radiocinematograf\u00eda mostr\u00f3 mantenimiento de la FEVI y de los vol\u00famenes, no se apreciaron alteraciones en el movimiento parietal pero se observ\u00f3 un trombo de 5 mm en la punta del VI. El hallazgo at\u00edpico de un trombo a pesar de una FEVI no alterada y los signos biol\u00f3gicos claros de inflamaci\u00f3n se valoraron como poco frecuentes y, en consecuencia, se realizaron pruebas serol\u00f3gicas para COVID-19. Los resultados fueron positivos para SARS-CoV-2 en IgG y IgM. Se trat\u00f3 al paciente con tocilizumab."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "a 46\u2010year\u2010old man with type I Brugada syndrome and arterial hypertension had been recently switched to ixekizumab 80\u00a0mg following secondary inefficacy of ustekinumab 45\u00a0mg for moderate\u2013severe chronic plaque psoriasis. One week after the first dose of ixekizumab, the patient developed fever and malaise. A nasopharyngeal swab resulted positive for SARS\u2010CoV\u20102. After 4\u00a0days from onset of symptoms, he presented to the Emergency Department with dyspnea and chest pain. Oxygen saturation was 90%, and thoracic ultrasound was consistent with bilateral interstitial pneumonia; chest x\u2010ray did not show lung opacities or pleural effusion. The patient was hospitalized and treated with hydroxychloroquine 400\u00a0mg BID p.o. the first day followed by 200mg BID, ceftriaxone 1g BID IM, and noninvasive continuous positive airway pressure (CPAP) in courses of prone ventilation. Antivirals were not given because of risk of arrhythmia. Fever remitted after 14\u00a0days, enabling transition from CPAP to low\u2010flow oxygen. The patient was discharged after 22\u00a0days, with 97% oxygen saturation on walking test. Two repeated SARS\u2010CoV\u20102 nasopharyngeal swabs resulted negative 30\u00a0days from diagnosis.",
        "es": "Hombre de 46 a\u00f1os con s\u00edndrome de Brugada de tipo I e hipertensi\u00f3n arterial. Recientemente hab\u00eda cambiado su medicaci\u00f3n a 80 mg de ixekizumab, tras ineficacia secundaria de 45 mg de ustekinumab para psoriasis cr\u00f3nica en placas moderada o grave. Una semana despu\u00e9s de la primera dosis de ixekizumab, el paciente present\u00f3 fiebre y malestar. Un frotis nasofar\u00edngeo dio positivo para SARS-CoV-2. Tras 4 d\u00edas desde el inicio de los s\u00edntomas, acudi\u00f3 al servicio de urgencias con disnea y dolor tor\u00e1cico. La saturaci\u00f3n de ox\u00edgeno era del 90%; una ecograf\u00eda tor\u00e1cica fue consistente con neumon\u00eda intersticial bilateral; la radiograf\u00eda tor\u00e1cica no mostr\u00f3 opacidades pulmonares ni derrame pleural. El paciente fue hospitalizado y se trat\u00f3 con 400 mg de hidroxicloroquina dos veces al d\u00eda por v\u00eda oral el primer d\u00eda, seguida de 200 mg dos veces al d\u00eda, 1 g de ceftriaxona dos veces al d\u00eda por v\u00eda intramuscular y ventilaci\u00f3n mec\u00e1nica positiva continua (PPC) no invasiva en ciclos de ventilaci\u00f3n en dec\u00fabito prono. No se le administraron antiv\u00edricos a causa del riesgo de arritmia. La fiebre remiti\u00f3 despu\u00e9s de 14 d\u00edas, lo que permiti\u00f3 pasar de la PPC a oxigenoterapia de bajo flujo. El paciente fue dado de alta a los 22 d\u00edas, con una saturaci\u00f3n de ox\u00edgeno del 97% en la prueba de la marcha. Dos frotis nasofar\u00edngeos repetidos para SARS-CoV-2 resultaron negativos a los 30 d\u00edas del diagn\u00f3stico."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 69-year-old male with known COVID-19 presented to the emergency department with constant mid-epigastric pain, constipation, and eructation. Physical examination revealed a temperature of 36.7 C, blood pressure of 185/110 mm Hg, pulse of 115 beats per minute, respiratory rate of 17 breaths per minute, and oxygen saturation of 95%. CT angiogram demonstrated a thrombus in the proximal segment of the superior mesenteric artery (SMA) with complete occlusion in the right ileocolic branches. The patient underwent a small bowel resection and SMA thromboembolectomy. Histopathology from the thromboembolectomy showed organizing thrombus while the bowel showed extensive mucosal necrosis and transmural inflammation consistent with marked ischemic-type injury. Electron microscopy showed viral particles clustered within membrane-bound cisternal spaces in enterocytes. Postoperatively, the patient\u2019s clinical course improved dramatically and he was eventually discharged for ongoing self-isolation.",
        "es": "Un hombre de 69 a\u00f1os con COVID-19 confirmada acudi\u00f3 al servicio de urgencias con dolor epig\u00e1strico constante, estre\u00f1imiento y eructos. La exploraci\u00f3n f\u00edsica mostr\u00f3 una temperatura de 36,7 \u00b0C, presi\u00f3n arterial de 185/110 mm Hg, pulso de 115 l.p.m., frecuencia respiratoria de 17 r.p.m. y saturaci\u00f3n de ox\u00edgeno del 95%. Una angiograf\u00eda por TAC revel\u00f3 un trombo en el segmento proximal de la arteria mesent\u00e9rica superior, con oclusi\u00f3n completa en las ramas ileocecales derechas. El paciente se someti\u00f3 a una resecci\u00f3n del intestino delgado y tromboembolectom\u00eda de la arteria mesent\u00e9rica superior. El an\u00e1lisis histopatol\u00f3gico de la tromboembolectom\u00eda mostr\u00f3 trombos organizados mientras que el intestino mostr\u00f3 necrosis mucosa extensa e inflamaci\u00f3n transparietal coherente con una lesi\u00f3n isqu\u00e9mica. La microscop\u00eda electr\u00f3nica mostr\u00f3 part\u00edculas v\u00edricas agrupadas dentro de los espacios cisternales delimitados por la membrana en los enterocitos. En el posoperatorio, el estado cl\u00ednico del paciente mejor\u00f3 considerablemente y, finalmente, fue dado de alta para confinamiento domiciliario."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 20-year old previously well man was brought to hospital following a seizure. For three days he had complained of myalgia, lethargy and fever. On attempting to get out of bed at home, he had experienced lightheadedness with blurred and double vision and felt his legs were too weak to allow him walk. He then had a generalised tonic-clonic seizure, which lasted one minute. In the wake of the seizure he was confused and aggressive, requiring intravenous midazolam in the emergency department. He was febrile (101.3 F) with heart rate 85bpm, respiratory rate 12, and sO2 97 % on room air. Respiratory examination was normal. His confusion resolved within six hours with no deficits and a normal neurological examination. He was isolated and treated with levetiracetam, aciclovir, ceftriaxone and vancomycin for possible central nervous system (CNS) infection. There was no prior history of seizures or epilepsy; psychomotor delay; head injury or CNS infection and no history of recent travel. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza was negative and isolation precautions were discontinued. Routine blood tests were largely unremarkable. Chest x-ray was normal. A CT brain and MRI brain were unremarkable, apart from mild mucosal thickening noted in the sphenoid sinus. CSF analysis demonstrated a lymphocytic pleocystosis (21 cells/mm3, 99 % mononuclear, 1% polymorphs) with normal protein and glucose. CSF culture demonstrated no growth and PCR for herpes simplex virus, varicella zoster virus, and enterovirus was negative. Within two days of his admission, the patient\u2019s wife developed respiratory symptoms and tested positive for SARS-CoV-2 at another hospital. The patient was isolated again and a repeat nasopharyngeal swab for SARS-CoV-2 was positive. CSF PCR for SARS-CoV-2 was negative. The patient remained well and was discharged home. EEG, performed on outpatient follow-up for infection control reasons, was normal.",
        "es": "Un hombre de 20 a\u00f1os, por lo dem\u00e1s sano, fue llevado al hospital tras una crisis epil\u00e9ptica. Durante tres d\u00edas se hab\u00eda quejado de mialgia, letargia y fiebre. Al intentar levantarse de la cama en su hogar, hab\u00eda tenido sensaci\u00f3n de mareo con visi\u00f3n borrosa y diplopia y not\u00f3 una debilidad en las piernas que le imped\u00eda andar. A continuaci\u00f3n, sufri\u00f3 una crisis tonicocl\u00f3nica generalizada, que dur\u00f3 un minuto. Tras la crisis, se mostr\u00f3 desorientado y agresivo, lo que requiri\u00f3 administraci\u00f3n de midazolam i.v. en urgencias. Ten\u00eda fiebre (38,5 C), pulso de 85 l.p.m., frecuencia respiratoria de 12 r.p.m. y sO2 de 97% en aire ambiental. La exploraci\u00f3n respiratoria fue normal. Su desorientaci\u00f3n remiti\u00f3 a las seis horas, sin carencias y una exploraci\u00f3n neurol\u00f3gica normal. Se aisl\u00f3 al paciente y se le trat\u00f3 con levetiracetam, aciclovir, ceftriaxona y vancomicina por posible infecci\u00f3n del sistema nervioso central (SNC). No ten\u00eda antecedentes de crisis o epilepsia, enlentecimiento psicomotor, traumatismo craneal ni infecciones del SNC, as\u00ed como tampoco de desplazamientos recientes. Un frotis nasofar\u00edngeo para pruebas de coronavirus 2 (SARS-CoV-2) y de gripe result\u00f3 negativo, de modo que se retiraron las precauciones de aislamiento. Los an\u00e1lisis de sangre habituales dieron resultados irrelevantes. La radiograf\u00eda tor\u00e1cica era normal. Una TAC y una RMN cerebrales no fueron significativas, excepto por un ligero engrosamiento mucoso apreciado en los senos esfenoidales. El an\u00e1lisis del LCR mostr\u00f3 pleocitosis linfoc\u00edtica (21 c\u00e9lulas/mm3, 99% mononucleares, 1% polim\u00f3rficas) con valores normales de prote\u00ednas y glucosa. El cultivo de LCR no mostr\u00f3 crecimientos y la PCR para virus del herpes simple, virus de la varicela z\u00f3ster y enterovirus fue negativa. A los dos d\u00edas del ingreso, la esposa del paciente mostr\u00f3 s\u00edntomas respiratorios y dio positivo en una prueba de SARS-CoV-2 en otro hospital. El paciente fue aislado de nuevo y un nuevo frotis nasofar\u00edngeo para SARS-CoV-2 dio resultado positivo. La PCR del LCR para detecci\u00f3n de SARS-CoV-2 fue negativa. El paciente continu\u00f3 en buen estado y fue dado de alta. El EEG realizado durante el seguimiento ambulatorio para control de infecciones, result\u00f3 normal."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 19-year old female presented to the emergency department with a 4-day history of fever (38.5\u00b0C), followed by chest pain and cutaneous rash. She was tachycardic (120 b.p.m.) and had an oxygen saturation of 97% in ambient air. Thorax and abdominal examination were normal. Skin examination showed a rash consisting in slightly erythematous confluent macules, involving the trunk and the limbs. On the palms and soles the macules merged into sharply edged areas of erythema with islands of spared skin. Chest X-ray and thoracic CT-scan were both negative. Electrocardiography showed sinus tachycardia and diffuse ST-segment elevation; troponin T level was 367 ng/L. Echocardiography demonstrated normal ventricular function, with no signs of pericardial effusion. A diagnosis of acute myopericarditis was made. Laboratory tests showed leucocytosis (18.2 x 10 9/L) with 6% of lymphocytes, and normal levels of hemoglobin, platelet count and lactic dehydrogenase. C-reactive protein (23.10 mg/L), as well as D-dimer (1095 ng/mL) and fibrinogen (974 mg/dL) levels were elevated. A screening for autoimmune diseases was negative. Serology ruled out Mycoplasma pneumoniae, Epstein-Barr virus, Cytomegalovirus, Coxsackievirus, Parvovirus B19, Hepatitis A-B-C virus, Treponema pallidum and Human Immunodeficiency Virus infection. Blood cultures were negative. Real-time reverse transcriptase-polymerase chain reaction assay on a nasopharyngeal swab specimen was positive forCOVID-19, while negative for Adenovirus, other Coronaviruses, Human Enterovirus, Influenza and  Parainfluenza Virus. Treatment was started with ceftriaxone, low molecular weight heparin, acetylsalicylic acid, pantoprazole, hydroxychloroquine and lopinavir-ritonavir. Antiviral and hydroxychloroquine therapy was discontinued after 2 days because of nausea, diarrhea and anemia. Colchicine (0,5 mg twice a day) was started, with a complete resolution of the cutaneous lesions, ECG normalization and progressive apyrexia. On day 8 nasopharyngeal swab was negative for COVID-19, and the patient was discharged.",
        "es": "Una mujer de 19 a\u00f1os acudi\u00f3 al servicio de urgencias con fiebre (38,5\u00b0C) de 4 d\u00edas de evoluci\u00f3n, seguida de dolor tor\u00e1cico y exantema cut\u00e1neo. Ten\u00eda taquicardia (120 l.p.m.) y una saturaci\u00f3n de ox\u00edgeno de 97% en aire ambiental. La exploraci\u00f3n tor\u00e1cica y abdominal fue normal. La exploraci\u00f3n cut\u00e1nea revel\u00f3 un exantema consistente en m\u00e1culas confluentes ligeramente eritematosas que afectaban al tronco y las extremidades. En las palmas y plantas, las m\u00e1culas se un\u00edan formando \u00e1reas claramente delimitadas de eritema, con islas de piel no afectada. La radiograf\u00eda tor\u00e1cica y la TAC tor\u00e1cica no dieron resultados relevantes. Un electrocardiograma revel\u00f3 taquicardia sinusal y elevaci\u00f3n difusa del segmento ST; el valor de troponina T era 367 ng/L. El electrocardiograma mostr\u00f3 actividad ventricular normal, sin signos de derrame peric\u00e1rdico. Se diagnostic\u00f3 miopericarditis aguda. Las pruebas anal\u00edticas mostraron leucocitosis (18,2 x 10 9/L) con 6% de linfocitos y valores normales de hemoglobina, trombocitos y lactato-deshidrogenasa. Los valores de prote\u00edna C-reactiva (23,10 mg/L), d\u00edmero D (1095 ng/mL) y fibrin\u00f3geno (974 mg/dL) eran altos. Las pruebas para enfermedades autoinmunitarias fueron negativas. Las pruebas serol\u00f3gicas descartaron infecciones por Mycoplasma pneumoniae, virus de Epstein-Barr, citomegalovirus, virus Coxsackie, parvovirus B19, virus de la hepatitis A-B-C, Treponema pallidum y VIH. Los hemocultivos resultaron negativos. Una prueba de PCR a partir de una muestra de frotis nasofar\u00edngeo fue positiva para COVID-19, a la vez que negativa para adenovirus, otros coronavirus, enterovirus humano, virus de la gripe y virus paragripal. Se inici\u00f3 tratamiento con ceftriaxona, heparina de bajo peso molecular, \u00e1cido acetilsalic\u00edlico, pantoprazol, hidroxicloroquina y lopinavir/ritonavir. La terapia antiv\u00edrica y la hidroxicloroquina se interrumpieron despu\u00e9s de 2 d\u00edas a causa de la aparici\u00f3n de n\u00e1useas, diarrea y anemia. Se inici\u00f3 administraci\u00f3n de colquicina (0,5 mg dos veces al d\u00eda), con una resoluci\u00f3n completa de las lesiones cut\u00e1neas, normalizaci\u00f3n del ECG y apirexia progresiva. El d\u00eda 8, un frotis nasofar\u00edngeo result\u00f3 negativo para COVID-19 y la paciente fue dada de alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A  35-year-old  woman  with  no  significant  previous  medical  history  presented  at  the Emergency Department of Fundaci\u00f3n Jim\u00e9nez D\u00edaz Hospital (Madrid, Spain) on April 14 with acral  purpuric  lesions  of  three  weeks  duration. These  had  started  as  oedematous,  erythematous areas and had appeared coincidentally with fever and coughing, which lasted only two days. There was no history of diarrhoea, ageusia, hyposmia or dyspnea. The patient stated that the skin of her feet acquired a  bluish discoloration after  standing for some  time. On examination,  arterial  pedal pulses were not palpable, and violaceous areas were seen on the dorsa of several toes on both feet. An ultrasound study ruled out vascular thrombosis. A nasopharyngeal swab RT-PCR study for SARS-CoV-2 RNA and an immunochromatographic  assay  kit  for serum IgG and IgM antibodies performed the same day were negative. A skin biopsy obtained while in the Emergency Department  showed  mild  perivascular  and  periadnexal  lymphocytic  inflammation  and  focal thrombosis of a small vessel. There was mild erythrocyte extravasation and occasional evidence of endothelial damage, but no overt vasculitis was identified. Employing a commercially available  antibody  (SARS-CoV/SARS-CoV-2  spike  1A9,  GeneTex.,  Inc.,  Irvine,  California, USA),  optimized  in  our  laboratory,  viral  spike  protein  was  distinctly  detected  by  conventional immunohistochemistry  as  fine  to  coarse,  bright  red  granular  deposits  in  the  cytoplasm  of cutaneous  dermal  vessels  and  eccrine  cells  (both  secretory  and  excretory). Appropriate negative and positive controls were performed: adult tonsil, a chilblain specimen from early 2019, biopsies from non-COVID-19 related inflammatory dermatoses and substitution of the antibody  with  saline  serum  as  negative  controls,  and  a  post-mortem  lung  specimen  from  a COVID-19 patient as positive control. Perivascular deposits of C5b9, C3 and  C1q  were  seen  on  direct  immunofluorescence  study  of  formalin-fixed,  paraffin-embedded tissue. Treatment with low-molecular weight heparin and low-dose aspirin was started; the lesions subsequently  healed,  and  at  the  time  of  latest  follow-up  (June  7)  the  patient  had  recovered completely and pedal pulses were palpable. A second serologic study (two months after beginning of the disease), this time by Enzyme-Linked Immunosorbent Assay, was negative for IgG and IgM against SARS-CoV-2.",
        "es": "Mujer de 35 a\u00f1os sin antecedentes relevantes que acudi\u00f3 al servicio de urgencias del Hospital de la Fundaci\u00f3n Jim\u00e9nez D\u00edaz (Madrid) el 14 de abril, con lesiones purp\u00faricas acras de tres semanas de evoluci\u00f3n. Hab\u00edan aparecido como zonas edematosas y eritematosas concurrentes con fiebre y tos, que dur\u00f3 solo dos d\u00edas. No hab\u00eda antecedentes de diarrea, ageusia, hiposmia o disnea. La paciente refiri\u00f3 que, tras estar de pie durante un rato, la piel de sus pies adquir\u00eda una coloraci\u00f3n azulada. A la exploraci\u00f3n, el pulso pedio no era palpable y se pod\u00edan apreciar zonas viol\u00e1ceas en el dorso de varios dedos de ambos pies. Una ecograf\u00eda descart\u00f3 trombosis vascular. Un ensayo RT-PCR para SARS-CoV-2 a partir de frotis nasofar\u00edngeo y un ensayo inmunocromatogr\u00e1fico para anticuerpos s\u00e9ricos IgG e IgM, realizados el mismo d\u00eda, dieron resultado negativo. Una biopsia cut\u00e1nea obtenida en el servicio de urgencias mostr\u00f3 leve inflamaci\u00f3n linfoc\u00edtica perivascular y perianexial y trombosis focal microvascular. Se apreci\u00f3 una leve extravasaci\u00f3n eritroc\u00edtica y evidencias auxiliares de lesiones endoteliales, pero no se observ\u00f3 vasculitis manifiesta. Mediante un kit comercial (SARS-CoV/SARS-CoV-2 esp\u00edcula 1A9, GeneTex Inc., Irvine, California, EE. UU. Se realizaron los controles negativos y positivos pertinentes: am\u00edgdala adulta, una muestra de eritema pernio de principios de 2019, biopsias de dermatosis inflamatorias no asociadas a COVID-19 y sustituci\u00f3n del anticuerpo por suero salino como controles negativos, as\u00ed como una muestra pulmonar postm\u00f3rtem de un paciente de COVID-19 como control positivo. Se observaron dep\u00f3sitos perivasculares de C5b9, C3 y C1q en un estudio de inmunofluorescencia de tejido parafinado fijado con formalina. Se inici\u00f3 un tratamiento con heparina de bajo peso molecular y una dosis baja de aspirina; las lesiones se curaron y en el momento del \u00faltimo control (7 de junio), la paciente se hab\u00eda recuperado completamente y el pulso pedio era palpable. Un segundo estudio serol\u00f3gico (dos meses tras el inicio de la enfermedad), esta vez mediante ensayo de inmunoadsorci\u00f3n enzim\u00e1tica (ELISA), dio resultado negativo para IgG e IgM de SARS-CoV-2."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "11-year-old previously well child who presented with status epilepticus requiring four anticonvulsant medications and cerebrospinal fluid evidence for encephalitis (921 red cells, 16 white cells, 8% neutrophils [normal 0% to 6%] with protein of 97 [normal: 40 to 170 mg/dL], and glucose of 92 [normal: 20 to 100 mg/dL]). He had a two-day history of generalized weakness without respiratory symptoms or fever at home; emergency room temperature was 102.7_F. Head computed tomography was negative. Electroencephalography revealed frontal intermittent delta activity. Nasopharyngeal swab was positive for COVID-19 as well as rhinovirus/enterovirus but the latter was absent in cerebrospinal fluid polymerase chain reaction. Recovery without treatment was complete in six days.",
        "es": "Se present\u00f3 un ni\u00f1o de 11 a\u00f1os, por lo dem\u00e1s sano, con estado epil\u00e9ptico que requiri\u00f3 anticonvulsivos; el l\u00edquido cefalorraqu\u00eddeo mostr\u00f3 evidencias de encefalitis (921 eritrocitos, 16 leucocitos, 8% neutr\u00f3filos [normal entre 0 y 6%], con prote\u00edna de 97 [normal: de 40 a 170 mg/dL] y glucosa de 92 [normal: de 20 a 100 mg/dL]). Presentaba dos d\u00edas de evoluci\u00f3n de debilidad generalizada sin s\u00edntomas respiratorios ni fiebre; la temperatura en urgencias era de 39,3 \u00baC. Una TAC craneal no dio resultados de relevancia. Un electroencefalograma revel\u00f3 actividad delta frontal intermitente. Un frotis nasofar\u00edngeo fue positivo para COVID-19 y para rinovirus/enterovirus, pero estos \u00faltimos no se hallaron en PCR del l\u00edquido cefalorraqu\u00eddeo. El paciente se recuper\u00f3 por completo sin necesidad de tratamiento al cabo de seis d\u00edas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 67-year-old man was admitted with fever, cough, nasal congestion, sore throat, and diarrhea 20 months after an uneventful heart transplantation. Chest computed tomography (CT) showed bilateral multifocal peripheral ground-glass opacities (GGOs). White blood cell count was 4,720/ml with lymphocyte count of 1,040/ml. Blood cultures and cytomegalovirus polymerase chain reaction (PCR) were unremarkable. C-reactive protein (CRP) was 0.55 mg/dl. Nasopharyngeal PCR for SARS-CoV-2 was positive, consistent with COVID-19 illness. Immunosuppression included 500 mg mycophenolate twice daily (BID) and tacrolimus with trough level of 7.6 ng/ml at admission. Tacrolimus was maintained for a goal level of 7\u201210 ng/ml. He continued to have intermittent fevers but was never hypoxic. Chest CT on Day 6 showed worsening GGOs. Hydroxychloroquine was started on Day 7 (400 mg BID on the first day, then 200 mg BID for 4 days). He was discharged on Day 9. He was readmitted after 2 days with confusion, anorexia, and emesis. He was alert, oriented only to person, and febrile. He had no previous history of delirium or encephalopathy and was on stable home dose of venlafaxine for the treatment of a history of depression. Examination was notable for postural and action tremor, without focal neurologic deficits. CRP was increased to 10.7 mg/dl with a mild elevation in aspartate transaminase and alanine transaminase to a maximum of 74 U/liter and 79 U/liter, respectively. Serum ammonia and thyroid-stimulating hormone were normal. Serum sodium was decreased to 133 milliequivalents/liter (normal range 135\u2212145 milliequivalents/liter)but returned to normal by Day 2 of readmission. Blood urea nitrogen and serum creatinine were 42 mg/dl and 1.73 mg/dl, respectively, unchanged from baseline. Trough tacrolimus level at readmission was 11.5 ng/ml and averaged to 10 \u00a7 1.2 ng/ml during the admission. Hydroxychloroquine was discontinued. CT scan of the head was unremarkable. Chest CT showed minimal progression of GGOs. Brain magnetic resonance imaging showed mild scattered foci of peri-ventricle deep and sub-cortical white matter ischemia. There was no evidence of encephalitis, posterior reversible encephalopathy, or leukoencephalopathy. Repeat magnetic resonance imaging after 1 week was unchanged. Electroencephalogram showed mild non-specific diffuse multifocal cerebral dysfunction with no seizure seen. Lumbar puncture showed 1 lymphocyte, normal protein, and glucose. Cerebrospinal fluid (CSF) was negative for herpes simplex PCR and Cryptococcus antigen. PCR of CSF, not validated for the detection of SARSCoV-2, was negative. By Day 16, CRP began to decline. Mental status slowly improved, and he was discharged 13 days after readmission. Executive function and memory remained poor but gradually returned to normal approximately 45 days after the onset of the encephalopathy.",
        "es": "Un hombre de 67 a\u00f1os ingres\u00f3 con fiebre, tos, congesti\u00f3n nasal, irritaci\u00f3n de garganta y diarrea, 20 meses despu\u00e9s de un trasplante card\u00edaco sin complicaciones. No se hallaba hip\u00f3xico. Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado perif\u00e9ricas, multifocales y bilaterales. La cifra de leucocitos era de 4720/ml, con una cifra de linfocitos de 1040/ml. Los hemocultivos y la PCR para citomegalovirus no dieron resultados relevantes. El valor de prote\u00edna C-reactiva era de 0,55 mg/dl. Una PCR de frotis nasofar\u00edngeo para SARS-CoV-2 result\u00f3 positiva, coherente con enfermedad por COVID-19. La pauta de inmunosupresi\u00f3n consist\u00eda en 500 mg de micofenolato dos veces al d\u00eda y tacrolimus a una concentraci\u00f3n m\u00ednima de 7,6 ng/ml al ingreso. Se retir\u00f3 el micofenolato y se mantuvo el tacrolimus con una concentraci\u00f3n objetivo de 7-10 ng/ml. El paciente continu\u00f3 con fiebre intermitente pero en ning\u00fan momento padeci\u00f3 hipoxia. Una TAC tor\u00e1cica el d\u00eda 6 mostr\u00f3 un empeoramiento de las opacidades de vidrio esmerilado. El d\u00eda 7 se inici\u00f3 una pauta de hidroxicloroquina (400 mg dos veces al d\u00eda el primer d\u00eda, luego 200 mg dos veces al d\u00eda durante 4 d\u00edas). Fue dado de alta el d\u00eda 9. Ingres\u00f3 de nuevo despu\u00e9s de dos d\u00edas, con desorientaci\u00f3n, anorexia y v\u00f3mitos. Se hallaba consciente, orientado solo respecto a personas y febril. No ten\u00eda antecedentes de delirio confusional ni de encefalopat\u00eda y estaba bajo tratamiento con venlafaxina por depresi\u00f3n. La exploraci\u00f3n revel\u00f3 temblor intencional y postural, sin carencias neurol\u00f3gicas focales. El valor de prote\u00edna C-reactiva era alto, con 10,7 mg/dl, y presentaba una ligera elevaci\u00f3n de la aspartato-aminotransferasa y la alanino-aminotransferasa con 74 U/litro y 79 U/litro, respectivamente. El amoniaco s\u00e9rico y la TSH ten\u00edan valores normales. El sodio s\u00e9rico presentaba un valor bajo, de 133 miliequivalentes/litro (intervalo normal: 135-145 miliequivalentes/litro),pero recuper\u00f3 valores normales el d\u00eda 2 del reingreso. El nitr\u00f3geno ureico y la creatinina s\u00e9rica ten\u00edan valores de 42 mg/dl y de 1,73 mg/dl, respectivamente, sin cambios respecto a los valores basales. La concentraci\u00f3n m\u00ednima de tacrolimus al reingreso era de 11,5 ng/ml, promediado a 10 \u00a7 1,2 ng/ml durante el ingreso. Se retir\u00f3 la hidroxicloroquina. Una TAC craneal no dio resultados relevantes. Una TAC tor\u00e1cica mostr\u00f3 un empeoramiento m\u00ednimo de las opacidades de vidrio esmerilado. Una RMN cerebral mostr\u00f3 leves focos dispersos de isquemia de sustancia blanca subcortical y periventricular profunda. No hab\u00eda evidencia de encefalitis, encefalopat\u00eda posterior reversible ni leucoencefalopat\u00eda. Una nueva RMN una semana despu\u00e9s no mostr\u00f3 cambios. Un electroencefalograma revel\u00f3 leves alteraciones cerebrales multifocales difusas e inespec\u00edficas, sin evidencia de crisis. Una punci\u00f3n lumbar dio valores normales de linfocitos, prote\u00ednas y glucosa. El an\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo fue negativo en PCR para herpes simple y para ant\u00edgenos de criptococo. La PCR del LCR, no validada para detecci\u00f3n de SARS-CoV-2, fue negativa. El d\u00eda 16, los valores de prote\u00edna C-reactiva empezaron a disminuir. El estado mental fue mejorando lentamente y el paciente fue dado de alta 13 d\u00edas despu\u00e9s del reingreso. La funci\u00f3n intencional y la memoria continuaron deficientes, pero se recuperaron gradualmente hasta la normalidad unos 45 d\u00edas despu\u00e9s del inicio de la encefalopat\u00eda."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "We describe the case of a 74-year-old man with a past history of hypertension, type 2 diabetes mellitus, and ischemic stroke who underwent a thrombectomy in 2017. He had been in solitary confinement since returning from a trip to a COVID-19 risk area 13 days earlier. He presented at the emergency room with general malaise and shortness of breath. He had had flu-like symptoms and fever for 2 days before admission, as well as self-limiting chest pain. On arrival at the emergency room, the patient had severe hypoxemic respiratory failure and was administered oxygen via a high-flow nasal cannula. His condition progressively worsened and he required endotracheal intubation and invasive mechanical ventilation. The admission electrocardiogram showed sinus tachycardia with minimal isolated ST-segment elevation in lead III and ST-segment depression in V2-V4. The tachycardia was not observed on successive electrocardiograms. The chest radiograph showed mainly peripheral cotton-wool infiltrates in both pulmonary fields, and the admission blood test showed acute kidney failure (creatinine, 2\u00a0mg/dL), and significant enzyme elevation with a creatine kinase MB level of 731\u00a0U/L and a high-sensitivity cardiac troponin T level of 1162\u00a0ng/L. Elevated levels were also observed for interleukin 6 (135\u00a0pg/mL), ferritin (145\u00a0\u03bcg/L), lactate dehydrogenase (992\u00a0U/L), D-dimer (55\u00a0mcg/mL), and N-terminal pro-brain natriuretic peptide (4076\u00a0pg/mL). A transthoracic echocardiogram was performed and showed left ventricular dysfunction with inferolateral hypokinesis. Given the high index of suspicion for COVID-19 based on the clinical presentation and the patient's recent trip, the patient was tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and tested positive. In the following hours, the patient developed clear hemodynamic deterioration followed by mixed shock, which required initiation of vasoactive support with noradrenaline up to a dose of 0.44\u00a0mg/kg/min. Emergency cardiac catheterization showed 3-vessel coronary artery disease with acute thrombotic occlusion of the right coronary artery. This was treated with percutaneous coronary intervention and the placement of 2 drug-eluting stents; the thrombus migrated to the posterior descending artery. The patient was administered dual antiplatelet therapy (aspirin and clopidogrel) and anticoagulation with sodium heparin. He was also started on hydroxychloroquine and tocilizumab. His condition progressed slowly over the following hours, with further hemodynamic deterioration. We therefore decided to perform a computed tomography scan of the chest and abdomen, which showed multiple arterial thrombosis and findings consistent with mesenteric ischemia, splenic infarction, and pulmonary thromboembolism (28%). The patient died 72\u00a0hours after admission.",
        "es": "Se describe el caso de un hombre de 74 a\u00f1os con antecedentes de hipertensi\u00f3n, diabetes tipo 2 e ictus isqu\u00e9mico, que se someti\u00f3 a una trombectom\u00eda en el 2017. Hab\u00eda estado en confinamiento en solitario desde su regreso de un viaje a una zona de riesgo de COVID-19 13 d\u00edas antes. Acudi\u00f3 a urgencias con malestar general y disnea. Hab\u00eda tenido s\u00edntomas paragripales y fiebre de dos d\u00edas de evoluci\u00f3n antes del ingreso, as\u00ed como dolor tor\u00e1cico de resoluci\u00f3n espont\u00e1nea. A su ingreso en urgencias, el paciente presentaba insuficiencia respiratoria hipox\u00e9mica grave y se le administr\u00f3 ox\u00edgeno mediante una c\u00e1nula nasal de alto flujo. Su estado empeor\u00f3 progresivamente y necesit\u00f3 intubaci\u00f3n endotraqueal y ventilaci\u00f3n mec\u00e1nica invasiva. El electrocardiograma al ingreso mostr\u00f3 taquicardia sinusal con m\u00ednima elevaci\u00f3n del segmento ST aislada en la derivaci\u00f3n III y descenso del segmento ST en V2-V4. En electrocardiogramas posteriores no se apreci\u00f3 taquicardia. La radiograf\u00eda tor\u00e1cica mostr\u00f3 infiltrados algodonosos b\u00e1sicamente perif\u00e9ricos en ambos campos pulmonares, y los an\u00e1lisis de sangre al ingreso revelaron insuficiencia renal aguda (creatinina 2 mg/dL) y aumento significativo de enzimas, con un valor de creatina-cinasa de 731 U/L y un valor de troponina cardiaca ultrasensible T de 1162 ng/L. Tambi\u00e9n se observaron valores altos de interleucina 6 (135 pg/mL), ferritina (145\u03bcg/L), lactato-deshidrogenasa (992U/L), d\u00edmero D (55mcg/mL) y prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral (4076pg/mL). Un ecocardiograma transtor\u00e1cico mostr\u00f3 disfunci\u00f3n ventricular izquierda con hipocinesis inferolateral. Teniendo en cuenta las altas posibilidades de COVID-19 a partir del cuadro cl\u00ednico y el reciente viaje del paciente, se hizo una prueba para s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 (SARS-CoV-2), con resultado positivo. En las horas siguientes, el paciente sufri\u00f3 un claro deterioro hemodin\u00e1mico seguido de un choque mixto, que requiri\u00f3 apoyo vasoactivo con noradrenalina con una dosis m\u00e1xima de 0,44 mg/kg/min. Una cateterizaci\u00f3n card\u00edaca de urgencia mostr\u00f3 arteriopat\u00eda coronaria trivascular con oclusi\u00f3n tromb\u00f3tica de la arteria coronaria derecha. Se trat\u00f3 mediante intervenci\u00f3n coronaria percut\u00e1nea y la colocaci\u00f3n de dos stents farmacoactivos; el trombo migr\u00f3 a la arteria descendente posterior. Al paciente se le administraron antiagregantes plaquetarios (aspirina y clopidogrel) y anticoagulantes con heparina s\u00f3dica. Tambi\u00e9n se inici\u00f3 una pauta con hidroxicloroquina y tocilizumab. Su estado empeor\u00f3 progresivamente durante las siguientes horas, con deterioro hemodin\u00e1mico. Se decidi\u00f3 realizar una TAC tor\u00e1cica y abdominal, que mostr\u00f3 m\u00faltiples trombosis arteriales y resultados coherentes con isquemia mesent\u00e9rica, infarto espl\u00e9nico y tromboembolia pulmonar (28%). El paciente muri\u00f3 72 horas despu\u00e9s del ingreso."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 21-year-old man presented to the emergency department with progressive 4-day history of fever, cough, dyspnea, diarrhea, nausea, headache, and sinonasal congestion. Aside from a medical history of hypertension, prediabetes, and class I obesity, the patient was otherwise healthy and denied tobacco, alcohol, substance abuse, or recent travel. Vital signs were remarkable for a body temperature of 37.5\u00b0C, blood pressure of 116/57\u2009mm Hg, pulse of 76 beats per minute, and oxygen saturation of 95% on room air. Neurologic examination was intact. Chest radiographs demonstrated patchy bilateral air space opacities without lobar consolidation. A nasopharyngeal swab was performed, and a respiratory pathogen panel was negative for all tested pathogens. Additionally, nasopharyngeal and oropharyngeal swab specimens were sent to an outside private laboratory for SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction (PCR) assay. He was discharged home with pulse oximetry monitoring, self-isolation instructions, and strict return precautions. During the next 24\u2009hours, the patient experienced increased dizziness with oxygen saturation falling into the mid-80s documented by pulse oximetry. He returned to the emergency department febrile (body temperature of 39.1\u00b0C), mildly tachycardic (102 beats per minute), tachypneic (28 breaths per minute), and hypoxic (89% on room air). Chest radiographs demonstrated increased bilateral air space opacities, and a complete blood count revealed lymphopenia (absolute lymphocyte count of 0.7 K/mm3). He was admitted for oxygen support and monitoring, and blood oxygenation was weaned from 2 L by nasal canula to room air. He was discharged home on hospital day 4, and his sent-out testing confirmed COVID-19 positivity the day after discharge. He initially did well with convalescence at home, but on day 16 of illness, he began to experience right-sided facial numbness and weakness. During 24\u2009hours, his symptoms became bilateral and resulted in severe dysarthria, necessitating a return to the emergency department. Neurologic examination demonstrated a bilateral lower motor neuron pattern of facial weakness with otherwise normal cranial nerve (CN) examination findings, preserved strength and sensation in all extremities, and intact muscle stretch reflexes. He was admitted for observation and underwent MR imaging of the brain and temporal bones, as well as fluoroscopically guided lumbar puncture for CSF sampling. The CSF was negative for bacterial culture and stain and demonstrated normal glucose levels (65 mg/dL), no leukocytes, and mildly elevated protein levels (49\u2009mg/dL). MR imaging demonstrated abnormal enhancement of the facial and abducens nerves bilaterally, as well as the right oculomotor nerve. The patient was discharged with stable facial weakness, no progression of symptoms, and oxygen saturation of 99% on room air. Neurology outpatient follow-up was arranged with multiple CSF and serum lab results pending. On day 19 of illness, he reported new subjective bilateral lower extremity weakness, bilateral upper extremity paresthesia, and continued facial weakness, prompting readmission for further work-up and treatment. Repeat neurologic examination demonstrated unchanged bifacial weakness, but new grade 4/5 weakness in the deltoids and hip flexors bilaterally, as well as diffuse areflexia. MR imaging of the total spine was performed, which did not reveal any suspicious spinal cord signal abnormality or abnormal enhancement of the cord or cauda equina. Electromyography and nerve conduction studies demonstrated findings consistent with an acute sensorimotor polyneuropathy with both demyelinating and axonal features. For religious reasons, he declined treatment with intravenous immunoglobulin (Ig) and alternatively underwent treatment with 5 cycles of plasma exchange, which he tolerated well with slight improvement in facial weakness and paresthesia. Findings of CSF labs and serologies remained negative except for serum herpes simplex virus (HSV), immunoglobulin G (IgG), and immunoglobulin M (IgM), and the patient was discharged to inpatient rehabilitation. He declined a repeat lumbar puncture that was offered before discharge.",
        "es": "Hombre de 21 a\u00f1os que acudi\u00f3 al servicio de urgencias con fiebre, tos, disnea, diarrea, n\u00e1useas, cefalea y congesti\u00f3n nasal de 4 d\u00edas de evoluci\u00f3n. Aparte de antecedentes de hipertensi\u00f3n, prediabetes y obesidad de clase I, el paciente ten\u00eda buen estado de salud y afirmaba no fumar ni consumir alcohol ni drogas ni haber realizado viajes recientes. Las constantes vitales mostraban temperatura de 37,5 \u00b0C, presi\u00f3n arterial de 116/57 mmHg, pulso de 76 l.p.m. y saturaci\u00f3n de ox\u00edgeno de 95% en aire ambiental. La exploraci\u00f3n f\u00edsica revel\u00f3 pulmones despejados y respiraci\u00f3n sin dificultades. La exploraci\u00f3n neurol\u00f3gica result\u00f3 normal. Las radiograf\u00edas tor\u00e1cicas mostraron infiltrados alveolares bilaterales parcheados sin consolidaci\u00f3n lobular. Se realiz\u00f3 un frotis nasofar\u00edngeo y un conjunto de pruebas de pat\u00f3genos respiratorios dio resultado negativo para todos ellos. Adem\u00e1s, se enviaron muestras de frotis orofar\u00edngeos y nasofar\u00edngeos a un laboratorio privado externo para una prueba de reacci\u00f3n en cadena de la polimerasa (RT-PCR) en tiempo real. El paciente fue dado de alta con monitorizaci\u00f3n de pulsioximetr\u00eda, instrucciones de aislamiento domiciliario y precauciones estrictas en caso de retorno. Durante las siguientes 24 horas, el paciente sufri\u00f3 un aumento de la sensaci\u00f3n de mareo y una ca\u00edda de la saturaci\u00f3n de ox\u00edgeno hasta alrededor del 85%, seg\u00fan pulsioximetr\u00eda. Regres\u00f3 al servicio de urgencias febril (temperatura de 39,1 \u00b0C), con ligera taquicardia (102 l.p.m. ), taquipnea (28 r.p.m.) Las radiograf\u00edas tor\u00e1cicas mostraron un aumento de los infiltrados alveolares bilaterales, mientras que un hemograma completo revel\u00f3 linfocitopenia (cifra de linfocitos de 0,7 K/mm3). Se le ingres\u00f3 con oxigenoterapia y monitorizaci\u00f3n; la oxigenaci\u00f3n se redujo de 2 L mediante c\u00e1nula nasal a aire ambiental. Se le dio de alta el d\u00eda 4 de hospitalizaci\u00f3n y las pruebas externas confirmaron COVID-19 el d\u00eda despu\u00e9s del alta. Inicialmente, evolucion\u00f3 bien durante la convalecencia en su domicilio, pero el d\u00eda 16 de enfermedad, empez\u00f3 a sufrir debilidad y entumecimiento facial derecho. A lo largo de 24 horas, los s\u00edntomas pasaron a ser bilaterales y culminaron en una disartria grave, que oblig\u00f3 a trasladarlo a urgencias. El paciente tambi\u00e9n refiri\u00f3 hipogeusia. La exploraci\u00f3n neurol\u00f3gica mostr\u00f3 un patr\u00f3n de debilidad motriz facial bilateral inferior, con pares craneales normales, fuerza normal, sensibilidad en todas las extremidades y reflejo miot\u00e1tico intacto. Se le ingres\u00f3 para su observaci\u00f3n y se someti\u00f3 a una RMN cerebral y de los huesos temporales, as\u00ed como una punci\u00f3n lumbar fluorosc\u00f3pica para obtener muestras de LCR. El LCR dio negativo para tinci\u00f3n y cultivos bacterianos y revel\u00f3 valores normales de glucosa (65 mg/dL), ausencia de leucocitos y ligera proteinorraquia (49 mg/dL). Una RMN revel\u00f3 un realce an\u00f3malo bilateral de los nervios facial y abducente, as\u00ed como del nervio motor ocular derecho. El paciente fue dado de alta con debilidad facial estable, sin empeoramiento de los s\u00edntomas y una saturaci\u00f3n de ox\u00edgeno del 99% en aire ambiental. Se acord\u00f3 un seguimiento ambulatorio neurol\u00f3gico, a la espera de diversos resultados anal\u00edticos serol\u00f3gicos y raqu\u00eddeos. El d\u00eda 19 de enfermedad, refiri\u00f3 nueva debilidad bilateral subjetiva de las extremidades inferiores, parestesia bilateral de las extremidades superiores y debilidad facial persistente, lo que llev\u00f3 a su reingreso para un seguimiento y tratamiento adicional. Una nueva exploraci\u00f3n neurol\u00f3gica no revel\u00f3 cambios en la debilidad facial, pero s\u00ed una nueva debilidad bilateral de grado 4/5 en los deltoides y los flexores de cadera, as\u00ed como arreflexia difusa. Una RMN raqu\u00eddea completa no revel\u00f3 anomal\u00edas sospechosas en la m\u00e9dula espinal ni realces an\u00f3malos medulares ni de la cola de caballo. An\u00e1lisis electromiogr\u00e1ficos y de conducci\u00f3n nerviosa mostraron resultados coherentes con una polineuropat\u00eda sensitivomotriz aguda con caracter\u00edsticas desmielinizantes y ax\u00f3nicas. Por razones religiosas, el paciente rechaz\u00f3 tratamiento con inmunoglobulina i.v. y se someti\u00f3 a un tratamiento con 5 ciclos de plasmaf\u00e9resis, bien tolerada y con ligera mejora de la debilidad facial y la parestesia. Los resultados anal\u00edticos de LCR y serol\u00f3gicos continuaron negativos excepto por virus del herpes simple, inmunoglobulina G e inmunoglobulina M; el paciente fue dado de alta para rehabilitaci\u00f3n en hospitalizaci\u00f3n general. Rechaz\u00f3 una nueva punci\u00f3n lumbar antes del alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 66-years old Maroccan woman, the resident in the Bologna area, was admitted to Imola Hospital on March 15th, 2020, for hyposthenia in all limbs, severe in lower, with a Medical Research Council (MRC) scale of 1/5 in distal and 2/5 in proximal of the lower extremities and 3/5 in distal and 4/5 in proximal of the upper extremities, with a distal tingling sensation and pronounced lumbar pain for about eight days. She was unable to walk, reported difficulty in swallowing, tendon reflexes were abolished. Vital signs were normal, medical history was negative and no infection was reported in the previous month. We performed nerve conduction studies consistent with demyelinating polyneuropathy and cerebrospinal fluid (CSF) analysis, consistent with our hypothesis (protein content 245\u00a0mg/dL, cells 13/mmc, polymorphonucleate 61.5%). Microbiologic testing on CSF and serum was negative (HSV1-2, EBV, VZV, CMV, HIV, Mycoplasma Pneumoniae, Borrelia). Anti-ganglioside antibodies were negative and excluded electrolytic abnormalities, heavy metal or drugs toxicity, endocrinological disorders, folate and vitamin B12 deficiency. Blood analysis showed elevated CPK (461\u00a0U/L, normal\u2009<\u2009145), CRP (5\u00b765\u00a0mg/dL, normal\u2009<\u20090\u00b75), lymphocytopenia (0\u00b768\u2009\u00d7\u2009109/L, normal 1\u00b710\u20134), mild increase of LDH (284\u00a0U/L, normal\u2009<\u2009248), GOT and GPT (549 and 547\u00a0U/L, normal\u2009<\u200935), similarly to COVID-19 patients laboratory profile. We performed a RT-PCR for SARS-CoV-2 on nasopharyngeal swab, which resulted positive. We found elevation of Interleukin 6 (11\u00a0pg/mL, normal\u2009<\u20095\u00b79), also associated with Covid-19 disease. She was transferred to Covid-19 department and received a five days course of intravenous immune globulin (IvIg), ritonavir 100\u00a0mg and darunavir 800\u00a0mg per day with hydroxychloroquine 200\u00a0mg twice daily, according to our hospital protocol for COVID-19 treatment. She never developed respiratory symptoms or fever; thoracic CT scan was normal. Immediately after IvIg, she significantly improved with a MRC scale of 4/5 in distal of upper limbs and 3/5 both proximal and distal in lower limbs, while facial diplegia has developed. About 3\u00a0weeks after the onset of neurological symptoms two nasopharyngeal swabs, 24\u00a0hours apart, resulted negative and she was transferred to rehabilitation care.",
        "es": "Mujer marroqu\u00ed de 66 a\u00f1os, residente en la zona de Bolonia, ingres\u00f3 en el hospital de Imola el 15 de marzo de 2020 con hipostenia en todas las extremidades, m\u00e1s intensa en las inferiores, con una puntuaci\u00f3n en la escala del Medical Research Council (MRC) de 1/5 en la parte distal y de 2/5 en la parte proximal de las extremidades inferiores, y de 3/5 en la parte distal y de 4/4 en la parte proximal de las superiores, con sensaci\u00f3n de hormigueo distal y lumbalgia intensa de ocho d\u00edas de evoluci\u00f3n. No pod\u00eda andar, refiri\u00f3 disfagia y los reflejos osteotendinosos estaban ausentes. Las constantes vitales eran normales, los antecedentes m\u00e9dicos eran irrelevantes y no refiri\u00f3 ninguna infecci\u00f3n durante el mes previo. Se realizaron estudios de conducci\u00f3n nerviosa coherentes con polineuropat\u00eda desmielinizante y an\u00e1lisis de l\u00edquido cefalorraqu\u00eddeo, consistente con nuestra hip\u00f3tesis (contenido de prote\u00ednas 245 mg/dL, c\u00e9lulas 13/mmc, polimorfonucleadas 61,5%). Las pruebas microbiol\u00f3gicas de LCR fueron negativas (VHS1-2, VEB, VVZ, CMV, VIH, Mycoplasma pneumoniae, Borrelia). Los anticuerpos antigangli\u00f3sidos fueron negativos y descartaron anomal\u00edas electrol\u00edticas, intoxicaci\u00f3n por metales pesados o f\u00e1rmacos, alteraciones endocrinas o carencia de folato o vitamina B12. Los an\u00e1lisis de sangre mostraron un valor elevado de creatina-cinasa (461U/L, normal \u2009< \u2009145) y de prote\u00edna C-reactiva (5,65mg/dL, normal\u2009 < \u20090,5), linfocitopenia (0,68\u2009\u00d7\u2009109/L, normal 1,10\u20134) y ligero aumento de LDH (284U/L, normal \u2009<\u2009 248) y de GOT y GPT (549 y 547U/L, normal\u2009 < \u200935), parecido a los resultados anal\u00edticos de pacientes con COVID-19. Se realiz\u00f3 una RT-PCR para SARS-CoV-2 de un frotis nasofar\u00edngeo, con resultado positivo. Se hall\u00f3 un aumento de interleucina 6 (11pg/mL, normal\u2009 < \u20095,9), tambi\u00e9n asociado a la COVID-19. Se traslad\u00f3 a la paciente a una planta de COVID-19 y se le administr\u00f3 una pauta de cinco d\u00edas de inmunoglobulina i.v., ritonavir 100 mg y darunavir 800 mg por d\u00eda, con hidroxicloroquina 200 mg dos veces al d\u00eda, seg\u00fan el protocolo de nuestro hospital para el tratamiento de la COVID-19. Nunca present\u00f3 s\u00edntomas respiratorios ni fiebre; la TAC tor\u00e1cica era normal. Tras la administraci\u00f3n de Ig, la paciente mejor\u00f3 significativamente con una puntuaci\u00f3n en la escala del MRC de 4/5 en la parte distal de las extremidades superiores y de 3/5 en las partes proximal y distal de las inferiores, con aparici\u00f3n de diplej\u00eda. Unas 3 semanas tras el inicio de los s\u00edntomas neurol\u00f3gicos, dos frotis nasofar\u00edngeos, tomados con 24 horas de diferencia, dieron resultado negativo; la paciente fue trasladada a una planta de rehabilitaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffWe present a 57-year old man with cough, dyspnea, headache, myalgia arthralgia, fever up to 38.7\u00b0C and abdominal pain worsening over 8 days. Extensive, symmetric livedo reticularis (LR) was present on trunk and thighs. Lab testing showed elevated C-reactive protein, ferritin, D-dimers and lymphopenia. Nasopharyngeal PCR detected SARS-CoV-2 and chest CT showed multifocal ground glass opacities, suggestive for COVID-19. Because of the unusual sudden onset of symmetric LR in a middle-aged man, an additional work-up for underlying conditions was performed. While antineutrophilic cytoplasmic antibodies, platelets, INR/APTT, rheumatoid factor, cryoglobulins and antiphospholipid antibodies were negative, antinuclear factor (ANA) was positive with nuclear pattern (titer 1/320, but without ENA-blot specificity). Previous ANA titer was unknown and so far, it has not been investigated whether COVID-19 can induce such antibodies. Infectious causes of livedo including HIV, Mycoplasma pneumonia, Syphilis, Legionella pneumophila, Influenza A/B, RSV, Hepatitis B/C were negative. During 8 days, oxygen, acetaminophen, hydroxychloroquine and low-molecular-weight-heparin in preventive dosing were administered. After discharge, livedo fluctuated, but progressively weaned. At three-weeks follow-up, inflammatory parameters were normal (besides insignificantly elevated ferritin), while the patient still experienced slight dyspnea on exertion.",
        "es": "Hombre de 57 a\u00f1os con tos, disnea, cefalea, mialgia, artralgia, fiebre de hasta 38,7 \u00b0C y dolor abdominal, de 8 d\u00edas de evoluci\u00f3n. El tronco y los muslos presentaban livedo reticular sim\u00e9trica y extensa. Las pruebas anal\u00edticas mostraron valores altos de prote\u00edna C-reactiva, ferritina y d\u00edmero D, as\u00ed como linfocitopenia. Una PCR de frotis nasofar\u00edngeo detect\u00f3 SARS-CoV-2 y una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado multifocales, indicativas de COVID-19. A causa de la inusual aparici\u00f3n s\u00fabita de livedo reticular sim\u00e9trica en un hombre de mediana edad, se realizaron pruebas adicionales para enfermedades preexistentes. Aunque los anticuerpos citoplasm\u00e1ticos antineutrof\u00edlicos, los trombocitos, el factor reumatoide INR/APTT, las crioglobulinas y los anticuerpos antifosfolip\u00eddicos dieron resultado negativo, el factor antinuclear fue positivo, con patr\u00f3n nuclear (valor 1/320, pero sin especificidad transferencia ENA). El valor previo del factor antinuclear era desconocido, y hasta la fecha no se ha investigado si la COVID-19 puede inducir este tipo de anticuerpos. Las causas infecciosas de livedo, como VIH, Mycoplasma pneumoniae, s\u00edfilis, Legionella pneumophila, gripe A/B, VRS, hepatitis B/C fueron negativas. Durante 8 d\u00edas, se administr\u00f3 ox\u00edgeno, acetaminofeno, hidroxicloroquina y heparina de bajo peso molecular en una pauta preventiva. Tras el alta, la livedo fluctu\u00f3 pero fue desapareciendo progresivamente. A las tres semanas, los par\u00e1metros inflamatorios eran normales (excepto por un valor muy ligeramente alto de ferritina), aunque el paciente a\u00fan sufr\u00eda una ligera disnea de esfuerzo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 37-year-old female patient with confirmed COVID-19 pneumonia presented with erythematous targetoid lesions distributed over the ventral and dorsal sides of the hands, and elbows. There were also painful ulcerations on the lip, tongue, and palate. The ocular and genital mucosal surfaces were normal. The lesions occurred on the 5th day of COVID-19 treatment, which included hydroxychloroquine (Day 1: 2x400 mg , Day 2-4: 2x200 mg), azithromycin (Day 1: 1x500 mg, Day 2-4: 1x250 mg ), and oseltamivir (2x75 mgfor five days). The symptoms related to COVID-19 pneumonia started 10 days before the rash. The patient had no previous medical history of a similar eruption. There was also no history of herpetic infection. Complete blood count, biochemical parameters and serological tests including Herpes simplex virus Ig M and Ig G, Ebstein-Barr virus Ig M and Ig G, Cytomegalovirus Ig M and Ig G, Hbs Ag, Anti HCV ve Mycoplasma Ig M ve Ig G antibodies were within normal limits. Biopsy was not performed due to the risk of infection. The patient was clinically diagnosed with Erythema multiforme major (EMM) and all medications were  stopped. The patient was then started on 40 mg/day oral methylprednisolone tapered by 5 mg every day. Topical anesthetic and antiseptic mouthwashes were also applied. On the 8th day of the treatment, pneumonia and the cutaneous lesions regressed considerably, and the patient was discharged without additional complications.",
        "es": "Mujer de 37 a\u00f1os, con neumon\u00eda por COVID-19 confirmada, se present\u00f3 con lesiones eritematosas en diana distribuidas por los lados dorsales y ventrales de las manos y los codos. Tambi\u00e9n presentaba \u00falceras dolorosas en los labios, la lengua y el paladar. Las mucosas oculares y genitales eran normales. Las lesiones aparecieron en el d\u00eda 5 de tratamiento para COVID-19, que consist\u00eda en hidroxicloroquina (d\u00eda 1: 2x400 mg, d\u00edas 2-4: 2x200 mg), azitromicina (d\u00eda 1: 1x500 mg, d\u00edas 2-4: 1x250 mg) y oseltamivir (2x75 mg durante 5 d\u00edas). Los s\u00edntomas asociados a neumon\u00eda por COVID-19 aparecieron 10 d\u00edas antes del exantema. La paciente no ten\u00eda antecedentes de erupciones similares. Tampoco ten\u00eda antecedentes de infecci\u00f3n herp\u00e9tica. El hemograma completo, los par\u00e1metros bioqu\u00edmicos y las pruebas serol\u00f3gicas para IgM e IgG del virus del herpes simple, IgM e IgG del virus de Epstein-Barr, IgM e IgG de citomegalovirus e IgM e IgG de VCH y Micoplasma estaban dentro de los l\u00edmites normales. No se realiz\u00f3 biopsia debido al riesgo de infecci\u00f3n. Se diagnostic\u00f3 a la paciente con eritema polimorfo grave y se interrumpi\u00f3 toda la medicaci\u00f3n. Se inici\u00f3 tratamiento con 40 mg/d\u00eda de metilprednisolona por v\u00eda oral, con disminuci\u00f3n de 5 mg por d\u00eda. Tambi\u00e9n se aplicaron enjuagues bucales antis\u00e9pticos y anest\u00e9sicos t\u00f3picos. El d\u00eda 8 de tratamiento, la neumon\u00eda y las lesiones cut\u00e1neas remitieron considerablemente y la paciente fue dada de alta sin complicaciones adicionales."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA  69-year-old  man  was  admitted  to  ICU  for  status  epilepticus  requiring  endotracheal intubation,  preceded  by  a  5-day  history  of  cough,  fever,  and  anosmia. SARS-CoV-2  was detected  by  RT-PCR  in  a  tracheal aspirate. Medical history was significant for diabetes mellitus, hypertension, and a single seizure, which had occurred one year earlier, related to hyperglycaemia and uncontrolled diabetes. Upon  admission  to  our  ICU,  the  patient  was  treated  with  intravenous levetiracetam. Brain  CT  (computerized  tomography)  was  unremarkable,  and electroencephalography (EEG) showed repetitive 1 Hz rhythmic bursts over the right frontal region,  suggestive  of  a  non-convulsive  status  epilepticus. Cerebrospinal  fluid  (CSF) examination was unremarkable, showing 1 leukocyte per cubic millimeter, 18 red blood cells per cubic millimeter, and protein and glucose levels respectively at 0.66 g/L and 10.5mmol/L (blood glucose at 20mmol/L). RT-PCR assay of the CSF was negative for SARS-CoV-2. All other tests for infectious agents and autoimmune disease were negative in serum and CSF. Brain MRI revealed hyperintensity of the right orbital prefrontal cortex adjacent to the olfactory bulb, which seemed to spread towards the right mesial prefrontal cortex and to the right caudate nucleus. No gadolinium enhancement was observed. After  a  multidisciplinary  discussion,  a  treatment  with  IV-Immunoglobulins  at  2g/kg  was administered. EEG  showed  persistent    short-interval  (0.7-1.2  sec)  lateralized  periodic discharges (LPDs) over the right frontal lobe on day 2. The patient improved after one week, allowing  for  weaning  from  mechanical  ventilation,  but  he  presented  signs  of  frontal  lobe syndrome  including  verbal  perseverations  and  imitation  behavior,  and  was  drowsy  for several days after extubation. MRI performed at day 15 showed the persistence of a marked hyperintensity of the right caudate nucleus  and  a significant decrease of the hyperintensity of the prefrontal cortex. MRI performed at day 30 was normal. We concluded  that  initial  MRI  hyperintensities  were  partly  due  to  peri-ictal  diffusion abnormalities.",
        "es": "Hombre de 69 a\u00f1os ingres\u00f3 en la UCI por estado epil\u00e9ptico que requiri\u00f3 intubaci\u00f3n endotraqueal, con 5 d\u00edas de evoluci\u00f3n y fiebre, tos y anosmia. En aspirado traqueal se detect\u00f3 SARS-CoV-2 mediante RT-PCR. Los antecedentes eran relevantes por diabetes mellitus, hipertensi\u00f3n y una crisis acaecida un a\u00f1o antes, asociada a hiperglucemia y diabetes no controlada. Al ingreso en la UCI, el paciente fue tratado con levetiracetam i.v. Una TAC cerebral no dio resultados relevantes; un electroencefalograma (EEG) mostr\u00f3 paroxismos r\u00edtmicos repetitivos a 1 Hz en la regi\u00f3n frontal derecha, indicativos de estado epil\u00e9ptico no convulsivo. Los an\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo (LCR) no dieron resultados relevantes, con 1 leucocito por mil\u00edmetro c\u00fabico, 18 eritrocitos por mil\u00edmetro c\u00fabico y valores de prote\u00ednas y glucosa, respectivamente, de 0,66 g/L y 10,5 mml/L (glucemia 20 mmol/L). Un ensayo RT-PCR del LCR fue negativo para SARS-CoV-2. Todas las dem\u00e1s pruebas para agentes infecciosos y enfermedades autoinmunitarias fueron negativas en suero y LCR. Una RMN cerebral revel\u00f3 hiperintensidad del c\u00f3rtex prefrontal orbital derecho adyacente al bulbo olfativo, que parec\u00eda extenderse hacia el c\u00f3rtex prefrontal medio derecho y el n\u00facleo caudado derecho. No se observ\u00f3 realce de gadolinio. Tras un an\u00e1lisis multidisciplinar, se administr\u00f3 un tratamiento con inmunoglobulinas i.v. a una dosis de 2 g/kg. El d\u00eda 2, el EEG mostr\u00f3 descargas peri\u00f3dicas lateralizadas persistentes en intervalos breves (0,7-1,2 s) en el l\u00f3bulo frontal derecho. El paciente mejor\u00f3 despu\u00e9s de una semana, lo que permiti\u00f3 retirar la ventilaci\u00f3n mec\u00e1nica, pero presentaba signos de s\u00edndrome del l\u00f3bulo frontal, como perseveraci\u00f3n verbal y conducta imitativa y se mostr\u00f3 somnoliento durante varios d\u00edas tras la extubaci\u00f3n. La RMN realizada el d\u00eda 15, mostr\u00f3 la persistencia de una clara hiperintensidad en el n\u00facleo caudado derecho y una disminuci\u00f3n significativa de la hiperintensidad del c\u00f3rtex prefrontal. La RMN realizada el d\u00eda 30 era normal. La conclusi\u00f3n fue que las hiperintensidades iniciales en las RMN eran debidas en parte a anomal\u00edas de difusi\u00f3n pericr\u00edticas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 58-year-old man presented to the emergency department because of a decreased level of consciousness and the inability to walk. Initial symptoms began with slowly progressive gait disturbance around one month before admission; however, consciousness profoundly deteriorated two days before the admission. There were no complaints of pulmonary symptoms such as cough or dyspnea. On admission, his body temperature was 37.10C; he was drowsy but could obey simple tasks, and speaking consisted of short, simple words. He could move all limbs; nevertheless, the left upper limb moved less. Deep tendon reflexes were brisk and plantar reflexes were upgoing. Initial investigations revealed Hb: 15.5 g/dL, WBC: 17,000 [lymphocyte count: 1020/mm3, normal range: 800\u20135000/mm3], CRP: 82 mg/L (normal<10 mg/L), ESR: 40 mm/h (normal<20 mm/h), and Ferritin 876 ng/mL (normal range: 12 to 300 ng/mL). CSF examination revealed WBCs: 0/mm3 (normal range: 0\u20135/mm3), Glucose: 105 mg/dL (normal<80 mg/dL), and protein: 15 mg/dL (normal<45 mg/dL). The CSF was negative for viruses such as herpes simplex, varicella-zoster, cytomegalovirus, and Epstein-Barr virus. Moreover, we did not found oligoclonal bands in CSF. Blood Interferon-Gamma Release Assays (IGRAs) for Tuberculosis, and ELISA for the Brucella antibody and Human Immunodeficiency Virus (HIV) antibody, were negative. Brain MRI of the patient, indicated diffuse confluent white matter hyperintensity on FLAIR-weighted MRI, particularly at the left-side without prominent enhancement on T1-weighted brain MRI. Moreover, the involvement of cortical as well as deep gray matter, and dorsal midbrain was evident. The chest computed tomography (CT) scan indicates bilateral multifocal peripheral consolidations with air-bronchogram consistent with SARS-CoV-2 infection. Nasopharyngeal and oropharyngeal swab real-time polymerase chain reaction (rt-PCR) were positive for SARS-CoV-2 virus but negative in the CSF. For the management of ADEM, we started intravenous dexamethasone 8 mg TDS, which resulted in an improvement in mental status after two days. At this time, the patient could communicate verbally; he was oriented to time and person and could walk with aid. Pulmonologists performed pulmonary management in the intensive care unit. However, after 10 days, status epilepticus developed, and unfortunately, the patient died one day later, probably because of status epilepticus.",
        "es": "Hombre de 58 a\u00f1os que ingres\u00f3 en el servicio de urgencias a causa de una disminuci\u00f3n de la consciencia e incapacidad de andar. Los s\u00edntomas iniciales empezaron con una alteraci\u00f3n de la marcha aproximadamente un mes antes del ingreso, con un empeoramiento progresivo y lento; sin embargo, el estado de consciencia se deterior\u00f3 profundamente dos d\u00edas antes del ingreso. No se refirieron s\u00edntomas pulmonares, como tos o disnea. Al ingreso, su temperatura era de 37,1 \u00baC; el paciente estaba somnoliento pero pod\u00eda obedecer instrucciones para realizar tareas simples; el habla consist\u00eda en palabras sencillas y breves. Pod\u00eda mover todas las extremidades, pero las superiores mostraban menos movilidad. Los reflejos osteotendinosos eran bruscos y el reflejo cut\u00e1neo plantar presentaba signo de Babinski. Los an\u00e1lisis iniciales revelaron Hb: 15,5 g/dL, leucocitos: 17.000 [linfocitos: 1020/mm3, intervalo normal: 800\u20135000/mm3], prote\u00edna C-reactiva: 82 mg/L (normal < 10 mg/L), VSG: 40 mm/h (normal < 20 mm/h) y ferritina 876 ng/mL (intervalo normal: 12 a 300 ng/mL). El an\u00e1lisis del LCR revel\u00f3 leucocitos: 0/mm3 (intervalo normal: 0\u20135/mm3), glucosa: 105 mg/dL (normal < 80 mg/dL) y prote\u00ednas: 15 mg/dL (normal < 45 mg/dL). El LCR fue negativo para virus, como el herpes simple, varicela z\u00f3ster, citomegalovirus y Epstein-Barr. Adem\u00e1s, no se hallaron bandas oligocl\u00f3nicas en el LCR. El ensayo de liberaci\u00f3n de interfer\u00f3n gamma para tuberculosis y el ensayo ELISA para anticuerpos de Brucella y VIH fueron negativos. Una RMN cerebral mostr\u00f3 hiperintensidad de sustancia blanca confluyente difusa en RMN con FLAIR, especialmente en el lado izquierdo, sin realce prominente con ponderaci\u00f3n en T1. Adem\u00e1s, era evidente la afectaci\u00f3n de la sustancia gris cortical y profunda y del mesenc\u00e9falo dorsal. Una TAC tor\u00e1cica indic\u00f3 consolidaciones multifocales bilaterales perif\u00e9ricas con broncograma a\u00e9reo coherente con infecci\u00f3n por SARS-CoV-2. Ensayos de RT-PCR a partir de frotis nasofar\u00edngeo y orofar\u00edngeo dieron positivo para SARS-CoV-2, pero estos fueron negativos en el LCR. Para el tratamiento de la EDA, se inici\u00f3 dexametasona i.v. 8 mg tres veces al d\u00eda, que llev\u00f3 a una mejora del estado mental despu\u00e9s de dos d\u00edas. En ese momento, el paciente pod\u00eda comunicarse verbalmente; estaba orientado respecto al tiempo y las personas y pod\u00eda andar con ayuda. El servicio de neumolog\u00eda aplic\u00f3 el tratamiento neumol\u00f3gico en la unidad de cuidados intensivos. Sin embargo, despu\u00e9s de 10 d\u00edas, el estado epil\u00e9ptico empeor\u00f3 y el paciente muri\u00f3 un d\u00eda despu\u00e9s, probablemente a causa del estado epil\u00e9ptico."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 16-year-old boy was admitted to our emergency department, in Lombardy, complaining of intense pain in his chest\u2014radiating to his left arm\u2014which had started 1 h earlier. The day before he had a fever of 38\u30fb3\u00b0C that decreased after 100 mg of nimesulide. He reported no other symptoms, no medical history, and no contact with anyone with confirmed COVID-19. We found his vital signs to be normal apart from his temperature which was raised at 38\u30fb5\u00b0C. On auscultation of the patient\u2019s chest, we heard normal heart sounds, no pericardial rub, and no abnormal respiratory signs. We found no lymphadenopathy, no rash, and no areas of localised tenderness on the chest wall. An electrocardiogram (ECG) showed inferolateral ST-segment elevation and a transthoracic echocardiography showed hypokinesia of the inferior and inferolateral segments of the left ventricle, with a preserved ejection fraction of 52%; no pericardial effusion was seen. Investigations showed raised high-sensitivity cardiac troponin I (9449 ng/L), creatine phosphokinase (671\u30fb0 U/L), C-reactive protein (32\u30fb5 mg/L), and lactate dehydrogenase (276\u30fb0 U/L) concentrations. The leucocyte count was 12\u30fb75 \u00d7 10\u2079 per L, the neutrophil count was 10\u30fb04 \u00d7 10\u2079 per L, and the lymphocyte count was 0\u30fb78 \u00d7 10\u2079 per L. We gave the boy aspirin to relieve his pain and transferred him to the coronary care unit with a working diagnosis of acute myocarditis. The patient\u2019s pain gradually improved and after 2 h had completely resolved. However, during the first night, he reported further chest pain; the ECG was repeated but no significant changes were seen . We started him on intravenous ibuprofen 600 mg three times a day and both his symptoms and raised temperature resolved. Tests for autoantibodies and cardiotropic viruses were negative . On day 3, a nasopharyngeal swab test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was positive, so we started hydroxychloroquine and antiviral therapy. Serial measurements of the patient\u2019s troponin concentration showed a gradual reduction from a peak of 16 862 ng/L on day 1, to 39 ng/L on day 8. The inflammatory markers also returned to normal and the ST-segment elevation on ECG resolved . On day 11\u2014after nasopharyngeal swabs taken on 2 consecutive days were negative\u2014MRI T2-weighted short-tau inversion recovery sequences showed changes supporting the diagnosis of acute myocarditis. On day 12, he was well, asymptomatic, and allowed home.",
        "es": "Un chico de 16 a\u00f1os ingres\u00f3 en nuestro servicio de urgencias, en la Lombard\u00eda, aquejado de dolor tor\u00e1cico intenso que radiaba a su brazo izquierdo, iniciado una hora antes. El d\u00eda anterior hab\u00eda tenido fiebre de 38,3 \u00b0C, que hab\u00eda remitido con 100 mg de nimesulide. No refiri\u00f3 otros s\u00edntomas, no ten\u00eda antecedentes y no hab\u00eda tenido contacto con casos confirmados de COVID-19. Sus constantes vitales eran normales, excepto por su temperatura, que era de 38,5 \u00b0C. A la auscultaci\u00f3n tor\u00e1cica, los tonos card\u00edacos eran normales, no se apreci\u00f3 roce peric\u00e1rdico y tampoco signos respiratorios an\u00f3malos. No se hall\u00f3 linfoadenopat\u00eda, exantemas ni zonas de dolor a la palpaci\u00f3n en la pared tor\u00e1cica. Un electrocardiograma (ECG) mostr\u00f3 elevaci\u00f3n del segmento ST inferolateral y un ecocardiograma transtor\u00e1cico mostr\u00f3 hipocinesia de los segmentos inferior e inferolateral del ventr\u00edculo izquierdo, con una fracci\u00f3n de expulsi\u00f3n de 52%; no se observ\u00f3 derrame peric\u00e1rdico. Los an\u00e1lisis mostraron un aumento de troponina I card\u00edaca ultrasensible (9449 ng/L), de creatina-fosfocinasa (671,0 U/L), de prote\u00edna C-reactiva (32,5 mg/L) y de lactato-deshidrogenasa (276,0 U/L). La cifra de leucocitos era 12,75 \u00d7 10\u2079 por L, la de neutr\u00f3filos 10,04 \u00d7 10\u2079 por L y la de linfocitos 0,78 \u00d7 10\u2079 por L. Se administr\u00f3 aspirina para mitigaci\u00f3n del dolor y se traslad\u00f3 al paciente a la UCI coronaria, con diagn\u00f3stico de miocarditis aguda. El dolor remiti\u00f3 gradualmente y, tras 2 h, hab\u00eda desaparecido por completo. Sin embargo, durante la primera noche, refiri\u00f3 dolor tor\u00e1cico; se repiti\u00f3 el ECG, pero no se observaron cambios relevantes. Se inici\u00f3 tratamiento con ibuprofeno i.v. 600 mg tres veces al d\u00eda y tanto sus s\u00edntomas como la fiebre remitieron. Las pruebas de autoanticuerpos y de virus cardiotr\u00f3picos fueron negativas. El d\u00eda 3, una prueba a partir de frotis nasofar\u00edngeo para s\u00edndrome de dificultad respiratoria aguda 2 (SARS-CoV-2) fue positiva, de modo que se inici\u00f3 tratamiento con hidroxicloroquina y antiv\u00edricos. Mediciones repetidas de la concentraci\u00f3n de troponina del paciente mostraron una reducci\u00f3n gradual de un m\u00e1ximo de 16.862 ng/L el d\u00eda 1 a 39 ng/L el d\u00eda 8. Los marcadores de inflamaci\u00f3n tambi\u00e9n regresaron a valores normales y se solucion\u00f3 la elevaci\u00f3n del segmento ST en el ECG. El d\u00eda 11, despu\u00e9s de que dos frotis nasofar\u00edngeos obtenidos en d\u00edas consecutivos fueran negativos, la secuencia STIR ponderada en T2 de la RMN mostr\u00f3 cambios coherentes con el diagn\u00f3stico de miocarditis aguda. El d\u00eda 12, el paciente se hallaba en buen estado y asintom\u00e1tico y fue dado de alta."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 6-week-old male child was admitted on 23 March 2020 to the Pediatric Emergency Services (PES) of University Hospital of Amiens-France due to fever (38.9\u00b0C) since 12\u2009h. He was born at 39 weeks\u2019 of gestation, Apgar scores at 1 and 5\u2009min were 10 and 10, respectively. Birth weight was 3160\u2009g. The mother was 25 years old with no relevant clinical history, and presented, a week before the baby\u2019s admission, ageusia and anosmia, without fever or other associated symptoms. The father was 28 years old and presented only anosmia the day before admission. On initial evaluation at PES, the infant presented good general condition but mildly whiny and hypotonic, was well fed with formula, weighed 5000\u2009g, with temperature of 38.2\u00b0C, heart rate of 160 beats per minute, respiratory rate of 30 breaths per minute, oxygen saturation (SpO2) of 100% in room air and blood pressure was 89/59\u2009mmHg. His abdomen was soft; the liver was palpable 0.5\u2009cm below the right costal margin, and presented no coughing and no dyspnea. The findings of the rest of the examination were unremarkable. 9.4\u201314.1 g/dl); and platelet count of 321.000/mm3 (n.r. 150.000-450.000/mm3). His lactate dehydrogenase level was 255 UI/l (n.r. 120\u2013246 UI/l) and renal and liver function values were normal. C-reactive protein; Procalcitonin, urine strip and cytology exam of urine were negative. Rapid screening test for influenza A and B was negative. Due to the symptoms of parents, the age and symptoms of baby (mildly whiny, fever and hypotonic), the child was admitted to the COVID-19 pediatric unit and was performed: aerobic and anaerobic blood cultures, cyto-bacteriological urine test and lumbar puncture. The SARS-CoV-2 test was performed on nasopharyngeal swab, urine, cerebrospinal fluid (CSF) and stool. Few hours after his hospitalization, the baby presented excessive crying, for that; we performed an abdominal ultrasound that was normal. Pending the results of microbiological tests, intravenous Cefotaxime (200\u2009mg/kg/day divided in four doses) associated to Gentamycin (5\u2009mg/kg/dose/day) and probiotics treatment was started. The patient\u2019s clinical condition improved 24\u2009h after hospitalization with a gradual disappearance of the fever and initial hypotonia. Nasopharyngeal swab and stool tested positive for SARS-CoV-2 by rRT-PCR assay. Aerobic and Anaerobic blood cultures tested negative, CSF cultures were sterile (both bacterial and virus: SARS-CoV-2, enterovirus ribonucleic acid, human herpes virus 6, herpes simplex virus, adenovirus). Despite the fact that urine test strip was negative, a few days later, the laboratory confirmed the positivity for Citrobacter koseri at the cyto-bacteriological urine test with good sensitivity to ongoing antibiotic treatment. Five days after admission, given the good health conditions and the normal results of blood and microbiological tests, the patient was discharged with home monitoring indications for the next 3 weeks. Furthermore, given the age of baby, parents will be contacted by phone every 2 days during the next 2 weeks to ensure his physical conditions. For the positivity of C.koseri in the urine and the results of antibiogram, he was prescribed Clavulanic Amoxicillin at home for another 6 days. Finally, for the presence of SARS-CoV-2 in the stool and stools relatively abundant, probiotics were prescribed for the next 2 weeks. Two weeks after discharge, the baby was well and afebrile with no diarrhea or vomiting. The parents were advised to continue home monitoring, with a visit to their doctor if necessary.",
        "es": "Un ni\u00f1o de 6 semanas ingres\u00f3 el 23 de marzo de 2020 en el servicio de urgencias pedi\u00e1tricas del Hospital Universitario de Amiens (Francia), con fiebre (38,9 \u00b0C) de 12 horas de evoluci\u00f3n. Hab\u00eda nacido a las 39 semanas de gestaci\u00f3n, con \u00edndice de Apgar a 1 minuto y a los 5 minutos de 10 y 10, respectivamente. El ni\u00f1o no regurgit\u00f3 tras el alumbramiento. El peso al nacimiento fue de 3.160 g. La madre ten\u00eda 25 a\u00f1os sin antecedentes relevantes y, una semana antes del ingreso del ni\u00f1o, present\u00f3 ageusia y anosmia, sin fiebre ni otros s\u00edntomas asociados. El padre ten\u00eda 28 a\u00f1os y solo refiri\u00f3 anosmia el d\u00eda anterior al ingreso. A la exploraci\u00f3n inicial en urgencias pedi\u00e1tricas, el ni\u00f1o se hallaba en buen estado general, pero ligeramente lloroso e hipot\u00f3nico, estaba bien alimentado con leche artificial y pesaba 5.000 g. Su temperatura era de 38,2 \u00b0C, pulso de 160 l.p.m., frecuencia respiratoria de 30 r.p.m., saturaci\u00f3n de ox\u00edgeno (SpO2) de 100% en aire ambiental y presi\u00f3n arterial de 89/59 mmHg. El abdomen era blando; el h\u00edgado era palpable 0,5 cm por debajo del reborde costal; el paciente no presentaba tos ni disnea. Los resultados del resto de la exploraci\u00f3n no eran remarcables. Las pruebas anal\u00edticas al ingreso revelaron una cifra de leucocitos de 8.500/mm3 (intervalo normal: 5.000\u201318.000/mm3); linfocitos 4.700/mm3 (intervalo normal: 1.100\u20133.200/mm3); neutr\u00f3filos 2.000/mm3 (intervalo normal: 1.800\u20136.300/mm3); valor de hemoglobina (Hb) de 10,9 \u2009g/dl (intervalo normal: 9,4\u201314,1 g/dl) y cifra de trombocitos de 321.000/mm3 (intervalo normal: 150.000-450.000/mm3). La concentraci\u00f3n de lactato-deshidrogenasa era de 255 UI/L (intervalo normal: 120\u2013246 UI/l); los valores de actividad renal y hep\u00e1tica eran normales. El an\u00e1lisis citol\u00f3gico y la tira reactiva de orina, procalcitonina y prote\u00edna C-reactiva no dieron resultados an\u00f3malos. Una prueba r\u00e1pida para gripe A y B result\u00f3 negativa. A causa de los s\u00edntomas de los padres, la edad y los s\u00edntomas del ni\u00f1o (lloroso, con fiebre e hipot\u00f3nico), se ingres\u00f3 al ni\u00f1o en la unidad pedi\u00e1trica de COVID-19 y se realizaron hemocultivos aer\u00f3bicos y anaer\u00f3bicos, an\u00e1lisis de orina citobacteriol\u00f3gico y punci\u00f3n lumbar. La prueba de SARS-CoV-2 se realiz\u00f3 a partir de frotis nasofar\u00edngeo, orina, heces y l\u00edquido cefalorraqu\u00eddeo (LCR). Pocas horas despu\u00e9s de la hospitalizaci\u00f3n, el ni\u00f1o present\u00f3 lloro excesivo, por lo que se practic\u00f3 una ecograf\u00eda abdominal, sin resultados relevantes. A la espera de las pruebas microbiol\u00f3gicas, se inici\u00f3 tratamiento con cefotaxima (200 mg/kg por d\u00eda, en cuatro dosis) y gentamicina (5 mg/kg por d\u00eda en una dosis) y probi\u00f3ticos. El estado cl\u00ednico del paciente mejor\u00f3 24 horas tras la hospitalizaci\u00f3n, con remisi\u00f3n gradual de la fiebre y de la hipoton\u00eda inicial. Los frotis orofar\u00edngeos y las heces dieron resultado positivo para SARS-CoV-2 mediante prueba de RT-PCR. Los hemocultivos aer\u00f3bicos y anaer\u00f3bicos dieron negativo; los cultivos de LCR fueron est\u00e9riles (para bacterias y virus: SARS-CoV-2, \u00e1cido ribonucleico de enterovirus, virus del herpes humano 6, virus del herpes simple, adenovirus). A pesar de que la tira reactiva era negativa, unos d\u00edas despu\u00e9s el laboratorio confirm\u00f3 positivo para Citrobacter koseri en el an\u00e1lisis de orina citobacteriol\u00f3gico, con buena sensibilidad al tratamiento antibi\u00f3tico en curso. Cinco d\u00edas despu\u00e9s del ingreso, teniendo en cuenta el buen estado de salud y los resultados normales de an\u00e1lisis de sangre y microbiol\u00f3gicos, el paciente fue dado de alta con indicaciones de monitorizaci\u00f3n domiciliaria durante las siguientes tres semanas. Adem\u00e1s, teniendo en cuenta la edad del ni\u00f1o, se contactar\u00eda con los padres, por tel\u00e9fono, cada dos d\u00edas durante las dos semanas siguientes, para supervisar su estado de salud. Por la presencia de C. koseri en la orina y los resultados del antibiograma, se le recet\u00f3 amoxicilina y \u00e1cido clavul\u00e1nico para los siguientes 6 d\u00edas. Finalmente, para la presencia de SARS-CoV-2 en las heces (relativamente abundantes) se le recet\u00f3 probi\u00f3ticos para las siguientes 2 semanas. Dos semanas despu\u00e9s del alta, el ni\u00f1o se encontraba bien de salud, afebril y sin diarrea o v\u00f3mitos. Se aconsej\u00f3 a los padres que continuaran la supervisi\u00f3n domiciliaria, con visita al m\u00e9dico en caso necesario."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 33-wk-old neonate was born by emergency cesarean section due to maternal complications. He was born in poor condition. He was intubated, given surfactant and ventilated for 72\u00a0h. He was extubated on to humidified high flow until day 5 of life. On day 9 of life, he became unwell with poor feed tolerance and respiratory distress requiring non-invasive ventilation. Chest X-ray showed patchy consolidation of right mid-zone and left peri-hilar region suggestive of infection. Blood results showed a mild elevation of CRP to 14\u00a0mg/L (Normal <10\u00a0mg/L) and a raised platelet count. Due to this clinical deterioration and chest X-ray findings, intravenous antibiotics were commenced. Respiratory secretions for influenza, respiratory syncytial virus, adenovirus, rhinovirus, human metapneumovirus and parainfluenza were negative, but surprisingly COVID-19 RT-PCR was positive. The parents had shown no signs of illness suggestive of COVID-19 over the previous 14 d and reported no contacts with others with suspected COVID-19. He was isolated and barrier nursed with the recommended personal protective equipment (PPE) until repeat COVID swab was negative at 12 d. A five\u00a0days course of intravenous antibiotics was given. The parents were asked to self-isolate for 14 d and remained well throughout isolation.",
        "es": "Parto por ces\u00e1rea de urgencia a las 33 semanas de gestaci\u00f3n, a causa de complicaciones maternas. El ni\u00f1o naci\u00f3 en mal estado de salud. Fue intubado, se le aplicaron tensioactivos y ventilaci\u00f3n durante 72 horas. Luego fue extubado y se pas\u00f3 a alto flujo con humidificaci\u00f3n hasta el 5.\u00ba d\u00eda de vida. El d\u00eda 9 de vida, su estado empeor\u00f3, con mala tolerancia a los alimentos e insuficiencia respiratoria que requiri\u00f3 ventilaci\u00f3n no invasiva. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 consolidaciones parcheadas de la zona media derecha y la regi\u00f3n perihiliar, indicativas de infecci\u00f3n. Los resultados de los an\u00e1lisis de sangre revelaron un ligero aumento de la prote\u00edna C-reactiva a 14 mg/L (valor normal < 10 mg/L) y aumento de la cifra de trombocitos. A causa de este deterioro cl\u00ednico y de los resultados radiol\u00f3gicos, se inici\u00f3 un tratamiento con antibi\u00f3ticos i.v. Las secreciones respiratorias dieron resultado negativo para gripe, virus sincicial respiratorio, adenovirus, rinovirus, metaneumovirus humano y virus paragripal, pero una RT-PCR para COVID-19 fue positiva. Los padres no hab\u00edan presentado signos de enfermedad indicativos de COVID-19 durante los 14 d\u00edas previos y refirieron no haber tenido contacto con otras personas sospechosas de COVID-19. El reci\u00e9n nacido fue aislado y protegido con el equipo de protecci\u00f3n individual recomendado, hasta que pruebas posteriores de COVID a partir de frotis fueron negativas el d\u00eda 12. Se estableci\u00f3 una pauta de cinco d\u00edas de antibi\u00f3ticos i.v. Se pidi\u00f3 a los padres que se confinaran durante 14 d\u00edas; permanecieron en buen estado de salud durante este tiempo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 63-year-old male, known for obesity, active smoking, and excessive alcohol consumption, without notable medical history and taking no medication, presented a viral syndrome for 7\u00a0days (light headache, rhinorrhea, odynophagia, myalgia, and temperature until 37.8\u00a0\u00b0C). On the day 12 after the first symptoms, he reported paresthesia and hypoesthesia on his feet, progressing in 2\u20133\u00a0days to the abdominal area. On d14, he developed mild weakness of the lower limbs, progressively worsening, and on day 16, he consulted the ER. The neurological examination revealed a moderate paresis in proximal predominance of lower limbs associated with pyramidal signs and sensory level T10. The cognitive, cranial nerves, and upper limbs\u2019 exam as well as the rest of systems exam was unremarkable. The blood analysis showed a leukopenia and a slightly raised C-reactive protein (CRP). A broad panel of infectious and immunological tests was performed, with comprehensive serologies and PCR on blood and CSF, which were all negative. Brain and spinal cord MRI did not show any abnormality. A lumbar puncture (LP) showed slight elevated leucocytes and proteins. The bacterial cultures and the polymerase chain-reaction (PCR) of the cerebrospinal fluid (CSF) for detection of virus and bacteria were negative. An electromyoneurography was normal. A new LP on the 6\u00a0day of hospitalization showed a slight elevation of leucocytes and proteins. A second spine MRI, 7\u00a0days after admission was normal. Since his admission, the patient presented a persistent neutropenia deemed of reaction origin (infectious, toxic, and other inflammatory) after several investigations including a bone-marrow biopsy. A body CT scan revealed a ground-glass opacity appearance on both lungs, suggestive of a typical SARS-CoV-2 infiltrate. A PET-CT did not reveal any malignancy. The chest CT scan was repeated 18\u00a0days after the initial one, showing a clear decrease of the apical pulmonary infiltrates and the lymphadenopathies. At admission, a nasopharyngeal smear, in the context of the ongoing COVID-19 pandemic, was negative for SARS-CoV-2. We repeated the test after the first CT results, and it was also negative. Posteriori we added a PCR for SARS-CoV-2 in the different CSF which was negative. A semi-quantitative SARS-CoV-2 serology showed the presence of both IgM and IgG at admission and at day 20 with lower IgM, suggesting a recent SARS-CoV-2 infection. The paresis progressed rapidly to paraplegia, with total anesthesia below T10 and sphincter dysfunction. Corticosteroid treatment was considered initially, but not administered, because of SARS-CoV-2 suspicion. The patient was treated by intravenous human immunoglobulins (IVIG) 0.4\u00a0g/kg for 5\u00a0days. We did not notice any neurological improvement after the immunoglobulin treatment. Given the two negative nasopharyngeal smears of SARS-CoV-2, the absence of respiratory symptoms, and disappearance of pulmonary infiltrates, a corticosteroid therapy IV for 5\u00a0days was started the day 21 from admission. The day 30 from his admission, the patient presented a slightly recover of his lower limbs strength and was transferred to a neurorehabilitation hospital.",
        "es": "Hombre de 63 a\u00f1os, con obesidad, tabaquismo y consumo excesivo de alcohol, sin antecedentes m\u00e9dicos relevantes y no medicado, present\u00f3 un s\u00edndrome v\u00edrico de 7 d\u00edas de evoluci\u00f3n (cefalea leve, rinorrea, odinofagia, mialgia y temperatura de hasta 37,8\u00b0C). El d\u00eda 12 despu\u00e9s de los primeros s\u00edntomas, refiri\u00f3 parestesia e hipoestesia en los pies, que evolucion\u00f3 a la zona abdominal en 2-3 d\u00edas. El d\u00eda 14 present\u00f3 debilidad de las extremidades inferiores, con empeoramiento progresivo; el d\u00eda 16 acudi\u00f3 al servicio de urgencias. La exploraci\u00f3n neurol\u00f3gica revel\u00f3 paresia moderada predominantemente proximal en las extremidades inferiores, asociada a signos piramidales y nivel sensorial T10. La exploraci\u00f3n cognitiva, de los pares craneales y de las extremidades superiores, as\u00ed como del resto de aparatos fue irrelevante. El an\u00e1lisis de sangre mostr\u00f3 leucocitopenia y un ligero aumento de prote\u00edna C-reactiva. Se realiz\u00f3 un extenso perfil de pruebas infecciosas e inmunol\u00f3gicas, con pruebas serol\u00f3gicas exhaustivas y PCR de sangre y LCR, todas ellas con resultado negativo. Las RMN cerebral y raqu\u00eddea no mostraron ninguna anomal\u00eda. Una punci\u00f3n lumbar mostr\u00f3 un valor ligeramente elevado de leucocitos y prote\u00ednas. Los cultivos bacterianos y la PCR de l\u00edquido cefalorraqu\u00eddeo (LCR) para detecci\u00f3n de virus y bacterias fueron negativos. Un electromioneurograma fue normal. Una nueva punci\u00f3n lumbar el d\u00eda 6 de hospitalizaci\u00f3n revel\u00f3 un ligero aumento de leucocitos y prote\u00ednas. Una segunda RMN raqu\u00eddea, 7 d\u00edas despu\u00e9s del ingreso, fue normal. A partir del ingreso, el paciente present\u00f3 una neutrocitopenia persistente, considerada reactiva (origen infeccioso, t\u00f3xico o inflamatorio) tras varios an\u00e1lisis, que incluyeron biopsia de m\u00e9dula \u00f3sea. Una TAC completa revel\u00f3 opacidades de vidrio esmerilado en ambos pulmones, indicativas de infiltrados t\u00edpicos por SARS-CoV-2. Una TAC TEP no revel\u00f3 ninguna neoplasia maligna. La TAC tor\u00e1cica se repiti\u00f3 18 d\u00edas despu\u00e9s de la inicial, y se observ\u00f3 una clara disminuci\u00f3n de los infiltrados pulmonares apicales y de linfoadenopat\u00edas. Al ingreso, un frotis nasofar\u00edngeo, en el contexto de la pandemia de COVID-19, result\u00f3 negativo para SARS-CoV-2. La prueba se repiti\u00f3 despu\u00e9s de los primeros resultados radiol\u00f3gicos y tambi\u00e9n fue negativa. Posteriormente, se realiz\u00f3 PCR para SARS-CoV-2 en las diferentes muestras de LCR, con resultado tambi\u00e9n negativo. Un an\u00e1lisis serol\u00f3gico semicuantitativo para SARS-CoV-2 mostr\u00f3 presencia de IgM e IgG al ingreso, as\u00ed como tambi\u00e9n el d\u00eda 20, con valor menor de IgM, lo que suger\u00eda una infecci\u00f3n reciente por SARS-CoV-2. La paresia empeor\u00f3 r\u00e1pidamente a paraplejia, con anestesia total por debajo de T10 y disfunci\u00f3n esfinteriana. Inicialmente se consider\u00f3 tratamiento con corticoesteroides, pero no se administraron a causa de la sospecha de SARS-CoV-2. El paciente fue tratado con inmunoglobulinas humanas i.v., 0,4 g/kg durante 5 d\u00edas. No se apreci\u00f3 ninguna mejora neurol\u00f3gica tras el tratamiento. Teniendo en cuenta los dos frotis nasofar\u00edngeos negativos para SARS-CoV-2, la ausencia de s\u00edntomas respiratorios y la desaparici\u00f3n de los infiltrados pulmonares, se inici\u00f3 una terapia con corticoesteroides i.v. durante 5 d\u00edas a partir del d\u00eda 21 de ingreso. El d\u00eda 30 de ingreso, el paciente mostr\u00f3 una leve mejora en sus extremidades inferiores y se traslad\u00f3 a un centro de neurorrehabilitaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An 8\u2010months\u2010old healthy and correctly immunized male presented to the emergency department (ED). He had five\u2010days of fever, cough, nasal congestion, and increased work of breathing over the previous hours. Chest auscultation showed hypoventilation with bilateral crackles. Oxygen therapy through nasal cannula was started, blood test including blood culture was performed and intravenous cefotaxima (200\u2009mg/kg/d) was administered. Chest X\u2010ray (CXR) revealed a left lower lobe (LLL) opacity and small pleural effusion. Laboratory findings showed increased levels of C\u2010reactive protein (CRP), procalcitonin (PCT), ferritin, and interleukin\u20106 . Reverse transcription\u2010polymerase chain reaction (RT\u2010PCR) on nasopharyngeal swab (NPS) for SARS\u2010CoV\u20102 revealed positive. His clinical condition deteriorated, he was transferred to the PICU. On admission, high flow nasal cannula (HFNC) oxygen therapy was initiated. There was no improvement so noninvasive ventilation (NIV) was started. Empirical drugs for coronavirus disease\u20102019 (COVID\u201019) were initiated (azithromycin 10\u2009mg/kg/d, lopinavir/ritonavir 12/3\u2009mg/kg/12\u2009h, and hydroxychloroquine 6.5\u2009mg/kg/12\u2009h). Forty\u2010eight hours later, he became apyretic with improved laboratory tests. However, he remained oxygen dependent on NIV. Blood culture taken in the ED was positive for S. pneumoniae . A new CXR showed increased pleural effusion, confirmed with chest ultrasound. A chest tube was placed which drained fluid consistent with empyema. S. pneumoniae (immunochromatographic rapid test) and SARS\u2010CoV\u20102 (RT\u2010PCR) were positive. Clindamycin (40\u2009mg/kg/d/8\u2009h) and steroids were started (methylprednisolone 1\u2009mg/kg/d). Clinical status progressively improved and he was weaned to HFNC 2 days later. On the 6th day of admission, he was switched to oxygen nasal cannula. A chest ultrasound showed significant improvement, so pleural tube was removed. He was discharged to the pediatric ward after 7 days in PICU. According to clinical improvement, oxygen supplementation and steroids were stopped on day 8. Twenty\u2010four hours later, he developed fever, tachycardia, and moderate respiratory distress. The patient was readmitted to PICU, HFNC was started again. The RT\u2010PCR on NPS was repeated and still positive for SARS\u2010CoV\u20102. A new CXR showed an air\u2010fluid level image in the LLL, consistent with necrotizing pneumonia, confirmed by chest computed\u2010tomography. Also, new blood cultures were done to discard other bacteria or coinfections. Methylprednisolone and hydroxychloroquine were reinitiated. Antibiotic therapy was switched to intravenous meropenem (20\u2009mg/kg/d/8\u2009h) and linezolid (10\u2009mg/kg/12\u2009h) to broaden the antibiotic spectrum. The patient improved during the next days. He was discharged to the pediatric ward again after 5 days in PICU. His chest ultrasound and bloodwork kept improving. He received steroids for 14 days. He was discharged home after 18 days. At home, he continued oral linezolid to complete a total of 14 days and steroids on a tapering schedule for 4 more days up to 18 days. At the present, he is being followed as outpatient in the general pediatric clinics and his RT\u2010PCR for SARS\u2010CoV\u201019 is already negative.",
        "es": "Un ni\u00f1o de 8 meses, en buen estado de salud y con el calendario de vacunaci\u00f3n al d\u00eda, fue llevado al servicio de urgencias. Ten\u00eda fiebre, tos y cogesti\u00f3n nasal de cinco d\u00edas de evoluci\u00f3n, as\u00ed como disnea en las \u00faltimas horas. La auscultaci\u00f3n tor\u00e1cica revel\u00f3 hipoventilaci\u00f3n con crepitantes bilaterales. Se inici\u00f3 oxigenoterapia con c\u00e1nula nasal, se realiz\u00f3 un an\u00e1lisis de sangre con hemocultivos y se administr\u00f3 cefotaxima i.v. (200 mg/kg al d\u00eda). Una radiograf\u00eda tor\u00e1cica revel\u00f3 opacidad en el l\u00f3bulo inferior izquierdo y ligero derrame pleural. Los resultados anal\u00edticos mostraron aumento de prote\u00edna C-reactiva, procalcitonina, ferritina e interleucina 6. Una RT-PCR de frotis nasofar\u00edngeo para SARS-CoV-2 dio resultado positivo. Su estado cl\u00ednico empeor\u00f3 y se traslad\u00f3 a la UCI pedi\u00e1trica. Al ingreso, se inici\u00f3 oxigenoterapia mediante c\u00e1nula nasal de alto flujo. Como no se apreci\u00f3 mejora, se inici\u00f3 ventilaci\u00f3n no invasiva. Se inici\u00f3 un tratamiento provisional para coronavirus 2019 (COVID-19) con azitromicina (10 mg/kg al d\u00eda), lopinavir/ritonavir (12/3 mg/kg cada 12 h) e hidroxicloroquina (6,5 mg/kg cada 12 h). 48 horas despu\u00e9s, el paciente se mostr\u00f3 apir\u00e9tico y las pruebas anal\u00edticas mejoraron. Sin embargo, a\u00fan necesitaba oxigenoterapia con ventilaci\u00f3n no invasiva. Los hemocultivos obtenidos en urgencias resultaron positivos para S. pneumoniae. Una nueva radiograf\u00eda tor\u00e1cica mostr\u00f3 un aumento del derrame pleural, confirmado con ecograf\u00eda tor\u00e1cica. Se aplic\u00f3 drenaje tor\u00e1cico, que obtuvo l\u00edquido consistente con enfisema, que dio positivo para S. pneumoniae (prueba r\u00e1pida inmunocromatogr\u00e1fica) y SARS\u2010CoV\u20102 (RT\u2010PCR). Se inici\u00f3 tratamiento con clindamicina (40 mg/kg por d\u00eda cada 8 h) y esteroides (metilprednisolona, 1 mg/kg al d\u00eda). El estado cl\u00ednico mejor\u00f3 progresivamente y se pas\u00f3 a c\u00e1nula nasal de alto flujo 2 d\u00edas despu\u00e9s. El d\u00eda 6 de ingreso, se pas\u00f3 a c\u00e1nula nasal. Una ecograf\u00eda tor\u00e1cica mostr\u00f3 una mejora importante, de modo que se retir\u00f3 el drenaje tor\u00e1cico. El paciente se traslad\u00f3 a la planta de pediatr\u00eda tras 7 d\u00edas en la UCI pedi\u00e1trica. Teniendo en cuenta la mejora cl\u00ednica, el d\u00eda 8 se retir\u00f3 la oxigenoterapia y los esteroides. 24 horas despu\u00e9s, present\u00f3 fiebre, taquicardia e insuficiencia respiratoria moderada. El paciente fue reingresado en la UCI pedi\u00e1trica y se aplic\u00f3 de nuevo oxigenoterapia con c\u00e1nula nasal de alto flujo. Se repiti\u00f3 la RT-PCR de frotis nasofar\u00edngeo, con resultado a\u00fan positivo para SARS-CoV-2. Una nueva radiograf\u00eda tor\u00e1cica mostr\u00f3 un nivel hidroa\u00e9reo en el l\u00f3bulo inferior izquierdo coherente con neumon\u00eda necrosante, confirmada mediante TAC tor\u00e1cica. Se realizaron nuevos hemocultivos para descartar otras bacterias o coinfecciones. Se administr\u00f3 nuevamente metilprednisolona e hidroxicloroquina. La terapia antibi\u00f3tica se cambi\u00f3 a meropenem i.v. (20 mg/kg por d\u00eda cada 8 h) y linezolid (10 mg/kg cada 12 h) para ampliar el espectro antibi\u00f3tico. El paciente mejor\u00f3 durante los d\u00edas siguientes y se traslad\u00f3 de nuevo a la planta de pediatr\u00eda tras 5 d\u00edas en la UCI pedi\u00e1trica. Las ecograf\u00edas tor\u00e1cicas y los an\u00e1lisis de sangre mostraron mejora continua. Recibi\u00f3 esteroides durante 14 d\u00edas. Fue dado de alta despu\u00e9s de 18 d\u00edas. En el hogar, prosigui\u00f3 el tratamiento con linezolid por v\u00eda oral para completar un total de 14 d\u00edas, as\u00ed como esteroides en una pauta de disminuci\u00f3n progresiva durante 4 d\u00edas m\u00e1s, hasta los 18. En el momento presente, se le hace un seguimiento ambulatorio en el consultorio pedi\u00e1trico general; sus RT-PCR para SARS-CoV-2 son negativas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 70 year-old African American female with a past medical history of hypertension and  complicated type 2 diabetes, presented to clinic secondary to fever, cough, and shortness of  breath that started one week ago. She endorsed possible exposure to COVID-19 at work. She  denied skin changes at that time. Vital signs and physical examination were normal whereas  laboratory results were positive for COVID-19. All other lab results including absolute lymphocyte count were normal. Therefore, she was advised to self-quarantine and take  acetaminophen for fever. However, she started to develop a rash on her left hip the next day. Due  to a worsening rash, she presented to her provider via video six days later. The rash started as a  tender red patch that developed multiple small painful non-hemorrhagic vesicles with severe  burning. By that time, her COVID-19 associated symptoms resolved. On physical examination,  the left superior buttock had an erythematous patch with multiple vesicles and hemorrhagic crust. Lower extremity neurologic examination was normal. No pictures were taken. After making a  clinical diagnosis of HZ, she was prescribed gabapentin for pain and no antiviral therapy.",
        "es": "Una mujer afroamericana de 70 a\u00f1os, con antecedentes de hipertensi\u00f3n y diabetes de tipo 2 con complicaciones, acudi\u00f3 al consultorio con fiebre, tos y disnea de una semana de evoluci\u00f3n. Refiri\u00f3 posible exposici\u00f3n a la COVID-19 en el trabajo. Neg\u00f3 tener alteraciones cut\u00e1neas en ese momento. Las constantes vitales y la exploraci\u00f3n f\u00edsica fueron normales, mientras que los resultados anal\u00edticos confirmaron COVID-19. Todas las dem\u00e1s pruebas anal\u00edticas, incluyendo cifra absoluta de linfocitos, resultaron normales. En consecuencia, se le aconsej\u00f3 autoconfinarse y tomar acetaminofeno para la fiebre. Sin embargo, al d\u00eda siguiente, empez\u00f3 a aparecer un exantema en la cadera izquierda. Debido su empeoramiento, se comunic\u00f3 mediante v\u00eddeo con su m\u00e9dico seis d\u00edas despu\u00e9s. El exantema se inici\u00f3 como una mancha roja sensible que desarroll\u00f3 m\u00faltiples ves\u00edculas peque\u00f1as dolorosas no hemorr\u00e1gicas, con escozor intenso. En ese momento, los s\u00edntomas asociados a COVID-19 ya hab\u00edan desaparecido. A la exploraci\u00f3n f\u00edsica, la nalga superior izquierda presentaba una mancha eritematosa con varias ves\u00edculas y superficie hemorr\u00e1gica. La exploraci\u00f3n neurol\u00f3gica de las extremidades inferiores fue normal. No se obtuvieron im\u00e1genes. Tras un diagn\u00f3stico cl\u00ednico de herpes z\u00f3ster, se le recet\u00f3 gabapentina para el dolor, sin terapia antiv\u00edrica."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 30-year-old woman with an unremarkable medical history developed nocturnal parosmia (an intense smell of sweaty feet) lasting for several hours. On the next day, she felt slightly unwell. No specific symptoms (cough, fever) were present. Two days later, she reported complete loss of smell and taste. Topical steroids b.i.d. and smell training were started. Postviral hyposmia was diagnosed, but (in the absence of known symptoms) SARS-CoV-2 infection was not suspected. The anosmia started to improve 6 days later and eventually disappeared altogether. Cranial MRI revealed no abnormalities. Fourteen days after the parosmia, it was publicized that hyposmia might be a symptom of SARS-CoV-2 infection. One day later, PCR testing for SARS-CoV-2 was positive.",
        "es": "Una mujer de 30 a\u00f1os, sin antecedentes remarcables, present\u00f3 parosmia nocturna (con olor intenso de pies sudados) durante varias horas. Al d\u00eda siguiente se sinti\u00f3 algo indispuesta. No ten\u00eda s\u00edntomas espec\u00edficos (tos, fiebre). Dos d\u00edas despu\u00e9s refiri\u00f3 p\u00e9rdida total del olfato y el gusto. Un otorrinolaring\u00f3logo diagnostic\u00f3 anosmia completa. Se inici\u00f3 tratamiento con esteroides por v\u00eda t\u00f3pica dos veces al d\u00eda. Se diagnostic\u00f3 hiposmia posv\u00edrica pero, en ausencia de s\u00edntomas conocidos, no se plante\u00f3 infecci\u00f3n por SARS-CoV-2. La anosmia empez\u00f3 a mejorar 6 d\u00edas despu\u00e9s hasta desaparecer por completo. Una RMN craneal no mostr\u00f3 anomal\u00edas. Catorce d\u00edas despu\u00e9s de la parosmia, se public\u00f3 que la hiposmia puede ser un s\u00edntoma de infecci\u00f3n por SARS-CoV-2. Un d\u00eda despu\u00e9s, una prueba PCR para SARS-CoV-2 fue positiva."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "Mr. G, a 43-year-old man without a significant past medical, substance use, or personal or family psychiatric history, presented to the emergency department for a headache and fever. At that visit, he was noted to have a temperature of 100.0\u00b0F; oxygen saturation was 99% on room air; and other vital signs were within normal limits. It was noted that it was possible he had COVID-19, but he did not meet criteria for testing at that time. He was discharged and advised to quarantine at home. Nine days later, he re-presented to the emergency department for fever and shortness of breath. He was febrile to 102.3\u00b0F and had tachycardia of 110 beats per minute; oxygen saturation was 99% on room air; and other vital signs were within normal limits. A chest x-ray was performed, which showed no acute cardiopulmonary abnormality. A COVID-19 nasopharyngeal swab polymerase chain reaction test was sent to an external laboratory. He was sent home with prescriptions for a 5-day course of oral azithromycin (500 mg on day 1, and then 250 mg on days 2\u20135), as-needed benzonatate for cough, and an as-needed albuterol inhaler. Three days later (12\u00a0d after his first emergency presentation), he came to the emergency department for a third time, reporting upper back pain and spasms. He also noted anxiety and insomnia due to his concern about COVID-19. He was afebrile; oxygen saturation was 96% on room air; and all other vital signs were within normal limits. He was notified during this visit that his previous COVID-19 polymerase chain reaction test was negative. He reported he had been compliant with the azithromycin and was encouraged to finish the course at home. His back pain was thought to be musculoskeletal, secondary to persistent coughing, and he was discharged home with a prescription for methocarbamol 750 mg 4 times a day for 7 days. Four days later (15\u00a0d after his first emergency presentation), Mr. G's wife called his primary care physician's office. She told the office she was concerned that he had been acting strangely since he was tested for COVID-19 in the emergency department 1 week prior. She noted that he had been talking to himself, not eating or drinking properly, and not showering. She was also concerned that he was frequently staring at the wall, and she reported that he was shaking and sweating without a fever. A televisit with a primary care provider took place later that day, but Mr. G did not come to the phone because of concern that the provider was \u201cthe devil.\u201d Together, his primary care provider and wife decided to bring him back to the emergency department. In the emergency department for the fourth time, Mr. G was noted to require a 2-person assist to transfer from a wheelchair to his stretcher because of weakness. His temperature was 100.2\u00b0F and heart rate was 107 beats per minute; oxygen saturation was 96% on room air; and other vital signs were within normal limits. His blood glucose was normal, as were serum electrolytes, procalcitonin, C-reactive protein, creatine kinase, and lactic acid. Serum drug screen was negative. Hematologic testing showed a normal total white blood count with 3% immature granulocytes as well as an elevated platelet count of 551 TH/\u03bcL. Hepatic function tests showed an alanine transaminase of 281 U/L and an aspartate transaminase of 79 U/L. His international normalized ratio was prolonged at 1.5. Repeat COVID-19 polymerase chain reaction testing was positive. Chest x-ray showed no acute cardiopulmonary process. He underwent computed tomography of his head without contrast which showed no acute intracranial abnormality. He then underwent a lumbar puncture after being medicated with 1 mg of intravenous midazolam, and his cerebrospinal fluid was unremarkable with no polymorphonuclear leukocytes or organisms seen on gram stain; 2 red blood cells/\u03bcL and 1 white blood cell/\u03bcL on cell count and differential; and protein of 32 mg/dL and glucose of 69 mg/dl. Mr. G was admitted that evening to the medical floor for further workup and treatment of altered mental status. The psychiatry consultation-liaison team was consulted the next day (hospital day 2). On that day, Mr. G was noted to be alert and oriented to person, place, and time, but he showed delayed verbal responses, profound muscle rigidity, and difficulty resisting gravity in all limbs, as well as profuse diaphoresis. His vital signs were also notable for temperature ranging up to 99.3\u00b0F, labile blood pressures (ranging from 107/70 to 156/103 over a 12-h period), an episode of tachypnea with a respiratory rate of 36 breaths per minute, and an oxygen saturation of 93 to 95% on room air. Per hospital policy at the time, to minimize exposure and transmission, the psychiatric team did not evaluate Mr. G in person because of his severe acute respiratory syndrome coronavirus 2 infection status and instead attempted to contact him via the phone in his hospital room. However, Mr. G did not answer, and his nurse reported he was too weak to hold a phone to his ear. Based on the information available at the time, the psychiatry team recommended 50 mg of oral quetiapine at bedtime to treat insomnia and potential psychotic symptoms. Mr. G ultimately did not receive the medication because he was unable to take oral medications. A urinary catheter was placed because Mr. G had not urinated during the hospitalization. His urine drug screen, obtained after catheter placement, was positive for benzodiazepines only. The following morning (hospital day 3), Mr. G's nurse noted him to be resting in bed in an abnormal posture, with his feet hovering above the bed and his arms in a decorticate position. Intravenous lorazepam 1 mg was administered in preparation for magnetic resonance imaging of the brain and spine, and Mr. G was observed 30 minutes after administration. He was sitting up in his bed and conversing with his roommate. He was no longer sweating and requested something to drink. At that point, he reported to his nurse that he had been hearing voices \u201ctrying to bring [him] to hell.\u201d He did undergo the magnetic resonance imaging scans, which demonstrated no fluid-attenuated inversion recovery or T2 signal, leptomeningeal contrast enhancement, white matter disease, or atrophy. Mr. G was treated initially with 1 mg of intravenous lorazepam 3 times daily, and by hospital day 5, he was stabilized on oral lorazepam 1 mg 4 times a day. During this time, he demonstrated no further signs of catatonia; he remained nonrigid, conversant, and eating and drinking adequately. Lorazepam was tapered to 1 mg 2 times a day by the day of discharge, hospital day 10, at which point Mr. G was speaking fluently, moving all extremities without difficulty,\u00a0and no psychosis was evident. He was evaluated by the psychiatry team via telephone 4 days after discharge; he was having no difficulty with movement or speech, and no psychosis was evident, but he was experiencing difficulty sleeping. Oral lorazepam was further reduced to 1 mg at bedtime. Mr. G was evaluated by his primary care physician via telephone 6 days after discharge, and he continued to report sleep disturbance, as well as sadness and anhedonia. His wife reported he remained improved but not fully recovered as he needed encouragement to engage in conversation and his occupation. On further psychiatric follow-up, he was continued on 1 mg of oral lorazepam nightly for residual psychomotor retardation as well as 6 mg of melatonin nightly for insomnia.",
        "es": "El se\u00f1or G, un hombre de 43 a\u00f1os sin antecedentes relevantes, toxicoman\u00edas ni antecedentes psiqui\u00e1tricos personales o familiares, acudi\u00f3 al servicio de urgencias con cefalea y fiebre. A la exploraci\u00f3n, su temperatura era de 37,8 \u00b0C, la saturaci\u00f3n de ox\u00edgeno era de 99% en aire ambiental y el resto de las constantes vitales estaban dentro de los l\u00edmites normales. Se se\u00f1al\u00f3 que era posible que tuviera COVID-19, pero no cumpl\u00eda con los criterios para realizar una prueba en ese momento, de modo que se le dio de alta y se le aconsej\u00f3 confinarse en su domicilio,Nueve d\u00edas despu\u00e9s, regres\u00f3 a urgencias con fiebre y disnea. A la exploraci\u00f3n, su temperatura era de 39 \u00b0C, con taquicardia a 110 l.p.m., la saturaci\u00f3n de ox\u00edgeno era de 99% en aire ambiental y el resto de las constantes vitales estaban dentro de los l\u00edmites normales. Se realiz\u00f3 una radiograf\u00eda tor\u00e1cica, que no mostr\u00f3 anomal\u00edas cardiopulmonares agudas. Se envi\u00f3 un frotis nasofar\u00edngeo para PCR de COVID-19 a un laboratorio externo. Se dio de alta al paciente con una prescripci\u00f3n de 5 d\u00edas de azitromicina oral (500 mg el d\u00eda 1 y luego 250 mg los d\u00edas 2 a 5), benzonatato a discreci\u00f3n para la tos e inhalaciones de albuterol a discreci\u00f3n. Tres d\u00edas despu\u00e9s (12 d\u00edas despu\u00e9s de su primer ingreso), regres\u00f3 a urgencias por tercera vez, con dorsalgia alta y espasmos. Tambi\u00e9n refiri\u00f3 angustia e insomnio a causa de su preocupaci\u00f3n por la COVID-19. El paciente estaba afebril, la saturaci\u00f3n de ox\u00edgeno era de 96% en aire ambiental y el resto de las constantes vitales estaban dentro de los l\u00edmites normales. Se le notific\u00f3 que su prueba de COVID-19 mediante PCR hab\u00eda dado resultado negativo. Refiri\u00f3 tambi\u00e9n que hab\u00eda cumplido la pauta de azitromicina y se le recomend\u00f3 que finalizara el tratamiento en su domicilio. Se consider\u00f3 que su dorsalgia era osteomuscular, secundaria a tos persistente, y se le dio de alta con una prescripci\u00f3n de metocarbamol 750 mg 4 veces al d\u00eda durante 7 d\u00edas. Cuatro d\u00edas despu\u00e9s (15 tras el primer ingreso en urgencias), la esposa del paciente llam\u00f3 a la consulta de su m\u00e9dico de cabecera. Inform\u00f3 que estaba preocupada porque su marido hab\u00eda estado actuando de modo extra\u00f1o desde que se le hab\u00eda hecho la prueba de COVID-19 una semana antes. Hab\u00eda notado que hablaba con \u00e9l mismo, no com\u00eda ni beb\u00eda adecuadamente y no se duchaba. Tambi\u00e9n estaba preocupada porque a menudo se quedaba mirando a la pared y temblaba y sudaba sin fiebre. M\u00e1s adelante ese mismo d\u00eda se realiz\u00f3 una visita telef\u00f3nica con un m\u00e9dico de atenci\u00f3n primaria, pero el paciente no se puso al tel\u00e9fono porque tem\u00eda que el m\u00e9dico \u00abfuera del diablo\u00bb. El m\u00e9dico y la esposa decidieron llevarlo nuevamente a urgencias. En urgencias, el paciente necesit\u00f3 la ayuda de dos personas para pasar de una silla de ruedas a la camilla, a causa de su debilidad. Su temperatura era de 37,9 \u00b0C, el pulso era de 107 l.p.m., la saturaci\u00f3n de ox\u00edgeno era de 96% en aire ambiental y el resto de las constantes vitales estaban dentro de los l\u00edmites normales. Su glucemia era normal, as\u00ed como los electrolitos s\u00e9ricos, la procalcitonina, la prote\u00edna C-reactiva, la creatina-cinasa y el \u00e1cido l\u00e1ctico. La prueba s\u00e9rica de drogas fue negativa. Las pruebas hematol\u00f3gicas mostraron una cifra total de leucocitos normal, con un 3% de granulocitos inmaduros y una cifra alta de trombocitos (551 TH/\u03bcL). Las pruebas funcionales hep\u00e1ticas dieron una alanina-transaminasa de 281 U/L y aspartato-transaminasa de 79 U/L. Su cociente internacional normalizado estaba alargado hasta 1,5. Una nueva prueba PCR para COVID-19 dio positivo. La radiograf\u00eda tor\u00e1cica no mostr\u00f3 afecciones cardiopulmonares agudas. Se realiz\u00f3 una TAC craneal sin contraste que tampoco mostr\u00f3 anomal\u00edas agudas intracraneales. Luego se practic\u00f3 una punci\u00f3n lumbar tras administrarle 1 mg de midazolam i.v. ; el an\u00e1lisis del l\u00edquido cefalorraqu\u00eddeo fue irrelevante, sin leucocitos polimorfos ni organismos en tinci\u00f3n de Gram, 2 eritrocitos/\u03bcLy 1 leucocito/\u03bcL en la f\u00f3rmula leucocitaria y valores de prote\u00ednas y glucosa de 32 mg/dL y 69 mg/dL, respectivamente. El paciente fue ingresado esa misma noche en la planta de hospitalizaci\u00f3n general para seguimiento y tratamiento de su alteraci\u00f3n mental. Al d\u00eda siguiente (d\u00eda 2 de hospitalizaci\u00f3n), se consult\u00f3 con el equipo de psiquiatr\u00eda. Ese d\u00eda, el paciente estaba alerta y orientado con respecto a personas, lugar y tiempo, pero tardaba en responder verbalmente, mostraba hiperton\u00eda y le costaba sostener en alto las extremidades; tambi\u00e9n presentaba sudoraci\u00f3n intensa. Sus constantes vitales tambi\u00e9n eran relevantes por la temperatura de hasta 37,4 \u00b0C, presi\u00f3n l\u00e1bil (de 107/70 a 156/103 en 12 horas), un episodio de taquipnea con frecuencia respiratoria de 36 r.p.m. De acuerdo con la pol\u00edtica del hospital en ese momento, para minimizar la exposici\u00f3n y la transmisi\u00f3n, el equipo de psiquiatr\u00eda no evalu\u00f3 al paciente en persona, a causa de un s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 y, en cambio, intent\u00f3 hablar con \u00e9l mediante el tel\u00e9fono de la habitaci\u00f3n del hospital. Sin embargo, el paciente no respondi\u00f3 y su enfermera inform\u00f3 que estaba demasiado d\u00e9bil como para sostener el tel\u00e9fono al lado de su oreja. A partir de la informaci\u00f3n disponible en ese momento, el equipo de psiquiatr\u00eda recomend\u00f3 50 mg de quetiapina por v\u00eda oral antes de acostarse, para tratar el insomnio y los posibles s\u00edntomas psic\u00f3ticos. Finalmente, el paciente no recibi\u00f3 la medicaci\u00f3n porque era incapaz de tomar medicamentos por v\u00eda oral. Se le coloc\u00f3 un cat\u00e9ter urinario porque no hab\u00eda orinado durante la hospitalizaci\u00f3n. El perfil de f\u00e1rmacos en orina, obtenido tras la colocaci\u00f3n del cat\u00e9ter, fue positivo solo para benzodiazepinas. A la siguiente ma\u00f1ana (d\u00eda 3 de hospitalizaci\u00f3n), la enfermera del paciente se\u00f1al\u00f3 que estaba en la cama en una posici\u00f3n an\u00f3mala, con los pies por encima de la cama y los brazos en postura de decorticaci\u00f3n. Se le administr\u00f3 1 mg de lorazepam i.v. como preparaci\u00f3n para la RMN cerebral y raqu\u00eddea y se le observ\u00f3 30 minutos despu\u00e9s de la administraci\u00f3n. Estaba sentado en la cama, conversando con su compa\u00f1ero de habitaci\u00f3n. Ya no sudaba y pidi\u00f3 algo de beber. En ese momento dijo a la enfermera que hab\u00eda estado oyendo voces que \u00abintentaban llevarlo al infierno\u00bb. Se le realiz\u00f3 la RMN, que no mostr\u00f3 se\u00f1ales en T2 o FLAIR, realce del contraste leptomen\u00edngeo, alteraciones de la sustancia blanca o atrofia. El paciente se trat\u00f3 inicialmente con 1 mg de lorazepam i.v. 3 veces al d\u00eda y, el d\u00eda 5 de hospitalizaci\u00f3n se estabiliz\u00f3 a 1 mg de lorazepam por v\u00eda oral 4 veces al d\u00eda. Durante este tiempo no mostr\u00f3 m\u00e1s signos de catatonia; continu\u00f3 sin hiperton\u00eda y conversativo y comi\u00f3 y bebi\u00f3 adecuadamente. El lorazepam se redujo a 1 mg dos veces al d\u00eda el d\u00eda del alta, en el d\u00e9cimo d\u00eda de hospitalizaci\u00f3n. En este momento, el paciente hablaba con fluidez, pod\u00eda mover todas las extremidades sin dificultades y no se apreciaba psicosis. 4 d\u00edas despu\u00e9s del alta fue evaluado por tel\u00e9fono por el equipo de psiquiatr\u00eda; no ten\u00eda dificultades motoras ni del habla y no se le apreciaba ning\u00fan tipo de psicosis, pero ten\u00eda problemas para dormir. Se le redujo el lorazepam por v\u00eda oral a 1 mg antes de acostarse. 6 d\u00edas despu\u00e9s del alta, el paciente fue evaluado por su m\u00e9dico de cabecera; continuaba refiriendo alteraciones del sue\u00f1o, adem\u00e1s de sensaci\u00f3n de tristeza y anhedonia. Su esposa afirm\u00f3 que hab\u00eda mejorado pero a\u00fan no estaba totalmente recuperado, pues necesitaba estimulaci\u00f3n para entablar una conversaci\u00f3n y para realizar su trabajo. En el seguimiento psiqui\u00e1trico posterior, se mantuvo 1 mg de lorazepam por v\u00eda oral a causa del enlentecimiento psicomotor, as\u00ed como 6 mg de melatonina por la noche para el insomnio."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "50-year-old man who was diagnosed with L\u00f6fgren syndrome in January 2019 presenting with cough, bilateral ankle joint swelling and mediastinal lymphadenopathy. ACE (37.3\u2009U/L, normal range <21.4) and soluble IL-2 receptor (1445\u2009U/mL, normal range <710) were elevated in the serum. The patient was treated with glucocorticoids until October 2019 with complete remission of clinical symptoms and normalisation of laboratory parameters. On 12 March 2020, the patient had contact with a person who later tested positive for SARS-CoV-2 RNA. One week after the SARS-CoV-2 contact, the patient developed fever (38\u00b0C) and dry cough suggesting SARS-CoV-2 infection. In addition, he developed pain in the ankles during night and with exercise. The fever remitted after 4 days, but the joint complaints persisted. SARS-CoV-2 RNA was negative in a combined nasopharyngeal and oral swab 14 days after contact with the patient with COVID-19. Due to persistent pain and swelling in both ankles, the patient re-initiated prednisolone treatment at doses of 20\u201330\u2009mg/day on 28 March (16 days after the SARS-CoV-2-contact) against medical advice. On 2 April, 5 days after initiation of prednisolone treatment, the patient presented with painful ankles and slight swelling of the right ankle. Auscultation revealed slight rales in two-thirds of the right lung. Laboratory tests showed an increase of leucocytes to 10 800/\u00b5L with 9400 neutrophils/\u00b5L and a borderline elevation of ACE in serum (21.9\u2009U/mL, normal range <21.4). C reactive protein and soluble IL2-receptor were normal. Unenhanced CT of the chest showed bilateral, peripheral, ill-defined ground-glass opacities involving mainly the right lower lobe. Additional consolidations were present in the right peripheral lung base and to a lesser extent in the left lower lobe. There were no typical findings for alveolar sarcoidosis-like peribronchovascular consolidations. The mediastinal lymph nodes were normal-sized and showed regression compared with previous CT examination from January 2019. Radiologists considered these CT changes as highly suspicious for COVID-19 pneumonia. Also, SARS-CoV-2 RNA was weakly positive in a nasopharyngeal swab (Ct value 37.9), but clearly positive in an oral swab (Ct value 34.7). Prednisolone was discontinued within 2\u2009days and treatment with hydroxychloroquine (HCQ) 400\u2009mg/day orally was initiated. The patient had an uneventful course of infection and could be dismissed 5 days later, after the SARS-CoV2 RNA was negative in the nasopharyngeal and oral swabs.",
        "es": "Hombre de 50 a\u00f1os, al que se le diagnostic\u00f3 s\u00edndrome de L\u00f6fgren en enero de 2019, con tos, inflamaci\u00f3n bilateral de la articulaci\u00f3n del tobillo y linfoadenopat\u00eda mediast\u00ednica. La ACE (37,3\u2009U/L, valor normal < 21,4) y el receptor de IL-2 soluble (1445\u2009U/mL, valor normal < 710) s\u00e9ricos eran elevados. El paciente fue tratado con glucocorticoides hasta octubre de 2019, con una remisi\u00f3n completa de los s\u00edntomas cl\u00ednicos y normalizaci\u00f3n de los par\u00e1metros anal\u00edticos. El 12 de marzo de 2020, el paciente hab\u00eda tenido contacto con una persona que, posteriormente, dio positiva en una prueba de ARN de SARS-CoV-2. Una semana despu\u00e9s del contacto con SARS-CoV-2, el paciente present\u00f3 fiebre (38 \u00b0C) y tos seca, indicativas de infecci\u00f3n por SARS-CoV-2. Adem\u00e1s, present\u00f3 dolor en los tobillos durante la noche y con esfuerzo. La fiebre remiti\u00f3 tras 4 d\u00edas, pero el dolor articular persisti\u00f3. Una prueba de ARN de SARS-CoV-2 en frotis nasofar\u00edngeo y orofar\u00edngeo fue negativa 14 d\u00edas despu\u00e9s del contacto con el paciente con COVID-19. A causa de dolor e inflamaci\u00f3n persistente en ambos tobillos, el d\u00eda 28 de marzo el paciente reinici\u00f3 el tratamiento con prednisolona a dosis de 20-30 mg/d\u00eda (16 d\u00edas tras el contacto con SARS-CoV-2), contra la recomendaci\u00f3n m\u00e9dica. El 2 de abril, 5 d\u00edas despu\u00e9s de iniciar el tratamiento con prednisolona, el paciente acudi\u00f3 con dolor en los tobillos y una ligera inflamaci\u00f3n del tobillo derecho. La auscultaci\u00f3n revel\u00f3 estertores leves en dos tercios del pulm\u00f3n derecho. Las pruebas anal\u00edticas indicaron un aumento de leucocitos a 10.800/\u00b5L con 9.400 neutr\u00f3filos/\u00b5L y un aumento lim\u00edtrofe de la ACE s\u00e9rica (21,9\u2009U/mL, valor normal < 21,4). La prote\u00edna C-reactiva y el receptor de IL-2 soluble eran normales. Una TAC tor\u00e1cica sin contraste mostr\u00f3 opacidades de vidrio esmerilado poco definidas, perif\u00e9ricas y bilaterales, con afectaci\u00f3n principal en el l\u00f3bulo inferior derecho. Se observaron tambi\u00e9n consolidaciones adicionales en la base pulmonar perif\u00e9rica derecha y, en menor grado, en el l\u00f3bulo inferior izquierdo. No hab\u00eda signos t\u00edpicos de consolidaciones peribroncovasculares de sarcoidosis alveolar. Los ganglios linf\u00e1ticos mediast\u00ednicos ten\u00edan tama\u00f1o normal y mostraban una regresi\u00f3n en comparaci\u00f3n con TAC previas de enero de 2019. Los radi\u00f3logos consideraron que estos cambios eran altamente indicativos de neumon\u00eda por COVID-19. La se\u00f1al de ARN de SARS-CoV-2 era d\u00e9bilmente positiva en un frotis nasofar\u00edngeo (valor Ct 37,9), pero claramente positiva en un frotis orofar\u00edngeo (valor Ct 34,7). En dos d\u00edas, se interrumpi\u00f3 la prednisolona y se inici\u00f3 tratamiento con hidroxicloroquina por v\u00eda oral a 400 mg/d\u00eda. El paciente present\u00f3 una evoluci\u00f3n sin complicaciones de la infecci\u00f3n y pudo ser dado de alta 5 d\u00edas despu\u00e9s, despu\u00e9s de que una prueba de ARN de SARS-CoV-2 fuera negativa en frotis nasofar\u00edngeo y orofar\u00edngeo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 25-year-old healthy man presented with 1-day history of headache, left-sided paresthesias, and ipsilateral paresis progressing within 12 hours to confusion and agitation. His axillary temperature was 38.2\u00b0C. Brain CT and MRI scans were normal. CSF showed lymphocytic pleocytosis and increased proteins. He was started on IV acyclovir, ampicillin, and ceftriaxone, which were discontinued when CSF cultures and PCR ruled bacterial or viral etiologies. PCR of SARS-CoV-2 was negative in CSF but positive in the nasopharyngeal swab. On day 2, he fully recovered except for amnesia of the previous 2 days.",
        "es": "Un hombre de 25 a\u00f1os, por lo dem\u00e1s sano, acudi\u00f3 con un d\u00eda de evoluci\u00f3n de cefalea, parestesia izquierda y paresia ipsilateral que, en 12 horas, evolucion\u00f3 a desorientaci\u00f3n e inquietud. Su temperatura axilar era de 38,2 \u00b0C. Las TAC y RMN cerebrales eran normales. El LCR mostr\u00f3 pleocitosis linfoc\u00edtica y proteinorraquia. Se inici\u00f3 tratamiento con acivlovir, ampicilina y ceftriaxona i.v., que se interrumpi\u00f3 cuando PCR y cultivos de LCR descartaron etiolog\u00edas bacterianas o v\u00edricas. La PCR de SARS-CoV-2 fue negativa en LCR pero positiva en frotis nasofar\u00edngeo. El d\u00eda 2, el paciente se recuper\u00f3 completamente excepto por amnesia de los 2 d\u00edas previos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A healthy 49-year-old man presented with fever, myalgias, and dry cough lasting 1 week. A few hours after admission, he developed difficulty naming objects, temporospatial disorientation, confusion, and agitation. A thoracic CT scan showed bilateral peripheral opacities suggestive of COVID-19 pneumonia. Brain CT and MRI scans obtained 2 days later were unremarkable. CSF showed lymphocytic pleocytosis and increased proteins. The patient was empirically started on acyclovir, ampicillin, and ceftriaxone, which were discontinued once CSF cultures and PCR returned negative. PCR for SARS-CoV-2 was positive in the nasopharyngeal swab, but negative in CSF. Three days later, he was back to normal except for amnesia of the previous days.",
        "es": "Hombre de 49 a\u00f1os, por lo dem\u00e1s sano, con fiebre, mialgia y tos seca de 1 semana de evoluci\u00f3n. Pocas horas despu\u00e9s del ingreso, present\u00f3 dificultad para nombrar objetos, desorientaci\u00f3n espaciotemporal, confusi\u00f3n e inquietud. Una TAC tor\u00e1cica mostr\u00f3 opacidades perif\u00e9ricas bilaterales, indicativas de neumon\u00eda por COVID-19. Las TAC y RMN craneales obtenidas dos d\u00edas despu\u00e9s fueron irrelevantes. El LCR mostr\u00f3 pleocitosis linfoc\u00edtica y proteinorraquia. Se inici\u00f3 un tratamiento emp\u00edrico con aciclovir, ampicilina y ceftriaxona, que se interrumpi\u00f3 en cuanto los cultivos y PCR de LCR dieron resultado negativo. La PCR para SARS-CoV-2 fue positiva en frotis nasofar\u00edngeo pero negativa en LCR. Tres d\u00edas despu\u00e9s, el paciente hab\u00eda recuperado la normalidad, excepto por amnesia de los d\u00edas anteriores."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "58-year-old man had a history of adequately controlled diabetes mellitus (HbA1c 6.5%) and presented to the ED on March 12 for 3 days of cough, shortness of breath, and fever. In the ED, he had a fever of 102.2\u00b0F and hypoxemia, with an oxygen saturation of 90% on room air. Influenza assay was negative. Chest x-ray showed bilateral airspace opacities. Nasopharyngeal swab submitted for SARS-CoV-2 PCR testing returned positive. The patient was admitted and started on ceftriaxone (1 g IV daily), azithromycin (500 mg IV daily), and hydroxychloroquine (800 mg loading dose, followed by 400 mg daily). On March 14 (day 5 of symptoms), his hypoxemia worsened despite a non-rebreather mask, with oxygen saturation decreasing to as low as 70%. C-reactive protein was 142 mg/L, and ferritin was 2,188 ng/mL. He was transferred to the ICU where he was intubated and mechanically ventilated. The patient met criteria for severe ARDS with an arterial oxygen partial pressure (PaO2)/fraction of inspired oxygen (FiO2) ratio as low as 98. He was treated with a protocol of daily prone positioning. On March 22, he developed acute kidney injury (AKI) requiring initiation of continuous renal replacement therapy (CRRT). Medical record review revealed no history of chronic kidney disease (CKD). Because of clotting of the dialysis circuit, he was treated with a continuous infusion of unfractionated heparin. On March 23, he developed bilateral pneumothoraces requiring chest tube placement. His condition deteriorated despite these measures. The patient developed shock refractory to vasopressor therapy and died on March 26.",
        "es": "Hombre de 58 a\u00f1os con antecedentes de diabetes mellitus bien controlada (HbA1c 6,5%) acudi\u00f3 al servicio de urgencias el 12 de marzo con tos, disnea y fiebre de 3 d\u00edas de evoluci\u00f3n. A la exploraci\u00f3n, present\u00f3 fiebre (39 \u00b0C) e hipoxemia, con una saturaci\u00f3n de ox\u00edgeno del 90% en aire ambiental. Una prueba de gripe result\u00f3 negativa. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades alveolares bilaterales. El frotis nasofar\u00edngeo que se envi\u00f3 para una prueba de SARS-CoV-2 mediante PCR dio resultado positivo. ), azitromicina (500 mg al d\u00eda i.v.) e hidroxicloroquina (dosis inicial 800 mg, luego 400 mg al d\u00eda). El 14 de marzo (d\u00eda 5 de sintomatolog\u00eda), su hipoxemia empeor\u00f3 a pesar de la mascarilla con reservorio, con una disminuci\u00f3n de la saturaci\u00f3n de ox\u00edgeno hasta el 70%. La prote\u00edna C-reactiva era de 142 mg/L; la ferritina, de 2.188 ng/mL. Se lo traslad\u00f3 a la UCI, donde fue intubado y se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica. El paciente cumpl\u00eda los criterios de SDRA grave, con un cociente de presi\u00f3n parcial de ox\u00edgeno arterial (PaO2) y fracci\u00f3n de ox\u00edgeno inspirado (FiO2) de 98. Se trat\u00f3 con un protocolo de colocaci\u00f3n diaria en dec\u00fabito prono. El d\u00eda 22 de marzo present\u00f3 lesi\u00f3n renal aguda (LRA), que requiri\u00f3 tratamiento renal sustitutivo continuo (TRSC). Una revisi\u00f3n de la historia cl\u00ednica no revel\u00f3 antecedentes de nefropat\u00eda cr\u00f3nica. A causa del taponamiento del circuito de di\u00e1lisis, se trat\u00f3 al paciente con una infusi\u00f3n continua de heparina no fraccionada. El 23 de marzo, present\u00f3 neumot\u00f3rax bilateral, que requiri\u00f3 colocaci\u00f3n de drenaje tor\u00e1cico. Su estado empeor\u00f3 a pesar de las medidas tomadas. El paciente desarroll\u00f3 choque resistente a terapia vasopresora y muri\u00f3 el 26 de marzo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "The 71-year-old man with a history of hypertension, CKD (stage 3), and sarcoidosis (inactive disease, not on treatment) presented to the ED on March 15. Symptoms included cough, fever of 102.6\u00b0F, and shortness of breath. He was tachycardic and hypoxemic, with an oxygen saturation as low as 70% on room air. Influenza assay was negative. Chest x-ray showed bilateral airspace opacities. C-reactive protein was 90.6 mg/L. Nasopharyngeal swab submitted for SARS-CoV-2 PCR testing returned positive. The patient was admitted directly to the ICU where he was intubated and mechanically ventilated. He met criteria for severe ARDS with a PaO2/FiO2 ratio as low as 76. He was treated with a protocol of daily prone positioning. Medications included ceftriaxone (1 g IV twice daily) and hydroxychloroquine (800 mg loading dose, followed by 400 mg daily). The patient's condition deteriorated rapidly, and he died on March 20.",
        "es": "Hombre de 71 a\u00f1os con antecedentes de hipertensi\u00f3n, nefropat\u00eda cr\u00f3nica (fase 3) y sarcoidosis (inactiva, sin tratamiento) acudi\u00f3 a urgencias el 15 de marzo. Sus s\u00edntomas eran tos, fiebre de 39,2 \u00b0C y disnea. Ten\u00eda taquicardia e hipoxemia, con saturaci\u00f3n de ox\u00edgeno del 70% en aire ambiental. Una prueba de gripe result\u00f3 negativa. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades alveolares bilaterales. La prote\u00edna C-reactiva era de 90,6 mg/dL. El frotis nasofar\u00edngeo que se envi\u00f3 para una prueba de SARS-CoV-2 mediante PCR dio resultado positivo. Se lo traslad\u00f3 directamente a la UCI, donde fue intubado y se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica. Cumpl\u00eda los criterios de SRDA grave, con un cociente PaO2/FiO2 de 76. Se trat\u00f3 con un protocolo de colocaci\u00f3n diaria en dec\u00fabito prono. La medicaci\u00f3n consisti\u00f3 en ceftriaxona (1 g dos veces al d\u00eda i.v.) e hidroxicloroquina (dosis inicial de 800 mg, luego 400 mg al d\u00eda). El estado del paciente empeor\u00f3 r\u00e1pidamente y muri\u00f3 el 20 de marzo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "61-year-old man with a history of hypertension, multiple sclerosis, and seizure disorder presented to the ED on March 14 with symptoms of fever, vomiting, and shortness of breath for 4 days. He was hypoxemic with an oxygen saturation of 90% on room air and febrile at 101.3\u00b0F upon presentation. Chest x-ray showed bilateral airspace opacities, more severe on the right. Influenza assay was negative. Nasopharyngeal swab submitted for SARS-CoV-2 PCR testing returned positive. On March 15 (day 5 of symptoms), the patient's hypoxemia worsened, and he was moved to the ICU where he was intubated and mechanically ventilated. C-reactive protein was 338 mg/dL, and lactate dehydrogenase was 714 U/L. He met criteria for severe ARDS with a PaO2/FiO2 ratio of 73. He was treated with a protocol of daily prone positioning. He developed AKI requiring initiation of CRRT on March 17. Medical record review revealed no history of CKD. Because of clotting of the dialysis circuit, he was treated with a continuous infusion of unfractionated heparin. Medications included azithromycin (500 mg IV daily), ceftriaxone (1 g IV daily), hydroxychloroquine (800 mg loading dose, followed by 400 mg daily), and dexamethasone (20 mg IV daily). Despite attempts to wean the patient off mechanical ventilation, he was unable to support his own respiratory efforts and remained on ventilation throughout his ICU stay. On March 30, the patient developed shock refractory to vasopressor therapy and died",
        "es": "Un hombre de 61 a\u00f1os con antecedentes de hipertensi\u00f3n y esclerosis m\u00faltiple acudi\u00f3 a urgencias el 14 de marzo con s\u00edntomas de fiebre, v\u00f3mitos y disnea de 4 d\u00edas de evoluci\u00f3n. Se hallaba hipox\u00e9mico, con una saturaci\u00f3n de ox\u00edgeno de 90% en aire ambiental y febril con 38,5 \u00b0C. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades alveolares bilaterales, m\u00e1s graves en el pulm\u00f3n derecho. Una prueba de gripe result\u00f3 negativa. El frotis nasofar\u00edngeo que se envi\u00f3 para una prueba de SARS-CoV-2 mediante PCR dio resultado positivo. El 15 de marzo (d\u00eda 5 de sintomatolog\u00eda), la hipoxemia del paciente empeor\u00f3 y fue trasladado a la UCI, donde fue intubado y se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica. El valor de prote\u00edna C-reactiva era de 338 mg/dL y la lactato-deshidrogenasa era de 714 U/L. Cumpl\u00eda los criterios de SRDA grave, con un cociente PaO2/FiO2 de 73. Se trat\u00f3 con un protocolo de colocaci\u00f3n diaria en dec\u00fabito prono. Desarroll\u00f3 lesi\u00f3n renal aguda, que requiri\u00f3 TRSC el 17 de marzo. Una revisi\u00f3n de la historia cl\u00ednica no revel\u00f3 antecedentes de nefropat\u00eda cr\u00f3nica. A causa del taponamiento del circuito de di\u00e1lisis, se trat\u00f3 al paciente con una infusi\u00f3n continua de heparina no fraccionada. ), ceftriaxona (1 g al d\u00eda, i.v. ), hidroxicloroquina (dosis inicial de 800 mg, luego 400 mg al d\u00eda) y dexametasona (20 mg al d\u00eda i.v.). A pesar de los intentos de retirar al paciente de la ventilaci\u00f3n mec\u00e1nica, no era capaz de respirar por s\u00ed mismo y permaneci\u00f3 con ventilaci\u00f3n durante su estancia en la UCI. El 30 de marzo, el paciente desarroll\u00f3 choque resistente a terapia vasopresora y muri\u00f3 el 26 de marzo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 20-year-old gravida 2 para 2 pregnant woman with no COVID-19 symptoms presented for delivery to another hospital at 39 weeks of gestation. She was tested for SARS-CoV-2 by RT-PCR because her father was diagnosed with COVID-19 a week earlier. She wore a surgical mask during normal vaginal delivery of a baby boy weighing 2,980\u2009g (normal for gestational age). Meanwhile, her NPS SARS-CoV-2 RT-PCR test result was positive, so mother and baby were separated immediately after delivery. Thus, the mother had no contact with the baby after birth. Both were transferred to our hospital within 8 hours of delivery with the maternal diagnosis of subclinical COVID-19, on April 5, 2020. The infant was admitted to the neonatal intensive care unit, while the mother was admitted to the infectious diseases and clinical microbiology ward. SARS-CoV-2 PCR test of an NPS obtained from the infant on admission (8\u201310 hours after birth) was reported as negative. The mother and infant were cared for in different clinical units to avoid contact with each other until discharge. In addition, the baby was not brought into contact with any other family members until discharge. Both mother and baby were healthy without fever or any other symptoms during their hospital follow-up. Their vital signs were stable and oxygen saturation levels were 98\u201399%. Expressed fresh breast milk (without pasteurization or freezing) was given to the infant by health care professionals under strict precautions (hand hygiene, face mask, etc.) within the first 24 hours of admission, on April 6, 2020. Meanwhile, after the first lactation, a breast milk sample was sent to the virology department of Ankara University for SARS-CoV-2 real-time RT-PCR testing. A positive result was returned, upon which feeding with expressed breast milk was discontinued. Breast milk samples were then tested for SARS-CoV-2 for the next 2 consecutive days to determine the viral shedding time. The infant received a total of \u223c240 cc of expressed breast milk in the first 36 hours of life. Because the infant was fed with breast milk for 24\u201336 hours until the mother's PCR test results were received, neonatal blood, stool, and NPS samples were obtained at 96 hours of age for SARS-CoV-2 real-time RT-PCR testing. One-step RT-PCR test targeting the S coding gene showed almost equal viral load values in breast milk samples taken on April 5, 8, and 9 (cycle threshold [Ct]: 29.20, 28.85, 32.28, respectively). Ct values of the infant's NPS, blood, and stool samples taken on April 9 were detected as 32.71, 33.10, 32.84, respectively. During follow-up, neither the mother nor infant exhibited any symptoms that required any intervention or treatment. Five days after admission, the mother was encouraged to breastfeed while taking the necessary precautions, and both were discharged from the hospital. On follow-up conducted by phone 2 weeks after discharge (on postnatal day 19), both mother and baby were reported to be healthy with no COVID-19 symptoms. The reassuring outcome in this infant may have been secondary to the protective effect of breastfeeding.",
        "es": "Una mujer de 20 a\u00f1os embarazada secundigesta secund\u00edpara, sin s\u00edntomas de COVID-19, acudi\u00f3 a otro hospital para el parto, con 39 semanas de gestaci\u00f3n. Se le hizo una prueba de SARS-CoV-2 mediante RT-PCR porque su padre hab\u00eda sido diagnosticado de COVID-19 una semana antes. La madre llevaba mascarilla quir\u00fargica durante el parto vaginal normal, con el que dio a luz a un ni\u00f1o de 2.980 g (normal para su edad gestacional). Mientras tanto, la prueba de SARS-CoV-2 mediante RT-PCR a partir de frotis nasofar\u00edngeo dio positivo, de modo que la madre y el ni\u00f1o se separaron inmediatamente despu\u00e9s del parto. La madre, pues, no tuvo contacto con el ni\u00f1o tras el nacimiento. Ambos se trasladaron a nuestro hospital a las 8 horas del parto, con un diagn\u00f3stico de la madre de COVID-19 subcl\u00ednica, el 5 de abril de 2020. El ni\u00f1o ingres\u00f3 en la UCI neonatal, mientras que la madre fue ingresada en la planta de enfermedades infecciosas. La prueba de SARS-CoV-2 mediante PCR a partir de frotis nasofar\u00edngeo obtenido del ni\u00f1o al ingreso (8-10 horas tras el nacimiento) dio resultado negativo. La madre y el ni\u00f1o fueron atendidos en unidades cl\u00ednicas diferentes, para evitar contacto mutuo durante hasta el alta. Adem\u00e1s, el ni\u00f1o no entr\u00f3 en contacto con ning\u00fan otro miembro de la familia hasta el alta. Tanto la madre como el ni\u00f1o presentaban buen estado de salud, sin fiebre ni otros s\u00edntomas durante su estancia hospitalaria. Sus constantes vitales eran estable y la saturaci\u00f3n de ox\u00edgeno era de 98-99%. Profesionales sanitarios, con estrictas medidas de precauci\u00f3n (manos, higiene, mascarilla, etc.) dieron al ni\u00f1o leche materna reci\u00e9n extra\u00edda (sin pasteurizar ni congelar) a las 24 horas del ingreso, el d\u00eda 6 de abril de 2020. Mientras, tras la primera lactaci\u00f3n, se envi\u00f3 una muestre de leche materna al departamento de virolog\u00eda de la universidad de Ankara para una prueba de SARS-CoV-2 mediante RT-PCR en tiempo real. El resultado fue positivo, momento a partir del cual se interrumpi\u00f3 la alimentaci\u00f3n con leche materna. Durante los dos d\u00edas siguientes se hicieron pruebas de SARS-CoV-2 de muestras de leche materna, para determinar el tiempo de presencia del virus. El ni\u00f1o recibi\u00f3 un total de \u223c240 cc de leche materna en las primeras 36 horas de vida. Como el ni\u00f1o recibi\u00f3 leche materna durante 24-36 horas hasta la recepci\u00f3n de los resultados de la prueba de PCR de la madre, se recogieron muestras de sangre, de heces y de frotis nasofar\u00edngeos del ni\u00f1o a las 96 horas de edad para una prueba mediante PCR. La PCR en un solo paso dirigida al gen S mostr\u00f3 cargas v\u00edricas casi iguales en muestras de leche obtenidas los d\u00edas 5, 8 y 9 (umbral de ciclo [Ct]: 29,20, 28,85, 32,28, respectivamente). Los valores Ct de las muestras de frotis nasofar\u00edngeos, sangre y heces del ni\u00f1o, obtenidas el 9 de abril, fueron 32,71, 33,10 y 32,84, respectivamente. Durante el seguimiento, ni la madre ni el ni\u00f1o mostraron s\u00edntomas que requirieran intervenci\u00f3n o tratamiento. Cinco d\u00edas despu\u00e9s del ingreso, se anim\u00f3 a la madre a dar el pecho al ni\u00f1o tomando las precauciones necesarias; ambos fueron dados de alta del hospital. En un seguimiento telef\u00f3nico 2 semanas despu\u00e9s del alta (d\u00eda 19 desde el nacimiento), la madre y el ni\u00f1o estaban en buen estado de salud, sin s\u00edntomas de COVID-19. El resultado reconfortante en este ni\u00f1o puede haber sido secundario al efecto protector de la leche materna."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 53 year-old man was referred from an intensive care unit for acute respiratory distress, pancytopenia and cytokine release syndrome (CRS). His symptoms had begun 3 weeks before with anosmia, ageusia, cough, fever and dyspnea. He had a medical history of mantle-cell lymphoma diagnosed in 2017, and was in complete remission following autologous bone marrow transplant in 2018 and 9 monthly maintenance infusions of anti-CD20 monoclonal antibody (last infusion 42 days before his symptoms appeared). Blood tests showed pancytopenia (hemoglobin = 7.9 g/dl, leukocytes = 0.8 G/L and platelets = 48 G/L) and elevated inflammatory markers (C-reactive protein = 235 mg/L, fibrinogen >10 g/L, ferritin 8,106 ng/mL and D-dimers = 1,132 ng/mL). COVID-19 tests by semi-quantitative SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) revealed negative findings in nasopharyngeal swab samples, but positive findings in bronchoalveolar lavage fluid, blood (cycle threshold (Ct) value = 30), and bone marrow aspiration samples. Other microbiological exams were negative. Bone marrow aspiration revealed neither hemophagocytosis features nor viral infection except SARS-CoV-2. Flow cytometry analysis of circulating leukocytes revealed the absence of circulating B-lymphocytes, a result of the repeated anti-CD20 antibody infusions, and a low T lymphocyte count (0.447 G/L). Serum protein electrophoresis revealed gammaglobulin level of 3 g/L (versus 4.9 g/L six months before). Thoracic CT-scan showed bilateral patchy ground-glass opacities. Upon admission, he received two successive infusions of tocilizumab (8 mg/kg) and an infusion of polyvalent immunoglobulins (400 mg/kg). He required respiratory support with non-invasive ventilation and high-flow oxygen therapy for 7 days. Clinical evolution was gradually favorable over two weeks, with apyrexia, reduced oxygen requirements and normalized inflammatory biomarker levels. However, at 45 days after admission, SARS-CoV-2 reverse transcription polymerase chain reaction test results remained positive in blood (Ct value = 35) and bone marrow. Moreover, SARSCoV- 2 serological testing detected no antiviral IgG, while pancytopenia persisted.",
        "es": "Un hombre de 53 a\u00f1os fue derivado desde una UCI con insuficiencia respiratoria aguda, pancitopenia y s\u00edndrome de liberaci\u00f3n de citocinas. Sus s\u00edntomas hab\u00edan empezado tres semanas antes, con anosmia, ageusia, tos, fiebre y disnea. Ten\u00eda antecedentes de linfoma de c\u00e9lulas del manto, diagnosticado en 2017, y se hallaba en remisi\u00f3n completa tras un autotrasplante de m\u00e9dula \u00f3sea en 2018 y 9 infusiones mensuales de mantenimiento de anticuerpos monoclonales anti-CD20 (la \u00faltima, 42 d\u00edas antes de la aparici\u00f3n de los s\u00edntomas). Los an\u00e1lisis de sangre mostraron pancitopenia (hemoglobina = 7,9 g/dl, leucocitos = 0,8 G/L y trombocitos 48 G/L) y valores altos de marcadores de inflamaci\u00f3n (prote\u00edna C-reactiva = 235 mg/L, fibrin\u00f3geno > 10 g/L, ferritina = 8.106 ng/mL y d\u00edmero D = 1.132 ng/mL). Las pruebas de COVID-19 mediante RT-PCR semicuantitativa dieron resultado negativo en muestras de frotis nasofar\u00edngeos, pero positivo en lavado broncoalveolar, sangre (umbral de ciclo, Ct = 30) y aspirados de m\u00e9dula \u00f3sea. Los dem\u00e1s an\u00e1lisis microbiol\u00f3gicos fueron negativos. El aspirado de m\u00e9dula \u00f3sea no revel\u00f3 hemofagocitosis ni infecci\u00f3n v\u00edrica, excepto por SARS-CoV-2. El an\u00e1lisis de citometr\u00eda de flujo de leucocitos circulantes revel\u00f3 ausencia de linfocitos B en circulaci\u00f3n, resultado de las repetidas infusiones de anticuerpos ant-CD20, y una cifra baja de linfocitos T (0,447 G/L). La electroforesis de prote\u00edna s\u00e9rica revel\u00f3 un valor de gammaglobulina de 3 g/L (frente a 4,9 g/L seis meses antes). Una TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado parcheadas bilaterales. Al ingreso, el paciente recibi\u00f3 dos infusiones sucesivas de tocilizumab (8 mg/kg) y una infusi\u00f3n de inmunoglobulinas polivalentes (400 mg/kg). Necesit\u00f3 respiraci\u00f3n asistida con ventilaci\u00f3n no invasiva y oxigenoterapia de alto flujo durante 7 d\u00edas. La evoluci\u00f3n cl\u00ednica fue favorable a lo largo de dos semanas, con apirexia, menores requisitos de ox\u00edgeno y normalizaci\u00f3n de los biomarcadores de inflamaci\u00f3n. Sin embargo, a los 45 d\u00edas tras el ingreso, los resultados de las pruebas de SARS-CoV-2 mediante RT-PCR segu\u00edan siendo positivos en sangre (valor Ct = 35) y m\u00e9dula \u00f3sea. Adem\u00e1s, las pruebas serol\u00f3gicas de SARS-CoV-2 no detectaron iGG antiv\u00edricas, mientras que se manten\u00eda la pancitopenia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 50-year-old woman without known history of specific diseases or using specific drugs, complaining of fever, chills and dry cough was hospitalized in our center. On admission, blood pressure was (BP)\u00a0=\u00a0130/80\u00a0mmHg, pulse rate (PR)\u00a0=\u00a080/min, body temperature (BT)\u00a0=\u00a037.2\u00b0C\u00a0and O2 saturation (in room air)\u00a0=\u00a095%. Baseline\u00a0ECG was within normal limits. Due to pulmonary involvement evidenced in chest CT scan, she was treated with levofloxacin, vancomycin, hydroxychloroquine, lopinavir/ritonavir, as well as heparin for prophylaxis of deep venous thrombosis at standard doses. There was no electrolyte abnormality during hospitalization. On the fifth day of hospitalization, the treating physician decided to discharge the patient and continue the rest of treatment at home. While being discharged; the patient developed a sudden cardiac arrest and died as resuscitation was ineffective.",
        "es": "Una mujer de 50 a\u00f1os, sin antecedentes conocidos de enfermedades ni consumo de f\u00e1rmacos, fue hospitalizada en nuestro centro aquejada de fiebre, escalofr\u00edos y tos seca. Al ingreso, la presi\u00f3n arterial era 130/80 mmHg, el pulso 80 l.p.m., la temperatura 37,2 \u00b0C y la saturaci\u00f3n de ox\u00edgeno (en aire ambiental) 95%. La exploraci\u00f3n inicial no revel\u00f3 ninguna anomal\u00eda. El ECG inicial no mostr\u00f3 resultados fuera de lo normal. Debido a la afectaci\u00f3n pulmonar evidenciada en TAC tor\u00e1cica, se trat\u00f3 a la paciente con levofloxacina, vancomicina, hidroxicloroquina, lopinavir/ritonavir y heparina como profilaxis de trombosis venosa profunda, a las dosis est\u00e1ndar. No se observaron alteraciones electrol\u00edticas durante la hospitalizaci\u00f3n. El quinto d\u00eda de hospitalizaci\u00f3n, el m\u00e9dico decidi\u00f3 dar de alta a la paciente y proseguir el tratamiento en casa. Durante el alta, la paciente sufri\u00f3 un paro cardiaco s\u00fabito y muri\u00f3 tras reanimaci\u00f3n inefectiva."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 60-year-old man without any history of specific diseases was referred to our hospital due to fever and dyspnea. He was diagnosed with COVID-19 and hospitalized. On admission, the patient's vital signs were BP\u00a0=\u00a0110/70, PR\u00a0=\u00a0105/min, BT\u00a0=\u00a038.7\u00b0C\u00a0and O2 saturation (in room air)\u00a0=\u00a082% which increased to >94% after applying O2 masks. During a clinical examination, crackles were heard in the patient\u2019s left lung. He was treated with oseltamivir, hydroxychloroquine, lopinavir/ritonavir\u00a0and azithromycin. The patient had no specific problems and the vital signs were normal with no evidence of electrolyte disturbances. The troponin I test was negative. Baseline ECG was normal. On day 2 of hospitalization, he suffered from cardiac arrest and unfortunately died as resuscitation was unsuccessful.",
        "es": "Un hombre de 60 a\u00f1os sin antecedentes de enfermedades espec\u00edficas fue derivado a nuestro hospital a causa de fiebre y disnea. Se le diagnostic\u00f3 COVID-19 y fue hospitalizado. Al ingreso, las constantes vitales del paciente eran: presi\u00f3n 110/70, pulso = 105 l.p.m., temperatura = 38,7 \u00b0C y saturaci\u00f3n de ox\u00edgeno (en aire ambiental) = 82%, que aument\u00f3 a > 94% con mascarilla de ox\u00edgeno. A la exploraci\u00f3n, se apreciaron crepitantes en el pulm\u00f3n izquierdo. Se le trat\u00f3 con oseltamivir, hidroxicloroquina, lopinavir/ritonavir y azitromicina. El paciente no ten\u00eda problemas espec\u00edficos y las constantes vitales eran normales, sin evidencia de alteraciones electrol\u00edticas. La prueba de troponina I fue negativa. El ECG inicial fue normal. El d\u00eda 2 de hospitalizaci\u00f3n, sufri\u00f3 un paro card\u00edaco y muri\u00f3 tras una reanimaci\u00f3n infructuosa."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 42-year-old woman, presented with fever and dry cough in the past 2 days to her family physician. She had a history of contacting someone with similar symptoms and no underlying problems. No abnormality was found in the physical examination, her temperature was 38\u00b0C and other vital signs were normal. Oxygen saturation was 98%. Imaging and laboratory tests were requested. Lab tests revealed elevated lactate dehydrogenase (648\u00a0units/liter (U/L), normal: 140\u2013280\u00a0U/L), C-reactive protein level (52 milligrams/Liter (mg/L), normal: <\u200910\u00a0mg/L), aspartate aminotransferase (59\u00a0U/L, normal: 10\u201340\u00a0U/L), thrombocytopenia, and leukopenia (white blood cells\u2009=\u20092600/microliter, 31% lymphocyte cells). Serology for rheumatoid factor, antinuclear factor, antideoxyribonucleic acid, antismooth muscle and antimitochondrial antibodies were negative as well as hepatitis B surface antigen and anti-hepatitis C virus antibodies. Due to COVID-19 pandemic and clinical findings, the nasopharyngeal swab test was done, and severe acute respiratory syndrome coronavirus 2 nucleic acid was detected by reverse transcription-polymerase chain reaction. HCQ 200\u00a0mg twice daily was started, and 500\u00a0mg of acetaminophen every 6\u00a0h. After two days, the patient presented with a pruritic erythematous maculopapular rash and flat atypical targets that started from the distal of upper extremities, rapidly involved the entire body and torn blisters that were only seen as ulcers on orolabial area. She had genital mucosal involvement but did not allow us to take pictures. The Nikolsky sign was positive. Finally, a diagnosis of Stevens\u2013Johnson syndrome (SJS) was made. Due to the likelihood of a drug reaction, HCQ was discontinued, and COVID-19 treatment was changed to lopinavir/ritonavir 400\u00a0mg twice daily in the hospital. Loratadine 10\u00a0mg twice daily and diphenhydramine 50\u00a0mg three times daily were given. She was discharged after five days with nonpruritic scalded skin on the distal of upper extremities.",
        "es": "Una mujer de 42 a\u00f1os con fiebre y tos seca de dos d\u00edas de evoluci\u00f3n acudi\u00f3 a su m\u00e9dico de cabecera. Ten\u00eda antecedentes de contacto con otra persona con s\u00edntomas similares, pero no ten\u00eda problemas preexistentes. A la exploraci\u00f3n f\u00edsica, no se hallaron anomal\u00edas; su temperatura era de 38 \u00b0C y el resto de las constantes vitales, normales. La saturaci\u00f3n de ox\u00edgeno era de 98%. Se solicitaron pruebas anal\u00edticas y de diagn\u00f3stico por la imagen. Las pruebas revelaron valor alto de lactato-deshidrogenasa (648 unidades/litro (U/L), normal: 140\u2013280U/L), de prote\u00edna C-reactiva (52 miligramos/litro (mg/L), normal: <\u200910mg/L), de aspartato-aminotransferasa (59U/L, normal: 10\u201340U/L), trombocitopenia y leucocitopenia (leucocitos \u2009=\u20092600/microlitro, 31% linfocitos). Las pruebas serol\u00f3gicas para anticuerpos reumatoideos, anticuerpos antinucleares, anticuerpos antiADN, anticuerpos antim\u00fasculo liso y anticuerpos antimitocondriales fueron negativas, as\u00ed como anticuerpos del ant\u00edgeno de superficie de la hepatitis B y de virus de la hepatitis C. En la TAC pulmonar se apreciaron leves opacidades de vidrio esmerilado parcheadas bilaterales. A causa de la pandemia de COVID-19 y los resultados cl\u00ednicos, se realiz\u00f3 una prueba de frotis nasofar\u00edngeo y se detect\u00f3 \u00e1cido nucleico del coronavirus 2 de s\u00edndrome de dificultad respiratoria aguda mediante RT-PCR. Se inici\u00f3 tratamiento con hidroxicloroquina 200 mg dos veces al d\u00eda y acetaminofeno 500 mg cada 6 horas. Despu\u00e9s de dos d\u00edas, el paciente present\u00f3 un exantema maculopapuloso eritematoso prur\u00edtico y lesiones en escarapela at\u00edpicas que se inici\u00f3 en el extremo distal de las extremidades superiores y afect\u00f3 r\u00e1pidamente a todo el cuerpo, as\u00ed como ampollas desgarradas que solo se apreciaban como \u00falceras en la zona orolabial. Ten\u00eda afectaci\u00f3n mucosa genital, pero la paciente no nos permiti\u00f3 tomar im\u00e1genes. El signo de Nikolski era positivo. Finalmente, se diagnostic\u00f3 s\u00edndrome de Stevens-Johnson. A causa de las probabilidades de una reacci\u00f3n farmacol\u00f3gica, se interrumpi\u00f3 la hidroxicloroquina y el tratamiento para la COVID-19 se cambi\u00f3 a lopinavir/ritonavir 400 mg dos veces al d\u00eda en el hospital. Tambi\u00e9n se administraron 10 mg de loratadina dos veces al d\u00eda y 50 mg de difenhidramina tres veces al d\u00eda. La paciente fue dada de alta cinco d\u00edas despu\u00e9s, con dermatosis exfoliativa no prur\u00edtica en el extremo distal de las extremidades superiores."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 62-year-old healthy male presented to the ED with complaints of cough, body ache,\u00a0and fever. The symptoms first appeared five days back. He had no chest pain, shortness of breath, or abdominal pain.\u00a0The patient was in good health up until now, with no significant medical or surgical history. He worked as a packet distributor and was active at his baseline. He is a non-smoker and has no known addictions. He had no history of recent travel, but had a history of contact with two COVID-positive individuals (grandson and friend), and therefore COVID was suspected, for which he tested positive.\u00a0On examination, he was not in distress and his vitals were stable.\u00a0Chest X-ray showed clear lung and pleural spaces, a normal heart with minimally tortuous aorta, and no evidence of any active cardiopulmonary, disease, or mild hypertrophic changes in the spine. Given his stable clinical condition, normal X-ray findings, and no underlying comorbidities, he was discharged home with symptomatic treatment. Following his discharge,\u00a0in the next couple of days, he developed worsening shortness of breath, spiking fever with intermittent chills, diaphoresis, and diarrhea for three days. He presented to the ED again after five days of his initial presentation for these complaints. On examination,\u00a0he was hypotensive with blood pressure of 94/44 mm Hg and was hypoxic at room air saturating to 82%, which improved to 94% on 15 L of non-rebreather. He was in distress with tachypnea. He was admitted and immediately\u00a0intubated, and a nasogastric tube was placed. Findings of the second chest X-ray\u00a0were concerning for low lung volumes and development of infectious/inflammatory process with interval development of bilateral airspace opacities, including a focal consolidation in the left upper lung. EKG showed atrial fibrillation with rapid ventricular response and non-specific T wave abnormality. He was given 3.5 L of fluid bolus to address his hypotension. Sodium bicarbonate and norepinephrine drip was also started for pressor support. Digoxin 0.25 mg was given intravenously for atrial fibrillation and was started on amiodarone drip as options for rate control were limited, considering his hypotension. With the concern for possible superimposed bacterial infection, he was empirically started on cefepime and vancomycin intravenously (both renally dosed). He was also started on hydroxychloroquine and doxycycline. Over the next six to seven hours, he continued to worsen clinically. Blood cultures were followed up and it grew imipenem-resistant Escherichia coli (it was sensitive to cefazolin and piperacillin/tazobactam). From being stable on day 1 of presentation, our patient continued to deteriorate overnight on subsequent admission. He eventually became bradycardic and was asystolic within one minute. The patient had an advance directive of \"do not resuscitate\" and died on the same night of admission due to septic shock with multiorgan dysfunction secondary to superimposed bacterial infection. He developed multifocal pneumonia due to COVID-19, which was possibly accelerated by superimposed E. coli infection or vice-versa. The possible sources of his E. coli bacteremia were either translocation from the bowel, given he was having diarrhea for three days, or a genitourinary source, as no symptoms pertaining to it were reported.",
        "es": "Un hombre de 62 a\u00f1os, por lo dem\u00e1s sano, acudi\u00f3 al servicio de urgencias aquejado de tos, artromialgia generalizada y fiebre. Los s\u00edntomas hab\u00edan aparecido cinco d\u00edas antes. No refiri\u00f3 dolor tor\u00e1cico, disnea ni dolor abdominal.El paciente estaba en buen estado de salud hasta ese momento, sin antecedentes m\u00e9dicos o quir\u00fargicos relevantes. Trabajaba como repartidor y estaba activo en situaci\u00f3n normal. No era fumador y no se le conoc\u00edan toxicoman\u00edas. No hab\u00eda realizado ning\u00fan viaje recientemente, pero hab\u00eda tenido contacto con dos individuos que eran positivos para COVID (su nieto y un amigo) y, por tanto, se sospech\u00f3 de COVID, para la que dio positivo.A la exploraci\u00f3n, no sent\u00eda malestar y sus constantes vitales eran estables.Una radiograf\u00eda tor\u00e1cica mostr\u00f3 pulmones y espacio pleural limpios, un coraz\u00f3n normal con aorta m\u00ednimamente tortuosa y sin evidencias de alteraciones cardiopulmonares ni alteraciones medulares hipertr\u00f3ficas leves. Teniendo en cuenta su estado cl\u00ednico estable, los resultados radiol\u00f3gicos normales y la ausencia de comorbilidades, se le dio de alta con tratamiento sintom\u00e1tico. Tras el alta, durante los dos d\u00edas siguientes desarroll\u00f3 disnea, fiebre aguda con escalofr\u00edos intermitentes y sudoraci\u00f3n, as\u00ed como diarrea durante tres d\u00edas. Acudi\u00f3 nuevamente a urgencias cinco d\u00edas despu\u00e9s de su visita inicial, con el cuadro indicado. A la exploraci\u00f3n, se hallaba hipotenso, con una presi\u00f3n de 94/44 mmHg, e hipox\u00e9mico con una saturaci\u00f3n en aire ambiental de 82%, que mejor\u00f3 a 94% con mascarilla con reservorio a 15 L. Sent\u00eda malestar y ten\u00eda taquipnea. Fue ingresado e intubado inmediatamente; se le coloc\u00f3 una sonda nasog\u00e1strica. Los resultados de la segunda radiograf\u00eda tor\u00e1cica eran preocupantes a causa de bajos vol\u00famenes pulmonares y del desarrollo de un proceso infeccioso/inflamatorio con presencia de opacidades alveolares bilaterales, incluyendo una consolidaci\u00f3n focal en la parte superior del pulm\u00f3n izquierdo. El ECG mostr\u00f3 fibrilaci\u00f3n auricular con respuesta ventricular r\u00e1pida y anomal\u00edas inespec\u00edficas de la onda T. Se le administr\u00f3 un bolo h\u00eddrico de 3,5 L para tratar la hipotensi\u00f3n. de digoxina para la fibrilaci\u00f3n auricular y se inici\u00f3 una pauta de infusi\u00f3n i.v. de amiodarona, pues las opciones para el control de la frecuencia card\u00edaca eran limitadas, teniendo en cuenta la hipotensi\u00f3n. Con la posibilidad de una infecci\u00f3n bacteriana superpuesta, se inici\u00f3 un tratamiento provisional de cefepima y vancomicina i.v. (ambas con dosis ajustada a la actividad renal). Tambi\u00e9n se inici\u00f3 una pauta con hidroxicloroquina y doxiciclina. Durante las siguientes seis o siete horas, su estado cl\u00ednico continu\u00f3 empeorando. En los hemocultivos se hall\u00f3 Escherichia coli resistente al imipenem (era sensible a cefazolina y a piperacilina/tazobactam). De una situaci\u00f3n estable con el cuadro cl\u00ednico inicial, el paciente fue empeorando durante la noche siguiente al ingreso. Finalmente, sufri\u00f3 bradicardia y un minuto despu\u00e9s, asistolia. El paciente hab\u00eda dejado instrucciones de \u00abno reanimaci\u00f3n\u00bb y muri\u00f3 la misma noche del ingreso a causa de choque s\u00e9ptico con insuficiencia multiorg\u00e1nica secundaria a una infecci\u00f3n bacteriana superpuesta. Desarroll\u00f3 neumon\u00eda multifocal a causa de la COVID-19, posiblemente acelerada por una infecci\u00f3n superpuesta de E. coli, o viceversa. Las posibles fuentes de su bacteremia por E. coli eran o bien traslocaci\u00f3n intestinal, teniendo en cuenta que hab\u00eda tenido diarrea durante tres d\u00edas, u origen genitourinario, aunque sin s\u00edntomas asociados."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "75-year old Caucasian never smoker, retired IT recruitment manager with a medical history of ischaemic heart disease and bypass surgery in 2001, chronic kidney disease, hypertension and dyslipidaemia. On 25th of March, he was admitted to a district general hospital with a week\u2019s history of worsening dyspnoea. At admission, he was in respiratory failure and acute (on chronic) kidney injury (AKI), and within a few hours required mechanical ventilation and initiated on intravenous (IV) antibiotics for a left lower zone consolidation. Due to ICU bed pressures, he was moved, 2\u00a0days later, to our hospital (a tertiary centre). He made a good respiratory recovery and was weaned of its support and oxygen over the next 48\u00a0h though did have 36\u00a0h of continuous veno-venous haemofiltration (CVVHF). Additionally, with high D-dimer levels at admission he was maintained on therapeutic IV unfractioned heparin; a CTPA conducted showed multiple segmental and sub-segmental filling defects, with widespread ground-glass opacities (GGOs) and areas of consolidation/ atelectasis. Subsequently, he was changed over to a new oral anti-coagulant (NOAC). Over the next 7\u00a0days, despite routine physiotherapy, the patient failed to convalesce with weakness in the lower limbs. Neurological examination of the lower limbs revealed an increased tone and reduced power bilaterally though more pronounced on the left. There was no loss of pulses or any sensory findings in the lower limbs and the Babinski sign was negative; coordination and gait were challenging to assess as the patient needed hoisting to stand. A CT scan of the head showed no acute intracranial abnormality. Persistent bilateral lower limb weakness and stiffness prompted a magnetic resonance imaging (MRI) scan of the head; this showed small vessel disease and infarcts in the parietal and occipital lobes, and in the midbrain and basal ganglia. The patient was subsequently moved to a neuro-rehabilitation centre on the 27th of April for ongoing management/ convalescence.",
        "es": "Hombre cauc\u00e1sico de 75 a\u00f1os, no fumador, director de contrataci\u00f3n de TI jubilado, con antecedentes de cardiopat\u00eda isqu\u00e9mica y revascularizaci\u00f3n quir\u00fargica en 2011, insuficiencia renal cr\u00f3nica, hipertensi\u00f3n y dislipidemia. El 25 de marzo, fue ingresado en un hospital regional con una semana de evoluci\u00f3n de disnea. Al ingreso, presentaba insuficiencia respiratoria y lesi\u00f3n renal aguda (sobrepuesta a la cr\u00f3nica) y, en pocas horas, requiri\u00f3 ventilaci\u00f3n mec\u00e1nica y se le administraron antibi\u00f3ticos i.v. por una consolidaci\u00f3n en la zona inferior izquierda. Debido a la carencia de camas de UCI, dos d\u00edas despu\u00e9s fue trasladado a nuestro hospital (centro de atenci\u00f3n especializada). Se recuper\u00f3 bien del problema respiratorio y la ventilaci\u00f3n y el ox\u00edgeno se retiraron durante las siguientes 48 horas, aunque se mantuvo con 36 horas de hemofiltraci\u00f3n continua venovenosa (HVVC). Adem\u00e1s, con valores altos de d\u00edmero D al ingreso, se mantuvo con heparina no fraccionada i.v. ; una APTC mostr\u00f3 m\u00faltiples im\u00e1genes lacunares segmentarias y subsegmentarias, con extensas opacidades de vidrio esmerilado y zonas de consolidaci\u00f3n/atelectasia. Posteriormente, se pas\u00f3 a un nuevo anticoagulante por v\u00eda oral. Durante los siguientes 7 d\u00edas, a pesar de fisioterapia rutinaria, el paciente no logr\u00f3 recuperarse totalmente, con debilidad en las extremidades inferiores. La exploraci\u00f3n neurol\u00f3gica de las extremidades inferiores revel\u00f3 hiperton\u00eda y disminuci\u00f3n de la fuerza bilateral, si bien m\u00e1s acusada en la izquierda. No se apreci\u00f3 p\u00e9rdida de pulso ni otros resultados sensoriales en las extremidades inferiores; el signo de Babinski era negativo, la coordinaci\u00f3n y la marcha eran de dif\u00edcil evaluaci\u00f3n pues el paciente necesitaba soporte para mantenerse en pie. Una TAC craneal no apreci\u00f3 ninguna anomal\u00eda intracraneal aguda. La debilidad y rigidez bilateral persistente de las extremidades inferiores motiv\u00f3 una RMN cerebral, que revel\u00f3 microangiopat\u00eda e infartos en los l\u00f3bulos parietal y occipital as\u00ed como en el mesenc\u00e9falo y los ganglios basales. El paciente se traslad\u00f3 a un centro de neurorrehabilitaci\u00f3n el 27 de abril para su convalecencia y tratamiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "49-year old never smoker Afro-Caribbean security guard with non-insulin dependent diabetes mellitus and hypertension. On the 29th of March, he was admitted with a 5-day history of cough, pyrexia and dyspnoea. His CXR showed left-sided patchy consolidation for which he started on IV antibiotics and unfractioned heparin for elevated D-dimers, and was initiated on CPAP therapy due to being hypoxic, though continued to deteriorate and was later intubated. He was transferred to our ICU due to bed pressures on the 31st of March where he was initiated on CVVHF for worsening AKI. From a respiratory perspective, he improved and was extubated on the 6th of April, and weaned of supplementary oxygen though still needed renal support intermittently. A renal ultrasound scan showed no abnormalities and a CTPA demonstrated a segmental pulmonary embolus, bilateral scattered air space shadowing and GGOs and small areas of consolidation. An echocardiogram on the 21st of April showed good biventricular function and no valvular or structural abnormalities. Despite routine physiotherapy, he had persistent bilateral lower limb weakness. Lower limb evaluation showed reduced power bilaterally (left\u2009>\u2009right) with difficulty in mobilising and coordination though the reflexes and sensation as well as peripheral pulses were intact. No significant upper limb neurological examination abnormalities were identified. An MRI scan showed an abnormal signal in the deep white matter bilaterally, likely to represent subcortical watershed infarcts. He was transferred to neuro-rehabilitation unit on the 27th of April.",
        "es": "Hombre afrocaribe\u00f1o de 49 a\u00f1os, guardia de seguridad, no fumador, con antecedentes de diabetes mellitus de tipo 2 e hipertensi\u00f3n. El 29 de marzo fue ingresado con tos, fiebre y disnea de 5 d\u00edas de evoluci\u00f3n. Su radiograf\u00eda tor\u00e1cica mostr\u00f3 consolidaciones parcheadas izquierdas, por lo que se inici\u00f3 tratamiento con antibi\u00f3ticos i.v. y heparina no fraccionada por d\u00edmero D elevado; tambi\u00e9n se inici\u00f3 terapia PPC a causa de la hipoxemia. Se traslad\u00f3 a nuestra UCI a causa de la falta de camas el 31 de marzo, donde se le aplic\u00f3 HVVC por empeoramiento de lesi\u00f3n renal aguda. Los problemas respiratorios mejoraron y fue extubado el 6 de abril y se le retir\u00f3 la oxigenoterapia, aunque a\u00fan necesitaba soporte renal intermitentemente. Una ecograf\u00eda renal no revel\u00f3 anomal\u00edas, y una APTC mostr\u00f3 un \u00e9mbolo pulmonar segmentario, infiltrados alveolares bilaterales, opacidades de vidrio esmerilado y peque\u00f1as \u00e1reas de consolidaci\u00f3n. Un ecocardiograma el 21 de abril revel\u00f3 buena actividad biventricular sin anomal\u00edas estructurales ni valvulopat\u00edas. A pesar de fisioterapia rutinaria, el paciente mostraba debilidad persistente bilateral en las extremidades inferiores. > der.) con dificultad para la locomoci\u00f3n y la coordinaci\u00f3n, aunque los reflejos y la sensibilidad, as\u00ed como el pulso perif\u00e9rico, estaban intactos. En la exploraci\u00f3n neurol\u00f3gica, no se identificaron anomal\u00edas de las extremidades superiores. Una RMN mostr\u00f3 una se\u00f1al an\u00f3mala bilateral en la sustancia blanca profunda, que pod\u00eda indicar infartos de la zona marginal subcortical. El 27 de abril se traslad\u00f3 al paciente a una unidad de neurorrehabilitaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 35-year-old primigravid patient at 22 2/7 weeks ofgestation presented to the emergency department after 7days of fever, cough, anosmia, and dyspnea. She hadunderlying hypertension, type 2 diabetes, and intermittentasthma. Her body mass index (BMI, calculated as weight inkilograms divided by height in meters squared) was 28. Outpatient medications included labetalol, metformin, andan albuterol inhaler. Findings from a detailed ultrasoundscan for fetal anatomy were normal. The patient was self isolatingbecause household members had tested positivefor SARS-CoV-2 infection. In the emergency department, her temperature was 39\u00b0C, heart rate was 118 beats per minute, respiratory rate was38 breaths per minute, and oxygen saturation was 95%with nasal cannula oxygen at 1 L/min. She had lymphopenia,and serum concentrations of IL-6 and C-reactive proteinwere markedly elevated, as seen with cytokine stormsyndromes. D-dimer, ferritin, and lactate dehydrogenaselevels were increased, but renal and hepatic function werenormal. Troponin and B-type natriuretic peptidelevels were normal. Nasopharyngeal swab was positive forSARS-CoV-2 infection, and a chest X-ray demonstratedbilateral patchy infiltrates. The fetal heart rate was withinthe normal range. The patient was admitted to the COVID-19 unit and managed with supplemental oxygen and prophylacticenoxaparin. She was placed in a modified proneposition, with supporting pillows beneath the gravid uterusand a slight upward tilt toward the left lateral decubitusposition. On hospital day 3, her dyspnea and cough worsened,and oxygen was increased to 6 L/min to maintain 95%saturation, the target for pregnant women. Owing to worseningrespiratory status and persistently elevated IL-6 andC-reactive protein levels, tocilizumab 400 mg was givenintravenously for off-label use after receiving informed consent. Compassionate use of remdesivir was requested andapproved by Gilead Sciences and the U.S. Food and DrugAdministration (FDA). Remdesivir was available the next day, and 200 mg wasadministered intravenously, followed by 100 mg/d for 4days. Hematologic, renal, and liver function tests werenotable only for a mild thrombocytosis. Serum IL-6 levelsincreased initially after receptor blockade with tocilizumabbut began to decrease by hospital day 6. C-reactiveprotein levels normalized by hospital day 9. At this time,the patient no longer required oxygen supplementation andher cough and dyspnea improved. She was dischargedhome in stable condition at 23 3/7 weeks of gestationand was advised to self-isolate until she was symptom freefor 7 days. Laboratory values were evaluated 6 days after hospital discharge and showed further normalizationof both C-reactive protein and IL-6 levels.",
        "es": "Una paciente de 35 a\u00f1os primigr\u00e1vida a 22 2/7 semanas degestaci\u00f3n acudi\u00f3 al servicio de urgencias tras 7 d\u00edas de fiebre, tos, anosmia y disnea. Ten\u00eda antecedentesde hipertensi\u00f3n, diabetes de tipo 2 y asmaintermitente. Su \u00edndice de masa corporal (IMC, calculado como el peso enkilos dividido por el cuadrado de la altura en metros) era 28. Su medicaci\u00f3n ambulatoria era labetalol, metformina yun inhalador de albuterol. Los resultados de una ecograf\u00eda detalladade anatom\u00eda fetal fueron normales. La paciente se hab\u00eda autoconfinadoporque los miembros de su unidad dom\u00e9stica hab\u00edan dado positivopara SARS-CoV-2. En urgencias, su temperatura era de 39\u00b0C, el pulso era de 118 l.p.m., la frecuencia respiratoria era de 38 r.p.m. y la saturaci\u00f3n de ox\u00edgeno era de 95%con ox\u00edgeno por c\u00e1nula nasal a 1 L/min. Ten\u00eda linfocitopeniay las concentraciones s\u00e9ricas de IL-6 y prote\u00edna C-reactivaeran claramente elevadas, tal como sucede en los s\u00edndromesde tormenta de citocinas. Los valores de d\u00edmero-D, ferritina y lactato-deshidrogenasaeran altos, pero la actividad renal y hep\u00e1tica erannormales. Los valores de troponina y de p\u00e9ptido natriur\u00e9tico de tipo Beran normales. Un frotis nasofar\u00edngeo fue positivo parainfecci\u00f3n por SARS-CoV-2 y una radiograf\u00eda tor\u00e1cica mostr\u00f3infiltrados parcheados bilaterales. El pulso fetal estaba dentrode los l\u00edmites normales. La paciente fue ingresada en la unidadde COVID-19 y se trat\u00f3 con oxigenoterapia y enoxaparinapreventiva. Se coloc\u00f3 en una posici\u00f3n en dec\u00fabito prono modificada,con almohadas de apoyo bajo el \u00fateroy una ligera inclinaci\u00f3n hacia el dec\u00fabito lateral izquierdo. El d\u00eda 3 de hospitalizaci\u00f3n, la disnea y la tos empeorarony se aument\u00f3 el ox\u00edgeno a 6 L/min para mantener una saturaci\u00f3ndel 95%, el objetivo para embarazadas. A causa del empeoramiento de su estado respiratorioy de los valores persistentemente altos de IL-6 y deprote\u00edna C-reactiva, se administr\u00f3 400 mg de tocilizumabi.v. Para uso extraoficial tras recibir el consentimiento informado. Se solicit\u00f3 uso compasivo de remdesivir, que fue autorizado por Gilead Sciences y la Administraci\u00f3n de Alimentos y Medicamentos de Estados Unidos (FDA). El remdesivir estuvo disponible el d\u00eda siguiente, y se administraron 200 mgi.v., seguidos de 100 mg/d durante 4.d\u00edas. Las pruebas funcionales hematol\u00f3gicas, renales y hep\u00e1ticas fueronrelevantes solo por una leve trombocitosis. Los valores de IL-6 s\u00e9ricaaumentaron inicialmente tras bloqueo del receptor con tocilizumabpero empezaron a disminuir el d\u00eda 6 de hospitalizaci\u00f3n. La prote\u00edna C-reactivase normaliz\u00f3 el d\u00eda 9 de hospitalizaci\u00f3n. En ese momento,la paciente ya no necesitaba oxigenoterapia ysu tos y disnea mejoraron. Fue dada de alta estable a las 23 3/7 semanas de gestaci\u00f3ny se le recomend\u00f3 autoconfinarse hasta que no tuviera s\u00edntomasdurante 7 d\u00edas. Los valores anal\u00edticos se evaluaron 6 d\u00edas despu\u00e9s del alta y mostraron una progresiva normalizaci\u00f3nde la prote\u00edna C-reactiva y la IL-6."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 57-year-old man was addressed to our hospital after 7 days of fever and cough worseningover the last 24 hours. On admission the patient presented signs of acute respiratory failureand was rapidly transferred to our Intensive Care Unit (ICU) on March 26 (Day 1) where hewas intubated and placed under mechanical ventilation. The patient had no historyof any acquired or inherited immunodeficiency and no underlying respiratory disease. He wasoverweight (body mass index = 30.6 kg/m2) with type 2 diabetes (blood glucose = 11.6mmol/L and glycosuria = 1.4 mmol/L on admission), hypertension, and a substitutedhypothyroidism. SARS-CoV-2 viral RNA was detected on admission on a tracheal aspiration. The patient\u2019s condition worsened with a PaO2/FIO2 ratio <90 mm Hg with a FiO2 of 100%. Aprotected specimen brush sample performed on day 2 remained sterile. While the patient\u2019s condition showed no improvement, a bronchoalveolar lavage (BAL) was performed on day 7. On day 9 this sample grew with 7x102/mL colony-forming unit (CFU) of mold while nobacteria were detected. The same day, a second BAL was performed: atypical fungal hyphaewere detected on microscopic examination, testing for galactomannan antigen was positive(index: 1.7) and the sample grew with 103/mL CFU of mold. The different cultures wereidentified as Fusarium proliferatum by mass spectrometry  and a liposomal amphotericin B-based therapy was started on day 12 (5 mg/kg/day for 2 days then 7 mg/kg/day). Antifungal susceptibility testing determined bygradient concentration strips method showed high Minimal Inhibitory Concentrations (MIC)(>32 mg/L) for voriconazole, posaconazole and isavuconazole. The MIC value for amphotericin B was 2 mg/L. Considering the very serious condition of the patient, caspofungin was added,assuming a potential synergistic effect with liposomal amphotericin B. When the patient's condition was beginning toimprove, caspofungin was stopped (day 29). Three others BAL performed on day 15, day22, and day 27 still grew with Fusarium proliferatum. Importantly, we noticed a gradual increase of the delay of culture positivity and a decrease in the number of colonies obtained. The galactomannan testing became negative, all of which indicated a reduction of the fungalload. The BALs performed on day 15 and day 27 also grew with a significant amount ofbacteria that led to specific antibiotic treatment. The patient\u2019s general condition slowlyimproved. He was extubated on day 30 then discharged to a post-ICU unit. Liposomalamphotericin B administration was stopped on day 35.",
        "es": "Un hombre de 57 a\u00f1os acudi\u00f3 a nuestro hospital tras 7 d\u00edas de fiebre y tos que empeoraron enlas \u00faltimas 24 horas. Al ingreso, el paciente presentaba signos de insuficiencia respiratoria aguday se traslad\u00f3 r\u00e1pidamente a nuestra unidad de cuidados intensivos (UCI) el 26 de marzo (d\u00eda 1), donde seintub\u00f3 y se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica. El paciente no ten\u00eda antecedentesde inmunodeficiencias hereditarias o adquiridas, como tampoco de neumopat\u00edas subyacentes. Ten\u00eda sobrepeso (\u00edndice de masa corporal = 30,6 kg/m2) con diabetes de tipo 2 (glucemia = 11,6mmol/L y glucosuria = 1,4 mmol/L al ingreso), hipertensi\u00f3n e hipotiroidismo contratamiento restitutivo. Al ingreso se detect\u00f3 ARN v\u00edrico de SARS-CoV-2 en un aspirado traqueal. El estado del paciente empeor\u00f3 con un cociente PaO2/FIO2 < 90 mm Hg con una FiO2 de 100%. Una muestra de raspado realizada el d\u00eda 2 permaneci\u00f3 est\u00e9ril. Mientras el estado del paciente no mejoraba, se realiz\u00f3 un lavado broncoalveolar el d\u00eda 7. El d\u00eda 9, esta muestra creci\u00f3 con 7x102/mL unidades formadoras de colonias (UFC) de hongos, sindetecci\u00f3n de bacterias. El mismo d\u00eda, en un segundo lavado broncoalveolar se detectaron hifas f\u00fangicas at\u00edpicasa la exploraci\u00f3n microsc\u00f3pica; una prueba de ant\u00edgeno de galactomanano fue positiva(\u00edndice: 1,7) y la muestra creci\u00f3 con 103/mL UFC de hongos. Los diferentes cultivos se identificaron como Fusarium proliferatum mediante espectroscop\u00eda de masas y se inici\u00f3 una terapia basada en anfotericina B lipos\u00f3mica el d\u00eda 12 (5 mg/kg/d\u00eda durante 2 d\u00edas y luego 7 mg/kg/d\u00eda). La prueba de susceptibilidad antif\u00fangica determinadamediante gradiente de concentraci\u00f3n mostr\u00f3 altas concentraciones inhibidoras m\u00ednimas (CIM)(> 32 mg/L) para voriconazol, posaconazol e isavuconazol. El CIM para la anfotericina B era de 2 mg/L. Teniendo en cuenta el grave estado del paciente, se a\u00f1adi\u00f3 caspofungina,asumiendo un potencial efecto sin\u00e9rgico con la anfotericina B lipos\u00f3mica. Cuando el estado del paciente empez\u00f3 amejorar, se interrumpi\u00f3 la caspofungina (d\u00eda 29). Se realizaron tres nuevos lavados, los d\u00edas 15,22 y 27, que a\u00fan mostraron crecimiento de Fusarium proliferatum. Cabe se\u00f1alar que se apreci\u00f3 un aumento gradual del tiempo que tardaban los cultivos en dar positivo y una disminuci\u00f3n del n\u00famero de colonias obtenidas; adem\u00e1s, la prueba de galactomanano dio negativa, todo lo cual apuntaba a una reducci\u00f3n de la carga f\u00fangica. Los lavados realizados los d\u00edas 15 y 27 tambi\u00e9n mostraron un crecimiento significativo de bacterias, que motiv\u00f3 un tratamiento antibi\u00f3tico espec\u00edfico. El estado general del paciente fue mejorandolentamente. Fue extubado el d\u00eda 30 y luego dado de alta a una unidad post-UCI. La administraci\u00f3n de anfotericina B lipos\u00f3mica se retir\u00f3 el d\u00eda 35."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 67-year-old male was admitted to the acute hospital from the ENT outpatient clinic on 1 March 2020 with stridor. He had hypopharyngeal squamous cell carcinoma treated in 2015 with radiotherapy. An emergency tracheostomy was inserted due to progressive airway obstruction. CT imaging and biopsy at tracheostomy with panendoscopy confirmed cancer recurrence. His Australian Modified Karnofsky score was 70% on admission but dropped to 40% during admission. He awaited discharge to a nursing home for ongoing best supportive care. On 8 April 2020, he became febrile (tympanic temperature 38.5\u00b0C). The following day, he tested positive for COVID-19 via RT-PCR. Humidified oxygen was started due to hypoxia (peripheral capillary oxygen saturation (SpO2) 89%). A Treatment Escalation Plan for ward-based care was agreed with patient and family. On 16 April 2020, he became tachypnoeic. A chest X-ray demonstrated \u2018typical features of COVID-19, with extensive, bilateral ground glass opacification\u2019. He was given a fentanyl patch (25 mcg/h) with anticipatory medications for breathlessnesss. Despite humidified oxygen 15\u2009L/min via tracheostomy mask, he further desaturated to 79% SpO2 with a respiratory rate of 32 per minute. He had a Glasgow Coma Scale score of 3. Using the COVID-GRAM tool, his probability for critical illness (ITU admission/intubation/death) was 99.3% at this time. On 19 April 2020, he was referred to the palliative care team. He received a continuous subcutaneous (SC) infusion of midazolam (10\u2009mg), morphine (15\u2009mg) and hyoscine (60\u2009mg), over 24\u2009hours. The clinical impression was that he was dying. His family was contacted and invited to visit him in hospital. His treatment was guided by the \u2018Priorities For Care\u2019 individualised care plan. The goal of care was comfort. On 23 April 2020, he became more alert. However, his breathing remained laboured so morphine was increased to 35\u2009mg/24\u2009hours. On 29 April 2020, the RT-PCR test remained positive for COVID-19. Following gradual clinical improvement, the morphine was reduced to 20\u2009mg/24\u2009hours. On 4 May 2020, the continuous SC infusion was stopped. Clinically assisted hydration and nutrition were not administered when the patients was thought to be dying. Bloods were rechecked on 4 May 20 revealing hypernatraemia (154\u2009mmol/L) and an acute kidney injury (estimated glomerular filtration rate dropped from >90\u2009mL/min to 42\u2009mL/min) . Clinically assisted nutrition and hydration were recommenced. On 6 May 2020, a final COVID-19 test was negative. His respiratory function returned to his baseline and he was later discharged to a nursing home.",
        "es": "Un hombre de 67 a\u00f1os ingres\u00f3 en el hospital de agudos procedente de un consultorio de otorrinolaringolog\u00eda el 1 de marzo de 2020 con estridor. Ten\u00eda carcinoma de c\u00e9lulas escamosas hipofar\u00edngeo, tratado en 2015 con radioterapia. Se practic\u00f3 una traqueostom\u00eda de urgencia a causa de la progresiva obstrucci\u00f3n de las v\u00edas respiratorias. La TAC y la biopsia en la traqueostom\u00eda con panendoscop\u00eda confirm\u00f3 una recidiva del c\u00e1ncer. Su puntuaci\u00f3n en el \u00edndice Australian Modified Karnofsky fue de 70% al ingreso, pero cay\u00f3 a 40% durante el proceso. Se retras\u00f3 el alta para derivarlo a una residencia m\u00e1s especializada en cuidados paliativos. El 8 de abril de 2020 estuvo febril (temperatura timp\u00e1nica 38,5 \u00b0C). El siguiente d\u00eda dio positivo en una prueba para COVID-19 mediante RT-PCR. Se le aplic\u00f3 ox\u00edgeno humidificado a causa de la hipoxia (saturaci\u00f3n de ox\u00edgeno capilar perif\u00e9rica (SpO2) 89%). Con el paciente y la familia se acord\u00f3 un plan gradual de tratamiento para cuidados en planta. El 16 de abril de 2020, present\u00f3 taquipnea. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 caracter\u00edsticas t\u00edpicas de COVID-19, con opacidades de vidrio esmerilado bilaterales generalizadas. Se le administr\u00f3 un parche de fentanilo (25 mcg/h) con medicaci\u00f3n anticipada para la disnea. A pesar del ox\u00edgeno humidificado a 15 L/min v\u00eda mascarilla de traqueostom\u00eda, el paciente desatur\u00f3 a 79% SpO2 con una frecuencia respiratoria de 32 r.p.m. Ten\u00eda una puntuaci\u00f3n de 3 en la escala de coma de Glasgow. Mediante la aplicaci\u00f3n COVID-GRAM, se calcul\u00f3 su probabilidad de enfermedad cr\u00edtica (ingreso UCI/intubaci\u00f3n/muerte) en 99,3% en ese momento. El 19 de abril de 2020 se deriv\u00f3 al equipo de cuidados paliativos. Recibi\u00f3 una infusi\u00f3n subcut\u00e1nea continua de midazolam (10 mg), morfina (15 mg) e hioscina (60 mg) a lo largo de 24 horas. La impresi\u00f3n cl\u00ednica era que estaba en estado terminal. Se contact\u00f3 con su familia para que lo visitaran en el hospital. Su tratamiento segu\u00eda el plan de atenci\u00f3n individualizada \u00abPrioridades de atenci\u00f3n\u00bb. El objetivo de los cuidados era el bienestar del paciente. El 16 de abril de 2020 estuvo m\u00e1s consciente. Sin embargo, su respiraci\u00f3n continuaba siendo fatigosa, de modo que se aument\u00f3 la morfina a 35 mg/24 horas. El 29 de abril de 2020, la prueba de RT-PCR segu\u00eda siendo positiva para COVID-19. Con una mejora cl\u00ednica gradual, se redujo la morfina a 20 mg/24 horas. El 4 de mayo de 2020, se retir\u00f3 la infusi\u00f3n subcut\u00e1nea continua. No se administr\u00f3 hidrataci\u00f3n y nutrici\u00f3n dirigida cl\u00ednicamente cuando se consider\u00f3 que el paciente estaba en estado terminal. Se hizo un nuevo an\u00e1lisis de sangre el 4 de mayo de 2020, que revel\u00f3 hipernatremia (154 mmol/L) y lesi\u00f3n renal aguda (la velocidad de filtraci\u00f3n glomerular estimada baj\u00f3 de > 90 mL/min a 42 mL/min). Se reinici\u00f3 la nutrici\u00f3n e hidrataci\u00f3n dirigida cl\u00ednicamente. El 6 de mayo de 2020, una prueba final de COVID-19 dio resultado negativo. Su actividad respiratoria regres\u00f3 a la situaci\u00f3n inicial y, posteriormente, fue dado de alta para pasar a una residencia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "79-year-old Caucasian male who was admitted to our hospital with general weakness, malaise and non-productive cough. The symptoms had been present for 8 days prior to admission. Eighteen years prior to admission a diagnosis of autoimmune aortitis of the abdominal aorta was established, which nowadays would have been classified as single organ vasculitis according to the 2012 Chapel Hill Consensus definition. The patient had been on serial immunosuppressive treatments with glucocorticoids either alone or in combination with azathioprine or 6-mercaptopurine, as well as six courses of intravenous cyclophosphamide until 14 months before the current presentation. At this point in time the patient was diagnosed with high-grade urothelial carcinoma of the bladder staged as T2N0M0 (with infiltration of the bladder musculature) after having presented with macrohematuria. He underwent transurethral resection of the bladder (TURB) and received intermittent radiotherapy with a maximum dose of 59.4 Gy and a simultaneous chemotherapy with 5-fluorouracil and mitomycine. During the 8 months prior to admission he was without antineoplastic or immunosuppressive treatment. The patient\u2019s further past medical history was comprised of chronic inflammatory demyelinating polyneuropathy, chronic obstructive pulmonary disease, coronary artery disease, type 2 diabetes mellitus, chronic kidney disease stage 3a, Parkinson\u2019s disease, osteoporosis and intermittent atrial fibrillation. On admission on March 6 2020, the patient\u2019s body temperature was 36.8\u00b0C, blood pressure 130/80 mmHg, pulse 80 beats per minute. His respiratory rate was 16/min, peripheral oxygen saturation was 94% while breathing ambient air. The white blood count revealed mild leukocytopenia with absolute lymphopenia of 370 lymphocytes/mm3 (reference range 1,090-2,990), mild thrombocytopenia with 102,000/mm3 (reference range 150,000- 350,000), a c-reactive protein (CRP) level of 75.1 mg/l (reference range < 8.2), and a lactate dehydrogenase of 418 U/l (reference range < 248). ANCA, antinuclear antibodies (ANA) and anti-GBM antibodies were negative. A chest X-ray was unremarkable. Blood cultures were drawn. The patient was given 2l of oxygen per minute per nasal canula and was admitted for further evaluation. A computed tomography of the chest showed extensive ground glass opacities suggestive of acute interstitial pneumonia. Within 4 days of admission the patient developed a body temperature of 38.3\u00b0C and his respiratory situation deteriorated, now presenting with a peripheral oxygen saturation of 89% under 2l of oxygen per minute as well as hemoptysis. Blood gas analysis confirmed hypoxemia with a paO2 of 61 mmHg and hyperventilation with a paCO2 of 31 mmHg. We administered intravenous piperacillin with tazobactam, cotrimoxazole and oral roxithromycine. Bronchoscopy revealed signs of chronic bronchitis with extensive and progressively hemorrhagic bronchial fluid from successive aliquots during the bronchoalveolar lavage (BAL) consistent with DAH. BAL revealed a total cell count of 10x 105 cells per ml, mostly comprised of alveolar macrophages (80%) and 1000 erythrocytes per mm\u00b3. Gram stains and PCRs for Legionella spp., Chlamydia spp., Mycoplasma spp., cytomegaly virus, Herpes simplex virus 1 and 2, influenza virus A and B, respiratory syncytial virus, pneumocystis jiroveci and Mycobacteria other than tuberculosis (MOTT) were negative. We transferred the patient to our intensive care unit (ICU) where non-invasive ventilation was commenced. Eventually, real-time PCR for SARS-CoV-2 2 from a nasopharyngeal swab was positive while other possible causes of pneumonia where excluded. Within the next 24 hours the patient continuously worsened to the point where invasive mechanical ventilation would have been necessary. According to the patient\u2019s will, we refrained from intubation and provided palliative care under which he deceased shortly that after. Diagnosis: DAH due to pulmonary SARS-CoV-2 infection.",
        "es": "Hombre cauc\u00e1sico de 79 a\u00f1os ingresado en nuestro hospital con debilidad general, malestar y tos no productiva. Hab\u00eda tenido estos s\u00edntomas durante los 8 d\u00edas anteriores al ingreso. 18 a\u00f1os antes del ingreso, se le diagnostic\u00f3 aortitis autoinmunitaria de la aorta abdominal, que actualmente se hubiera clasificado como vasculitis de \u00f3rgano \u00fanico seg\u00fan la definici\u00f3n de consenso de Chapel Hill de 2012. El paciente hab\u00eda estado sometido a varios tratamientos inmunosupresores con glucocorticoides, bien en solitario o bien en combinaci\u00f3n con azatioprina o 6-mercaptopurina, as\u00ed como seis ciclos de ciclofosfamida i.v. En ese momento, el paciente fue diagnosticado con carcinoma urotelial de vejiga de evoluci\u00f3n r\u00e1pida, en estadio T2N0M0 (con infiltraci\u00f3n en la musculatura vesical), tras haber presentado macrohematuria. Se someti\u00f3 a cistectom\u00eda transuretral y recibi\u00f3 radioterapia intermitente con una dosis m\u00e1xima de 59,4 Gy y quimioterapia simult\u00e1nea con 5-fluorouracil y mitomicina. Durante los 8 meses anteriores al ingreso, estuvo sin tratamiento inmunosupresor o antineopl\u00e1sico. El resto de los antecedentes m\u00e9dicos eran polineuropat\u00eda desmielinizante inflamatoria, enfermedad pulmonar obstructiva cr\u00f3nica, arteriopat\u00eda coronaria, diabetes mellitus de tipo 2, nefropat\u00eda cr\u00f3nica en estadio 3a, enfermedad de Parkinson, osteoporosis y fibrilaci\u00f3n auricular intermitente. Al ingreso, el 6 de marzo de 2020, la temperatura del paciente era 36,8 \u00b0C, la presi\u00f3n arterial, 130/80 mmHg y el pulso, 80 l.p.m. La frecuencia respiratoria era 16 r.p.m. y la saturaci\u00f3n de ox\u00edgeno era 94% en aire ambiental. La cifra de leucocitos indic\u00f3 leucocitopenia con una linfocitopenia absoluta de 370 linfocitos/mm3 (intervalo de referencia 1.090-2.990), leve trombocitopenia con 102.000/mm3 (intervalo de referencia 150.000-350.000), un valor de prote\u00edna C-reactiva de 75,1 mg/l (valor de referencia < 8,2) y un valor de lactato-deshidrogenasa de 418 U/l (valor de referencia < 248). La prueba para anticuerpos anticitopl\u00e1smicos de neutr\u00f3filos (ANCA), anticuerpos antinucleares (ANA) y anticuerpos anti-GBM fue negativa. La radiograf\u00eda tor\u00e1cica era normal. Se realizaron hemocultivos. Se administr\u00f3 al paciente 2 litros de ox\u00edgeno por minuto mediante c\u00e1nula nasal, y se le ingres\u00f3 para su evaluaci\u00f3n posterior. Una TAC tor\u00e1cica revel\u00f3 extensas opacidades de vidrio esmerilado, indicativas de neumon\u00eda intersticial aguda. A los 4 d\u00edas del ingreso, el paciente present\u00f3 una temperatura de 38,3 \u00b0C y su estado respiratorio empeor\u00f3, con una saturaci\u00f3n de ox\u00edgeno de 89% con 2 litros de ox\u00edgeno por minuto, as\u00ed como hemoptisis. La gasometr\u00eda confirm\u00f3 la hipoxemia con una PaO2 de 61 mmHg e hiperventilaci\u00f3n con una PaCO2 de 31 mmHg. con tazobactam, cotrimoxazol y roxitromicina por v\u00eda oral. Una broncoscopia mostr\u00f3 signos de bronquitis cr\u00f3nica con l\u00edquido bronquial progresivamente hemorr\u00e1gico a partir de sucesivas muestras iguales durante el lavado broncoalveolar, coherente con hemorragia alveolar difusa (HAD). El lavado revel\u00f3 una cifra total de 10x105 c\u00e9lulas por ml, b\u00e1sicamente formada por macr\u00f3fagos alveolares (80%) y 1000 eritrocitos por mm\u00b3. Tinciones de Gram y PCR para Legionella spp., Chlamydia spp., Mycoplasma spp., citomegalovirus, virus del herpes simple 1 y 2, virus de la gripe A y B, virus respiratorio sincitial, Pneumocystis jiroveci y micobacterias no tuberculosas fueron todas negativas. Trasladamos el paciente a la UCI, donde se inici\u00f3 ventilaci\u00f3n no invasiva. Finalmente, una PCR en tiempo real para SARS-CoV-2 a partir de un frotis nasofar\u00edngeo fue positiva, a la vez que se descartaron otras posibles causas de neumon\u00eda. En las siguientes 24 horas, el paciente empeor\u00f3 progresivamente, hasta el punto en que se consider\u00f3 indicada la ventilaci\u00f3n mec\u00e1nica invasiva. De acuerdo con la voluntad del paciente, no se intub\u00f3 y se le impartieron cuidados paliativos, con los cuales muri\u00f3 poco despu\u00e9s. Diagn\u00f3stico: HAD por infecci\u00f3n pulmonar con SARS-CoV-2."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "70-year-old Caucasian male who had been in his usual state of health until 6 weeks prior to admission. At this time, he was referred from his general practitioner to another hospital with malaise and intermittent, daily fever, usually in the second half of the day, rising up to 39.0\u00b0C. Other than that, no specific symptoms were present, no travel history, no sick contacts. Apart from nucleus pulposus prolapse of the lumbar spine there was no remarkable past medical history. Elevated laboratory markers of inflammation were found with a maximum CRP of 233 mg/dl (reference range < 8.2) and erythrocyte sedimentation rate (ESR) of > 100 mm/h. An extensive medical workup was conducted using computed tomography of the thorax, abdomen, and pelvis, blood cultures, magnetic resonance imaging (MRI) of the spine, transthoracic and transesophageal echocardiography, bone marrow aspiration and biopsy and 15-FDG-PET/CT; none of which came out remarkable. ANCA, ANA, anti-GBM antibodies, serologies of human immunodeficiency virus, cytomegaly virus, Epstein-Barr virus, leishmaniosis, brucella spp., leptospirosis, rickettsia spp. and treponema pallidum were negative. Complement factors C3 and C4 were normal. Two courses of antibiotic treatment with ampicillin/clavulanic acid and piperacillin/tazobactam were ineffective. On admission to our hospital, the patient continued to develop daily, intermittent fever. His blood pressure was 130/70 mmHg, pulse 77 beats per minute, temperature 37.7\u00b0C. On examination, we detected an erythematous rash on the ventral thorax that was independent of the fever episodes, and bilateral pretibial and perimalleolar edema. Blood analysis revealed a leukocytosis of 21.000/mm3 with a neutrophil count of 70% and hypereosinophilia of 4.290 eosinophils/mm3 (reference range 0.03-0.44), a CRP level of 188 mg/dl, an ESR of 108/h, a LDH of 184 U/l and a pro-brain natriuretic peptide level of 5116 pg/ml (reference range 0-125). The initially impaired kidney function with a creatinine of 1.8 mg/dl (reference range 0.41-1.44) rapidly deteriorated to a creatinine of 3.5 mg/dl and peripheral edema progressed. Ultrasound guided kidney biopsy finally revealed extensive tubular-interstitial infiltration of eosinophils showing unremarkable glomeruli, no evidence of vasculitis or granulomatous disease. A cardiac MRI without gadolinium enhancement due to compromised renal function revealed evidence of myocardial thickening (septum diameter 1.3 cm) and the aspect of infiltrative myocardial disease. After repeat bone marrow aspiration and biopsy provided no evidence of systemic mastocytosis or myeloproliferative disease and genetic analyses for bcr-abl, JAK2 and FIP1L1-PDGFRA/B were negative, we established the diagnosis of idiopathic hypereosinophilic syndrome (iHES) and put the patient on 500 mg intravenous prednisolone per day. At this point in time patient no. 1 was admitted to the same room as patient no. 2. After 3 days of intravenous prednisolone at a dose of 500 mg per day, CRP levels dropped to 35 mg/l, eosinophil counts normalized, both fever and rash dissolved and the patient\u2019s general health improved. On day 4, after having had 4 days of contact with patient no. 1 he developed massive hemoptysis and hypoxemic respiratory failure. A computed tomography of the chest revealed bilateral ground glass opacities with peribronchovascular consolidations consistent with DAH. The patient was referred to our ICU. A BAL was performed confirming alveolar bleeding by progressive hemorrhagic return in sequential aliquots. Gram steins and a broad infective PCR panel  returned negative. After a nasopharyngeal swab was positive for SARS-CoV-2 (PCR) we diagnosed COVID-19, most likely as a result of an in-hospital transmission. After tapering of glucocorticoid therapy and supportive therapy the patient gradually recovered. Diagnosis: DAH due to pulmonary SARS-CoV-2 infection. Idiopathic hypereosinophilic syndrome.",
        "es": "Hombre cauc\u00e1sico de 70 a\u00f1os que hab\u00eda estado en su estado normal de salud hasta 6 semanas antes del ingreso. En ese momento, su m\u00e9dico de cabecera lo hab\u00eda derivado a otro hospital con malestar y fiebre diaria intermitente, en general durante la segunda mitad del d\u00eda, con un m\u00e1ximo de 39,0 \u00b0C. A parte de esto, no hab\u00eda otros s\u00edntomas, as\u00ed como tampoco antecedentes de desplazamientos o de contactos con enfermos. Excepto por un prolapso pulposo nuclear de la columna lumbar, el paciente no ten\u00eda antecedentes m\u00e9dicos remarcables. Se hallaron valores altos de marcadores de inflamaci\u00f3n, con un m\u00e1ximo de prote\u00edna C-reactiva de 233 mg/dl (valor de referencia < 8,2) y una velocidad de sedimentaci\u00f3n globular (VSG) superior a 100 mm/h. Se realiz\u00f3 una exhaustiva evaluaci\u00f3n m\u00e9dica con TAC tor\u00e1cica, abdominal y p\u00e9lvica, hemocultivos, RMN medular, ecocardiograma transtor\u00e1cico y transesof\u00e1gico, aspiraci\u00f3n y biopsia de m\u00e9dula y TEP/TC con 15-FDG; ninguno de los an\u00e1lisis dio resultados relevantes. Las pruebas de anticuerpos anticitoplasm\u00e1ticos de neutr\u00f3filos (ANCA), anticuerpos antinucleares (ANA) y anticuerpos anti-GBM, VIH, citomegalovirus, virus de Epstein-Barr, leishmaniosis, brucella spp., leptospirosis, rickettsia spp y treponema pallidum fueron negativas. Los factores del complemento C3 y C4 eran normales. Dos pautas de antibi\u00f3ticos con ampicilina/\u00e1cido clavul\u00e1nico y con piperacilina/tazobactam fueron inefectivas. Al ingreso en nuestro hospital, el paciente continu\u00f3 presentando fiebre diaria intermitente. Su presi\u00f3n arterial era 130/70 mmHg, el pulso era 77 l.p.m., la temperatura era 37,7 \u00b0C. A la exploraci\u00f3n, se apreci\u00f3 un exantema eritematoso en la zona ventral, independiente de los episodios de fiebre, as\u00ed como edema bilateral pretibial y perimaleolar. Los an\u00e1lisis de sangre revelaron leucocitosis de 21.000/mm3 con una cifra de neutr\u00f3filos del 70% e hipereosinofilia con 4.290 eosin\u00f3filos/mm3 (intervalo de referencia 0,03-0,44), un valor de prote\u00edna C-reactiva de 188 mg/dl, VSG de 108/h, LDH de 184 U/l y p\u00e9ptido natriur\u00e9tico cerebral de 5.116 pg/ml (intervalo de referencia 0-125). La insuficiencia renal inicial con un valor de creatinina de 1,8 mg/dl (intervalo de referencia 0,41-1,44) empeor\u00f3 r\u00e1pidamente a un valor de creatinina de 3,5 mg/dl y progresi\u00f3n del edema perif\u00e9rico. Una biopsia de ri\u00f1\u00f3n guiada por ec\u00f3grafo revel\u00f3 finalmente infiltraci\u00f3n tubular-intersticial de eosin\u00f3filos extensa, con glom\u00e9rulos anodinos, sin evidencia de vasculitis o de granulopat\u00edas. Una RMN cardiaca sin realce de gadolinio a causa del deterioro de la actividad renal revel\u00f3 evidencias de engrosamiento mioc\u00e1rdico (di\u00e1metro del tabique 1,3 cm) y el aspecto de miocardiopat\u00eda infiltrativa. Despu\u00e9s de que una nueva aspiraci\u00f3n y biopsia de m\u00e9dula no aportara pruebas de mastocitosis sist\u00e9mica o de enfermedad mieloproliferativa, y de que los an\u00e1lisis gen\u00e9ticos para bcr-abl, JAK2 y FIP1L1-PDGFRA/B fueran negativos, se estableci\u00f3 un diagn\u00f3stico de s\u00edndrome hipereosinof\u00edlico idiop\u00e1tico y se administr\u00f3 al paciente 500 mg de prednisolona i.v. al d\u00eda. Despu\u00e9s de 3 d\u00edas de prednisolona i.v. a una dosis de 500 mg por d\u00eda, los valores de prote\u00edna C-reactiva bajaron a 35 mg/l, las cifras de eosin\u00f3filos se normalizaron, la fiebre y el exantema remitieron y el estado general de salud del paciente mejor\u00f3. El d\u00eda 4, tras haber estado cuatro d\u00edas en contacto con el paciente n.\u00ba 1, present\u00f3 hemoptisis masiva e insuficiencia respiratoria hipox\u00e9mica. Una TAC tor\u00e1cica revel\u00f3 opacidades de vidrio esmerilado bilaterales con consolidaciones peribroncovasculares, coherentes con hemorragia alveolar difusa (HAD). Se traslad\u00f3 al paciente a nuestra UCI. Se realiz\u00f3 un lavado broncoalveolar que confirm\u00f3 hemorragia alveolar mediante resultados progresivamente hemorr\u00e1gicos en muestras secuenciales iguales. La tinci\u00f3n de Gram y un amplio panel infectivo de PCR dieron resultado negativo. Despu\u00e9s de que un frotis nasofar\u00edngeo dio positivo para SARS-CoV-2 (PCR), se diagnostic\u00f3 COVID-19, probablemente como resultado de transmisi\u00f3n intrahospitalaria. Tras ajustar la terapia con glucocorticoides y la terapia paliativa, el paciente se recuper\u00f3 gradualmente. Diagn\u00f3stico: HAD por infecci\u00f3n pulmonar con SARS-CoV-2. S\u00edndrome hipereosinof\u00edlico idiop\u00e1tico."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 59-year-old woman with grade 2 obesity and a history of iodinated contrast media allergy, but without any other known comorbidity, was admitted to the Strasbourg University Hospital for severe dyspnea with a four-day history of fatigue, myalgia and a fever of up to 41\u25e6C. When paramedics arrived at her home, the patient was in respiratory distress. Oxygen saturation was at 85%under 15 L/min of nasal oxygen, which required an immediate oro-tracheal intubation on-site. Upon admission to the intensive care unit, oxygen saturation was 95% under FiO2 100%. Breath sounds were bilateral with bronchial rales. Laboratory tests revealed a slight neutrophilia(8.13 g/L), lymphopenia (0.73 g/L), a high biological inflammatory syndrome (C-reactive protein [CRP]: 114 mg/L). Prothrombin and activated partial thromboplastin times were normal. Liver function tests revealed a mild cytolysis (twice normal). The chest radiography showed bilateral diffuse ground-glass opacities that were consistent with a COVID-19 infection. A nasopharyngeal swab, using RT-PCR, tested positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Initial management consisted of treatment with lopinavir/ritonavir, combined with probabilistic intravenous amoxicillin-clavulanic acid and spiramycin for 5 days, with curative low-molecular weight heparin. On day 7, two days after stopping antiviral and antibiotic treatments, the patient\u2019s respiratory condition deteriorated. A ventilator-associated pneumonia was suspected, despite negative results on all bacteriological respiratory samples and blood cultures. A nasopharyngeal swab and tracheal aspiration still revealed positive RT-PCR results for SARS-CoV-2. The patient then began7-day probabilistic treatment with piperacillin-tazobactam and linezolid. Her respiratory status improved gradually, which enabled extubation on day 13.Abbreviations: CRP, C-Reactive Protein; CT, Computed Tomography; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.On day 14, a nasopharyngeal swab and expectorations, using RT-PCR, tested negative for SARS-CoV-2.On day 15, the patient was transferred to the pneumology department for further care and treatment. She had fully recovered rapidly, including the withdrawal of oxygen therapy, despite the persistence of bibasilar rales, without any other respiratory symptoms or fever. CRP decreased to 9.3 mg/L. Over the following days, chest radiography follow-up demonstrated a partial regression of the ground-glass opacities that were initially observed. Furthermore, diabetes mellitus was diagnosed during hospitalization (fasting glycemia 1.43 g/L [normal range, 0.74\u20131.06], glycated hemoglobin 6.7%).Between days 8 and 25 of hospitalization, three specific serologies for SARS-CoV-2 were performed, all of which strongly demonstrated positive IgM and IgG levels (BIOSYNEX COVID-19 BSS rapid test, Strasbourg, France). The symptoms\u2019 onset had occurred more than 10 days before the first serology, which can explain these results.After day 24, the patient was discharged from hospital. But the day after, she experienced intermittent fever (peak temperature of 39.5\u25e6C) and complained of a dry cough and abundant purulent sputum production (\u201cvomica\u201d) with halitosis. Her CRP rose to 219 mg/L. Chest radiography revealed the presence of diffuse bilateral ground-glass opacities and a rounded opacity surmounting the right diaphragm. A chest computed tomography (CT) scan revealed one pulmonary abscess (43 mm inner diameter) in the right lower lobe. This was associated with subpleural ground-glass opacities with basal and peripheral predominance and linear alveolar condensations, consistent with partially resolved moderate-to-severeCOVID-19 pneumonia (involving approximately 50% of pulmonary parenchyma). One RT-PCR test for SARS-CoV-2 on a nasopharyngeal swab returned weakly positive, but the next control samples remained negative.All bacteriological cultures (expectorations, hemocultures),aspergillus serology, and antigenemia that were performed were negative. Maxillary sinuses and dental radiographies performed to investigate an extrathoracic infectious cause were normal. A specific clinical evaluation found a mild dysphagia, which was probably secondary to the intubation.Finally, the patient fully recovered after a 14 days-intravenous treatment with piperacillin-tazobactam and levofloxacin, followed with at home-treatment with amoxicillin-clavulanic acid and levofloxacin for seven more days.Clinical follow-up at one-month post-discharge revealed no symptoms and chest radiography was normalized.",
        "es": "Una mujer de 59 a\u00f1os con obesidad de grado 2 y antecedentes de alergia a medios de contraste yodados, pero sin otras comorbilidades conocidas, ingres\u00f3 en el hospital universitario de Estrasburgo con disnea grave, cuatro d\u00edas de fatiga, mialgia y fiebre de hasta 41 \u00baC. Cuando los auxiliares sanitarios llegaron a su domicilio, la paciente presentaba disnea. La saturaci\u00f3n de ox\u00edgeno era de 85% con 15 L/min de ox\u00edgeno por c\u00e1nula nasal, que requiri\u00f3 una intubaci\u00f3n orotraqueal inmediata in situ. Al ingreso en la UCI, la saturaci\u00f3n de ox\u00edgeno era de 95%, con FiO2 100%. Se apreciaron ruidos respiratorios bilaterales con estertores bronquiales. Las pruebas anal\u00edticas revelaron una ligera neutrofilia (8,13 g/L), linfocitopenia (0,73 g/L) y un s\u00edndrome inflamatorio intenso (prote\u00edna C-reactiva: 114 mg/L). El tiempo de protrombina y el tiempo de tromboplastina parcial activado eran normales. Las pruebas funcionales hep\u00e1ticas revelaron ligera cit\u00f3lisis (doble de lo normal). Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado difusas bilaterales, coherentes con una infecci\u00f3n por COVID-19. Un frotis nasofar\u00edngeo dio positivo para s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 (SARS-CoV-2) mediante RT-PCR. El manejo inicial consisti\u00f3 en un tratamiento con lopinavir/ritonavir, combinado con espiramicina y amoxicilina/\u00e1cido clavul\u00e1nico i.v. El d\u00eda 7, dos d\u00edas despu\u00e9s de finalizar los tratamientos antiv\u00edrico y antibi\u00f3tico, el estado respiratorio de la paciente empeor\u00f3. Se sospech\u00f3 neumon\u00eda asociada al respirador, a pesar de resultados negativos de todas las muestras bacteriol\u00f3gicas respiratorias y hemocultivos. Un nuevo frotis nasofar\u00edngeo y un aspirado traqueal todav\u00eda dieron resultado positivo para SARS-CoV-2 con RT-PCR. A continuaci\u00f3n, la paciente inici\u00f3 un tratamiento probabil\u00edstico de 7 d\u00edas con piperacilina/tazobactam y linezolid. Su estado respiratorio mejor\u00f3 gradualmente, lo que permiti\u00f3 extubarlo el d\u00eda 13. El d\u00eda 14, un frotis nasofar\u00edngeo y el esputo dieron negativo para SARS-CoV-2 mediante RT-PCR. La paciente se recuper\u00f3 por completo con rapidez, incluyendo la retirada de oxigenoterapia, a pesar de la persistencia de estertores bibasales, sin otros s\u00edntomas respiratorios ni fiebre. La prote\u00edna C-reactiva baj\u00f3 a 9,3 mg/L. Durante los d\u00edas siguientes, una radiograf\u00eda tor\u00e1cica de seguimiento evidenci\u00f3 una regresi\u00f3n parcial de las opacidades de vidrio esmerilado observadas inicialmente. Adem\u00e1s, durante la hospitalizaci\u00f3n se le diagnostic\u00f3 diabetes mellitus (glucemia en ayunas 1,43 g/L [intervalo normal: 0,74-1,06], glucohemoglobina 6,7%). El inicio de los s\u00edntomas se hab\u00eda producido m\u00e1s de 10 d\u00edas antes del primer an\u00e1lisis serol\u00f3gico, lo que puede explicar estos resultados. Despu\u00e9s del d\u00eda 24, la paciente fue dado de alta. Sin embargo, al d\u00eda siguiente experiment\u00f3 fiebre intermitente (con un m\u00e1ximo de 39,5 \u00baC) y tuvo tos seca y abundante expectoraci\u00f3n purulenta (tos v\u00f3mica) con halitosis. La prote\u00edna C-reactiva subi\u00f3 a 219 mg/L. Una radiograf\u00eda revel\u00f3 la presencia de opacidades de vidrio esmerilado bilaterales difusas y una opacidad redondeada sobre el diafragma derecho. Una TAC tor\u00e1cica revel\u00f3 un absceso pulmonar (di\u00e1metro interno 43 mm) en el l\u00f3bulo inferior derecho. Este estaba asociado a opacidades de vidrio esmerilado subpleurales con predominancia basal y perif\u00e9rica y condensaciones alveolares lineales, cuadro coherente con neumon\u00eda por COVID-19 entre moderada y grave parcialmente superada (con afectaci\u00f3n de aproximadamente el 50% del par\u00e9nquima pulmonar). Una prueba mediante RT-PCR para SARS-CoV-2 a partir de un frotis nasofar\u00edngeo dio un resultado d\u00e9bilmente positivo, pero las siguientes muestras de control fueron negativas. Todos los cultivos bacteriol\u00f3gicos (esputo, hemocultivos), an\u00e1lisis serol\u00f3gico de Aspergillus y antigenemia fueron tambi\u00e9n negativos. Las radiograf\u00edas dentales y de los senos paranasales que se realizaron para investigar posibles causas de infecci\u00f3n extrator\u00e1cica dieron resultados normales. Una evaluaci\u00f3n cl\u00ednica espec\u00edfica hall\u00f3 disfagia leve, posiblemente secundaria a la intubaci\u00f3n. Finalmente, la paciente se recuper\u00f3 por completo tras un tratamiento i.v."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 21 year-old-female presented to the ED with left-sided facial and neck swelling. She presented to another ED eight days prior with fever, cough, and dyspnea and diagnosed with COVID-19. Despite improvement of her respiratory symptoms, she developed progressive unilateral facial and neck swelling causing subjective malocclusion and trismus. On review of systems, she reported decreased oral intake but denied persistent fevers, dental pain or facial weakness. On examination, the patient had normal vital signs and moderate left-sided cheek, preauricular, and submandibular swelling without erythema, induration or fluctuance. The intraoral exam was normal, with no purulent drainage expressible from Stensen's duct and normal occlusion. The rest of her physical exam was unremarkable. Imaging and blood laboratory values were obtained to work-up a differential that included infectious parotitis, sialolithiasis, salivary gland abscess, and neoplasm. Laboratory values were notable for a leukopenia to 3170/uL without lymphopenia. Computed tomography (CT) of the neck demonstrated: diffuse asymmetric enlargement and swelling of the left parotid gland without an obstructing stone, mass, or abscess; periparotid inflammatory fat stranding; and free fluid extending into the left submandibular, submental, and parapharyngeal spaces and along the left sternocleidomastoid and strap muscles. Otolaryngology was consulted given the extension of free fluid into surrounding anatomical spaces. Her history, exam and CT findings were felt to be most consistent with uncomplicated acute infectious parotitis. Her sensation of malocclusion was attributed to inflammation surrounding her muscles of mastication. The patient was prescribed a course of amoxicillin/clavulanate to treat a possible concomitant bacterial parotitis and advised to apply warm compresses, massage the gland, use sialagogues to increase salivary flow and stay hydrated.",
        "es": "Una mujer de 21 a\u00f1os acudi\u00f3 al servicio de urgencias con inflamaci\u00f3n izquierda facial y del cuello. Hab\u00eda acudido ocho d\u00edas antes a otro servicio de urgencias con fiebre, tos y disnea y se le diagnostic\u00f3 COVID-19. A pesar de la mejora de sus s\u00edntomas respiratorios, present\u00f3 una inflamaci\u00f3n unilateral progresiva en el rostro y el cuello, que provoc\u00f3 oclusi\u00f3n dental defectuosa subjetiva y trismo. A la exploraci\u00f3n, refiri\u00f3 falta de apetito, pero neg\u00f3 fiebres persistentes, dolor de muelas o debilidad facial. La paciente ten\u00eda constantes vitales normales y una moderada inflamaci\u00f3n en la mejilla izquierda, preauricular y submandibular, sin eritema, induraci\u00f3n o fluctuaci\u00f3n. La exploraci\u00f3n intraoral fue normal, sin secreci\u00f3n purulenta exprimible del conducto parot\u00eddeo, y oclusi\u00f3n normal. El resto de la exploraci\u00f3n fue anodino. Los resultados anal\u00edticos y de diagn\u00f3stico por la imagen llevaron a un diagn\u00f3stico diferencial que inclu\u00eda parotiditis infecciosa, sialolitiasis, absceso de las gl\u00e1ndulas salivales y neoplasia. En los valores anal\u00edticos era destacable la leucocitopenia de 3.170/uL sin linfocitopenia. Una TAC craneomaxilofacial revel\u00f3: inflamaci\u00f3n y aumento de tama\u00f1o asim\u00e9trico y difuso de la gl\u00e1ndula par\u00f3tida izquierda, sin obstrucci\u00f3n, masa o absceso en el conducto parot\u00eddeo, acumulaci\u00f3n de grasa inflamatoria periparot\u00eddea y l\u00edquido libre que se extend\u00eda hacia los espacios submandibular izquierdo, submentoniano y parafar\u00edngeo y a lo largo de los m\u00fasculos esternocleidomastoideo e infrahioideos. Se consult\u00f3 con el equipo de otorrinolaringolog\u00eda a causa de la extensi\u00f3n de l\u00edquidos en los espacios anat\u00f3micos adyacentes. El historial, la exploraci\u00f3n y los resultados radiol\u00f3gicos parec\u00edan m\u00e1s consistentes con una parotiditis infecciosa aguda sin complicaciones. Su sensaci\u00f3n de oclusi\u00f3n defectuosa se atribuy\u00f3 a la inflamaci\u00f3n alrededor de sus m\u00fasculos masticatorios. Se le recet\u00f3 una pauta de amoxicilina/clavulanato para tratar una posible parotiditis bacteriana concomitante y se le aconsej\u00f3 aplicar compresas calientes, masajes en la gl\u00e1ndula, usar sial\u00f3gogos para aumentar el flujo salivar y mantenerse hidratada."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "\ufeffA 38-year-old man presented with a 6-day history of gradually worsening cough and asthenia and secondary anosmia and ageusia. He had no prior personal medical history. His mother had a history of diabetes mellitus and his son was followed for haemophilia A. His spouse had exhibited similar symptoms a week earlier. On admission to the emergency room, clinical examination revealed crackles in the right lung, tachypnoea with a respiratory rate of 40 per min, tachycardia with a pulse of 119 beats per minute, an oxygen saturation of 66% while breathing ambient air. Body temperature was 39.8\u00b0C and blood pressure 117/72\u2005mmHg. Initial computed tomographic pulmonary angiography (CTPA) showed bilateral ground-glass opacities, condensation in the right lower lobe, and no sign of pulmonary embolism. Nasal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing was obtained and result of the RT-PCR testing was positive. The patient was promptly transferred to the Intensive Care Unit, where oxygen therapy with high flow nasal cannula was initiated with an oxygen outflow of 50\u2005L\u00b7min\u22121 and a fraction of inspired oxygen (FiO2) of 1 initially, along with an empirical course of antibiotics (ceftriaxone and levofloxacin). A trial of prone therapy was started, yielding immediate positive results. While in prone position, the patient was no longer tachypnoeic, and required lower levels of oxygen support, allowing us to delay initiating mechanical ventilation. Over the next few days, prone positioning was regularly performed. Although PaO2 levels were around 75\u2005mmHg on an FiO2 of 0.8 corresponding to a Horowitz (PaO2/FiO2) ratio of 90, the patient did not exhibit any clinical signs of respiratory distress, no shortness of breath nor tachypnoea. His ROX index [(SpO2/FiO2)/ respiratory rate] remained steadily superior to 5. Considering the above, mechanical ventilation was therefore not initiated. Fever quickly receded, and inflammatory marker levels decreased. Antibiotics were discontinued on day-4 because of lack of evidence of any secondary bacterial infection. On day-10, because the patient still required high levels of oxygen via high-flow nasal cannula, a control CTPA was performed. It showed no evidence of pulmonary embolism, but rapid onset of extensive pulmonary honeycombing fibrosis in the territories where ground glass opacities had been present. Multidisciplinary meeting concluded that rapid onset pulmonary fibrosis complicated the course of severe Covid-19 pneumonia. Search for other causes of interstitial lung disease including autoimmune disease was negative. Treatment included daily high-dose intravenous corticosteroids boluses of 250 milligrams for three days, followed by 1 milligram per kilogram per day, associated with antifibrotic therapy with nintedanib. The patient's condition improved and he was transferred to pneumology wards on day 18 on oxygen therapy (6\u2005L\u00b7min\u22121).",
        "es": "Un hombre de 38 a\u00f1os acudi\u00f3 con tos, astenia y anosmia y ageusia secundarias, de 6 d\u00edas de evoluci\u00f3n. No ten\u00eda antecedentes m\u00e9dicos. Su madre ten\u00eda antecedentes de diabetes mellitus y su hijo estaba en seguimiento por hemofilia A. Su esposa hab\u00eda tenido s\u00edntomas similares una semana antes. Al ingreso en urgencias, la exploraci\u00f3n cl\u00ednica revel\u00f3 crepitantes en el pulm\u00f3n derecho, taquipnea con una frecuencia respiratoria de 40 r.p.m., taquicardia con un pulso de 119 l.p.m. y saturaci\u00f3n de ox\u00edgeno de 66% en aire ambiental. La temperatura era de 39,8 \u00b0C y la presi\u00f3n arterial de 117/72 mHg. Una angiograf\u00eda pulmonar por TAC (APTC) inicial mostr\u00f3 opacidades de vidrio esmerilado bilaterales y condensaci\u00f3n en el l\u00f3bulo inferior derecho, sin signos de embolia pulmonar. Se obtuvo un frotis nasal para una prueba de s\u00edndrome de dificultad respiratoria aguda por coronavirus 2 (SARS-CoV-2) y el resultado de la prueba mediante RT-PCR fue positivo. El paciente fue trasladado r\u00e1pidamente a la UCI, donde se inici\u00f3 oxigenoterapia con c\u00e1nula nasal de alto flujo, con una salida de 50 L/min y una fracci\u00f3n de ox\u00edgeno inspirado (FiO2) inicial de 1, junto con una pauta provisional de antibi\u00f3ticos (ceftriaxona y levofloxacina). Se inici\u00f3 una prueba de terapia en dec\u00fabito prono, que dio resultados inmediatos. Mientras estaba en dec\u00fabito prono, el paciente no mostr\u00f3 taquipnea y requiri\u00f3 menos ox\u00edgeno, lo que nos permiti\u00f3 retrasar el inicio de la ventilaci\u00f3n mec\u00e1nica. Durante los siguientes d\u00edas, se realiz\u00f3 regularmente la colocaci\u00f3n en dec\u00fabito prono. Aunque los valores de PaO2 estaban alrededor de 75 mmHg con una FiO2 de 0,8, lo que corresponde a un cociente de Horowitz (PaO2/FiO2) de 90, el paciente no mostr\u00f3 signos cl\u00ednicos de dificultad respiratoria, disnea o taquipnea. Su \u00edndice ROX [(SpO2/FiO2)/frecuencia respiratoria] permaneci\u00f3 siempre por encima de 5. Considerando el cuadro anterior, no se inici\u00f3 la ventilaci\u00f3n mec\u00e1nica. La fiebre remiti\u00f3 r\u00e1pidamente y los valores de marcadores de inflamaci\u00f3n disminuyeron. Se retiraron los antibi\u00f3ticos el d\u00eda 4, por la falta de evidencia de sobreinfecciones bacterianas. El d\u00eda 10, como el paciente todav\u00eda requer\u00eda valores altos de ox\u00edgeno por c\u00e1nula nasal de alto flujo, se realiz\u00f3 una APTC de control. No se apreciaron signos de embolia pulmonar, pero s\u00ed r\u00e1pida aparici\u00f3n de fibrosis pulmonar extensiva en panal de abeja en las zonas donde se hab\u00edan observado opacidades de vidrio esmerilado. Una reuni\u00f3n interdisciplinaria lleg\u00f3 a la conclusi\u00f3n que el r\u00e1pido inicio de la fibrosis pulmonar complicaba la evoluci\u00f3n de la neumon\u00eda grave por Covid-19. La b\u00fasqueda de otras causas de enfermedad pulmonar intersticial, incluyendo enfermedades autoinmunitarias, fue negativa. de una dosis alta de corticoesteroides, con 250 mg al d\u00eda durante tres d\u00edas, seguidos de una dosis de 1 miligramo por kg por d\u00eda, en conjunci\u00f3n con terapia antifibr\u00f3tica con nintedanib. El estado del paciente mejor\u00f3 y fue trasladado a la planta de neumolog\u00eda el d\u00eda 18, con oxigenoterapia (6 L/min)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 39-year old patient without any medical history presented chest pain and dyspnea for 2 days. He had no fever or cough. The ECG performed in the emergency room showed diffuse ST elevation associated with PQ depression. Initial laboratory testing showed CRP 22 mg/L, leucocytes 13.7\u00d7109/L, troponin 15.4 \u00b5g/L (N<0.05 \u00b5g/L), arterial lactate 6 mmol/L, sodium 126 mmol/L, and potassium 5.6 mmol/L. The chest computerized tomography-Scan showed both pleural and pericardial effusions, atelectasis but without any typical SARS-CoV-2 acute lung injury. Since his wife was diagnosed with SARS-CoV-2, reverse transcription polymerase chain reaction was performed and found to be positive. Echocardiography confirmed a moderate circumferential pericardial effusion, without any sign of tamponade. Cardiac magnetic resonance imaging was performed at day 5 confirming the diagnosis of myopericarditis with a subepicardial late gadolinium enhancement and T2 myocardial hyperintensity in the basal inferolateral segment. The patient was treated with colchicine 1 mg daily. The patient presented with mild evidence of heart failure, including dyspnea, pleural effusion, and an elevated NT-proBNP (N-terminal pro-B-type natriuretic peptide; 4473 pg/mL), controlled with low doses of diuretics for 4 days. Hyperkalemia was controlled with insulin but hyponatremia persisted despite a fluid restricted diet. Adrenal insufficiency had been excluded. The respiratory condition was stable with no more than 1 L/min of oxygen. The pleural fluid was an exudate with 28 g/L of protein and 376 IU/L of LDH. Troponin peak level was at 25 \u00b5g/L (N<0.05 \u00b5g/L) and CRP peak level at 141 mg/L. One episode of paroxysmal atrial fibrillation was treated successfully with amiodarone without any recurrence. Pericardial effusion completely disappeared at day 5 of the treatment with colchicine. The second complication was rhabdomyolysis, associated with severe foot and leg myalgias, with a peak CPK level of 17\u2009070 IU/L (day 5) resulting in mild acute renal failure (creatinine 113 \u00b5mol/L on day 6). Immunologic tests (myositis specific and associated antibodies, antinuclear antibodies, anti-cyclic citrullinated peptide antibodies, ANCA, CH50, C3-C4) were all negative. The third complication was severe acute hepatic injury with ASAT 556 IU/L (15\u00d7 upper normal value), ALAT 557 IU/L (8\u00d7), cholestasis, and elevated total bilirubin at 36 \u00b5mol/L, but normal prothrombin time ratio at 96%. Viral hepatitis serologies were negative. The patient was discharged on day 10 with decreasing ASAT (416 IU/L, 11\u00d7 normal value), still increasing ALAT (557 IU/L, 8\u00d7 normal value), normalized bilirubin (11 \u03bcmol/L), resolving rhabdomyolysis (resolved myalgia, CPK 2093 IU/L), decreasing CRP (20 mg/L) and troponin (3.2 \u03bcg/L), resolved acute renal failure (creatinine 72 \u03bcmol/L), and resolved symptoms of heart failure (no dyspnea, NT-proBNP 804 pg/mL on day 8).",
        "es": "Un paciente de 39 a\u00f1os sin antecedentes m\u00e9dicos presentaba dolor tor\u00e1cico y disnea de dos d\u00edas de evoluci\u00f3n. No presentaba fiebre ni tos. El ECG realizado en urgencias mostr\u00f3 elevaci\u00f3n del segmento ST difusa, asociada a descenso PQ. Los resultados anal\u00edticos iniciales fueron: prote\u00edna C-reactiva 22 mg/L, leucocitos 13,7\u00d7109/L, troponina 15,4 \u00b5g/L (N < 0,05 \u00b5g/L), lactato arterial 6 mmol/L, sodio 26 mmol/L, potasio 5,6 mmol/L. La TAC tor\u00e1cica mostr\u00f3 derrame pleural y epic\u00e1rdico y atelectasia, pero sin ninguna lesi\u00f3n pulmonar aguda t\u00edpica de SARS-CoV-2. Como a su esposa se le hab\u00eda diagnosticado SARS-CoV-2, se realiz\u00f3 una prueba de RT-PCR, que dio resultado positivo. Un ecocardiograma confirm\u00f3 un derrame peric\u00e1rdico perimetral moderado, sin signos de taponamiento. El d\u00eda 5 se realiz\u00f3 una RMN card\u00edaca, que confirm\u00f3 el diagn\u00f3stico de miopericarditis con realce tard\u00edo con gadolinio subepic\u00e1rdico e hiperintensidad mioc\u00e1rdico en T2 en el segmento basal inferolateral. El paciente se trat\u00f3 con colchicina, 1 mg al d\u00eda. El paciente present\u00f3 evidencia de insuficiencia card\u00edaca leve, con disnea, derrame pleural y valor alto de prohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral (4473 pg/mL), controlada con dosis bajas de diur\u00e9ticos durante 4 d\u00edas. La hiperpotasemia se control\u00f3 con insulina, pero la hiponatremia continu\u00f3 a pesar de una dieta con restricci\u00f3n de fluidos. Se descart\u00f3 insuficiencia suprarrenal. El estado respiratorio era estable, sin superar nunca 1 L/min de ox\u00edgeno. El l\u00edquido pleural era un exudado con 28 g/L de prote\u00edna y 376 UI/L de LDH. El valor m\u00e1ximo de troponina era de 25 \u00b5g/L (N < 0,05 \u00b5g/L) y el de prote\u00edna C-reactiva, de 141 mg/L. Un episodio de fibrilaci\u00f3n auricular parox\u00edstica se trat\u00f3 con \u00e9xito con amiodarona, sin recurrencia. El derrame peric\u00e1rdico desapareci\u00f3 por completo el d\u00eda 5 de tratamiento con colchicina. Una segunda complicaci\u00f3n fue rabdomi\u00f3lisis, asociada con mialgias intensas en los pies y las piernas, con un valor m\u00e1ximo de creatina-cinasa de 17.070 UI/L (d\u00eda 5) que llev\u00f3 a insuficiencia renal aguda leve (creatinina 113 \u00b5mol/L el d\u00eda 6). Las pruebas inmunol\u00f3gicas (miositis espec\u00edfica y anticuerpos asociados, anticuerpos antinucleares, anticuerpos antip\u00e9ptido c\u00edclico, citrulinado anticuerpos anticitopl\u00e1smicos de neutr\u00f3filos, CH50, C3-C4) fueron todas negativas. La tercera complicaci\u00f3n fue una lesi\u00f3n hep\u00e1tica aguda grave, con ASAT 556 UI/L (15\u00d7 valor normal superior), ALAT 557 UI/L (8\u00d7), colestasis y bilirrubina total elevada (36 \u00b5mol/L), pero cociente de tiempo de protrombina normal (96%). Las pruebas serol\u00f3gicas de hepatitis v\u00edrica fueron negativas. El paciente fue dado de alta el d\u00eda 10, con disminuci\u00f3n de la ASAT (416 UI/L, 11\u00d7 valor normal), ALAT a\u00fan al alza (557 UI/L, 8\u00d7 valor normal), bilirrubina normalizada (11 \u03bcmol/L), rabdomi\u00f3lisis en resoluci\u00f3n (mialgia superada, CPK 2093 UI/L), disminuci\u00f3n de prote\u00edna C-reactiva (20 mg/L) y troponina (3,2 \u03bcg/L), insuficiencia renal aguda resuelta (creatinina 72 \u03bcmol/L) y desaparici\u00f3n de los s\u00edntomas de insuficiencia card\u00edaca (no disnea, NT-proBNP 804 pg/mL el d\u00eda 8)."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 6-year-old girl was admitted to our hospital because of fever,headache, sore throat, and rash in the form numerous small purple dotson the skin of both forearms and legs. Three days earlier, she began tofeel fatigued and had an elevated temperature with a maximum of 39.0\u00b0C. She received oral paracetamol at a dose of 10 mg/kg three to fourtimes a day. In anamnesis, the child had no underlying condition. Shelived in a region of Poland where cases of COVID-19 had been recentlyreported, so she could have been exposed to the virus in the community. On admission, vital signs were as follows: blood pressure 100/62mmHg, temperature 36.5 \u00b0C, heart rate 102/min, respiratory rate 14/min, oxygen saturation 99 %. Physical examination was notable formany petechiae on the skin, and hepatomegaly. In laboratory tests,leukopenia, neutropenia, erythrocytopenia, and thrombocytopeniawere noted, along with an elevated level of C-reactive protein andelevated activity of alanine and asparagine aminotransferase. We noted severe pancytopenia, with extreme neutropenia (0.00 \u00d7 103/\u03bcl), a low number of natural killer cells (0.01 \u00d7 103/\u03bcl), decreasingnumber of helper T-lymphocytes, and an increasing number of cytotoxicT-lymphocytes. Additionally, there was an elevated levelof ferritin, a moderate elevate the level of interleukin 6 and fibrinogen. In the fourth and fifth weeks of treatment, we observed bradycardiawith a heart rate of 48\u201350/min and increased level of brain natriuretic peptide. The chest X-ray indicated normal lungs and enlargement of the  heart. Abdominal ultrasound confirmed hepatomegaly and enlargedkidneys bilaterally (right 9.8 cm, left 11.5 cm). Echocardiography andelectrocardiography (Holter) were normal. We excluded an acute infection(PCR or/and serological methods) caused by herpes simplexviruses 1 and 2, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus,human herpesviruses 6 and 7, enteroviruses, adenoviruses, influenzaviruses type A and B, respiratory syncytial virus, parechovirus,parvovirus B19, human immunodeficiency virus, hepatitis B and Cviruses, and Toxoplasma gondi. We found SARS-CoV-2 RNA in a nasopharyngealswab (RT-PCR method). The test used was a CE IVD BosphoreNovel Coronavirus Detection Kit v2. (cut-off value 61.5 copies/mL for gen E; 193.5 copies/mL for gen ORF1ab). We confirmed anasymptomatic SARS-CoV-2 infection in the girl\u2019s mother. Based on alllaboratory tests, bone marrow aspiration, and biopsy results, we establisheda diagnosis of COVID-19-associated severe aplastic anemia. We started therapy for COVID-19 with intravenous immunoglobulin(IVIG) in one dose of 2 g/kg. Additionally, we applied azithromycin 10mg/kg/24 h once a day. After seven days, because of the poor effect oftreatment, we repeated IVIG at the same dose, ceased azithromycin,and introduced lopinavir-ritonavir (10 mg + 2.5 mg twice a day). Thetherapy with lopinavir-ritonavir ended after five days because of anitchy rash on the skin. We administrated intravenous methylprednisolonefor 5 days (30 mg/kg) with an oral dexamethasone taper (0.1 mg/kg/24 h). The patient needed blood and platelet transfusions and asystematic evaluation because of the risk of serious bacterial, fungal, ornew viral infection. She received antibiotics and antifungal drugs. Weconsidered tocilizumab but the level of IL-6 was only slightly elevated,and we did not apply this treatment. For five weeks from the beginningof the disease, we repeated SARS-CoV-2 RNA detection tests at leastonce a week, and the results were always positive. Then, we transfusedconvalescent plasma (inactivated using methylene blue) with antibodiesagainst SARS-CoV-2 IgG at a titer of 1:700 once in a 200 mLdose. We did not observe any adverse events. For the next three weeks,we repeated tests for the detection of SARS-CoV-2 RNA in nasopharyngealswabs seven times. All these results were negative. The hematologicparameters did not improve after SARS-CoV-2 elimination.",
        "es": "Una ni\u00f1a de 6 a\u00f1os ingres\u00f3 en nuestro hospital con fiebre,cefalea, irritaci\u00f3n de garganta y exantema en forma de numerosos peque\u00f1os puntos p\u00farpuraen la piel de antebrazos y piernas. Tres d\u00edas antes empez\u00f3a sentirse cansada y ten\u00eda fiebre con un m\u00e1ximo de 39,0\u00b0C. Se le dio paracetamol por v\u00eda oral a una dosis de 10 mg/kg, entre tres y cuatroveces por d\u00eda. En la anamnesis, la ni\u00f1a no presentaba otras afecciones. Viv\u00edaen una regi\u00f3n de Polonia en la que se hab\u00edan registrado recientemente casos de COVID-19,de modo que pod\u00eda haber estado expuesta al virus comunitariamente. Al ingreso, las constantes vitales eran: presi\u00f3n arterial 100/61mmHg, temperatura 36,5 \u00b0C, pulso 102/min, frecuencia respiratoria 14/min, saturaci\u00f3n de ox\u00edgeno 99 %. La exploraci\u00f3n f\u00edsica fue relevante porm\u00faltiples petequias en la piel y hepatomegalia. En las pruebas anal\u00edticas se detect\u00f3leucocitopenia, neutrocitopenia, eritrocitopenia y trombocitopenia,junto con un valor alto de prote\u00edna C-reactiva yalta actividad de alanina- y asparagina-aminotransferasa. Se apreci\u00f3 pancitopenia grave, con neutrocitopenia extrema (0,00 \u00d7 103/\u03bcl), baja cantidad de linfocitos citol\u00edticos naturales (0,01 \u00d7 103/\u03bcl), disminuci\u00f3n deln\u00famero de linfocitos T colaboradores y un aumento de linfocitosT citot\u00f3xicos. Adem\u00e1s, se observ\u00f3 un valor alto deferritina, un valor moderadamente alto de interleucina 6 y de fibrin\u00f3geno. En la cuarta y quinta semanas de tratamiento, se observ\u00f3 bradicardiacon un pulso de 48\u201350/min y un aumento del p\u00e9ptido natriur\u00e9tico cerebral. La radiograf\u00eda tor\u00e1cica mostr\u00f3 pulmones normales y cardiomegalia. Una ecograf\u00eda abdominal confirm\u00f3 la hepatomegalia y dilataci\u00f3n bilateral de los ri\u00f1ones (derecho 9,8 cm, izquierdo 11,5 cm). El ecocardiograma yel electrocardiograma (Holter) fueron normales. Se descart\u00f3 infecci\u00f3n aguda(PCR y/o serolog\u00eda) causada por virus 1 y 2 del herpes simple,virus de la varicela z\u00f3ster, virus de Epstein-Barr, citomegalovirus,virus de herpes humano 6 y 7, enterovirus, adenovirus, virus de la gripeA y B, virus respiratorio sincicial, parechovirus,parvovirus B19, VIH, virus de la hepatitisB y C y Toxoplasma gondii. Se hall\u00f3 ARN de SARS-CoV-2 en un frotis nasofar\u00edngeo(m\u00e9todo RT-PCR). La prueba empleada fue un CE IVD BosphoreNovel Coronavirus Detection Kit v2. (valor de corte 61,5 copias/mL para el gen E; 193,5 copias/mL para el gen ORF1ab). Se confirm\u00f3 unainfecci\u00f3n asintom\u00e1tica por SARS-CoV-2 en la madre de la ni\u00f1a. A partir de todaslas pruebas anal\u00edticas, aspirados medulares y resultados de biopsias, se estableci\u00f3un diagn\u00f3stico de anemia apl\u00e1sica grave asociada a COVID-19. Se inici\u00f3 un tratamiento para COVID-19 con inmunoglobulina i.v. a una dosificaci\u00f3n de 2 g/kg. Adem\u00e1s, se administr\u00f3 azitromicina 10mg/kg/24 h una vez al d\u00eda. Despu\u00e9s de siete d\u00edas, a causa del escaso efecto deltratamiento, se repiti\u00f3 la administraci\u00f3n de IG i.v. Con la misma dosis, se retir\u00f3 la azitromicinay se inici\u00f3 lopinavir/ritonavir (10 mg + 2,5 mg dos veces al d\u00eda). Laterapia con lopinavir/ritonavir finaliz\u00f3 despu\u00e9s de cinco d\u00edas a causa deun exantema pruriginoso. Se administr\u00f3 metilprednisolona i.v. durante 5 d\u00edas (30 mg/kg) con ajuste de dosis de dexametasona oral (0,1 mg/kg/24 h). La paciente necesit\u00f3 transfusiones de sangre y de trombocitos y una evaluaci\u00f3n sistem\u00e1tica a causa del riesgo de infecciones gravesbacterianas, f\u00fangicas o v\u00edricas. Recibi\u00f3 antibi\u00f3ticos y antif\u00fangicos. Seconsider\u00f3 tocilizumab, pero el valor de IL-6 era solo ligeramente elevado,de modo que no se aplic\u00f3 este tratamiento. Durante cinco semanas desde el inicio dela enfermedad, se repitieron las pruebas de detecci\u00f3n de SARS-CoV-2 por lo menosuna vez por semana, y los resultados fueron siempre positivos. As\u00ed, se transfundi\u00f3plasma de convaleciente (inactivado con azul de metileno) con anticuerposfrente a IgG de SARS-CoV-2, con una diluci\u00f3n de 1:700 una sola vez en una dosisde 200 mL. No se observaron efectos adversos. Durante las tres siguientes semanas,se repitieron siete veces las pruebas de detecci\u00f3n de ARN de SARS-CoV-2 en frotisnasofar\u00edngeos; todos los resultados fueron negativos. Los par\u00e1metros hematol\u00f3gicosno mejoraron tras la eliminaci\u00f3n del SARS-CoV-2."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 46-year-old man presented with mild cough and fever for 4 days. He was a known case of hypertension and had history of contact with suspicious cases of SARS-CoV-2. Clinical examination and vital signs were normal apart from low grade fever (temperature: 38.2C). Chest \u2013X-ray was normal. Hematological tests showed lymphopenia, high (58) erythrocyte sedimentation rate (ESR). Real Time-Polymerase Chain Reaction (RT-PCR) for nasopharyngeal swab was positive for SARS-CoV-2, serum ferritin was 746\u00a0ng/ml. The patient was admitted in the corona isolation unit center (CIUC). He received Hydroxychloroquine (400\u00a0mg\u00a0b.i.d) and Azithromycin (500\u00a0mg q.d.). The patient's condition progressed, on the second day, he developed dyspnea (respiratory rate: 35 breaths/minute), oxygen saturation was 80%, temperature: 39.5\u00a0C, arterial blood gases (ABG) on room air showed PaCO2: 23\u00a0mmHg, PaO2: 57\u00a0mmHg, PaO2/FiO2: 114\u00a0mmHg. Chest x-ray showed right upper zone ground glass opacity with small area of consolidation. Computed tomography (CT) scan showed small subpleural ground glass opacity (GGO) affecting both lower lobes and right upper lobe. The patient was put on noninvasive oxygen therapy, Meropenem vial (1\u00a0g\u00a0t.i.d. ), Hydroxychloroquine (400\u00a0mg\u00a0b.i.d) and Kaletra tablet (Lopinavir/Ritonavir 800/200, b.i.d), and enoxaparin (4000 IU q.d.). After 3 days, the patient did not respond to the management strategy and deteriorated more and more. The dyspnea increased, (Oxygen saturation 60% without O2, became 90% on 10\u00a0L O2 through nasal cannula), bilateral diffuse course crackles, temperature 39.5\u00a0C, ABG on 10\u00a0L O2 through nasal cannula showed PaCO2: 33\u00a0mmHg, PaO2: 58\u00a0mmHg, PaO2/FiO2: 96\u00a0mmHg, serum ferritin: 1074\u00a0ng/ml, ESR: 91, D-dimer 1140\u00a0ng/ml, C-reactive protein (CRP): 37\u00a0mg/dL, with normal troponin test. CT scan showed diffuse bilateral GGO and multiple areas of consolidation in different regions of the entire lung. Despite his treatment, the patient received 200\u00a0ml of CP from a previously recovered moderate COVID-19 patient after performing necessary investigations for donor plasma (hemoglobin level and viral screen). The patient started to improve clinically, 4 days later, he was quite stable, no dyspnea, oxygen saturation on room air reached 95%, and the chest x-ray resolved partially. The patient was discharged from the hospital 16 days after admission in a healthy condition without symptoms, chest examination was clear, no significant radiological findings on chest-x-ray, and there were three consecutive negative RT-PCR tests each with at least 24\u00a0h apart.",
        "es": "Hombre de 46 a\u00f1os con tos leve y fiebre de 4 d\u00edas de evoluci\u00f3n. Ten\u00eda antecedentes de hipertensi\u00f3n y de contacto con presuntos casos de SARS-CoV-2. La exploraci\u00f3n cl\u00ednica y las constantes vitales eran normales, excepto por febr\u00edcula (temperatura: 38,2 C). La radiograf\u00eda tor\u00e1cica era normal. Las pruebas hematol\u00f3gicas mostraron linfocitopenia y una alta velocidad de sedimentaci\u00f3n globular (58). Una RT-PCR a partir de frotis nasofar\u00edngeo dio resultado positivo para SARS-CoV-2; la ferritina s\u00e9rica era de 746 ng/ml. El paciente fue ingresado en la unidad de aislamiento de coronavirus. Se le administr\u00f3 hidroxicloroquina (400 mg dos veces al d\u00eda) y azitromicina (500 mg al d\u00eda). El estado del paciente empeor\u00f3 y el segundo d\u00eda present\u00f3 disnea (frecuencia respiratoria: 35 r.p.m), la saturaci\u00f3n de ox\u00edgeno era de 80% y la temperatura, de 39,5C, la gasometr\u00eda arterial en aire ambiental dio PaCO2: 23mmHg, PaO2: 57mmHg, PaO2/FiO2: 114\u2009mmHg. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado en la zona superior derecha, con una peque\u00f1a \u00e1rea de consolidaci\u00f3n. Una TAC mostr\u00f3 peque\u00f1as opacidades de vidrio esmerilado subpleurales que afectaban a ambos l\u00f3bulos inferiores y al l\u00f3bulo superior derecho. Se aplic\u00f3 al paciente oxigenoterapia no invasiva y se le administr\u00f3 un vial de meronepem (1 g tres vecs al d\u00eda), hidroxicloroquina (400 mg dos veces al d\u00eda) y comprimidos de Kaletra (lopinavir/ritonavir, 800/200 dos veces al d\u00eda), as\u00ed como enoxaparina (4000 UI cada d\u00eda). Despu\u00e9s de 3 d\u00edas, el paciente no respond\u00eda a la pauta de tratamiento y empeor\u00f3 a\u00fan m\u00e1s. La disnea aument\u00f3 (saturaci\u00f3n de ox\u00edgeno 60% sin O2, que pas\u00f3 a 90% con 10 L O2 con c\u00e1nula nasal), se apreciaron subcrepitantes difusos bilaterales, la temperatura era de 39,5 C y la gasometr\u00eda arterial a 10 L O2 con c\u00e1nula nasal dio PaCO2: 33mmHg, PaO2: 58mmHg, PaO2/FiO2: 96mmHg, ferritina s\u00e9rica: 1074ng/ml, VSG: 91, d\u00edmero D: 1140ng/ml, prote\u00edna C-reactiva (CRP): 37mg/dL, con troponina normal. Una TAC mostr\u00f3 opacidades de vidrio esmerilado bilaterales difusas y diversas \u00e1reas de consolidaci\u00f3n en diferentes regiones de todo el pulm\u00f3n. A pesar del tratamiento, el paciente recibi\u00f3 200 ml de suero de convaleciente de un paciente recuperado de COVID-19 moderada, tras realizar las pruebas necesarias del plasma del donante (hemoglobinemia y pruebas v\u00edricas). El paciente empez\u00f3 a mejorar cl\u00ednicamente; 4 d\u00edas despu\u00e9s estaba bastante estable, sin disnea, la saturaci\u00f3n de ox\u00edgeno en aire ambiental lleg\u00f3 a 95% y la radiograf\u00eda tor\u00e1cica mostr\u00f3 resoluci\u00f3n parcial de las lesiones. El paciente fue dado de alta del hospital 16 d\u00edas despu\u00e9s del ingreso, en buen estado de salud y sin s\u00edntomas; la exploraci\u00f3n tor\u00e1cica era normal, la radiograf\u00eda tor\u00e1cica no dio resultados radiol\u00f3gicos relevantes y tres pruebas consecutivas mediante RT-PCR, espaciadas un m\u00ednimo de 24 horas, fueron negativas."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An 18-year-old man with a past medical history of bipolar disorder, autistic spectrum disorder, attention deficit hyperactivity disorder, hypothyroidism, and mild persistent asthma was brought to the emergency department by her mother due to alteration of consciousness. His mother also reported that he had a fever, nasal congestion, and cough for seven days. His current medication included lithium 450 mg twice daily, clozapine 100 mg daily, and levothyroxine. On examination, he was somnolent but arousable. He was not in acute distress and could answer simple questions and oriented. His vital signs were as follows: RR\u00a018 breaths/min, T\u00a0101.3\u00b0F, HR\u00a0120 bpm, BP\u00a0120/60 mmHg, and SpO2\u00a098% on room air. His lung exam was normal. Laboratory tests showed WBC\u00a011.79 x 103/mm3 with lymphocytes 17%, elevated Cr 1.81 mg/dl\u00a0(baseline 1 mg/dl), and lithium level 2.60 mmol/L. ECG\u00a0showed sinus tachycardia with an HR of 107 bpm. CXR\u00a0was normal. A nasopharyngeal swab for the SARS-CoV-2 polymerase chain reaction test\u00a0returned positive. He was admitted to the pediatric intensive care unit due to COVID-19 infection, AKI, and lithium toxicity. Aggressive intravenous normal saline was administered for the treatment of lithium intoxication and AKI. He did not receive hemodialysis. His mental status was improved. He received symptomatic treatment for the COVID-19 infection. His conditions were resolving, and he was discharged home without any complications on hospital day 11. He did not develop\u00a0hypoxemia throughout the hospital course. Lithium was discontinued with a plan to resume on the follow-up visit.",
        "es": "Un hombre de 18 a\u00f1os con antecedentes de trastorno bipolar, trastorno del espectro autista, trastorno por d\u00e9ficit de atenci\u00f3n con hiperactividad, hipotiroidismo y asma leve persistente fue llevado por su madre al servicio de urgencias a causa de la alteraci\u00f3n de la conciencia. Su madre tambi\u00e9n refiri\u00f3 que ten\u00eda fiebre, congesti\u00f3n nasal y tos de siete d\u00edas de evoluci\u00f3n. Su medicaci\u00f3n actual era de 450 mg de litio dos veces al d\u00eda, 100 mg de clozapina al d\u00eda y levotiroxina. A la exploraci\u00f3n, estaba somnoliento pero despertable. No ten\u00eda ning\u00fan malestar agudo, pod\u00eda responder preguntas sencillas y se mostraba orientado. Sus constantes vitales eran: frecuencia respiratoria 18 r.p.m., temperatura 38,5 \u00baC, pulso 120 l.p.m., presi\u00f3n 120/60 y SpO2 98% en aire ambiental. La exploraci\u00f3n pulmonar era normal. Las pruebas anal\u00edticas dieron una cifra de leucocitos de 11,79 x 103/mm3 con 17% de linfocitos, creatinina alta 1,81 mg/dl (referencia 1 mg/dl) y concentraci\u00f3n de litio 2,60 mmol/L. El ECG mostr\u00f3 taquicardia sinusal con un pulso de 107 l.p.m. Una radiograf\u00eda tor\u00e1cica fue normal. Un frotis nasofar\u00edngeo para SARS-CoV-2 analizado mediante RT-PCR dio resultado positivo. Fue ingresado en la UCI pedi\u00e1trica a causa de la infecci\u00f3n por COVID-19, lesi\u00f3n renal aguda e intoxicaci\u00f3n por litio. Se administr\u00f3 una dosis agresiva de soluci\u00f3n salina i.v. para tratar la intoxicaci\u00f3n por litio y la lesi\u00f3n renal aguda. No se someti\u00f3 a hemodi\u00e1lisis. Su estado mental mejor\u00f3. Recibi\u00f3 un tratamiento sintom\u00e1tico para la infecci\u00f3n por COVID-19. Su estado fue mejorando y fue dado de alta sin m\u00e1s complicaciones el d\u00eda 11 de hospitalizaci\u00f3n. Durante la evoluci\u00f3n hospitalaria no present\u00f3 nunca hipoxemia. Se interrumpi\u00f3 el tratamiento con litio, con intenci\u00f3n de reintroducirlo en una visita de seguimiento."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "An obese (BMI 33\u00a0kg/m2), 44-year-old white nulliparous woman with a singleton pregnancy presented at the hospital's emergency room at 32\u00a0weeks of gestation with myalgia and dry cough that had started 15\u00a0days earlier (covid day 1), fever in the last 7\u00a0days (covid day 7), and dyspnea in the last 24\u00a0h (covid day 14). She had a history of breast cancer treated four years earlier with surgery, chemotherapy, and radiotherapy. During chemotherapy, she had had right upper arm thrombosis treated with full-dose enoxaparin for three months and prophylactic enoxaparin for another three months. Her temperature was 37.5\u00a0\u00b0C, heart rate (HR) 109/min, blood pressure (BP) 109\u00a0\u00d7\u00a065\u00a0mmHg, respiratory rate (RR) 18/min and O2 saturation (SpO2) 93% on room air (pulse oximetry). Nasopharyngeal swab for SARS-CoV-2 (RT-PCR) was positive. She was admitted to the intensive care unit (ICU) and received oxygen 2\u00a0L/min through a nasal cannula, with initial improvement in oxygen saturation. She received azithromycin, ceftriaxone, oseltamivir and hydroxychloroquine. Chest X-ray showed faint bilateral patchy opacities; chest CT had bilateral ground-glass opacities involving >50% of the lungs. Fetal cardiotocography and Doppler ultrasound were normal. Over the next 12\u00a0h, the respiratory pattern worsened, RR increased to 44/min, PaO2/FIO2 decreased from 246 to 177, and oxygen supplementation was increased to 6\u00a0L/min. She was intubated in the ICU under rapid sequence, put on lung protective ventilation, received noradrenaline and continuous sedation with midazolam and fentanyl. Six hours after intubation, norepinephrine was increased to maintain mean arterial pressure at 65\u00a0mmHg, but PaO2/FiO2 worsened and the patient was transferred to the operating room for an emergency CS due to cardiovascular instability. The surgery was uneventful with normal blood loss (575\u00a0mL). The 1900\u00a0g male newborn (1-min and 5-min Apgar scores 1 and 2, respectively) was intubated and transferred to the NICU; he died 9\u00a0h later. Umbilical artery blood pH was 6.8, pCO2 114, pO2 82 and lactate 116. Neonatal nasopharyngeal swab was negative for SARS-CoV-2. Placental histology indicated chronic intervillous hypoxemia without chorioamnionitis. In the immediate postoperative period (hospital day 4/covid day 18), PaO2/FiO2 improved (338) and the patient remained clinically stable over the next two days, despite worsening lung X-ray. On hospital day 7/covid day 21 her clinical condition deteriorated again, PaO2/FiO2 declined (243) and leukocytes, platelets, troponin, D-dimer and ferritin increased. The multiprofessional team suspected she was developing pulmonary microthrombi and increased antithrombotic prophylaxis (enoxaparin 60\u00a0mg/day) to full anticoagulation dose (120\u00a0mg/day). On hospital day 12/covid day 26), laboratory exams and radiological pattern improved, she was extubated and PaO2/FiO2 remained stable until discharge (hospital day 15/covid day 29) on full anticoagulation.",
        "es": "Una mujer blanca obesa (IMC 33kg/m2) de 44 a\u00f1os nul\u00edpara, con embarazo \u00fanico, acudi\u00f3 a urgencias del hospital a las 32 semanas de gestaci\u00f3n con mialgia y tos seca que hab\u00edan empezado 15 d\u00edas antes (d\u00eda 1 de covid), fiebre en los \u00faltimos 7 d\u00edas (d\u00eda de covid 7) y disnea en las \u00faltimas 24 h (d\u00eda de covid 14). Ten\u00eda antecedentes de c\u00e1ncer de mama tratado cuatro a\u00f1os antes con cirug\u00eda, quimioterapia y radioterapia. Durante la quimioterapia, hab\u00eda sufrido una trombosis en el brazo derecho, tratada con dosis completa de enoxaparina durante tres meses y enoxaparina profil\u00e1ctica durante tres meses m\u00e1s. Su temperatura era 37,5\u00b0C, pulso 109/min, presi\u00f3n arterial 109\u00d765mmHg, frecuencia respiratoria 18/min y saturaci\u00f3n de ox\u00edgeno (SpO2) 93% en aire ambiental (pulsioximetr\u00eda). El frotis nasofar\u00edngeo que se envi\u00f3 para una prueba de SARS-CoV-2 mediante RT-PCR dio resultado positivo. La paciente fue ingresada en la UCI y recibi\u00f3 ox\u00edgeno a 2 L/min por c\u00e1nula nasal, con una mejora inicial de la saturaci\u00f3n de ox\u00edgeno. Recibi\u00f3 azitromicina, ceftriaxona, oseltamivir e hidroxicloroquina. Una radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades parcheadas bilaterales d\u00e9biles; la TAC tor\u00e1cica, opacidades de vidrio esmerilado bilaterales con afectaci\u00f3n en m\u00e1s del 50% de los pulmones. Una cardiotocograf\u00eda fetal y una ecograf\u00eda Doppler fueron normales. Durante las siguientes 12 h, el estado respiratorio empeor\u00f3, la frecuencia respiratoria aument\u00f3 a 44/min, el PaO2/FIO2 disminuy\u00f3 de 246 a 177 y se aument\u00f3 el aporte de ox\u00edgeno a 6 L/min. La paciente fue intubada en la UCI en secuencia r\u00e1pida, se aplic\u00f3 ventilaci\u00f3n protectora y recibi\u00f3 noradrenalina y sedaci\u00f3n continua con midazolam y fentanilo. Seis horas despu\u00e9s de la intubaci\u00f3n, se aument\u00f3 la norepinefrina para mantener la presi\u00f3n arterial media a 65 mmHg, pero el PaO2/FiO2 empeor\u00f3 y se traslad\u00f3 la paciente a quir\u00f3fano para ces\u00e1rea de urgencia a causa de inestabilidad cardiovascular. La intervenci\u00f3n fue anodina, con hemorragia normal (575 mL). El reci\u00e9n nacido pesaba 1900 g (Apgar a 1 minuto y 5 minutos de 1 y 2, respectivamente) y fue intubado y trasladado a la UCI neonatal; muri\u00f3 9 horas despu\u00e9s. El pH de la sangre umbilical era 6,8, pCO2 114, pO2 82 y lactato 116. La PCR de frotis nasofar\u00edngeo neonatal fue negativa para SARS-CoV-2. El an\u00e1lisis histol\u00f3gico placentario indic\u00f3 hipoxemia intervellosa cr\u00f3nica sin corioamnionitis. En el posoperatorio inmediato (d\u00eda de hospitalizaci\u00f3n 4/d\u00eda de covid 18), la PaO2/FiO2 mejor\u00f3 (338) y la paciente permaneci\u00f3 cl\u00ednicamente estable durante los dos d\u00edas siguientes, a pesar de un empeoramiento de las im\u00e1genes radiol\u00f3gicas pulmonares. El d\u00eda 7 de hospitalizaci\u00f3n/d\u00eda de covid 21), su estado cl\u00ednico volvi\u00f3 a empeorar, la PaO2/FiO2 disminuy\u00f3 (243) y los valores de leucocitos, trombocitos, troponina, d\u00edmero D y ferritina aumentaron. El equipo interdisciplinario sospech\u00f3 que estaba desarrollando microtrombos pulmonares y aument\u00f3 el tratamiento antitromb\u00f3tico (enoxaparina 60 mg/d\u00eda) a una dosis completa anticoagulante (120 mg/d\u00eda). El d\u00eda 12 de hospitalizaci\u00f3n/d\u00eda de covid 26, las pruebas anal\u00edticas y las im\u00e1genes radiol\u00f3gicas mejoraron; la paciente fue extubada y la PaO2/FiO2 permaneci\u00f3 estable hasta el alta (d\u00eda 15 de hospitalizaci\u00f3n/d\u00eda de covid 29) con dosis completa de anticoagulantes."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 29-year-old white obese (BMI 30.6\u00a0kg/m2) woman (G2P1) with a singleton pregnancy presented at the emergency department at 28\u00a0weeks of gestation complaining of fever and dyspnea with a positive COVID-19 RT-PCR test 7\u00a0days earlier. Dyspnea had started in the last 12\u00a0h (hospital day 1/covid day 7). Her medical and obstetric history were unremarkable. She had taken methyldopa 1\u00a0g/day from 13\u00a0weeks of gestation due to hypertension. She was afebrile, HR was 96/min, BP 146\u00a0\u00d7\u00a089\u00a0mmHg, SpO2 96% on room air, RR 24/min; chest X-ray showed patchy opacities predominantly in the left lung. Chest CT scan showed bilateral, mostly peripheral, ground-glass opacities with multiple areas of parenchymal consolidation involving approximately 25% of each lung. Cardiotocography and fetal Doppler were normal. She was admitted to the semi-intensive care unit and given azithromycin, hydroxychloroquine and betamethasone (12\u00a0mg/day for 2\u00a0days for fetal lung maturation). She received oxygen 2\u00a0L/min through a nasal cannula with improvement of oxygen saturation. Within 48\u00a0h, the respiratory pattern improved, PaO2/FiO2 increased (from 461 to 580) with 3\u00a0L of oxygen supplementation; laboratory exams were stable. On hospital day 3 (covid day 9) clinical condition deteriorated, RR increased (35/min) and PaO2/FIO2 decreased (181). The multiprofessional team decided to intubate the patient and perform an emergency CS. In the operating room she was intubated under rapid sequence and was immediately put on lung protective ventilation. The CS was uneventful, with normal blood loss (320\u00a0mL). The 1390\u00a0g male infant (1-min and 5-min Apgar scores 7 and 9, respectively) was transferred to the NICU; nasopharyngeal swab was negative for SARS-CoV-2 on days 1, 7 and 14. In the immediate postoperative period, PaO2/FiO2 improved and the patient remained clinically stable. On the third postoperative day (hospital day 6/covid day 12) D-dimer increased and chest X-ray images worsened. The multiprofessional team suspected that she was developing pulmonary microthrombi and increased prophylactic enoxaparin to a full anticoagulation dose (120\u00a0mg/day). She was extubated on hospital day 7/covid day 13 and discharged from the ICU on hospital day 9/covid day 15. On hospital day 11/covid day 17, her clinical condition remained stable, laboratory and radiological exams improved, and she was discharged home with enoxaparin anticoagulation. The neonate remained in hospital (67th day of life, 3545\u00a0g) and required O2 during breastfeeding.",
        "es": "Una mujer blanca obesa (IMC 30,6kg/m2) de 29 a\u00f1os, secundigesta prim\u00edpara, con embarazo \u00fanico, acudi\u00f3 a urgencias a las 28 semanas de gestaci\u00f3n, aquejada de fiebre y disnea con un resultado positivo de COVID-19 mediante RT-PCR en una prueba realizada 7 d\u00edas antes. La disnea hab\u00eda empezado en las \u00faltimas 12 h (d\u00eda 1 de hospitalizaci\u00f3n/d\u00eda 7 de covid). Sus antecedentes m\u00e9dicos y obst\u00e9tricos eran irrelevantes. Hab\u00eda tomado metildopa (1 g/d\u00eda) a partir de las 13 semanas de gestaci\u00f3n a causa de hipertensi\u00f3n. Estaba afebril, el pulso era 96/min, la presi\u00f3n arterial 146\u00d789mmHg, SpO2 96% en aire ambiental, la frecuencia respiratoria 24/min; la radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades parcheadas predominantemente en el pulm\u00f3n izquierdo. La TAC tor\u00e1cica mostr\u00f3 opacidades de vidrio esmerilado bilaterales, b\u00e1sicamente perif\u00e9ricas, con m\u00faltiples \u00e1reas de consolidaci\u00f3n parenquimatosa que afectaba aproximadamente el 25% de cada pulm\u00f3n. La cardiotocograf\u00eda y la ecografia Doppler fetales fueron normales. Fue ingresada en la unidad de cuidados semiintensivos y se le administr\u00f3 azitromicina, hidroxicloroquina y betametasona (12 mg/d\u00eda durante 2 d\u00edas para maduraci\u00f3n pulmonar fetal). Recibi\u00f3 ox\u00edgeno a 2 L/min con c\u00e1nula nasal, con mejora de la saturaci\u00f3n de ox\u00edgeno. A las 48 horas, el estado respiratorio mejor\u00f3, el PaO2/FiO2 aument\u00f3 (de 461 a 580) con 3L de aporte de ox\u00edgeno; las pruebas anal\u00edticas se manten\u00edan estables. El d\u00eda 3 de hospitalizaci\u00f3n (d\u00eda 9 de covid), el estado cl\u00ednico empeor\u00f3, la frecuencia respiratoria aument\u00f3 (35/min) y el PaO2/FiO2 disminuy\u00f3 (181). El equipo interdisciplinario decidi\u00f3 intubar a la paciente y realizar una ces\u00e1rea de urgencia. En el quir\u00f3fano fue intubada en secuencia r\u00e1pida y se le aplic\u00f3 de inmediato ventilaci\u00f3n protectora. La intervenci\u00f3n fue anodina, con hemorragia normal (320 mL). El reci\u00e9n nacido pesaba 1390 g (Apgar a 1 minuto y 5 minutos de 7 y 9, respectivamente) y fue trasladado a la UCI neonatal; un frotis nasofar\u00edngeo fue negativo para SARS-CoV-2 en los d\u00edas 1, 7 y 14. En el posoperatorio inmediato, el PaO2/FiO2 aument\u00f3 y la paciente permaneci\u00f3 cl\u00ednicamente estable. El tercer d\u00eda posoperatorio (d\u00eda 6 de hospitalizaci\u00f3n/d\u00eda 12 de covid), el d\u00edmero D aument\u00f3 y las im\u00e1genes radiol\u00f3gicas tor\u00e1cicas empeoraron. El equipo interdisciplinario sospech\u00f3 que estaba desarrollando microtrombos pulmonares y aument\u00f3 el tratamiento con enoxaparina a una dosis completa anticoagulante (120 mg/d\u00eda). La paciente fue extubada el d\u00eda 7 de hospitalizaci\u00f3n/d\u00eda 13 de covid y fue dada de alta de la UCI el d\u00eda 9 de hospitalizaci\u00f3n/d\u00eda 15 de covid. El d\u00eda 11 de hospitalizaci\u00f3n/d\u00eda 17 de covid, su estado cl\u00ednico permaneci\u00f3 estable, los resultados anal\u00edticos y radiol\u00f3gicos mejoraron y fue dada de alta con anticoagulantes. El reci\u00e9n nacido permaneci\u00f3 en el hospital (d\u00eda 67 de vida, 3545 g) y requiri\u00f3 O2 durante la lactancia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 76-year-old woman with a medical history of hypertension and diabetes presented with 3 days of nausea, nonbilious, nonbloody vomiting, and watery diarrhea. She subsequently developed fever, dry cough, shortness of breath, fatigue, and malaise. Her physical examination was notable for diffuse wheezing and bilateral crackles in the lower lung bases. Over the course of the first day of hospitalization, she became hypoxic, with oxygen saturations ranging between 80% and 90% despite 100% FIO2 via a high-flow nasal cannula. She then became hemodynamically unstable with a blood pressure of 87/62 mm Hg, tachycardia to 104 bpm, tachypneic with a respiratory rate of 44, and a maximum temperature of 103.1\u00b0F. Laboratory findings at that time revealed a white blood cell count of 7.7\u2009\u00d7\u2009103/\u03bcL, hemoglobin of 11.7 g/dL, creatinine of 0.8 mg/dL, aspartate aminotransferase of 84 U/L, alanine aminotransferase of 38 U/L, albumin of 3.3 g/dL, lactate dehydrogenase of 398 U/L, D-dimer 1,091 ng/mL, and ferritin 1,332 ng/mL. Blood and urine cultures were negative. The patient tested positive for COVID-19 by nucleic acid amplification. Thoracic x-ray revealed multifocal bilateral airspace opacities with right lower lung atelectasis. Given the clinical situation of acute hypoxic respiratory failure in the setting of positive SARS-CoV-2 testing, she was intubated, mechanical ventilated, and transferred to the intensive care unit (ICU). She required vasopressor support with norepinephrine for hypotension and shock. She was treated with 5 days of hydroxychloroquine and azithromycin and 1 dose of tocilizumab while in the ICU. Her clinical symptoms improved with low tidal volume ventilation, and she was transferred to the medical ward in stable condition after 8 days in the ICU.",
        "es": "Una mujer de 76 a\u00f1os con antecedentes de hipertensi\u00f3n y diabetes, acudi\u00f3 a urgencias con n\u00e1useas, v\u00f3mito no hemorr\u00e1gico no bilioso y diarrea de 3 d\u00edas de evoluci\u00f3n. Posteriormente present\u00f3 fiebre, tos seca, disnea, fatiga y malestar. La exploraci\u00f3n f\u00edsica fue relevante por sibilancias difusas y crepitantes bilaterales en las bases pulmonares. Durante el primer d\u00eda de hospitalizaci\u00f3n, estuvo hipox\u00e9mica, con una saturaci\u00f3n de ox\u00edgeno entre 80% y 90% a pesar de FIO2 de 100% con c\u00e1nula nasal de alto flujo. Luego se inestabiliz\u00f3 hemodin\u00e1micamente, con una presi\u00f3n de 87/62 mmHg, taquicardia de 104 l.p.m., taquipnea con una frecuencia respiratoria de 44 y una temperatura m\u00e1xima de 39,5 \u00b0C. Las pruebas anal\u00edticas en ese momento revelaron una cifra de leucocitos de 7,7\u2009\u00d7\u2009103/\u03bcL, hemoglobinemia de 11,7 g/dL, creatinina de 0,8 mg/dL, aspartato-aminotransferasa de 84 U/L, alanina-aminotransferasa de 38 U/L, alb\u00famina de 3,3 g/dL, lactato-deshidrogenasa de 398 U/L, d\u00edmero D de 1.091 ng/mL y ferritina de 1.332 ng/mL. Los hemocultivos y urocultivos fueron negativos. La paciente dio positivo en una prueba de COVID-19 mediante amplificaci\u00f3n de \u00e1cido nucleico. Una radiograf\u00eda tor\u00e1cica revel\u00f3 opacidades alveolares bilaterales multifocales con atelectasia en la zona inferior del pulm\u00f3n derecho. Dado el estado cl\u00ednico de insuficiencia respiratoria hipox\u00e9mica aguda en el contexto de resultado positivo para SARS-CoV-2, la paciente fue intubada, se le aplic\u00f3 ventilaci\u00f3n mec\u00e1nica y se traslad\u00f3 a la UCI. Requiri\u00f3 apoyo vasopresor con norepinefrina para hipotensi\u00f3n y choque. Fue tratada con hidroxicloroquina y azitromicina durante 5 d\u00edas y una dosis de tocilizumab durante su estancia en la UCI. Sus s\u00edntomas cl\u00ednicos mejoraron con ventilaci\u00f3n de bajo volumen corriente y se la traslad\u00f3 a la planta de hospitalizaci\u00f3n general en situaci\u00f3n estable tras 8 d\u00edas en la UCI."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "84-year-old woman with medical history of high blood pressure, betalactam allergy, heart failure, atrial fibrillation treated by rivaroxaban, diabetes mellitus treated with insulin, chronic renal failure and chronic respiratory failure under long-term oxygen (1 liter / 15 hours a day). The patient exhibited specific symptomatology of COVID-19 with cough, fever, and respiratory signs with oxygen desaturation at 79%. The COVID-19 diagnosis was made  on  the  typical  CT  scan  appearance  on  March  24,  2020,  with  bilateral  ground  glass lesions predominating on the right lung, confirmed by a positive SARS-CoV-2 RT-PCR performed on nasopharyngeal sample on March 26 (cycle threshold [Ct] of 31.4). She was hospitalized in an acute care unit dedicated to COVID-19 on the same day. The patient received  levofloxacin  for  seven  days  and  a  short  course  of  corticosteroids  by Methylprednisolone,  which  resulted  in  clinical  and  biological  improvements  allowing  the patient to be referred to a COVID-19 rehabilitation care unit on April 7. During her stay in this unit, C-Reactive protein and lymphocytes rate were normalized. On May 4, more than one  month  after  the  first  episode,  the  patient  presented  with  hyperthermia  and  respiratory signs. She was re-admitted into an acute care unit dedicated to COVID-19, and SARS-CoV-2 RT-PCR tests performed on May 8, in nasopharyngeal swab and sputum were positive (Ct of 17.5  and  18.1,  respectively). Viral  cultures  of  sputum  and  nasopharyngeal  secretions performed on Vero cells showed cytopathic effect in plaque assay. Virological sequencing has been  carried  out  and  belongs  to  the  B1  (European)  lineage  according  to  the  Pangolin classification. Chest CT scan was compatible with COVID-19 acute infection and revealed bilateral moderate lung lesions (10 to 25%), which were greater than previously. The biological inflammatory syndrome was very marked with CRP at 304.5 mg/L and a deep lymphopenia  at  0.47  Giga/L  and  IL6=  235  ng/L. Neutralizing  antibodies  to  SARS-CoV-2 were negative on May 8 and faintly positive (rate of 1:10) on May 15. The patient was treated symptomatically with oxygen therapy and non-invasive ventilation due to respiratory acidosisfrom May 12. She received levofloxacin from May 5 and aztreonam from May 8, although no superinfection  was  documented. Methylprednisolone  60  mg/day  was  added  on  May  10. Immunotherapy by tocilizumab (8mg/kg) was administered on May 12. The patient finally died on May 17 due to respiratory and heart failure despite high-dose furosemide.",
        "es": "Mujer de 84 a\u00f1os con antecedentes de hipertensi\u00f3n, alergia a betalact\u00e1micos, insuficiencia cardiaca, fibrilaci\u00f3n auricular tratada con rivaroxaban, diabetes mellitus tratada con insulina, insuficiencia renal cr\u00f3nica e insuficiencia respiratoria cr\u00f3nica con oxigenoterapia de larga duraci\u00f3n (1 litro/ 15 horas al d\u00eda). La paciente mostraba s\u00edntomas espec\u00edficos de COVID-19 con tos, fiebre y signos respiratorios con una saturaci\u00f3n de ox\u00edgeno de 79%. El diagn\u00f3stico de COVID-19 se bas\u00f3 en el aspecto t\u00edpico de la TAC el 24 de marzo de 2020, con opacidades en vidrio esmerilado bilaterales predominantes en el pulm\u00f3n derecho, y confirmado con una RT-PCR positivapara SARS-CoV-2 a partir de una muestra nasofar\u00edngea el 26 de marzo (umbral de ciclo [Ct] de 31,4). Fue hospitalizada ese mismo d\u00eda en una UCI destinada a COVID-19. La paciente recibi\u00f3 levofloxacina durante 7 d\u00edas y una pauta corta de corticoesteroides (metilprednisolona), que llev\u00f3 a una mejora cl\u00ednica y biol\u00f3gica y permiti\u00f3 trasladarla a una unidad de rehabilitaci\u00f3n de COVID-19 el 7 de abril. Durante su estancia en esta unidad, la prote\u00edna C-reactiva y los linfocitos se normalizaron. El 4 de mayo, m\u00e1s de un mes despu\u00e9s del primer episodio, la paciente present\u00f3 hipertermia y signos respiratorios. Fue reingresada en una UCI destinada a COVID-19 y SARS-CoV-2. Las pruebas mediante RT-PCR realizadas el 8 de mayo a partir de frotis nasofar\u00edngeo y esputo fueron positivas (Ct de 17,5 y 18,1, respectivamente). Los cultivos v\u00edricos de esputo y secreciones nasofar\u00edngeas realizados en c\u00e9lulas vero mostraron efecto citop\u00e1tico en an\u00e1lisis de lisis. Se ha realizado la secuenciaci\u00f3n virol\u00f3gica y pertenece al linaje B1 (europeo) seg\u00fan la clasificaci\u00f3n de pangolines. La TAC tor\u00e1cica era compatible con infecci\u00f3n aguda por COVID-19 y revel\u00f3 lesiones pulmonares moderadas bilaterales (10 a 25%), m\u00e1s extendidas que antes. El s\u00edndrome de inflamaci\u00f3n biol\u00f3gico era muy acusado, con prote\u00edna C-reactiva a 304,5 mg/L y una fuerte linfocitopenia a 0,47 Giga/L e IL6 = 235 ng/L. Los anticuerpos neutralizantes de SARS-CoV-2 eran negativos el 8 de mayo y ligeramente positivos (cociente 1:10) el 15 de mayo. La paciente fue tratada sintom\u00e1ticamente con oxigenoterapia y ventilaci\u00f3n no invasiva a causa de acidosis respiratoria a partir del 12 de mayo. Se le administr\u00f3 levofloxacina a partir del 5 de mayo y aztreonam a partir del 8, aunque no se report\u00f3 sobreinfecci\u00f3n. El 10 de mayo se a\u00f1adi\u00f3 metilprednisolona a 60 mg/d\u00eda. El 12 de mayo se administr\u00f3 inmunoterapia con tocilizumab (8 mg/kg). La paciente muri\u00f3 el 17 de mayo a causa de insuficiencia respiratoria y card\u00edaca, a pesar de dosis altas de furosemida."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "90-year-old  dependent  woman  living  in  a  nursing  home  and  exhibiting diabetes  mellitus,  hypertension,  hypothyroidism,  and  major  neurodegenerative  pathology (Alzheimer's disease). Diagnosis of COVID-19 was suspected in early April 2020 based on a clinical picture of cardiorespiratory decompensation with atrial fibrillation with fever and was confirmed on April 5 with SARS-CoV-2 RT-PCR positive test on a nasopharyngeal specimen (Ct of 21). She was hospitalized in a COVID-19 acute care unit. The chest CT scan revealed signs  of  pleural  effusions  bilaterally,  with  no  sign  typical  of  pulmonary  SARS-CoV-2 infection. The patient received various treatments with preventive anticoagulation (the risk-benefit ratio was not in favor of curative anticoagulation), diuretics, and antibiotics by ofloxacine and 5 days of prednisolone 40 mg/day. Clinical improvement was noted, and the patient was transferred to a COVID-19 rehabilitation care unit on April 21, before she was able to return to her nursing home on May 7. The patient kept an inflammatory syndrome witha CRP stable at 55 in the context of chronic pressures sores. Her second hospitalization, in a COVID-19 acute care unit on May 11, was motivated by the onset of major dehydration with hypernatremia  measured  at  166  mmol/L,  oxygen  saturation  at  93%  under  four  liters  of oxygen, melena and marked deterioration of her general condition. Biology reported a marked lymphopenia  at  0.18  Giga/L  and  CRP  at  181  mg/L. The  SARS-CoV-2  RT-PCR  test  was positive on a nasopharyngeal swab (Ct at 18.8) on May 6. On May 14, following respiratory degradation,  a  chest  CT  scan  showed  pulmonary  condensation  and  bilateral  diffuse  crazy paving affecting approximately 25 to 50% of the lung parenchyma, with bilateral proximal lobar pulmonary embolism. No serological test was performed. Palliative care was decided after discussion with the family and multidisciplinary validation.",
        "es": "Mujer de 90 a\u00f1os dependiente que vive en una residencia y presenta diabetes mellitus,hipertensi\u00f3n, hipotiroidismo y neurodegeneraci\u00f3n grave (enfermedad de Alzheimer). A principios de abril de 2020 se tuvo la sospecha de COVID-19 a partir de un cuadro cl\u00ednico de descompensaci\u00f3n cardiorrespiratoria, fibrilaci\u00f3n auricular y fiebre, y se confirm\u00f3 el 5 de abril con una prueba positiva de SARS-CoV-2 mediante RT-PCR a partir de una muestra nasofar\u00edngea (Ct de 21). Se la hospitaliz\u00f3 en una UCI de COVID-19. Una TAC tor\u00e1cica revel\u00f3 signos de derrame pleural bilateral, sin signos t\u00edpicos de infecci\u00f3n pulmonar por SARS-CoV-2. La paciente recibi\u00f3 varias dosis de anticoagulantes preventivos (el cociente de riesgos no favorec\u00eda un tratamiento anticoagulante terap\u00e9utico), diur\u00e9ticos y antibi\u00f3ticos (ofloxacina), as\u00ed como 5 d\u00edas de prednisolona a 40 mg/d\u00eda. Se apreci\u00f3 una mejora cl\u00ednica y la paciente fue trasladada a una unidad de rehabilitaci\u00f3n de COVID-19 el 21 de abril, antes de poder regresar a su residencia el 7 de mayo. La paciente continu\u00f3 presentando s\u00edndrome inflamatorio con prote\u00edna C-reactiva estable a 55 en condiciones de \u00falceras por presi\u00f3n cr\u00f3nicas. Su segunda hospitalizaci\u00f3n, en una UCI de agudos de COVID-19 el 11 de mayo, fue causada por la aparici\u00f3n de una deshidrataci\u00f3n intensa con hipernatremia medida a 166 mmol/L, saturaci\u00f3n de ox\u00edgeno de 93% con cuatro litros de ox\u00edgeno, melena y un claro deterioro de su estado general. Los an\u00e1lisis revelaron una clara linfocitopenia 0,18 Giga/L y prote\u00edna C-reactiva a 181 ng/L. La prueba de SARS-CoV-2 mediante RT-PCR fue positiva a partir de un frotis nasofar\u00edngeo (Ct de 18,8) el 6 de mayo. El 14 de mayo, tras un empeoramiento del estado respiratorio, una TAC tor\u00e1cica revel\u00f3 condensaci\u00f3n pulmonar y patr\u00f3n en empedrado difuso bilateral que afectaba aproximadamente el 25 a 50% del par\u00e9nquima pulmonar, con embolia pulmonar lobular proximal bilateral. No se realiz\u00f3 ninguna prueba serol\u00f3gica. Tras discusi\u00f3n con la familia y validaci\u00f3n interdisciplinaria, se decidi\u00f3 aplicar cuidados paliativos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "84-year-old woman with medical history of rhythmic heart disease treated with a pacemaker, pulmonary embolism treated with rivaroxaban, arterial hypertension, and rheumatoid arthritis treated with methotrexate fifteen milligrams per week and corticosteroids (prednisone  13  mg/day). She  exhibited  symptomatology  of  COVID-19  combining  fever, asthenia,  ageusia,  and  respiratory  signs  with  dry  cough,  polypnea (breathing  rate  32/min), oxygen desaturation with 93% under 3 liters of oxygen. She was hospitalized in an acute care unit dedicated to COVID-19 on April 16, 2020, with a positive diagnosis of COVID-19 based on  a  typical  chest  CT  scan  showing  lung  lesions  such  as  crazy  paving  and  ground  glass opacity greater than 50% bilaterally. The SARS-CoV-2 RT-PCR test performed on nasophyngeal  sample  was  negative  twice. These  were  probably  false  negatives  due  to inadequate  sampling. Patient  has  a  typical  COVID19  symptomatology  and  no  other infectious cause found. Sputum could not be collected. The CRP was measured at 160mg/L and lymphocytes at 0.13 Giga/L. The patient received ceftriaxone for seven days, rovamycine for  five  days,  and  discontinuation  of  methotrexate  treatment  replaced  by  an  increase  incorticosteroids  (prednisone  60  mg/day)  and  oxygen  therapy  until  four  liters. There  was  a clinical-biological  improvement,  with  oxygen  withdrawal  and  normalization  of  the inflammatory syndrome that allowed the patient to be referred to a rehabilitation care unit dedicated  to  COVID-19  on  April  27  under  prednisone  30  mg/day. Sudden  respiratory deterioration occurred on May 6, with 80% desaturation requiring oxygen therapy, dry cough, and fever. Nasopharyngeal samples for SARS-Cov-2 RT-PCR test were found positive (Ct at 16.9 and 14.7 on May 8 and 11, respectively). Viral culture was performed on Vero cells and found positive. Virological sequencing has been carried out and belongs to the B1 (European) lineage  according  to  the  Pangolin  classification . CT-scan  revealed  a  severe  bilateral pneumonia. At readmission, biology reported marked lymphopenia at 0.23 Giga/L, CRP at 146 mg/L and IL6 at 201 ng/L. A rise of neutralizing antibodies against SARS-CoV-2 was observed from May 8 to May 15 (titers from <10 to 40). She received ceftriaxone and methylprednisolone  60  mg/day  from  May  8  and  high-flow  oxygen. Cotrimoxazole  was adjuncted on May 19 to rule out plausible pneumocystosis superinfection. After validation in a multidisciplinary meeting, the patient received convalescent COVID-19 plasma transfusion on May 16. However, the respiratory status deteriorated with major desaturation despite 20liters of oxygen and she finally died on May 23.",
        "es": "Mujer de 84 a\u00f1os con antecedentes de arritmias tratadas con marcapasos, embolia pulmonar tratada con rivaroxaban, hipertensi\u00f3n arterial y artritis reumatoide tratada con metotrexato (15 mg por semana) y corticoesteroides (prednisona, 13 mg/d\u00eda). Presentaba s\u00edntomas de COVID-19, con fiebre, astenia, ageusia y signos respiratorios con tos seca, polipnea (frecuencia respiratoria 32/min) y saturaci\u00f3n de ox\u00edgeno de 93% con 3 litros de ox\u00edgeno. Se la hospitaliz\u00f3 en una UCI de COVID-19 el 16 de abril de 2020, con diagn\u00f3stico de COVID-19 a partir de los resultados de una TAC tor\u00e1cica que mostraba lesiones como patr\u00f3n en empedrado y opacidades de vidrio esmerilado superiores al 50% y bilaterales. La prueba de SARS-CoV-2 mediante RT-PCR a partir de una muestra nasofar\u00edngea dio resultado negativo dos veces. Probablemente, se trataba de falsos negativos por una incorrecta toma de las muestras. La paciente ten\u00eda s\u00edntomas t\u00edpicos de la COVID-19 y no se hallaron otras causas de infecci\u00f3n. No se pudieron recoger muestras de esputo. La concentraci\u00f3n de prote\u00edna C-reactiva era de 160 mg/L y la cifra de linfocitos, 0,13 Giga/L. La paciente recibi\u00f3 ceftriaxona durante siete d\u00edas, rovamicina durante cinco d\u00edas y se interrumpi\u00f3 el tratamiento con metotrexato, sustituido por un aumento de corticoesteroides (prednisona, 60 mg/d\u00eda) y oxigenoterapia hasta cuatro litros. Se apreci\u00f3 una mejora cl\u00ednica y anal\u00edtica, lo que permiti\u00f3 retirar la oxigenoterapia, con normalizaci\u00f3n del s\u00edndrome inflamatorio que permiti\u00f3 trasladar a la paciente a una unidad de rehabilitaci\u00f3n destinada a COVID-19 el 27 de abril, con prednisona a 30 mg/d\u00eda. El 6 de mayo se produjo un s\u00fabito empeoramiento respiratorio, con saturaci\u00f3n de 80% que requiri\u00f3 oxigenoterapia, tos seca y fiebre. Las muestras nasofar\u00edngeas para prueba de SARS-CoV-2 mediante RT-PCR resultaron positivas (Ct de 16,9 y 14,7 los d\u00edas 8 y 11 de mayo, respectivamente) Se realizaron cultivos v\u00edricos en c\u00e9lulas vero y resultaron positivos. Se ha realizado la secuenciaci\u00f3n virol\u00f3gica y la cepa pertenece al linaje B1 (europeo) seg\u00fan la clasificaci\u00f3n de pangolines. Una TAC revel\u00f3 neumon\u00eda bilateral grave. Al reingreso, los an\u00e1lisis mostraron linfocitopenia clara a 0,23 Giga/L, prote\u00edna C-reactiva a 146 mg/L e IL-6 a 201 ng/L. Se observ\u00f3 un aumento de anticuerpos neutralizantes contra SARS-CoV-2 entre el 8 y el 15 de mayo (diluciones de < 10 a 40). La paciente recibi\u00f3 ceftriaxona y metilprednisolona 60 mg/d\u00eda a partir de 8 de mayo y ox\u00edgeno a alto flujo. Se a\u00f1adi\u00f3 cotrimoxazol el 19 de mayo para descartar posible sobreinfecci\u00f3n por neumocistos. Tras validaci\u00f3n en una reuni\u00f3n interdisciplinaria, la paciente recibi\u00f3 una transfusi\u00f3n de plasma de convaleciente de COVID-19 el 16 de mayo. Sin embargo, el estado respiratorio empeor\u00f3 con desaturaci\u00f3n masiva a pesar de aporte de 20 L de ox\u00edgeno; la paciente finalmente muri\u00f3 el 23 de mayo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 65-year-old Malay male presented to the Emergency Department with acute lethargy for the past one week, which he initially attributed to fasting during Ramadan. Over the past two days, he felt intermittently nauseous, and vomited small amounts of non-bloody, non-bilious gastric contents twice a day while fasting, but he did not have diarrhea or abdominal pain. He denied fever or respiratory symptoms. His family physician found leukopenia in his blood tests and referred him to the Emergency Department. Before his symptoms started, he was well and working full-time. His only medication was oral allopurinol 100mg once a day for gout prophylaxis. Otherwise, he had no significant past medical history or family history. He did not consume supplements, was teetotal and never smoked. On examination, he was afebrile and hemodynamically stable with no supplemental oxygen required, but his oral mucosa was dry. Cardiac, respiratory, abdominal and neurological examinations were normal, and the patient was clinically euthyroid. Blood investigations revealed severe hyponatremia (sodium concentration, 115mmol/L), a raised inflammatory marker (C-reactive protein, 29.5mg/L), and leukopenia (total leukocytes, 1.8x10 9/L). Serum creatinine, urea, potassium and bicarbonate concentrations were unremarkable, and the patient was not anemic or thrombocytopenic. The elevated C-reactive protein and leukopenia prompted a search for the source of an occult infection, and consequently a chest X-ray revealed patchy airspace opacities in the middle and lower lobes of the right lung indicative of community-acquired pneumonia. Due to the COVID-19 outbreak in Singapore, he was isolated in the Respiratory Infection Surveillance Ward and a nasopharyngeal swab was obtained for a SARS-CoV-2 reverse transcriptase-polymerase chain reaction (RT-PCR) test, which was positive. Conversely, PCR for atypical organisms such as Mycoplasma, Chlamydophilia and Bordetella, were negative. Since the patient had no cough, we could not send sputum for tests. Further investigations were performed to determine the cause of the severe hyponatremia. A thyroid function test revealed a low thyroid stimulating hormone level of 0.221mIU/L, a normal free T4 level of 12.86pmol/L, and an undetectable free T3 level (<2.0mcg/dL). A short tetracosactrin (Synacthen) test conducted at 8am showed an adequate adrenal response (299nmol/L at 0mins; 630nmol/L, 30mins; 834nmol/L, 60mins). Blood and urine tests were not suggestive of Syndrome of Inappropriate Anti-Diuretic Hormone (SIADH; serum osmolarity, 256mOsm/kg; urine osmolarity, 83mOsm/kg; urine sodium, <20mmol/mL). The patient was reviewed by an endocrinologist, who diagnosed severe hypovolemic hyponatremia and euthyroid sick syndrome. Having been diagnosed with mild COVID-19 pneumonia, the patient was transferred to the COVID-19 Isolation Ward. The patient was empirically treated with oral amoxicillin 875mg with clavulanate 125mg (Augmentin) twice a day and oral doxycycline 100mg twice a day for seven days. For his severe hypovolemic hyponatremia, the patient was judiciously hydrated with a slow intravenous isotonic saline infusion, and serum sodium concentration increased from 115 to 127mmol/L over one day, and then to 132mmol/L over four days. Subsequently, his lethargy, nausea and vomiting resolved. Since the patient remained afebrile and hemodynamically stable, with no supplemental oxygen required, he was not treated with antivirals. On the eighth day of his admission, the patient was discharged to a quarantine facility within the community.",
        "es": "Un hombre malayo de 65 a\u00f1os acudi\u00f3 al servicio de urgencias con letargia aguda durante la \u00faltima semana, que inicialmente atribuy\u00f3 al ayuno del Ramad\u00e1n. Durante los \u00faltimos dos d\u00edas, tuvo n\u00e1useas y vomit\u00f3 peque\u00f1as cantidades de contenido g\u00e1strico no bilioso y no hemorr\u00e1gico dos veces al d\u00eda durante el ayuno, pero no refiri\u00f3 diarrea ni dolor abdominal. Afirm\u00f3 no tener fiebre ni s\u00edntomas respiratorios. Su m\u00e9dico de familia hall\u00f3 leucocitopenia en sus an\u00e1lisis de sangre y lo deriv\u00f3 a urgencias. Antes del inicio de los s\u00edntomas, se hallaba bien de salud y trabajabaa tiempo completo. Su \u00fanica medicaci\u00f3n era alopurinol 100 mg al d\u00eda por v\u00eda oral como prevenci\u00f3n de la gota. Por lo dem\u00e1s, no ten\u00eda antecedentes m\u00e9dicos ni familiares de relevancia. No consum\u00eda suplementos, era abstemio y nunca hab\u00eda fumado. A la exploraci\u00f3n, estaba afebril y hemodin\u00e1micamente estable, sin necesidad de ox\u00edgeno, pero su mucosa bucal estaba seca. La exploraci\u00f3n neurol\u00f3gica, respiratoria y abdominal fueron normales y el paciente estaba cl\u00ednicamente eutiroideo. Las pruebas anal\u00edticas revelaron hiponatremia grave (concentraci\u00f3n de sodio 115 mmol/L), aumento de marcadores de inflamaci\u00f3n (prote\u00edna C-reactiva, 29,5 mg/L) y leucocitopenia (cifra total de leucocitos, 1,8x109/L). Las concentraciones de creatinina s\u00e9rica, urea, potasio y bicarbonato eran anodinas, y el paciente no se hallaba an\u00e9mico ni trombocitop\u00e9nico. El valor elevado de prote\u00edna C-reactiva y la leucocitopenia llevaron a buscar la fuente de alguna infecci\u00f3n y, en consecuencia, se hizo una radiograf\u00eda tor\u00e1cica que revel\u00f3 opacidades alveolares parcheadas en los l\u00f3bulos medio e inferior del pulm\u00f3n derecho, indicativas de neumon\u00eda extrahospitalaria. Debido al brote de COVID-19 en Singapur, fue aislado en la planta de neumolog\u00eda y se obtuvo un frotis nasofar\u00edngeo para una prueba de SARS-CoV-2 mediante reacci\u00f3n en cadena de la polimerasa con transcriptasa inversa (RT-PCR), que dio positivo. En cambio, la PCR para organismos at\u00edpicos, como Mycoplasma, Chlamydia y Bordetella, fue negativa. Como el paciente no ten\u00eda tos, no pudimos recoger esputo para las pruebas. Se realizaron pruebas complementarias para determinar la causa de la hiponatremia grave. Una prueba funcional tiroidea revel\u00f3 una baja concentraci\u00f3n de la hormona estimuladora de la tiroides, con 0,221 mUI/L, un valor de T4 libre normal, con 12,86 pmol/L y un valor de T3 libre Indetectable (< 2,0 mcg/dL). Una prueba r\u00e1pida de tetracosactrina (Synacthen) realizada a las 08:00 mostr\u00f3 una respuesta suprarrenal adecuada (299 nmol/L a 0 min; 630 nmol/L a 30 min; 834 nmol/L a 60 min). Los an\u00e1lisis de sangre y de orina no dieron indicaciones de secreci\u00f3n inadecuada de hormona antidiur\u00e9tica (SIHAD, osmolaridad s\u00e9rica 256 mOsm/kg; osmolaridad de orina 83 mOsm/kg; natriuria, < 20 mmol/mL). El paciente fue visitado por un endocrin\u00f3logo, que diagnostic\u00f3 hiponatremia hipovol\u00e9mica grave y s\u00edndrome del enfermo eutiroideo. Al hab\u00e9rsele diagnosticado neumon\u00eda leve por COVID-19, el paciente fue trasladado a la planta de aislamiento de COVID-19. El paciente recibi\u00f3 un tratamiento provisional de amoxicilina por v\u00eda oral (875 mg) con clavulanato (125 mg, Augmentine) dos veces al d\u00eda y doxiciclina (100 mg) dos veces al d\u00eda durante siete d\u00edas. Para tratar la hiponatremia hipovol\u00e9mica grave, el paciente recibi\u00f3 hidrataci\u00f3n con una infusi\u00f3n salina isot\u00f3nica i.v. y la concentraci\u00f3n de sodio s\u00e9rico aument\u00f3 de 115 a 127 mmol/L en un d\u00eda y, luego, hasta 132 mmol/L en cuatro d\u00edas. Como el paciente continu\u00f3 afebril y hemodin\u00e1micamente estable, sin necesidad de ox\u00edgeno, no fue tratado con antiv\u00edricos. Al octavo d\u00eda de su ingreso, el paciente fue dado de alta y se traslad\u00f3 a un centro de cuarentena."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "He presentedto the emergency department in a regional hospital with symptomsof high fever and abdominal pain, fatigue and a sore throat. Of note,he and several of his siblings shared a history of suspected exposureto a coronavirus disease 2019 patient 3 weeks prior to presentation. On examination, he had signs of acute pharyngitis, nonpurulentconjunctivitis, diffuse abdominal tenderness and an extensivemaculopapular rash (on the palms, knees and ankles) with nohemodynamic or respiratory compromise. He was admitted to thepediatric ward with suspected Scarlet fever and later developedheadache and nuchal rigidity. Computed tomography scan was normal,and a lumbar puncture was performed. Cerebrospinal fluid hadmild pleocytosis and normal glucose levels, and was negative forbacterial and viral pathogens. Of note, 2 nasopharyngeal swabs forSARS-CoV-2 were negative as was a wide infectious workup. On his third hospitalization day, he developed warm shock,was transferred to the local pediatric intensive care unit and requiredintubation and hemodynamic support with epinephrine and milrinone. Laboratory findings were notable for elevated Troponin-I(922 ng/L) and unproportionally high pro-BNP (>35,000 pg/mL laboratory limit). An echocardiogram showed mildly reduced systolicleft ventricular function with ejection fraction 50% and mildmitral regurgitation (MR). Coronary arteries were normal. As theclinical manifestation at this point was consistent with atypical KD,he was treated with IVIG and high-dose aspirin and transferred toour tertiary center pediatric intensive care unit. During his stay, he was intubated and mechanically ventilated,and required fluctuating doses of inotropic and vasopressorsupport. Echocardiogram showed normal systolic left ventricularfunction with moderate concentric MR and mild Aortic regurgitation. Laboratory workup showed high C-reactive Protein (24 mg/dL), mild normocytic anemia, borderline thrombocytopenia, mildcoagulation disturbance (INR 2.23) with normal fibrinogen valuesand high D-dimer (3573 ng/mL). Blood cultures and respiratoryviral panels were negative in sputum and blood with one SARSCoV-2 nasopharyngeal swab positive and associated serologicalconfirmation of past SARS-CoV-2 infection with positive IgG andIgA (tested on serum sampled prior to IVIG treatment). Rheumatologicalinvestigation revealed very low levels of complement factorsC3 and C4 (26 and <1.68 mg/dL, respectively) and negativeantinuclear antibodies. The next day, he developed clonus; urgent brain magneticresonance imaging and MRA demonstrated diffuse small low-signalfoci of hemosiderosis in the subcortical white matter of bothhemispheres and the corpus callosum. In addition to the hemodynamic involvement, he developed acute respiratory distresssyndrome and small bilateral pleural effusions. Under the workingdiagnosis of refractory atypical Kawasaki associated with SARSCov-2, he was treated with an additional IVIG dose and a 5-daycourse of pulse methylprednisolone. Considering the signs of CNSmicrohemorrhages, anticoagulation was not started. Over the next3 days, his cardiovascular and pulmonary dysfunctions resolved,and he was successfully extubated. Neurologically, he regained fullconsciousness and gross strength improved rapidly. As abdominalpain and vomiting persisted, an abdominal computed tomographyscan was performed showing signs of mild pancreatitis and moderateamount of ascites. Follow-up laboratory showed a gradualdecline in Troponin I, pro-BNP level and inflammation markers,and an increase in C3 and C4 levels to normal. On a follow-upexamination 2 weeks after discharge, his echocardiogram showedmild coronary enlargement of 3.5 mm, with a small coronary aneurysmin the right coronary artery. MR and AR resolved, and cardiacfunction was normal. His neurological examination was normalapart from general muscle weakness",
        "es": "Adolescente de 16 a\u00f1os, por lo dem\u00e1s sano, que acudi\u00f3 anuestro servicio de urgencias en un hospital regional, con s\u00edntomasde hipertermia y dolor abdominal, cansancio e irritaci\u00f3n de garganta. Era relevanteque \u00e9l y varios de sus hermanos compart\u00edan un historial de presunta exposici\u00f3na un paciente de enfermedad por coronavirus 2019 3 semanas antes del cuadro. A la exploraci\u00f3n, ten\u00eda signos de faringitis aguda, conjuntivitisno purulenta, dolor abdominal difuso a la palpaci\u00f3n y un exantemamaculopapular extenso (en las palmas de las manos, rodillas y tobillos), sinafectaci\u00f3n hemodin\u00e1mica o respiratoria. Fue ingresado en laplanta de pediatr\u00eda con presunta escarlatina y luego present\u00f3cefalea y rigidez nucal. Una TAC dio resultados normales,y se realiz\u00f3 una punci\u00f3n lumbar. El l\u00edquido cefalorraqu\u00eddeo mostr\u00f3pleocitosis leve y glucorraquia normal, y fue negativo parapat\u00f3genos bacterianos y v\u00edricos. Cabe se\u00f1alar que 2 frotis nasofar\u00edngeos para SARS-CoV-2 fueron negativos, as\u00ed como un amplio panel de pruebas para enfermedades infecciosas. En su tercer d\u00eda de hospitalizaci\u00f3n, present\u00f3 choque t\u00e9rmico, fue trasladado a la UCI pedi\u00e1trica local y necesit\u00f3intubaci\u00f3n y soporte hemodin\u00e1mico con epinefrina y milrinona. Los resultados anal\u00edticos fueron relevantes por un alto valor de troponina-I(922 ng/L) y un valor desproporcionadamente alto de pro-BNP (> 35.000 pg/mL; l\u00edmite anal\u00edtico). Un ecocardiograma mostr\u00f3 una funci\u00f3n ventricular izquierda sist\u00f3licalevemente reducida, con fracci\u00f3n de expulsi\u00f3n del 50% y una leveInsuficiencia mitral. Las arterias coronarias eran normales. Comoen este momento el cuadro cl\u00ednico era consistente con nefropat\u00eda at\u00edpica,se trat\u00f3 al paciente con inmunoglobulina i.v. y dosis alta de aspirina, y se le traslad\u00f3 ala UCI pedi\u00e1trica de nuestro centro terciario. Durante su estancia, fue intubado y sometido a ventilaci\u00f3n mec\u00e1nica,y necesit\u00f3 dosis variables de apoyo in\u00f3tropo yvasopresor. El ecocardiograma mostr\u00f3 una funci\u00f3n ventricular izquierda sist\u00f3licanormal, con insuficiencia mitral conc\u00e9ntrica moderada y una leve regurgitaci\u00f3n a\u00f3rtica. Las pruebas anal\u00edticas mostraron valor alto de prote\u00edna C-reactiva (24 mg/dL), leve anemia normoc\u00edtica, trombocitopenia lim\u00edtrofe, levealteraci\u00f3n de coagulaci\u00f3n (INR 2,23) con valores normales de fibrin\u00f3geno y valor alto de d\u00edmero D (3573 ng/mL). Los hemocultivos y los panelesv\u00edricos respiratorios fueron negativos en esputo y sangre, con un frotisnasofar\u00edngeo positivo para SARS-CoV-2 y confirmaci\u00f3n serol\u00f3gicade infecci\u00f3n previa por SARS-CoV-2, con IgG e IgA positivas(probadas en suero obtenido antes del tratamiento con IG i.v.). La exploraci\u00f3nreumatol\u00f3gica revel\u00f3 valores muy bajos de factores de complementoC3 y C4 (26 y < 1,68 mg/dL, respectivamente), as\u00ed como anticuerpos antinucleares negativos. El siguiente d\u00eda, el paciente present\u00f3 clono; una RMN cerebral de urgenciay una ARM mostraron focos de siderosis difusos y peque\u00f1os con baja se\u00f1alen la sustancia blanca subcortical de amboshemisferios y el cuerpo calloso. Adem\u00e1s de la afectaci\u00f3n hemodin\u00e1mica, el paciente present\u00f3 s\u00edndrome de dificultad respiratoria aguday peque\u00f1os derrames pleurales bilaterales. Con el diagn\u00f3sticoprovisional de Kawasaki at\u00edpico resistente asociado a SARS-CoV-2,se le trat\u00f3 con una dosis adicional de IG i.v. y una pauta de 5 d\u00edasde metilprednisolona pulsada. Teniendo en cuenta los signos de microhemorragias delSNC, no se inici\u00f3 tratamiento anticoagulante. Durante los siguientes 3 d\u00edas,se resolvieron las alteraciones cardiovasculares y pulmonaresy el paciente fue extubado con \u00e9xito. Neurol\u00f3gicamente, recuper\u00f3 la plenaconciencia y la fuerza general mejor\u00f3 r\u00e1pidamente. Como persist\u00edael dolor abdominal y los v\u00f3mitos, se realiz\u00f3 una TAC abdominalque mostr\u00f3 signos de pancreatitis leve y ascitismoderada. Las pruebas anal\u00edticas adicionales mostraron una disminuci\u00f3ngradual de los valores de troponina I, pro-BNP y marcadores de inflamaci\u00f3n,as\u00ed como un aumento de C3 y C4 hasta los valores normales. En una exploraci\u00f3nde seguimiento 2 semanas despu\u00e9s del alta, el ecocardiograma mostr\u00f3un leve engrosamiento coronario de 3,5 mm, con un peque\u00f1o aneurisma coronarioen la arteria coronaria derecha. La insuficiencia mitral y a\u00f3rtica se hab\u00edan resuelto, y la actividadcard\u00edaca era normal. La exploraci\u00f3n neurol\u00f3gica fue normalexcepto por debilidad muscular general."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 46-year-old staff nurse presented to an emergency doctor on 12 April 2020 with a 24-hour history of a widespread red-raised blanching and itchy rash. Her partner had just recovered from presumed COVID-19 infection; having only had mild symptoms, she was not tested and was back at work. Our patient was on day 13 of self-isolation and was hoping to return to work the following day. She had no fever or continuous cough but did have some nasal congestion. The patient had a history of hay fever, a possible nut allergy and mild asthma. She had not been prescribed any regular medications and had not taken any over-the-counter medications; she had no known allergies to medications. The general practitioner described a classical urticarial rash affecting her upper and lower limbs in addition to her trunk. A diagnosis of probable idiopathic urticaria was suggested and the patient was prescribed fexofenadine hydrochloride 180\u2009mg, to be taken two to four times per day. The following day the rash worsened and was now associated with swelling of her lips and hands; she now felt feverish and had developed a dry cough. She had a slight wheeze but no tongue or throat swelling. She was subsequently assessed by another general practitioner, her temperature was 36\u00b0C, her pulse was 98 beats/min and her oxygen saturation was 98%\u2009on room air. She had a widespread urticarial eruption affecting her face, arms, torso, legs and loins. The general practitioner who examined her diagnosed urticaria, but also documented the possibility of an allergic reaction or a viral illness. Reverse transcriptase PCR test on combined nasopharyngeal/oropharyngeal swabs was positive for SARS-CoV-2, 2 days after first presenting to the emergency doctor. A skin biopsy was not carried out. She was advised to continue taking fexofenadine hydrochloride 180\u2009mg four times per day and she was commenced on prednisolone 40\u2009mg once daily for 3\u2009days. The GP advised self-isolation for 7 days and suggested testing for infection with SARS-CoV-2. Prednisolone helped her lip and hand swelling, but her rash was still itchy and chlorphenamine maleate 4\u2009mg four times per day was subsequently added. The rash resolved completely over the next few days. The patient made a full clinical recovery and did not undergo further PCR testing before resuming her duties.",
        "es": "Una enfermera de 46 a\u00f1os acudi\u00f3 a un m\u00e9dico de urgencias el 12 de abril de 2020 con 24 horas de evoluci\u00f3n de palidez generalizada y exantema pruriginoso. Su pareja acababa de recuperarse de supuesta infecci\u00f3n de COVID-19; con solo s\u00edntomas leves, no se le hizo ninguna prueba y regres\u00f3 al trabajo. Nuestra paciente se hallaba en el d\u00eda 13 de autoconfinamiento y esperaba regresar al trabajo al d\u00eda siguiente. No ten\u00eda fiebre ni tos persistente, pero s\u00ed cierta congesti\u00f3n nasal. La paciente ten\u00eda antecedentes de fiebre del heno, posible alergia a los frutos secos y asma leve. No tomaba ninguna medicaci\u00f3n cr\u00f3nica ni hab\u00eda tomado ning\u00fan medicamento de compra sin receta; no ten\u00eda alergias farmacol\u00f3gicas conocidas. El m\u00e9dico describi\u00f3 un exantema urticarial cl\u00e1sico que afectaba a las extremidades superiores e inferiores as\u00ed como al tronco. Sugiri\u00f3 un diagn\u00f3stico de probable urticaria idiop\u00e1tica y se le recet\u00f3 hidrocloruro de fexofenadina 180 mg, de dos a cuatro veces al d\u00eda. El d\u00eda siguiente, el exantema empeor\u00f3 y se asoci\u00f3 ahora a hinchaz\u00f3n de labios y manos; la paciente se notaba febril y ten\u00eda tos seca. Se apreciaba una leve sibilancia pero no hab\u00eda inflamaci\u00f3n de la lengua o la garganta. Posteriormente, fue evaluada por otro m\u00e9dico; su temperatura era de 36 \u00b0C, el pulso era de 98 l.p.m. y la saturaci\u00f3n de ox\u00edgeno era de 98% en aire ambiental. Ten\u00eda una erupci\u00f3n urticarial generalizada que afectaba al rostro, los brazos, el torso, las piernas y la zona lumbar. El m\u00e9dico diagnostic\u00f3 urticaria, pero tambi\u00e9n se\u00f1al\u00f3 la posibilidad de una reacci\u00f3n al\u00e9rgica o una enfermedad v\u00edrica. Una prueba de RT-PCR a partir de frotis nasofar\u00edngeo/orofar\u00edngeos fue positiva para SARS-CoV-2, 2 d\u00edas despu\u00e9s de la primera visita a urgencias. No se realiz\u00f3 biopsia cut\u00e1nea. Se aconsej\u00f3 a la paciente proseguir el tratamiento con hidrocloruro de fexofenadina 180 mg cuatro veces al d\u00eda y se le a\u00f1adi\u00f3 prednisolona 40 mg una vez al d\u00eda, durante 3 d\u00edas. El m\u00e9dico aconsej\u00f3 autoconfinamiento durante 7 d\u00edas y sugiri\u00f3 una prueba para infecci\u00f3n por SARS-CoV-2. La prednisolona mejor\u00f3 la inflamaci\u00f3n de labios y manos, pero el exantema segu\u00ed siendo pruriginoso y se a\u00f1adi\u00f3 al tratamiento maleato de clorfenamina 4 mg cuatro veces al d\u00eda. El exantema remiti\u00f3 completamente en los d\u00edas siguientes. La paciente se recuper\u00f3 por completo y no se someti\u00f3 a ninguna prueba m\u00e1s de PCR antes de volver a su trabajo."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "57-year-old man with a diagnosis of relapsing-remitting MS since 1996. He started disease-modifying treatment with interferon beta 1-a, which was switched by FNG in 2013 because of the disease\u2019s activity  (i.e.,  persistent clinical and MRI inflammatory activity despite the previous treatment with interferon beta 1-a). The last Expanded Disability Status Scale was 6.0, mainly due to left  hemiparesis. His lymphocyte count in the previous year ranged from 700-900/\u00b5L, and the last MRI in 2019 showed a moderate disease burden, without any clinical and MRI sign of disease activity. The last test before admission showed 500-lymphocytes/\u00b5L. He experienced a fall at home in the first week of March 2020. Since then, he started complaining of back pain at the dorsal-lumbar region that worsened with trunk movements. On March 25, he developed  fever and malaise. He was admitted to thehospital, where a temperature of 38\u00baC (100.4\u00baF) was registered. Neurological examination showed no changes in comparison to the last assessment in the MS Clinic. Blood tests showed elevated C-reactive protein (12.83 mg/dL [normal range: <0.50]) and lymphopenia (500/ \u00b5L). Chest X-ray was unremarkable, but a fracture of the sixth thoracic vertebra was confirmed. The real-time PCR for SARS-CoV-2 from a nasopharyngeal swab was positive, and the patient was started with hydroxychloroquine for 7 days. FNG was maintained, and during the following three weeks, he persisted with intermittent fever, but no respiratory complications (pO2 82 mmHg, pCO2 35 mmHg) and normal chest radiographs. Because of the risk of spinal instability, he underwent back surgery on April 18, without complications. Two days later, FNG was discontinued due to low lymphocyte count (100/\u00b5L). After a week (day 30 since symptom onset), lymphocytes increased (800/\u00b5L), but the patient progressively developed fever (38.5\u00baC) and dyspnea, requiring oxygen via nasal cannula. A new chest X-ray was performed, showing new bilateral infiltrates. C-reactive protein persisted elevated (6.93mg/dL). At this moment, pO2was 70 mmHg, and pCO2 was 36 mmHg. Other infectious etiologies were ruled out, and the PCR for SARS-CoV-2 remained positive. A delayed clinical exacerbation of COVID-19 was the main possibility, and thus, methylprednisolone (80md/day) was prescribed for a week. The patient progressively improved during the following week, he did not require oxygen supplementation anymore but persisted with an abnormal chest radiograph and a positive nasopharyngeal PCR. FNG was restarted after lowering of methylprednisolone, without further complications.",
        "es": "Hombre de 57 a\u00f1os con diagn\u00f3stico de esclerosis m\u00faltiple recidivante desde 1996. Inici\u00f3 el tratamiento de modificadores de la esclerosis m\u00faltiple con interfer\u00f3n beta 1-2, que se reemplaz\u00f3 por FNG en 2013 a causa de la actividad de la enfermedad (actividad inflamatoria persistente cl\u00ednica y en RMN a pesar del tratamiento previo con interfer\u00f3n beta 1-a). La \u00faltima puntuaci\u00f3n en la escala expandida del estado de incapacidad fue de 6,0, b\u00e1sicamente a causa de hemiparesia izquierda. Su cifra de linfocitos en el a\u00f1o anterior estaba entre 700 y 900 por microlitro, y la \u00faltima RMN en 2019 mostr\u00f3 una carga de morbimortalidad moderada, sin signos cl\u00ednicos o de RMN de actividad de la enfermedad. La \u00faltima prueba antes del ingreso dio 500 linfocitos/\u00b5L. Sufri\u00f3 una ca\u00edda en su casa la primera semana de marzo de 2020. Desde entonces, empez\u00f3 a quejarse de dorsalgia en la zona dorsal-lumbar, que se agudizaba al mover el tronco. El 25 de marzo, present\u00f3 fiebre y malestar. Fue ingresado en elhospital, con una temperatura de 38 \u00baC. La exploraci\u00f3n neurol\u00f3gica no apreci\u00f3 cambios respecto a la \u00faltima evaluaci\u00f3n en el consultorio de esclerosis m\u00faltiple. Los an\u00e1lisis de sangre dieron valores altos de prote\u00edna C-reactiva (12,83 mg/dL [intervalo normal: < 0,50]) y linfocitopenia (500/\u00b5L). La radiograf\u00eda tor\u00e1cica fue anodina, pero confirm\u00f3 una fractura de la sexta v\u00e9rtebra tor\u00e1cica. La PCR en tiempo real para SARS-CoV-2 a partir de un frotis nasofar\u00edngeo fue positiva, y se inici\u00f3 tratamiento con hidroxicloroquina durante 7 d\u00edas. Se mantuvo el FNG y durante las tres semanas siguientes continu\u00f3 con fiebre intermitente, pero sin complicaciones respiratorias (pO2 82 mmHg, pCO2 35 mmHg) y radiograf\u00edas tor\u00e1cicas normales. A causa del riesgo de inestabilidad vertebral, se le practic\u00f3 cirug\u00eda dorsal el 18 de abril, sin complicaciones. Dos d\u00edas despu\u00e9s, se interrumpi\u00f3 el FNG a causa de una baja cifra de linfocitos (100/\u00b5L). Despu\u00e9s de una semana (d\u00eda 30 desde el inicio de los s\u00edntomas), los linfocitos aumentaron (800/\u00b5L), pero el paciente present\u00f3 fiebre (38,5 \u00baC) y disnea, que requiri\u00f3 ox\u00edgeno v\u00eda c\u00e1nula nasal. Se realiz\u00f3 una nueva radiograf\u00eda tor\u00e1cica, que mostr\u00f3 infiltrados bilaterales. La prote\u00edna C-reactiva continu\u00f3 elevada (6,93 mg/dL). En ese momento, la pO2era de 70 mmHg y la pCO2 era de 36 mmHg. Se descartaron otras causas infecciosas y la PCR para SARS-CoV-2 continu\u00f3 siendo positiva. Una exacerbaci\u00f3n cl\u00ednica diferida de COVID-19 se plante\u00f3 como principal posibilidad; por tanto, se recet\u00f3 metilprednisolona (80 md/d\u00eda) durante una semana. El paciente mejor\u00f3 progresivamente durante la semana siguiente, no necesit\u00f3 m\u00e1s oxigenoterapia pero continu\u00f3 teniendo radiograf\u00edas tor\u00e1cicas an\u00f3malas y PCR positivas de frotis nasofar\u00edngeo. Se recuper\u00f3 el FNG tras disminuir la metilprednisolona, sin m\u00e1s complicaciones."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 78-years-old man with dyslipidemia was admitted to our Emergency Department with 4\u00a0days of fever and no other symptoms. Clinical examination was normal apart from a temperature of 37.2\u00a0\u00baC. Laboratory tests showed lymphopenia, increased fibrinogen, LDH, and D-Dimer. Chest X-Ray (CXR) showed multilobar interstitial opacities in the right lung. At admission, we started treatment with piperacillin-tazobactam, azithromycin, hydroxychloroquine, methylprednisolone, and enoxaparin at a dose of 60\u00a0mg daily. Forty-eight hours later the patient continued with persistent fever and an increase in oxygen requirements. CXR presented a rapid progression of opacities and a significant increase in acute reactants such as ferritin and IL-6 were detected, so a single dose of 600\u00a0mg of tocilizumab was administered following hospital protocols (severity criteria). On day 5 from admission (9\u00a0days from the onset of the symptoms), the patient presented a clear improvement in the following 72\u00a0h, with a decrease in C-reactive protein (CRP) and ferritin values. Despite an initial decrease, D-Dimer significantly increased to 3570\u00a0\u00b5g/L. A CT-angiography was performed, showing multiple segmental pulmonary embolisms, multilobar pneumonia, and three floating thrombi in the aortic arch and descending aorta. Low weight molecular heparin (LWMH) was started at an anticoagulant dose. We diagnosed no coagulopathy or bleeding events. The patient worsened to severe respiratory failure and died on day 18th from admission to hospital.",
        "es": "Un hombre de 78 a\u00f1os con dislipidemia acudi\u00f3 a nuestro servicio de urgencias tras 4 d\u00edas de fiebre, sin m\u00e1s s\u00edntomas. La exploraci\u00f3n cl\u00ednica fue normal excepto por una temperatura de 37,2 \u00baC. Las pruebas anal\u00edticas mostraron linfocitopenia y aumento de fibrin\u00f3geno, LDH y d\u00edmero D. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades intersticiales multilobulares en el pulm\u00f3n derecho. Al ingreso, se inici\u00f3 tratamiento con piperacilina/tazobactam, azitromicina, hidroxicloroquina, metilprednisolona y enoxaparina a una dosis de 60 mg al d\u00eda. 48 horas despu\u00e9s, el paciente continuaba con fiebre persistente y un aumento de las necesidades de ox\u00edgeno. La radiograf\u00eda tor\u00e1cica mostr\u00f3 un r\u00e1pido progreso de las opacidades y se detect\u00f3 un aumento significativo de reactantes agudos, como ferritina e IL-6, de modo que se administr\u00f3 una dosis \u00fanica de 600 mg de tocilizumab de acuerdo con los protocolos del hospital (criterios de gravedad). El d\u00eda 5 del ingreso (9 d\u00edas desde el inicio de los s\u00edntomas), el paciente presentaba una clara mejora en las \u00faltimas 72 h, con una disminuci\u00f3n de los valores de prote\u00edna C-reactiva y de ferritina. A pesar de una disminuci\u00f3n inicial, el d\u00edmero D aument\u00f3 considerablemente hasta 3570\u00b5g/L. Se practic\u00f3 una angiograf\u00eda por TAC, que mostr\u00f3 m\u00faltiples embolias pulmonares segmentarias, neumon\u00eda multilobular y tres trombos flotantes en el cayado a\u00f3rtico y la aorta descendente. Se inici\u00f3 la administraci\u00f3n de heparina de bajo peso molecular (HBPM) a una dosis anticoagulante. No se diagnostic\u00f3 coagulopat\u00eda ni episodios hemorr\u00e1gicos. El paciente empeor\u00f3 a causa de insuficiencia respiratoria grave y muri\u00f3 el d\u00eda 18 de hospitalizaci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 76-year-old man with hypertension, dyslipidemia, and diabetes mellitus was admitted to our emergency department with fever, asthenia, and pain in the lower back area for the last 2 weeks. Upon arrival, he presented high-temperature, 120 beats per minute, basal oxygen saturation of 87%, and 22 breaths per minute. Laboratory tests showed lymphopenia and increased fibrinogen, D-Dimer, LDH, creatinine, and CRP. CXR revealed uni-lobar opacities in the lower left lobe. At admission, we started treatment with azithromycin, hydroxychloroquine, ceftriaxone, methylprednisolone, and enoxaparin 40\u00a0mg daily. Ninety-six hours later, the patient continued with fever, dyspnea, and tachypnea, requiring high oxygen flow to increase oxygen saturation up to 92%. CRP, D-dimer, ferritin, and IL-6 values increased progressively. CXR presented a worsening with the appearance of multilobar and bilateral opacities, so we increased LMWH dose to 60\u00a0mg daily and a single dose of tocilizumab was administered, with no clinical improvement. On day 11th from admission (day 26 from the onset of the symptoms), the patient presented an abrupt episode of loss of strength in the right body with fall to the ground. The examination showed global aphasia, oculo-cephalic deviation to the left, and right faciobrachiocrural hemiplegia. The unenhanced brain CT (UBCT) showed no evidence of acute hemorrhage, mass effect, or midline shift. We started treatment with intravenous acetylsalicylic acid and reduced the dose of LMW heparin to 40\u00a0mg daily, but no neurological improvement was observed. Forty-eight hours later a new UBCT was performed, showing signs compatible with complete ischemic stroke of the left middle cerebral artery with hyperdense vessel sign in the left intracranial internal carotid artery. We performed an angio-CT of the cerebral arteries and carotids as an extension study of ischemic stroke. It showed complete occlusion of the left internal carotid artery, incidentally, two intraluminal thrombi of 8\u00a0mm each were identified in the ascending aorta. We did not consider fibrinolysis or embolectomy for the hours of the evolution of the symptoms. We increased LMWH dose to anticoagulant doses, and the patient was discharged to a mid-stay center to complete rehabilitation. We intended to maintain anticoagulant treatment for at least 3\u00a0months after the event and decide in a specialized consultation after posterior reevaluation with new clinical, analytical, and imaging information unless the appearance of a major adverse event or new scientific evidence that would establish another management.",
        "es": "Un hombre de 76 a\u00f1os con hipertensi\u00f3n, dislipidemia y diabetes mellitus ingres\u00f3 en nuestro servicio de urgencias con fiebre, astenia y lumbalgia de 2 semanas de evoluci\u00f3n. Al ingreso, presentaba hipertermia, 120 l.p.m., saturaci\u00f3n de ox\u00edgeno de 87% y 22 r.p.m. Las pruebas anal\u00edticas mostraron linfocitopenia y aumento de fibrin\u00f3geno, d\u00edmero D, creatinina y prote\u00edna C-reactiva. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades unilobulares en el l\u00f3bulo inferior izquierdo. Al ingreso, se inici\u00f3 tratamiento con azitromicina, hidroxicloroquina, ceftriaxona, metilprednisolona y enoxaparina a una dosis de 40mg al d\u00eda. 96 horas despu\u00e9s, el paciente continuaba con fiebre, disnea y taquipnea, y requiri\u00f3 oxigenoterapia de alto flujo para aumentar la saturaci\u00f3n de ox\u00edgeno a 92%. Los valores de prote\u00edna C-reactiva, d\u00edmero D, ferritina e IL-6 aumentaron progresivamente. La radiograf\u00eda tor\u00e1cica mostr\u00f3 un empeoramiento con aparici\u00f3n de opacidades bilaterales y multilobulares, de modo que se aument\u00f3 la dosis de HBPM a 60 mg al d\u00eda y se administr\u00f3 una dosis \u00fanica de tocilizumab, sin mejora cl\u00ednica. El d\u00eda 11 de ingreso (d\u00eda 26 desde el inicio de los s\u00edntomas), el paciente present\u00f3 un episodio s\u00fabito de p\u00e9rdida de fuerza muscular en la parte derecha del cuerpo, con ca\u00edda. La exploraci\u00f3n mostr\u00f3 afasia global, desviaci\u00f3n oculocef\u00e1lica hacia la izquierda y hemiplegia faciobraquiofemoral derecha. Una TAC cerebral sin contraste no aport\u00f3 evidencias de hemorragia aguda, efectos tumorales o desplazamiento de la l\u00ednea media. Se inici\u00f3 tratamiento con \u00e1cido acetilsalic\u00edlico i.v. y se redujo de la dosis de HBPM a 40 mg al d\u00eda, pero no se observaron mejoras neurol\u00f3gicas. 48 horas despu\u00e9s, se realiz\u00f3 una nueva TAC cerebral sin contraste, que mostr\u00f3 signos compatibles con ictus isqu\u00e9mico completo de la arteria cerebral media izquierda, con signo de vasos hiperdensos en la arteria car\u00f3tida interna intracraneal izquierda. Se realiz\u00f3 una angiograf\u00eda por TAC de las arterias cerebrales y car\u00f3tidas como estudio complementario del ictus isqu\u00e9mico. Revel\u00f3 oclusi\u00f3n completa de la arteria car\u00f3tida interna izquierda y, fortuitamente, se identificaron dos trombos intraluminales de 8 mm en la aorta ascendente. No se consider\u00f3 fibrin\u00f3lisis ni emboloectom\u00eda por la evoluci\u00f3n de los s\u00edntomas. Se aument\u00f3 la dosis de HBPM a dosis anticoagulantes y el paciente fue dado de alta a un centro de convalecencia para su rehabilitaci\u00f3n completa. La intenci\u00f3n era mantener un tratamiento anticoagulante durante al menos 3 meses tras el episodio y decidir en interconsulta especializada tras reevaluaci\u00f3n posterior con nueva informaci\u00f3n cl\u00ednica, anal\u00edtica y de diagn\u00f3stico por la imagen, excepto por la aparici\u00f3n de alg\u00fan episodio adverso grave o de nuevas pruebas cient\u00edficas que respaldaran otro manejo terap\u00e9utico."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 64-years-old man, a former smoker, with hypertension and severe obstructive sleep apnea syndrome, attended our emergency department because of dry cough, dyspnea, and a high fever for the last 4 days. Clinical examination was normal apart from a temperature of 37.3\u00a0\u00baC. Laboratory tests showed increased fibrinogen, D-Dimer, and CRP. CXR showed uni-lobar interstitial opacities in the right upper lobe. We started treatment with hydroxychloroquine and azithromycin, and the patient was discharged 48\u00a0h later. During ambulatory follow-up, the patient presented CXR with extensive pulmonary opacities, lymphopenia, and a significant increase of CRP, and so he was re-admitted adding to the previous treatment methylprednisolone and a single dose of 600\u00a0mg of tocilizumab (day 4 from the first visit to the emergency department). All the laboratory inflammation markers improved but D-Dimer sharply increased to 4640\u00a0\u00b5g/L, so 7\u00a0days from admission (day 11 from the onset of symptoms), a CT to look for an APE was performed, showing a floating thrombus in the middle segment of the descending thoracic aorta. We started LMWH at an anticoagulant dose. In a control of CT angiography 17 days later, we found no aortic thrombi.",
        "es": "Un hombre de 64 a\u00f1os, exfumador, con hipertensi\u00f3n y s\u00edndrome de apnea del sue\u00f1o obstructiva grave, acudi\u00f3 a nuestro servicio de urgencias con tos seca, disnea e hipertermia de 4 d\u00edas de evoluci\u00f3n. La exploraci\u00f3n cl\u00ednica fue normal excepto por una temperatura de 37,3 \u00baC. Las pruebas anal\u00edticas mostraron aumento de fibrin\u00f3geno, d\u00edmero D y prote\u00edna C-reactiva. La radiograf\u00eda tor\u00e1cica mostr\u00f3 opacidades intersticiales unilobulares en el l\u00f3bulo superior derecho. Iniciamos tratamiento con hidroxicloroquina y azitromicina y el paciente fue dado de alta 48 h despu\u00e9s. Durante el seguimiento ambulatorio, el paciente present\u00f3 radiograf\u00eda tor\u00e1cica con extensas opacidades pulmonares, linfocitopenia y un aumento significativo de prote\u00edna C-reactiva, de modo que fue reingresado y, al tratamiento previo, se a\u00f1adi\u00f3 metilprednisolona y una dosis \u00fanica de 600 mg de tocilizumab (d\u00eda 4 desde la primera visita a urgencias). Todos los marcadores de inflamaci\u00f3n mejoraron, pero el d\u00edmero D aument\u00f3 considerablemente a 4640\u00b5g/L, de modo que 7 d\u00edas despu\u00e9s del ingreso (d\u00eda 11 desde la aparici\u00f3n de s\u00edntomas), se realiz\u00f3 una TAC para buscar edema agudo de pulm\u00f3n (EAP), que mostr\u00f3 un trombo flotante en el segmento medio de la aorta descendente. Se inici\u00f3 tratamiento con HBPM a una dosis antitromb\u00f3tica. En una angiograf\u00eda por TAC de control 17 d\u00edas despu\u00e9s, no se hallaron trombos a\u00f3rticos."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "75-year-old man developed fever, chills, and a productivecough on March 19, 2020. His cardiovascular riskfactors included hypertension, obesity, former smoking,and renal failure. A severe acute respiratory syndrome coronavirus2 test was positive, and home quarantine was advised;however, worsening dyspnea required hospitalization. Besides cough, fever (38.7\u00b0C), and low oxygen saturation(88%, without oxygen), laboratory results revealed elevatedC-reactive protein (82 mg/liter), elevated myoglobin (636 mg/liter), troponin T (high sensitive, 80 ng/liter), andN-terminal proB-type natriuretic peptide (833 ng/liter). Electrocardiogram revealed left anterior fascicular blockand T-wave inversion in lead aVL. Screening tests for other viruses (Adenovirus;Coronaviridae 229E, HKU1, NL63, OC43; HumanBocavirus; Metapneumovirus; Rhinovirus/Enterovirus; Parainfluenza1\u22124) were negative. Severe acute respiratorysyndrome coronavirus 2 infection was reconfirmed in thelaboratory. Because troponin was rising (191 ng/liter), coronaryangiography was performed on March 23, 2020, andepicardial stenosis was excluded, but left ventricular (LV)end-diastolic filling pressure was elevated at 14 mm Hg. Echocardiogram performed on the same day revealed normalLV and right ventricular function with signs of concentricLV remodeling and no regional wall motionabnormality. Cardiac MRI was performed on March 24,2020 for evaluation of possible inflammatory myocardialinjury. Because of dyspnea, the cardiac MRI (Philips 1.5Tesla) examination was performed during free breathingusing mostly single-shot sequences. Normal LV and rightventricular function and no regional wall motion abnormalitieswere noted. No focal fibrosis was detected in late gadoliniumenhancement sequences. Globaledema in T2 weighted images was visible as well as globally elevated T2 (56 ms, referent 48 \u00a7 3ms) and T1(1,090 ms, referent 989 \u00a7 28 ms) mapping times, suggesting acute myocardialinjury. On March 26, 2020, hypoxic respiratoryfailure (saturation of 80%) required mechanical ventilation. The patient improved and was extubated, and thelevel of cardiac biomarkers declined (N-terminal proBtypenatriuretic peptide 631 ng/liter, troponin 61 ng/liter)in due course.",
        "es": "Hombre de 75 a\u00f1os que present\u00f3 fiebre, escalofr\u00edos y tos productivael 19 de marzo de 2020. Sus factores de riesgo cardiovasculareran hipertensi\u00f3n, obesidad, ex-tabaquismoe insuficiencia renal. Una prueba para s\u00edndrome de dificultad respiratoria aguda grave por coronavirus2 fue positiva, y se aconsej\u00f3 cuarentena domiciliaria;sin embargo, una disnea en agravaci\u00f3n requiri\u00f3 hospitalizaci\u00f3n. Adem\u00e1s de tos, fiebre (38,7 \u00b0C) y baja saturaci\u00f3n de ox\u00edgeno(88% sin ox\u00edgeno), las pruebas anal\u00edticas mostraron valores elevados deprote\u00edna C-reactiva (82 mg/m), mioglobina (636 mg/l), troponina T (ultrasensible, 80 ng/l) yprohormona N-terminal del p\u00e9ptido natriur\u00e9tico cerebral (833 ng/l). El electrocardiograma revel\u00f3 bloqueo fascicular anterior izquierdoe inversi\u00f3n de la onda T en derivaci\u00f3n aVL. Las pruebas para otros virus (adenovirus;Coronaviridae 229E, HKU1, NL63, OC43; bocavirushumano; metaneumovirus; rinovirus/enterovirus; paragripal1\u22124) fueron negativas. El s\u00edndrome de dificultad respiratoria aguda grave por coronavirus2 fue reconfirmado en el laboratorio. Como la troponina estaba aumentando (191 ng/l), se realiz\u00f3una angiograf\u00eda coronaria el 23 de marzo de 2020, en la quese descart\u00f3 estenosis epic\u00e1rdica, pero la presi\u00f3n de llenado telediast\u00f3licadel ventr\u00edculo izquierdo (VI) era alta, con 14 mmHg. Un ecocardiograma realizado el mismo d\u00eda revel\u00f3 actividad normaldel VI y del VD, con signos de remodelaci\u00f3n conc\u00e9ntricadel VI y sin anomal\u00edas del movimientoparietal. El 24 de marzo de 2020 se realiz\u00f3 una RMN card\u00edaca para evaluar posible lesi\u00f3n mioc\u00e1rdicainflamatoria. A causa de la disnea, la RMN card\u00edaca (Philips 1,5Tesla) se realiz\u00f3 en respiraci\u00f3n libreempleando b\u00e1sicamente secuencias de una sola toma. Se apreci\u00f3 actividad normal del VI y del VD,sin anomal\u00edas en el movimiento parietal regional. No se detect\u00f3 fibrosis focal con secuencias de realcetard\u00edo con gadolinio. En las im\u00e1genesponderadas en T2 se apreciaba un edema global as\u00ed como valores elevados de T2 (56 ms, referencia 48 \u00a7 3ms) y T1(1.090 ms, referencia 989 \u00a7 28 ms), lo que suger\u00eda lesi\u00f3n mioc\u00e1rdicaaguda. El 26 de marzo de 2020, un episodio de insuficienciarespiratoria hipox\u00e9mica (saturaci\u00f3n 80%) requiri\u00f3 ventilaci\u00f3n mec\u00e1nica. El paciente mejor\u00f3 y fue extubado; los valores de los biomarcadorescard\u00edacos disminuyeron (prohormona N- terminal del p\u00e9ptido natriur\u00e9tico cerebral631 ng/l, troponina 61 ng/l)progresivamente."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 51-year-old man without personal or family history of neurological disease was hospitalised after 10 days of fever and cough. COVID-19 was diagnosed by reverse-transcriptase PCR on nasal swab and bilateral ground-glass opacities on thoracic CT scan. At day 12, he was admitted in intensive care unit (ICU) for non-invasive ventilation. The result of the neurological examination was normal. At day 21, while the patient had been weaned off oxygen, he became unresponsive and rapidly comatose (Glasgow Coma Scale 6: E1, V1, M4) with a disconjugated gaze. The patient was groaning and showing rhythmic movements of the right upper limb. An urgent brain MRI, including diffusion-weighted imaging (DWI) and MR angiogram, ruled out vertebrobasilar ischaemic stroke; gradient echo T2*-weighted images excluded haemorrhage and thrombus in the venous system. It revealed only subtle hyperintensities in bilateral thalami on FLAIR sequence. Consciousness impairment required tracheal intubation. He was hyperthermic (39\u00b0C) without shock. Blood and cerebrospinal fluid (CSF) samples revealed thrombopenia and lymphopenia, mild inflammatory response (C reactive protein, ferritin and fibrinogen), CSF albumin-cytological dissociation with increased CSF IgG antibodies (91.9\u2009mg/L, normal 10\u201330\u2009mg/L) and altered blood\u2013brain barrier integrity (CSF/serum albumin index=17.3, normal <6.5). An electroencephalogram revealed symmetrical background activity of low-voltage delta waves without spatial organisation, triphasic waves or paroxysmal activity. He showed unresponsive coma (Glasgow Coma Scale=3), pyramidal syndrome, right-sided sixth nerve palsy and no corneal reflex. A second brain contrast-enhanced MRI at day 22 revealed progressing lesions with diffuse hyperintense lesions in the thalami, cerebellum, brainstem, supratentorial grey and white matters on FLAIR images without gadolinium-enhanced lesions. At this time, the patient no longer had respiratory viral excretion (two negative RT-PCR at 48-hour interval on tracheal aspirations). A second CSF sampling revealed no meningitic cytological pattern and PCR results were negative for SARS-CoV-2 and other common viruses. Anti-ganglioside autoantibodies were not found in patient\u2019s serum (immunodot anti-ganglioside 5003; GA Generic Assays, Dahlewitz, Germany) and autoantibodies against myelin oligodendrocyte glycoprotein were not found in serum and CSF (cell-based assay, FA 1156-1003-50; EuroImmun, L\u00fcbeck, Germany). Anti-neuronal autoantibodies against intracellular (immunodot PNS9DIV-24; Ravo, Freiburg, Germany) and surface (cell-based assays: NMDAR, AMPAR, GABAbR, AMPA1/2, Caspr2, Lgi1, DPPX, FA 112d-1003-6; EuroImmun) neuronal antigens were negative in serum and CSF. Indirect immunofluorescence (performed by the immunological laboratory) revealed a specific and atypical IgG staining on monkey cerebellum slices (Ref 504225; Inova Diagnostic, San Diego, USA) and on rat hippocampal slices (EuroImmun). No specific staining was observed on other tissues (rat stomach, kidney and liver and on HeLa cells). On monkey cerebellum (data not shown), a staining around Purkinje cells, evoking basket cells, was associated with an unusual but weak staining of fibres in the inner part of the molecular layer. The granule cell layer and the rest of the molecular layer were not stained. On rat hippocampal slices, an unusual and strong staining was observed in the fibre tracts. Hippocampal structure was completely negative as well as some areas of this fibre tract adjacent to the hippocampus Ammon\u2019s horn. However, other regions of the fibre network, as ventral hippocampal commissure, the brachium of the colliculus and the stria medullaris, seemed strongly stained. High-dose methylprednisolone (1\u2009g.day\u22121 for 3 days) and intravenous polyvalent immunoglobulins (total dose: 2\u2009g.kg-1 over 5 days) were initiated at day 22. A new MRI at day 25 showed stable lesions, except for a restriction in apparent diffusion coefficient in both thalami and supratentorial white matter. Bilateral and symmetrical distribution of such lesions with a delayed onset of restricted diffusion allowed us to rule out stroke, but rather suggested an evolution towards necrosis. Neurological status improved, allowing weaning from mechanical ventilation after 5 days of treatment and discharge from ICU at day 29. The patient showed complete motor recovery. Comprehension was initially limited to simple motor commands. Verbal stereotypes and perseverations were observed at day 26. At day 35, a new MRI showed a significant improvement of previously observed brain lesions while clinical examination revealed fatigue, memory and attentional impairment.",
        "es": "Un hombre de 51 a\u00f1os sin antecedentes personales o familiares de trastornos neurol\u00f3gicos fue hospitalizado tras 10 d\u00edas de fiebre y tos. Se diagnostic\u00f3 COVID-19 mediante RT-PCR de un frotis nasal y a partir de opacidades de vidrio esmerilado en una TAC tor\u00e1cica. El d\u00eda 12, fue ingresado en la UCI para aplicar ventilaci\u00f3n no invasiva. La exploraci\u00f3n neurol\u00f3gica inicial fue normal. El d\u00eda 21, habi\u00e9ndole retirado el ox\u00edgeno, se volvi\u00f3 arreactivo y r\u00e1pidamente comatoso (escala de coma de Glasgow 6: E1, V1, M4) con mirada no conjugada. El paciente gem\u00eda y presentaba movimientos r\u00edtmicos de la extremidad superior derecha. Una RMN de urgencia, ponderada por difusi\u00f3n, y una angiograf\u00eda por resonancia magn\u00e9tica descartaron ictus isqu\u00e9mico vertebrobasal; las im\u00e1genes ponderadas en T2* en eco de gradiente excluyeron hemorragia y trombos en el sistema venoso. Solo se apreciaron unas ligeras hiperintensidades en los t\u00e1lamos en secuencia FLAIR. La disminuci\u00f3n de la conciencia requiri\u00f3 intubaci\u00f3n traqueal. El paciente se hallaba hipert\u00e9rmico (39 \u00b0C) sin choque. Las muestras de sangre y de l\u00edquido cefalorraqu\u00eddeo (LCR) revelaron trombocitopenia y linfocitopenia, leve respuesta inflamatoria (prote\u00edna C-reactiva, ferritina y fibrin\u00f3geno), disociaci\u00f3n albumino-citol\u00f3gica del LCR con un aumento de anticuerpos IgG (91,9\u2009mg/L, normal 10\u201330\u2009mg/L) y alteraci\u00f3n de la integridad de la barrera hematoencef\u00e1lica (\u00edndice LCR/alb\u00famina s\u00e9rica = 17,3, normal < 6,5). Un electroencefalograma revel\u00f3 actividad de fondo sim\u00e9trica de ondas delta de bajo voltaje sin organizaci\u00f3n espacial y ondas trif\u00e1sicas de actividad parox\u00edstica. El paciente mostr\u00f3 coma arreactivo (escala de coma de Glasgow = 3), s\u00edndrome piramidal, par\u00e1lisis del VI par craneal y ausencia de reflejo corneal. Una segunda RMN con contraste el d\u00eda 22 revel\u00f3 avance de las lesiones con lesiones hiperintensas difusas en el t\u00e1lamo, cerebelo, mesenc\u00e9falo y sustancia gris y blanca tentorial en im\u00e1genes FLAIR, pero sin lesiones con realce de gadolinio. En ese momento, el paciente no presentaba eliminaci\u00f3n v\u00edrica respiratoria (dos RT-PCR negativas en un intervalo de 48 horas a partir de aspirado traqueal). Una segunda muestra de LCR revel\u00f3 ausencia de patrones citol\u00f3gicos mening\u00edticos y los resultados de la PCR fueron negativos para SARS-CoV-2 y otros virus habituales. No se hallaron anticuerpos antigangli\u00f3sidos en el suero del paciente (inmunotransferencia 5003; GA Generic Assays, Dahlewitz, Alemania) as\u00ed como tampoco autoanticuerpos contra glucoprote\u00edna de la mielina oligodendroc\u00edtica en suero ni en el LCR (ensayo celular, FA 1156-1003-50; EuroImmun, L\u00fcbeck, Alemania). Los anticuerpos antineuronales contra ant\u00edgenos neuronales intracelulares (inmunotransferencia PNS9DIV-24; Ravo, Freiburg, Alemania) y superficiales (ensayo celular: NMDAR, AMPAR, GABAbR, AMPA1/2, Caspr2, Lgi1, DPPX, FA 112d-1003-6; EuroImmun) fueron negativos en suero y LCR. La inmunofluorescencia indirecta (realizada en el laboratorio de inmunolog\u00eda) revel\u00f3 una tinci\u00f3n at\u00edpica y espec\u00edfica de IgG en cortes de cerebelo de mono (Ref 504225; Inova Diagnostic, San Diego, Estados Unidos) y en cortes hipoc\u00e1mpicos de rata (EuroImmun). No se observ\u00f3 tinci\u00f3n espec\u00edfica en otros tejidos (est\u00f3mago, ri\u00f1\u00f3n e h\u00edgado de rata y c\u00e9lulas HeLa). En cerebelo de mono, una tinci\u00f3n alrededor de c\u00e9lulas de Purkinje, similar a neuronas en cesta, se asoci\u00f3 a una tinci\u00f3n d\u00e9bil pero inusual de fibras en la parte interna de la capa molecular. La capa de c\u00e9lulas granulares y el resto de la capa molecular no estaban te\u00f1idas. En c\u00e9lulas hipoc\u00e1mpicas de rata, se observ\u00f3 una tinci\u00f3n fuerte e inusual en los fasc\u00edculos. La estructura hipoc\u00e1mpica era totalmente negativa, as\u00ed como algunas \u00e1reas de este fasc\u00edculo adyacente al asta de Am\u00f3n. Sin embargo, otras regiones de los fasc\u00edculos, como el surco hipoc\u00e1mpico ventral, el brazo del col\u00edculo y la estr\u00eda medular, parec\u00edan fuertemente te\u00f1idas. Se inici\u00f3 tratamiento con dosis alta de metilprednisolona (1\u2009g.d\u00eda\u22121 durante 3 d\u00edas) e inmunoglobulinas polivalentes i.v. (dosis total: 2\u2009g.kg-1 durante 5 d\u00edas) el d\u00eda 22. Una nueva RMN el d\u00eda 25 mostr\u00f3 lesiones estables, excepto por una restricci\u00f3n en el coeficiente de difusi\u00f3n aparente en ambos t\u00e1lamos y la sustancia blanca supratentorial. La distribuci\u00f3n bilateral y sim\u00e9trica de estas lesiones, con un inicio diferido de difusi\u00f3n restringida, nos permiti\u00f3 descartar un ictus, y suger\u00eda m\u00e1s bien una evoluci\u00f3n hacia necrosis. El estado neurol\u00f3gico mejor\u00f3, lo que permiti\u00f3 retirar la ventilaci\u00f3n mec\u00e1nica tras 5 d\u00edas de tratamiento; el paciente sali\u00f3 de la UCI el d\u00eda 29. Mostr\u00f3 una recuperaci\u00f3n motriz completa. La comprensi\u00f3n verbal se limitaba inicialmente a \u00f3rdenes motrices simples. El d\u00eda 26 se observaron perseveraciones y estereotipos verbales. El d\u00eda 35, una nueva RMN mostr\u00f3 una mejora significativa de las lesiones cerebrales observadas previamente, mientras que la exploraci\u00f3n cl\u00ednica mostr\u00f3 fatiga y deficiencias de memoria y de atenci\u00f3n."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "A 15-year-old boy experienced frontal headaches with retro-orbital pain accompanied by fever and intense sweating. By 5th May, the adolescent reported emetic episodes, weakness and pain in the lower limbs, which ascended to his upper limbs. On 8th May, with no history of previous surgeries or hospitalizations, and no recent vaccinations reported, he was admitted to a local pediatric hospital. A COVID-19 rapid test was performed and showed a positive result for IgG and IgM. The initial blood tests and cerebral spinal fluid (CSF) analysis (cytometry, biochemistry) and CSF aerobic culture performed on admission revealed no abnormalities. The patient was initially treated with methylprednisolone, azithromycin, albendazole and, 3 days later, was transferred to the reference hospital COVID in the Amazon State, Brazil. On admission to our hospital, the adolescent was in good general condition with no respiratory symptoms. The neurologic examination revealed normal consciousness and speech, normal cranial nerve function, progressive symmetrical limb weakness (Medical Research Council score 3/5 for the upper limbs and 2/5 for the lower limbs), absent deep tendon reflexes, normal plantar response and no sensory loss. Nasopharyngeal swabs analysed using polymerase chain reaction (PCR) tested negative for influenza and positive for SARS-CoV-2. Another cytometric and biochemical CSF analysis, approximately 2\u2009weeks following the initial unspecific symptoms, presented results inside the normal parameters. PCR testing of the CSF was negative for the most prevalent etiologies (including Herpesvirus HSV1, HSV2, CMV, EBV, VZV; Zika virus; Dengue virus and Chikungunya virus), as well as for SARS-CoV-2. The chest tomography and the cranial, thoracic and lumbar spine magnetic resonance imaging (MRI) revealed no abnormalities. Blood tests, including blood count, serum glucose, C-reactive protein, electrolytes, kidney function and liver enzymes were within normal range. The serology for hepatitis B and C, human immunodeficiency virus and Venereal Disease Research Laboratory tests were negative. Electroneurography revealed normal sensory nerve action potential, though severe reduction of the nerve compound muscle action potential amplitude in all motor nerves studied, with relatively preserved conduction velocities. F waves were absent in the studied nerves. These abnormalities are therefore compatible with the acute motor axonal neuropathy (AMAN) variant of GBS. Given the patient\u2019s clinical history of a rapidly progressive symmetrical weakness with supporting electroneurography findings, a recent SARS-CoV-2 infection confirmed through the PCR test, negative microbiologic results for other etiologies in CSF and normal MRI, a diagnosis of GBS associated with COVID-19 was made. On 15th May, the patient was started on 400\u2009mg/kg/day of intravenous immune globulin (IVIG) therapy for a planned 5 days course. Despite some improvement after IVIG therapy, weakness in the upper and lower extremities persisted, however, and he is currently undergoing motor physiotherapy.",
        "es": "Adolescente de 15 a\u00f1os con cefalea frontal con dolor retroorbital, fiebre y sudoraci\u00f3n intensa. El 5 de mayo, el paciente report\u00f3 episodios em\u00e9ticos, debilidad y dolor en las extremidades inferiores, que progres\u00f3 hacia sus extremidades superiores. El 8 de mayo, sin antecedentes de cirug\u00eda ni de hospitalizaci\u00f3n, y sin vacunaci\u00f3n reciente, fue ingresado en un hospital pedi\u00e1trico local. Una prueba r\u00e1pida de COVID-19 dio resultado positivo para IgG e IgM. Los an\u00e1lisis de sangre y de l\u00edquido cefalorraqu\u00eddeo (LCR) iniciales (citometr\u00eda, bioqu\u00edmica) y cultivos aer\u00f3bicos de LCR realizados al ingreso no revelaron anomal\u00edas. El paciente fue tratado inicialmente con metilprednisolona, azitromicina, albendazol y, 3 d\u00edas despu\u00e9s, fue trasladado al hospital de referencia de COVID en el estado de Amazonas, Brasil. Al ingreso en el hospital, el paciente estaba en buen estado general, sin s\u00edntomas respiratorios. La exploraci\u00f3n neurol\u00f3gica mostr\u00f3 conciencia y habla normales, actividad normal de los pares craneales, debilidad sim\u00e9trica progresiva de las extremidades (puntuaci\u00f3n del Medical Research Council 3/5 para las superiores y 2/5 para las inferiores), ausencia de reflejos osteotendinosos, signo de Babinski normal y sin p\u00e9rdida sensorial. Los frotis nasofar\u00edngeo analizados mediante PCR dieron negativo para gripe y positivo para SARS-CoV-2. Otro an\u00e1lisis citom\u00e9trico y bioqu\u00edmico de LCR, unas 2 semanas despu\u00e9s de los s\u00edntomas iniciales inespec\u00edficos, dio resultados dentro de los par\u00e1metros normales. La PCR del LCR fue negativa para los virus m\u00e1s habituales (herpes 1, herpes 2, citomegalovirus, Epstein-Barr, varicela z\u00f3ster, zika, dengue y chikungunya), as\u00ed como para SARS-CoV-2. Una TAC tor\u00e1cica y craneal y una RMN tor\u00e1cica, craneal y lumbar no revel\u00f3 anomal\u00edas. Los an\u00e1lisis de sangre, con hemograma completo, glucosa s\u00e9rica, prote\u00edna C-reactiva, electrolitos, funci\u00f3n renal y enzimas hep\u00e1ticas estaban dentro de los l\u00edmites normales. La serolog\u00eda para hepatitis B y C, VIH y las pruebas para enfermedades ven\u00e9reas fueron negativos. Un electroneurograma revel\u00f3 potenciales de acci\u00f3n sensoriales normales, aunque con una gran reducci\u00f3n de la amplitud de los potenciales de acci\u00f3n en todos los nervios motores estudiados, con velocidades de conducci\u00f3n relativamente preservadas. Las ondas F estaban ausentes en todos los nervios estudiados. Estas anomal\u00edas son compatibles con la neuropat\u00eda ax\u00f3nica motora aguda del SGB. Dados los antecedentes cl\u00ednicos del paciente de una debilidad sim\u00e9trica progresiva, con respaldo de los resultados del electroneurograma, reciente infecci\u00f3n por SARS-CoV-2 confirmada por PCR, resultados microbiol\u00f3gicos negativos para otras causas en LCR y RMN normales, se diagnostic\u00f3 SGB asociado a COVID-19. El 15 de mayo, el paciente inici\u00f3 un tratamiento de 400 mg/kg/d\u00eda de inmunoglobulina i.v. en una pauta de 5 d\u00edas. A pesar de una cierta mejora tras la terapia con IG, la debilidad en las extremidades superiores e inferiores persisti\u00f3 y, en estos momentos, el paciente est\u00e1 en fisioterapia."
    },
    {
        "file_name": "32644205.en-checkpoint.txt",
        "en": "29-year-old woman with a medical history of gastric by-pass one year earlier and family history of diabetes (aunts with type 2 diabetes; a cousin with type 1 diabetes diagnosed at the age of 7\u00a0years). She presented two months earlier (20 March 2020) severe asthenia, fever, stiffness and dyspnea. Then, she presented anosmia and ageusia, with anorexia (25 march). She was admitted at the emergency department, symptomatic treatment was delivered for a suspected COVID-19 infection, and she was discharged (glycemia was normal at this time). Two weeks after, she did no longer have any symptoms. But one month after her first symptoms of COVID-19 (24 April), she presented acute polyuria\u2013polydipsia syndrome. Diabetes mellitus was diagnosed (12 may) with a glycemia of 3.7\u00a0g/l (20.5\u00a0mmol/l), non-significant ketosis (0.7\u00a0mmol/l) and normal bicarbonate level (26\u00a0mmol/l). HbA1c level was 11.8% (105\u00a0mmol/mol). Her weight was 120\u00a0kg before gastric by-pass, 65\u00a0kg before COVID-19 and 57\u00a0kg (BMI of 21.5\u00a0kg/m2) at diabetes diagnosis. The diabetes was immediately insulin requiring, and she was treated with basal bolus regimen. She did not present metabolic comorbidities and markers (no hypertension, negative CRP (<\u20090.6\u00a0mg/l, Hdlc 0.46\u00a0g/l, Ldlc 0.43\u00a0g/l, triglycerides 0.42\u00a0g/l, normal ALT, AST, gGT and ferritin levels, no liver steatosis at the CT scan). Lipase and TSH levels were normal; pancreatic CT scan was normal. C-peptide was low at 0.07\u00a0pmol/ml (normal values between 0.37 and 1.47). Autoantibodies against pancreatic beta cells were tested, and finally, glutamic acid decarboxylase-65 autoantibodies (GAD-65A) were positive (93UI/ml, N\u2009<\u200917) in favor of immune-mediated type 1 diabetes, whereas tyrosine phosphatase IA2 antibodies (IA2A) and zinc transporter 8 antibodies (ZnT8A) were negative. SARS-CoV2 serology was positive, confirming previous COVID-19 infection.",
        "es": "Mujer de 29 a\u00f1os con antecedentes de bypass g\u00e1strico un a\u00f1o antes e historia familiar de diabetes (t\u00edas con diabetes de tipo 2; un primo con diabetes de tipo 1 diagnosticada a los 7 a\u00f1os de edad). Se present\u00f3 dos meses antes (20 de marzo de 2020) con astenia grave, fiebre, rigidez y disnea. Luego present\u00f3 anosmia y ageusia, con anorexia (25 de marzo). Fue ingresada en el servicio de urgencias y se inici\u00f3 tratamiento sintom\u00e1tico por presunta infecci\u00f3n por COVID-19 y fue dada de alta (la glucemia era normal). Dos semanas despu\u00e9s, ya no ten\u00eda s\u00edntomas. Sin embargo, un mes despu\u00e9s de sus primeros s\u00edntomas de COVID-19 (24 de abril), present\u00f3 poliuria-polidipsia agudo. Se diagnostic\u00f3 diabetes mellitus (12 de mayo) con una glucemia de 3,7 g/l (20,5 mmol/l), cetosis no significativa (0,7 mmol/l) y valor normal de bicarbonato (26 mmol/l). El valor de HbA1c era 1,8% (105 mmol/mol). Su peso era de 120 kg antes del bypass g\u00e1strico y de 65 kg antes de COVID-19 y de 57 kg (IMC de 21,5kg/m2) en el momento del diagn\u00f3stico de diabetes. La diabetes requiri\u00f3 insulina inmediatamente, y fue tratada con una pauta de bolo basal. No presentaba comorbilidades metab\u00f3licas y los marcadores eran normales (no hipertensi\u00f3n, prote\u00edna C-reactiva negativa (<\u20090,6mg/l, Hdlc 0,46g/l, Ldlc 0,43g/l, triglic\u00e9ridos 0,42g/l, ALT, AST, gGT y ferritina normales, sin esteatosis hep\u00e1tica en la TAC). Los valores de lipasa y TSH eran normales; la TAC pancre\u00e1tica fue normal. El p\u00e9ptido C era bajo con 0,07 pmol/ml (valores normales entre 0,37 y 1,47). Se comprobaron anticuerpos contra c\u00e9lulas beta pancre\u00e1ticas y, finalmente, fueron positivos autoanticuerpos anti-descarboxilasa-65 del \u00e1cido glut\u00e1mico (GAD-65A, 93 IU/ml, N\u2009<\u200917) a favor de diabetes de tipo 1 inmunitaria, mientras que los anticuerpos anti-tirosina fosfatasa IA2 y anti-transportador de zinc-8 fueron negativos. La serolog\u00eda de SARS-CoV-2 fue positiva, confirmando la infecci\u00f3n por COVID-19."
    }
]